0001493152-22-028254.txt : 20221012 0001493152-22-028254.hdr.sgml : 20221012 20221012160656 ACCESSION NUMBER: 0001493152-22-028254 CONFORMED SUBMISSION TYPE: 10-K PUBLIC DOCUMENT COUNT: 126 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20221012 DATE AS OF CHANGE: 20221012 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SRAX, Inc. CENTRAL INDEX KEY: 0001538217 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ADVERTISING AGENCIES [7311] IRS NUMBER: 452925231 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-37916 FILM NUMBER: 221306927 BUSINESS ADDRESS: STREET 1: 2629 TOWNSGATE ROAD #215 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 BUSINESS PHONE: 323-694-9800 MAIL ADDRESS: STREET 1: 2629 TOWNSGATE ROAD #215 CITY: WESTLAKE VILLAGE STATE: CA ZIP: 91361 FORMER COMPANY: FORMER CONFORMED NAME: SOCIAL REALITY, Inc. DATE OF NAME CHANGE: 20131112 FORMER COMPANY: FORMER CONFORMED NAME: SOCIAL REALITY DATE OF NAME CHANGE: 20111227 10-K 1 form10-k.htm
0001538217 false FY P7Y 0001538217 2021-01-01 2021-12-31 0001538217 2021-06-30 0001538217 2022-09-23 0001538217 2021-12-31 0001538217 2020-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001538217 SRAX:ClassACommonStockMember 2021-12-31 0001538217 SRAX:ClassACommonStockMember 2020-12-31 0001538217 2020-01-01 2020-12-31 0001538217 us-gaap:CommonStockMember 2019-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001538217 us-gaap:RetainedEarningsMember 2019-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2019-12-31 0001538217 2019-12-31 0001538217 us-gaap:CommonStockMember 2020-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001538217 us-gaap:RetainedEarningsMember 2020-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2020-12-31 0001538217 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001538217 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001538217 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001538217 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001538217 us-gaap:CommonStockMember 2021-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001538217 us-gaap:RetainedEarningsMember 2021-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2021-12-31 0001538217 us-gaap:CustomerConcentrationRiskMember us-gaap:AccountsReceivableMember SRAX:CustomerOneMember 2021-01-01 2021-12-31 0001538217 us-gaap:CustomerConcentrationRiskMember SRAX:CustomerOneMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001538217 us-gaap:CustomerConcentrationRiskMember SRAX:CustomerTwoMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001538217 us-gaap:CustomerConcentrationRiskMember SRAX:CustomerThreeMember us-gaap:AccountsReceivableMember 2020-01-01 2020-12-31 0001538217 us-gaap:CustomerConcentrationRiskMember SRAX:RevenueMember us-gaap:SalesRevenueNetMember 2020-01-01 2020-12-31 0001538217 SRAX:BritePoolIncMember 2021-12-28 2021-12-29 0001538217 SRAX:BritePoolIncMember SRAX:SeriesDConvertiblePreferredStockMember 2021-12-28 2021-12-29 0001538217 SRAX:SeriesDConvertiblePreferredStockMember 2021-12-28 2021-12-29 0001538217 us-gaap:CommonStockMember 2021-12-28 2021-12-29 0001538217 SRAX:SeriesDConvertiblePreferredStockAndCommonStockMember 2021-12-28 2021-12-29 0001538217 2021-12-28 2021-12-29 0001538217 SRAX:BIGTokensMember 2021-12-29 0001538217 SRAX:BIGTokensMember 2021-12-28 2021-12-29 0001538217 2021-12-29 0001538217 SRAX:LDMicroIncMember 2020-09-14 2020-09-15 0001538217 SRAX:LDMicroIncMember 2020-09-13 2020-09-15 0001538217 SRAX:LDMicroIncMember 2020-12-30 2021-01-02 0001538217 SRAX:LDMicroIncMember SRAX:ForecastMember 2021-03-30 2021-04-01 0001538217 SRAX:LDMicroIncMember SRAX:ForecastMember 2021-06-29 2021-07-01 0001538217 SRAX:LDMicroIncMember SRAX:ClassACommonStockMember 2020-09-13 2020-09-15 0001538217 SRAX:LDMicroIncMember 2021-01-01 2021-12-31 0001538217 SRAX:NoncompeteMember 2020-01-01 2020-12-31 0001538217 SRAX:CustomerListMember 2020-01-01 2020-12-31 0001538217 SRAX:LDMicroIncMember 2020-09-15 0001538217 SRAX:TrademarkMember 2020-09-15 0001538217 SRAX:TrademarkMember 2020-09-13 2020-09-15 0001538217 SRAX:DomainNameMember 2020-09-15 0001538217 SRAX:DomainNameMember 2020-09-13 2020-09-15 0001538217 SRAX:NoncompeteMember 2020-09-15 0001538217 SRAX:NoncompeteMember 2020-09-13 2020-09-15 0001538217 SRAX:CustomerListMember 2020-09-15 0001538217 SRAX:CustomerListMember 2020-09-13 2020-09-15 0001538217 2020-09-15 0001538217 SRAX:LDMicroIncMember 2020-01-01 2020-12-31 0001538217 SRAX:ProFormaAdjustmentMember 2020-01-01 2020-12-31 0001538217 SRAX:ProFormaCombinedMember 2020-01-01 2020-12-31 0001538217 us-gaap:ScenarioAdjustmentMember 2020-01-01 2020-12-31 0001538217 2020-01-22 0001538217 2020-01-30 0001538217 2020-01-20 2020-01-22 0001538217 2020-01-28 2020-01-30 0001538217 SRAX:AgreementsToSellAccountsReceivableMember 2020-03-22 2020-03-24 0001538217 SRAX:TenPercentMember 2021-01-01 2021-12-31 0001538217 SRAX:TwentyPercentMember 2021-01-01 2021-12-31 0001538217 SRAX:ThirtySixPercentMember 2021-01-01 2021-12-31 0001538217 us-gaap:CommonClassAMember 2020-01-20 2020-01-22 0001538217 us-gaap:CommonClassAMember 2020-01-28 2020-01-30 0001538217 SRAX:AgreementsToSellAccountsReceivableAmmendedMember 2020-04-08 2020-04-09 0001538217 SRAX:AgreementsToSellAccountsReceivableAmmendedMember 2020-01-20 2020-01-22 0001538217 SRAX:AgreementsToSellAccountsReceivableAmmendedMember 2020-01-28 2020-01-30 0001538217 us-gaap:AccountsPayableMember 2020-06-28 2020-06-30 0001538217 us-gaap:AccruedLiabilitiesMember 2020-06-28 2020-06-30 0001538217 SRAX:DebenturesMember 2020-06-28 2020-06-30 0001538217 SRAX:DebenturesMember 2020-06-30 0001538217 SRAX:PIPETechnologiesMember 2020-01-01 2020-12-31 0001538217 SRAX:PIPETechnologiesMember 2021-12-31 0001538217 SRAX:PIPETechnologiesMember 2021-01-01 2021-12-31 0001538217 2021-12-27 2021-12-31 0001538217 SRAX:ReceivablePurchaseAndSaleAgreementMember SRAX:BIGtokenMember 2021-10-29 0001538217 SRAX:ReceivablePurchaseAndSaleAgreementMember SRAX:BIGtokenMember 2021-10-28 2021-10-29 0001538217 SRAX:ReceivablePurchaseAndSaleAgreementMember SRAX:BIGtokenMember 2021-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2020-12-31 0001538217 us-gaap:PreferredStockMember 2020-12-31 0001538217 us-gaap:WarrantMember 2020-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2021-01-01 2021-12-31 0001538217 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2021-12-31 0001538217 us-gaap:PreferredStockMember 2021-12-31 0001538217 us-gaap:WarrantMember 2021-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2019-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2020-01-01 2020-12-31 0001538217 SRAX:DesignatedAssetsMember 2021-12-31 0001538217 SRAX:DesignatedAssetsMember 2021-09-20 0001538217 SRAX:DesignatedAssetsMember 2021-09-21 2021-12-31 0001538217 SRAX:DesignatedAssetsMember 2021-01-01 2021-12-31 0001538217 SRAX:HaylardMDLLCMember 2020-10-30 0001538217 SRAX:HaylardMDLLCMember 2020-10-29 2020-10-30 0001538217 SRAX:HaylardMDLLCMember srt:MaximumMember 2020-10-29 2020-10-30 0001538217 SRAX:MDCoInvestLLCMember 2020-10-30 0001538217 SRAX:MDCoInvestLLCMember 2020-10-29 2020-10-30 0001538217 SRAX:MDCoInvestLLCMember srt:MaximumMember 2020-10-29 2020-10-30 0001538217 SRAX:RatedCorporateDebtMember 2021-01-01 2021-12-31 0001538217 SRAX:RatedCorporateDebtMember 2021-12-31 0001538217 SRAX:RatedCorporateDebtMember srt:MaximumMember 2021-01-01 2021-12-31 0001538217 us-gaap:OfficeEquipmentMember 2021-12-31 0001538217 us-gaap:OfficeEquipmentMember 2020-12-31 0001538217 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001538217 us-gaap:NoncompeteAgreementsMember 2020-12-31 0001538217 us-gaap:IntellectualPropertyMember 2021-12-31 0001538217 us-gaap:IntellectualPropertyMember 2020-12-31 0001538217 SRAX:SoftwareMember 2021-12-31 0001538217 SRAX:SoftwareMember 2020-12-31 0001538217 SRAX:InternallyDevelopedSoftwareMember 2021-12-31 0001538217 SRAX:InternallyDevelopedSoftwareMember 2020-12-31 0001538217 us-gaap:TrademarksMember 2021-12-31 0001538217 us-gaap:TrademarksMember 2020-12-31 0001538217 us-gaap:CustomerListsMember 2021-12-31 0001538217 us-gaap:CustomerListsMember 2020-12-31 0001538217 us-gaap:InternetDomainNamesMember 2021-12-31 0001538217 us-gaap:InternetDomainNamesMember 2020-12-31 0001538217 SRAX:FactoringFacilityMember 2021-12-31 0001538217 SRAX:FactoringFacilityMember 2020-12-31 0001538217 SRAX:LDMicroMember 2020-01-01 2020-12-31 0001538217 SRAX:LDMicroMember 2021-01-01 2021-12-31 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2020-04-17 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2020-04-16 2020-04-17 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2021-12-31 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2020-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-02-28 0001538217 SRAX:ShortTermPromissoryNotesMember srt:ChiefFinancialOfficerMember 2020-02-28 0001538217 SRAX:ShortTermPromissoryNotesMember 2021-01-01 2021-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2021-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-01-01 2020-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember srt:ChiefFinancialOfficerMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember us-gaap:AccruedLiabilitiesMember SRAX:TwoRemainingNoteHoldersMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember us-gaap:AccruedLiabilitiesMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember SRAX:DebenturesMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember SRAX:DebenturesMember 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-06-30 0001538217 SRAX:TermloanMember 2020-02-28 0001538217 SRAX:TermloanMember 2020-02-26 2020-02-28 0001538217 2020-02-28 0001538217 SRAX:TermloanMember 2020-04-29 2020-05-02 0001538217 us-gaap:WarrantMember 2020-02-28 0001538217 us-gaap:WarrantMember SRAX:SecondDrawdownMember 2020-02-28 0001538217 us-gaap:WarrantMember SRAX:SecondDrawdownMember 2020-02-26 2020-02-28 0001538217 us-gaap:WarrantMember srt:MaximumMember 2020-02-28 0001538217 us-gaap:WarrantMember 2020-02-26 2020-02-28 0001538217 SRAX:TermloanMember 2020-05-28 2020-06-30 0001538217 SRAX:TermloanMember 2020-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember 2020-06-25 0001538217 SRAX:OIDConvertibleDebenturesMember us-gaap:AccountsReceivableMember 2020-06-25 0001538217 SRAX:OIDConvertibleDebenturesMember 2020-06-24 2020-06-25 0001538217 SRAX:OIDConvertibleDebenturesMembersMember 2020-02-27 2020-02-28 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember us-gaap:MeasurementInputExpectedTermMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember SRAX:PlacementAgentMember 2021-01-01 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember SRAX:PlacementAgentMember 2021-12-31 0001538217 SRAX:SecuritiesPurchaseAgreementMember SRAX:PlacementAgentMember 2021-01-01 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:PriorToClosingDateMember 2020-06-29 2020-06-30 0001538217 SRAX:OIDConvertibleDebenturesMember 2020-06-29 2020-06-30 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:AfterTheClosingDateMember 2020-06-29 2020-06-30 0001538217 SRAX:ClassACommonStockMember 2020-01-01 2020-12-31 0001538217 SRAX:DebentureHoldersMember 2021-01-01 2021-12-31 0001538217 SRAX:ClassACommonStockMember SRAX:DebentureHoldersMember 2021-01-01 2021-12-31 0001538217 SRAX:DebentureHoldersMember 2021-12-31 0001538217 SRAX:IssuanceDuringTheYearMember 2021-12-31 0001538217 SRAX:ExtensionMember 2021-12-31 0001538217 SRAX:ConversionMember 2021-12-31 0001538217 SRAX:AmortizationMember 2021-12-31 0001538217 SRAX:IssuanceDuringTheYearMember 2020-12-31 0001538217 SRAX:ExtensionMember 2020-12-31 0001538217 SRAX:RedemptionMember 2020-12-31 0001538217 SRAX:ConversionMember 2020-12-31 0001538217 SRAX:AmortizationMember 2020-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2021-08-16 2021-08-17 0001538217 us-gaap:SeriesAPreferredStockMember srt:MaximumMember 2021-09-20 0001538217 us-gaap:SeriesAPreferredStockMember 2021-09-20 0001538217 us-gaap:SeriesAPreferredStockMember 2021-09-19 2021-09-20 0001538217 SRAX:SeriesOnePreferredStockMember 2021-12-31 0001538217 SRAX:ClassBCommonStockMember 2021-12-31 0001538217 us-gaap:NonperformingFinancingReceivableMember 2021-01-01 2021-01-31 0001538217 us-gaap:NonperformingFinancingReceivableMember 2020-01-31 0001538217 2020-01-01 2020-01-31 0001538217 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommonClassAMember 2020-01-01 2020-01-31 0001538217 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommonClassAMember 2020-06-29 2020-06-30 0001538217 SRAX:BoardOfDirectorsMember SRAX:ClassACommonStockMember 2021-08-02 2021-08-31 0001538217 SRAX:BoardOfDirectorsMember us-gaap:CommonStockMember 2021-08-02 2021-08-31 0001538217 SRAX:AtTheMarketSalesAgreementMember 2021-01-01 2021-12-31 0001538217 SRAX:ShareBuyBackProgramMember 2021-01-01 2021-12-31 0001538217 SRAX:TwoThousandAndTwelveEquityCompensationPlanMember us-gaap:CommonClassAMember 2012-01-31 0001538217 SRAX:TwoThousandAndFourteenteenEquityCompensationPlanMember us-gaap:CommonClassAMember 2014-11-05 0001538217 SRAX:TwoThousandAndSixteenEquityCompensationPlanMember us-gaap:CommonClassAMember 2016-02-23 0001538217 SRAX:TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember 2016-02-22 2016-02-23 0001538217 SRAX:NonExecutiveDirectorsMember 2020-04-01 2020-04-30 0001538217 SRAX:NonExecutiveDirectorsMember 2020-04-30 0001538217 2020-04-01 2020-04-30 0001538217 2020-04-30 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-08-31 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-08-28 2020-08-31 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-11-30 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-11-28 2020-11-30 0001538217 us-gaap:WarrantMember 2021-02-04 0001538217 us-gaap:WarrantMember 2021-02-03 2021-02-04 0001538217 us-gaap:WarrantMember us-gaap:MeasurementInputExpectedTermMember 2021-02-04 0001538217 us-gaap:WarrantMember us-gaap:MeasurementInputOptionVolatilityMember 2021-02-04 0001538217 us-gaap:WarrantMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2021-02-04 0001538217 us-gaap:WarrantMember 2021-02-21 0001538217 SRAX:NewWarrantMember 2021-02-21 0001538217 us-gaap:WarrantMember 2021-02-20 2021-02-21 0001538217 SRAX:NewWarrantMember 2021-02-20 2021-02-21 0001538217 2021-02-20 2021-02-21 0001538217 2021-02-21 0001538217 2021-01-01 2021-03-31 0001538217 2021-03-31 0001538217 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001538217 2019-01-01 2019-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel1Member 2020-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel2Member 2020-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember us-gaap:FairValueInputsLevel3Member 2020-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001538217 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001538217 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001538217 2022-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:SeriesAPreferredStockMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:SeriesAPreferredStockMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001538217 us-gaap:CommonStockMember 2020-12-31 0001538217 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:CommonStockMember 2021-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember 2020-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001538217 us-gaap:WarrantMember 2020-12-31 0001538217 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001538217 us-gaap:WarrantMember 2021-12-31 0001538217 us-gaap:PreferredStockMember 2020-12-31 0001538217 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:PreferredStockMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember SRAX:PutOptionPricingModelMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:MinimumMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:CommonStockMember SRAX:PutOptionPricingModelMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:MaximumMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertiblePreferredStockMember SRAX:PutOptionPricingModelMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:MinimumMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertiblePreferredStockMember SRAX:PutOptionPricingModelMember us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember srt:MaximumMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleDebtSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:MeasurementInputMaturityMember srt:MinimumMember 2021-01-01 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleDebtSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:MeasurementInputMaturityMember srt:MaximumMember 2021-01-01 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ConvertibleDebtSecuritiesMember us-gaap:ValuationTechniqueDiscountedCashFlowMember us-gaap:MeasurementInputDiscountRateMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputPriceVolatilityMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MinimumMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember srt:MaximumMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputMaturityMember srt:MinimumMember 2021-01-01 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputMaturityMember srt:MaximumMember 2021-01-01 2021-12-31 0001538217 SRAX:SequirePlatformRevenueMember 2021-01-01 2021-12-31 0001538217 SRAX:SequirePlatformRevenueMember 2020-01-01 2020-12-31 0001538217 SRAX:ConferenceRevenueMember 2021-01-01 2021-12-31 0001538217 SRAX:ConferenceRevenueMember 2020-01-01 2020-12-31 0001538217 SRAX:OtherRevenuesMember 2021-01-01 2021-12-31 0001538217 SRAX:OtherRevenuesMember 2020-01-01 2020-12-31 0001538217 us-gaap:SubsequentEventMember SRAX:BigTokenIncMember SRAX:SafeAgreementMember 2022-02-13 2022-02-15 0001538217 SRAX:CVRAgreementMember SRAX:InstitutionalInvestorMember us-gaap:SubsequentEventMember 2022-06-13 0001538217 SRAX:CVRAgreementMember SRAX:InstitutionalInvestorMember us-gaap:SubsequentEventMember 2022-06-12 2022-06-13 0001538217 us-gaap:SubsequentEventMember SRAX:HoldersMember 2022-07-01 0001538217 us-gaap:SubsequentEventMember SRAX:HoldersMember 2022-06-29 2022-07-01 0001538217 us-gaap:SubsequentEventMember SRAX:BridgeNoteMember 2022-07-01 0001538217 us-gaap:SubsequentEventMember SRAX:BridgeNoteMember 2022-06-29 2022-07-01 0001538217 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember 2022-08-08 0001538217 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember 2022-08-07 2022-08-08 0001538217 us-gaap:SubsequentEventMember SRAX:CreditAgreementMember 2022-08-08 0001538217 SRAX:CreditAgreementAndRevolvingNoteMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember 2022-08-08 0001538217 us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember SRAX:CreditAgreementAndRevolvingNoteMember us-gaap:CashMember 2022-08-08 0001538217 SRAX:CreditAgreementAndRevolvingNoteMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember SRAX:BridgeNoteMember 2022-06-28 0001538217 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember SRAX:TrancheOneMember 2022-08-08 0001538217 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember SRAX:TrancheTwoMember 2022-08-08 0001538217 us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:InstitutionalInvestorMember SRAX:TrancheThreeMember 2022-08-08 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember 2020-06-01 2020-06-30 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember 2018-11-29 2018-11-29 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember SRAX:TrancheOneMember 2018-11-29 2018-11-29 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember 2017-10-27 2017-10-27 0001538217 us-gaap:SubsequentEventMember us-gaap:WarrantMember 2022-09-27 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure SRAX:segment

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-K

 

(Mark One)

 

☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the fiscal year ended DECEMBER 31, 2021

 

or

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _______________

 

Commission file number: 001-37916

 

SRAX, INC.

(Exact name of registrant as specified in its charter)

 

Delaware   45-2925231

(State or other jurisdiction of

incorporation or organization)

  

(I.R.S. Employer

Identification No.)

 

2629 Townsgate Road #215,

Westlake Village, CA 91361

(Address of principal executive offices) (Zip Code)

 

Registrant’s telephone number, including area code: (323) 694-9800

 

Securities registered under Section 12(b) of the Act:

 

Title of Class   Trading Symbol   Name of Each Exchange on Which Registered
Class A Common Stock, $0.001 par value   SRAX   Nasdaq Global Market

 

Securities registered under Section 12(g) of the Act:

 

None

(Title of class)

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. ☐ Yes ☒ No

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☐ Yes ☒ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☐ Yes ☒ No

 

Indicate by check mark if disclosure of delinquent filers pursuant to Item 405 of Regulation S-K (§229.405 of this chapter) is not contained herein, and will not be contained, to the best of registrant’s knowledge, in definitive proxy or information statements incorporated by reference in Part III of this Form 10-K or any amendment to this Form 10-K. ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
Emerging Growth Company ☐  

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant has filed a report on and attestation to its management’s assessment of the effectiveness of its internal control over financial reporting under Section 404(b) of the Sarbanes-Oxley Act (15 U.S.C. 7262(b)) by the registered public accounting firm that prepared or issued its audit report. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). ☐ Yes ☒ No

 

State the aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was sold, or the average bid and asked prices of such common equity, as of the last business day of the registrant’s most recently completed second fiscal quarter. $121,972,024 based on the closing price of $5.44 on June 30, 2021.

 

Indicate the number of shares outstanding of each of the registrant’s classes of common stock, as of the latest practicable date. 26,315,178 shares of Class A common stock are outstanding as of October 10, 2022.

 

DOCUMENTS INCORPORATED BY REFERENCE

 

None.

 

 

 

 

 

 

TABLE OF CONTENTS

 

    Page No.
  Part I  
     
Item 1. Business. 1
Item 1A. Risk Factors. 4
Item 1B. Unresolved Staff Comments. 11
Item 2. Description of Property. 11
Item 3. Legal Proceedings. 11
Item 4. Mine Safety Disclosures. 11
   
  Part II  
     
Item 5. Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities. 12
Item 6. Selected Financial Data. 15
Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations. 15
Item 7A. Quantitative and Qualitative Disclosures About Market Risk. 25
Item 8. Financial Statements and Supplementary Data. 25
Item 9. Changes in and Disagreements With Accountants on Accounting and Financial Disclosure. 25
Item 9A. Controls and Procedures. 25
Item 9B. Other Information. 26
     
  Part III  
     
Item 10. Directors, Executive Officers and Corporate Governance. 27
Item 11. Executive Compensation. 31
Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters. 38
Item 13. Certain Relationships and Related Transactions, and Director Independence. 40
Item 14. Principal Accounting Fees and Services. 41
     
  Part IV  
     
Item 15. Exhibits, Financial Statement Schedules. 42
Item 16. Form 10-K Summary.3 44

 

i

 

 

PART I

 

We urge you to read this entire Annual Report on Form 10-K, including the “Risk Factors” section, the financial statements and the related notes included therein. As used in this Annual Report, unless context otherwise requires, the words “we,” “us,” “our,” “the Company,” “SRAX,” “Registrant” refer to SRAX, Inc. and its subsidiaries. Additionally, and reference to “LD Micro” refers to the Company’s wholly owned subsidiary, LD Micro, Inc. and the assets used in its operations. Any reference to “BIGToken” and “BIGToken, Inc.”, or the “BIGToken Project” refer to the Company’s previously wholly owned subsidiary, BIGToken, Inc. and the assets used in its operations. BIGToken was divested pursuant to a share exchange agreement that closed on February 4, 2021.

 

Any reference to “common share” or “common stock,” refers to our $0.001 par value Class A common stock. Any reference to our Series A Preferred Stock refers to our $0.001 par value Series A Non-Voting Preferred Stock.

 

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

 

The statements contained in this Annual Report on Form 10-K that are not purely historical are considered to be “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995 and Section 21E of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). These forward-looking statements include, but are not limited to: any projections of revenues, earnings, or other financial items; any statements of the strategies, plans and objectives of management for future operations; any statements concerning proposed new products or developments; any statements regarding future economic conditions or performance; any statements of belief; and any statements of assumptions underlying any of the foregoing. Forward-looking statements may include the words “may,” “will,” “estimate,” “intend,” “continue,” “believe,” “expect” or “anticipate” and any other similar words. These statements represent our expectations, beliefs, anticipations, commitments, intentions, and strategies regarding the future and include, but are not limited to, the risks and uncertainties outlined in Item 1.A Risk Factors and Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations and those discussed in other documents we file with the Securities and Exchange Commission (SEC). Readers are cautioned that actual results could differ materially from the anticipated results or other expectations that are expressed in forward-looking statements within this report. The forward-looking statements included in this report speak only as of the date hereof, and we undertake no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law. Given these risks and uncertainties, readers are cautioned not to place undue reliance on such forward-looking statements.

 

ITEM 1. BUSINESS.

 

Overview

 

We are a technology firm focused on enhancing communications between public companies and their shareholders and investors. We currently have two distinct business units:

 

  ● Our unique SaaS platform, Sequire, which allows issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels. Through Sequire, we offer tools and related data and insight services to allow issuers of publicly traded securities to better understand their position in the market.
     
  ● LD Micro organizes and hosts investor conferences for micro and small-cap companies.

 

We derive our revenues from the:

 

  ● Licensing of our proprietary SaaS platform;
     
  ● Sales of proprietary data;
     
  ● Attendance and sponsorship fees from investor conferences and events; and
     
  ● Sales of insight and consulting services.

 

Sequire

 

The Sequire platform is a central hub where companies can manage certain administrative functions, reach out and engage with shareholders as well as identify potential new investors. The platform utilizes machine learning and advanced analytics to bring our clients actionable information that we believe can be used to maximize ROI through better investor and stockholder communications. Clients then can engage with targeted shareholder groups across marketing channels including email, social media, programmatic, and hyperlocal.

 

When interpreting data, clients can see gains and losses over time, buying/selling trends, total outstanding shares, new shareholders, and shareholders broken out by percentage. Based on this data, we can assist our users in developing customized communications campaign utilizing targeted ads and messaging.

 

Among other features, the Sequire platform provides its users tools to monitor investor sentiment and activities and simplify back office administration such as:

 

  ● real-time level-two trading data,
     
  ● the ability to monitor the activities of competitive public companies of the user,
     
  ● news alerts,
     
  ● custom survey feature to enhance shareholder communications;
     
  ● real-time and searchable warrant and option ledgers; and
     
  ● integrated communication between investor relations programs and corporate communication firms.

 

Data Targeting

 

We help our clients build an investor base through targeted advertising and marketing campaigns, tailored to their needs. Using data-driven insights, we help clients meet their unique marketing objectives, whether they’re messaging existing investors, new investors, or consumers.

 

1

 

 

Website Disclosing the Value of our Securities Portfolio

 

Pursuant to the terms of the transaction documents in our Senior Secured Revolving Credit Facility entered into on August 8, 2022, we are required to disseminate more current information regarding our portfolio of securities that we receive from customers. Accordingly, we have elected to disseminate such required information via a website at https://srax.com/stock-portfolio (the “Portfolio Website”). The most current information about the portfolio of securities will be available on the Portfolio Website, which will be updated daily. Additionally, the Portfolio Website describes or details the value of such portfolio of securities separately that are currently restricted or unrestricted. The Portfolio Website additionally outlines the dollar value of securities that have been sold in a given quarter.

 

Individuals accessing the Portfolio Website are cautioned that the value of securities contained on the Portfolio Website are calculated by multiplying the quoted price of each security on its applicable exchange or interdealer quotation system, by the quantity owned. This method does not take into account any adjustment of value based on liquidity, the potential lack of an active market, excessive bid-ask spread, and other inputs used generally for valuing securities under the generally accepted principles of accounting (GAAP), the financial accounting standards board (FASB) and U.S. securities laws. Accordingly, the dollar values contained on the Portfolio Website may not be indicative of the fair value of the securities that we own, and the value for which we may be able to sell such securities could be materially and substantially less than that presented on the Portfolio Website. Additionally, the value of the securities contained on the Portfolio Website may be materially different from the value ascribed to such securities in our periodic reports filed with the Securities and Exchange Commission. Further, as a result of the potential holding periods of such securities and other restrictions on transferability or sale, we may, with respect to any specific security, (i) realize substantially less value upon the sale of such security or (ii) realize no value at all. Additionally, any disclosure with regard to the ability to sell as a result of such securities being unrestricted is subject to change and is highly dependent on facts that may change and that we have no control over. Any projections of sales for any future quarter or other time period are forward looking and speculative and you should not place any reliance on such projections. In addition, the values of securities listed on the Portfolio Website do not take into account any embedded features that may result in the adjustment of any conversion prices or issuance of additional shares. You are further cautioned not to rely on the values listed on the Portfolio Website for purposes of determining the fair value of our portfolio of securities.

 

Our team of experts takes a deep dive into each company, building out unique messaging to suit their target investors. Once media campaigns are built, they are run through the Sequire platform across multiple target segments. We then track performance and modify the campaign for the best possible results. Our clients have needs to target particular sectors and exchanges, and the value we deliver lies in the hyper-specific investor insights necessary for that kind of focused outreach.

 

We are maximizing the efficacy of our media campaigns by providing our clients with custom-built landing pages that are crafted to educate, engage, and convert new investors. When a new investor clicks through an ad, they will land on a story-driven page with data-tracking software embedded to collect analytics for later use.

 

Virtual Events and LD Micro

 

LD Micro is the premier event platform for micro-cap and small cap companies. In September of 2020, we acquired LD Micro, and hosted the 2020 Main Event on our Sequire Virtual Events platform. The 2021 Main Event had over 3,000 attendees and hosted webinars with over 500 companies. We are currently planning to expand the number and subject matter of our conferences and events. Through the events platform, we have the ability to host a variety of virtual events and conferences including investor conferences, earnings calls, shareholder meetings, annual, investor/analyst days, corporate town halls, roadshows, and more. We believe that our ability to offer users a seamless, centrally managed virtual events solution that can be customized to any industry will help transform our platform into the premier investor event tool.

 

Marketing and sales

 

We market our services through our in-house sales and marketing team. Our team focuses on social media, including Facebook, LinkedIn and Twitter, public relations (PR), industry events and the creation of white papers which assist in our marketing efforts and are used as lead generation tools.

 

Intellectual property

 

We currently rely on a combination of patents, trade secret laws and restrictions on disclosure to protect our intellectual property rights. Our success depends on the protection of the proprietary aspects of our technology as well as our ability to operate without infringing on the proprietary rights of others. We also enter into proprietary information and confidentiality agreements with our employees, consultants and commercial partners and control access to, and distribution of, our software documentation and other proprietary information. We currently have eight (8) US patent applications filed.

 

Government regulation

 

We are subject to a variety of laws and regulations in the United States that involve matters central to our business. Many of these laws and regulations are still evolving and being tested in courts and could be interpreted in ways that could harm our business. We are also subject to many of the laws that cover the securities industry and are regulated by the Securities and Exchange Commission.

 

These laws may involve privacy, data protection and personal information, rights of publicity, content, intellectual property, advertising, marketing, distribution, data security, data retention and deletion, electronic contracts and other communications, competition, protection of minors, consumer protection, product liability, taxation, economic or other trade prohibitions or sanctions, anti-corruption law compliance, securities law compliance, and online payment services. In particular, we are subject to federal, state, and foreign laws regarding privacy and protection of people’s data. Foreign data protection, privacy, content, competition, and other laws and regulations can impose different obligations or be more restrictive than those in the United States. U.S. federal and state and foreign laws and regulations, which in some cases can be enforced by private parties in addition to government entities, are constantly evolving and can be subject to significant change. As a result, the application, interpretation, and enforcement of these laws and regulations are often uncertain, particularly in the new and rapidly evolving industry in which we operate and may be interpreted and applied inconsistently from country to country and inconsistently with our current policies and practices.

 

Proposed or new legislation and regulations could also significantly affect our business. For example, the European General Data Protection Regulation (GDPR) took effect in May 2018 and applies to all of our products and services used by people in Europe. The GDPR includes operational requirements for companies that receive or process personal data of residents of the European Union that are different from those previously in place in the European Union and includes significant penalties for non-compliance. The California Consumer Privacy Act, which took effect in January 2020, also establishes certain transparency rules and creates new data privacy rights for users. Similarly, there are a number of legislative proposals in the European Union, the United States, at both the federal and state level, as well as other jurisdictions that could impose new obligations or limitations in areas affecting our business, such as liability for copyright infringement. In addition, some countries are considering or have passed legislation implementing data protection requirements or requiring local storage and processing of data or similar requirements that could increase the cost and complexity of delivering our services.

 

2

 

 

We may become the subject of investigations, inquiries, data requests, requests for information, actions, and audits by government authorities and regulators in the United States, Europe, and around the world, particularly in the areas of privacy, data protection, law enforcement, consumer protection, and competition, as we continue to grow and expand our operations. We are currently, and may in the future be, subject to regulatory orders or consent decrees, including the modified consent order we entered into in July 2019 with the U.S. Federal Trade Commission (FTC) which is pending federal court approval and which, among other matters, will require us to implement a comprehensive expansion of our privacy program. Orders issued by, or inquiries or enforcement actions initiated by, government or regulatory authorities could cause us to incur substantial costs, expose us to unanticipated civil and criminal liability or penalties (including substantial monetary remedies), interrupt or require us to change our business practices in a manner materially adverse to our business, divert resources and the attention of management from our business, or subject us to other remedies that adversely affect our business.

 

Employees and Human Capital Resources

 

As of August 31, 2022, we had 10 full-time employees. Of these employees, 5 are engaged in executive management, 68 in information technology including those participating in our research and development efforts, 17 in sales and marketing, 28 in integration and customer support and 12 in administration. All employees are employed “at will.” We believe our relations with our employees are generally positive and we have no collective bargaining agreements with any labor unions.

 

Our human capital resources objectives include, as applicable, identifying, recruiting, retaining, incentivizing and integrating our existing and new employees. The principal purposes of our equity and cash incentive plans are to attract, retain and reward personnel, whether existing employees or new hires, through the granting of stock-based and cash-based compensation awards. We believe that this increases value to our stockholders and the success of our company by motivating such individuals to perform to the best of their abilities and achieve our objectives.

 

We provide our employees and their families with access to health and wellness programs, including benefits that provide protection and security concerning events that may require time away from work or that impact their financial well-being; and that offer choices where possible so employees can customize their benefits to meet their needs. In response to the COVID-19 pandemic, we implemented significant changes that we determined were in the best interest of our employees, as well as the community in which we operate, and which comply with government regulations, including working in a remote environment where appropriate or required. As of the date of this Annual Report, all of our employees are currently working remotely.

 

Our history

 

We were originally organized in August 2009 as a California limited liability company under the name Social Reality, LLC, and we converted to a Delaware corporation effective January 1, 2012. Social Reality, LLC began business in May 2010. Upon the conversion, we changed our name to Social Reality, Inc. On August 15, 2019, we formally changed our Name to SRAX, Inc. In September of 2020, we acquired LD Micro as a wholly owned subsidiary. In February of 2021 we completed the divestiture of our BIGToken subsidiary and the related platform.

 

Additional information

 

We file annual and quarterly reports on Forms 10-K and 10-Q, current reports on Form 8-K and other information with the Securities and Exchange Commission (“SEC” or the “Commission”). The public may read and copy any materials that we file with the Commission at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549, on official business days during the hours of 10:00 a.m. to 3:00 p.m. You may obtain information on the operation of the Public Reference Room by calling the Commission at 1-800-SEC-0330. The Commission also maintains an Internet site at http://www.sec.gov that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the Commission.

 

Other information about SRAX can be found on our website www.srax.com. Reference in this document to that website address does not constitute incorporation by reference of the information contained on the website.

 

3

 

 

ITEM 1A. RISK FACTORS.

 

Please consider the following risk factors carefully. If any one or more of the following risks were to occur, it could have a material adverse effect on our business, prospects, financial condition and results of operations, and the market price of our securities could decrease significantly. Statements below to the effect that an event could or would harm our business (or have an adverse effect on our business or similar statements) mean that the event could or would have a material adverse effect on our business, prospects, financial condition and results of operations, which in turn could or would have a material adverse effect on the market price of our securities. Although we have organized the risk factors below under headings to make them easier to read, many of the risks we face involve more than one type of risk. Consequently, you should read all of the risk factors below carefully before making any decision to acquire or hold our securities.

 

Risks Related to our Business

 

We have a history of operating losses and there are no assurances we will report profitable operations in the foreseeable future.

 

For the years-ended December 31, 2021 and 2020, we reported income/(loss) from operations of $(85,000) and ($7,032,000), respectively, and accumulated deficit of ($30,355,000) and ($50,342,000), respectively. Our future success depends on our ability to continue to grow our revenues, contain our operating expenses and generate profits. We do not have any long-term agreements with our customers. There are no assurances that we will be able to increase our revenues and cash flow to a level which supports profitable operations. We may continue to incur losses in future periods until such time, if ever, as we are successful in significantly increasing our revenues and cash flow beyond what is necessary to fund our ongoing operations and pay our obligations as they become due. If we significantly increase our revenues in future periods, the rapid growth may strain our organization and we may encounter difficulties in maintaining the quality of our operations. If we are not able to successfully increase our revenues, it is unlikely we will be able to generate sufficient cash from operations to pay our operating expenses and service our debt obligations or report profitable operations in future periods.

 

Our auditors have expressed substantial doubt about our ability to continue as a going concern.

 

Our auditors’ report on our December 31, 2021 consolidated financial statements expresses an opinion that our capital resources as of the date of their audit report were not sufficient to sustain operations or complete our planned activities for the upcoming year unless we raised additional funds. Based upon our cash position on December 31, 2021, there is substantial doubt about our ability to continue as a going concern past the first quarter of 2023. Our ability to continue as a going concern is based on several factors; (i) our ability to sustain our current operating performance, and (ii) our ability to raise additional capital. If we are not successful with either of these, we may no longer be able to continue as a going concern and may cease operation or seek bankruptcy protection.

 

We may need to raise additional capital to pay our indebtedness as it comes due.

 

In June 2020, we entered into a securities purchase agreement with institutional investors for the issuance of approximately $16.1 million in principal of debentures, of which $1,267,000 remains outstanding as of December 31, 2021. In July 2022, we amended certain terms of the debentures whereby in exchange for an additional five percent (5%) to be added onto the outstanding principal, we extended the maturity dates by six (6) months or until December 31, 2023 as well as extended the date we are required to begin making amortization payments until January 1, 2023. In addition, the holders of the debentures have the unilateral right to extend the maturity date and amortization payments by another six (6) months each in exchange for another additional five percent (5%) to be added to the principal of the debentures. On July 1, 2022, we entered into an original issue discount bridge loan with a principal amount of $650,000 in exchange for $500,000 in cash. On August 8, 2022, the bridge loan was exchanged for revolving notes in the senior secured revolving credit facility whereby we received $4,930,000 cash on the first draw down. Of the amount received, we paid off approximately $3.75 million of outstanding obligations. The payment of the debentures and revolving credit facility are secured by substantially all the assets and the intellectual property of the Company. Further, in addition to payments required pursuant the revolving credit facility, the lender is also entitled to ten percent (10%) of the net proceeds of any sales of securities acquired from our customers during the term of the loan. As a result, this will further negatively impact our cash flows from operations and may require us to raise additional capital earlier than previously anticipated. Depending on our level of operations, we may not be able to generate sufficient cash flow to repay the debentures or revolving credit facility as they come due. If we are not able to generate enough cashflow through the operation of our business, we will need to raise additional capital through the sale of debt or equity or the sale of assets, in order to make the required payments. If we are unable to make the required payments, or if we fail to comply with the various requirements and covenants of the debentures and revolving credit facility, we would be in default, which would permit the holders of the debentures and lender in the revolving credit facility to accelerate the maturity and require immediate repayment and lead to potential foreclosure on the assets securing the debt. If we are unable to refinance or repay our indebtedness as it becomes due, including upon an event of default, we may become insolvent and be unable to continue operations.

 

Our outstanding loan obligations contain substantial covenants that may impact our business, our ability to secure additional debt financing, and our ability to pay our debts as they become due.

 

As of August 31, 2022, we have approximately (i) $1.1 million outstanding of our secured convertible debentures issued in June 2020 that are due and payable on December 31, 2023 and (ii) $5,580,000 of revolving notes outstanding pursuant to our senior secured revolving credit facility. Each of the debentures and revolving notes / credit facility contain a number of affirmative and negative covenants, including, but not limited to: reporting requirements, certain financial covenants related to our stock portfolio, collateral limitations, certain limitations on liens and indebtedness, dispositions, mergers and acquisitions, restricted payments and investments, corporate changes and limitations on waivers and amendments to certain agreements, our organizational documents, etc. Our failure to comply with the covenants in the credit agreement governing the credit facility and the debentures and associated transaction documents could result in an event of default that, if not cured or waived, could result in the acceleration of all or a substantial portion of our debt and potential foreclosure on the assets pledged to secure the debt.

 

Further, we agreed to pay the lender in the credit facility, an amount equal to ten percent (10%) of the net proceeds actually received by us from the sale any securities of a customer that we acquired during the term of the revolving note(s). Given that we have not yet achieved profitability, and we will additionally be required to make payments upon the sales of our customer’s securities to the lender, we may be unable to continue to meet our obligations as they become due.  If we are unable to refinance or repay our indebtedness as it becomes due or upon an event of default, we may become insolvent and be unable to continue operations.

 

Additionally, the revolving loan obligations under our secured credit facility provide for variable repayment terms ranging from 10% to 30% of the net proceeds actually received upon the sale of our customer’s securities that we receive pursuant to the provision of services. This will further negatively impact our cash flows and may further accelerate the anticipated timeframe in which we need to raise additional capital.

 

4

 

 

Our failure to maintain an effective system of internal control over financial reporting, has resulted in the need for us to restate previously issued financial statements. As a result, current and potential stockholders may lose confidence in our financial reporting, which could harm our business and value of our stock.

 

Or management has determined that, as of December 31, 2021, we did not maintain effective internal controls over financial reporting based on criteria set forth by the Committee of Sponsoring Organizations of the Treadway Commission in Internal Control-Integrated Framework as a result of identified material weaknesses in our internal control over financial reporting. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis.

 

Natural disasters, epidemic or pandemic disease outbreaks, trade wars, political unrest or other events could disrupt our business or operations or those of our development partners, manufacturers, regulators or other third parties with whom we conduct business now or in the future.

 

A wide variety of events beyond our control, including natural disasters, epidemic or pandemic disease outbreaks (such as the recent novel coronavirus outbreak), trade wars, political unrest or other events could disrupt our business or operations or those of our manufacturers, regulatory authorities, or other third parties with whom we conduct business. These events may cause businesses and government agencies to be shut down, supply chains to be interrupted, slowed, or rendered inoperable, and individuals to become ill, quarantined, or otherwise unable to work and/or travel due to health reasons or governmental restrictions. These limitations could negatively affect our business operations and continuity, and could negatively impact ability to timely perform basic business functions, including making SEC filings and preparing financial reports. If our operations or those of third parties with whom we have business are impaired or curtailed as a result of these events, the development and commercialization of our products and product candidates could be impaired or halted, which could have a material adverse impact on our business.

 

A pandemic, epidemic or outbreak of an infectious disease in the markets in which we operate or that otherwise impacts our facilities or advisors could adversely impact our business.

 

If a pandemic, epidemic, or outbreak of an infectious disease including the recent outbreak of respiratory illness caused by a novel coronavirus (COVID-19) or other public health crisis were to affect our operations, facilities or those of our customers or suppliers, our business could be adversely affected. A pandemic typically results in social distancing, travel bans and quarantine, and this may limit access to our facilities, customers, management, support staff and professional advisors. These factors, in turn, may not only materially impact our operations, financial condition and demand for our services but our overall ability to react timely to mitigate the impact of this event. Also, it may hamper our efforts to comply with our filing obligations with the Commission

 

Regulatory, legislative or self-regulatory developments regarding internet privacy matters could adversely affect our ability to conduct our business.

 

The United States and foreign governments have enacted, considered or are considering legislation or regulations that could significantly restrict our ability to collect, process, use, transfer and pool data collected from and about consumers and devices. Trade associations and industry self-regulatory groups have also promulgated best practices and other industry standards relating to targeted advertising. Various U.S. and foreign governments, self-regulatory bodies and public advocacy groups have called for new regulations specifically directed at the digital advertising industry, and we expect to see an increase in legislation, regulation and self-regulation in this area. The legal, regulatory and judicial environment we face around privacy and other matters is constantly evolving and can be subject to significant change. Additionally, the interpretation and application of data protection laws in the U.S., Europe and elsewhere are often uncertain and in flux. Legislative and regulatory authorities around the world may decide to enact additional legislation or regulations, which could reduce the amount of data we can collect or process and, as a result, significantly impact our business. Similarly, clarifications of and changes to these existing and proposed laws, regulations, judicial interpretations and industry standards can be costly to comply with, and we may be unable to pass along those costs to our clients in the form of increased fees, which may negatively affect our operating results. Such changes can also delay or impede the development of new solutions, result in negative publicity and reputational harm, require significant incremental management time and attention, increase our risk of non-compliance and subject us to claims or other remedies, including fines or demands that we modify or cease existing business practices, including our ability to charge per click or the scope of clicks for which we charge. Additionally, any perception of our practices or solutions as an invasion of privacy, whether or not such practices or solutions are consistent with current or future regulations and industry practices, may subject us to public criticism, private class actions, reputational harm or claims by regulators, which could disrupt our business and expose us to increased liability. Finally, our legal and financial exposure often depends in part on our clients’ or other third parties’ adherence to privacy laws and regulations and their use of our services in ways consistent with visitors’ expectations. We rely on representations made to us by clients that they will comply with all applicable laws, including all relevant privacy and data protection regulations. We make reasonable efforts to enforce such representations and contractual requirements, but we do not fully audit our clients’ compliance with our recommended disclosures or their adherence to privacy laws and regulations. If our clients fail to adhere to our contracts in this regard, or a court or governmental agency determines that we have not adequately, accurately or completely described our own solutions, services and data collection, use and sharing practices in our own disclosures to consumers, then we and our clients may be subject to potentially adverse publicity, damages and related possible investigation or other regulatory activity in connection with our privacy practices or those of our clients.

 

5

 

 

Unfavorable media coverage could negatively affect our business.

 

Unfavorable publicity regarding, for example, our privacy practices, terms of service, regulatory activity, the actions of third parties, the use of our products or services for illicit, objectionable, or illegal ends or the actions of other companies that provide similar services to us, could adversely affect our reputation. Such negative publicity also could have an adverse effect on the size, engagement, and loyalty of our customer base which could adversely affect our business and financial results.

 

Our business is subject to complex and evolving U.S. and foreign laws and regulations regarding privacy, data protection, content, competition, consumer protection, and other matters. Many of these laws and regulations are subject to change and uncertain interpretation, and could result in claims, changes to our business practices, monetary penalties, increased cost of operations, or declines in user growth or engagement, or otherwise harm our business.

 

We are subject to a variety of laws and regulations in the United States and abroad that involve matters central to our business, such as privacy, data protection and personal information, rights of publicity, content, intellectual property, advertising, marketing, distribution, data security, data retention and deletion, electronic contracts and other communications, competition, protection of minors, consumer protection, taxation and securities law compliance. Expansion of our activities in certain jurisdictions, or other actions that we may take, may subject us to additional laws, regulations, or other government scrutiny. In addition, foreign data protection, privacy, content, competition, and other laws and regulations can impose different obligations or be more restrictive than those in the United States.

 

Additionally, as we expand our product offerings, we may become subject to the European General Data Protection Regulation (GDPR), effective as of May 2018. The GDPR increases privacy rights for individuals in Europe, extends the scope of responsibilities for data controllers and data processors and imposes increased requirements and potential penalties on companies offering goods or services to individuals who are located in Europe or monitoring the behavior of such individuals (including by companies based outside of Europe). Noncompliance can result in penalties of up to the greater of €20 million, or 4% of global company revenues.

 

These U.S. federal and state and foreign laws and regulations, which in some cases can be enforced by private parties in addition to government authorities, are constantly evolving and can be subject to significant change. As a result, the application, interpretation, and enforcement of these laws and regulations are often uncertain, particularly in the newer industry in which we operate, and may be interpreted and applied inconsistently from country to country and inconsistently with our current policies and practices.

 

These laws and regulations, as well as any associated inquiries or investigations or any other government actions, may be costly to comply with and may delay or impede our international growth, result in negative publicity, increase our operating costs, require significant management time and attention, and subject us to remedies that may harm our business.

 

Security breaches and improper access to or disclosure of our data or user data, or other hacking and phishing attacks on our systems, could harm our reputation and adversely affect our business.

 

Our industry is prone to cyber-attacks by third parties seeking unauthorized access to our data or users’ data or to disrupt our ability to provide service. Any failure to prevent or mitigate security breaches and improper access to or disclosure of our data or user data, including personal information, content, or payment information from or to users, or information from marketers, could result in the loss or misuse of such data, which could harm our business and reputation and diminish our competitive position. In addition, computer malware, viruses, social engineering (predominantly spear phishing attacks), and general hacking have become more prevalent in our industry. As a result of recent attention and growth of, the size of our user base, and the types and volume of personal data on our systems, we believe that we are a particularly attractive target for such breaches and attacks. Our efforts to address undesirable activity may also increase the risk of retaliatory attacks. Such attacks may cause interruptions to the services we provide, degrade the user experience, cause users or marketers to lose confidence and trust in our products, impair our internal systems, or result in financial harm to us. Our efforts to protect our company data or the information we receive may also be unsuccessful due to software bugs or other technical malfunctions; employee, contractor, or vendor error or malfeasance; government surveillance; or other threats that evolve. In addition, third parties may attempt to fraudulently induce employees or users to disclose information in order to gain access to our data or our users’ data. Cyber-attacks continue to evolve in sophistication and volume, and inherently may be difficult to detect for long periods of time. Although we are currently in the process of developing systems and processes that are designed to protect our data and user data, to prevent data loss and to prevent or detect security breaches, we cannot assure you that such measures will ultimately become operational or provide absolute security, and we may incur significant costs in protecting against or remediating cyber-attacks.

 

6

 

 

Affected parties or government authorities could initiate legal or regulatory actions against us in connection with any actual or perceived security breaches or improper disclosure of data, which could cause us to incur significant expense and liability or result in orders or consent decrees forcing us to modify our business practices. Such incidents or our efforts to remediate such incidents may also result in a decline in our active user base or engagement levels. Any of these events could have a material and adverse effect on our business, reputation, or financial results.

 

If we were to lose or have limited access to certain platforms or data sources, we will lose our existing revenue from these platform and sources.

 

The loss of access to any platforms or data sources could limit our ability to effectively grow a portion of our operations. Our business would be harmed if these platforms:

 

  ● discontinues or limits access to its platform by us and other application developers;
     
  ● modify terms of service or other policies, including fees charged to, or other restrictions on, us or other application developers, or changes how the personal information of its users is made available to application developers;
     
  ● establishes more favorable relationships with one or more of our competitors; or
     
  ● develops its own competitive offerings.

 

We depend on the services of our executive officers and the loss of any of their services could harm our ability to operate our business in future periods.

 

Our success largely depends on the efforts and abilities of our executive officers, including Christopher Miglino, Michael Malone, and Christopher Lahiji, the president of our wholly owned subsidiary, LD Micro. We are a party to an employment agreement with each of Mr. Miglino, Mr. Malone and Mr. Lahiji. Although we do not expect to lose their services in the foreseeable future, the loss of any of them could materially harm our business and operations in future periods until such time as we were able to engage a suitable replacement.

 

Weak economic conditions may reduce consumer demand for products and services.

 

A weak economy in the United States could adversely affect demand for advertising products, and services. A substantial portion of our revenue is derived from businesses that are highly dependent on discretionary spending by individuals, which typically falls during times of economic instability. Accordingly, the ability of our advertisers to increase or maintain revenue and earnings could be adversely affected to the extent that relevant economic environments remain weak or decline further. We currently are unable to predict the extent of any of these potential adverse effects.

 

Certain of our business affiliates have operations outside of the United States that are subject to numerous operational risks.

 

Certain of our affiliates have operations in countries other than the United States. In many foreign countries, it is not uncommon to encounter business practices that are prohibited by certain regulations, such as the Foreign Corrupt Practices Act and similar laws. Although certain of our business affiliates have undertaken compliance efforts with respect to these laws, their respective employees, contractors and agents, as well as those companies to which they outsource certain of their business operations, may take actions in violation of their policies and procedures. Any such violation, even if prohibited by the policies and procedures of these business affiliates or the law, could have certain adverse effects on the financial condition of these business affiliates. Any failure by these affiliates to effectively manage the challenges associated with the international operation of their businesses could materially adversely affect their, and hence our, financial condition.

 

In the event that we are unable to conduct business with certain third-party providers of data and information integral to our operations, our revenue and business prospects may suffer.

 

We rely on access to certain third-party providers of data in the investment sector in order for the Sequire platform to function and provide meaningful data and insights for our customers. We have benefited from the data that these third-parties have provided to us on behalf of their customers. In the event that we lose access to these third-party providers, it would limit our ability to effectively market the Sequire platform and sell our services to our customers. In the event that these third-party providers change their terms or our ability to access their data on a cost-effective basis to us, our business may be materially harmed.

 

7

 

 

Competitors may create products that compete with the Sequire platform and there can be no assurances that we will be able to protect our intellectual property related to Sequire.

 

The Sequire platform’s success depends heavily on our intellectual property and the continued development and innovation of the platform. Notwithstanding, there may be competitors seeking to compete by creating similar platforms with more aggressive pricing or lower cost structures, greater functionality, and by emulating the services provided by the Sequire platform. Furthermore, certain of the information that we implement in our Sequire platform is either publicly available or ascertained through third-party service providers for which no barrier to entry exists. Companies with significantly more resources than us may attempt to create competing products at lower prices. Furthermore, there can be no assurances that we are able to adequately defend our trade secrets or intellectual property rights with respect to competitors.

 

Our insurance coverage strategy may not be adequate to protect us from all business risks.

 

We may be subject, in the ordinary course of business, to losses resulting from accidents, acts of God and other claims against us, for which we may have no insurance coverage. As a general matter, we do not maintain as much insurance coverage as many other companies do, and in some cases, we do not maintain any at all. Additionally, the policies that we do have may include significant deductibles or self-insured retentions, policy limitations and exclusions, and we cannot be certain that our insurance coverage will be sufficient to cover all future losses or claims against us. A loss that is uninsured or which exceeds policy limits may require us to pay substantial amounts, which may harm our financial condition and operating results.

 

Risks Related to receipt of Securities for Services

  

Many of the securities we receive for services do not have an active trading market, and we value these securities at fair value as determined in good faith under procedures adopted by our Board of Directors, which valuation is inherently subjective and may not reflect what we may actually realize for the sale of these securities.

 

The majority of securities comprising our stock portfolio are, and are expected to continue to be, in securities that have a limited market, limited liquidity, high volatility, and accordingly, their market price may not accurately reflect the true value in the event that they were traded on an active market. As of December 31, 2021, we had unrealized losses from our stock portfolio of approximately $8.0 million. The fair value of assets whose true values are not readily ascertainable are determined in good faith under procedures adopted by our Board of Directors. Our Board of Directors utilizes the services of independent third-party valuation firms in determining the fair value of a portion of the securities we hold. Investment professionals from our investment adviser also prepare valuations using sources and/or proprietary models depending on the availability of information on our assets and the type of asset being valued, all in accordance with our valuation policy. Accordingly, the actual value of the securities we received could be substantially less than we previously estimated.

 

Because fair valuations, and particularly fair valuations of securities without efficient markets are inherently uncertain, may fluctuate over short periods of time, and are often based to a large extent on estimates, comparisons and qualitative evaluations of information, it may be more difficult for investors to value accurately our securities and could lead to undervaluation or overvaluation of our Common Stock. In addition, the valuation of these types of securities may result in substantial write-downs and earnings volatility.

 

The value ascribed to our assets in our financial statements as of a particular date may be materially greater than or less than the value that would be realized if our assets were to be liquidated as of such date. For example, if we were required to sell a certain asset or all or a substantial portion of our assets on a particular date, the actual price that we would realize upon the disposition of such asset or assets could be materially less than the value of such asset or assets as reflected in our financial statements. Volatile market conditions could also cause reduced liquidity in the market for certain assets, which could result in liquidation values that are materially less than the values of such assets as reflected in our financial statements.

 

We run the risk of inadvertently being deemed to be an investment company that is required to register under the Investment Company Act of 1940.

 

We run the risk of inadvertently being deemed to be an investment company that is required to register under the Investment Company Act of 1940 (the “Investment Company Act”) because a significant portion of our assets consists of securities in companies in which we own less than a majority interest. The risk varies depending on events beyond our control, such as significant appreciation or depreciation in the market value of certain of our publicly traded holdings, adverse developments with respect to our ownership of certain of our subsidiaries, and transactions involving the sale of certain assets. If we are deemed to be an inadvertent investment company, we may seek to rely on a safe-harbor under the Investment Company Act that would provide us a one-year grace period to take steps to avoid being deemed to be an investment company. In order to ensure we avoid being deemed an investment company, we have taken, and may need to continue to take, steps to reduce the percentage of our assets that constitute investment assets under the Investment Company Act. These steps have included, among others, selling marketable securities that we might otherwise hold for the long-term and deploying our cash in non-investment assets. We have recently sold marketable securities, including at times at a loss, and we may be forced to sell our investment assets at unattractive prices or to sell assets that we otherwise believe benefit our business in the future to remain below the requisite threshold. We may also seek to acquire additional non-investment assets to maintain compliance with the Investment Company Act, and we may need to incur debt, issue additional equity or enter into other financing arrangements that are not otherwise attractive to our business. Any of these actions could have a material adverse effect on our results of operations and financial condition. Moreover, we can make no assurance that we would successfully be able to take the necessary steps to avoid being deemed to be an investment company in accordance with the safe harbor. If we were unsuccessful, then we would have to register as an investment company, and we would be unable to operate our business in its current form. We would be subject to extensive, restrictive, and potentially adverse statutory provisions and regulations relating to, among other things, operating methods, management, capital structure, indebtedness, dividends, and transactions with affiliates. If we were deemed to be an investment company and did not register as an investment company when required to do so, there would be a risk, among other material adverse consequences, that we could become subject to monetary penalties or injunctive relief, or both, that we would be unable to enforce contracts with third parties, and/or that third parties could seek to obtain rescission of transactions with us undertaken during the period in which we were an unregistered investment company.

 

8

 

 

We are not, and do not intend to become, regulated as an investment company under the U.S. Investment Company Act of 1940 (and similar legislation in other jurisdictions) and if we are deemed an “investment company” under the U.S. Investment Company Act of 1940, applicable restrictions would make it impractical for us to operate as contemplated.

 

The Investment Company Act and the rules thereunder (and similar legislation in other jurisdictions) provide certain protections to investors and impose certain restrictions on companies that are registered as investment companies. Among other things, such rules limit or prohibit transactions with affiliates, impose limitations on the issuance of debt and equity securities and impose certain governance requirements. We have not been and do not intend to become regulated as an investment company and we intend to conduct our activities so that we will not be deemed to be an investment company under the Investment Company Act (and similar legislation in other jurisdictions). In order to ensure that we are not deemed to be an investment company, we may be required to materially restrict or limit the scope of our operations or plans related to Sequire, which may limit us in the types of acquisitions that we may make and we may need to modify our organizational structure or dispose of assets that we would not otherwise dispose of. Moreover, if anything were to happen which would potentially cause us to be deemed an investment company under the Investment Company Act, it would be impractical for us to operate as intended pursuant to the Sequire platform and our business, financial condition and results of operations would be materially adversely affected. Accordingly, we would be required to take extraordinary steps to address the situation, such as the modification and restructuring of our Sequire platform, which would materially adversely affect our ability to derive revenue.

 

Sequire’s services are primarily paid for in restricted shares of its customers’ stock, which are often smaller publicly traded companies with volatile stock prices, limited liquidity, riskier operations and whose securities are frequently quoted on the OTC Markets, which includes the OTCQX, OTCQB as well as the OTC Pink, which typically quotes securities with increased risk and less liquidity.

 

Payment related to our Sequire platform and services is often made through the equity securities of our customers instead of cash. Since larger companies typically pay in cash, the securities issued are often those of smaller public companies that often have limited operating histories, limited operating cash, and negative cash flows. Additionally, these securities are primarily restricted, and are subject to legal holding periods pursuant to Rule 144 or other applicable exemptions. As of December 31, 2021 approximately $11.4 million of our holdings are issued by companies whose securities trade on the OTC Markets Inc. Additionally, of these securities quoted on the OTC Markets, approximately 69% are quoted on the OTC Pink. While our agreements for OTC issuers may contain certain provisions providing for the issuance of additional securities upon certain events, the value of such securities on the date of receipt compared to the date when we are able to legally sell the securities may decrease significantly, and the stock price of such issuers is often volatile, unpredictable, and with limited liquidity. Additionally, the OTC Pink has less stringent requirements for listing than even other OTC Markets, such as the OTCQB or OTCQX. Often, the OTC Pink lists companies that (i) may not be providing current information, (ii) may not have independent directors, (iii) may have little to no trading, and (iv) may be very volatile. As a result, the value of the equity received on the date of payment may be significantly greater than the actual revenue derived by us upon a sale of the securities. Furthermore, there is no guarantee that the companies that we receive securities from will remain solvent or maintain “current information”, or other required criteria during the legally required holding period under Rule 144, which would result in the loss of some or all of our anticipated revenue. These risks are significantly increased for OTC Pink issuers. As we are not experienced traders, there can be no assurances that our personnel responsible for selling the securities will do so at opportune times or be able to maximize profitability.

 

Our receipt of securities in lieu of cash may be negatively affected by a downturn in the U.S. and/or global securities markets and could significantly reduce our revenue.

 

General political and economic conditions and events such as U.S. fiscal and monetary policies, economic recessions, inflationary events, governmental shutdowns, trade tensions and disputes, global economic slowdowns, widespread health epidemics or pandemics, natural disasters, terrorist attacks, wars, changes in local and national economic and political conditions, regulatory changes or changes in the laws, or interest rate or currency rate fluctuations could create a downturn in the U.S. and/or global securities markets. As we often receive restricted securities of companies, a downturn in the U.S. or global markets may impact such companies and the value of the securities we receive for services pursuant to the Sequire platform.

 

Risks Related to Ownership of our Securities; Listing of our Securities.

 

Our Common Stock does not currently meet the continued listing requirements for the Nasdaq Market and accordingly is subject to delisting.

 

On April 19, 2022, we received a written notice from the Nasdaq Stock Market LLC that we are not in compliance with Nasdaq Listing Rule 5250(c)(1), because we had not yet filed our Annual Report on Form 10-K for the year ended December 31, 2021. Nasdaq Listing Rule 5250(c)(1) requires listed companies to timely file all required periodic reports with the SEC. Pursuant to Nasdaq rules, we have 60 calendar days from the date of the notification letter, or until June 20, 2022, to file the 2021 Annual Report on Form 10-K. Additionally, on May 24, 2022, we received another written notice from Nasdaq that we are further not in compliance with Nasdaq Listing Rule 5250(c)(1) because we had not yet filed our Quarterly Report on Form 10-Q for the quarter ended March 31, 2022. Similarly, on August 17, 2022, we received another written notice from Nasdaq that we are further not in compliance with Nasdaq Listing Rule 5250(c)(1) because we had not yet filed our Quarterly Report on Form 10-Q for the quarter ended June 30, 2022.

 

Nasdaq previously provided the Company with an extension of one hundred eighty (180) days from the initial due date of the 2021 Form 10-K or until October 12, 2022, to regain compliance with Nasdaq’s continued listing rule as it relates to all of the untimely filings. Accordingly, the Company’s (i) 2021 Form 10-K, (ii) March 30, 2022 Form 10-Q, and (iii) June 30, 2022 Form 10-Q are all required to be filed with the SEC by October 12, 2022.

 

If our shares lose their status on the Nasdaq Market, we believe that our shares would likely be eligible to be quoted on the inter-dealer electronic quotation and trading system operated by OTC Markets Group, commonly referred to as the over-the-counter market. These markets are generally considered not to be as efficient as, and not as broad as, the Nasdaq Market. If our common stock is delisted, this would, among other things, substantially impair our ability to raise additional funds and could result in a loss of institutional investor interest and fewer development opportunities for us.

 

Conversions of our convertible debentures, notes issued under our revolving credit facility, and the exercise of our common stock warrants may dilute the ownership interest of existing stockholders or may otherwise depress the price of our common stock.

 

The conversion of some or all of the outstanding convertible debentures or the revolving note issued in our secured revolving credit facility would dilute the ownership interests of existing stockholders. Any sales in the public market of the common stock issuable upon such conversion or exercise of outstanding warrants could adversely affect their prevailing market prices. In addition, the existence of the convertible debentures, revolving note, and outstanding warrants may encourage short selling by market participants because the conversion of such notes could be used to satisfy short positions, or the anticipated conversion of such debentures into shares of our common stock could depress the price of our common stock.

 

9

 

 

The market price of our common stock may be volatile.

 

The market for our common shares is characterized by significant price volatility when compared to seasoned issuers, and we expect that our share price will continue to be more volatile than those of a seasoned issuer. The volatility in our share price is attributable to a number of factors. Mainly however, we are a speculative or “risky” investment due to our limited operating history, lack of significant revenues to date, our continued operating losses and missed guidance. As a consequence of this enhanced risk, more risk-adverse investors may, under the fear of losing all or most of their investment in the event of negative news or lack of progress, be more inclined to sell their shares on the market more quickly and at greater discounts than would be the case with the stock of a seasoned issuer. Additionally, in the past, plaintiffs have often initiated securities class action litigation against a company following periods of volatility in the market price of its securities. We may in the future be the target of similar litigation. Securities litigation could result in substantial costs and liabilities and could divert management’s attention and resources.

 

The trading price of the shares of our common stock is likely to be highly volatile and could be subject to wide fluctuations in response to various factors, some of which are beyond our control. In addition to the factors discussed in this “Risk Factors” section and elsewhere in this quarterly report, these factors include:

 

  ● the success of competitive products;
     
  ● actual or anticipated changes in our growth rate relative to our competitors;
     
  ● announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures, collaborations or capital commitments;
     
  ● regulatory or legal developments in the United States and other countries;
     
  ● the recruitment or departure of key personnel;
     
  ● the level of expenses;
     
  ● actual or anticipated changes in estimates to financial results, development timelines or recommendations by securities analysts;
     
  ● variations in our financial results or those of companies that are perceived to be similar to us;
     
  ● fluctuations in the valuation of companies perceived by investors to be comparable to us
     
  ● inconsistent trading volume levels of our shares;
     
  ● announcement or expectation of additional financing efforts;
     
  ● sales of our common stock by us, our insiders or our other stockholders;
     
  ● additional issuances of securities upon the exercise of outstanding options and warrants;
     
  ● market conditions in the technology sectors; and
     
  ● general economic, industry and market conditions.

 

In addition, the stock market in general, and advertising technology companies in particular, have experienced extreme price and volume fluctuations that have often been unrelated or disproportionate to the operating performance of these companies. Broad market and industry factors may negatively affect the market price of our common stock, regardless of our actual operating performance. The realization of any of these risks could have a dramatic and material adverse impact on the market price of the shares of our common stock.

 

The Revolving Note issued under our senior secured revolving credit facility contains an adjustment to the price at which the note can be converted into our common stock, which may result in further dilution to our shareholders.

 

The revolving note issued in our August 2022 secured revolving credit facility, of which $5,580,000 in principal is currently outstanding, is convertible into our common stock at a conversion price of $15.00 per share (the “Conversion Price”). Notwithstanding, the Conversion Price is subject to adjustment upon certain enumerated events which includes the sale of our common stock or equivalents at a deemed price equal to or less than $5.00 per share. On August 31, 2022, the closing price of our common stock was $2.37 per share. In the event that we are required to raise additional capital through the sale of our equity or debt securities, given our current market price, it is likely that the Conversion Price would be adjusted, and we may be required to issue a significantly greater number of shares upon conversion, than currently anticipated, resulting in greater dilution to our existing shareholders.

 

We may be subject to securities litigation, which is expensive and could divert management attention.

 

The market price of the shares of our common stock may be volatile, and in the past companies that have experienced volatility in the market price of their securities have been subject to securities class action litigation. We may be the target of this type of litigation in the future. Securities litigation against us could result in substantial costs and divert our management’s attention from other business concerns, which could seriously harm our business. To the extent that any claims or suits are brought against us and successfully concluded, we could be materially adversely affected, jeopardizing our ability to operate successfully. Furthermore, our human and capital resources could be adversely affected by the need to defend any such actions, even if we are ultimately successful in our defense.

 

10

 

 

Failure to meet the financial performance guidance or other forward-looking statements we have provided to the public could result in a decline in our stock price.

 

We have previously provided, and may provide in the future, public guidance on our expected financial results for future periods. Although we believe that this guidance provides investors with a better understanding of management’s expectations for the future and is useful to our stockholders and potential stockholders, such guidance is comprised of forward-looking statements subject to the risks and uncertainties. Our actual results may not always be in line with or exceed the guidance we have provided. For example, in the past, we have missed guidance a number of times. If our financial results for a particular period do not meet our guidance or if we reduce our guidance for future periods, the market price of our common stock may decline.

 

Delaware law contains anti-takeover provisions that could deter takeover attempts that could be beneficial to our stockholders.

 

Provisions of Delaware law could make it more difficult for a third-party to acquire us, even if doing so would be beneficial to our stockholders. Section 203 of the Delaware General Corporation Law may make the acquisition of our company and the removal of incumbent officers and directors more difficult by prohibiting stockholders holding 15% or more of our outstanding voting stock from acquiring us, without our board of directors’ consent, for at least three years from the date they first hold 15% or more of the voting stock.

 

If securities or industry analysts do not publish research or publish inaccurate or unfavorable research about our business, the trading price of our common stock and trading volume could decline.

 

The trading market for our shares of our common stock will depend in part on the research and reports that securities or industry analysts publish about us or our business. A small number of securities and industry analysts currently publish research regarding our Company on a limited basis. In the event that one or more of the securities or industry analysts who have initiated coverage downgrade our securities or publish inaccurate or unfavorable research about our business, the price of our shares of common stock would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on us regularly, demand for our securities could decrease, which might cause the trading price of our shares of common stock and trading volume to decline.

 

The elimination of monetary liability against our directors and officers under Delaware law and the existence of indemnification rights held by our directors and officers may result in substantial expenditures by us and may discourage lawsuits against our directors and officers.

 

Our certificate of incorporation eliminates the personal liability of our directors and officers to our company and our stockholders for damages for breach of fiduciary duty as a director or officer to the extent permissible under Delaware law. Further, our bylaws provide that we are obligated to indemnify any of our directors or officers to the fullest extent authorized by Delaware law. We are also parties to separate indemnification agreements with certain of our directors and our officers which, subject to certain conditions, require us to advance the expenses incurred by any director or officer in defending any action, suit or proceeding prior to its final disposition. Those indemnification obligations could result in our company incurring substantial expenditures to cover the cost of settlement or damage awards against our directors or officers, which we may be unable to recoup. These provisions and resultant costs may also discourage us from bringing a lawsuit against any of our current or former directors or officers for breaches of their fiduciary duties, and may similarly discourage the filing of derivative litigation by our stockholders against our directors and officers even if such actions, if successful, might otherwise benefit us or our stockholders.

 

ITEM 1B. UNRESOLVED STAFF COMMENTS.

 

Not applicable to a smaller reporting company.

 

ITEM 2. DESCRIPTION OF PROPERTY.

 

As a result of COVID-19, we our currently operating as a virtually distributed operation. We lease our principal executive offices, located in Westlake Village, California and consisting of approximately 500 square feet on a month-to-month basis at a rate of $1,000 per month. We also maintain offices in Mexicali, Mexico where we lease approximately 3,400 square feet of office space under a lease agreement terminating in September 2023 at an annual rental of $140,000 plus a value-added tax (VAT) or its equivalent in the Mexican national currency and a 10% VAT for maintenance and certain overhead expenses. We believe both locations are suitable and adequate for our current levels of operations and anticipated growth.

 

ITEM 3. LEGAL PROCEEDINGS.

 

As of the date of this Annual Report, there are no material pending legal or governmental proceedings relating to our company or properties to which we are a party, and to our knowledge there are no material proceedings to which any of our directors, executive officers or affiliates are a party adverse to us or which have a material interest adverse to us.

 

ITEM 4. MINE SAFETY DISCLOSURES.

 

Not applicable.

 

11

 

 

PART II

 

ITEM 5. MARKET FOR REGISTRANT’S COMMON EQUITY, RELATED STOCKHOLDER MATTERS AND ISSUER PURCHASES OF EQUITY SECURITIES.

 

Market for Our Common Equity

 

Class A Common Stock.

 

Our Class A common stock is listed on the Nasdaq Global Market under the symbol “SRAX.”

 

As of August 31, 2022, there were approximately 47 holders of record of our common stock. Because many of our shares of common stock are held by brokers and other institutions on behalf of stockholders, we are unable to estimate the total number of beneficial holders represented by these record holders, but it is well in excess of the number of record holders.

 

Dividend policy

 

Common Stock

 

We have never paid cash dividends on either our Class A common stock or our Class B common stock. Under Delaware law, we may declare and pay dividends on our capital stock either out of our surplus, as defined in the relevant Delaware statutes, or if there is no such surplus, out of our net profits for the fiscal year in which the dividend is declared and/or the preceding fiscal year. If, however, the capital of our company, computed in accordance with the relevant Delaware statutes, has been diminished by depreciation in the value of our property, or by losses, or otherwise, to an amount less than the aggregate amount of the capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets, we are prohibited from declaring and paying out of such net profits and dividends upon any shares of our capital stock until the deficiency in the amount of capital represented by the issued and outstanding stock of all classes having a preference upon the distribution of assets shall have been repaired.

 

Series A Preferred Stock

 

We issued a one-time return of capital consisting of a total of 36,462,417 shares of our Series A Preferred Stock to Qualified Recipients (as defined below) on a 1-for-1 as converted to common stock basis (the “Dividend”). The record date for the Dividend was September 20, 2021 (the “Record Date”). The Series A Preferred Stock entitles the Qualified Recipients with the right to receive the net proceeds from sales of certain securities received by SRAX as payment from its customers for access to the Sequire Platform services (the “Designated Assets”).

 

As of the Record Date, the following holders of securities were entitled to receive the Dividend (collectively, the “Qualified Recipients):

 

(i) each outstanding share of common stock, of which 25,160,504 shares were issued and outstanding,
   
(ii) each share of common stock underlying outstanding common stock purchase warrants containing a contractual right to receive the Dividend of which, 10,377,645 were outstanding, and
   
(iii) each original issue discount senior convertible debenture issued on June 30, 2020, containing a contractual right to receive the Dividend on an as converted to common stock basis, of which $2,486,275 of Debentures were outstanding in principal and interest, convertible into 924,268 shares of common stock.

 

12

 

 

As of the Record Date, the Designated Assets had an aggregate value of approximately $6.5 million and consisted of securities (i) from twenty-five (25) companies that trade or are quoted on the OTC Markets, (ii) having stock prices ranging from $0.01 to $5.15, (iii) with aggregate values of the securities held by the Company ranging from $1,930 to $900,000, and (iv) with the average value held by the Company equal to $260,000 per issuer. The Designated Assets consist of (a) 24 issuers’ common stock and (b) one (1) issuer’s convertible debt instrument that is convertible into common stock.

 

The securities and cash that underly the Designated Assets had a market value of $3,925,000 as of December 31, 2021.

 

During the fourth quarter and portion of the third quarter of 2021, we sold an aggregate of approximately $680,000 of the Designated Assets. On January 30, 2022, we distributed the net proceeds from those shares to holders of our Series A Preferred Shares. Pursuant to the distribution, each holder of Series A Preferred Stock received approximately $0.01 per share.

 

During the first quarter of 2022, we sold an aggregate of $268,000 of the Designated Assets. The sale of Designated Assets did not result in sufficient proceeds to declare a distribution pursuant to the terms of the Series A Preferred Stock.

 

During the second quarter of 2022, we sold an aggregate of $127,000 of the Designated Assets. The sale of Designated Assets did not result in sufficient proceeds to declare a distribution pursuant to the terms of the Series A Preferred Stock.

 

As of June 30, 2022, after taking into account the sale of approximately $691,000, $268,000, and $127,000 during 2021, first quarter of 2022, and the second quarter of 2022, respectively, of the Designated Assets, the remaining Designated Assets have an aggregate value of approximately $2,789,383 (pursuant to the same valuation methods that our other securities are valued in this Annual Report, with such quoted market price potentially being greater or lesser than such value) and subsequent to sales and other transactions, consisted of securities (i) from nineteen (19) companies that trade or are quoted on the OTC Markets, (ii) having quoted stock prices ranging from $0.001 to $2.50, (iii) with aggregate values of the securities held by us ranging from $0 to $550,000, and (iv) with an average value equal to $93,000 per issuer. The Designated Assets consist of (a) 19 issuers’ common stock and (b) cash.

 

Securities Authorized for Issuance under Equity Compensation Plans

 

See information contained in Part III Item 12 of Annual Report entitled “Equity Compensation Plan Information.”

 

Recent sales of unregistered securities

 

The following information is given with regard to unregistered securities sold since January 1, 2021. The following securities were issued in private offerings pursuant to the exemption from registration contained in the Securities Act of 1933, as amended (the “Securities Act”) and the rules promulgated thereunder in reliance on Section 4(2) thereof, relating to offers of securities by an issuer not involving any public offering:

 

  ● During 2021 we issued a total of 183,772 shares of A common stock in connection with the cashless exercise of 445,294 common stock purchase warrants.
     
  ● On March 15, 2021, we issued Brock Pierce, our newly appointed Board member, an option to purchase 803 shares of common Stock for joining the Board. The Grant covers the period from March 10, 2021 (his appointment date), through April 15, 2021. The options have an exercise price of $4.48 per share, a term of seven (7) years, and will vest fully on April 15, 2021. The options were issued as payment for services on the Board from March 10, 2021 through April 15, 2021 and is valued at $2,958. The options were issued from our 2014 equity compensation plan.
     
  ● On January 2, 2022 Michael Malone, our Chief Financial Officer exercised an option to purchase 100,000 shares of our common stock that was issued on December 15, 2018. The option was exercised on a cashless basis and included 57,016 shares withheld pursuant to the cashless exercise and an additional 16,732 shares withheld for tax withholding. Accordingly, we issued Mr. Malone 26,252 shares of common stock.
     
  ● On January 6, 2022, we issued Michael Malone, our Chief Financial Officer, a conditional option to purchase 100,000 shares of Class A common stock. The option is a conditional grant, subject to shareholder approval. Assuming approval by the shareholders, the option has an exercise price of $4.25 per share, a term of seven (7) years and vests in equal quarterly installments over a three (3) year period from the grant date. The option had a Black-Scholes value on the grant date of $331,000.
     
  ● On January 3, 2022, we issued four (4) common stock purchase options to our non-employee directors, pursuant to our amended non-employee director compensation policy. Each option entitled the holder to purchase 29,533 shares of common stock at an exercise price of $4.35 per share, for an aggregate exercise amount of $128,468.55. The options vest in equal quarterly over a one (1) year period from the issuance date. The options expire on the seven (7) year anniversary of the issuance date. Each option has a Black-Scholes value of $100,000.

 

13

 

 

  ● On January 6, 2022, we issued Christopher Miglino, our Chief Executive Officer, an option to purchase 120,000 shares of common stock. The option has an exercise price of $4.25 per share, a term of seven (7) years and vests in equal quarterly installments over a three (3) year period from the grant date. The option had a Black-Scholes value on the grant date of $397,000.
     
  ● On January 6, 2022, we issued our employees, options to purchase an aggregate of 380,000 shares of common stock. Each of the options has an exercise price of $4.25 per share, a term of five (5) years, and vests in equal quarterly installments over a three (3) year period from the grant date. The aggregate of the 380,000 options had a Black-Scholes value on the grant date $1,126,000.
     
  ● On January 6, 2022, we issued our employees, options to purchase an aggregate of 120,000 shares of common stock. Each of the options is a conditional grant, subject to shareholder approval. Each of the options has an exercise price of $4.25 per share, and 100,000 have a term of seven (7) years and 20,000 have a term of five (5) years, and each vest in equal quarterly installments over a three (3) year period from the grant date. The aggregate of the 120,000 options had a Black-Scholes value on the grant date of $390,000.
     
  ● During the second quarter of 2022, warrant holders exercised 689,173 warrants on a cashless basis for an aggregate of 195,525 shares of common stock.
     
  ● On June 13, 2022, we entered into an agreement with an institutional investor whereby in exchange for the payment of $404,513.40 (the “Purchase Price”), the investor received (i) the right to receive the net proceeds upon the sale of certain securities of the Company (“CVR Payments”) with a quoted price equal to $674,190 (with a guaranteed minimum return of 120% of such Purchase Price and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the CVR Payments.
     
  ● On July 1, 2022, we issued an original issue discount bridge note in principal amount of $650,000 to an institutional investor in exchange for $500,000 in cash. The Bridge Note was non-interest bearing and a maturity date of August 15, 2022. Effective August 8, 2022, the bridge note was exchanged for revolving notes in the senior secured revolving credit facility.
     
  ● On August 8, 2022, we entered into a senior secured revolving credit facility agreement with an institutional investor to initially borrow up to $9,450,000 in the aggregate from time to time, subject to certain conditions. The loans are secured by all of our assets. There is currently $5,580,000 in principal outstanding on the revolving loans, which are convertible into our common stock at a conversion price of $15.00 per share, subject to adjustment for stock splits, dividends, fundamental transactions, and upon sales of our equity securities at $5.00 per share or less. In addition, as part of the transaction we extended the maturity dates of 2,590,358 outstanding common stock purchase warrants held by the lender until September 30, 2023.
     
    The revolving loans are convertible into our common stock at an initial price per share of $15.00, subject to adjustment in certain enumerated events, including deemed sales of our common stock or common stock equivalents at a price per share that is $5.00 or less.

 

Purchases of equity securities by the issuer and affiliated purchasers.

 

The following table provides information about our repurchases of our common stock that is registered pursuant to Section 12 of the Securities Exchange Act of 1934 during the year ended December 31, 2021.

 

Period  Total Number
of Shares
Purchased(b)		   Average
Price Paid
Per Share		   Total Number of
Shares
Purchased as
Part of Publicly
Announced Plans
or Programs (a)(b)		   Approximate Dollar Value of Shares
That May Yet be Purchased Under
the Plans or Programs (a)(b)		 
                 
August 1, to August 31, 2021   —    —    —   $10,000,000 
                     
September 1 to September 30, 2021   —    —    —   $10,000,000 
                     
October 1 to October 31, 2021   —    —    —   $10,000,000 
                     
November 1 to November 30, 2021   155,000    5.12    155,000   $9,206,000 
                     
December 1 to December 31, 2021   —    —    —   $9,206,000 
Total   155,000    5.12    155,000    9,206,000 

 

(a) In August 2021, our Board of Directors approved a share repurchase program pursuant to which we are authorized to repurchase up to $10,000,000 of our common stock in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices. The total remaining authorization for future common share repurchases under our share repurchase program was $9.2 million as of December 31, 2021. Under the program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable law and regulation. This includes purchases pursuant to Rule 10b5-1 plans, including accelerated share repurchases. The program does not have an expiration date.

 

14

 

 

ITEM 6. SELECTED FINANCIAL DATA.

 

Not applicable to a smaller reporting company.

 

ITEM 7. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

 

The following Management’s Discussion and Analysis of Financial Condition and Results of Operations contains forward-looking statements regarding our business development plans, timing, strategies, expectations, anticipated expenses levels, business prospects and positioning with respect to market, demographic and pricing trends, business outlook, technology spending and various other matters (including contingent liabilities and obligations and changes in accounting policies, standards and interpretations) and express our current intentions, beliefs, expectations, strategies or predictions. These forward-looking statements are based on a number of assumptions and currently available information and are subject to a number of risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth under “Special Note Regarding Forward-Looking Statements” and under “Risk Factors” and elsewhere in this annual report. The following discussion should be read in conjunction with our financial statements and related notes thereto included elsewhere in this annual report.

 

Our Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is provided in addition to the accompanying consolidated financial statements and notes to assist readers in understanding our results of operations, financial condition, and cash flows. MD&A is organized as follows:

 

Executive Overview

 

Financial results:

 

  ● Revenue was $26.7 million, up approximately 312% for year ended December 31, 2021 versus 2020.
     
  ● Cash, cash equivalents and marketable securities were $17.0 million as of December 31, 2021.

 

Reportable Segments

 

We have a single operating and business segment, Sequire, which is comprised of two reporting units; Sequire and LD Micro. Our Sequire segment includes the licensing of our SaaS based Sequire platform and related services, and our event and conference operations. The segment amounts included in MD&A are presented on a basis consistent with our internal management reporting. All differences between our internal management reporting basis and accounting principles generally accepted in the United States of America (“GAAP”), along with certain corporate-level and other activity, are included in Corporate and Other. Our management, along with our chief executive officer, who acts as our Chief Operating Decision Maker (as such term is defined accounting segment reporting guidance), review financial information presented on a consolidated basis for purposes of allocating resources and evaluating performance and do not evaluate using asset information.

 

Deconsolidation of BIGToken, Inc.

 

On December 29, 2021, our subsidiary BIGtoken, Inc. (fka Force Protection Video Equipment) completed a merger with BritePool, Inc. (BritePool). As a result of the transaction our ownership interest in BIGToken was reduced from 65.9% to 36.45% of the issued and outstanding common stock. As part of the transaction, we entered into an exchange agreement pursuant to which we converted 135,870,262,448 or approximately 50% of the issued and outstanding shares of BIGToken into non-voting Series D Convertible Preferred Stock (“Series D Stock”). The decrease in our ownership of voting equity resulted in our loss of the ability to exert significant control over BIGToken resulted in us deconsolidating its operation.

 

We have classified the related assets and liabilities associated with BIGToken’s business as discontinued operations in our consolidated balance sheet. The financial results of BIGToken’s business has been presented as discontinued operations in our consolidated statement of income for all periods presented through the respective transaction close date. Please see “Note 2 — Discontinued Operations” in our consolidated financial statements included elsewhere in this report for additional information. As such, the discussion of our results of operations and the related tables, below do not included the operations of BIGToken, as its results of operations have been included in discontinued operations on the consolidated statements of operations.

 

15

 

 

Business Focus

 

During 2021, we have focused on: (i) the continued growth of our Sequire platform’s functionality and user base and (ii) the expansion of LD micro events and offerings.

 

Covid-19

 

Our business has been impacted by the COVID-19 pandemic, which has resulted in authorities implementing numerous preventative measures to contain or mitigate the outbreak of the virus, such as travel bans and restrictions, limitations on business activity, quarantines, and shelter-in-place orders. These measures have caused, and are continuing to cause, business slowdowns or shutdowns in affected areas, both regionally and worldwide, which have significantly impacted our business and results of operations. We are unable to predict the impact of the pandemic on user growth and engagement with any certainty, and we expect these trends to continue to be subject to volatility.

 

More recently, we believe the pandemic has contributed to an acceleration in the shift of commerce from offline to online, as well as increasing consumer demand for purchasing products as opposed to services, and we experienced increasing demand for our products as a result of these trends. The impact of the pandemic on our overall results of operations, remains highly uncertain for the foreseeable future.

 

We intend to continue to invest in our business based on our company priorities, and we anticipate that additional investments in our network infrastructure, as well as scaling our headcount to support our growth, will continue to drive expense growth in 2022.

 

FINANCIAL CONDITION

 

Going Concern

 

Cash on hand and marketable securities at December 31, 2021 was approximately $1.35 million and $15.6 million, respectively. Based upon our cash flow projections taking into account cash, marketable securities and the projected cash flows from operations we believe we have enough liquidity, taking into account the uncertainty related to the ongoing pandemic and general economic uncertainty, to continue to fund operations at their currently level through the remainder of the year.

 

The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash from the sales of its services to in excess of operating expenses. In addition, the Company’s operations may require additional financial support or additional financing. These factors create uncertainty or doubt about the Company’s ability to continue as a going concern within one year after the date that the consolidated financial statements are issued. The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

 

Cash, Cash Equivalents, and Investments

 

As of December 31, 2021, we had (i) cash of $1.35 million , and (ii) marketable securities of $15.6 million for a total of approximately $17 million  compared to $8.90 million as of December 31, 2020. Cash and cash equivalents consist primarily of highly liquid investments such as money market funds and deposits held at major banks. In addition, we had availability of $1,000,000 of unused amounts available under a credit facility as of December 31, 2021. Certain of such unused amounts are subject to satisfying specified conditions prior to draw-down (such as pledging to our lenders sufficient subscriptions and customer contracts).

 

16

 

 

Components of Results of Operations

 

Revenues

 

Sequire Platform: We recognize revenue from the licensing of our Sequire platform, data, marketing and insight services performed in conjunction with the Sequire platform. We recognize revenue using the percentage of completion method based primarily on time.

 

Conference Revenue. We recognize revenue from hosting conferences and associated sponsorships. We receive payment from presenting companies and sponsors of the conferences.

 

2020 was the first full year of operations for our Sequire business. We charge a base monthly license fee for a Sequire subscription, which ranges from $1,000 per month up to $5,000 per month.

 

During the third quarter of 2020, we acquired LD Micro, Inc. LD Micro’s primary line of business was the hosting of investor related conferences. Historically, LD Micro’s investor conferences have been in-person, however, during the past year we have successfully hosted virtual conferences leveraging Sequire’s platform technology to execute these events.

 

The following table presents net revenues by type for the periods indicated (in dollars, except percentages):

 

   Year Ended December 31, 
   2021   2020   % Change 
Sequire platform revenue  $24,514,000   $5,976,000    310%
Conference revenue   1,229,000    503,000    144%
Other revenues   964,000    -    n/a 
Total net revenues  $26,707,000   $6,479,000    312%

 

Operating Expenses

 

Cost of revenue. Our cost of revenue consists primarily of expenses associated with the cost of media from third parties. If the estimated consideration expected to be received under a revenue contract less than the estimated cost to fulfill our obligations under the contract, the Company will record a liability for the estimated cost in excess of estimated consideration in the period this is knowable.

 

Employee Related Costs. These are the costs we incur to employ our staff.

 

Platform costs. Consist of the technology and content hosting of our Sequire.

 

Marketing, data services and sales. These are the costs we incur to market our products, data service fees and third-party selling costs.

 

Depreciation and Amortization. Depreciation and Amortization cost represent an allocation of the costs incurred to acquire the long-lived assets used in our business over their estimated useful lives. Our long-lived assets consist of property and equipment and internally developed software.

 

General and administrative. General and administrative expense consists primarily of human resources, information technology, professional fees, IT and facility overhead, and other general corporate expense. We expect our general and administrative expense to increase in absolute dollars primarily as a result of the increased costs associated with being a stand-alone public company. However, we also expect our general and administrative expense to fluctuate as a percentage of our revenue in future periods based on fluctuations in our revenue and the timing of such expense.

 

2020 was the first full year of operations for our Sequire business. We charge a base monthly license fee for a Sequire subscription, which ranges from $1,000 per month up to $5,000 per month.

 

During the third quarter of 2020, we acquired LD Micro, Inc. LD Micro’s primary line of business was the hosting of investor related conferences. Historically, LD Micro’s investor conferences have been in-person, however, during the past year we have successfully hosted virtual conferences leveraging Sequire’s platform technology to execute these events.

 

17

 

 

Operating Expenses

 

The following table presents operating expenses for the periods indicated (in dollars, except percentages):

 

   Year Ended December 31, 
   2021   2020   % Change 
Cost of revenues   

6,521,000

    

1,789,000

    

265

%
% of net revenues   

24

%   

28

%     
Employee related costs   7,533,000    4,683,000    61%
% of net revenues   28%   72%     
Platform costs   214,000    960,000    (78)%
% of net revenues   1%   15%     
Marketing, data service and sales   6,330,000    1,717,000    269%
% of net revenues   24%   27%     
Depreciation and Amortization   842,000    772,000    9%
% of net revenues   3%   12%     
General and administrative   5,352,000    3,590,000    49%
% of net revenues   20%   55%     
Total operating expenses   26,792,000    13,511,000    98%

 

Revenues

 

Revenues for the year ended December 31, 2021 increased to approximately $26,707,000 compared to approximately $6,479,000 for the year ended December 31, 2020. Sequire’s continued growth was primarily driven by the growth of the services provided to issuers through the Sequire platform. During the year ended December 31, 2021, the Company closed sales with total gross contract value of approximating $44,000,000.

 

In certain circumstances, the Company accepts payment in the form of securities of our publicly held customers. The Company values the securities in accordance with ASC 820, see the Valuation section of our Management Discussion and Analysis section for further discussion.

 

Sequire Operating Expenses

 

Operating expenses consisted of the following:

 

Costs of revenue: Sequire’s operating expenses for the years ended December 31, 2021 and 2020 were approximately $6,521,000 and $1,789,000, respectively.

 

Employee Related Costs. These are the costs we incur to employ our staff. Employee related costs increased to $7,533,000 during the year ended December 31, 2021 compared to $4,683,000 for the year ended December 31, 2020. The increase is primarily the result of an increase in staffing expenses due to an increase in the number of employees in all departments of the business to support the growth in operations during the year. We expect these expenses to continue to increase in absolute dollars as revenue increases.

 

Platform costs. Consist of the technology and content hosting. Platform costs for the year ended December 31, 2021 were $214,000. For the year ended December 31, 2020 Platform costs were $960,000. These costs decreased from the prior year due to the Company’s elimination of the outsourcing of certain function to support to the Company’s platform. We expect these costs to continue to increase in absolute dollars as we continue to grow but expect that they continue to decrease as a percentage of our revenues.

 

Marketing, data services and sales. These are the costs we incur to market our products and third-party services and selling costs. Marketing, data services and sales for the years ended December 31, 2021 and 2020 were $6,330,000 and $1,717,000, respectively. We expect these costs to continue to grow in nominal dollars as we continue to grow but expect that they continue to decrease as a percentage of our revenues.

 

Depreciation and Amortization. Depreciation and Amortization cost represent an allocation of the costs incurred to acquire the long-lived assets used in our business over their estimated useful lives. Our long-lived assets primarily consist of internally developed software. For the years ended December 31, 2021 and 2020 depreciation and amortization were $842,000 and $772,000, respectively. We expect these expenses to continue to increase as we anticipate further investment in long-lived assets to support our business growth.

 

18

 

 

Corporate and Other Operating Expenses

 

Corporate and Other Operating expense consists primarily of human resources, information technology, professional fees, IT and facility overhead, and other general corporate expense. General and Administrative expenses were approximately $5,352,000 and $3,590,000 million for the years ended December 31, 2021 and 2020, respectively. The increase in expense for the year is driven by an increase in corporate employee and staffing related expenses to support the growth of the Company.

 

We expect our general and administrative expense to increase in absolute dollars as we continue to grow our business. However, we also expect our general and administrative expense to decrease as a percentage of our revenues as revenues increase.

 

Net Loss

 

The Company’s Net Loss for the year-ended December 31, 2021 was $41,227,000. This represented an increase of $26,522,000 from the prior year. The increase in Net Loss for the year ended December 31, 2021 was primarily due to an increase in Net loss from our Discontinued Operations.

 

Discontinued Operations represent the results from operations of BIGtoken. Upon the deconsolidation of BIGtoken, BIGtoken’s operating results, assets, liabilities and cash flows for all periods presented have been classified as discontinued operations within the Consolidated Financial Statements.

 

Loss from discontinued operations for the year ended December 31, 2021 was $25,060,000, which represented an increase of $20,419,000 from the year ended December 31,2020. The loss from discontinued operations for the year-ended December 31, 2021 includes a loss of $10,684,000 related to our disposal of BIGtoken.

 

See “Note 2 – Discontinued Operations” in our consolidated financial statements included elsewhere in this report for additional information.

 

Loss from continuing operations for the year ended December 31, 2021 was $16,167,000, which represented an increase of $6,103,000 from the year ended December 31,2020.

 

Cash Flows

 

   Year Ended December 31, 
   2021   2020 
(In $)        
Net cash provided by (used in):          
Continuing operating activities   (15,317,000)   (9,154,000) 
Continuing investing activities   3,998,000    6,221,000
Continuing financing activities   15,443,000    7,862,000 

 

Cash flows from continuing operating activities

 

The primary use of operating cash is to pay our media, data and platform vendors, employees and others for a wide range of services. Cash flows used in operating activities increased by $6,163,000 during the year ended December 31, 2021, primarily driven by an increase in operating expenses and costs of revenues, partially offset by increases in cash receipts and revenues.

 

The Company expects to continue to use cash in excess of receipts generated from operations for the foreseeable future due to the substantial portion of the Company’s sales paid for in marketable securities of our customers. The Company classifies sales of marketable securities received from our customers for the payment of our services as investing activities.

 

19

 

 

Cash flows from continuing investing activities

 

Our principal recurring investing activities are the funding of our internal software development and the sale of marketable securities. During the years ended December 31, 2021, and 2020, net cash provided by investing activities was $3,998,000 and $6,221,000, respectively. Expenditures for software development were $798,000 and $633,000 for the years ended December 31, 2021, and 2020, respectively. Deferred payments related to our acquisition of LD Micro during the year December 31, 2021, were $3,004,000. During years ended December 31, 2021, the Company generated $8,666,000 from the sale of marketable securities and purchased $1,450,000 of marketable securities.

 

Cash flows from continuing financing activities

 

During the years ended December 31, 2021, we generated net cash from financing activities of $15,443,000. During the years ended December 31, 2020, cash provided by financing activities was $7,862,000.

 

Recently Issued Accounting Pronouncements

 

For further information on recently issued accounting pronouncements, see Note 1—Summary of Significant Accounting Policies in the accompanying notes to Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” of our Annual Report on Form 10-K.

 

Off balance sheet arrangements

 

As of the date of this report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with us is a party, under which we have any obligation arising under a guarantee contract, derivative instrument or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets.

 

Liquidity and Capital Resource Requirements

 

Our primary source of cash is from proceeds received from the sale of marketable securities we receive from our customers as consideration for our services, as well as cash proceeds received directly from customers as consideration.

 

Our primary use of cash is the payment of our operating costs, which consist primarily of employee-related expenses, such as compensation and benefits, as well as general operating expenses for our SaaS operations, marketing, facilities and overhead costs, and capital expenditures. We also utilize cash for debt service, stock repurchases, dividends on the Preferred Stock, and business acquisitions. Cash generated from operations, along with our existing cash, cash equivalents, and short-term investments, are our primary sources of operating liquidity, and we believe that our operating liquidity is currently insufficient to support our business operations, including debt service, and capital expenditure requirements.

 

We believe that our current sources of funds, along with the financing source described below, will provide us with adequate liquidity during the 12-month period following December 31, 2021, including to repay our remaining debt obligations. Our future capital requirements will depend on many factors, however, the Company’s primary source of capital is the sale of marketable securities received as consideration for the licensing of our Sequire platform and the associated services. The marketable securities the Company receives are primarily issued through an exemption to registration and as a result are restricted from resale into the public market for a period of time. The periods of restriction are generally at least six months, and in some cases up to two years. These restriction periods often change based on circumstances outside of the Company’s control, such as the issuers status with filing of current information. Since a majority of the marketable securities are primarily listed on the OTC Markets, they are more likely to experience such changes in restriction periods. The changes in restriction periods in conjunction with market volatility make it difficult to predict the timing of the associated cash flows from the sales of these marketable securities. Additionally, other factors such as , our subscription growth rate, subscription renewal activity, including the timing and the amount of cash received from customers, the expansion of sales and marketing activities, the timing and extent of spending to support development efforts, the introduction of new and enhanced products, the continuing market adoption of Sequire.

 

Financing Arrangements

 

In May 2020, we entered into an at-the-market Sales Agreement with B. Riley FBR, Inc. for the sale of up to $3,125,000 of shares of our Class A Common Stock. The at-the-market agreement was entered into pursuant to a takedown from our shelf registration statement declared effective on December 11, 2019 (Registration No. 333-235298). During 2021, we sold 53,616 shares under such agreement at an average per share price of $5.47 resulting in gross proceeds of $293,000 and net proceeds of $284,000 after deducting commissions and other costs and expenses associated with such sales. On April 15, 2022 we lost our ability to utilize Form S-3 registration statements for the registration of our securities. Accordingly, we are no longer able to utilize the ATM.

 

During the three months ended March 31, 2022 the Company entered into a factoring agreement with a financial institution to sell certain accounts receivable and future sales of up to $3 million. The factoring agreement was fully paid off with the proceeds of our revolving credit facility described below. Pursuant to the revolving credit facility, we are precluded from entering into future factoring agreements while loans are outstanding under the credit facility.

 

We may, in the future, enter into arrangements to acquire or invest in complementary businesses, products, and technologies. Finally, we continually evaluate our cash needs and may decide it is best to raise additional capital or seek alternative financing sources to fund the rapid growth of our business, including through drawdowns on existing debt facilities. Conversely, we may also from time to time determine that it is in our best interests to voluntarily repay certain indebtedness early or repurchase our common stock through our Stock buy-back program.

 

On August 8, 2022, we entered into a revolving line of credit allowing us to borrow up to $9.45 million in principal. Until such time that the Company becomes current on its reporting obligations under the Securities Exchange Act of 1934, the maximum amount accessible is limited to $5.5 million. The revolving credit line has a two-year term with a variable repayment schedule that is tied to the proceeds the Company generates from the sale of marketable securities from its portfolio. The principal repayment as a percentage of proceeds from marketable securities is 10% for the first three months and increase up to 20% after 12 months. Further, we agreed to pay the lender in the credit facility, an amount equal to ten percent (10%) of the net proceeds actually received by us from the sale any securities of a customer that we acquired during the term of the revolving note(s).

 

20

 

 

As of December 31, 2021, our cash on hand was approximately $1.35 million. We reported a net loss from continuing operations for both the years ended December 31, 2021 and 2020.

 

We have historically financed our operations primarily from the sale of debt and equity securities. Recently, our operations from Sequire and LD Micro have resulted in increased revenue, but we are still not cash flow positive, and accordingly cannot fund our operations solely from our revenue. Notwithstanding our recent revolving credit facility financing (including the bridge note), for which we have received approximately $5.5 million, partially offset by the required payments we made under outstanding obligations of $3.75 million at closing, we are still unable to meet all of our obligations as they become due. We anticipate that we will need to continue to fund our operations from the sale of debt and equity securities. Additionally, we are delinquent in our SEC reporting obligations and have received notices from Nasdaq that if we are not current with our reporting obligations by October 12, 2022, we will be delisted. Although we have been historically successful in raising capital through the sale of our equity and debt securities, and management believes that such capital sources will be available should they be required, there can be no assurance that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. Further, in the event we are delisted from Nasdaq, raising capital through the sale of our equity or debt securities will be more challenging as investors are historically less likely to purchase securities that are not listed on a national exchange.

 

Capital Allocation Framework

 

As noted above, after cash utilization required for working capital, capital expenditures, and required debt service, we expect that our primary usage of cash will be for business combinations, repayment of outstanding indebtedness, and/or stock repurchases under repurchase programs that may be in place from time to time (subject to the terms of our 2020 Credit Agreement). For further information regarding our recent stock repurchase program, see above.

 

Critical Accounting Policies and Estimates

 

Critical accounting estimates are those estimates made in accordance with generally accepted accounting principles that involve a significant level of estimation uncertainty and have had or are reasonably likely to have a material impact on the financial condition or results of operations of the registrant.

 

Revenue Recognition

 

We derive and report our revenue in two categories: (a) recurring revenue, which includes bundled SaaS, unbundled SaaS, and optional managed services, and (b) nonrecurring revenue, which primarily consists of our event revenue. We account for a contract with a customer when approved, the contract is committed, the rights of the parties, including payment terms, are identified, the contract has commercial substance and consideration is probable of collection. We recognize revenue when control of the promised goods or services is transferred to our customers, in an amount that reflects the consideration that we expect to receive in exchange for those services. Products sold by us are delivered electronically. We generate all of our revenue from contracts with customers. We generally invoice a customer in advance of delivery, or in accordance with specific contractual provisions. Payments are due as per contract terms and do not contain a significant financing component. The primary purpose of our invoicing terms is to provide customers with simplified and predictable ways of purchasing our goods and services, and not to provide financing to or from customers.

 

We account for revenue in accordance with Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606). Our revenue recognition policies require us to make significant judgments and estimates. In applying our revenue recognition policy, we must determine which portions of our revenue are recognized at a point in time and which portions must be deferred and recognized over time. We analyze various factors including, but not limited to, the selling price of undelivered services when sold on a stand-alone basis, our pricing policies, the creditworthiness of our customers, and contractual terms and conditions in helping us to make such judgments about revenue recognition. Changes in judgment on any of these factors could materially impact the timing and amount of revenue recognized in a given period.

 

Our contracts with customers often include promises to transfer multiple products and services to a customer. In contracts with multiple performance obligations, we identify each performance obligation and evaluate whether the performance obligations are distinct within the context of the contract at contract inception. Performance obligations that are not distinct at contract inception are combined. For bundled SaaS arrangements, we determine whether the services performed during the initial phases of an arrangement, such as setup activities, are distinct. In most cases, we consider our bundled SaaS deliverable to represent a single performance obligation comprised of a series of distinct services that are substantially the same and that have the same pattern of transfer (i.e., distinct days of service). We record deferred revenue attributable to certain process transition, setup activities where such activities do not represent separate performance obligations. Implementation, support, and other services are typically considered distinct performance obligations when sold with a software license unless these services are determined to significantly modify the software. The transaction price is generally in the form of a fixed fee at contract inception.

 

21

 

 

We enter into contracts to sell our products and services, and while some of our sales agreements contain standard terms and conditions, there are agreements that contain non-standard terms and conditions and include promises to transfer multiple goods or services. As a result, significant interpretation and judgment is sometimes required to determine the appropriate accounting for these transactions including: (1) whether performance obligations are considered distinct and required to be accounted for separately or combined, including allocation of transaction price; (2) developing an estimate of the stand-alone selling price, or SSP, of each distinct performance obligation; (3) combining contracts that may impact the allocation of the transaction price between product and services; and (4) estimating and accounting for variable consideration, including rights of return, rebates, price protection, expected penalties or other price concessions as a reduction of the transaction price.

 

We then look to how control transfers to the customer in order to determine the timing of revenue recognition. Revenue related to bundled SaaS, professional services and customer education services is typically recognized over time as the services are performed.

 

Accounting for Business Combinations

 

We allocate the purchase price of acquired companies to the tangible and intangible assets acquired, including in-process research and development assets, and liabilities assumed, based upon their estimated fair values at the acquisition dates, with the remaining unallocated purchase prices recorded as goodwill. These fair values are typically estimated with assistance from independent valuation specialists. The purchase price allocation process requires us to make significant estimates and assumptions, especially at the acquisition date with respect to intangible assets, contractual support obligations assumed, contingent consideration arrangements, and pre-acquisition contingencies.

 

Although we believe the assumptions and estimates we have made in the past have been reasonable and appropriate, they are based in part on historical experience and information obtained from the management of the acquired companies and are inherently uncertain.

 

Examples of critical estimates in valuing certain of the intangible assets we have acquired or may acquire in the future include but are not limited to:

 

  ● future expected cash flows from software license sales, SaaS and support agreements, consulting contracts, other customer contracts, and acquired developed technologies;
  ● expected costs to develop in-process research and development into commercially viable products and estimated cash flows from the projects when completed;
  ● the acquired company’s brand and competitive position, as well as assumptions about the period of time the acquired brand will continue to be used in the combined company’s product portfolio;
  ● cost of capital and discount rates; and
  ● estimating the useful lives of acquired assets as well as the pattern or manner in which the assets will amortize.

 

Goodwill and Other Acquired Intangible Assets

 

We test goodwill for impairment at the reporting unit level, which can be an operating segment or one level below an operating segment, on an annual basis as of December 31, or more frequently if changes in facts and circumstances indicate that impairment in the value of goodwill may exist. Subsequent to the divestiture of BIGtoken, Inc. on December 28, 2021, we became a pure-play data/insights company that operates as a single reporting unit.

 

In testing for goodwill impairment, we may elect to utilize a qualitative assessment to evaluate whether it is more likely than not that the fair value of a reporting unit is less than its carrying amount. If we elect to bypass a qualitative assessment, or if our qualitative assessment indicates that goodwill impairment is more likely than not, we perform quantitative impairment testing. If our quantitative testing determines that the carrying value of the reporting unit exceeds its fair value, goodwill impairment is recognized in an amount equal to that excess, limited to the total goodwill allocated to the reporting unit.

 

22

 

 

When we decide to perform a qualitative assessment, we assess and make judgments regarding a variety of factors which potentially impact the fair value of the reporting unit, including general economic conditions, industry and market-specific conditions, customer behavior, cost factors, our financial performance and trends, our strategies and business plans, capital requirements, management and personnel issues, and our stock price, among others. We then consider the totality of these and other factors, placing more weight on the events and circumstances that are judged to most affect the reporting unit’s fair value or the carrying amount of its net assets, to reach a qualitative conclusion regarding whether it is more likely than not that the fair value of the reporting unit exceeds its carrying amount.

 

When we perform quantitative impairment testing, we utilize one or more of three primary approaches to assess fair value: (a) an income-based approach, using projected discounted cash flows, (b) a market-based approach, using valuation multiples of comparable companies, and (c) a transaction-based approach, using valuation multiples for recent acquisitions of similar businesses made in the marketplace.

 

Our estimate of fair value of our reporting unit is based on a number of subjective factors, including: (a) appropriate consideration of valuation approaches (income approach, comparable public company approach, and comparable transaction approach), (b) estimates of future growth rates, (c) estimates of our future cost structure, (d) discount rates for our estimated cash flows, (e) selection of peer group companies for the comparable public company and the comparable transaction approaches, (f) required levels of working capital, (g) assumed terminal value, and (h) time horizon of cash flow forecasts.

 

The determination of reporting units also requires judgment. We assess whether a reporting unit exists within a reportable segment by identifying the unit, determining whether the unit qualifies as a business under GAAP, and assessing the availability and regular review by segment management of discrete financial information for the unit.

 

We review intangible assets that have finite useful lives and other long-lived assets when an event occurs indicating the potential for impairment. If any indicators are present, we perform a recoverability test by comparing the sum of the estimated undiscounted future cash flows attributable to the assets in question to their carrying amounts. If the undiscounted cash flows used in the test for recoverability are less than the long-lived assets carrying amount, we determine the fair value of the long-lived asset and recognize an impairment loss if the carrying amount of the long-lived asset exceeds its fair value. The impairment loss recognized is the amount by which the carrying amount of the long-lived asset exceeds its fair value.

 

For all our goodwill and other intangible asset impairment reviews, the assumptions and estimates used in the process are complex and often subjective. They can be affected by a variety of factors, including external factors such as industry and economic trends, and internal factors such as changes in our business strategy or our internal forecasts. Although we believe the assumptions, judgments, and estimates we have used in our assessments are reasonable and appropriate, a material change in any of our assumptions or external factors could lead to future goodwill or other intangible asset impairment charges.

 

Based upon our December 31, 2021 quantitative goodwill impairment review of our reporting unit, we concluded that the estimated fair value of our reporting units exceeded its carrying value. Our reporting unit carried goodwill of $17.9 million at December 31, 2021.

 

Accounting for Stock-Based Compensation

 

We recognize the cost of employee services received in exchange for awards of equity instruments based on the grant-date fair value of the award.

 

Awards are generally subject to multi-year vesting periods. We recognize compensation expense for awards on a straight-line basis over the requisite service periods of the awards, which are generally the vesting periods.

 

Changes in assumptions can materially affect the estimate of fair value of stock-based compensation and, consequently, the related expense recognized. The assumptions we use in calculating the fair value of stock-based payment awards represent our best estimates, which involve inherent uncertainties and the application of judgment. As a result, if factors change and we use different assumptions, our stock-based compensation expense could be materially different in the future.

 

23

 

 

Going concern assessment

 

With the implementation of Financial Accounting Standards Board’s (“FASB”) standard on going concern, Accounting Standards Update (“ASU”) No. 2014-15, we assess going concern uncertainty in our consolidated financial statements to determine if we have sufficient cash and cash equivalents on hand and working capital, including available loans or lines of credit, if any, to operate for a period of at least one year from the date our consolidated financial statements are issued, which is referred to as the “look-forward period” as defined by ASU No. 2014-15. As part of this assessment, based on conditions that are known and reasonably knowable to us, we consider various scenarios, forecasts, projections, and estimates, and we make certain key assumptions, including the timing and nature of projected cash expenditures or programs, and our ability to delay or curtail those expenditures or programs, if necessary, among other factors. Based on this assessment, as necessary or applicable, we make certain assumptions around implementing curtailments or delays in the nature and timing of programs and expenditures to the extent we deem probable those implementations can be achieved and we have the proper authority to execute them within the look-forward period in accordance with ASU No. 2014-15.

 

Valuation

 

Definition and Hierarchy

 

Fair value is defined as the price received to sell an asset or paid to transfer a liability (i.e. the “exit price”) in an orderly transaction between market participants at the measurement date.

 

In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels:

 

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.

 

Level 2 – Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly.

 

Level 3 – Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. Therefore, even when market assumptions are not readily available, the fund’s own assumptions reflect those that market participants would use in pricing the asset or liability at the measurement date.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fund’s level is based on the lowest significant level input to the fair value measurement.

 

Valuation Techniques and Inputs

 

Investments in securities and listed on major securities exchanges are valued at their last reported sales price as of the valuation date.

 

Many over-the-counter contracts have bid and ask prices that are observable in the marketplace. Bid prices reflect the highest price that the marketplace participants are willing to pay for an asset. Ask prices represent the lowest price that the marketplace participants are willing to accept for an asset. For securities whose inputs are based on bid-ask prices, the Company’s valuation policies do not require that fair value always be a predetermined point in the bid-ask range.

 

The Company’s policy for securities traded in OTC markets and for listed securities for which no sale was reported on that date are generally valued at their last reported bid price if held long and last reported ask

 

These securities are categorized in Level 1 of the fair value hierarchy to the extent these securities are actively traded. Securities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 of the fair value hierarchy.

 

Investments in Restricted Securities of Public Companies

 

Investments in restricted securities of public companies cannot be offered for sale to the public until the company complies with certain statutory requirements. The valuation will not exceed the listed price on any major securities exchange. Investments in restricted securities of public companies are generally categorized in Level 1 of the fair value hierarchy. However, investments in restricted securities in public companies may be categorized in Level 2 or 3 of the fair value hierarchy depending on the level of observable liquidity. If the restriction on the sale of the restricted securities exceeds 180 days, the Company applies a marketability discount due to the nature of the restriction related to the security.

 

24

 

 

Recently Issued Accounting Pronouncements

 

For further information on recently issued accounting pronouncements, see Note 1—Summary of Significant Accounting Policies in the accompanying notes to Consolidated Financial Statements included in Part II, Item 8, “Financial Statements and Supplementary Data” of this Annual Report.

 

Off balance sheet arrangements

 

As of the date of this report, we do not have any off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, changes in financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to investors. The term “off-balance sheet arrangement” generally means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with us is a party, under which we have any obligation arising under a guarantee contract, derivative instrument or variable interest or a retained or contingent interest in assets transferred to such entity or similar arrangement that serves as credit, liquidity or market risk support for such assets.

 

ITEM 7A. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

 

Not applicable for a smaller reporting company.

 

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA.

 

Please see our consolidated financial statements beginning on page F-1 of this annual report.

 

ITEM 9. CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURE.

 

None.

 

ITEM 9A. CONTROLS AND PROCEDURES.

 

Evaluation of Disclosure Controls and Procedures

 

Our management, consisting of our Principal Executive Officer and Chief Financial Officer has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) as of December 31, 2021. This evaluation included consideration of the controls, processes and procedures that are designed to ensure that information required to be disclosed by the Company in the reports the Company files or submits under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and to provide reasonable assurance that such information is accumulated and communicated to the Company’s management, including its Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure. Management has identified material weaknesses in the Company’s internal control over financial reporting. Based on that evaluation, management concluded that our disclosure controls and procedures as of December 31, 2021 were ineffective.

 

25

 

 

Inherent Limitations over Internal Controls

 

The Company’s internal control over financial reporting is designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. generally accepted accounting principles (“GAAP”). The Company’s internal control over financial reporting includes those policies and procedures that:

 

(i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets;

 

(ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and

 

(iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

(iv) Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Management’s Annual Report on Internal Control Over Financial Reporting

 

The Company’s management is responsible for establishing and maintaining adequate internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act). Internal control over financial reporting is a process designed by, or under the supervision of the Chief Executive Officer and Chief Financial Officer and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. Management conducted an assessment of the effectiveness of the Company’s internal control over financial reporting based on the criteria set forth in Internal Control – Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (2013).

 

Based on the Company’s assessment, management has concluded that, our internal control over financial reporting was ineffective as of December 31, 2021 because of the following material weaknesses in internal controls over financial reporting:

 

  ● a lack of internal valuation experts
  ● a lack of sufficient in-house qualified accounting staff;
  ● a lack of validation of completeness and accuracy of internally prepared data, including key reports generated from systems, utilized in the operations of controls, leading to delays in the Company’s closing process;
  ● inadequate controls and segregation of duties due to limited resources and number of employees;
  ●

Lack of internal personnel to properly evaluate the fair value and the associated revenue recognition related to our non-cash revenue contracts;

  ● substantial reliance on manual reporting processes and spreadsheets external to the accounting system for financial reporting leading to delays in the Company’s closing process;
  ● lack of adequate controls in the accounting for internally developed software costs.,
  ● products and services; and the recording of sophisticated, material financing transactions which are heavily dependent upon the use of estimates and assumptions and require us using consultants;
  ● and our lack of experience in monitoring and administering, the Company’s internal control over financial reporting

 

To mitigate the items identified in the assessment, we rely heavily on direct management oversight of transactions, along with the use of legal and accounting professionals/consultants. As we grow, we expect to increase the number of employees, which would enable us to implement adequate segregation of duties within the internal control framework.

 

Remediation

 

We are continuing to seek ways to remediate these weaknesses, which stem from our small workforce and limited resources. The Company plans to hire an independent valuation expert to value the securities it receives as consideration for its services.

 

Changes in Internal Control over Financial Reporting

 

No change in our internal control over financial reporting occurred during the quarter ended December 31, 2021 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting. This annual report does not include an attestation report of our registered public accounting firm regarding internal control over financial reporting. Management’s report was not subject to attestation by our registered public accounting firm pursuant to the rules of the Securities and Exchange Commission that permit us to provide only management’s report in this annual report.

 

ITEM 9B. OTHER INFORMATION.

 

None.

 

26

 

 

PART III

 

ITEM 10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE.

 

The names of our directors and executive officers and their ages, positions, and biographies as of August 31, 2022 (except as expressly stated) are set forth below. Our executive officers are appointed by, and serve at the discretion of the Board. There are no family relationships among any of our directors or executive officers.

 

Named Executive Officers and Directors

 

Name   Age   Positions   Position
Since		  
Christopher Miglino     53   Chairman of the Board, Chief Executive Officer, President     2010  
Michael Malone     40   Chief Financial Officer     2019  
Christopher Lahiji     38   Director, President of LD Micro, Inc. (Subsidiary)     2020  
Mark Savas     54   Director     2012  
Robert Jordan     53   Director     2017  
Colleen DiClaudio     44   Director     2017  
Brock Pierce     41   Director     2021  

 

The following is biographical information on the current members of our executive officers and board of directors:

 

Christopher Miglino. Since co-founding our company in April 2010, Mr. Miglino has served as our Chief Executive Officer and a member of our board of directors. He was appointed President of our company in January 2017. He also served as our Chief Financial Officer from April 2010 until November 2014. Mr. Miglino has spent the past 20 years working in the digital advertising space and has successfully launched and sold two internet companies. Both of these companies were sold to publicly-traded companies on the NASDAQ. He has a detailed understanding of the relationship between technology and brands. Mr. Miglino previously served as a Board member for EVmo, Inc. (fka YaYYo, Inc) [OTC: YAYO] and served on their compensation committee until January 2020. Mr. Miglino also served as chairman of the Board and as interim chief executive officer of BIGtoken, Inc., a former majority owned subsidiary of SARX [OTC: BGTK]. In evaluating Mr. Miglino’s specific experience, attributes and skills in connection with his appointment to our board, we took into account his role as a co-founder of our company, his operational experience in our company as well as his professional experience in our business sector.

 

Christopher Lahiji. Christopher Lahiji has served as the president of LD Micro, Inc., our wholly owned subsidiary since it was acquired in September 2020. Mr. Lahiji has over 14 years of experience creating, managing, and running in-person and virtual conferences in the public sector. He has served as the president of LD Micro since 2006, providing investor conferences and data to micro-cap public corporations. In evaluating Mr. Lahiji’s specific experience, attributes and skills in connection with his appointment to our board, we took into account his founding of LD Micro, as well as his operational experience in LD Micro as well as professional experience in the investor conference space.

 

Michael Malone. Michael Malone has served as our chief financial officer since January 2019. Mr. Malone has over fourteen (14) years of experience in corporate finance in public and private companies. From 2014 until December 2018, he served as Vice President Finance of Westwood One, LLC, a subsidiary of Cumulus Media, Inc. (NYSE: “CMLS”), an audio broadcast network in New York. Prior to that, from January 2013 through June 2014, he served as Finance Director / Controller for Cumulus Media Network’, audio broadcast network in Georgia, until its merger with Westwood One, LLC. Prior to that from 2012 to 2013, he worked as Director of Internal Auditing of Cumulus Media. He holds a BA in accounting from Monmouth College.

 

Marc Savas. Mr. Savas has been a member of our board of directors since January 2012. Mr. Savas has over 15 years of experience in management and sales consulting and six years of experience in real estate easement acquisitions. Since January 2007 he has served as CEO of Living Full Blast, Inc., overseeing business development and consulting for numerous companies and putting together sales teams for such companies. In addition, from January 1998 until January 2006, Mr. Savas was also CEO for Unfair Advantage Inc., where he conducted 118 management consulting projects, many of which were created using programs that his company had designed. Additionally, from January 2005 until January 2009, Mr. Savas was the national Vice President of Business Development for Connexion Technologies where he built national teams of qualified individuals to effectively secure easements from large real estate owners in order to build telecommunication systems through their properties. In evaluating Mr. Savas’s specific experience, attributes and skills in connection with his appointment to our board, we took into account his management consulting and operational experience.

 

27

 

 

Robert Jordan. Mr. Jordan has been a member of our board of directors since March 2017. He is a seasoned business executive who has spent the past 20 years acquiring, managing and divesting middle-market companies spanning a variety of industries. Since 2016 he has served as Chief Executive Officer of Yoi Corporation, a Los-Angeles-based company that provides software as a service (SaaS)-based mobile digital tools for line managers. In 2013, Mr. Jordan founded Tribeca Capital Partners LLC, a private investment holding company focused on acquiring and operating lower middle market companies. Immediately prior to founding Tribeca Capital Partners LLC, from 2003 to 2013 Mr. Jordan was Chief Executive Officer of KMS Software Company, LLC, a leading human capital management SaaS company which he successfully sold to SAP AG in April 2013. Prior to KMS, Mr. Jordan held chief executive officer roles at a number of companies across several industry sectors and senior management positions at both The Walt Disney Company and Pepsi-Cola Bottling Company. He received a BSBA from Northern Arizona University and attended Executive Education programs at both Harvard Business School and UCLA School of Business. In evaluating Mr. Jordan’s specific experience, attributes and skills in connection with his appointment to our board, we took into account his executive level and senior management business experience coupled by his private investment company experience.

 

Colleen DiClaudio. Ms. DiClaudio has been a member of our board of directors since September 2017. She currently serves as president of 340B Technologies, a 340B software solutions healthcare technology company she co-founded in August 2014. From June 2009 through August 2014 she served as vice president of business development of CompleteCare Health Network, located in New Jersey. Ms. DiClaudio has received a Master’s Degree of Public Health from the University of Medicine and Dentistry of New Jersey and a Bachelor’s Degree in Public Health from Stockton University. In evaluating Ms. DiClaudio’s specific experience, attributes and skills in connection with his appointment to our board, we took into account her experience in the healthcare technology sector and entrepreneurial background.

 

Brock Pierce. Mr. Pierce has been a member of our board of directors since March 2021. Mr. Piece is currently employed or associated with the following entities: (i) Areytos Experiences, LLC, since March 2020, (ii) The Roundtable LLC, since February 2020, (iii) Affinity Media PR LLC, since May 2019, (iv) Percival Services LLC, since January 2019, (v) Unicorn Ventures LLC, since March 2018, and (vi) Integro Foundation Inc., since December 2017. Mr. Pierce has co-founded, advised, and funded over 100 companies, primarily focused on technological innovation and blockchain technologies. Mr. Pierce also ran as a presidential candidate in the United States for the 2020 election. In evaluating Mr. Pierce’s specific experience, attributes and skills in connection with his appointment to our board, we took into account his investment experience and knowledge of various technology industries.

 

Code of Ethics

 

We are committed to maintaining the highest standards of honest and ethical conduct in running our business efficiently, serving our stockholders interests and maintaining our integrity in the marketplace. To further this commitment, we have adopted our Code of Conduct and Business Code of Ethics, which applies to all our directors, officers and employees. To assist in its governance, our Board has formed three standing committees composed entirely of independent directors, Audit, Compensation and Corporate Governance and Nominating committees. A discussion of each committee’s function is set forth below.

 

Bylaws

 

Our bylaws, the charters of each Board committee, the independent status of a majority of our board of directors, our Code of Conduct and Business Code of Ethics provide the framework for our corporate governance. Copies of our Bylaws, Committee Charters, Code of Conduct and Business Code of Ethics may be found on our website at www.SRAX.com under the tab Investors – Governance. Copies of these materials also are available without charge upon written request to our Corporate Secretary at 2629 Townsgate Road #215, Westlake Village, CA 91361.

 

28

 

 

Board of directors

 

The Board of Directors oversees our business affairs and monitors the performance of management. In accordance with our corporate governance principles, the board of directors does not involve itself in day-to-day operations. The directors keep themselves informed through discussions with the Chairman and Chief Executive Officer and our Chief Financial Officer and by reading the reports and other materials that we send them and by participating in board of directors and committee meetings. Directors are elected for a term of one year. Our directors hold office until their successors have been elected and duly qualified unless the director resigns or by reason of death or other cause is unable to serve in the capacity of director. If any director resigns, dies or is otherwise unable to serve out his or her term, or if the Board increases the number of directors, the Board may fill any vacancy by a vote of a majority of the directors then in office, although less than a quorum exists. A director appointed to fill a vacancy shall serve for the unexpired term of his or her predecessor. Vacancies occurring by reason of the removal of directors without cause may only be filled by vote of the stockholders.

 

The Board currently holds regularly scheduled meetings and calls for special meetings or acts through unanimous written consents as necessary. Meetings of the Board may be held telephonically or via electronic video format. Directors are expected to attend all Board meetings and meetings of the committees of the Board on which they serve and to spend the time needed and meet as frequently as necessary to properly discharge their duties. Information with regard to committee meetings is provided for below. Although attendance of meetings is encouraged, we do not have a formal policy regarding attendance by directors at Board and committee meetings.

 

Board leadership structure and Board’s role in risk oversight

 

Mr. Miglino serves as both the Chairman of our Board of Directors and our Chief Executive Officer. We do not have a lead independent director. Given the small size of the Board and limited number of executive officers, the Board has determined that a lead independent director is currently not necessary.

 

Risk is inherent with every business, and how well a business manages risk can ultimately determine its success. We face a number of risks, including credit risk, liquidity risk, operational risk, strategic risk and reputation risk. Management is responsible for the day-to-day management of the risks we face, while the Board, as a whole and through its committees, has responsibility for the oversight of risk management. In its risk oversight role, the Board has the responsibility to satisfy itself that the risk management processes designed and implemented by management are adequate and functioning as designed. To do this, the Board meets regularly to review SRAX’s risks. Our Chief Financial Officer generally attends the Board meetings and is available to address any questions or concerns raised by any member of the Board on risk management and any other matter. The independent members of the Board work together to provide strong, independent oversight of our management and affairs through the Board’s standing committees and, when necessary, special meetings of independent directors. Our independent directors may meet at any time in their sole discretion without any other directors or representatives of management present. Each independent director has access to the members of our management team or other employees as well as full access to our books and records. We have no policy limiting, and exert no control over, meetings of our independent directors.

 

Board committees

 

The Board of Directors has standing Audit, Compensation, Compensation and Corporate Governance and Nominating committees. Each committee has a written charter. The charters are available on our website at www.SRAX.com. All committee members are independent directors. Information concerning the current membership and function of each committee is as follows:

 

Director  

Audit

Committee

  

Compensation

Committee

  

Corporate

Governance and

Nominating

Committee

Marc Savas     (1)  
Colleen DiClaudio       (1)
Robert Jordan   (1)        

 

  (1) Denotes chairperson.

 

29

 

 

Independence

 

Our Class A common stock is listed on the Nasdaq Global Market. As such, we are subject to the Nasdaq Stock Market LLC (“Nasdaq”) director independence standards. In accordance with these standards, in determining independence the Board affirmatively determines whether a director has a “material relationship” with SRAX that would compromise his or her independence from management or would cause him or her to fail to meet the Nasdaq’s specific independence criteria. When assessing the “materiality” of a director’s relationship with SRAX, the Board considers all relevant facts and circumstances, not merely from the director’s standpoint, but from that of the persons or organizations with which the director has an affiliation, and, where applicable, the frequency and regularity of the services, and whether the services are being carried out at arm’s length in the ordinary course of business. Material relationships can include commercial, consulting, charitable, familial and other relationships. A relationship is not material if, in the Board’s judgment, it is not inconsistent with the Nasdaq’s director independence standards and it does not compromise a director’s independence from management.

 

Applying the Nasdaq’s standards, the Board has determined that Messrs. Savas, Jordan, and Pierce, and Ms. DiClaudio are each “independent” as that term is defined by the Nasdaq’s independence standards.

 

Audit Committee

 

We have a designated audit committee in accordance with section 3(a)(58)(A) of the Exchange Act. The members of the Audit Committee are Robert Jordan (Chairperson), Colleen DiClaudio, and Marc Savas. The main function of our Audit Committee is to oversee our accounting and financial reporting processes. The Audit Committee assists the Board in fulfilling its oversight and monitoring responsibility of reviewing the financial information provided to shareholders and others, appoints SRAX’s independent registered public accounting firm, reviews the services performed by the independent registered public accounting firm and SRAX’s finance department, evaluates SRAX’s accounting policies and the system of internal controls established by management and the Board, reviews significant financial transactions, and oversees enterprise risk management.

 

The Board has determined that Robert Jordan qualifies as an “audit committee financial expert” within the meaning of SEC rules. An audit committee financial expert is a person who can demonstrate the following attributes: (1) an understanding of generally accepted accounting principles and financial statements; (2) the ability to assess the general application of such principles in connection with the accounting for estimates, accruals and reserves; (3) experience preparing, auditing, analyzing or evaluating financial statements that present a breadth and level of complexity of accounting issues that are generally comparable to the breadth and complexity of issues that can reasonably be expected to be raised by the Company’s financial statements, or experience actively supervising one or more persons engaged in such activities; (4) an understanding of internal controls and procedures for financial reporting; and (5) an understanding of audit committee functions. Mr. Jordan has also been determined to be “independent” by the Board as such term is defined in the NASDAQ listing standards. Additionally, Mr. Jordan meets the independence standards for audit committees under the NASDAQ rules.

 

Compensation Committee

 

The Compensation Committee assists the Board in:

 

  ● Recommending, in executive session at which our chief executive officer is not present, the compensation and awards / bonuses for our CEO or president, if such person is acting as the CEO, as well as other executive officers;
     
  ● discharging its responsibilities for approving and evaluating our officer compensation plans, policies and programs;
     
  ● reviewing and recommending to the Board, compensation to be provided to our employees and directors; and
     
  ● administering our equity compensation plan(s).

 

30

 

 

The Compensation Committee is charged with ensuring that our compensation programs are competitive, designed to attract and retain highly qualified directors, officers and employees, encourage high performance, promote accountability and assure that employee interests are aligned with the interests of our stockholders. The Compensation Committee is composed of two directors, each of whom has been determined by the Board to be independent within the meaning of Rule 5605 of the Nasdaq Marketplace Rules.

 

Mr. Savas and Ms. DiClaudio are the current members of the Compensation Committee.

 

Corporate Governance and Nominating Committee

 

The Corporate Governance and Nominating Committee:

 

  ● assists the Board in selecting nominees for election to the Board;
     
  ● monitor the composition of the Board;
     
  ● develops and recommends to the Board, and annually reviews, a set of effective corporate governance policies and procedures applicable to our company; and
     
  ● regularly review the overall corporate governance of the Company and recommends improvements to the Board as necessary.

  

The purpose of the Corporate Governance and Nominating Committee is to assess the performance of the Board and to make recommendations to the Board from time to time, or whenever it shall be called upon to do so, regarding nominees for the Board and to ensure our compliance with appropriate corporate governance policies and procedures. The Corporate Governance and Nominating Committee is composed of two directors, each of whom has been determined by the Board to be independent within the meaning of Rule 5605 of the Nasdaq Marketplace Rules.

 

Mr. Savas and Ms. DiClaudio are the current members of the Corporate Governance and Nominating Committee.

 

Delinquent Section 16(a) Reports

 

Section 16(a) of the Exchange Act requires our officers, directors, and stockholders owning more than ten percent of our common stock, to file reports of ownership and changes in ownership with the SEC and to furnish us with copies of such reports. Based solely on our review of Form 3, 4 and 5’s, the following table provides information regarding any of the reports which were filed late during the fiscal year ended December 31, 2021:

 

Name of Reporting Person   Type of Report and Number Filed Late   No. of
Transactions
Reported Late
Marc Savas   Form 4   1
Robert Jordan   Form 4   1
Colleen DiClaudio   Form 4   1
Brock Pierce   Form 4   1

 

ITEM 11. EXECUTIVE COMPENSATION.

 

Say-on-Pay

 

At our 2020 Annual Meeting of Stockholders held on December 31, 2020, we submitted two proposals to our stockholders regarding our executive compensation practices.

 

31

 

 

The first was an advisory vote on the 2019 compensation awarded to our named executive officers (commonly known as a “say-on-pay” vote). At our 2020 annual meeting, excluding broker non-votes, approximately 2,925,180 shares cast votes with regard to the say-on-pay proposal. Of those, 2,827,179 or approximately 97%, of the shares approved the compensation of named executive officers. We believe that the outcome of our say-on-pay vote signals our stockholders’ support of our compensation approach, specifically our efforts to retain and motivate our named executive officers. In light of this stockholder support, the Compensation Committee determined not to change its approach to compensation. However, even though stockholders demonstrated overwhelming support for our compensation approach in 2020, the Compensation Committee annually reviews our compensation practices to determine how they might be improved. The Compensation Committee will continue to consider the outcome of say-on-pay votes when making future compensation decisions for our named executive officers.

 

The second proposal was a vote on the frequency of future stockholder advisory votes regarding compensation awarded to named executive officers (commonly known as a “say-when-on-pay” vote). The frequency of every three years received the highest number of votes cast. Upon review and in accordance with the foregoing results, our Board of Directors determined that we would hold our next say-on-pay vote in three years, at our 2023 Annual Meeting.

  

Summary Compensation Table

 

The following table summarizes all compensation recorded by us in each of the last two completed years ended December 31, for:

 

  ● all individuals serving as our principal executive officer or acting in a similar capacity;
  ● our two most highly compensated named executive officers, whose annual compensation exceeded $100,000; and
  ● up to two additional individuals for whom disclosure would have been made in this table but for the fact that the individual was not serving as a named executive officer of our company, at December 31, 2021.

 

The value attributable to any option awards is computed in accordance with FASB ASC Topic 718. The assumptions made in the valuations of the option awards are included in Note 11 of the Notes to our Consolidated Financial Statements for the year ended December 31, 2021.

 

Name and principal position  Year  

Salary

($)

  

Bonus

($)

  

Option

Awards

($)(1)

  

All

other

compensation

($)

  

Total

($)

 
                         
Christopher Miglino,   2021    340,000    225,000    -    32,295(2)   597,295 
Chief Executive Officer   2020    340,000    50,000    648,489(3)   41,031(2)   1,079,520 
                               
Michael Malone   2021    200,000    75,000    -    9,795(2)   284,795 
Chief Financial Officer   2020    200,000    75,000    -    21,554(2)   296,554 
                               
Christopher Lahiji   2021    332,423    -    -    10,745(2)   343,168 
President, LD Micro (4)    2020    58,749    -    -    6,428(2)   65,177(5)

 

(1) The amounts included in the “Option Awards” column represent the aggregate grant date fair value of the stock options, computed in accordance with ASC Topic 718. The assumptions made in the valuations of the option awards are included in Note 17 of the notes to our consolidated financial statements appearing in the 10-K for the year end December 31, 2021 for options awarded in 2021 or prior.
(2) Healthcare benefits paid by the Company.
(3) Represents and option to purchase 300,000 shares of Class A Common Stock at an exercise of $2.97 per share and a term of 5 years. The options were fully vested on the grant date.
(4) Mr. Lahiji joined as president of LD Micro, the Company’s wholly owned subsidiary and as a member of the Board of Directors on September 16, 2020.
(5) Does not include Cash or Class A Common Stock received as a result of the acquisition of LD Micro, Inc. that closed on September 16, 2020.

 

32

 

 

Employment agreements and how the executive’s compensation is determined

 

We are a party to an employment agreement with each of Messrs. Miglino, Malone, and Lahiji which provide the compensation arrangements with these individuals. The Company has not engaged a compensation consultant or other consultant performing similar functions to advise the Company on compensation arrangements for our executive officers. Notwithstanding, as described under the heading “Director Compensation”, the Company engaged a compensation consultant to advise on the Company’s non-employee director compensation policy.

 

Employment Agreement with Mr. Miglino

 

We employ Christopher Miglino as our Chief Executive Officer for a term of four years pursuant to an employment agreement entered into on January 1, 2012. The employment agreement automatically renews for successive two-year terms unless either party provides notice of non-renewal not later than three (3) months before the conclusion of the then current term. As compensation for his services, Mr. Miglino was initially entitled to receive a base salary of $192,000 which is subject to an annual review. Subsequent to several amendments, effective October 1, 2018, Mr. Miglino’s salary was increased to $340,000 per annum. In addition, he is eligible to receive an annual bonus based upon the achievement of certain to-be-established goals fixed by the Board, which is payable in cash or non-cash compensation as determined by the Board, as well as a discretionary bonus as determined by the Board. Mr. Miglino is entitled to participate in all benefit plans we may offer, up to 45 days of paid vacation annually and reimbursement for out-of-pocket expenses incurred in furtherance of our business.

 

In addition to accrued obligations (including but not limited to, reimbursements, unpaid salary, unused vacation days, etc.), the following table sets forth the payments that would be made to Mr. Miglino in accordance with his employment agreement had he been terminated by us without cause or by Mr. Miglino for Good Reason, or termination as a result of disability on December 31, 2021.

 

Name 

Terminated
Without Cause /

For Good Reason

   Termination as a
result of Disability		 
         
Christopher Miglino          
Salary (1)  $680,000   $680,000 
Accelerated Vesting of Awards   —    — 
Health Care   43,074    — 
Total:  $723,074   $680,000 

 

(1) Amount equal to twenty-four (24) months of Base Salary. Amount is to be paid over a twenty-four (24) month period.

 

Employment Agreement with Michael Malone

 

On December 15, 2018 we entered into an Employment Agreement with Mr. Malone pursuant to which he was engaged to serve as Chief Financial Officer to be effective January 2, 2019. Under the terms of the employment agreement, Mr. Malone’s compensation includes:

 

  ● an annual base salary of $200,000;
     
  ● an annual bonus of $100,000, payable in equal quarterly installments beginning on April 1, and subject to the timely filings of our periodic reports;
     
  ● a one-time option grant to purchase 100,000 shares of Class A Common Stock with a grant date of December 15, 2018, an exercise price of $2.56 per share, a term of three (3) years that vests quarterly over a three (3) year period subject to continued employment;
     
  ● the reimbursement of up to $20,000 in expenses incurred in moving and temporary living arrangements within the first sixty (60) days following the effective date; and
     
  ● annual paid time off of 30 days per year.

 

33

 

 

Mr. Malone is entitled to participate in all benefit programs we offer our other executive officers and expense reimbursement. The employment agreement with Mr. Malone contains customary confidentiality, non-disclosure and noninterference provisions.

 

The following table sets forth the payments that would be made to Mr. Malone in accordance with his employment agreement had he been terminated by us “without cause” on December 31, 2021.

 

Name 

Terminated

Without Cause

   Termination as a
result of Disability		 
         
Michael Malone          
Salary (1)  $33,667   $— 
Total:  $33,667   $— 

 

Employment Agreement with Christopher. Lahiji

 

Effective September 16, 2020, we entered into an employment agreement with Christopher Lahiji pursuant to which he was engaged to serve as the president of LD Micro, Inc., our wholly owned subsidiary acquired in September 2020. Mr. Lahiji’s employment agreement is for a term of three (3) years. Under the terms of the employment agreement, Mr. Lahiji’s compensation includes:

 

  ● an annual base salary of $335,000;
     
  ● an annual bonus at the discretion of the board of directors with a target bonus of fifteen percent (15%) of his base salary;
     
  ● the right to receive equity incentive awards commensurate with those of similarly situated officers of SRAX;
     
  ● A remove office allowance of $1,000 per month; and
     
  ● annual paid time off of 30 days per year.

 

Upon a termination of Mr. Lahiji’s employment, he will receive the following severance benefits as applicable:

 

  (i) Upon termination for death: his estate will receive (i) salary earned but not paid through termination, (ii) pay for all contractually earned but unused days off, (iii) any annual bonus earned but unpaid through the date of termination, (iv) three (3) months of remote office allowance, and (v) any previously incurred but unpaid business expenses (collectively, “Final Compensation”);
  (ii) Upon termination for disability: Mr. Lahiji will receive the Final Compensation;
  (iii) Upon termination by the Parent “for cause” or by Mr. Lahiji without “good reason” as such terms are defined in the Employment Agreement, Mr. Lahiji will receive the Final Compensation;
  (iv) Upon a termination by the Parent other than “for cause” or by Mr. Lahiji for “good reason”: Mr. Lahiji will receive (i) the Final Compensation, (ii) twenty four (24) months of his base salary over a twenty four (24) month period, (iii) continued COBRA coverage for twenty four (24) months, and (iv) the immediate vesting of all outstanding equity grants

 

Mr. Lahiji is entitled to participate in all benefit programs we offer our other executive officers and expense reimbursement. The employment agreement with Mr. Lahiji contains customary confidentiality, non-disclosure and noninterference provisions.

 

34

 

 

The following table sets forth the payments that would be made to Mr. Lahiji in accordance with his employment agreement had he been terminated by us “without cause” or by him for “good reason” on December 31, 2021.

 

Name 

Terminated

Without Cause /

For Good Reason

 
     
Christopher Lahiji (1)     
Salary  $670,000 
Accelerated Vesting of Awards   — 
Health Care   43,074 
Total:  $713,074 

 

Equity Compensation Plans

 

Our named executive officers participate in our equity compensation plans which are as follows:

 

2012 Equity Compensation Plan

 

Our 2012 Equity Compensation Plan (“2012 Plan”) was administered by our board or any of its committees. The purposes of the 2012 Plan were to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to Employees, Directors and Consultants, and to promote the success of our business. The issuance of awards under our 2012 Plan was at the discretion of the administrator, which has the authority to determine the persons to whom any awards were granted and the terms, conditions and restrictions applicable to any award. Under our 2012 Plan, we may grant stock options, restricted stock, stock appreciation rights, restricted stock units, performance units, performance shares and other stock-based awards. Our 2012 Plan authorized the issuance of up to 600,000 shares of Class A common stock for the foregoing awards. As of December 31, 2021, we have granted awards under the 2012 Plan equal to approximately 1,334,867 shares of our Class A common stock (with all issuances in excess of 600,000 occurring subsequent to cancellations or forfeitures of certain shares under the 2012 Plan), and 901,428 shares have been cancelled or forfeited. As of January 1, 2022, the 2012 Plan terminated pursuant to its terms.

 

2014 Equity Compensation Plan

 

Our 2014 Equity Compensation Plan (“2014 Plan”) is administered by our board or any of its committees. The purposes of the 2014 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to Employees, Directors and Consultants, and to promote the success of our business. The issuance of awards under our 2014 Plan is at the discretion of the administrator, which has the authority to determine the persons to whom any awards shall be granted and the terms, conditions and restrictions applicable to any award. Under our 2014 Plan, we may grant stock options, restricted stock, stock appreciation rights, restricted stock units, performance units, performance shares and other stock-based awards. Our 2014 Plan authorizes the issuance of up to 1,600,000 shares of Class A common stock for the foregoing awards. As of December 31, 2021, we have granted awards under the 2014 Plan equal to approximately 1,672,694 shares of our Class A common stock (with all issuances in excess of 1,600,000 occurring subsequent to cancellations or forfeitures of certain shares under the 2014 Plan), and 335,733 shares have been cancelled or forfeited. Accordingly, there are 263,039 shares of Class A common stock available for future awards under the 2014 Plan. In the event of a change in control, awards under the 2014 Plan will become fully vested unless such awards are assumed or substituted by the successor corporation.

 

35

 

 

2016 Equity Compensation Plan

 

Our 2016 Equity Compensation Plan (“2016 Plan”) is administered by our board or any of its committees. The purposes of the 2016 Plan are to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to Employees, Directors and Consultants, and to promote the success of our business. The issuance of awards under our 2016 Plan is at the discretion of the administrator, which has the authority to determine the persons to whom any awards shall be granted and the terms, conditions and restrictions applicable to any award. Under our 2016 Plan, we may grant stock options, restricted stock, stock appreciation rights, restricted stock units, performance units, performance shares and other stock-based awards. Our 2016 Plan authorizes the issuance of up to 600,000 shares of Class A common stock for the foregoing awards. As of December 31, 2021, we have granted awards under the 2016 Plan equal to approximately 829,717 shares of our Class A common stock (with all issuances in excess of 600,000 occurring subsequent to cancellations or forfeitures of certain shares under the 2016 Plan), and 591,833 shares have been cancelled or forfeited. Accordingly, there are 362,116 shares of common stock available for future awards under the 2016 Plan. In the event of a change in control, awards under the 2016 Plan will become fully vested unless such awards are assumed or substituted by the successor corporation. Under the 2016 Plan, we made a conditional grant to our CFO that is subject to the approval of our shareholders to increase the number of shares issuable under the 2016 Plan.

 

Outstanding Equity Awards Value at Fiscal Year-End

 

The following table provides information concerning unexercised options, stock that has not vested and equity incentive plan awards for each named executive officer outstanding as of December 31, 2021.

 

   OPTION AWARDS   STOCK AWARDS
Name 

Number of securities underlying unexercised options

(#)

exercisable

  

Number of securities underlying unexercised options

(#)

unexercisable

  

Equity incentive

plan awards: Number of securities underlying unexercised unearned options

(#)

  

Option

exercise

price

($)

  

Option

expiration

date

 

Number of shares or units of stock that have not vested

(#)

 

Market value of shares or units of stock that have not vested

($)

  

Equity incentive

plan awards: Number of unearned shares, units or other rights that have not vested

(#)

  

Equity incentive

plan awards: Market or payout value of unearned shares, units or other rights that have not vested

(#)

 
                                          
Christopher Miglino   300,000    0              2.97   11/13/2025                                         
                                          
Michael Malone   100,000    0         2.56   1/2/2022                  

 

36

 

 

DIRECTOR COMPENSATION 

 

Role of Compensation Consultant

 

The Compensation Committee is authorized to retain the services of one or more compensation advisors, as it sees fit, in connection with the oversight of our non-employee director and executive compensation program and related policies and practices. During 2021, the Compensation Committee retained Aon PLC (“Aon”), a compensation consulting firm with regard to our non-employee director compensation policy. Aon was engaged to provide the Compensation Committee with information, recommendations, and other advice relating to the non-employee director compensation policy only and not with regard to any executive compensation policies. Aon was directly engaged and served at the discretion of the Compensation Committee and provided no other services to the Company.

 

Current Director Compensation Policy

 

On October 29, 2021, the Company’s Compensation Committee amended the Company’s non-employee director compensation policy. Effective January 1, 2022, non-employee directors will be entitled to cash compensation of:

 

  ● Annual base compensation for serving on our Board of $30,000; and

 

  ● Additional Annual Committee Compensation of:

 

  ○ Audit Committee

 

  ■ Chair — $14,000

 

  ■ Member — $7,500

 

  ○ Compensation Committee

 

  ■ Chair — $10,000

 

  ■ Member - $5,000

 

  ○ Nomination and Governance Committee

 

  ■ Chair — $7,500

 

  ■ Member — $3,000

  

Cash compensation will be paid quarterly over the year.

 

In addition, each director will be entitled to receive an annual stock option grant equal to $100,000. The number of options will be determined using the Black Scholes option pricing model. The options will vest quarterly over the grant year and have a term of seven years.

 

Legacy Director Compensation Policy

 

Effective April 15, 2018 and up until December 31, 2021, each non-employee director received $30,000 as an annual board fee payable as follows:

 

  ● Up to $15,000 in cash paid quarterly over the grant year; and
     
  ● The balance in Class A common stock purchase options issued on April 15 of each year and vesting quarterly over the grant year and have a term of seven (7) years. The stock options will be valued using the Black-Scholes option pricing model and are subject to customary assumptions used in the preparation of financial statements.

 

37

 

 

Director Compensation for 2021

 

The following table provides information concerning the compensation paid to our non-executive directors for their services as members of our board of directors for the year ended December 31, 2021. The information in the following table excludes any reimbursement of out-of-pocket travel and lodging expenses which we may have paid.

 

The awards with respect to which values are provided under the column “Option Awards” below are exclusively stock options, which have realizable value only if they actually vest over time and to the extent, if any, that our stock price exceeds the applicable exercise prices. The values provided below for these awards are based on applicable accounting standards, and do not necessarily reflect the actual amounts realized or realizable pursuant to the underlying stock options.   

 

Name   Fees earned or paid in cash ($)    

Stock

awards

($)

     Option awards ($)     Non-equity incentive plan compensation ($)    

Nonqualified deferred compensation earnings

($)

     All other compensation ($)    

Total

($)

  
Colleen DiClaudio     15,000 (1)                    15,000 (2)          —            —            —       30,000  
Marc Savas     15,000 (1)             15,000 (2)     —       —       —       30,000  
Brock Pierce     -               24,000 (3)     —       —       —       24,000  
Robert Jordan     15,000 (1)             15,000 (2)     —       —       —       30,000  

 

  (1) Compensation includes (i) portion of cash payment applicable to 2021 year for Board year beginning 4/15/20 and ending 4/14/2021 and (ii) portion of cash payment applicable for 2021 year for Board year beginning 4/15/21 until 12/31/2021.
     
  (2) Compensation applicable to 2021 year includes $15,000 from the vesting of 5,730 Class A common stock purchase options. Of these options, (i) 2,809 options have an issuance date of 4/15/20, an exercise price per share of $1.95, a term of seven (7) years, and vest quarterly on 7/15/20, 10/15/20, 1/15/21, and 4/15/21, and (ii) 2,921 options have an issuance date of 4/15/21, an exercise price per share of $4.38, a term of seven (7) years, and vest quarterly on 7/15/21, 10/15/21, 1/15/22, and 4/15/22,
     
  (3) Mr. Pierce joined the Board in March of 2021. Mr. Pierce elected to receive all options. Such amount includes (i) 803 options having an issuance date of March 10, 2021, an exercise price of $4.48 per share, a term of seven (7) years, and vest quarterly on 7/15/21, 10/15/21, 1/15/22, and 4/15/22 and (ii) 5,842 options having an issuance date of 4/15/21, an exercise price of $4.38 per share, a term of seven (7) years, and vest quarterly on 7/15/21, 10/15/21, 1/15/22, and 4/15/22

 

ITEM 12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS.

 

BENEFICIAL OWNERSHIP OF SHARES OF CLASS A COMMON STOCK 

 

At August 31, 2022, we had 26,226,401 shares of Class A common stock issued and outstanding. The following table sets forth information known to us as of August 31, 2022 relating to the beneficial ownership of shares of our Class A common stock by:

 

  ● each person who is known by us to be the beneficial owner of 5% or more of any class of our voting securities;
     
  ● Each of our current directors and nominees;
     
  ● each of our current named executive officers; and
     
  ● all current named executive officers and directors as a group.

 

Beneficial ownership is determined according to the rules of the SEC. Beneficial ownership means that a person has or shares voting or investment power of a security and includes any securities that person or group has the right to acquire within 60 days after the measurement date. This table is based on information supplied by officers, directors and principal shareholders. Except as otherwise indicated, we believe that each of the beneficial owners of the common stock listed below, based on the information such beneficial owner has given to us, has sole investment and voting power with respect to such beneficial owner’s shares, except where community property laws may apply.

 

       Common Stock         
       Common Shares         
       Underlying         
   Common   Convertible       Percent of 
Name and Address of Beneficial Owner(1) 

Shares

   Securities (2)   Total  

Class (2)

 
                 
Directors and named Executive Officers                    
Christopher Miglino   887,575    330,000    1,217,575    4.57%
Christopher Lahiji (3)   1,490,000    -    1,490,000    5.66%
Marc Savas   11,945    43,230    55,175     * 
Robert Jordan   6,510    43,230    49,740     * 
Colleen DiClaudio   7,813    43,230    51,043     * 
Michael Malone (4)   27,544         27,544     * 
Brock Pierce   20,000    31,282    51,282    * 
                     
All directors and executive officers as a group (7 persons)   2,451,387    490,971    2,942,358    10.98%
                     
Beneficial Owners of 5% or more                    
Whitefort Capital Master Fund, LP (5)   

1,713,410

    

-

    

1,713,410

    

6.51

%
Percy Rockdale LLC (6)   

2,604,576

    

-

    

2,604,576

    

9.90

%

 

* Less than one percent.

 

(1) Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and to the information contained in the footnotes to this table. Unless otherwise indicated, the address of the beneficial owner is 2629 Townsgate Rd. #215, Westlake Village, CA 91361.

 

38

 

 

(2) Pursuant to Rules 13d-3 and 13d-5 of the Exchange Act, beneficial ownership includes any shares as to which a shareholder has sole or shared voting power or investment power, and also any shares which the shareholder has the right to acquire within 60 days, including upon exercise of common shares purchase options or warrants. There are 26,315,178 shares of Class A common stock issued and outstanding as of August 31, 2022.

 

(3) Mr. Lahiji is a party to a voting agreement with SRAX whereby Mr. Lahiji appoints Mr. Miglino, or any successor designated by the Board of Directors to vote the shares of Common Stock issued in the LD Micro acquisition transaction until December 31, 2022. Mr. Lahiji is also a party to a lock-up agreement whereby Mr. Lahiji is restricted from selling the shares of Common Stock issued to him in the LD Micro acquisition transaction until September 16, 2023.
   
(4) Does not include conditional option grant to purchase 100,000 shares issued on January 6, 2022 to Mr. Malone that is subject to shareholder approval. Assuming shareholder approval, the option vests quarterly over the grant year.
   
(5) Disclosed pursuant to Schedule 13(g) filed with the SEC on February 3, 2022. Address of beneficial owner is 12 East 49th Street, 40th Floor, New York, New York 10017. Reporting Person is managed by Whitefort Capital Management, LP. David Salanic and Joseph Kaplan are co-managing partners at Whitefort Capital Management.
   
(6) Disclosed pursuant to Schedule 13(g) filed with the SEC on February 4, 2022. Address of beneficial owner is 595 Madison Avenue, 29th Floor, New York, NY 10022. Shares are owned by Percy Rockdale which owns 234,540 shares and Continental General Insurance Company (“GCIC”), which owns 2,370,036 shares. Continental Insurance Group, Ltd. (“CIG”), as the sole owner of CGIC may be deemed to be the beneficial owner and Continental General Holdings LLC (“CGH”), as the sole owner of CIG may be deemed to be the beneficial owner. Michael Gorzynski, as the sole manager of Percy Rockdale and as a manager and executive chairman of CGH, may be deemed beneficially own the shares.

 

EQUITY COMPENSATION INFORMATION

 

Securities Authorized for Issuance under Equity Compensation Plans

 

The following table sets forth securities authorized for issuance under any equity compensation plans approved by our shareholders as well as any equity compensation plans not approved by our stockholders as of December 31, 2021:

 

Plan category 

Number of securities to be issued

upon exercise of

outstanding options, warrants and rights(a)

  

Weighted average exercise price of

outstanding options, warrants

and rights ($)

   Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in column (a) 
             
Plans approved by our stockholders:               
2012 Equity Compensation Plan (1)   400,000   $2.87    166,561 
2014 Equity Compensation Plan   864,127   $3.10    263,039 
2016 Equity Compensation Plan   67,660   $2.84    328,783 
Plans not approved by stockholders               
N/A               

 

(1)2012 Equity Compensation Plan expired on January 1, 2022.

 

39

 

 

ITEM 13. CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS, AND DIRECTOR INDEPENDENCE.

 

Related Party Transactions Procedure

 

We review all known relationships and transactions in which SRAX and our directors, executive officers, and significant stockholders or their immediate family members are participants to determine whether such persons have a direct or indirect interest. Our management, in consultation with our outside legal consultants, determines based on specific fact and circumstances whether SRAX or a related party has a direct or indirect interest in these transactions. In addition, our directors and executive officers are required to notify us of any potential related party transactions and provide us with the information regarding such transactions.

 

If it is determined that a transaction is a related party transaction, the Audit Committee must review the transaction and either approve or disapprove it. In determining whether to approve or ratify a transaction with a related party, the Audit Committee will take into account all of the relevant facts and circumstances available to it, including, among any other factors it deems appropriate:

 

● the benefits to us of the transaction;
   
● the nature of the related party’s interest in the transaction;
   
● whether the transaction would impair the judgment of a director or executive officer to act in the best interests of SRAX and our shareholders;
   
● the potential impact of the transaction on a director’s independence; and
   
● whether the transaction is on terms no less favorable than terms generally available to an unaffiliated third party under the same or similar circumstances.

 

Any member of the Audit Committee who is a related party with respect to a transaction under review may not participate in the deliberations or vote on the approval of the transaction.

 

Related Party Transactions

 

Summarized below are certain transactions and business relationships between SRAX and persons who are or were an executive officer, director or holder of more than five percent of any class of our securities since January 1, 2020.

 

Information regarding disclosure of an employment relationship or transaction involving an executive officer and any related compensation solely resulting from that employment relationship or transaction is included in the Section of this Annual Report entitled “Executive Compensation.”

 

Information regarding disclosure of compensation to a director for the year ended December 31, 2021 is included in the Section of this Annual Report entitled “Director Compensation.”

 

●During the fiscal year of January 1, 2020 through December 31, 2020, we paid the following compensation to our non-employee Board members:

 

○an aggregate of $60,000 in cash paid in quarterly payments;

 

○an aggregate of 3,237 Class A common stock purchase options that vested during 2020 out of 11,252 initial options issued on April 15, 2019, with each such option having an exercise price of $5.49 per share, a term of seven (7) years and such portion that vested in 2020 was valued at $17,260 in the aggregate;

 

○an aggregate of 26,805 Class A common stock purchase options that vested during 2020 out of 37,630 initial options issued on April 15, 2020, with each such option having an exercise price of $1.95 per share, a term of seven (7) years and such vested portion was valued at $42,739 in the aggregate;

 

●Christopher Miglino, our CEO, served on the board of directors of one of our advertising customers, EVmo, Inc. (fka YayYo, Inc.) which purchases advertising at market rates. As of January 22, 2020, Mr. Miglino was no longer a member of the board of directors of YayYo, Inc.

 

●On September 4, 2020, pursuant to our agreement and plan of merger with LD Micro, Inc., we agreed to issue the shareholders of LD Micro (i) $4,000,000 with (a) $1,000,000 upon closing, (b) $1,000,000 on January 1, 2021, (c) $1,000,000 on April 1, 2021, and (d) $1,000,000 on July 1, 2021, and (ii) 1,600,000 shares of Class A Common Stock at the closing. Pursuant to his position as a shareholder of LD Micro, Christophe Lahiji, the president of LD Micro, Inc. and a member of our Board received 1,490,000 shares of Class A Common Stock and will be entitled to receive approximately 85% of the cash compensation. Mr. Lahiji is currently subject to a lock-up agreement with respect to his shares of SRAX for 36 months from the date of the closing of the merger with LD Micro and a voting agreement to vote his shares pursuant to the Board’s recommendations, which is effective until December 31, 2023

 

●The Company subleased a suite at the Sofi Stadium in Los Angeles from an entity wholly owned by Christopher Miglino, our CEO. The sublease is for a period of one (1) year, at a rate of $382,500, and commenced on the date that the stadium opened to the general public. We believe that such annual rate is a discount from prevailing market rates and is less than the master lease rate. During May of 2022, the Company renewed the lease for four (4) additional National Football League seasons for average per year of approximately $496,836 over four (4) years. This amount is a pass-through of the actual expenses incurred by our affiliate without markup. The lease terminates in February 2026.

 

●On August 4, 2021, the Board declared a one-time bonus payment of $15,000 to all non-employee directors. As a result, the Company paid an aggregate of $60,000 in bonuses.

 

●On October 29, 2021, the Compensation Committee amended the Company’s non-employee director compensation policy. The policy became effective January 1, 2022 and is set forth below under the section entitled “Director Compensation”.

 

●On January 3, 2022, we issued four (4) common stock purchase options to our non-employee directors, pursuant to our amended non-employee director compensation policy. Each option entitled the holder to purchase 29,533 shares of Class A Common Stock at an exercise price of $4.35 per share, for an aggregate exercise amount of $128,468.55. The options vest in equal quarterly over a one (1) year period from the issuance date. The options expire on the seven (7) year anniversary of the issuance date. Each option has a Black-Scholes value of $100,000.

 

40

 

 

●On January 6, 2022, we issued Michael Malone, our Chief Financial Officer, a conditional option to purchase 100,000 shares of Class A common stock. The option is subject to shareholder approval as a conditional grant. Assuming approval by the shareholders, the option has an exercise price of $4.25 per share, a term of seven (7) years and vests in equal quarterly installments over a three (3) year period from the grant date. The option had a Black-Scholes value on the grant date of $330,821.

 

●On January 6, 2022, we issued Christopher Miglino, our Chief Executive Officer, an option to purchase 120,000 shares of Class A common stock. The option has an exercise price of $4.25 per share, a term of seven (7) years and vests in equal quarterly installments over a three (3) year period from the grant date. The option had a Black-Scholes value on the grant date of $396,986.

 

●We entered into certain agreements and transactions with BIGtoken, Inc. our former subsidiary since January 1, 2020. We owned more than 50% of the outstanding common stock of BIGtoken until November 1, 2021, upon the completion of a merger by BIGtoken with a third party whereby SRAX ceased to be a majority owner of BIGtoken and Christopher Miglino and Michael Malone, were replaced as CEO and CFO respectively, by management of the target in the merger. Additionally, on December 30, 2021, SRAX converted the common stock of BIGtoken that it owned into a class of preferred stock of BIGtoken with no voting rights and a beneficial ownership limitation of 4.99%. On June 30, 2022, Christopher Miglino resigned as a board member of BIGtoken and we had no further officers or directors of SRAX performing any services for BIGtoken. The following represents transactions entered into between SRAX and BIGtoken since January 1, 2020:

 

○Pursuant to the divestiture of BIGtoken on February 4, 2021, we (i) entered into a share exchange agreement whereby we received 149,562,566,584 shares of common stock of BIGtoken (fka Force Protection Video Equipment Corp.) (ii) entered into a transition services agreement with BIGtoken, (iii) entered into a master separation agreement with BIGtoken, and (iv) entered into a registration agreement with BIGtoken with respect to the shares of common stock received pursuant to the exchange agreement.
   
 ○On December 29, 2021 we exchanged our 149,562,566,584 shares of common stock of BIGtoken for 242,079 shares of Series D Preferred Stock of BIGtoken, which (i) converts back into the same number of shares owned prior to the exchange, (ii) has a beneficial ownership limitation of 4.99% (can be increased to 9.99% on 61 days notice), and (iii) is no-voting, except as required by law.
   
 ○On February 11, 2022, we entered into a simple agreement for future equity (“SAFE”) with BIGtoken whereby we funded $300,000 and in March of 2022, we funded an additional $700,000. Upon BIGtoken completing an offering of its securities, amounts due under the SAFE will convert, at our option, into shares of Series D Preferred Stock of BIGtoken. The SAFE additionally provides that we will receive warrants to purchase Series D Preferred Stock of BIGtoken upon the completion of an equity financing.
   
 ○Between December 2021 and March 31, 2022, we factored receivables of approximately $1.2 million for BIGtoken. As of June 30, 2022, $0.4 million is due and payable to us from BIGtoken.

 

ITEM 14. PRINCIPAL ACCOUNTING FEES AND SERVICES.

 

The following table summarizes the aggregate fees billed to us by our independent auditor for 2021 and 2020. All fees were paid to RBSM LLP.

 

   2021   2020 
Audit Fees  $342,500   $326,250 
Audit-Related Fees   -    - 
Tax Fees   -    - 
All Other Fees   45,000    45,000 
Total  $387,500   $371,250 

 

Audit Fees — This category includes the audit of our annual financial statements, review of financial statements included in our Quarterly Reports on Form 10-Q and services that are normally provided by the independent registered public accounting firm in connection with engagements for those fiscal years. This category also includes advice on audit and accounting matters that arose during, or as a result of, the audit or the review of interim financial statements.

 

Audit-Related Fees — This category consists of assurance and related services by the independent registered public accounting firm that are reasonably related to the performance of the audit or review of our financial statements and are not reported above under “Audit Fees.” The services for the fees disclosed under this category include consultation regarding our correspondence with the Securities and Exchange Commission and other accounting consulting.

 

Tax Fees — This category consists of professional services rendered by our independent registered public accounting firm for tax compliance and tax advice. The services for the fees disclosed under this category include tax return preparation and technical tax advice.

 

Pre-Approval of Independent Auditor Services and Fees

 

Our Board has adopted a procedure for pre-approval of all fees charged by our independent registered public accounting firm. Under the procedure, the Audit Committee of the Board approves the engagement letter with respect to audit, tax and review services. Other fees are subject to pre-approval by the Audit Committee. The audit and tax fees, and all other fees paid to the auditors with respect to 2021 were pre-approved by the Audit Committee. RBSM LLP did not provide any other services during 2021 except those listed above.

 

41

 

 

PART IV

 

ITEM 15. EXHIBITS, FINANCIAL STATEMENT SCHEDULES.

 

Documents filed as part of this report:

 

  (1) Financial Statements. See Index to Consolidated Financial Statements appearing on page F-1.
     
  (2) Exhibits

 

            Incorporated by Reference
        Filed/                
Exhibit       Furnished       Exhibit       Filing
No.   Description   Herewith   Form   No.   File No.   Date
                         
3.01(i)   Certificate of Incorporation, filed on 8/3/11         S-1   3.01(i)   333-179151   1/24/12
3.02(i)   Certificate of Correction to Certificate of Incorporation, filed on 8/31/11         S-1   3.01(ii)   333-179151   1/24/12
3.03(i)   Certificate of Amendment to Certificate of Incorporation authorizing 1:5 reverse stock split         8-K   3.5   000-54996   9/19/16
3.04(i)   Certificate of Amendment to Certificate of Incorporation as Amended, effective 8/25/19       8-K   3.01(i)   001-37916   8/15/19
3.05(ii)   Amended and Restated Bylaws of Social Reality, Inc. adopted March 27, 2019       8-K   3.01(ii)   001-37916   4/2/19
3.06(i)   Form of Certificate of Designation of preferences, Rights and Limitations of Series A Non-Voting Preferred Stock       8-K   3.01   001-37916   9/24/21
3.07(i)   Certificate of Validation and Certificate of Increase filed on January 31, 2022       8-K/A   3.01(i)   001-37916   2/2/2022
4.01   Specimen of Class A Common Stock Certificate       8-A12B   4.1   001-37916   10/12/16
4.02   Class A Common Stock Purchase Warrant Issued to Investors in October 2014       8-K   4.7   000-54996   11/4/14
4.03   Class A Common Stock Purchase Warrant issued in Steel Media Transaction dated October 30, 2014       8-K   4.8   000-54996   11/4/14
4.04   Class A Common Stock Warrant issued in September 2016 Offering       8-K   4.6   000-54996   10/6/16
4.05   Class A Common Stock Warrant issued to October 2013 Offering       8-K   4.7   000-54996   10/24/13
4.06   Class A Common Stock Warrant issued to T.R. Winston & Company issued 8/22/13       10-Q   4.5   000-54996   11/13/13
4.07   Class A Common Stock Warrant issued to Investors in January 2014 Offering       8-K   4.6   000-54966   1/27/14
4.08   Class A Common Stock Warrant issued to Investors in September 2016       8-K   4.6   000-54966   10/6/16
4.09   Class A Common Stock Warrant issued to Investors in January 2017 Offering       8-K   4.1   001-37916   1/4/17
4.10   Class A Common Stock Warrant issued to Investors in January 2017 Offering (2nd Warrant)       8-K   4.2   001-37916   1/4/17
4.11   Class A Common Stock Placement Agent Warrant issued in January 2017 Offering       8-K   4.3   001-37916   1/4/17
4.12   Class A Common Stock Placement Agent Warrant issued in October 2016 Offering       10-K   4.12   001-37916   3/31/17
4.13   Class A Common Stock Warrant issued in Leapfrog Media Trading Acquisition       10-K   4.13   001-37916   4/2/18
4.14   Form of 12.5% Secured Convertible Debenture issued in April 2017 Offering       8-K   4.2   001-33672   4/21/17
4.15   Class A Common Stock Warrant issued in April 2017 Offering       8-K   4.1   001-33672   4/21/17
4.16   Form of Class A Common Stock Placement Agent Warrant issued in April 2017 Offering       8-K   4.3   001-33672   4/21/17
4.17**   2016 Equity Compensation Plan       1/20/17   A-1   001-37916   1/20/17
4.18**   2014 Equity Compensation Plan       8-K   10.33   000-54996   11/10/14
4.19   2012 Equity Compensation Plan       S-1   4.02   333-179151   1/24/12
4.20   Form of Stock Option Agreement for 2012, 2014 and 2016 Equity Compensation Plan       S-1   4.03   333-179151   1/24/12
4.21   Form of Restricted Stock Unit Agreement for 2012, 2014 and 2016 Equity Compensation Plan       S-1   4.04   333-179151   1/24/12
4.22   Form of Restricted Stock Award Agreement for 2012, 2014 and 2016 Equity Compensation Plan       S-1   4.05   333-179151   1/24/12
4.23   Class A Common Stock Warrant Issued to Investors and Placement Agents in October 2017 Offering       8-K   4.02   001-37916   10/27/17
4.24   Form of Placement Agent Warrant from April 2019 Offering       8-K   4.01   001-37916   4/10/19
4.25   Form of Series A Common Stock Warrant from August 2019 Offering       8-K   4.01   001-37916   8/14/19

 

42

 

 

4.26   Form of Series B and Series C Common Stock Warrant from August 2019 Offering       8-K   4.02   001-37916   8/14/19
4.27   Form of Placement Agent Warrant from August 2019 Offering       8-K   4.03   001-37916   8/14/19
4.28   Form of Class A common stock purchase warrant issued in February 2020 Offering       8-K   4.01   001-37916   3/5/20
4.29   Form of Original Issue Discount Senior Secured Convertible Debenture from June 2020 Offering       8-K   4.01   001-37916   6/30/20
4.30   Form of Warrant from June 2020 Offering       8-K   4.02   001-37916   6/30/20
4.31   Form of Placement Agent Warrant from June 2020 Offering       S-3   4.06   333-240270   7/31/20
10.01   Purchase Agreement among Richard Steel, Steel Media, and Social Reality, dated 10/30/14       8-K   2.1   000-54996   11/4/14
10.02   Asset Purchase Agreement with LeapFrog Media Trading dated 4/20/17       10-K   10.02   001-37916   4/2/18
10.03   Amendment to Asset Purchase Agreement with Leapfrog Media Trading dated 8/17/17       10-K   10.03   001-37916   4/2/18
10.04   Transition Services Agreement in Leapfrog Media Trading Transaction       10-K   10.04   001-37916   4/2/18
10.05   Sample Leakout Agreement in Leapfrog Media Trading Transaction       10-K   10.05   001-37916   4/2/18
10.06   Form of Securities Purchase Agreement for April 2017 Offering       8-K   10.1   001-37916   4/21/17
10.07   Form of Security Agreement for April 2017 Offering       8-K   10.2   001-37916   4/21/17
10.08   Form of Registration Rights Agreement for April 2017 Offering       8-K   10.3   001-37916   4/21/17
10.09   Form of Securities Purchase Agreement for October 2017 Offering       8-K   10.01   001-37916   10/27/17
10.10**   Employment Agreement with Christopher Miglino dated 1/1/12       S-1   10.01   333-179151   1/24/12
10.11**   Form of Proprietary Information, Inventions and Confidentiality Agreement       S-1   10.03   333-179151   1/25/12
10.12**   Form of Indemnification Agreement with Officers and Directors       S-1   10.04   333-179151   1/25/12
10.13   Services Agreement with Servicios y Asesorias Planic, S.A. de cv dated 1/25/13       10-K   10.9   000-54996   3/31/15
10.14   Financing and Security Agreement with FastPay Partners, LLC       8-K   10.41   000-54996   9/23/16
10.15   Securities Purchase Agreement for January 2017 Offering       8-K   10.1   001-37916   1/4/17
10.16   Placement Agent Agreement for January 2017 Offering with Chardan Capital Markets       8-K   10.2   001-37916   1/4/17
10.17   Letter Agreement dated 1/5/17       10-K   10.35   001-37916   3/31/17
10.18   Insider Trading Policy adopted as of 2/23/16       10-K   10.36   001-37916   3/31/17
10.19   Form of Securities Purchase Agreement for April 2019 Offering       8-K   10.01   001-37916   4/10/19
10.20   Form of Placement Agent Agreement from April 2019 Offering       8-K   10.02   001-37916   4/10/19
10.21   Form of Securities Purchase Agreement from August 2019 Offering       8-K   10.01   001-37916   8/14/19
10.22   Form of First Placement Agent Agreement from August 2019 Offering       8-K   10.02   001-37916   8/14/19
10.23   Form of Second Placement Agent Agreement from August 2019 Offering       8-K   10.03   001-37916   8/14/19

 

43

 

 

10.24   Form of Term Loan and Security Agreement from February 2020 Offering       8-K   10.01   001-37916   3/5/20
10.25   Form of Intellectual Property Security Agreement from February 2020 Offering       8-K   10.01   001-37916   3/5/20
10.26   Form of Securities Purchase Agreement from June 2020 Offering       8-K   10.01   001-37916   6/30/20
10.27   Form of Registration Rights Agreement from June 2020 Offering       8-K   10.02   001-37916   6/30/20
10.28   Form of Security Agreement from June 2020 Offering       8-K   10.03   001-37916   6/30/20
10.29   Agreement and Plan of Merger dated September 4, 2020 between SRAX, Inc., Townsgate Merger Sub 1, and LD Micro, Inc.       8-K   10.01   001-37916   9/11/20
10.30   Lock-up agreement dated September 4, 2020 between SRAX and Christopher Lahiji       8-K   10.02   001-37916   9/11/20
10.31   Voting Proxy Agreement dated September 4, 2020 between SRAX and Christopher Lahiji       8-K   10.03   001-37916   9/11/20
10.32   Employment Agreement between SRAX and Christopher Lahiji Dated September 4, 2020       8-K   10.04   001-37916   9/11/20
10.33   Unit Redemption Agreement dated October 30, 2020 between SRAX and Halyard MD, LLC       8-K   10.01   001-37916   11/3/20
10.34   Unit Redemption Agreement dated October 30, 2020 between SRAX and MD CoInvest, LLC       8-K   10.02   001-37916   11/3/20
10.35   Share Exchange Agreement between SRAX, Force Protection Video Equipment Corp, and Paul Feldman, dated September 30, 2020       8-K   10.01   001-37916   10/4/20
10.36   Exchange Agreement with FPVD dated December 29, 2021       8-K   10.01   001-37916   12/30/21
10.37   Form of Contingent Value Right Agreement dated June 13, 2022   *                
10.38   Form of Bridge Note dated July 1, 2022   *                
10.39   Form of Safe entered into with BIGtoken on February 11, 2022   *              
10.40   Form of Revolving Note from August 2022 Senior Secured Revolving Credit Facility       8-K   4.01   001-37916   8/12/22
10.41   Form of Credit Agreement from August 2022 Senior Secured Revolving Credit Facility       8-K   10.01   001-37916   8/12/22
10.42   Form of Guaranty Agreement from August 2022 Senior Secured Revolving Credit Facility       8-K   10.02   001-37916  

8/12/22

10.43   Form of Security Agreement (SRAX) from August 2022 Senior Secured Revolving Credit Facility       8-K   10.03   001-37916   8/12/22
10.44   Form of Security Agreement (LD Micro) from August 2022 Senior Secured Credit Facility       8-K   10.04   001-37916   8/12/22
10.45   Form of Patent Security Agreement from August 2022 Senior Secured Revolving Credit Facility       8-K   10.05   001-37916   8/12/22
10.46   Form of Trademark Security Agreement from August 2022 Senior Secured Revolving Credit Facility       8-K   10.06   001-37916   8/12/22
10.47   Form of Pledge and Escrow Agreement from August 2022 Senior Secured Revolving Credit Facility       8-K   10.07   001-37916   8/12/22
10,48   Form of Registration Rights Agreement from August 2022 Senior Secured Revolving Credit Facility       8-K   10.08   001-37916   8/12/22
10.49   Form of Fee Letter from August 2022 Senior Secured Revolving Credit Facility       8-K   10.09   001-37916   8/12/22
14.01   Code of Ethics and Conduct       S-1/A   99.1  

001-37916

   6/4/12
21.01   Subsidiaries of Registrant   *                
31.1/31.2   Certification of the Principal Executive Officer and Principal Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002   *                
32.1/32.2   Certification of Principal Executive Officer and Principal Financial Officer Pursuant to 18 U.S.C. § 1350   *                
101.INS   Inline XBRL Instance Document   *                
101.SCH   Inline XBRL Taxonomy Extension Schema   *                
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase   *                
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase   *                
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase   *                
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase   *                

 

* Filed herein

** Management contracts or compensation plans or arrangements in which directors or executive officers are eligible to participate.

 

ITEM 16. FORM 10-K SUMMARY.

 

None.

 

44

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

  SRAX, Inc.
     
October 12, 2022 By:  /s/ Chris Miglino
    Chris Miglino, Chief Executive Officer

 

POWER OF ATTORNEY

 

Each person whose signature appears below hereby constitutes and appoints Christopher Miglino his true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him and in his name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) and supplements to this report, and to file the same, with all exhibits thereto, and other documents in connection therewith, with the Securities and Exchange Commission, and hereby grants to such attorney-in-fact and agent, full power and authority to do and perform each and every act and thing requisite and necessary to be done, as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

 

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed below by the following persons on behalf of the registrant in the capacities and on the dates indicated.

 

Name   Positions   Date
         

/s/ Christopher Miglino

Christopher Miglino

   Chairman of the Board of Directors, Chief Executive Officer; principal executive officer   October 12, 2022
         

/s/ Michael Malone

Michael Malone

   Chief Financial Officer, principal financial and accounting officer   October 12, 2022
         

/s/ Marc Savas

Marc Savas

   Director   October 12, 2022
         

/s/ Colleen DiClaudio

Colleen DiClaudio

   Director   October 12, 2022
         

/s/ Robert Jordan

Robert Jordan

   Director   October 12, 2022

 

45

 

 

INDEX TO FINANCIAL STATEMENTS

 

  Page
Report of Independent Registered Public Accounting Firm F-2
Consolidated Balance Sheets as of December 31, 2021 and 2020 F-5
Consolidated Statements of Operations for the years ended December 31, 2021 and 2020 F-6
Consolidated Statements of Changes in Stockholders’ equity for the years ended December 31, 2021 and 2020 F-7
Consolidated Statements of Cash Flows for the years ended December 31, 2021 and 2020 F-8
Notes to Consolidated Financial Statements F-9

 

F-1

 

 

 

Report of Independent Registered Public Accounting Firm

 

To the Board of Directors and Shareholders of

SRAX, Inc.

 

Opinion on the Financial Statements

 

We have audited the accompanying consolidated balance sheets of SRAX, Inc. (the “Company”), as of December 31, 2021 and 2020, and the related consolidated statements of operations, stockholders’ equity and cash flows for each of the two years in the period ended December 31, 2021 and the related notes (collectively referred to as the “consolidated financial statements”). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company as of December 31, 2021 and 2020, and the results of its operations and its cash flows for each of the two years in the period ended December 31, 2021, in conformity with accounting principles generally accepted in the United States of America.

 

Substantial Doubt about the Company’s Ability to Continue as a Going Concern

 

The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As discussed in Note 1 to the consolidated financial statements, the Company has recurring losses from operations, limited cash flow, and an accumulated deficit. These conditions raise substantial doubt about the Company’s ability to continue as a going concern. Management’s plans in regard to these matters are also described in Note 1. The consolidated financial statements do not include any adjustment that might result from the outcome of this uncertainty. Our opinion is not modified with respect to that matter.

 

Basis for Opinion

 

These consolidated financial statements are the responsibility of the Company’s management. Our responsibility is to express an opinion on these consolidated financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United States) (PCAOB) and are required to be independent with respect to the Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB.

 

We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The company is not required to have, nor were we engaged to perform, an audit of the Company’s internal control over financial reporting. As part of our audits, we are required to obtain an understanding of internal control over financial reporting, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control over financial reporting. Accordingly, we express no such opinion.

 

Our audits included performing procedures to assess the risks of material misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable basis for our opinion.

 

New York, NY Washington DC, Las Vegas, NV, San Francisco, CA,

Athens GRE, Beijing, CHN, Mumbai and Pune IND

Member of ANTEA International with affiliated offices worldwide

 

F-2
 

 

Critical Audit Matters

 

The critical audit matters communicated below are matters arising from the current period audit of the consolidated financial statements that were communicated or required to be communicated to the audit committee and that (i) relate to accounts or disclosures that are material to the consolidated financial statements and (ii) involved our especially challenging, subjective, or complex judgments. The communication of critical audit matters does not alter in any way our opinion on the consolidated financial statements, taken as a whole, and we are not, by communicating the critical audit matters below, providing separate opinions on the critical audit matters or on the accounts or disclosures to which they relate.

 

Investment Valuation

 

As described in Notes 6 and 25 to the consolidated financial statements, the Company’s consolidated investments total $19,700,000 at December 31, 2021. Investments primarily consist of common stock of publicly traded companies.

 

We identified the valuation of marketable securities as a critical audit matter. The Company uses a third-party consultant to provide guidance and assistance to the Company’s management in developing the assumptions, inputs, pricing models utilized in the Put Option Pricing Models (POPMs) used in the calculations to determine discounts at the contracts’ inception dates and each of the respective balance sheet dates for financial statement reporting purposes in order to comply with the Financial Accounting Standards Board (FASB) Accounting Standards Codification (ASC) Topic 320, Investments – Debt and Equity Securities and FASB Accounting Standards Update (ASU) No. 2016-01, Financial Instruments – Overall (Subtopic 825-10) Recognition and Measurement of Financial Assets and Financial Liabilities, and ASC 820, Fair Values.

 

An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. The Company initially classifies securities between debt securities, equity securities, warrants, convertible debt, or preferred stock. For convertible debt securities the Company evaluated the security in its current “all-in” form as convertible debt and did not use the “if converted” value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities were valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity.

 

If the Company determines the listed securities trading market is not an active market, the Company observes other transactions reported by the listed company including private equity transactions, non-cash equity transactions, the trading price and other factors. The Company determined a fair value of the respective security’s price based on this analysis. This price is the lower of the listed price or the fair value based on the analysis.

 

How the Critical Audit Matter Was Addressed in the Audit

 

  ● Reviewed the qualifications, independence, objectives and scope of the third-party specialist.
  ● Used historical average daily trading volumes in conjunction with the estimated shares that can be transacted per day in order to determine the average expected days to sell securities, and whether a discount for lack of marketability is appropriate.
  ● With the assistance of an internal valuation specialist, we tested the methodology and assumptions used in the valuation. This includes testing of the model that was used to determine the value of the protective put model. Specific assumptions that were tested in the model include the stock price of the securities, volatility of the securities, the risk-free rate of interest, dividend yield, and the time-to-maturity (holding period). The assumptions used in the time-adjusted analysis include the evaluation of the Company’s holdings based on historical trading data.
  ● Tested proper classification of investment valuations within the Fair Value Hierarchy as set forth in ASC 820. We tested management’s analysis of the securities, which considered the Company’s holdings relative to the average daily trading volume of the securities over a period of time to determine whether the investment required a discount for lack of marketability.
  ● Developed an independent expectation for comparison to the Company’s estimate.

 

F-3
 

 

  ● We tested information produced by the Company as audit evidence, to evaluate whether the information is sufficient and appropriate for purposes of the audit by performing procedures to (1) test the accuracy and completeness of the information, and (2) evaluate whether the information is sufficiently precise and detailed for purposes of the audit.
  ● We used data from an external source, and evaluated the relevance and reliability of the data, and included historical stock prices and historical trading activity.
  ● We identified and tested the assumptions used by the Company which were significant assumptions to the accounting estimate. These included active market or inactive market, marketability – restrictions on resale, liquidity – estimated days to liquidate, and volatility.
  ● Reviewed and evaluated evidence of securities acquired by agreeing to contract amount, contract date, and stock certificates or agreements.

 

Revenue Recognition

 

As described in Note 1 to the consolidated financial statements, the Company derives its revenues primarily from annual contracts which include subscription fees earned from customers accessing the platform and managed services. The Company accounts for revenue contracts with customers by applying the requirements of ASC 606, Revenue from Contracts with Customers. The Company’s subscription agreements generally have annual contractual terms and are billed in advance and the amounts are non-refundable. Revenues are recognized ratably over the related contractual term beginning on the date that the platform is made available to a customer. The Company recognizes revenues ratably because the customer receives and consumes the benefits of the platform throughout the contractual period. For the year ended December 31, 2021, the Company’s revenue was $26.7 million.

 

We identified revenue recognition as a critical audit matter. The principal considerations for our determination that performing procedures relating to revenue recognition involved a high degree of audit effort in performing audit procedures and evaluating audit evidence related to the Company’s revenue recognition.

 

The Company’s financial reporting process involves determining the estimated fair value of the marketable securities received as consideration for services rendered to the Company’s customers. The transaction price is determined based on the consideration to which the Company will be entitled to receive in exchange for transferring goods or services to the customer. In cases which the Company receives marketable securities as payment the transaction price is determined to be the lower of the fair market value of the securities received or the contract amount.

 

How the Critical Audit Matter Was Addressed in the Audit

 

Addressing the matter involved performing procedures and evaluating audit evidence in connection with forming our overall opinion on the consolidated financial statements. Our audit procedures related to the Company’s determination of revenue recognition for contracts accounted for over time included the following, among others:

 

  ● Tested revenue transactions on a sample basis by tracing revenue transactions to source documents, including customer contracts, orders, invoices, marketable securities received and cash receipts, where applicable;
  ● Tested securities valuations at contract date.
  ● Tested that the deferred revenue was the lower of the contract price or the securities price.
  ● Tested the completeness and accuracy of data provided by management;
  ● Tested management’s identification of distinct performance obligations by evaluating whether the underlying goods, services, or both were highly interdependent and interrelated;
  ● Inquired and tested the estimates to complete with senior management to understand the service delivery process;
  ● Tested the contract costs through a combination of tests of details, in which we selected individual costs and obtained supporting documentation; and,
  ● Tested the mathematical accuracy of management’s calculation of revenue and deferred revenue for the performance obligation.
  ● Rolled forward activity in deferred income as a result in change in fair value.

 

We have served as the Company’s auditor since 2011

 

/s/ RBSM LLP

New York, NY

October 12, 2022

PCAOB ID: 587

 

F-4
 

 

SRAX, INC.

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31,

 

   2021   2020 
         
Assets          
Current assets          
Cash and cash equivalents  $1,348,000   $450,000 
Accounts receivable, net   821,000    1,409,000 
Contracts receivable   844,000    - 
Marketable securities   15,617,000    8,447,000 
Designated assets for return of capital   3,925,000    - 
Prepaid expenses and other current assets   430,000    361,000 
           
Current assets of discontinued operations   -    1,206,000 
Total current assets   22,985,000    11,873,000 
           
Notes receivable   935,000    893,000 
Property and equipment, net   114,000    117,000 
Intangible assets, net   1,443,000    1,492,000 
Right of use assets   257,000    366,000 
Other assets   36,000    2,000 
Goodwill   17,906,000    17,906,000 
Long-term assets of discontinued operations   -    6,364,000 
Total assets  $43,676,000   $39,013,000 
           
Liabilities and stockholders’ equity          
Current liabilities          
Accounts payable and accrued expenses  $4,095,000   $2,708,000 
Deferred revenue   12,859,000    4,842,000 
Other current liabilities   763,000    3,417,000 
Payroll protection loan - current portion   10,000    747,000 
OID notes payable   1,164,000    6,016,000 
Series A preferred stock, authorized 36,462,417 shares, $0.001 par value, 36,462,417 shares and none issued and outstanding, respectively   3,925,000    - 
Current liabilities of discontinued operations   -    1,305,000 
Total current liabilities   22,816,000    19,035,000 
           
Right of use liability - long term   114,000    243,000 
Payroll protection loan - long term   -    379,000 
Deferred tax liability   -    131,000 
Total liabilities   22,930,000    19,788,000 
           
Commitments and contingencies (Note 19)   -    - 
           
Stockholders’ equity          
Class A common stock, authorized 250,000,000 shares, $0.001 par value, 25,995,172 and 16,145,778 shares issued and outstanding, respectively   26,000    16,000 
Additional paid in capital   51,075,000    69,551,000 
Accumulated deficit   (30,355,000)   (50,342,000)
Total stockholders’ equity   20,746,000    19,225,000 
Total liabilities and stockholders’ equity  $43,676,000   $39,013,000 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-5
 

 

SRAX, INC.

CONSOLIDATED STATEMENTS OF OPERATIONS

YEARS ENDED DECEMBER 31,

 

   2021   2020 
         
Revenues  $26,707,000   $6,479,000 
           
Cost and expenses          
Cost of revenue   6,521,000    1,789,000 
Employee related costs   7,533,000    4,683,000 
Marketing and selling expenses   6,330,000    1,717,000 
Platform costs   214,000    960,000 
Depreciation and amortization   842,000    772,000 
General and administrative expenses   5,352,000    3,590,000 
Total cost and expenses   26,792,000    13,511,000 
           
Income (loss) from operations   (85,000)    (7,032,000)
           
Other income (expense)          
Financing costs   (10,295,000)   (12,150,000)
Realized gain on marketable securities   804,000    684,000 
Unrealized gain (loss) on marketable securities   (7,904,000)   261,000 
Realized loss on designated assets   (84,000)   - 
Unrealized loss on designated assets   (2,378,000)   - 
Gain on sale of SRAXmd, net   -    7,873,000 
Interest income   42,000    - 
Other income   1,144,000    - 
Change in fair value of preferred stock   2,462,000    - 
Change in fair value of derivative liabilities   -    321,000 
Total other expense   (16,209,000)   (3,011,000)
           
Loss before provision for income taxes   (16,294,000)   (10,043,000)
Provision for income tax benefit (expense)   127,000   (21,000)
Loss from continuing operations   (16,167,000)   (10,064,000)
           
Discontinued operations          
Loss before income tax benefits   (14,376,000)   (4,641,000)
Loss on disposal of subsidiary   (10,684,000)   - 
Income tax benefit   -    - 
Loss from discontinued operations   (25,060,000)   (4,641,000)
Net loss   (41,227,000)   (14,705,000)
           
Net loss attributable to non-controlling interest in discontinued operations   6,465,000    - 
           
Net loss attributable to SRAX, Inc.  $(34,762,000)  $(14,705,000)
           
Basic and diluted loss per share          
Continuing operations  $(0.69)  $(0.69)
Discontinued operations attributable to SRAX, Inc.   (0.79)   (0.32)
Net loss per share, basic and diluted  $(1.48)  $(1.01)
           
Weighted average shares outstanding, basic and diluted   23,550,744    14,649,788 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-6
 

 

SRAX, INC.

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

YEAR ENDED DECEMBER 31, 2021 AND 2020

 

                               
   Common Stock   Additional
paid-in		   Accumulated   Noncontrolling   Stockholders’ 
   Shares   Amount   Capital   Deficit   Interest   Equity 
                         
Balance, December 31, 2019   13,997,452   $14,000   $48,129,000   $(35,637,000)  $-   $12,506,000 
Stock based compensation   -    -    1,710,000    -    -    1,710,000 
Relative fair value of warrants issued with notes payable   -    -    4,331,000    -    -    4,331,000 
Shares issued for extension agreement   36,700    -    71,000    -    -    71,000 
Shares issued for debt extinguishment   100,000    -    181,000    -    -    181,000 
Conversion of debt to equity   411,626    -    434,000    -    -    434,000 
Common stock issued for the acquisition of a subsidiary   1,600,000    2,000    4,262,000    -    -    4,264,000 
Reclassification of warrants from liability to equity   -    -    4,076,000    -    -    4,076,000 
Premium on debt extinguishment   -    -    46,000    -    -    46,000 
Beneficial conversion feature   -    -    6,311,000    -    -    6,311,000 
Net loss   -    -    -    (14,705,000)   -    (14,705,000)
Balance, December 31, 2020   16,145,778    16,000    69,551,000    (50,342,000)   -    19,225,000 
Stock based compensation   -    -    1,006,000    -    -    1,006,000 
Shares issued for cash   53,616    -    284,000    -    -    284,000 
Conversion of convertible debt to equity   3,122,167    3,000    5,971,000    -    -    5,974,000 
Shares issued for exercise of warrants, net of offering costs   6,828,611    7,000    15,945,000    -    -    15,952,000 
Warrants issued as an inducement to exercise warrants   -    -    7,737,000    -    -    7,737,000 
Acquisition of noncontrolling interest of FVPD   -    -    -    -    (95,000)   (95,000)
Warrants issued by FVPD for SRAX, Inc. debenture holders   -    -    -    -    885,000    885,000 
Series B convertible preferred stock issued by FPVD   -    -    -    -    5,860,000    5,860,000 
Beneficial conversion feature FPVD series B convertible preferred stock   -    -    -    -    5,860,000    5,860,000 
Dividends on preferred stock   -    -    (6,387,000)   -    -    (6,387,000)
Disposition of subsidiary   -    -    (42,239,000)   54,749,000    (6,045,000)   6,465,000 
Repurchase and retirement of shares   (155,000)   -    (793,000)   -    -    (793,000)
Net loss attributable to SRAX, Inc.   -    -    -    (34,762,000)   -    (34,762,000)
Net loss attributable to non controlling interest in discontinued operations   -    -    -    -    (6,465,000)   (6,465,000)
Balance, December 31, 2021   25,995,172   $26,000   $51,075,000   $(30,355,000)  $-   $20,746,000 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-7
 

 

SRAX, INC.

CONSOLIDATED STATEMENTS OF CASH FLOWS

YEARS ENDED DECEMBER 31,

 

 

           
   2021   2020 
         
Cash flows from operating activities          
Net loss  $(41,227,000)  $(14,705,000)
Less: Loss from discontinued operations, net of tax   (25,060,000)   (4,641,000)
Loss from continuing operations   (16,167,000)   (10,064,000)
Adjustments to reconcile net loss to net cash used in operating activities:          
Unrealized loss (gain) on marketable securities   7,904,000    (261,000)
Realized gain on marketable securities   (804,000)   (684,000)
Unrealized loss on designated assets   2,378,000    - 
Realized loss on designated assets   84,000    - 
Gain on sale of SRAXmd   -    (7,873,000)
Interest income   (42,000)   - 
Change in fair value of preferred stock   (2,462,000)   - 
Change in fair value of derivative liabilities   -    (321,000)
Forgiveness of payroll protection program loan   (1,116,000)   - 
Warrants issued by FVPD for SRAX, Inc. debenture holders   885,000    - 
Loss on extinguishment of debt   -    1,103,000 
Warrant inducement charge   7,737,000    - 
Marketable securities received for accounts receivable previously written off   (409,000)   - 
Amortization of debt issue costs   854,000    9,128,000 
Stock based compensation   1,006,000    1,615,000 
Provision for bad debts   (20,000)   17,000 
Depreciation expense   72,000    28,000 
Amortization of intangibles   847,000    744,000 
Net change in right of use asset and liability   (20,000)   (19,000)
Non-cash financing expense   268,000    - 
Changes in operating assets and liabilities          
Accounts receivable   1,680,000    (1,439,000)
Prepaid expenses and other current assets   (820,000)   400,000 
Accounts payable and accrued expenses   3,278,000    1,521,000 
Deferred revenue   (20,669,000)   - 
Other current liabilities   350,000    (3,049,000)
Deferred tax liability   

(131,000

)   - 
Net cash used in continuing operations   (15,317,000)   (9,154,000)
Net cash used in discontinued operations   (8,118,000)   (4,335,000)
Net cash used in operating activities   (23,435,000)   (13,489,000)
           
Cash flows from investing activities          
Proceeds from the sale of marketable securities   8,666,000    519,000 
Proceeds from the sale of designated assets   

686,000

    

-

 
Purchase of marketable securities   (1,450,000)   - 
Proceeds from sale of SRAXmd, net   -    7,000,000 
Acquisition of LD Micro, net of cash acquired   -    (697,000)
Payment for deferred consideration to LD Micro   (3,004,000)   - 
Acquisition of property and equipment   (69,000)   - 
Acquisition of intangible assets   (798,000)   (633,000)
Other assets   (33,000)   32,000 
Net cash from continuing operations   3,998,000    6,221,000 
Net cash from (used in) discontinued operations   841,000    (175,000)
Net cash from investing activities   4,839,000    6,046,000 
           
Cash flows from financing activities          
Proceeds from the issuance of common stock units   284,000    - 
Proceeds from the exercise of warrants   15,952,000    - 
Repurchase of shares   (793,000)     
Proceeds from OID notes payable, less issuance costs   -    11,988,000 
Redemption of OID notes payable   -    (6,070,000)
Proceeds from issuance of short-term notes payable, less issuance costs   -    960,000 
Repayment of short-term notes payable   -    (100,000)
Proceeds from payroll protection program   -    1,084,000 
Proceeds from the issuance of notes payable   -    2,130,000 
Repayment of notes payable   -    (2,130,000)
Net cash from continuing operations   15,443,000    7,862,000 
Net cash from discontinued operations   4,736,000    - 
Net cash from financing activities   20,179,000    7,862,000 
           
Net increase in cash from continuing operations   4,124,000    4,929,000 
Net decrease in cash from discontinued operations   (2,541,000)   (4,510,000)
Cash, cash equivalents and board designated restricted cash beginning of year   451,000    32,000 
Cash, cash equivalents and board designated restricted cash end of year   2,034,000    451,000 
Less: Cash from discontinued operations   -    1,000 
Cash, cash equivalents and board designated restricted cash from continuing operations   2,034,000    450,000 
Cash reserved for designated asset for return of capital   

(686,000

)   - 
Cash and cash equivalents  $

1,348,000

   $450,000 
           
Supplemental schedule of cash flow information          
Cash paid for interest  $-   $176,000 
Cash paid for taxes  $-   $- 
           
Supplemental schedule of noncash investing and financing activities          
Common stock received in lieu of cash for accounts receivable  $27,842,000   $8,406,000 
Convertible notes converted into shares  $5,974,000   $434,000 
Designation of marketable securities for dividend distribution  $6,387,000   $- 
Dividends on preferred stock  $6,387,000   $- 
Vesting of common stock award  $-   $94,000 
Relative fair value of warrants issued with term loan  $-   $83,000 
Derivative liabilities transferred to equity  $-   $4,076,000 
Shares of common stock issued for extension agreement  $-   $71,000 
Fair value of BCF for debt financings  $-   $6,311,000 
Fair value of warrants issued for debt financings  $-   $4,248,000 
Premium on debt financings  $-   $46,000 
Original issue discount recorded on OID convertible debentures  $-   $1,931,000 
Shares issued for the acquisition of a subsidiary  $-   $4,264,000 
Common stock issued to settle liability  $

-

  

$

181,000

 

 

The accompanying notes are an integral part of these consolidated financial statements

 

F-8
 

 

SRAX, INC.

Notes to Consolidated Financial Statements

For the Years Ended December 31, 2021 and 2020

 

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization

 

SRAX, Inc. (“SRAX”, “we”, “us”, “our” or the “Company”) is a Delaware corporation formed on August 2, 2011. We are headquartered in Westlake Village, California but work as a distributed virtual Company. The Consolidated Financial Statements consist of SRAX and its wholly owned subsidiary LD Micro, Inc. (“LD Micro”).

 

We are a technology firm focused on enhancing communications between public companies and their shareholders and investors. We currently have two distinct business units, which we consider to be one reporting unit:

 

  ● Our unique SaaS platform, Sequire provides users many features which allow issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels.
  ● Through LD Micro, we organize and host investor conferences within the micro and small- cap markets, and plan to create several more niche events for the investor community.

 

Each of SRAX’s business units deliver valuable insights that assist our clients with their investor relations and communications initiatives.

 

On December 29, 2021, we deconsolidated our majority owned subsidiary BIG Token, Inc. (“BIGToken”) (formerly known as Force Protection Video Equipment Corporation). After the deconsolidation, we do not beneficially own controlling interest in BIGtoken, and no longer consolidate BIGtoken into our financial results for periods ending after December 31, 2021. The financial results of BIGtoken for the years ended December 31, 2021 and 2020 are presented as income from discontinued operations, net of taxes on the consolidated statements of operations and its assets and liabilities as of December 31, 2021 are presented as assets and liabilities of discontinued operations on the consolidated balance sheets. The historical consolidated statement of cash flows has also been revised to reflect the effect of the deconsolidation. See Note 2 – Discontinued Operations. Unless noted otherwise, discussion in the notes to the consolidated financial statements pertain to continuing operations.

 

Liquidity and Going Concern

 

The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. As of December 31, 2021, the Company had cash and cash equivalents of $1,348,000 which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited Consolidated Financial Statements are issued.

 

The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

 

In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flow and cash usage forecasts, and obligations and debts. Although management has a long history of successful capital raises, the analysis used to determine the Company’s ability as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next 12 months.

 

We expect that our existing cash and cash equivalents, our accounts receivable and marketable securities as of December 31, 2021, will not be sufficient to enable us to fund our anticipated level of operations through one year from the date these financial statements are issued.  We anticipate raising additional capital through the private and public sales of our equity or debt securities and selling our marketable securities, or a combination thereof. Although management believes that such capital sources will be available, there can be no assurances that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. If we do not raise sufficient capital in a timely manner, among other things, we may be forced to scale back our operations or cease operations altogether.

 

F-9
 

 

The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, and uncertain. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.

 

The consolidated financial statements include the accounts of the Company and its subsidiaries from the acquisition date of majority voting control of the subsidiary.

 

Business Segments

 

The Company uses the “management approach” to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics.

 

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition.

 

Use of Estimates

 

The consolidated financial statements have been prepared in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) and requires management of the Company to make estimates and assumptions in the preparation of these consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.

 

The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company’s revenue recognition, allowance for doubtful accounts and sales credits, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisition, goodwill, other intangible assets, put rights and valuation of other assets and liabilities.

 

Fair Value of Financial Instruments

 

The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

 

In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels:

 

  ● Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.;
  ● Level 2 - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly.; and
  ● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. Therefore, even when market assumptions are not readily available, the fund’s own assumptions reflect those that market participants would use in pricing the asset or liability at the measurement date.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fund’s level is based on the lowest significant level input to the fair value measurement.

 

F-10
 

 

Valuation Techniques and Inputs

 

Investments in securities and securities sold short that are both freely tradable and listed on major securities exchanges are valued at their last reported sales price as of the valuation date.

 

Many over-the-counter contracts have bid and ask prices that are observable in the marketplace. Bid prices reflect the highest price that the marketplace participants are willing to pay for an asset. Ask prices represent the lowest price that the marketplace participants are willing to accept for an asset.

 

An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. The Company initially classifies securities between debt securities, equity securities, warrants, convertible debt, or preferred stock. The Company does not have any debt securities as of December 31, 2021 and 2020. Warrants are initially valued at cost, if acquired for cash, or at intrinsic value. For convertible debt securities the investor generally should evaluate the security in its current “all-in” form as convertible debt and not use the “if converted” value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities are valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity.

 

The Company considers there to be an active market based on the guidance in ASC 820-10-35-54C. In an active market, transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. An orderly transaction assumes exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities. Whether transactions take place with sufficient frequency and volume to constitute an active market is a matter of judgement and depends on the facts and circumstances of the market for the asset or liability. If the Company determines that the trading market for a security is not an active market the Company evaluates the stock price based on other observable or unobservable inputs. A market with limited activity may still provide relevant pricing information when there is no contrary evidence that the pricing information is not relevant to the fair value of the asset. In certain situations, the Company’s security holdings represent share quantities that materially exceed the average daily trading volume of the securities in their primary market. Thus, the Company considers a discount due to the lack of liquidity. If the Company determines it can liquidate its position within 180 days based on 10% of the securities average daily trading volume, no discount is applied. Rule 144 also has an alternative volume limit for affiliates of up to 10% of the tranche (or class) outstanding for debt securities. We believe this provides a reasonable basis to suggest this 10% of trading volume should have minimal impact on market prices.

 

Securities with a marketability holding period in excess of 180 days is subjected to a discount for marketability. If a security has both a marketability holding period over 180 days and a liquidation period of over 180 days the Company will evaluate the impact of both the marketability and liquidity discounts. The Company utilizes the quoted market price on the date of valuation calculates a discount for marketability and liquidity based on a protective put option pricing model that factors in both the lack of marketability and liquidity.

 

Independent Valuation Expert

 

The Company uses a third party specialist to provide guidance around the assumptions, inputs, pricing models utilized valuation calculations into the various Put Option Pricing Models (POPMs) used in the calculations to determine discounts at contract inceptions date and each of the respective balance sheet dates.

 

If the Company has access to material non-public information regarding an investee, it will consider this information as an input for purposes of valuing the security. In these situations, the Company will consider the impact this information will have on the valuation of the securities on a case-by-case basis. These situations could arise due to the Company being an affiliate of the issuer or an officer or director of the Company is an affiliate of the issuer.

 

These securities are categorized in Level 1 of the fair value hierarchy to the extent these securities are actively traded. Securities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 of the fair value hierarchy.

 

Investments in Restricted Securities of Public Companies

 

Investments in restricted securities of public companies cannot be offered for sale to the public until the company complies with certain statutory requirements. The valuation will not exceed the listed price on any major securities exchange. Investments in restricted securities of public companies are generally categorized in Level 2 of the fair value hierarchy. However, investments in public companies may be categorized in Level 3 of the fair value hierarchy depending on the level of observable liquidity. Specifically, if the Company determines the market activity is not sufficient to conclude the market activity represents an Active Market pursuant to ASC 820 -10 -35 36B.

 

The Company evaluates the trading activity of each listed security to determine if the trading market is an Active Market for purposes of evaluating Fair Value under ASC 820. The Company evaluated the number of trade observations during the year, the percentage of the total trading days the security traded on its listed market during the full year or the portion of the year if the security was initially listed during the year, and at the dollar value of the trading activity for the full year as a percentage of the market capitalization of the security. If the Company determines the listed securities trading market is not an active market it looks at other transactions reported by the listed company including private equity transactions, non-cash equity transactions, the trading price and other factors. The Company determines a fair value of the stock price based on this analysis. This price is the lower of the listed price or the fair value based on the analysis. The Company also considers the marketability and liquidity discounts on the listed security in determining fair value.

 

Cash and Cash Equivalents

 

The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are recorded at cost, which approximates its fair value. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. As of December 31, 2021 and 2020, the Company had $1,098,000 and $200,000 in excess of the federal insurance limit, respectively.

 

F-11
 

 

Accounts Receivable

 

Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company usually does not require collateral. Allowance for doubtful accounts was approximately $130,000 and $15,000 as of December 31, 2021 and 2020, respectively.

 

Concentration of Credit and Significant Customer Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any loss on these accounts.

 

As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately 11%. As of December 31, 2020, the Company had three customers with accounts receivable balances of approximately 43.41%, 11.60%, and 10.53%.

 

For the year ended December 31, 2021, the Company had no customers that account for a significant percentage of total revenue. For the year ended December 31, 2020, the Company had one customer that accounted for 18.1% of total revenue.

 

Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the years ended December 31, 2021 or 2020, respectively.

 

Property and equipment

 

Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years.

 

Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment.

 

Intangible assets

 

Intangible assets consist of intellectual property, trademarks, trade names, and non-compete agreements, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years.

 

F-12
 

 

Costs incurred to develop computer software for internal use are capitalized once: (1) the preliminary project stage is completed, (2) management authorizes and commits to funding a specific software project, and (3) it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred prior to meeting the qualifications are expensed as incurred. Capitalization of costs ceases when the project is substantially complete and ready for its intended use. Post-implementation costs related to the internal use computer software, are expensed as incurred. Internal use software development costs are amortized using the straight-line method over its estimated useful life which ranges up to three years. Software development costs may become impaired in situations where development efforts are abandoned due to the viability of the planned project becoming doubtful or due to technological obsolescence of the planned software product. For the years ended December 31, 2021, and 2020 there has been no impairment associated with internal use software. For the years ended December 31, 2021, and 2020, the Company capitalized software development costs of $798,000 and $633,000, respectively.

 

During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use.

 

The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred.

 

Right of Use Assets and Lease Obligations

 

The Right of Use Asset and Lease Liability reflect the present value of the Company’s estimated future minimum lease payments over the lease term, which may include options that are reasonably assured of being exercised, discounted using a collateralized incremental borrowing rate.

 

Typically, renewal options are considered reasonably assured of being exercised if the associated asset lives of the building or leasehold improvements exceed that of the initial lease term. Therefore, the Right of Use Asset and Lease Liability may include an assumption on renewal options that have not yet been exercised by the Company.

 

As the rate implicit in leases are not readily determinable, the Company uses an incremental borrowing rate to calculate the lease liability that represents an estimate of the interest rate the Company would incur to borrow on a collateralized basis over the term of a lease within a particular currency environment.

 

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur or circumstances indicate the fair value of a reporting unit is below its carrying value. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. The Company performed its most recent annual goodwill impairment test as of December 31, 2021 using market data and discounted cash flow analysis. Based on this analysis, it was determined that the fair value exceeded the carrying value of its reporting units. The Company concluded the fair value of the goodwill exceed the carrying value accordingly there were no indicators of impairment for the years ended December 31, 2021 and 2020.

 

The Company had historically performed its annual goodwill and impairment assessment on December 31st of each year. This aligns the Company with other advertising sales companies who also generally conduct this annual analysis in the fourth quarter.

 

F-13
 

 

When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the impairment testing methodology primarily using the income approach (discounted cash flow method).

 

We compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows if the carrying value of a reporting unit exceeds its fair value, then the amount by which it exceeds its fair value will be recognized as an impairment.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.

 

Derivatives

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, Distinguishing Liabilities From Equity and FASB ASC Topic No. 815, Derivatives and Hedging. Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments.

 

The Company has adopted ASU 2017-11, Earnings per share (Topic 260), provided that when determining whether certain financial instruments should be classified as liability or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. If a down round feature on the conversion option embedded in the note is triggered, the Company will evaluate whether a beneficial conversion feature exists, the Company will record the amount as a debt discount and will amortize it over the remaining term of the debt.

 

If the down round feature in the warrants that are classified as equity is triggered, the Company will recognize the effect of the down round as a deemed dividend, which will reduce the income available to common stockholders.

 

Warrant Liability

 

The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black-Scholes option pricing model, at each measurement date.

 

Debt Discounts

 

The Company accounts for debt discounts originating in connection with conversion features that remain embedded in the related notes in accordance with ASC 470-20, Debt with Conversion and Other Options. These costs are classified on the consolidated balance sheet as a direct deduction from the debt liability. The Company amortizes these costs over the term of its debt agreements as interest expense-debt discount in the consolidated statement of operations.

 

F-14
 

 

Revenue Recognition

 

On January 1, 2018, we adopted ASU 2014-09, “Revenue from Contracts with Customers” (Topic 606) (“ASC 606”) and applied this guidance to those contracts which were not completed at the date of adoption using the modified retrospective method. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods (ASC 605). The adoption did not have a significant impact to the nature and timing of our revenues, results of operations, cash flows and statement of financial position. 

 

Revenue from all sale types is recognized at transaction price, the amount we expect to be entitled to in exchange for transferring goods or providing services. Transaction price is calculated as selling price net of variable consideration which may include estimates for future returns, sales incentives and price protection related to current period product revenue. Our standard obligation to our direct customers generally provides for a full refund in the event that such product is not merchantable or is found to be damaged or defective. In determining estimates for future returns, we estimate variable consideration at the expected value amount which is based on management’s analysis of historical data, channel inventory levels, current economic trends and changes in customer demand for our products. Sales incentives and price protection are determined based on a combination of the actual amounts committed and through estimating future expenditure based upon historical customary business practice. We continue to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur.

 

We enter into contracts to sell our products and services, and while some of our sales agreements contain standard terms and conditions, there are agreements that contain non-standard terms and conditions and include promises to transfer multiple goods or services. As a result, significant interpretation and judgment is sometimes required to determine the appropriate accounting for these transactions including: (1) whether performance obligations are considered distinct and required to be accounted for separately or combined, including allocation of transaction price; (2) developing an estimate of the stand-alone selling price, or SSP, of each distinct performance obligation; (3) combining contracts that may impact the allocation of the transaction price between product and services; and (4) estimating and accounting for variable consideration, including rights of return, rebates, price protection, expected penalties or other price concessions as a reduction of the transaction price.

 

Revenue from contracts with customers is recognized when the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to be entitled to in exchange for those goods or services.

 

The Company derives its revenue primarily from the licensing of our Sequire Platform and Services associated with our customer’s use of the platform, consisting of data insights, marketing, creative, and paid media advertising Revenue is recognized at a point in time when control of the goods is transferred to the customer, generally occurring ratably over the contract period. The amount recognized reflects the consideration the Company expects to be entitled to in exchange for the transferred services.

 

Licensing and Service revenue is generally recognized over time on a ratable basis over the contract term beginning on the date that the service is expected to begin. Service contracts are generally for 12 months in length, billed either monthly or annually and generally in advance. Services revenue are typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. 

 

Deferred Revenue

 

Deferred revenue consists of platform and services fees that the Company has received consideration in advance of satisfying performance under the associated contract. The majority of the Company’s deferred revenue balance consists of the unrecognized portion of Service revenue that the Company has received consideration in marketable securities, which is recognized as revenue ratably over the contractual service period.

 

F-15
 

 

ASC Topic 606 is a comprehensive revenue recognition model that requires revenue to be recognized when control of the promised goods or services are transferred to our customers at an amount that reflects the consideration that we expect to receive. Application of ASC Topic 606 requires us to use more judgment and make more estimates than under former guidance. Application of ASC Topic 606 requires a five-step model applicable to all product offering revenue streams as follows:

 

Identification of the contract, or contracts, with a customer

 

A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration.

 

We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit or financial information pertaining to the customer.

 

Identification of the performance obligations in the contract

 

Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract.

 

When a contract includes multiple promised goods or services, we apply judgment to determine whether the promised goods or services are capable of being distinct and are distinct within the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. The Company has identified three distinct services promised within its contracts: (1) subscription to the Platform for a fixed monthly fee (Platform revenue), (2) Managed Services (including, data and marketing campaigns for a fixed monthly fee (managed services), and (3) Ancillary data, which consists of various data attributes that supplement the data available within the Sequire platform. The Managed Services to be delivered to the customer are within the discretion of the Company, and there are no minimum or maximum guaranties to be delivered.

 

Determination of the transaction price

 

The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods or services to our customer. We estimate any variable consideration included in the transaction price using the expected value method that requires the use of significant estimates for discounts, cancellation periods, refunds and returns. In cases which the Company receives marketable securities as payment the transaction price is determined to be the lower of the fair market value of the securities received or the contract amount.

 

Allocation of the transaction price to the performance obligations in the contract

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. We determine SSP based on the price at which the performance obligation would be sold separately.

 

During the second quarter of 2020, the Company provided its customers the ability to pay for the Sequire services with the issuance of the customers’ common stock or other securities. For contacts paid with any type of security, Management considers whether there is any marketability of liquidity discounts in determining the fair value of the security on the contract date.

 

The Company’s contract with its customers is for a period of one year or less than one year and the Company is applying the practical expedient, therefore, the transaction price is not adjusted for any significant financing component. The Company evaluates whether there is an existence of a significant financing component in the contract. This is evaluated based on the marketability holding period and liquidity issues than can extend the ability to sale the securities. For any marketability restrictions over 180 days the Company provides a marketability discount. For any liquidity issues that would take the Company in excess of 180 days to liquidate the security the Company applies a liquidity discount. Where there is both a marketability and liquidity issue the Company provides a discount considering both. ASC 606-10-32-23 The fair value of the noncash consideration may vary after contract inception because of the form of the consideration (for example, a change in the price of a share to which an entity is entitled to receive from a customer). Changes in the fair value of noncash consideration after contract inception that are due to the form of the consideration are not included in the transaction price.

 

F-16
 

 

Recognition of revenue when, or as, we satisfy a performance obligation

 

We recognize revenue at the point in time that the related performance obligation is satisfied by transferring the promised goods or services to our customer. The Company has performed a limited analysis of the performance efforts and has determined that the effort for the managed services is typically front loaded and as a result of performing services for SEC reporting companies’ additional efforts are maintained throughout the year. The Company considers the services to be delivered ratably during any service period and as such is amortizing the contract price on a straight line method over the contract period.

 

Principal versus Agent Considerations

 

When another party is involved in providing goods or services to our customer, we apply the principal versus agent guidance in ASC Topic 606 to determine if we are the principal or an agent to the transaction. When we control the specified goods or services before they are transferred to our customer, we report revenue gross, as principal. If we do not control the goods or services before they are transferred to our customer, revenue is reported net of the fees paid to the other party, as agent. Our evaluation to determine if we control the goods or services within ASC Topic 606 includes the following indicators:

 

We are primarily responsible for fulfilling the promise to provide the specified good or service.

 

When we are primarily responsible for providing the goods and services, such as when the other party is acting on our behalf, we have indication that we are the principal to the transaction. We consider if we may terminate our relationship with the other party at any time without penalty or without permission from our customer.

 

We have risk before the specified good or service have been transferred to a customer or after transfer of control to the customer.

 

We may commit to obtaining the services of another party with or without an existing contract with our customer. In these situations, we have risk of loss as principal for any amount due to the other party regardless of the amount(s) we earn as revenue from our customer.

 

The entity has discretion in establishing the price for the specified good or service.

 

We have discretion in establishing the price our customer pays for the specified goods or services.

 

Contract Liabilities

 

Contract liabilities consist of customer advance payments and billings in excess of revenue recognized. We may receive payments from our customers in advance of completing our performance obligations. We record contract liabilities equal to the amount of payments received in excess of revenue recognized, including payments that are refundable if the customer cancels the contract according to the contract terms. Contract liabilities have been historically low historically recorded as current liabilities on our consolidated financial statements when the time to fulfill the performance obligations under terms of our contracts is less than one year. We have no long-term contract liabilities which would represent the amount of payments received in excess of revenue earned, including those that are refundable, when the time to fulfill the performance obligation is greater than one year.

 

Practical Expedients and Exemptions

 

We have elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:

 

  ● We adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception;
     
  ● We made the accounting policy election to not assess promised goods or services as performance obligations if they are immaterial in the context of the contract with the customer;
     
  ● We made the accounting policy election to exclude any sales and similar taxes from the transaction price; and
     
  ● We adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

 

F-17
 

 

Stock-Based Compensation

 

We account for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Common stock awards

 

The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded in accordance with ASC 718 on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.

 

Warrants

 

In connection with certain financing, and consulting arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period.

 

Income Taxes

 

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Earnings Per Share

 

We use ASC 260, “Earnings Per Share” for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share are the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.

 

There were 11,867,520 common share equivalents at December 31, 2021 and 15,366,426 at December 31, 2020. For the year ended December 31, 2021 and 2020 these potential shares were excluded from the computation of diluted net earnings per share as their effect would have been antidilutive.

 

F-18
 

 

Recently Issued Accounting Standards

 

In January 2020, the FASB issued ASU 2020-01, which clarifies the interactions between Topics 321, 323 and 815. This ASU clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, the amendments clarify the accounting for certain forward contracts and purchased options accounted for under Topic 815. Our adoption of this ASU did not impact our consolidated financial statements or disclosures.

 

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a limited period of time to ease the potential burden in accounting treatments related to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. Adoption of the expedients and exceptions is elective and is permitted upon issuance of the guidance through December 31, 2022. The adoption had no material impact on the Company’s financial position, results of operations and cash flows.

 

In May 2020, the SEC adopted amendments to the financial disclosure requirements in Regulation S-X including the significance tests in the “significant subsidiary” definition in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 to improve their application and to assist registrants in making more meaningful determinations of whether a subsidiary or an acquired or disposed business is significant. In addition, to address the unique attributes of investment companies and business development companies, the SEC updated the significance tests in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 by (i) revising the investment test to compare the registrant’s investments in and advances to the acquired or disposed business to the registrant’s aggregate worldwide market value if available; (ii) revising the income test by adding a revenue component; (iii) expanding the use of pro forma financial information in measuring significance; and (iv) conforming, to the extent applicable, the significance threshold and tests for disposed businesses to those used for acquired businesses. The amendment became effective January 1, 2021.

 

In August 2020, the FASB issued ASU 2020-06, which simplifies the accounting for convertible instruments by removing certain separation models (including the cash conversion model and the beneficial conversion feature model) for convertible instruments. As a result, for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815 or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features are no longer separated from the host contract. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost as long as no other features require bifurcation and recognition as derivatives. This ASU is effective for fiscal years beginning after December 15, 2021.

 

In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables–Nonrefundable Fees and Other Costs, (“ASU 2020-08”). This ASU clarifies that an entity should reevaluate whether a callable debt security is within the scope of ASC paragraph 310-20-35-33 for each reporting period. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of ASU 2020-08 did not have a material impact on its consolidated financial statements since the Company does not have any convertible debt.

 

On November 15, 2019, the FASB delayed the effective date of FASB ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments.” This ASU amends several aspects of the measurement of credit losses on certain financial instruments, including replacing the existing incurred credit loss model and other models with the Current Expected Credit Losses (CECL) model and amending certain aspects of accounting for purchased financial assets with deterioration in credit quality since origination.

 

Rule 2a-5 under the 1940 Act was adopted by the SEC in December 2020 and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. As noted above, the if the Company were determined to be an Investment Company we would be required to comply with the rule. We are evaluating the impact of adopting Rule 2a-5 on the consolidated financial statements and intend to comply with the new rule’s requirements should we be required to do so on or before the compliance date in September 2022.

 

The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.

 

NOTE 2 – DISCONTINUED OPERATIONS

 

On December 29, 2021, The Company’s wholly owned subsidiary BIGToken completed a merger transaction with BritePool, Inc. (“BritePool”) (the “Merger”). As a result of the Merger, BIGToken issued 183,445,351,631 shares of its common stock (“Acquisition Shares”) for all of the issued and outstanding equity shares of BritePool. On December 29, 2021, as a condition for the closing of the Merger, the Company exchanged 149,562,566,584 shares of BIGToken common stock for 242,078 shares of BIGToken’s Series D Convertible Preferred Stock (“Series D Stock”) (the “Exchange”). Simultaneously with the Exchange, the Company converted 22,162 shares of the Series D Stock into 13,692,304,136 shares of BIGToken’s common stock, or approximately 4.99% of the issued and outstanding shares of BIGToken’s common stock.

 

The Series D Stock is non-redeemable, non-voting with liquidation preference being the same as if the Series D Stock had been converted into shares of FVPD common stock. Each share of the Series D Stock is convertible into 617,828 shares of BIGToken’s common stock, subject to a conversion limitation such that the number of shares of the BIGToken common stock outstanding immediately after giving effect to the issuance of BIGToken common stock to the Company upon conversion of the Series D Stock shall not be more than 4.99% (“Beneficial Ownership Limitation”). However, the Company upon not less than sixty-one days’ prior notice to BIGToken, may increase or decrease the Beneficial Ownership Limitation amount provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of BIGToken’s common stock outstanding immediately after giving effect to the issuance of the common stock upon conversion of the Series D Stock. As of the Exchange date, the Series D Stock and common stock of BIGtoken had a fair value of approximately $31,000.

 

F-19
 

 

BIGToken’s issuance of the Acquisition Share and the Exchange caused the Company’s BIGToken common stock holdings to decrease from approximately 66% to approximately 4.99%; Therefore, the Company no longer controlled the operations of BIGToken. Given the Company’s loss of control over the operations of BIGToken, the Company deconsolidated BIGToken, as of December 29, 2021, in accordance with ASC 810 Consolidations. Based on the deconsolidation of BIGToken, the Company recognized a loss of $10,684,000 calculated, as follows:

 

SCHEDULE OF DECONSOLIDATION OF BUSINESS

      
Consideration received  $- 
Fair value of Series D Stock and Common stock   31,000 
Carrying amount of non-controlling interest of BIGToken   6,045,000 
Previous equity adjustments of non-controlling interest   (12,510,000)
Total consolidations   (6,434,000)
      
Book basis of investment in BIGToken   4,250,000 
Loss on disposal of subsidiary  $(10,684,000)

 

As the transaction causing the deconsolidation of BIGToken, was a result of BIGToken issuing additional shares of its common stock for acquisition of BritePool, the Company received no cash or other consideration.

 

In accordance with ASC 820 – Fair Value Measurement, the Company determined the Series D Stock would be classified as level 3 asset consistent with the account policy for determining the fair value of an asset or liability. As there is no observable market for quoted market price for an identical asset. The Company engaged an independent third party valuation expert to estimate the fair value of the Series D Stock.

 

As of the Exchange date, the carrying basis of the non-controlling interest was approximately $6,465,000, which included approximately $12,510,000 related to BIGToken’s recording of a $5,860,000 Beneficial conversion feature for convertible preferred stock, issuance of convertible preferred stock in the amount of $5,860,000, $885,000 for the fair value of warrants issued to the Company’s debenture holders and less other amounts of approximately $95,000. These transactions were recognized in equity outside of the accumulated other comprehensive income (loss) related to ownership interest, which did not result in a loss of control, so they would not be included in the calculation of the gain or loss from deconsolidation because these amounts resulted from transactions among shareholders and are not directly attributable to the non-controlling interest.

 

The following table presents the aggregate carrying amounts of assets and liabilities of discontinued operations of BIGToken in the consolidated balance sheet as of December 31, 2020:

 

     
Carrying amounts of assets included as part of discontinued operations:    
Cash and cash equivalents  $1,000 
Accounts receivable, net   1,199,000 
Prepaid expenses and other current assets   6,000 
Property and equipment, net   1,000 
Goodwill   5,445,000 
Intangible assets, net   917,000 
Total assets classified as discontinued operations in the consolidated balance sheet  $7,569,000 
      
Carrying amounts of liabilities included as part of discontinued operations:     
Accounts payable and accrued expenses  $853,000 
Other current liabilities   452,000 
Total liabilities classified as discontinued operations in the consolidated balance sheet  $1,305,000 

 

F-20
 

 

The financial results of BIGToken are presented as income from discontinued operations, net of income taxes on our consolidated income through December 29, 2021, when our deconsolidation occurred. The following table presents the financial results of BIGToken:

 

           
   Year ended December 31, 
   2021   2020 
Revenues  $3,431,000   $2,168,000 
Cost of revenue   1,090,000    800,000 
Gross profit   2,341,000    1,368,000 
           
Operating expense          
Employee related costs   2,419,000    3,212,000 
Marketing and selling expenses   1,136,000    958,000 
Platform costs   1,350,000    707,000 
Depreciation and amortization   530,000    531,000 
General and administrative expenses   4,152,000    530,000 
Total operating expense   9,587,000    5,938,000 
           
Loss from operations of discontinued operations   (7,246,000)   (4,570,000)
           
Other expense          
Financing costs   (5,872,000)   - 
Realized loss on marketable securities   -    (71,000)
Impairment of goodwill   (1,258,000)   - 
Total other expense   (7,130,000)   (71,000)
           
Loss from discontinued operations before provision for income taxes   (14,376,000)   (4,641,000)
Provision for income taxes   -     
Loss from discontinued operations, net of income taxes  $(14,376,000)  $(4,641,000)

 

 

NOTE 3 – ACQUISITIONS

 

On September 15, 2020 (“Closing Date”), an Agreement and Plan of Merger (the “Agreement”) was entered into by and among SRAX, Inc. a Delaware corporation (“Parent”), Townsgate Merger Sub 1, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub 1”), LD Micro, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub 2”), LD Micro, Inc., a California corporation (the “Acquiree”, “LD Micro”), and Christopher Lahiji, the sole stockholder of the Acquiree (the “Stockholder”). Merger Sub 1 and Merger Sub 2 are sometimes collectively referred to as “Merger Sub.”

 

The parties intend that Merger Sub 1 will be merged with and into the Acquiree (the “First Merger”), with the Acquiree surviving the First Merger, and then the Acquiree will be merged with and into Merger Sub 2 (the “Second Merger,” and together with the First Merger, the “Merger”), with Merger Sub 2 surviving the Second Merger.

 

As consideration, the Company will pay cash payable as follows: (i) $1,000,000 at the Closing, (ii) $1,000,000 on January 1, 2021, (iii) $1,000,000 on April 1, 2021, and (iv) $1,000,000 on July 1, 2021 and subject to adjustment or off-set. Additionally, the Company issued 1,600,000 shares of its Class A common stock. The total consideration to be paid by the Company is $7,610,000, as adjusted, as follows:

 

      
Calculation of the purchase price:    
Fair value of stock at closing  $4,264,000 
Cash at closing   1,000,000 
Deferred payments   2,771,000 
Less cash received   (303,000)
Transaction expenses   10,000 
Working capital adjustment   (132,000)
Purchase price  $7,610,000 

 

The transaction was accounted for using the acquisition method. Accordingly, goodwill has been measured as the excess of the total consideration over the amounts assigned to the identifiable assets acquired and liabilities assumed.

 

The deferred payments of $3,000,000 were discounted using the yield on a CCC rated corporate debt for 3-month, 6-month and 9-month maturities, respectively. The implied discount is approximately $229,000, which will be amortized over the term on the payments.

 

The purchase price includes working capital adjustments that are based on our preliminary estimates and assumptions that are subject to change.

 

F-21
 

 

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed:

 

      
Accounts receivable, net  $30,000 
Intangibles   468,000 
Goodwill   7,706,000 
Accounts payable and accrued liabilities   (324,000)
Payroll protection loan   (42,000)
Other current liabilities   (97,000)
Deferred tax liability   (131,000)
Net assets acquired  $7,610,000 

 

Intangible assets consisted of the following:

 

    Fair Value     Life in Years
Trademark   $ 271,000     Indefinite
Domain name     3,000     Indefinite
Noncompete     8,000     5 years
Customer list     186,000     3 years
    $ 468,000      

 

The estimated fair values for the trademark and domain name were determined by using the relief-from-royalty method. The estimated fair value for the customer list and noncompete were determined using the excess earnings and differential method of comparing having an asset in-place versus not having the asset in place, respectively.

 

The Company has estimated the preliminary purchase price allocations based on historical inputs and data as of September 15, 2020. The preliminary allocation of the purchase price is based on the best information available and is pending, amongst other things: (i) the finalization of the valuation of the fair values and useful lives of tangible assets acquired; (ii) the finalization of the valuations and intangible assets acquired; (iii) finalization of the valuation of accounts payable and accrued expenses; and (iv) finalization of the fair value of non-cash consideration.

 

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date.

 

The amounts of revenue and earnings of the Acquiree since the acquisition date included in the consolidated statements of operations for the year ended December 31, 2020 follows:

 

Revenues $ -  
Net loss $   (51,000 )

 

The following pro forma information presents the combined results of operations as if the acquisitions had been completed on January 1, 2020. The pro forma results include the amortization associated with the preliminary estimates for the acquired intangible assets.

 

The pro forma results do not reflect any cost saving synergies from operating efficiencies, or the effect of the incremental costs incurred in integrating the two companies. Accordingly, these pro forma results are presented for informational purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations.

 

F-22
 

 

Pro Forma Consolidated Statements of Operations

For the Year ended December 31, 2020

 

    SRAX, Inc.     LD Micro, Inc.     Pro Forma Adjustment     Pro Forma Combined  
Revenues   $ 6,479,000     $ 937,000     $ -     $ 7,416,000  
Cost of revenues     (1,789,000 )     (98,000 )     -       (1,887,000 )
Operating expenses     (11,722,000 )     (858,000 )     171,000       (12,409,000 )
Other expense     (3,011,000 )     (1,000 )     -       (3,012,000 )
Provision for income taxes     (21,000 )     -       -       (21,000 )
Net loss   $ (10,064,000 )   $ (20,000 )   $ 171,000     $ (9,913,000 )

 

The following summarizes the pro forma adjustments made for the year ended December 31, 2020:

 

         
Amortization of intangibles acquired   $ 64,000  
Employee related costs     (235,000 )
Financing costs     -  
Net income (loss)   $ (171,000 )

 

Amortization relates to the acquired noncompete and customer list amounting to $2,000 and $62,000, respectively for the year ended December 31, 2020.

 

Employee related cost are contracted cost amounting to $235,000 for the year ended December 31, 2020.

 

NOTE 4 – SALE AND PURCHASE OF ACCOUNTS RECEIVABLE

 

On January 22, 2020 and January 30, 2020, the Company entered into financing agreements, with a single unrelated purchaser to sell, with full recourse, certain accounts receivable with a face value of $454,000 and $75,000, respectively, for a purchase price of $454,000 and $56,000, respectively. Transactions under these agreements were accounted for as financing of accounts receivable and the related accounts receivable was not removed from our consolidated balance sheet at the time of the sales transactions, a liability was recorded for the proceeds received. The terms of the agreements are as follows:

 

Pursuant to the initial purchase agreement, commencing on March 24, 2020, the purchaser may, at its sole discretion, exercise a put option, to cause the Company to purchase from purchaser, any of the outstanding January 22, 2020 receivables which were not collected by the purchaser. Effective April 9, 2020, the put option was extended until June 23, 2020.

 

The purchase price payable by Company to the Purchaser for the receivables upon exercise of the Put Option shall be equal to one hundred and thirty-six percent (136%) of the then remaining outstanding balance of the applicable receivables.

 

Upon the occurrence of a payment made on the applicable receivables, the Company is required to pay a true up amount as follows:

 

a. ten percent (10%) of the portion of the receivables which are paid on or before the 30th day following the effective date of the agreement;

b. twenty percent (20%) of the portion of the receivables which are paid after the 30th day but on or before the 60th day following the effective date of the agreement; and

c. thirty-six percent (36%) of the portion of the receivables which are paid after the 60th day following the effective date of the agreement.

 

In order to secure performance by the Company, the purchaser was granted a security interest in: (i) 239,029 shares of the Company’s Class A common stock in connection with the sale of the $454,000 receivable and (ii) 29,519 shares of the Company’s Class A common stock in connection with the sale of the $75,000 receivable. The shares have been issued and are being held by the Company’s transfer agent. Since the shares are not outstanding, the Company has treated them as shares reserved for collateral.

 

F-23
 

 

Since the purchaser of the receivables has recourse, the Company accounted for the purchase price as a liability. Upon the purchaser’s election of the put option or the true up, as applicable the Company will treat the put option price or the true up amounts as interest.

 

On April 9, 2020 the Company entered into an agreement to amend the January 22 and 30 accounts receivable agreements. The purchaser agreed to amend the put option date as described above to June 23, 2020 and June 30, 2020 for the sale of receivables originating on January 22, 2020 and January 30, 2020, respectively. As consideration for the extension the Company agreed to issue the purchaser 32,668 and 4,032 shares of Class A common stock for the receivable sale originating on January 22, 2020 and January 30, 2020, respectively.

 

On June 30, 2020, the Purchaser converted the payable of $510,000 and accrued interest of $184,000 (“Old Debt”) into approximately $788,000 of the OID Convertible Notes payable (“Debentures”) (See Note 17 - OID Convertible Debentures). The conversion was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. At the date of issuance, the Debenture had a fair market value of approximately $815,000. The transaction created a loss on extinguishment of approximately $546,000, which consisted of (i) the difference of value between the Old Debt and the fair value of the new debt of approximately $95,000, (ii) the difference between the face value of the debenture and the fair value of the Debenture of approximately $27,000 and (iii) $424,000 for fair value of warrants issued with the Debenture. Also, since the Debenture was convertible into the Company’s common stock, a $27,000 premium associated with the conversion feature was recorded as additional paid in capital.

 

Since the purchaser of the receivables has recourse, the Company accounted for the purchase price as a liability. Upon the purchaser’s election of the put option or the true up, as applicable the Company will treat the put option price or the true up amounts as interest.

 

In December 2020, the Company entered into an agreement with a third-party lender whereby it sold the Company’s right to future subscription revenues of $570,000 for net proceeds of $528,000. Under the terms of the agreement, the Company may borrow funds collateralized by the right to the revenues from Sequire platform contracts. The third party lender receives a discount on the amount sold and remits the net amount to the Company. The Company bears the risk of credit loss on the contracts. These transactions are accounted for as secured borrowing arrangements and not as a sale of financial assets. In December 2021, the Company entered into another agreement through which it sold future subscriptions amounting to $625,000 for net proceeds of $576,000.

 

The amount of borrowings outstanding was approximately $631,000 as of December 31, 2021 and $570,000 at December 31, 2020. As of December 31, 2021, our availability to draw additional funds through this agreement was approximately $1,000,000. These balances are included with Accounts Payable and Accrued Expenses within our consolidated balance sheet.

 

On October 29, 2021, the Company (“Purchaser”) and BIGtoken (“Seller”) entered into a receivable purchase and sale agreement whereby BIGtoken sell, assign, transfer, convey and deliver to the Company all rights, title and interest for its receivable aggregating $352,000 for a purchase price of $327,000, sup representing a 7% discount. As of December 31, 2021, the outstanding receivable amounts to $352,000.

 

NOTE 5 – CONTRACTS RECEIVABLE

 

Contracts receivable represents amounts for which non-cancellable revenue contracts with customers have been finalized but the payment in the form of securities issued by the customer which could be a common stock, preferred stock or convertible debentures have not been received by the Company. Contracts receivable that will be received during the succeeding 12-month period is recorded as current contracts receivable, and the remaining portion, if any, is recorded as long-term contracts receivable. As of December 31, 2021 and 2020, contracts receivable amounted to $844,000 and none, respectively.

 

NOTE 6 – MARKETABLE SECURITIES

 

During the second quarter of 2020, the Company began offering customers of its Sequire segment who purchase services on the Company’s proprietary SaaS platform the option to pay the contract price in securities issued by the Customer which could be a common stock, preferred stock or convertible debentures. The customer’s securities must be trading on a United States securities exchange. In accordance with ASC 606 - Revenue Recognition, the Company will value the shares received at the fair market value of the date the contract is executed. The shares received will be accounted for in accordance with ASC 320 and ASC 321 – Investments – Debt and Equity Securities, as such the shares will be classified as available-for-sale securities and will be measured at each reporting period at fair value with the unrealized gain or (loss) as a component of other income (expense). Upon the sale of the shares, the Company will record the final gain or (loss) in the consolidated statement of operations as a component of net income (loss).

 

F-24
 

 

The movement in this account is as follows:

 

   Balance as of                 
   December 31,   Common   Convertible   Preferred     
   2021   Stock   Debentures   Stock   Warrants 
Balances at beginning of year  $8,447,000   $7,764,000   $

683,000

   $-   $- 
Additions   34,914,000    29,281,000    4,602,000    1,031,000    - 
Sale of marketable securities   (8,666,000)   (8,156,000)   (510,000)   -   - 
Designation for dividend distribution   (10,790,000)   (10,577,000)   

(213,000

)   -   - 
Change in fair value   (8,288,000)   (7,577,000)   

(375,000

)   (432,000)   96,000 
Balances at end of year  $15,617,000   $10,735,000   $4,187,000   $599,000   $96,000 

 

   Balance as of         
   December 31,   Common   Convertible 
   2020   Stock   Debentures 
Balances at beginning of year  $83,000   $83,000   $— 
Additions   8,406,000    7,496,000    910,000 
Sale of marketable securities   (916,000)   (916,000)   — 
Change in fair value   874,000    1,101,000    (227,000)
Balances at end of year  $8,447,000   $7,764,000   $683,000 

 

The Company’s sales of securities for the year ended December 31, 2021, were approximately $8,666,000, with a book basis of approximately $7,862,000 which represented a gain of $804,000, which the Company recorded as other income included in the gains from marketable securities.

 

The Company accounts for its investments in equity securities in accordance with ASC 321-10 Investments - Equity Securities. The equity securities may be classified into two categories and accounted for as follows:

 

● Equity securities with a readily determinable fair value are reported at fair value, with unrealized gains and losses included in earnings. Any dividends received are recorded in interest income, the fair value of equity investments with fair values is primarily obtained from third-party pricing services.
   
● Equity securities without a readily determinable fair value are reported at their cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer and their impact on fair value. Any dividends received are recorded in interest income. For equity investments without readily determinable fair values, when an orderly transaction for the identical or similar investment of the same issuer is identified, we use the valuation techniques permitted under ASC 820 Fair Value Measurement to evaluate the observed transaction(s) and adjust the fair value of the equity investment. See discussion of the Company’s valuation policy in Note 1 – Fair Value of Financial Instruments.

 

NOTE 7 – DESIGNATED ASSETS FOR RETURN OF CAPITAL

 

On August 17, 2021, the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock to shareholders, debenture holders, and certain warrant holders (“Recipients”) as of record on September 20, 2021. The board designated certain of the Company’s marketable securities (“Designated Assets”) to be used when liquidated, as a return of capital to the Recipients. See Note 19 - Series A Preferred Stock for more details.

 

As of December 31, 2021, designated assets consist of the following:

 

      
Cash  $686,000 
Marketable securities   3,239,000 
Balance  $

3,925,000

 

 

F-25
 

 

The movement in designated assets is as follows:

 

Designated assets as of September 20, 2021  $6,387,000 
Sale of designated assets   (770,000)
Proceeds from sale of designated assets   686,000 
Change in fair value of designated assets   (2,378,000)
Balances as of December 31, 2021  $3,925,000 

 

The Company’s sale of the designated marketable securities for the year ended December 31, 2021, were approximately $686,000, with a book basis of approximately $770,000 which represented a loss of $84,000, which the Company recorded as other expense included in the loss from designated assets.

 

NOTE 8 – NOTES RECEIVABLE

 

On October 30, 2020, a unit redemption agreement was entered into by and between the Company and Haylard MD, LLC (“Haylard”). The Company owns 10,000,000 Class A Units of Haylard. The Company desires to sell and transfer to Haylard, and Haylard desires to redeem and purchase from the Company. The price to be paid for all of the Units shall be $6,718,000 at closing and $960,000 upon the earlier of (a) the third anniversary of the closing and (b) a Sale of Haylard, for a total consideration of $7,678,000, provided that if Haylard consummates a Sale of Haylard within one hundred and eighty (180) calendar days after the closing, and the amount to be paid in respect of a Class A Unit in connection with such transaction after taking into account all fees, costs, expenses, escrows, indemnities, purchase price adjustments, repayments of indebtedness and other holdbacks as reasonably determined and calculated in good faith by Haylard is greater than $0.7677543, then Haylard shall pay to the Company an amount equal to such excess for each Unit redeemed and purchased hereunder by wire transfer of immediately available funds to the account specified by the Company.

 

On October 30, 2020, a unit redemption agreement was entered into by and between the Company and MD CoInvest, LLC, (“CoInvest”). The Company owns 420,000 Units of CoInvest. The Company desires to sell and transfer to CoInvest, and CoInvest desires to redeem and purchase from the Company. The price to be paid for all of the Units shall be $282,000 at closing and $40,000 upon the earlier of (a) the third anniversary of the closing and (b) a Sale of CoInvest, for a total consideration of $322,000, provided that if CoInvest consummates a Sale of CoInvest within one hundred and eighty (180) calendar days after the closing, and the amount to be paid in respect of a Class A Unit in connection with such transaction after taking into account all fees, costs, expenses, escrows, indemnities, purchase price adjustments, repayments of indebtedness and other holdbacks as reasonably determined and calculated in good faith by CoInvest is greater than $0.7677543, then CoInvest shall pay to the Company an amount equal to such excess for each Unit redeemed and purchased hereunder by wire transfer of immediately available funds to the account specified by the Company.

 

The deferred payments of $960,000 and $40,000 were discounted using the yield on a CCC rated corporate debt for 3-year maturity. The implied discount is approximately $107,000, which will be amortized over 3 years. Notes receivable as of December 31, 2021 and 2020 amounted to $935,000 and $893,000, respectively.

 

NOTE 9 – PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following as of December 31:

 

    2021     2020  
Office equipment   $ 471,000     $ 402,000  
Accumulated depreciation     (357,000 )     (285,000 )
Property and equipment, net   $ 114,000     $ 117,000  

 

Depreciation expense for the years ended December 31, 2021 and 2020 was $72,000 and $28,000, respectively.

 

F-26
 

 

NOTE 10 – INTANGIBLE ASSETS

 

Intangible assets consist of the following as of December 31:

 

    2021     2020  
Non-compete agreement   $ 1,258,000     $ 1,258,000  
Intellectual property     756,000       756,000  
Acquired Software     756,000       617,000  
Internally developed software     2,726,000       2,048,000  
Trademark     271,000       271,000  
Customer list     186,000       186,000  
Domain name     17,000       36,000  
Total cost     5,970,000       5,172,000  
Accumulated amortization     (4,527,000 )     (3,680,000 )
Intangible assets, net   $ 1,443,000     $ 1,492,000  

 

Amortization expenses amounted to $847,000 and $744,000 for the years ended December 31, 2021 and 2020, respectively.

 

Trademark has indefinite life and not subject to amortization. The estimated future amortization expense for the years ended December 31, are as follows:

 

      
2022  $632,000 
2023   404,000 
2024   136,000 
Intangible assets  $1,172,000 

 

As of December 31, 2021 and 2020, goodwill amounted to $17,906,000, an addition of $7,706,000 in 2020 was due to acquisition of LD Micro (see Note 3 - Acquisitions). There were no impairments during the years ended December 31, 2021 and 2020.

 

NOTE 11 – RIGHT TO USE ASSET

 

We determine whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if we obtain the rights to direct the use of and to obtain substantially all of the economic benefit from the use of the underlying asset. Some of our leases include both lease and non-lease components which are accounted for as a single lease component as we have elected the practical expedient. Some of our operating lease agreements include variable lease costs, primarily taxes, insurance, common area maintenance or increases in rental costs related to inflation. Substantially all of our equipment leases and some of our real estate leases have terms of less than one year and, as such, are accounted for as short-term leases as we have elected the practical expedient.

 

Operating leases are included in the right-of-use lease assets, other current liabilities and long-term lease liabilities on the Consolidated Balance Sheet. Right-of-use assets and lease liabilities are recognized at each lease’s commencement date based on the present values of its lease payments over its respective lease term. When a borrowing rate is not explicitly available for a lease, our incremental borrowing rate is used based on information available at the lease’s commencement date to determine the present value of its lease payments. Operating lease payments are recognized on a straight-line basis over the lease term. We had no financing leases as of December 31, 2021.

 

We have operating leases for office space. Our leases have remaining lease terms of approximately 1.75 years. We consider renewal options in determining the lease term used to establish our right-of-use assets and lease liabilities when it is determined that it is reasonably certain that the renewal option will be exercised.

 

F-27
 

 

As of December 31, 2021, there were no material variable lease costs or sublease income. Cash paid for operating leases are classified in operating expenses and were $175,000 and $192,000 for the years ended December 31, 2021 and 2020, respectively. The following tables summarize the lease expense for the year ended December 31:

 

   2021   2020 
Operating lease expense  $163,000   $163,000 
Short-term lease expense   12,000    29,000 
Total lease expense  $175,000   $192,000 

 

The below table summarizes these lease asset and liability accounts presented on our accompanying Consolidated Balance Sheets for the year ended December 31:

 

Operating Leases*  Consolidated Balance Sheet Caption  2021   2020 
Operating lease right-of-use assets - non-current  Right of use asset  $257,000   $366,000 
              
Operating lease liabilities – current  Other current liabilities  $130,000   $109,000 
Operating lease liabilities - non-current  Right to use liability - long term   114,000    243,000 
Total operating lease liabilities     $244,000   $352,000 

 

Components of Lease Expense

 

We recognize lease expense on a straight-line basis over the term of our operating leases, as reported within “selling, general and administrative” expense on the accompanying consolidated statement of operations.

 

Weighted Average Remaining Lease Term and Applied Discount Rate

 

  

Weighted

Average

Remaining

Lease Term

 

Weighted

Average

Discount Rate

 
Operating leases as of December 31, 2021  1.75 years   18%

 

Future Contractual Lease Payments as of December 31, 2021

 

The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest,

 

and (iii) present value of future lease payments for the years ending December 31:

 

Operating Leases - future payments    
2022   163,000 
2023   123,000 
Total future lease payments, undiscounted   286,000 
Less: Implied interest   (42,000)
Present value of operating lease payments   244,000 

 

NOTE 12 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses as of December 31, are comprised of the following:

 

   2021   2020 
Accounts payable, trade  $1,938,000   $1,900,000 
Accrued expenses   1,518,000    537,000 
Accrued compensation   213,000    232,000 
Accrued commissions   303,000    32,000 
Accrued interest   123,000    7,000 
Accounts payable and accrued expenses  $4,095,000   $2,708,000 

 

F-28
 

 

NOTE 13 – DEFERRED REVENUE

 

Deferred revenue represents amounts billed for which revenue has not yet been recognized. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue, and the remaining portion, if any, is recorded as long-term deferred revenue. As of December 31, 2021, deferred revenue was $12,859,000, as compared to $4,842,000 as of December 31, 2020.

 

NOTE 14 – OTHER CURRENT LIABILITIES

 

The following table summarizes the composition of other current liabilities presented on our accompanying Consolidated Balance Sheets:

   December 31,
2021		   December 31,
2020		 
Operating lease liabilities - current  $130,000   $109,000 
Other current liabilities   633,000    3,308,000 
Total other current liabilities  $763,000   $3,417,000 

 

As of December 31, 2021 and 2020, other current liabilities consist of amounts payable on a factoring facility amounting to $633,000 and $573,000, respectively (See Note 4 – Sale and Purchases of Accounts Receivable) and deferred payments amounting to $2,735,000 related to the acquisition of LD Micro (See Note 3 – Acquisitions) as of December 31, 2020.

 

During the year ended December 31, 2021, the Company made $3,004,000 in deferred contractual payments related to the LD Micro acquisition.

 

NOTE 15 - PAYCHECK PROTECTION PROGRAM LOAN

 

On April 17, 2020, we entered into a promissory note evidencing an unsecured approximately $1,084,000 loan under the Paycheck Protection Program (PPP). The loan is being made through Cross River Bank. The term of the loan is two years with an interest rate of 1%, which shall be deferred for the first six months of the term of the loan. The promissory note evidencing the loan contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the promissory note. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, and/or filing suit and obtaining judgment against the Company.

 

On September 15, 2020, $42,000 of the payroll protection loan of LD Micro was assumed in connection with the acquisition. This amount is expected to be forgiven, otherwise the Company will be reimbursed by Sellers of LD Micro. This is classified under current liabilities.

 

During the year ended December 31, 2021, the PPP loan in the of $1,116,000 was forgiven. As of December 31, 2021 and 2020, PPP loans outstanding amounted to $10,000 and $1,126,000, respectively.

 

NOTE 16 – SHORT TERM PROMISSORY NOTES

 

In February 2020, the Company entered into three separate short-term promissory notes with an aggregate principal value of $450,000 (the “Notes”), of which $100,000 was borrowed from the Company’s Chief Financial Officer.

 

The notes are due and payable on May 12, 2020 (“Maturity Date”). The notes will accrue interest as follows: (i) on the origination date, ten percent (10%) of the principal amount was added to each note, (ii) on March 12, 2020, an additional ten percent (10%) of the principal amount was added to each note, and (iii) on April 12, 2020, an additional sixteen percent (16%) of the principal amount was added to each notes.

 

F-29
 

 

The note holders were granted security interests (in amounts equal to the face value of their investments on a dollar for share basis) in an aggregate of 450,000 shares of the Company’s Class A common stock (“Security Shares”). The shares have been issued and are being held by the Company’s transfer agent. Since the shares are not outstanding, the Company has treated them as shares reserved for collateral.

 

The interest imputed on the origination date was treated as an original issue discount with the $45,000 amortized over the term of the Notes. On each of the interest date, the Company accrued and expensed the related interest.

 

On the Maturity Date, one of the Note’s was amended to (i) extend the maturity date to December 31, 2020 and (ii) to release 100,000 shares of the Security Shares. The modification was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. Based on the amended terms the fair value of the amended note approximated the book value of the old Note. The fair value of the Security Shares was approximately $181,000, which was expensed as a loss on the extinguishment.

 

On June 30, 2020, the short-term note payable to the Company’s Chief Financial Officer in the amount of approximately $136,000 was repaid from the proceeds of the OID Convertible Notes Payable.

 

On June 30, 2020, the two remaining Note Holders converted the Notes of approximately $350,000 and accrued interest of approximately $126,000 (“Old Debt”) into approximately $541,000 of the OID Convertible Debentures (See Note 17 - OID Convertible Debentures). The conversion was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. At the date of issuance, the Debentures had a fair market value of approximately $560,000. The transaction created a loss on extinguishment of approximately $375,000, which consisted of (i) the difference of value between the Old Debt and the fair value of the Debentures of approximately $65,000, (ii) the difference between the face value of the debenture and the fair value of the Debenture of approximately $19,000 and (iii) $291,000 for fair value of warrants issued with the Debenture. Also, since the Debenture was convertible into the Company’s common stock, a $18,000 premium associated with the conversion feature was recorded as additional paid in capital.

 

As of December 31, 2020, there is no outstanding loan balance on this account.

 

NOTE 17 – TERM LOAN NOTE

 

On February 28, 2020, the Company entered into a term loan and security agreement with a BRF Finance Co. LLC as lender. Pursuant to the loan agreement, the Company can borrow up to $5,000,000, subject to the conditions described below.

 

Under the loan: (i) the Company received an initial draw of $2,500,000 on February 28, 2020 and (ii) the Company is eligible to receive an additional $2,500,000 loan within (30) days of the Company entering into an at the market sales agreement with the lender and the filing of an at the market offering on Form S-3 with the SEC registering the shares to be sold pursuant to the at the market sales agreement. The Company agreed to file the ATM by May 1, 2020. Additionally, the Company will be required to increase the dollar amount authorized under the at the market sales agreement each time additional capacity of at least $1,000,000 is available under our shelf registration statement.

 

The loan is secured by substantially all of the assets of the Company pursuant to the loan agreement and the intellectual property security agreement entered into in connection with the transaction.

 

The loan bears interest at ten percent (10%) per annum and has a maturity date of March 1, 2022. Beginning on August 1, 2020 and continuing on the first day of each month thereafter until the maturity date, the Company will make monthly payments of principal and interest on an eighteen (18) month straight line amortization schedule, based on the principal outstanding on July 31, 2020. Additionally, the Company will have the option of a one (1) time payment-in-kind payment for a monthly required payment of principal and interest, which will defer such payments and result in a recalculation of the amortization schedule. In the event that the Company is late on any payments under the Loan, a late charge of three percent (3%) of the amount of the payment due will be assessed.

 

F-30
 

 

At origination the Company paid lender: (i) an origination fee of $300,000, (ii) $35,000 in attorneys’ fees reimbursement, and (iii) certain other costs and expenses associated with the completion of the loan, including but not limited to escrow fees and recording fees. Accordingly, the Company received net proceeds of approximately $2,164,000 as of May 1, 2020.

 

The Loan may be prepaid in whole or in part at any time at the discretion of the Company. The loan also provides for mandatory prepayments of all of the net cash received upon (i) a sale of the company’ assets, (ii) raising additional capital through the issuance of equity or debt securities, or (iii) sales under the at the market sales agreement described above.

 

As part of the loan the Company agreed to issue to Lender: (i) 500,000 Common Stock purchase warrants on the date of the origination date and (ii) 500,000 Common Stock purchase warrants on the date of the second drawdown. The warrants have an exercise price equal to a 25% premium of the closing price of the Common Stock on their respective date of issue (provided that the exercise price of the warrants cannot be less than $2.50 per share, subject to adjustment contained therein). The initial warrant has an exercise price of $3.60. The warrants will expire on October 31, 2022. The warrants allow for cashless exercise in the event that they are not subject to a registration statement on the six (6) month anniversary of their respective issuances. The warrants do not contain any price protection or non-standard anti-dilution provisions.

 

In accordance with ASC 470 - Debt, the Company has allocated the cash proceeds to the loan and the warrants. The relative fair value of the initial warrant issued was $83,000, which is being amortized and expensed over the term of the Notes.

 

The Company evaluated the loan and warrant agreements in accordance with ASC 815 Derivatives and Hedging. Based on this evaluation, the Company has determined that no provisions required derivative accounting.

 

On June 30, 2020, the principal and interest of approximately $2,585,000 was paid from the proceeds from the OID Convertible Debentures.

 

As of December 31, 2020, there is no outstanding loan balance on this account.

 

NOTE 18 – OID CONVERTIBLE DEBENTURES

 

On June 25, 2020, the Company entered into a definitive securities purchase agreement (the “Securities Purchase Agreement or Transaction”) with certain accredited and institutional investors (the “Purchasers”) for the purchase and sale of an aggregate of: (i) $16,101,000 in principal amount of Original Issue Discount Senior Secured Convertible Debenture (the “Debentures”) for $14,169,000 (representing a 12% original issue discount) (“Purchase Price”) and (ii) warrants to purchase up to 6,440,561 shares of the Company’s Class A common stock (the “Warrants”) in a private placement (the “Offering”). The Purchase Price consists of (a) $13,000,000 in cash and (b) the cancellation of $1,169,000 in outstanding debt, consisting of the accounts receivable loans of $510,000 with accrued interest of $184,000, and the short-term promissory notes of $350,000 with accrued interest of $125,000.

 

The Debentures, which mature on December 31, 2021, pay interest in cash at the rate of 12.0% per annum commencing on June 30, 2021, with such interest payable quarterly, beginning on October 1, 2021. Commencing after the six-month anniversary of the issuance of the Debentures, the Company will be required to make amortization payments (“Amortization Payments”) with each Purchaser having the right to delay such Amortization Payments by a six month period up to three separate times (each, an “Extension”) in exchange for five percent in principal being added to the balance of such applicable Debenture on each such Extension. Accordingly, upon a Purchaser exercising three Extensions, such Purchaser’s Debenture will mature and be due and payable on June 30, 2023. Beginning on the date that the first Amortization Payment is due, and on a monthly basis thereafter, the Company will be required to pay one hundred fifteen percent of the value of one-twelfth of the outstanding principal plus any additional accrued interest due.

 

In the event a Purchaser converts a portion of its Debenture into shares of the Company’s Common Stock, such amount will be deducted from the next applicable Amortization Payment. In the event such conversion exceeds the next applicable Amortization Payment, such excess amount will be deducted, in reverse order, from future Amortization Payments. The Company’s obligations under the Debentures are secured by substantially all of the assets of the Company pursuant to a security agreement (the “Security Agreement”).

 

F-31
 

 

The Debentures are convertible at the option of the holder into shares of the Company’s common stock at an initial conversion price of $2.69 per share, subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Debentures do not have any price protection or price reset provisions with respect to future issuances of securities.

 

Subject to the Company’s compliance with certain equity conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that (i) the Company sells or reprices any securities (each, a “Redemption Financing”), or (ii) the Company disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to cause the Company (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures.

 

The Debentures also contain certain customary events of default provisions, including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, failure to register the shares underlying the Debentures in Warrants (as described below), changes in control of the Company, delisting of its securities from its trading market, and the entering or filing of certain monetary judgments against the Company. Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the Purchaser’s election, immediately due and payable in cash. The Company is also subject to certain negative covenants (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser) under the Debentures, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends.

 

The Warrants are initially exercisable at 2.50 per share and, are subject to cashless exercise after six months if the shares underlying the Warrants are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities.

 

Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company.

 

The Company also agreed to use proceeds from the Offering to pay (i) $2,500,000 in outstanding principal plus accrued interest pursuant to the Company’s Term Loan and Security Agreement entered into on February 28, 2020 with BRF Finance Co., LLC (the “Term Loan”) and (ii) $136,000 in outstanding short-term promissory notes and accrued interest (collectively, the “Debt Repayments”).

 

In connection with Securities Purchase Agreement, the Company will issue to the Placement Agent (as defined below), an aggregate of 478,854 Common Stock purchase warrants (“PA Warrants”). The PA Warrants are substantially similar to the Warrants, except that the PA Warrants have an exercise price of $3.3625 per share. The fair value of the PA Warrants at issuance was estimated to be $360,000 based on a risk-free interest rate of .11%, an expected term of 2.417 years, an expected volatility of 96% and a 0% dividend yield.

 

F-32
 

 

Pursuant to a registration rights agreement (“Registration Rights Agreement”), the Company has agreed to file a registration statement registering the resale of the shares of the common stock underlying the Debentures and the Warrants within forty-five days from the date of the Registration Rights Agreement. The Company also agrees to have the registration statement declared effective within 90 days from the date of the Registration Rights Agreement and keep the registration statement continuously effective until the earlier of (i) the date after which all of the securities to be registered thereunder have been sold, or (ii) the date on which all the securities to be registered thereunder may be sold without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 under the Securities Act. The Company is also obligated to pay the Investors, as partial liquidated damages, a fee of 2.0% of each Purchaser’s subscription amount per month in cash upon the occurrence of certain events, including our failure to file and(or) have the registration statement declared effective within the time periods provided.

 

Bradley Woods & Co. Ltd. (“Placement Agent”) acted as the placement agent, in connection with the sale of the securities pursuant to the Securities Purchase Agreement. Pursuant to an engagement agreement entered into by and between the Company and the Placement Agent, the Company agreed to pay the Placement Agent a cash commission of $1,040,000. Pursuant to the discussion above, the Company also issued an aggregate of 478,854 PA Warrants to the Placement Agent. The Company has agreed to include the shares of our common stock underlying the PA Warrants to be included in the registration statement to be filed. Additionally, upon the exercise of Warrants issued in the Offering, the Placement Agent will be entitled to eight percent (8%) of the cash proceeds received from such exercises.

 

The Transaction closed on June 30, 2020 (the “Closing Date”), with approximately $3,800,000 cash proceeds received prior to Closing date, $4,200,000 received on the closing date and $5,000,000 received after the closing date. The gross proceeds received from the Offering were approximately $13,000,000 and net proceeds of approximately $9,100,000 after deducting the Placement Agent fees, the Debt Repayments and other offering expenses. Also, the Company reimbursed the lead Purchaser $75,000 for legal fees, which was deducted from the required subscription amount to be paid.

 

The Company evaluated all of the associated financial instruments in accordance with ASC 815 Derivatives and Hedging. Based on this evaluation, the Company has determined that no provisions required derivative accounting.

 

In accordance with ASC 470 - Debt, the Company first allocated the cash proceeds to the loan and the warrants on a relative fair value basis, secondly, the proceeds were allocated to the beneficial conversion feature.

 

During the year ended December 31, 2020, the Company recognized amortization expense of $5,639,000.

 

During the year ended December 31, 2020, holders of debenture principal converted $1,118,000 debenture into 411,626 shares of the Company’s class A common stock. As a result of these conversions and issuance of common stock, the Company wrote-off debt discount and increased additional paid in capital by $434,000.

 

During the year ended December 31, 2020, majority of the debenture holders exercise their rights to delay amortization payment by six months in exchange for 5% additional principal. Total additional principal due to extension amounted to $472,000.

 

During the year ended December 31, 2021, certain Debenture holders converted $8,387,000 of principal into 3,122,167 shares of the Company’s class A common stock shares. As a result of these conversions, the Company reduced the principal balance by approximately $8,387,000 and reduced the debt discount by approximately $2,413,000 for a net book value of $5,974,000, which was transferred to additional paid-in capital.

 

During the year ended December 31, 2021, the holders of the remaining Debentures notified the Company of their election to defer the inception of amortization payments due under the Debentures until June 30, 2022. As a result of their election, the holders are entitled to a 5% increase of their then current principal balance as a fee. The Company recorded this fee as a financing cost during the year ended December 31, 2021.

 

F-33
 

 

The table below summarizes the transactions during the year end December 31, 2021:

   Principal   Debt discount   Net book value 
Balance at beginning of year  $9,386,000   $(3,370,000)  $6,016,000 
Extension   268,000    -    268,000 
Conversion   (8,387,000)   2,413,000    (5,974,000)
Amortization   -    854,000    854,000 
Total  $1,267,000   $(103,000)  $1,164,000 

 

As of December 31, 2021, the Company has classified the debt as current liability because the management intends to redeem the remaining convertible debentures within the following 12 months.

 

The table below summarizes the transactions during the year   end December 31, 2020:

 

   Principal   Debt discount   Net book value 
Issuance during the year  $16,101,000   $(12,731,000)  $3,370,000 
Extension   472,000    -    472,000 
Redemption   (6,069,000)   3,037,000    (3,032,000)
Conversion   (1,118,000)   685,000    (433,000)
Amortization   -    5,639,000    5,639,000 
Total  $9,386,000   $(3,370,000)  $6,016,000 

 

NOTE 19 – COMMITMENTS AND CONTINGENCIES

 

Other Commitments

 

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise due to their status or service as directors, officers or employees. The Company has also agreed to indemnify certain former officers, directors and employees of acquired companies in connection with the acquisition of such companies. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors and employees of acquired companies, in certain circumstances.

 

It is not possible to determine the maximum potential amount of exposure under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each agreement. Such indemnification agreements may not be subject to maximum loss clauses.

 

Employment agreements

 

We have entered employment agreements with key employees. These agreements may include provisions for base salary, guaranteed and discretionary bonuses and option grants. The agreements may contain severance provisions if the employees are terminated without cause, as defined in the agreements.

 

Litigation

 

From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. In addition, the Company may receive letters alleging infringement of patent or other intellectual property rights. The Company is not currently a party to any material legal proceedings, nor is the Company aware of any pending or threatened litigation that would have a material adverse effect on the Company’s business, operating results, cash flows or financial condition should such litigation be resolved unfavorably.

 

Business Interruption

 

The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.

 

F-34
 

 

NOTE 20 – SERIES A PREFERRED STOCK

 

On August 17, 2021, the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock (“Preferred Stock”) to certain Qualified Recipients (as defined below) on a 1-for-1 as converted to common stock basis (the “Dividend”). The record date for the Dividend is September 20, 2021 (the “Record Date”). The preferred stock entitles the Qualified Recipients with the right to receive the net proceeds from sales of certain securities of issuers that the Company received through its Sequire Platform services.

 

On September 20, 2021, the Company filed a certificate of designation (the “COD”) of preferences, rights, and limitations of Series A Non-Voting Preferred Stock (“Series A Preferred Stock”) with the Secretary of State of Delaware. Pursuant to the COD, the Company is authorized to issue up to 36,462,417 shares of Series A Preferred Stock (the “Dividend Shares”).

 

As of the Record Date, the following holders of securities were entitled to receive the Dividend (collectively, the “Qualified Recipients):

 

  i. each outstanding share of Class A common stock (the “Common Stock”), of which 25,160,504 shares were issued and outstanding,
  ii. each share of Common Stock underlying outstanding common stock purchase warrants containing a contractual right to receive the Dividend (“Warrants”) of which, 10,327,645 were outstanding, and
  iii. each original issue discount senior convertible debenture (the “Debentures”) issued on June 30, 2021, containing a contractual right to receive the Dividend on an as converted to Common Stock basis, of which $2,486,275 of Debentures were outstanding in principal and interest, convertible into 974,268 shares of Common Stock.

 

Accordingly, the Company issued 36,462,417 shares of Series A Preferred Stock to the Qualified Recipients on an as converted to Common Stock basis. The Dividend was delivered on September 27, 2021.

 

The Company’s management has evaluated the Preferred Stock in accordance with ASC 480 – Distinguishing Liabilities from Equity. Management has determined that the cancellation clause of the Preferred Stock deemed it to be mandatorily redeemable and should be classified as a liability. The fair value of the Preferred stock as of December 31, 2021 amounted to $3,925,000.

 

NOTE 21 – STOCKHOLDERS’ EQUITY

 

Authorized Shares

 

Preferred Stock

 

We are authorized to issue 50,000,000 of preferred stock, par value $0.001, of which 200,000 shares were designated as Series 1 Preferred Stock. Our board of directors, without further stockholder approval, may issue preferred stock in one or more series from time to time and fix or alter the designations, relative rights, priorities, preferences, qualifications, limitations and restrictions of the shares of each series. The rights, preferences, limitations and restrictions of different series of preferred stock may differ with respect to dividend rates, amounts payable on liquidation, voting rights, conversion rights, redemption provisions, sinking fund provisions and other matters. Our board of directors may authorize the issuance of preferred stock, which ranks senior to our common stock for the payment of dividends and the distribution of assets on liquidation. In addition, our board of directors can fix limitations and restrictions, if any, upon the payment of dividends on both classes of our common stock to be effective while any shares of preferred stock are outstanding.

 

F-35
 

 

Common Stock

 

We are authorized to issue an aggregate of 259,000,000 shares of common stock. Our certificate of incorporation provides that we will have two classes of common stock: Class A common stock (authorized 250,000,000 shares, par value $0.001), which has one vote per share, and Class B common stock (authorized 9,000,000 shares, par value $0.001), which has ten votes per share. Any holder of Class B common stock may convert his or her shares at any time into shares of Class A common stock on a share-for-share basis. Otherwise, the rights of the two classes of common stock are identical. As of December 31, 2021, the Company had 25,995,172 shares issued and outstanding. As of December 31, 2020, the Company had 16,145,778 shares issued and outstanding.

 

In January 2020, we sold non-performing receivables in the aggregate amount of $529,000 for a purchase price of $510,000 whereby in the event of payment on the receivables being received, we agreed to provide a true-up to the purchaser of the receivable of between 10% and 36% depending on the payment date. In the event of nonpayment of the receivables by March 24, 2020 and March 30, 2020, as applicable to the receivables, the purchaser may require us to purchase any outstanding portion of the receivables for 136% of its outstanding balance (“Payment Date”). In order to secure our performance to repurchase the receivables, we pledged 239,029 shares of our Class A common stock. The purchaser and Company agreed to extend the Payment Date until June 23 and June 30, 2020, as applicable, in exchange for an aggregate of 36,700 Class A common shares.

 

In August 2021, our Board of Directors approved a share repurchase program pursuant to which we are authorized to repurchase up to $10,000,000 of our Class A Common Stock in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices. The total remaining authorization for future common share repurchases under our share repurchase program was $10.0 million as of September 30, 2021. Under the program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable law and regulation. This includes purchases pursuant to Rule 10b5-1 plans, including accelerated share repurchases. The program does not have an expiration date.

 

During the year ended December 31, 2021, the Company sold 53,616 shares of common stock, resulting in proceeds of approximately $284,000, through sales under its At the Market (ATM) offering.

 

During the year ended December 31, 2021, the Company repurchased 155,000 shares of Common Stock, for an aggregate purchase price of $793,000 pursuant to the Company’s Share Buy-Back program. The shares were retired as of December 31, 2021.

 

NOTE 22 – STOCK OPTIONS, AWARDS AND WARRANTS

 

2012, 2014 and 2016 Equity Compensation Plans

 

In January 2012, our board of directors and stockholders authorized the 2012 Equity Compensation Plan, which we refer to as the 2012 Plan, covering 600,000 shares of our Class A common stock. On November 5, 2014, our board of directors approved the adoption of our 2014 Equity Compensation Plan (the “2014 Plan”) and reserved 600,000 shares of our Class A common stock for grants under this plan. On February 23, 2016, our board of directors approved the adoption of our 2016 Equity Compensation Plan (the “2016 Plan”) and reserved 600,000 shares of our Class A common stock for grants under this plan. The purpose of the 2012, 2014 and 2016 Plans is to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our employees, directors and consultants and to promote the success of our company’s business. The 2012, 2014 and 2016 Plans are administered by our board of directors. Plan options may either be:

 

  ● incentive stock options (ISOs),
  ● non-qualified options (NSOs),
  ● awards of our common stock,
  ● stock appreciation rights (SARs),
  ● restricted stock units (RSUs),
  ● performance units,
  ● performance shares, and
  ● other stock-based awards.

 

Any option granted under the 2012, 2014 and 2016 Plans must provide for an exercise price of not less than 100% of the fair market value of the underlying shares on the date of grant, but the exercise price of any ISO granted to an eligible employee owning more than 10% of our outstanding common stock must not be less than 110% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $100,000. The exercise price of any NSO granted under the 2012, 2014 or 2016 Plans is determined by the Board at the time of grant but must be at least equal to fair market value on the date of grant. The term of each plan option and the manner in which it may be exercised is determined by the board of directors or the compensation committee, provided that no option may be exercisable more than 10 years after the date of its grant and, in the case of an incentive option granted to an eligible employee owning more than 10% of the common stock, no more than five years after the date of the grant. The terms of grants of any other type of award under the 2012, 2014 or 2016 Plans is determined by the Board at the time of grant. Subject to the limitation on the aggregate number of shares issuable under the plans, there is no maximum or minimum number of shares as to which a stock grant or plan option may be granted to any person.

 

F-36
 

 

Transactions involving our stock options for the years ended December 31, 2021 and 2020, respectively, are summarized as follows:

 

In April 2020 the Company issued 36,172 options to purchase the Company’s common stock at a price of $1.95 to our non-executive directors. Each of our four non-executive directors received 9,043 options that vest 1/4th quarterly over the next year with an expiration date of April 15, 2027. The options were valued using the Black Scholes option pricing model at a total of $60,000 based on the seven-year term, implied volatility of 100% and a risk-free equivalent yield of 0.24%, stock price of $1.95.

 

In August 2020, 430,000 common stock options having an exercise price of $2.70 per share with an option value as of the grant date of $859,000 calculated using the Black-Scholes option pricing model were granted to several employees and members of our management team. The expense associated with this option award will be recognized in operating expenses ratably over the vesting period of five years.

 

In November 2020, 300,000 common stock options having an exercise price of $2.97 per share with an option value as of the grant date of $649,000 calculated using the Black-Scholes option pricing model were granted to an employee. The expense associated with this option award will be recognized in operating expenses at date of grant.

 

   Number of Shares   Weighted Average Strike Price/Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding — December 31, 2019   1,192,519   $4.14    2.17   $—   $— 
Granted   766,172    2.77    3.00    521,000    2.72 
Exercised   —    —    —    —    — 
Forfeited   (316,367)   5.14    —    —    3.14 
Outstanding — December 31, 2020   1,642,324    3.30    2.81    —    — 
Vested and exercisable — December 31, 2020   844,742    3.54    2.62    333,000    3.54 
Unvested and non-exercisable - December 31, 2020   797,582    2.81    3.00    207,000    2.09 
                          
Outstanding — December 31, 2020   1,642,324    3.30    2.81    —    — 
Granted   21,627    4.38    6.29    2,000    3.60 
Exercised   (12,500)   2.70    3.63    —    2.00 
Forfeited   (319,671)   4.60    0.65    —    3.49 
Outstanding — December 31, 2021   1,331,780    3.02    2.39    1,969,000    2.13 
Vested and exercisable — December 31, 2021   870,750    3.05    2.27    1,265,000    2.15 
Unvested and non-exercisable - December 31, 2021   461,030   $2.96    2.62   $703,000   $2.10 

 

F-37
 

 

During the years ended December 31, 2021 and 2020, we recorded compensation expense of $1,006,000 and $1,615,000, respectively, related to stock-based compensation.

 

As of December 31, 2021, compensation cost related to the unvested options not yet recognized was approximately $811,000. The weighted average period over which the $811,000 will vest is estimated to be 2.83 years.

 

Transactions involving our warrants for the years ended December 31, 2021 and 2020, respectively, are summarized as follows:

 

As part of the Company’s Convertible Debenture offering in June 2020 (as described in Note 17 – OID Convertible Debentures), the Company negotiated the ability to release the BIGToken business, as security for the OID Convertible Debentures, for the purposes of selling BIGToken. As consideration for the release, the Company agreed to require the purchaser of BIGToken to issue warrants in the new entity. The warrants were to represent 13% of the new entities issued and outstanding on a fully diluted basis upon closing. As disclosed in Note 3 – Acquisitions, the Company entered into an agreement to merge BIGToken with FPVD on February 4, 2021, which required the issuance of 25,568,064,462 warrants. Based on a valuation from an independent third-party, the fair-market value of the warrants required to be issued was determined to be $885,000 based on implied 3-year volatility of 92.30%, a risk-free equivalent yield of 18% and stock price of $0.00006552.

 

On February 21, 2021 the Company entered into an agreement with the certain Debenture holders to exercise 4,545,440 of the Warrants issued in the June 2020 Debenture offering. As an inducement for the Warrant holders to exercise the Warrants, the holders receive a new registered warrant (“New Warrant”) to purchase an aggregate of 4,545,440 shares of the Company’s common stock at an exercise price of $7.50 per share. The New Warrants expire on January 31, 2022. Each holder agreed to pay $0.125 for each New Warrant. The Company received net proceeds of approximately $11,022,000, consisted of the exercise price of $11,363,000, $568,000 for the purchase of the New Warrant less solicitation fees of approximately $909,000.

 

The New Warrants were valued using the Black Scholes option pricing model at a total of $7,737,000 based on a one-year term, implied volatility of 96%, a risk-free equivalent yield of 11%, and stock price of $5.83. The fair value of the New Warrants was expensed and included in Financing Costs.

 

During the quarter ended March 31, 2021, the Company: (i) received cash of approximately $4,930,000, (ii) cancelled 349,197 warrants (as a result of cashless exercises) and (iii) issued an aggregate of 2,283,171 shares of Common Stock, in connection with the exercise of outstanding warrants.

 

In total the Company issued a total of 6,828,611 shares of common stock, for the exercise of warrants, with net proceeds of $15,952,000.

 

F-38
 

 

   Number of Shares   Weighted Average Strike Price/Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding — December 31, 2019   6,237,430   $3.57    2.68   $—   $— 
Granted   7,421,054    2.63    1.82    3,929,000    1.38 
Exercised   —    —    —    —    — 
Forfeited   (1,073,201)   —    —    —    — 
Outstanding — December 31, 2020   12,585,283    2.98    1.78    4,460,000    1.38 
Vested and exercisable — December 31, 2020   12,285,283    2.94    1.74    4,460,000    1.38 
Unvested and non-exercisable - December 31, 2020   300,000    4.75    3.37    —    — 
                          
Outstanding — December 31, 2020   12,585,283    2.98    1.78    4,460,000    1.38 
Granted   4,582,345    7.48    0.11    —    1.70 
Exercised   (7,148,501)   2.74    0.78    —    — 
Forfeited   —    —    —    —    — 
Outstanding — December 31, 2021   10,019,127    5.21    0.47    6,779,000    1.70 
Vested and exercisable — December 31, 2021   9,719,127    5.22    0.41    6,779,000    1.70 
Unvested and non-exercisable - December 31, 2021   300,000   $4.75    2.37   $—   $— 

 

NOTE 23 – RELATED PARTY TRANSACTIONS

 

The Company has subleased a suite at the Sofi Stadium in Los Angeles from an entity wholly owned by Christopher Miglino, our CEO. The sublease is for a period of one (1) year, at a rate of $382,500, and commencing on the date that the stadium opens to the general public (“Sublease”). We believe that such annual rate is a discount from prevailing market rates and is less than the master lease rate. In September 2021, the Company started paying $39,000 for the monthly lease payment for the 2nd year lease. The total amount paid during 2021 pursuant to the arrangement was $477,000.

 

The Sublease entitles the Company to game tickets, optional tickets for other stadium events, and suite and conference room access during business days. The Company determined that the sublease agreement does not meet the definition of a lease in accordance with ASC 842, Leases.

 

NOTE 24 – INCOME TAXES

 

Income tax (benefit) expense from continuing operations for the year ended December 31, 2021 consisted of the following:

 

   Current   Deferred   Total 
Federal  $—   $(132,000)  $(132,000)
State   5,000    —   5,000
Subtotal   5,000    (132,000)   (127,000)
Valuation allowance   —    —    — 
Total  $5,000   $(132,000)  $(127,000)

 

Income tax expense from continuing operations for the year ended December 31, 2020 consisted of the following:

   Current   Deferred   Total 
Federal  $—   $—    - 
State   21,000    —    21,000 
Subtotal   21,000    —    21,000 
Valuation allowance   —    —    — 
Total  $21,000   $—   $21,000 

 

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

   2021   2020 
Taxes calculated at federal rate   21.0%   21.0%
Stock based compensation   0.0%   (2.7)%
Permanent differences   (1.0)%   

(13.4

)%
Change in valuation allowance   (15.1)%   (2.1)%
Fair market adjustment derivatives   0.0%   0.5%
Prior year true-ups   0.0%   (3.3)%
Other adjustments   (4.1)%   (0.1)%
Provision for income tax benefit (expense)   0.8%   

(0.1

)%

 

F-39
 

 

The tax effects, rounded to thousands, of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at December 31, are presented below:

 

   2021   2020 
Deferred Tax Assets          
Net operating loss carryforwards  $10,003,000   $9,040,000 
Bad debt expense   33,000    136,000 
Fixed assets   -    

9,000

 
Accrued interest   -    - 
Stock based compensation   525,000    567,000 
Interest expense limitation carryover   220,000    

629,000

 
Contribution carryover   5,000    

5,000

 
Lease liability   62,000    

97,000

 
Unrealized gain on marketable securities   2,668,000    120,000 
Other accruals   124,000    173,000 
Total Deferred Tax Assets   13,640,000    10,776,000 
           
Deferred Tax Liabilities          
Fixed assets   

(29,000

)   -
Right-of-use asset   (66,000)   

(101,000

)
Intangibles   (455,000)   (690,000)
Interest expense limitation carryover   (59,000)   - 
Prepaid expenses   (15,000)   (17,000)
Total Deferred Tax Liabilities   (624,000)   (808,000)
           
Net Deferred Tax Assets   13,016,000    9,968,000 
Valuation Allowance   (13,016,000)   (9,968,000)
           
Net deferred tax / (liabilities)  $—   $— 

 

Deferred tax assets and liabilities are computed by applying the federal and state income tax rates in effect to the gross amounts of temporary differences and other tax attributes, such as net operating loss carry-forwards. In assessing if the deferred tax assets will be realized, the Company considers whether it is more likely than not that some or all of these deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which these deductible temporary differences reverse.

 

During the years ended December 31, 2021 and 2020, the valuation allowance increased by $2,996,000 and $2,375,000, respectively. The increase for both years was attributable to the increase in our net operating loss carryforwards. The total valuation allowance results from the Company’s estimate of its inability to recover its net deferred tax assets.

 

At December 31, 2021, the Company has federal and state net operating loss carry forwards, which are available to offset future taxable income, of approximately $34,933,000 and $73,733,000 respectively, both of which begin to expire in 2032 and 2032 respectively. These carry forwards may be subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code of 1986, and similar state provisions if the Company experienced one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382 and 383, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percentage points over a three-year period. The Company has not completed an IRC Section 382/383 analysis. If a change in ownership were to have occurred, NOL and tax credit carryforwards could be eliminated or restricted. If eliminated, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, will not impact the Company’s effective tax rate.

 

The Company files income tax returns in the United States and various state jurisdictions. Due to the Company’s net operating loss posture all tax years are open and subject to income tax examination by tax authorities. The Company’s policy is to recognize interest expense and penalties related to income tax matters as tax expense. As of December 31, 2021 and 2020, there are no unrecognized tax benefits, and there are no significant accruals for interest related to unrecognized tax benefits or tax penalties.

 

The Company is in the process of analyzing their NOL and has not determined if the company has had any change of control issues that could limit the future use of NOL. NOL carryforwards that were generated after 2017 of approximately $29.4 million may only be used to offset 80% of taxable income and are carried forward indefinitely.

 

F-40
 

 

NOTE 25 – FAIR VALUE OF FINANCIAL INSTRUMENTS

 

The carrying amounts of certain financial instruments, including cash and cash equivalents and accounts payable and accrued expenses, approximate their respective fair values due to the short-term nature of such instruments.

 

Additionally, the Company has a deferred note receivable with a notional amount of $1,000,000. The deferred payments of $960,000 and $40,000 were discounted using the yield on a CCC rated corporate debt for 3-year maturity. The implied discount is approximately $107,000, which will be amortized over 3 years. Notes receivable as of December 31, 2021 and 2020 amounted to $935,000 and $893,000, respectively.

 

Assets and Liabilities Measured at Fair Value on a Recurring Basis

 

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The Company had the following financial assets and liabilities as of December 31, 2021 and 2020:

 

 

       Quoted Prices   Significant     
   Balance as of   in Active
Markets for		   Other
Observable		   Significant
Unobservable		 
   December 31   Identical Assets   Inputs   Inputs 

  2021   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Marketable securities  $15,617,000   $6,134,000   $2,448,000   $7,035,000 
Designated assets   3,925,000    259,000    3,666,000    — 
Contract assets   

844,000

    

—

    —    

844,000

 
Total assets  $20,386,000   $6,393,000   $6,114,000   $

7,879,000

 

 

       Quoted Prices   Significant     
   Balance as of  

in Active

Markets for

   Other
Observable		   Significant Unobservable 
   December 31,   Identical Assets   Inputs   Inputs 
  2020   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Marketable securities  $8,447,000   $7,764,000   $683,000   $— 
Total assets  $8,447,000   $7,764,000   $683,000   $— 

 

The Contract assets represent a forward contractual right of to receive securities pursuant to a revenue contract. As of December 31, 2021, the Company determined the value of the securities underlying the Contract asset to have a fair value of $844,000.

 

 

             
   As of Dec. 31, 2021   
   Level 1   Level 2   Level 3   Fair Value 
Liabilities:                    
Series A Preferred Stock  $—   $3,925,000    -   $3,925,000 
Total liabilities  $—   $3,925,000    -    $3,925,000 

 

             
   As of December 31, 2020  
   Level 1   Level 2   Level 3   Fair Value 
Liabilities:                    
Series A Preferred Stock  $—   $—   $      -   $- 
Total liabilities  $—   $—   $-   $ - 

 

F-41
 

 

Changes in level 3 assets measured at fair value

 

The following table presents additional information about Level 3 assets measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of assets classified within the Level 3 category. As a result, the unrealized gains and losses for the assets and liabilities within the Level 3 category may include changes in fair value that were attributable to both observable and unobservable inputs. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Changes in Level 3 assets measured at fair value for the year ended December 31, 2021 were as follows:

 

Assets  Beginning
Balance January 1, 2021		   Acquisitions   Sales and dispositions  

Transfers into

Level 3

   Transfers out of Level 3 (a)   Realized &
Unrealized Gains (Losses)(b)		   Ending Balance Dec 31, 2021 
                             
Common stocks   -   $2,665,000   $-   $400,000   $(534,000)  $(377,000)  $2,154,000 
Convertible Debt   -   $4,267,000   $-   $410,000   $(213,000)  $(278,000)  $4,186,000 
Warrants   -   $-   $-   $-   $-   $96,000   $96,000 
Preferred stocks   -   $1,031,000   $(510,000)  $500,000   $-   $(422,000)  $599,000 
Total Investments   -   $7,963,000   $(510,000)  $1,310,000   $(747,000)  $(981,000)  $7,035,000 

 

a.Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital.
  
b.Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations.

 

Valuation processes for Level 2 and 3 Fair Value Measurements

 

Fair value measurement of certain of our marketable securities fall within Level 2 and 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

 

The Company classifies certain assets as Level 3 assets if the estimated fair value was derived from level 3 inputs. The Company utilizes a put option pricing model to arrive at a discount for lack of marketability and liquidity associated with restrictions on sales into the public market. The Company generally classifies restricted securities in public companies as level 2, however in circumstances where the observed level of liquidity is low and the quoted market price is deemed unreliable they may be categorized in Level 3 of the fair value hierarchy. The Company considers marketable securities without sufficient liquidity to sell within 6 months of the date of acquisition and securities that will not be eligible for resale in the public markets through Rule 144 for 1 year from the date acquisition to be valued with Level 2 inputs.

 

The fair value of the Company’s Series A Preferred Stock may change significantly, impacting the Company’s assumptions used to estimate its fair value. The valuation of the Series A Preferred Stock is primarily based on the valuation of its underlying marketable securities. The marketable securities that are underlying the Series A Preferred Stock are classified as Designated Assets on the Company’s balance sheet and include Level 1 and Level 2 marketable securities and cash.

 

The following table lists the significant unobservable inputs used to value assets classified as Level 3 of December 31, 2021. The table is not intended to be all-inclusive, but instead identifies the significant unobservable inputs relevant to the determination of fair values. The other Level 3 assets have been valued using unadjusted third-party transactions and, unadjusted historical third-party information, or the unadjusted net asset values of the securities’ issuer. No unobservable inputs internally developed by the Company have been applied to these assets, and therefore are omitted from the following table.

Assets   Valuation technique   Unobservable inputs   Range
             
Common stocks   Put option pricing model   Discount for lack of marketability   0% - 54%
             
Convertible preferred stock   Put option pricing model   Discount for lack of marketability   0% - 54%
             
 Convertible Debt    Discounted cash flow   Maturity   0 - 35 months
        Risk adjusted discount factor   26%
             
    Option pricing model   Volatility   100%
        Risk-free interest rate   0.78 % 1.04%
        Dividend yield   0%
        Time to maturity   0 - 35 months

 

Sensitivity of Level 3 measurements to changes in significant unobservable inputs

 

The process of estimating the fair value of securities without active markets involves significant estimates and judgement on behalf of management. These estimated fair values may not be realized in a current sale or immediate settlement of the asset or liability. Additionally, there are inherent uncertainties in any fair value measurement techniques, and changes in the underlying assumptions used could significantly affect the fair value measurement amounts.

 

Changes in each of these significant unobservable valuation inputs will impact the fair value measurement of the financial instrument generally as follows:

 

●An increase or decrease in the volatility of the common stock that underlies our holdings in convertible debt would result in a directionally similar change in the estimated fair value.
   
●An increase or decrease in the risk-free interest rate or risk adjusted discount factor would result in an inverse change in the estimated fair value of our convertible debt.
   
●An increase in the dividend yield would increase the estimated value of the convertible debt.
   
●A change in the maturity may result in either an increase or decrease in estimated fair value of the convertible debt.
   
 ●An increase or decrease in the discount for lack of marketability of our common stock holdings and the common stock that underlies our preferred stock would generally result in an inverse change in the estimated fair value.

 

Instruments for which unobservable inputs are significant to their fair value measurement (i.e., Level 3) include securities in which we deem their market to be inactive or unreliable. The Company reviews and updates the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next that are related to the observable inputs to a fair value measurement may result in a reclassification from one hierarchy level to another.

 

F-42
 

 

Valuation technique refinements

 

During the year-ended December 31, 2021, the Company refined its valuation techniques to enhance consideration of unobservable inputs for the valuation of Level 2 and Level 3 marketable securities.

 

If quoted market prices are not available for the specific security, or if the observed quoted market price is deemed unreliable, then fair values are estimated by using pricing models, considering third-party transactions, unadjusted historical third-party information, and the unadjusted net asset values of the issuer. The pricing models primarily use market-based or independently sourced market parameters as inputs, including, but not limited to, yield curves, interest rates, equity or debt prices, and credit spreads. In addition to market information, models also incorporate transaction details, such as maturity and cash flow assumptions. Securities valued in this manner would generally be classified within Level 2 and Level 3 of the valuation hierarchy and primarily include such instruments as convertible debt.

 

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

 

NOTE 26 – REVENUE DISAGGREGATION

 

The Company has two operating units and one reportable segment. The Sequire segment includes the licensing of the Company’s proprietary SaaS platform and associated data analysis technologies. Additionally, the Sequire segment comprises consumer and investor targeted marketing solutions to allow users of our SaaS platform to act on the insights obtained through our technologies. Lastly, reported under Sequire is our business unit LD Micro, which is in the business of hosting events and conference for microcap public companies.

 

The following table summarizes revenue by business unit:

 

   2021   2020 
Sequire platform revenue  $24,514,000   $5,976,000 
Conference revenue   1,229,000    503,000 
Other revenues   964,000    - 
Total revenues  $26,707,000   $6,479,000 

 

As of December 31, 2021 and 2020, revenue contract liabilities were approximately $12,859,000 and $4,842,000, respectively.

 

F-43
 

 

NOTE 27 – SUBSEQUENT EVENTS

 

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The management of the Company determined the following reportable events:

 

SAFE agreement

 

On February 15, 2022 The Company entered into a simple agreement for future equity (the “SAFE”) with BIGtoken, Inc. (BIGToken), its former subsidiary. Pursuant to the SAFE, SRAX has agreed to invest $1,000,000 in the SAFE. The amount funded into the SAFE at a given time is referred to herein as the “SAFE Amount”.

 

Pursuant to the terms of the SAFE, at any time that the Company sells its securities (a “Financing”) prior to the termination of the SAFE, the Company may, at its option, convert the SAFE into: (i) the number of shares of non-voting Series D Convertible Preferred Stock (“Series D Preferred Stock”) equal to such (a) SAFE Amount divided by (b) the lowest price per share of equity securities sold in any Financing (prior to the termination of the SAFE) multiplied by eighty percent (80%) (the “Conversion Price”) and (ii) such number of warrants to purchase Series D Preferred Stock (the “Warrants”) equal to the SAFE Amount divided by the Conversion Price. Upon issuance, the Warrants will (i) have a term of five (5) years, (ii) an exercise price equal to the Conversion Price, and (iii) contain price protection provisions for subsequent financings.

 

CVR Agreement

 

On June 13, 2022, the Company entered into an agreement with an institutional investor whereby in exchange for the payment of $404,513.40 (the “Purchase Price”), the investor received (i) the right to receive the net proceeds upon the sale of certain securities of the Company (“CVR Payments”) with a quoted price equal to $674,190 (with a guaranteed minimum return of 120% of such Purchase Price and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the CVR Payments.

 

Extension of Outstanding Original Issue Discount Senior Secured Convertible Debentures

 

On July 1, 2022, the holders (“Holders”) of $1,102,682 in principal of the Company’s Original Issue Discount Senior Secured Convertible Debentures (“Debentures”), representing all of the outstanding Debentures that were originally issued on June 30, 2020, entered into an agreement with the Company to (i) extend the maturity date of the Debentures until December 31, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures. The Debentures, including the additional principal added to the Debentures are secured by substantially all of the assets of the Company pursuant to a security agreement entered into between the Company and Holders contemporaneous with the original issuance of the Debentures (the “Security Agreement”).

 

Bridge Note

 

On July 1, 2022, the Company issued an original issue discount bridge note in principal amount of $650,000 (“Bridge Note”) to an institutional investor in exchange for $500,000 in cash. The bridge note was non-interest bearing and had a maturity date of August 15, 2022. The Company’s obligations pursuant to the bridge note were secured by substantially all of the assets of the Company pursuant to the terms of the Security Agreement.

 

On August 8, 2022, as described below, the Bridge Note was exchanged for a revolving note in the Senior Secured Revolving Credit Facility.

 

RBSM LLP Declining to Stand for Reappointment

 

On June 30, 2022, RBSM LLP (“RBSM”), the independent registered public accounting firm to the Company, informed the Company of its decision not to stand for re-appointment as the independent registered public accounting firm of the Company. RBSM will cease its services as the Company’s independent registered accountants effective with the filing of the Company’s annual report on Form 10-K with the United States Securities and Exchange Commission. The Company’s Audit Committee accepted the resignation of RBSM and has selected a new independent public accounting firm.

 

Revolving Credit Facility

 

On August 8, 2022 (“Effective Date”), the Company entered into a senior secured revolving credit facility agreement (the “Credit Agreement”) with an institutional investor (the “Lender”) to initially borrow up to $9,450,000 (“Loan Amount”) in the aggregate from time to time, subject to certain conditions (each a “Revolving Loan”). The Revolving Loan is secured by all the assets of the Company and is guaranteed by LD Micro, Inc. (collectively, Company and LD Micro are referred to as the “Credit Parties”). In addition to the Credit Agreement, the Credit Parties, as applicable, also entered into a: (i) Revolving Note, (ii) Security Agreements, (iii) Fee Agreement and (iv) Registration Rights Agreement (collectively the “Loan Documents”). As part of the transaction, the Company also amended and restated Lender’s outstanding warrants to extend the maturity date of a total of 2,590,358 Common Stock purchase warrants until September 30, 2023.

 

For the Company enter into the Credit Agreement , we were required to issue 33,000 shares of the Company’s common stock as a breakup fee to an unrelated lender as a result of a failed offering.

 

F-44
 

 

Credit Agreement and Revolving Note

 

On the Effective Date, the Lender advanced $5,580,000 consisting of $4,930,000 in cash and the exchange of the $650,000 bridge note entered into on June 28, 2022, which was previously disclosed on the Company’s Current Report on Form 8-K filed on July 7, 2022 with the SEC. Provided that no event of default has occurred under the Loan Documents, upon the Company becoming current with its filing obligations under the Securities Exchange Act of 1934, as amended, as well as any other obligations of its principal trading market, Lender will advance up to an additional $3,870,000. Future Revolving Loan amounts (but not in excess of the Loan Amount) are subject to a borrowing base calculation.

 

The principal balance of each Revolving Loan will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%. The Revolving Loans have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents.

 

Commencing on the first day of each month after the Effective Date (each a “Payment Date”), the outstanding balance of the Revolving Loan will be paid as follows:

 

a.With respect to the first, second and third months, 10% of the monthly collections from the sale of securities received by the Company from its customers during the prior month;

 

b.With respect to the fourth, fifth and sixth months, 15% of the monthly collections from the sale of securities received by the Company from its customers during the prior month; and

 

c.With respect to each successive Payment Date, 20% of the monthly collections from the sale of securities received by the Company from its customers during the prior month.

 

Additionally, with respect to any Payment Date where the applicable monthly collection from the sale of securities received by the Company from its customers during the prior month exceeds $2,000,000, the Company will make an additional payment equal to 30% of any amounts in excess of $2,000,000.

 

The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends and fundamental transactions. Moreover, in the event the Company is deemed to have issued or sold shares of its Common Stock while the Revolving Loan is outstanding at a price equal to or less than $5.00 per share, the conversion price will adjust to such lower applicable price.

 

Security Agreements

 

In order to perfect Lender’s security interest, the Credit Parties entered into: (i) Security Agreements, (ii) Guaranty Agreements, (iii) Pledge Agreements and (iv) Security Account Control Agreements and Deposit Account Control Agreements (collectively “Security Agreements”). The Security Agreements provide for a general lien on all of the Credit Parties’ assets, including each party’s respective intellectual property.

 

Extension of Warrants

 

As part of the transactions contemplated by the Loan Documents, the Company additionally agreed to extend the expiration dates of the following outstanding Common Stock purchase warrants held by the Lender or its affiliated entities until September 30, 2023:

 

(a)a warrant to purchase 1,363,636 shares of Common Stock issued on June 30, 2020, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2020;

 

(b)a warrant to purchase 166,667 shares of Common Stock issued on November 29, 2018, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on November 30, 2018; and

 

(c)a warrant to purchase 530,027 shares of Common Stock issued on November 29, 2018, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on November 30, 2018;

 

(d)a warrant to purchase 530,028 shares of Common Stock issued on October 27, 2017 that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on October 27, 2017.

 

Fee Agreement

 

As consideration for Lender entering into the Loan Documents, Lender will be entitled to receive, in addition to any payment made under the Credit Agreement, 10% of the net proceeds received by the Company from the sales of securities received during the term of the Revolving Loan.

 

Common stock issue for Options and Warrants

 

Subsequent to December 31, 2021, the Company issued approximately 287,000 shares of the Company’s common stock for the exercise of warrants and/or stock options.

 

F-45
 GRAPHIC 2 form10-k_001.jpg begin 644 form10-k_001.jpg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

U,BLK>;Q/IR21[E;P\\) M&X\H63(KS.75M0C\!R0+>SF&&^-BD;.640!,!"#P0!Z\T7"Q[Y!<"6TCN'1H M0R!RLN 4XS@X.,CZUY7HGQ%OI?%,@U'5+<:9')/YN856(Q;ML)MW'SRDG /! M'7VKT73-.M%\*VNFB+-I]C6'RRQ.4*8(R3GI[UXO86D=SH&KWL[SR7'A^14T MIVG<_90' &T9QT '.>E#8(]F\3:_;>&O#EYJ]SRD$>40G!=SPJ_B2!7,^ O& M$U^FH:9K6IV5WJ-B@N6N;5U,;PL,\8[H$(;Q?-B9Y+AHV M^ZTBQ95B.AP232^)-/M(_$/AJXCMXTE:ZDMV9!C=$\;;D('4' X/I3 H-XVO M=1UKPXVGZ?>0:9?O,RO,L8^UHL3,NT9++D@$9QD5H)X]TZ_LXS8"X,TUC/>- M^Z!-J(\@^8N1@[P5QW(/;FN(T,-%\3[+2%DE.GZ9-*MG TC,(1L(P,G.,<<] M*[&'1]/LY?&\UO:I')=9\YESELP GZX+!FV]]H M.*X/6P9=9\&Z0[R-I\MM:LT!H/4$C!%0:/:06WCC6_)C" M 6EH@ Z!5#@ #MBN4\&;K_XGZS+=R2326"/%;.[DE$9^5)S\PXXSG';%%P/4 MZ***H04444 %)2T4 %126\,W$L,;C_:4&I:* L4CI&FEL_8+8'U6( _I4T=I 1#%_JPR^P<_XU/13NQ61__]D! end GRAPHIC 3 image_001.jpg begin 644 image_001.jpg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end EX-10.37 4 ex10-37.htm

 

Exhibit 10.37

 

CONTINGENT VALUE RIGHT

 

This contingent value right agreement (“Agreement”) is dated as of June 13, 2022 (“Effective Date”), by and among SRAX, Inc. (the “Seller”) and [______] (the “Purchaser”).

 

W I T N E S S E T H:

 

WHEREAS, the Purchaser desires to purchase from the Seller and the Seller desires to sell to the Purchaser: a contingent value right that entitles Purchaser to receive the proceeds upon the sale of the securities described on Schedule A hereto (“Securities”);

 

NOW, THEREFORE, in consideration of the mutual covenants contained herein, and intending to be legally bound, the parties hereto agree as follows:

 

ARTICLE I

 

Purchase and Sale of the Common Stock

 

Section 1.1. Purchase and Sale of the Contingent Value Right.

 

(a) Upon the terms and subject to the conditions of this Agreement and on the basis of the representations, warranties and agreements contained herein, the Purchaser agrees to pay to Seller an amount equal to $404,513.40 in US Dollars on the Effective Date (“Purchase Price”) in exchange for the Seller selling, assigning, transferring and conveying to the Purchaser the right to receive the proceeds (less expenses and brokerage fees from the sales) from the sale of the Securities by Seller if and when sold by Seller (the “CVR”).

 

(b) Seller further agrees that beginning on the Effective Date, if prior to the sale of any of the Securities, the Seller receives additional securities as a result of the ownership of the Securities, as applicable (“Additional Securities”), such Additional Securities will become part of the Securities and will be subject to the same terms and conditions of this Agreement upon sale.

 

(c) Upon any sale of Securities by the Seller, the Seller shall remit payment of the amount of proceeds received from the sale of such Securities to the Purchaser, less expenses and brokerage fees incurred during such sales (“CVR Payments”). Such CVR Payments will be made by Seller to Purchaser on the first business day following each previous week in which such applicable Securities were sold. Seller will continue to make the CVR Payments to Purchaser until such time that all of the Securities have been sold. In the event that the Securities have all been sold and all CVR Payments made to Purchaser in the aggregate are less than 120% of the Purchase Price, then within five (5) business days thereafter, the Seller will pay such amount to Purchaser equal to: 120% of the Purchase Price less the total aggregate amount of the CVR Payments made.

 

 
 

 

(d) Notwithstanding the foregoing, on the 90th day following the date that the Purchase Price is received by the Seller up to and until the 120th day following the date that the Purchase Price is received by the Seller, the Purchaser shall have the option to demand that the Seller pay the Purchaser the following amount (“CVR Option Amount” within five (5) business days of such notice: 120% of the initial Purchase Price less any CVR Payments previously paid by Seller to Purchaser. For purposes of clarity, upon payment of the CVR Option Amount, all future right to any payments upon sales of the Securities or Additional Securities still held by Seller shall remain the sole property of Seller and Purchaser shall have no right to receive future amounts upon the sale of Securities or any amounts further under this Agreement.

 

Section 1.2. Closing Deliveries. At the closing, subject to the terms and conditions hereof, Purchaser shall cause Seller to pay the Purchase Price pursuant to the wire instructions to be provided by Seller and upon such payment of the Purchase Price, Seller shall confirm ownership of the CVR by Purchaser.

 

ARTICLE II

 

Representations and Warranties Regarding the Seller

 

The Seller hereby represents and warrants to the Purchaser as follows:

 

Section 2.1. Authorization. Seller is the owner and has the rights to the Securities. Seller did not offer or sell the Securities by any form of general solicitation or general advertising. Seller not an “affiliate” of the any of the issuers of the Securities, as defined in Rule 405 and Rule 144 under the Securities Act of 1933, as amended (the “1933 Act”). Seller has the power and authority to execute and deliver this Agreement and to perform its obligations hereunder, all of which have been duly authorized by all requisite action. This Agreement has been duly authorized, executed and delivered by it and constitutes its valid and binding obligation, enforceable against it in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles. For purposes of this paragraph, the “Seller” includes any person that would be included with the Seller for purposes of Rule 144(a)(2).

 

Section 2.2. No Consents/Advice. No notice to, filing with, or authorization, registration, consent or approval of any governmental authority or other individual, partnership, corporation, joint stock company, unincorporated organization or association, trust or joint venture, or a governmental agency or political subdivision thereof (each, a “Person”) is necessary for the execution, delivery or performance of this Agreement or the consummation of the transactions contemplated hereby by it. Seller has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary or appropriate in connection with the terms of this Agreement.

 

Section 2.3. Ownership of the Securities. Seller owns, or will own (with respect to the Additional Securities) the Securities beneficially and of record, free and clear of any liens, claims or encumbrances, (collectively, “Encumbrances”). Other than this Agreement, it has not entered into any agreement, arrangement or other understanding (i) granting any option, warrant or right of first refusal with respect to the Securities to any Person, (ii) restricting its right to sell the Securities, or (iii) restricting any other of its rights with respect to the Securities. Upon execution of this Agreement, the CVR will be the only Encumbrance created by the Seller with respect to the Securities and Seller further represents and warrants that it will not, without the written approval of Purchaser, create any other Encumbrances under these Securities.

 

2

 

 

Section 2.4. Brokers. No Person is or will be entitled to a broker’s, finder’s, investment banker’s, financial adviser’s or similar fee from it in connection with this Agreement or any of the transactions contemplated hereby.

 

Section 2.5 No Litigation. There is no action, suit, proceeding, judgment, claim or investigation pending, or to the knowledge of the Seller, threatened against the Seller which could reasonably be expected in any manner to challenge or seek to prevent, enjoin, alter or materially delay any of the transactions contemplated hereby.

 

Section 2.6 Bankruptcy. Seller is not under the jurisdiction of a court in a Title 11 or similar case (within the meaning of Bankruptcy Code Section 368(a)(3)(A) (or related provisions)) or involved in any insolvency proceeding or reorganization.

Section 2.7 Additional Securities. Seller agrees to notify Purchaser immediately upon the issuance of any Additional Securities and to cause such Additional Securities to be subject to the terms of this Agreement, as applicable.

 

ARTICLE III

 

Representations and Warranties Regarding the Purchaser

 

The Purchaser hereby represents and warrants to the Seller as follows:

 

Section 3.1. Authorization. It has the power and authority to execute and deliver this Agreement and to perform its obligations hereunder, all of which have been duly authorized by all requisite action. This Agreement has been duly authorized, executed and delivered by it and constitutes its valid and binding agreement, enforceable against it in accordance with its terms, subject to bankruptcy, insolvency, fraudulent transfer, reorganization, moratorium and similar laws of general applicability relating to or affecting creditors’ rights and to general equity principles.

 

Section 3.2. Access to Information. It has received all information regarding the Securities that it deems necessary or advisable to evaluate the risks and merits of the purchase of the CVR. It acknowledges that neither the Seller nor any of its authorized representatives have made any representation or warranty regarding the Securities or an investment in the CVR, other than as contained herein. Purchaser has made its own investigation of the issuers of the Securities in making Purchaser’s determination to purchase the CVRs. Purchaser understands that its investment in the CVR involves a significant degree of risk.

 

3

 

 

Section 3.3. Brokers. No person is or will be entitled to a broker’s, finder’s, investment banker’s, financial adviser’s or similar fee from it in connection with this Agreement or any of the transactions contemplated hereby.

 

Section 3.4. Financial Resources. It has presently available to it sufficient cash resources to enable it to pay the Purchase Price.

 

ARTICLE IV

 

Survival, Amendment and Waiver

 

Section 4.1. Survival. The representations and warranties contained in this Agreement or any certificate delivered in connection herewith shall survive the sale of the Securities and payment of the CVR Payments or CVR Option Amount as contemplated hereby.

 

Section 4.2. Amendments. This Agreement (including the provisions of this Section 4.2) may not be amended or modified except by an instrument in writing signed on behalf of all of the parties affected by such amendment or modification.

 

Section 4.3. Extension; Waiver. The parties hereto may (i) extend the time for performance of any of the obligations or other acts of the other parties hereto, (ii) waive any inaccuracies in the representations and warranties of the other parties hereto contained herein or in any document delivered pursuant hereto, and (iii) waive compliance with any of the agreements of the other parties hereto or satisfaction of any of the conditions to such party’s obligations contained herein. Any agreement on the part of a party hereto to any such extension or waiver shall be valid only if set forth in an instrument in writing signed on behalf of such party. The failure of a party hereto to assert any of its rights hereunder shall not constitute a waiver of such rights.

 

ARTICLE V

 

Miscellaneous

 

Section 5.1. Notices. All notices, requests, claims, demands, waivers and other communications hereunder shall be in writing and shall be deemed to have been duly given when delivered by hand, when delivered by courier, three days after being deposited in the mail (registered or certified mail, postage prepaid, return receipt requested), or when received by facsimile transmission or electronic mail at the coordinates or addresses provided by the parties.

 

Section 5.2. Expenses. Each of the parties hereto shall pay its own expenses incident to this Agreement and the transactions contemplated herein.

 

4

 

 

Section 5.3. Governing Law; Consent to Jurisdiction; Waiver of Jury Trial. This Agreement shall be governed by, and construed in accordance with, the internal laws of the State of Delaware, without reference to the choice of law principles thereof. Each party hereto irrevocably waives any objection to the laying of venue of any such suit, action or proceeding brought in such courts and irrevocably waives any claim that any such suit, action or proceeding brought in any such court has been brought in an inconvenient forum. EACH OF THE PARTIES HERETO WAIVES ANY RIGHT TO REQUEST A TRIAL BY JURY IN ANY LITIGATION WITH RESPECT TO THIS AGREEMENT AND REPRESENTS THAT COUNSEL HAS BEEN CONSULTED SPECIFICALLY AS TO THIS WAIVER.

 

Section 5.4. Assignment; Successors and Assigns; No Third Party Rights. This Agreement may not be assigned by operation of law or otherwise, and any attempted assignment shall be null and void. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective heirs, successors, permitted assigns and legal representatives. This Agreement shall be for the sole benefit of the parties to this Agreement and their respective heirs, successors, permitted assigns and legal representatives and is not intended, nor shall be construed, to give any Person, other than the parties hereto and their respective heirs, successors, assigns and legal representatives, any legal or equitable right, remedy or claim hereunder.

 

Section 5.5. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed an original agreement, but all of which together shall constitute one and the same instrument.

 

Section 5.6. Titles and Headings. The titles and headings in this Agreement are for reference purposes only, and shall not in any way affect the meaning or interpretation of this Agreement.

 

Section 5.7. Entire Agreement. This Agreement constitute the entire agreement among the parties with respect to the matters covered hereby and thereby and supersede all previous written, oral or implied understandings among them with respect to such matters.

 

Section 5.8. Severability. The invalidity of any portion hereof shall not affect the validity, force or effect of the remaining portions hereof. If it is ever held that any restriction hereunder is too broad to permit enforcement of such restriction to its fullest extent, such restriction shall be enforced to the maximum extent permitted by law.

 

Section 5.9. Interpretation. Unless otherwise indicated to the contrary herein by the context or use thereof: (i) the words, “herein,” “hereto,” “hereof” and words of similar import refer to this Agreement as a whole and not to any particular Section or paragraph hereof; (ii) words importing the masculine gender shall also include the feminine and neutral genders, and vice versa; and (iii) words importing the singular shall also include the plural, and vice versa.

 

Section 5.10. No Strict Construction. Each of the parties hereto acknowledge that this Agreement has been prepared jointly by the parties hereto, and shall not be strictly construed against either party.

 

[Remainder of page intentionally left blank]

 

5

 

 

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed as of the day and year first above written.

 

  SELLER:
     
  SRAX, INC.
     
  By:                     
  Name:   
  Title:  
     
  PURCHASER:
     
  By:  
  Name:  
  Title:  

 

6

 EX-10.38 5 ex10-38.htm

 

Exhibit 10.38

 

NEITHER THIS NOTE NOR THE SECURITIES THAT ARE ISSUABLE TO THE COMPANY UPON CONVERSION HEREOF (COLLECTIVELY, THE “SECURITIES”) HAVE BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “1933 ACT”), OR THE SECURITIES LAWS OF ANY STATE OR OTHER JURISDICTION. NEITHER THE SECURITIES NOR ANY INTEREST OR PARTICIPATION THEREIN MAY BE OFFERED FOR SALE, SOLD, TRANSFERRED OR ASSIGNED: (I) IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE 1933 ACT OR APPLICABLE STATE SECURITIES LAWS; OR (II) IN THE ABSENCE OF AN OPINION OF COUNSEL, IN A FORM ACCEPTABLE TO THE ISSUER, THAT REGISTRATION IS NOT REQUIRED UNDER THE 1933 ACT OR; (III) UNLESS SOLD, TRANSFERRED OR ASSIGNED PURSUANT TO RULE 144 UNDER THE 1933 ACT.

 

PROMISSORY NOTE

 

July 1, 2022   Principal Amount: $650,000
    Purchase Price: $500,000

 

FOR VALUE RECEIVED, SRAX, INC., a corporation incorporated under the laws of the State of Delaware (the “Company”), hereby promises to pay to the order of [_____________] (the “Holder”), the principal amount of Six Hundred Fifty Thousand and zero/100 United States Dollars (US$650,000.00), on the maturity date (the “Maturity Date”), which shall be August 15, 2022 or such other date as mutually agreed to in writing by the Company and Holder. This Promissory Note (as may be amended or supplemented from time to time, this “Note”) shall bear no interest except following an Event of Default as provided herein.

 

The Purchase Price of this Note shall be equal to Five Hundred Thousand and zero/100 United States Dollars (US$500,000.00). The Company shall pay to the Holder an original issue discount in the amount of One-Hundred Fifty Thousand and zero/100 United States Dollars (US$150,000.00) (the “OID”). The OID has been added to the principal amount of this Note and as such the aggregate principal amount of this Note is Six Hundred Fifty Thousand and zero/100 United States Dollars (US$650,000.00).

 

1. Payments of Principal.

 

(a) Payment of Principal. The principal amount of this Note shall be paid to the Holder on the Maturity Date. It is intent of the Company and the Holder to engage in good faith efforts to agree a financing of the Company by the Holder on mutually acceptable terms, subject due diligence by the parties and internal approval by Holder, on or prior the Maturity Date (the “Qualified Financing”). Upon the consummation of the Qualified Financing, provided it shall have occurred on or prior to the Maturity Date, the amounts owing hereunder shall be exchanged for indebtedness in the Qualified Financing (for clarity, inclusive of the anticipated 10% original issue discount of the Qualified Financing, the principal amount of such exchanged indebtedness shall equal $722,222.22). For the avoidance of doubt, nothing herein shall obligate the Holder to consummate the Qualified Financing.

 

1

 

 

(b) No Interest. The unpaid principal balance of this Note shall bear no interest.

 

(c) General Payment Provisions. All payments on this Note shall be made in lawful money of the United States of America by certified bank check or wire transfer to such account as the Holder may designate by written notice to the Company in accordance with the provisions of this Note. Whenever any amount expressed to be due by the terms of this Note is due on any day which is not a Business Day, the same shall instead be due on the next succeeding Business Day. For purposes of this Note, “Business Day” shall mean any day other than a Saturday, Sunday or a day on which commercial banks in the State of New York are authorized or required by law or executive order to remain closed.

 

2. Exchange of Note and Issuance of Warrant.

 

(a) At the option of the Holder, upon an Event of Default or if upon the Maturity Date the amounts owing under this Note have not been repaid in accordance with its terms or exchanged for indebtedness in the Qualified Financing, this Note shall be extinguished in exchange for the addition of $738,637.00 to the outstanding principal balance of that certain Original Issued Discount Senior Secured Convertible Debenture, due June 25, 2023 (as amended following the issuance thereof, the “Prior Debenture”), issued by the Company to the Holder pursuant to the terms of that certain Securities Purchase Agreement, dated as of June 25, 2020 (the “Purchase Agreement”), among the Company and each purchaser identified on the signature pages thereto.

 

(b) Upon the extinguishment of this Note and the increase of the principal balance of the Prior Debenture, the Company shall also issue a Common Stock Purchase Warrant, with substantially the same terms as the warrant issued pursuant to the Purchase Agreement and in the form attached hereto as Annex A (the “Warrant”) to purchase 295,455 shares of the Company’s Class A common stock of the Company, par value $0.001 per share (the “Common Stock”).

 

(c) The Company by its signature hereto and the Holder by its acceptance of the Warrant acknowledges that the Warrant when issued shall have been deemed to have been issued pursuant to the terms of the Purchase Agreement

 

(d) At the option of the Holder, upon an Event of Default or a failure by the Company to repay the amounts owing under this Note upon the Maturity Date, the principal balance of the Prior Debenture shall be deemed increased as provided in Section 2(a) hereof and the Warrant shall be deemed issued to the Holder, without any further direction, acknowledgement or action of the Company.

 

(e) The Company hereby acknowledges, represents, warrants, and confirms to the Holder that: (i) each of this Note, the Warrant and the Transaction Documents (as defined in the Purchase Agreement) executed by the Company, are valid and binding obligations of the Company, enforceable against the Company in accordance with their respective terms; (ii) all other obligations of the Company under the Transaction Documents (as defined in the Purchase Agreement) and under the Warrant, shall be and continue to be and remain secured by and under the Security Agreement (as defined in the Purchase Agreement); and (iii) no oral representations, statements, or inducements have been made by the Holder, or any agent or representative of the Holder, with respect to this Note, the Warrant or the Transaction Documents (as defined in the Purchase Agreement).

 

2

 

 

3. Grant of Security. The Company hereby acknowledges that it previously granted a security interest, as that term is defined in the Uniform Commercial Code of Delaware (the “UCC”), under the Security Agreement to the Collateral (as such term is defined in the Security Agreement), as security for the payment and performance of all the obligations of the Company pursuant to the Prior Debentures. The Company agrees and acknowledges that all of its obligations under this Note, now or hereafter existing whether for principal, interest, fees, expenses or otherwise are considered part of the Obligation (as defined in the Security Agreement) and pursuant to the Security Agreement grants a Security Interest (as defined in the Security Agreement) to the Collateral.

 

4. Defaults and Remedies.

 

(a) Events of Default. An “Event of Default” means: (i) a default for five (5) days in payment on this Note; (ii) failure by the Company to comply with any material provision of this Note, (iii) the Company, pursuant to or within the meaning of any Bankruptcy Law (as defined herein): (A) commence a voluntary case; (B) consent to the entry of an order for relief against it in an involuntary case; (C) consent to the appointment of a Custodian (as defined herein) of it or for all or substantially all of its property; (D) make a general assignment for the benefit of its creditors; or (E) admit in writing that it is generally unable to pay its debts as the same become due; or (iv) a court of competent jurisdiction enters an order or decree under any Bankruptcy Law that: (A) is for relief against the Company in an involuntary case; (B) appoints a Custodian of the Company for all or substantially all of its property; or (C) orders the liquidation of the Company, and the order or decree remains unstayed and in effect for sixty (60) days. “Bankruptcy Law” means Title 11, U.S. Code, or any similar Federal or state law for the relief of debtors. The term “Custodian” means any receiver, trustee, assignee, liquidator or similar official under any Bankruptcy Law.

 

(b) Remedies. If an Event of Default occurs and is continuing, the Holder of this Note may declare all of this Note, including any interest and other amounts due that have not or will not be converted under Section 2 hereof, to be due and payable immediately. The Security Interest created by the Security Agreement shall be enforceable if an Event of Default shall have occurred and be continuing.

 

(c) Holder Appointed Attorney-in-Fact. The Company hereby irrevocably appoints the Holder as the Company’s attorney-in-fact, with full authority in the name, place and stead of the Company, from time to time in the Holder’s discretion upon the occurrence and during the continuance of an Event of Default to take any action and to execute any document which the Holder may deem necessary or advisable to accomplish the purposes of this Note.

 

3

 

 

(d) Non-Interference with Remedies; Specific Performance. The Company agrees that following the occurrence and during the continuance of an Event of Default it will not at any time pledge, claim or take the benefit of any appraisal, valuation, stay, extension, moratorium or redemption law now or hereafter in force in order to prevent or delay the enforcement of this Note, or the absolute sale of the whole or any part of the Collateral or the possession thereof by any purchaser at any sale hereunder, and the Company waives the benefit of all such laws to the extent it lawfully may do so. The Company agrees that it will not interfere with any right, power or remedy of the Holder provided for in this Note now or hereafter existing at law or in equity or by statute or otherwise, or with the exercise or beginning of the exercise by the Holder of any one or more of such rights, powers or remedies.

 

5. Lost or Stolen Note. Upon notice to the Company of the loss, theft, destruction or mutilation of this Note, and, in the case of loss, theft or destruction, of an indemnification undertaking by the Holder to the Company in a form reasonably acceptable to the Company and, in the case of mutilation, upon surrender and cancellation of the Note, the Company shall execute and deliver a new Note of like tenor and date and in substantially the same form as this Note.

 

6. Cancellation. After all principal and accrued interest at any time owed on this Note has been paid in full, this Note shall automatically be deemed canceled, shall be surrendered to the Company for cancellation and shall not be re-issued.

 

7. Waiver of Notice. To the extent permitted by law, the Company hereby waives demand, notice, protest and all other demands and notices in connection with the delivery, acceptance, performance, default or enforcement of this Note.

 

8. Governing Law. This Note shall be construed and enforced in accordance with, and all questions concerning the construction, validity, interpretation and performance of this Note shall be governed by, the laws of the State of Delaware, without giving effect to provisions thereof regarding conflict of laws. Each party hereto hereby irrevocably submits to the non-exclusive jurisdiction of the state and federal courts sitting in the Southern District of New York for the adjudication of any dispute hereunder or in connection herewith or with any transaction contemplated hereby or discussed herein, and hereby irrevocably waives, and agrees not to assert in any suit, action or proceeding, any claim that it is not personally subject to the jurisdiction of any such court, that such suit, action or proceeding is brought in an inconvenient forum or that the venue of such suit, action or proceeding is improper. Each party hereto hereby irrevocably waives personal service of process and consents to process being served in any such suit, action or proceeding by sending by certified mail or overnight courier a copy thereof to such party at the address indicated in the preamble hereto and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein shall be deemed to limit in any way any right to serve process in any manner permitted by law. THE COMPANY HEREBY IRREVOCABLY WAIVES ANY RIGHT IT MAY HAVE, AND AGREES NOT TO REQUEST, A JURY TRIAL FOR THE ADJUDICATION OF ANY DISPUTE HEREUNDER OR IN CONNECTION HEREWITH OR ARISING OUT OF THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY.

 

4

 

 

9. Indemnity and Expenses. The Company agrees:

 

(a) To indemnify and hold harmless the Holder and each of its partners, employees, agents and affiliates from and against any and all claims, damages, demands, losses, obligations, judgments and liabilities (including, without limitation, attorneys’ fees and expenses) in any way arising out of or in connection with this Note; and

 

(b) To pay and reimburse the Holder upon demand for all costs and expenses (including, without limitation, attorneys’ fees and expenses) that the Holder may incur in connection with (i) the exercise or enforcement of any rights or remedies (including, but not limited to, collection) granted hereunder or otherwise available to it (whether at law, in equity or otherwise), or (ii) the failure by the Company to perform or observe any of the provisions hereof. The provisions of this Section shall survive the execution and delivery of this Note, the repayment of any or all of the principal or interest owed pursuant hereto, and the termination of this Note.

 

10. Remedies, Characterizations, Other Obligations, Breaches and Injunctive Relief. The remedies provided in this Note shall be cumulative and in addition to all other remedies available under this Note, at law or in equity

 

11. Usury Savings Clause. Notwithstanding any provision in this Note, the total liability for payments of interest and payments in the nature of interest, including, without limitation, all charges, fees, exactions, or other sums which may at any time be deemed to be interest, shall not exceed the limit imposed by the usury laws of the jurisdiction governing this Note or any other applicable law. In the event the total liability of payments of interest and payments in the nature of interest, including, without limitation, all charges, fees, exactions or other sums which may at any time be deemed to be interest, shall, for any reason whatsoever, result in an effective rate of interest, which for any month or other interest payment period exceeds the limit imposed by the usury laws of the jurisdiction governing this Note, all sums in excess of those lawfully collectible as interest for the period in question shall, without further agreement or notice by, between, or to any party hereto, be applied to the reduction of the outstanding principal balance of this Note immediately upon receipt of such sums by the Holder hereof, with the same force and effect as though the Company had specifically designated such excess sums to be so applied to the reduction of such outstanding principal balance and the Holder hereof had agreed to accept such sums as a penalty-free payment of principal; provided, however, that the Holder of this Note may, at any time and from time to time, elect, by notice in writing to the Company, to waive, reduce, or limit the collection of any sums in excess of those lawfully collectible as interest rather than accept such sums as a prepayment of the outstanding principal balance. It is the intention of the parties that the Company does not intend or expect to pay nor does the Holder intend or expect to charge or collect any interest under this Note greater than the highest non-usurious rate of interest which may be charged under applicable law.

 

12. Specific Shall Not Limit General; Construction. No specific provision contained in this Note shall limit or modify any more general provision contained herein. This Note shall be deemed to be jointly drafted by the Company and the Holder and shall not be construed against any person as the drafter hereof.

 

5

 

 

13. Failure or Indulgence Not Waiver. No failure or delay on the part of this Note in the exercise of any power, right or privilege hereunder shall operate as a waiver thereof, nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other right, power or privilege.

 

14. Notice. Any notice, request or other communication to be given or made under this Note to the parties shall be in writing. Such notice, request or other communication shall be deemed to have been duly given or made when it shall be delivered by hand, international courier (confirmed by facsimile), electronic mail or facsimile (with a hard copy delivered within two (2) Business Days) to the party to which it is required or permitted to be given or made at such party’s address specified below or at such other address as such party shall have designated by notice to the party giving or making such notice, request or other communication, it being understood that the failure to deliver a copy of any notice, request or other communication to a party to whom copies are to be sent shall not affect the validity of any such notice, request or other communication or constitute a breach of this Note.

 

If to the Company: SRAX, Inc.
  2629 Townsgate Road
  #215
  Westlake Village, CA 91361
  Attention:  
  E-Mail:  
   
If to the Holder: [*]
  [*]
  [*]
  Attention:  
  E-Mail:  
     
With a copy to (which shall not constitute Notice):
  [*]
  [*]
  [*]
  Attention:  
  E-Mail:  

 

[signature page follows]

 

6

 

 

IN WITNESS WHEREOF, the Company has caused this Note to be executed on and as of the Issuance Date.

 

  SRAX, INC.
     
  By:
  Name:   
  Title:  

 

Date: July 1, 2022

 

Principal Amount: $650,000.00

 

[ signature page to Note ]

 

7

 

 

ANNEX A

 

WARRANT

 

8

 

 

 EX-10.39 6 ex10-39.htm

 

Exhibit 10.39

 

THIS INSTRUMENT AND ANY SECURITIES ISSUABLE PURSUANT HERETO HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED IN THIS SAFE AND UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM.

 

BIGTOKEN, INC.

 

SAFE

(Simple Agreement for Future Equity)

 

THIS CERTIFIES THAT, in exchange for the payment by SRAX, Inc. (the “Investor”) of $[*] (the “Purchase Amount”) on or about February 10, 2022, BIGtoken, Inc., a Florida corporation (the “Company”), issues to the Investor the right to certain securities of the Company’s, subject to the terms described below.

 

The “Discount Rate” is 80%.

 

The “Warrant Coverage” is 100%.

 

See Section 2 for certain additional defined terms.

 

1. Events

 

(a) Financing. At any time there is a Financing prior to the termination of this Safe, this Safe may be converted, at the option of the Investor, into: (i) the number of shares of Safe Preferred Stock equal to the applicable Purchase Amount divided by the Discount Price and (ii) Warrants to purchase such number of shares of Safe Preferred Stock equal to the applicable Purchase Amount divided by the Discount Price. Provided that upon conversion of the Safe, in no event will the number of Warrants held by Investor exceed such number of shares equal to the applicable Purchase Amount divided by the Discount Price.

In connection with the conversion of this Safe into shares of Safe Preferred Stock and Warrants, the Investor will execute and deliver to the Company all of the transaction documents related to the Financing; provided, that such documents (i) are the same documents to be entered into with the purchasers of the Financing, with appropriate variations for the Safe Preferred Stock if applicable, and (ii) have customary exceptions to any drag-along applicable to the Investor, including (without limitation) limited representations, warranties, liability and indemnification obligations for the Investor.

 

(b) Liquidity Event. If there is a Liquidity Event before the termination of this Safe, this Safe will automatically be entitled (subject to the liquidation priority set forth in Section 1(d) below) to receive a portion of Proceeds, due and payable to the Investor immediately prior to, or concurrent with, the consummation of such Liquidity Event, equal to, at the election of the Investor, the greater of (i) the Purchase Amount (the “Cash-Out Amount”), (ii) the amount payable on the number of shares of Common Stock equal to the Purchase Amount divided by the Discount Price or (iii) such number of shares of Safe Preferred Stock and Warrants equal to the Purchase Amount divided by the Discount Price (the “Conversion Amount”). If any of the Company’s securityholders are given a choice as to the form and amount of Proceeds to be received in a Liquidity Event, the Investor will be given the same choice, provided that the Investor may not choose to receive a form of consideration that the Investor would be ineligible to receive as a result of the Investor’s failure to satisfy any requirement or limitation generally applicable to the Company’s securityholders, or under any applicable laws.

 

Notwithstanding the foregoing, in connection with a Change of Control intended to qualify as a tax-free reorganization, the Company may reduce the cash portion of Proceeds payable to the Investor by the amount determined by its board of directors in good faith for such Change of Control to qualify as a tax-free reorganization for U.S. federal income tax purposes, provided that such reduction (A) does not reduce the total Proceeds payable to such Investor and (B) is applied in the same manner and on a pro rata basis to all securityholders who have equal priority to the Investor under Section 1(d).

 

 

 

 

(c) Dissolution Event. If there is a Dissolution Event before the termination of this Safe, the Investor will automatically be entitled (subject to the liquidation priority set forth in Section 1(d) below) to receive a portion of Proceeds equal to the Cash-Out Amount, due and payable to the Investor immediately prior to the consummation of the Dissolution Event.

 

(d) Liquidation Priority. In a Liquidity Event or Dissolution Event, this Safe is intended to operate like standard non-participating Preferred Stock. The Investor’s right to receive its Cash-Out Amount is:

 

(i) Junior to payment of outstanding indebtedness and creditor claims, including contractual claims for payment and convertible promissory notes (to the extent such convertible promissory notes are not actually or notionally converted into Capital Stock);

 

(ii) On par with payments for other Safes and/or Preferred Stock, and if the applicable Proceeds are insufficient to permit full payments to the Investor and such other Safes and/or Preferred Stock, the applicable Proceeds will be distributed pro rata to the Investor and such other Safes and/or Preferred Stock in proportion to the full payments that would otherwise be due; and

 

(iii) Senior to payments for Common Stock.

 

The Investor’s right to receive its Conversion Amount is (A) on par with payments for Common Stock and other Safes and/or Preferred Stock who are also receiving Conversion Amounts or Proceeds on a similar as-converted to Common Stock basis, and (B) junior to payments described in clauses (i) and (ii) above (in the latter case, to the extent such payments are Cash-Out Amounts or similar liquidation preferences).

 

(e) Termination. This Safe will automatically terminate (without relieving the Company of any obligations arising from a prior breach of or non-compliance with this Safe) immediately following the earliest to occur of: (i) the issuance of all Safe Preferred Stock to the Investor pursuant to the conversion of the entire Purchase Price of this Safe under Section 1(a); or (ii) the payment, or setting aside for payment, of amounts due the Investor pursuant to Section 1(b) or Section 1(c).

 

2. Definitions

 

“Capital Stock” means the capital stock of the Company, including, without limitation, the “Common Stock” and the “Preferred Stock.”

 

“Change of Control” means (i) a transaction or series of related transactions in which any “person” or “group” (within the meaning of Section 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended), becomes the “beneficial owner” (as defined in Rule 13d-3 under the Securities Exchange Act of 1934, as amended), directly or indirectly, of more than 50% of the outstanding voting securities of the Company having the right to vote for the election of members of the Company’s board of directors, (ii) any reorganization, merger or consolidation of the Company, other than a transaction or series of related transactions in which the holders of the voting securities of the Company outstanding immediately prior to such transaction or series of related transactions retain, immediately after such transaction or series of related transactions, at least a majority of the total voting power represented by the outstanding voting securities of the Company or such other surviving or resulting entity or (iii) a sale, lease or other disposition of all or substantially all of the assets of the Company.

 

“Convertible Securities” includes this Safe and other convertible securities issued by the Company, including but not limited to: (i) other Safes; (ii) convertible promissory notes and other convertible debt instruments; and (iii) convertible securities that have the right to convert into shares of Capital Stock.

 

“Discount Price” means the Lowest price per share of equity securities sold in any Financing (prior to the termination of this Safe) multiplied by the Discount Rate.

 

-2-

 

 

“Dissolution Event” means (i) a voluntary termination of operations, (ii) a general assignment for the benefit of the Company’s creditors or (iii) any other liquidation, dissolution or winding up of the Company (excluding a Liquidity Event), whether voluntary or involuntary.

 

“Financing” means a bona fide transaction or series of transactions with the principal purpose of raising capital, pursuant to which the Company issues securities.

 

“Liquidity Event” means a Change of Control or the listing of the Company’s Capital Stock on a National Securities Exchange.

 

“National Securities Exchange” means a securities exchange that has registered with the SEC under Section 6 of the Securities Exchange Act of 1934.

 

“Options” includes options, restricted stock awards or purchases, RSUs, SARs, warrants or similar securities, vested or unvested.

 

“Proceeds” means cash and other assets (including without limitation stock consideration) that are proceeds from the Liquidity Event or the Dissolution Event, as applicable, and legally available for distribution.

 

“Promised Options” means promised but ungranted Options that are the greater of those (i) promised pursuant to agreements or understandings made prior to the execution of, or in connection with, the term sheet or letter of intent for the Financing or Liquidity Event, as applicable (or the closing of any Financing or consummation of the Liquidity Event, if there is no term sheet or letter of intent), (ii) in the case of an Financing, treated as outstanding Options in the calculation of the Standard Preferred Stock’s price per share, or (iii) in the case of a Liquidity Event, treated as outstanding Options in the calculation of the distribution of the Proceeds.

 

“Safe” means an instrument containing a future right to shares of Capital Stock or Convertible Securities, similar in form and content to this instrument, purchased by investors for the purpose of funding the Company’s business operations. References to “this Safe” mean this specific instrument.

 

“Safe Preferred Stock” means the shares of non-voting Series D Preferred Stock issued to the Investor in an Equity Financing, having the identical rights, privileges, preferences and restrictions as contained in the certificate of designation attached hereto as Exhibit A.

 

“SEC” means the United States Securities and Exchange Commission.

 

“Unissued Option Pool” means all shares of Capital Stock that are reserved, available for future grant and not subject to any outstanding Options or Promised Options (but in the case of a Liquidity Event, only to the extent Proceeds are payable on such Promised Options) under any equity incentive or similar Company plan.

 

“Warrant” means a warrant to purchase such number of shares of Safe Preferred Stock equal to the applicable Purchase Amount divided by the Discount Price. The Warrant will have: (i) an exercise price equal to the Discount Price, (ii) price protection, but will not result in additional shares underlying the Warrant, and (iii) a term of 5 years.

 

-3-

 

 

3. Company Representations

 

(a) The Company is a corporation duly organized, validly existing and in good standing under the laws of its state of incorporation, and has the power and authority to own, lease and operate its properties and carry on its business as now conducted.

 

(b) The execution, delivery and performance by the Company of this Safe is within the power of the Company and has been duly authorized by all necessary actions on the part of the Company (subject to section 3(d)). This Safe constitutes a legal, valid and binding obligation of the Company, enforceable against the Company in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity. To its knowledge, the Company is not in violation of (i) its current certificate of incorporation or bylaws, (ii) any material statute, rule or regulation applicable to the Company or (iii) any material debt or contract to which the Company is a party or by which it is bound, where, in each case, such violation or default, individually, or together with all such violations or defaults, could reasonably be expected to have a material adverse effect on the Company.

 

(c) The performance and consummation of the transactions contemplated by this Safe do not and will not: (i) violate any material judgment, statute, rule or regulation applicable to the Company; (ii) result in the acceleration of any material debt or contract to which the Company is a party or by which it is bound; or (iii) result in the creation or imposition of any lien on any property, asset or revenue of the Company or the suspension, forfeiture, or nonrenewal of any material permit, license or authorization applicable to the Company, its business or operations.

 

(d) No consents or approvals are required in connection with the performance of this Safe, other than: (i) the Company’s corporate approvals; (ii) any qualifications or filings under applicable securities laws; and (iii) necessary corporate approvals for the authorization of Capital Stock issuable pursuant to Section 1.

 

(e) To its knowledge, the Company owns or possesses (or can obtain on commercially reasonable terms) sufficient legal rights to all patents, trademarks, service marks, trade names, copyrights, trade secrets, licenses, information, processes and other intellectual property rights necessary for its business as now conducted and as currently proposed to be conducted, without any conflict with, or infringement of the rights of, others.

 

4. Investor Representations

 

(a) The Investor has full legal capacity, power and authority to execute and deliver this Safe and to perform its obligations hereunder. This Safe constitutes valid and binding obligation of the Investor, enforceable in accordance with its terms, except as limited by bankruptcy, insolvency or other laws of general application relating to or affecting the enforcement of creditors’ rights generally and general principles of equity.

 

(b) The Investor is an accredited investor as such term is defined in Rule 501 of Regulation D under the Securities Act, and acknowledges and agrees that if not an accredited investor at the time of an Equity Financing, the Company may void this Safe and return the Purchase Amount. The Investor has been advised that this Safe and the underlying securities have not been registered under the Securities Act, or any state securities laws and, therefore, cannot be resold unless they are registered under the Securities Act and applicable state securities laws or unless an exemption from such registration requirements is available. The Investor is purchasing this Safe and the securities to be acquired by the Investor hereunder for its own account for investment, not as a nominee or agent, and not with a view to, or for resale in connection with, the distribution thereof, and the Investor has no present intention of selling, granting any participation in, or otherwise distributing the same. The Investor has such knowledge and experience in financial and business matters that the Investor is capable of evaluating the merits and risks of such investment, is able to incur a complete loss of such investment without impairing the Investor’s financial condition and is able to bear the economic risk of such investment for an indefinite period of time.

 

-4-

 

 

5. Miscellaneous

 

(a) Any provision of this Safe may be amended, waived or modified by written consent of the Company and the Investor.

(b) Any notice required or permitted by this Safe will be deemed sufficient when delivered personally or by overnight courier or sent by email to the relevant address listed on the signature page, or 48 hours after being deposited in the U.S. mail as certified or registered mail with postage prepaid, addressed to the party to be notified at such party’s address listed on the signature page, as subsequently modified by written notice.

 

(c) The Investor is not entitled, as a holder of this Safe, to vote or be deemed a holder of Capital Stock for any purpose other than tax purposes, nor will anything in this Safe be construed to confer on the Investor, as such, any rights of a Company stockholder or rights to vote for the election of directors or on any matter submitted to Company stockholders, or to give or withhold consent to any corporate action or to receive notice of meetings, until shares have been issued on the terms described in Section 1.

 

(d) Neither this Safe nor the rights in this Safe are transferable or assignable, by operation of law or otherwise, by either party without the prior written consent of the other; provided, however, that this Safe and/or its rights may be assigned without the Company’s consent by the Investor (i) to the Investor’s estate, heirs, executors, administrators, guardians and/or successors in the event of Investor’s death or disability, or (ii) to any other entity who directly or indirectly, controls, is controlled by or is under common control with the Investor, including, without limitation, any general partner, managing member, officer or director of the Investor, or any venture capital fund now or hereafter existing which is controlled by one or more general partners or managing members of, or shares the same management company with, the Investor; and provided, further, that the Company may assign this Safe in whole, without the consent of the Investor, in connection with a reincorporation to change the Company’s domicile.

 

(e) In the event any one or more of the provisions of this Safe is for any reason held to be invalid, illegal or unenforceable, in whole or in part or in any respect, or in the event that any one or more of the provisions of this Safe operate or would prospectively operate to invalidate this Safe, then and in any such event, such provision(s) only will be deemed null and void and will not affect any other provision of this Safe and the remaining provisions of this Safe will remain operative and in full force and effect and will not be affected, prejudiced, or disturbed thereby.

 

(f) All rights and obligations hereunder will be governed by the laws of the State of California, without regard to the conflicts of law provisions of such jurisdiction.

 

(g) The parties acknowledge and agree that for United States federal and state income tax purposes this Safe is, and at all times has been, intended to be characterized as stock, and more particularly as common stock for purposes of Sections 304, 305, 306, 354, 368, 1036 and 1202 of the Internal Revenue Code of 1986, as amended. Accordingly, the parties agree to treat this Safe consistent with the foregoing intent for all United States federal and state income tax purposes (including, without limitation, on their respective tax returns or other informational statements).

 

(Signature page follows)

 

-5-

 

 

IN WITNESS WHEREOF, the undersigned have caused this Safe to be duly executed and delivered.

 

  BIGTOKEN, INC.
   
  By:  
    David J. Moore
    CEO
     
  Address:
   
  Email:
   
  INVESTOR:
   
  By: SRAX, Inc.
  Name: Michael Malone  
  Title: CFO  

 

  Address:  
   
  Email:  

 

 

 

 EX-21.01 7 ex21-01.htm

 

Exhibit 21.01

 

List of Subsidiaries

 

1. LD Micro, Inc.

 

 
 EX-31.1 8 ex31-1.htm

 

EXHIBIT 31.1

 

Rule 13a-14(a)/15d-14(a) Certification

 

I, Christopher Miglino, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2021 of SRAX, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: October 12, 2022 /s/ Christopher Miglino
  Christopher Miglino, Chief Executive Officer, principal executive officer

 

 
 EX-31.2 9 ex31-2.htm

 

EXHIBIT 31.2

 

Rule 13a-14(a)/15d-14(a) Certification

 

I, Michael Malone, certify that:

 

1. I have reviewed this Annual Report on Form 10-K for the year ended December 31, 2021 of SRAX, Inc.;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  (a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
  (b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
  (c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
  (d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  (a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
  (b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Dated: October 12, 2022 /s/ Michael Malone
  Michael Malone, Chief Financial Officer, principal financial and accounting officer

 

 
 EX-32.1 10 ex32-1.htm

 

EXHIBIT 32.1

EXHIBIT 32.2

 

Section 1350 Certification

 

In connection with the Annual Report of SRAX, Inc. (the “Company”) on Form 10-K for the year ended December 31, 2021 as filed with the Securities and Exchange Commission (the “Report”), I, Christopher Miglino, Chief Executive Officer, and I, Michael Malone, the Chief Financial Officer, of the Company, do hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended, and
   
2. The information contained in the Report fairly presents, in all material respects, the financial conditions and results of operations of the Company.

 

October 12, 2022 /s/ Christopher Miglino
  Christopher Miglino, Chief Executive Officer, principal executive officer

 

October 12, 2022 /s/ Michael Malone
  Michael Malone, Chief Financial Officer, principal financial and accounting officer

 

A signed original of this written statement required by Section 906, or other document authenticating, acknowledging, or otherwise adopting the signatures that appear in typed form within the electronic version of this written statement has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

 

 
 EX-101.SCH 11 srax-20211231.xsd INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Consolidated Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Consolidated Statements of Operations link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Consolidated Statements of Cash Flows link:presentationLink link:calculationLink link:definitionLink 00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - DISCONTINUED OPERATIONS link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - ACQUISITIONS link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - SALE AND PURCHASE OF ACCOUNTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - CONTRACTS RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - MARKETABLE SECURITIES link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - NOTES RECEIVABLE link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - PROPERTY AND EQUIPMENT link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - INTANGIBLE ASSETS link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - RIGHT TO USE ASSET link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - DEFERRED REVENUE link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - OTHER CURRENT LIABILITIES link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - SHORT TERM PROMISSORY NOTES link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - TERM LOAN NOTE link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - OID CONVERTIBLE DEBENTURES link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - SERIES A PREFERRED STOCK link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - STOCKHOLDERS’ EQUITY link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - RELATED PARTY TRANSACTIONS link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - INCOME TAXES link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - REVENUE DISAGGREGATION link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - SUBSEQUENT EVENTS link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - DISCONTINUED OPERATIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000036 - Disclosure - ACQUISITIONS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000037 - Disclosure - MARKETABLE SECURITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000038 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables) link:presentationLink link:calculationLink link:definitionLink 00000039 - Disclosure - PROPERTY AND EQUIPMENT (Tables) link:presentationLink link:calculationLink link:definitionLink 00000040 - Disclosure - INTANGIBLE ASSETS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000041 - Disclosure - RIGHT TO USE ASSET (Tables) link:presentationLink link:calculationLink link:definitionLink 00000042 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000043 - Disclosure - OTHER CURRENT LIABILITIES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000044 - Disclosure - OID CONVERTIBLE DEBENTURES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000045 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000046 - Disclosure - INCOME TAXES (Tables) link:presentationLink link:calculationLink link:definitionLink 00000047 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) link:presentationLink link:calculationLink link:definitionLink 00000048 - Disclosure - REVENUE DISAGGREGATION (Tables) link:presentationLink link:calculationLink link:definitionLink 00000049 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000050 - Disclosure - SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details) link:presentationLink link:calculationLink link:definitionLink 00000051 - Disclosure - SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000052 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000053 - Disclosure - SCHEDULE OF CALCULATIONS OF PURCHASE PRICE (Details) link:presentationLink link:calculationLink link:definitionLink 00000054 - Disclosure - SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED (Details) link:presentationLink link:calculationLink link:definitionLink 00000055 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION (Details) link:presentationLink link:calculationLink link:definitionLink 00000056 - Disclosure - SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000057 - Disclosure - SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS (Details) link:presentationLink link:calculationLink link:definitionLink 00000058 - Disclosure - SUMMARY OF PRO FORMA ADJUSTMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000059 - Disclosure - ACQUISITIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000060 - Disclosure - SALE AND PURCHASE OF ACCOUNTS RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000061 - Disclosure - CONTRACTS RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000062 - Disclosure - SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000063 - Disclosure - MARKETABLE SECURITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000064 - Disclosure - SCHEDULE OF DESIGNATED ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000065 - Disclosure - SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000066 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000067 - Disclosure - NOTES RECEIVABLE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000068 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) link:presentationLink link:calculationLink link:definitionLink 00000069 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000070 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000071 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000072 - Disclosure - INTANGIBLE ASSETS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000073 - Disclosure - SCHEDULE OF COMPONENT OF LEASE EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000074 - Disclosure - SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000075 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000076 - Disclosure - SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000077 - Disclosure - RIGHT TO USE ASSET (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000078 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) link:presentationLink link:calculationLink link:definitionLink 00000079 - Disclosure - DEFERRED REVENUE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000080 - Disclosure - SCHEDULE OF OTHER CURRENT LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000081 - Disclosure - OTHER CURRENT LIABILITIES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000082 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000083 - Disclosure - SHORT TERM PROMISSORY NOTES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000084 - Disclosure - TERM LOAN NOTE (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000085 - Disclosure - SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details) link:presentationLink link:calculationLink link:definitionLink 00000086 - Disclosure - OID CONVERTIBLE DEBENTURES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000087 - Disclosure - SERIES A PREFERRED STOCK (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000088 - Disclosure - STOCKHOLDERS’ EQUITY (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000089 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000090 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details) link:presentationLink link:calculationLink link:definitionLink 00000091 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000092 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000093 - Disclosure - SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE (Details) link:presentationLink link:calculationLink link:definitionLink 00000094 - Disclosure - SCHEDULE OF EFFECTIVE TAX RATE (Details) link:presentationLink link:calculationLink link:definitionLink 00000095 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) link:presentationLink link:calculationLink link:definitionLink 00000096 - Disclosure - INCOME TAXES (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000097 - Disclosure - SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000098 - Disclosure - SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details) link:presentationLink link:calculationLink link:definitionLink 00000099 - Disclosure - SCHEDULE OF FAIR VALUE AT ASSETS (Details) link:presentationLink link:calculationLink link:definitionLink 00000100 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details) link:presentationLink link:calculationLink link:definitionLink 00000101 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000102 - Disclosure - SCHEDULE OF REVENUE BY BUSINESS UNIT (Details) link:presentationLink link:calculationLink link:definitionLink 00000103 - Disclosure - REVENUE DISAGGREGATION (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000104 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 12 srax-20211231_cal.xml INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT EX-101.DEF 13 srax-20211231_def.xml INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT EX-101.LAB 14 srax-20211231_lab.xml INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Class of Stock [Axis] Series A Preferred Stock [Member] Class A common stock [Member] Equity Components [Axis] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Noncontrolling Interest [Member] Concentration Risk Type [Axis] Customer Concentration Risk [Member] Concentration Risk Benchmark [Axis] Accounts Receivable [Member] Customer [Axis] Customer One [Member] Customer Two [Member] Customer Three [Member] Product and Service [Axis] Revenue [Member] Revenue Benchmark [Member] Business Acquisition [Axis] Brite Pool Inc [Member] Series D Convertible Preferred Stock [Member] Series D Convertible Preferred Stock and Common Stock [Member] Title of Individual [Axis] BIG Tokens [Member] LD Micro Inc [Member] Scenario [Axis] Forecast [Member] Noncompete [Member] Customer List [Member] Trademark [Member] Domain Name [Member] Pro Forma Adjustment [Member] Pro Forma Combined [Member] Scenario, Adjustment [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Agreements to Sell Accounts Receivable [Member] Asset Class [Axis] Ten Percent [Member] Twenty Percent [Member] Thirty Six Percent [Member] Common Class A [Member] Agreements to Sell Accounts Receivable Ammended [Member] Financial Instrument [Axis] Accounts Payable [Member] Accrued Liabilities [Member] Debentures [Member] PIPE Technologies [Member] Receivable Purchase and Sale Agreement [Member] Legal Entity [Axis] BIGtoken [Member] Debt Instrument [Axis] Convertible Debentures [Member] Preferred Stock [Member] Warrant [Member] Designated Assets [Member] Haylard MDLLC [Member] Statistical Measurement [Axis] Maximum [Member] MD CoInvest, LLC [Member] Rated Corporate Debt [Member] Long-Lived Tangible Asset [Axis] Office Equipment [Member] Finite-Lived Intangible Assets by Major Class [Axis] Noncompete Agreements [Member] Intellectual Property [Member] Software [Member] Internally Developed Software [Member] Trademarks [Member] Customer Lists [Member] Internet Domain Names [Member] Factoring Facility [Member] Related Party [Axis] LD Micro [Member] Paycheck Protection Program Loan [Member] Short-Term Promissory Notes [Member] Chief Financial Officer [Member] Award Type [Axis] Two Remaining Note Holders [Member] Term Loan [Member] Second Drawdown [Member] OID Convertible Debentures [Member] OID Convertible Debentures [Member] Securities Purchase Agreement [Member] Measurement Input Type [Axis] Measurement Input, Risk Free Interest Rate [Member] Measurement Input, Expected Term [Member] Measurement Input, Price Volatility [Member] Measurement Input, Expected Dividend Rate [Member] Placement Agent [Member] Prior To Closing Date [Member] After The Closing Date [Member] Debenture Holders [Member] Issuance Beginning of Year [Member] Extension [Member] Conversion [Member] Amortization [Member] Redemption [Member] Series 1 Preferred Stock [Member] Class B Common Stock [Member] Financial Instrument Performance Status [Axis] Nonperforming Financial Instruments [Member] Board of Directors [Member] At the Market Sales Agreement [Member] Share Buy-Back Program [Member] Plan Name [Axis] 2012 Equity Compensation Plan [Member] 2014 Equity Compensation Plan [Member] 2016 Equity Compensation Plan [Member] 2012, 2014 and 2016 Equity Compensation Plans [Member] Non-Executive Directors [Member] Employees and Members of Management Team [Member] Measurement Input, Option Volatility [Member] New Warrant [Member] Chief Executive Officer [Member] Measurement Frequency [Axis] Fair Value, Recurring [Member] Investment Type [Axis] Marketable Securities [Member] Fair Value Hierarchy and NAV [Axis] Fair Value, Inputs, Level 1 [Member] Fair Value, Inputs, Level 2 [Member] Fair Value, Inputs, Level 3 [Member] Contracts Receivable [Member] Convertible Debt Securities [Member] Valuation Approach and Technique [Axis] Put Option Pricing Model [Member] Measurement Input, Discount for Lack of Marketability [Member] Minimum [Member] Convertible Preferred Stock [Member] Valuation Technique, Discounted Cash Flow [Member] Measurement Input, Maturity [Member] Measurement Input, Discount Rate [Member] Valuation Technique, Option Pricing Model [Member] Sequire Platform Revenue [Member] Conference Revenue [Member] Other Revenues [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Big Token Inc [Member] Safe Agreement [Member] CVR Agreement [Member] Institutional Investor [Member] Holders [Member] Bridge Note [Member] Credit Facility [Axis] Revolving Credit Facility [Member] Credit Agreement [Member] Credit Agreement and Revolving Note [Member] Cash and Cash Equivalents [Axis] Cash [Member] Vesting [Axis] Tranche One [Member] Tranche Two [Member] Tranche Three [Member] Security Agreements [Member] Class of Warrant or Right [Axis] Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated By Reference ICFR Auditor Attestation Flag Auditor Name Auditor Location Auditor Firm ID Statement of Financial Position [Abstract] Assets Current assets Cash and cash equivalents Accounts receivable, net Contracts receivable Marketable securities Designated assets for return of capital Prepaid expenses and other current assets Current assets of discontinued operations Total current assets Notes receivable Property and equipment, net Intangible assets, net Right of use assets Other assets Goodwill Long-term assets of discontinued operations Total assets Liabilities and stockholders’ equity Current liabilities Accounts payable and accrued expenses Deferred revenue Other current liabilities Payroll protection loan - current portion OID notes payable Series A preferred stock, authorized 36,462,417 shares, $0.001 par value, 36,462,417 shares and none issued and outstanding, respectively Current liabilities of discontinued operations Total current liabilities Right of use liability - long term Payroll protection loan - long term Deferred tax liability Total liabilities Commitments and contingencies (Note 19) Stockholders’ equity Class A common stock, authorized 250,000,000 shares, $0.001 par value, 25,995,172 and 16,145,778 shares issued and outstanding, respectively Additional paid in capital Accumulated deficit Total stockholders’ equity Total liabilities and stockholders’ equity Statement [Table] Statement [Line Items] Temporary equity, shares authorized Temporary equity, par value Temporary equity, shares outstanding Temporary Equity, Shares Outstanding Common stock, shares authorized Common stock, par value Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenues Cost and expenses Cost of revenue Employee related costs Marketing and selling expenses Platform costs Depreciation and amortization General and administrative expenses Total cost and expenses Income (loss) from operations Other income (expense) Financing costs Realized gain on marketable securities Unrealized gain (loss) on marketable securities Realized loss on designated assets Unrealized loss on designated assets Gain on sale of SRAXmd, net Interest income Other income Change in fair value of preferred stock Change in fair value of derivative liabilities Total other expense Loss before provision for income taxes Provision for income tax benefit (expense) Loss from continuing operations Discontinued operations Loss before income tax benefits Loss on disposal of subsidiary Income tax benefit Loss from discontinued operations Net loss Net loss attributable to non-controlling interest in discontinued operations Net loss attributable to SRAX, Inc. Basic and diluted loss per share Continuing operations Discontinued operations attributable to SRAX, Inc. Net loss per share, basic and diluted Weighted average shares outstanding, basic and diluted Balance Balance, shares Stock based compensation Relative fair value of warrants issued with notes payable Shares issued for extension agreement Shares issued for extension agreement, shares Shares issued for debt extinguishment Shares issued for debt extinguishment, shares Conversion of convertible debt to equity Conversion of convertible debt to equity, shares Common stock issued for the acquisition of a subsidiary Common stock issued for the acquisition of a subsidiary, shares Reclassification of warrants from liability to equity Premium on debt extinguishment Beneficial conversion feature Net loss attributable to SRAX, Inc. Shares issued for cash Shares issued for cash, shares Shares issued for exercise of warrants, net of offering costs Shares issued for exercise of warrants, net of offering costs, shares Warrants issued as an inducement to exercise warrants Acquisition of noncontrolling interest of FVPD Warrants issued by FVPD for SRAX, Inc. debenture holders Series B convertible preferred stock issued by FPVD Beneficial conversion feature FPVD series B convertible preferred stock Dividends on preferred stock Disposition of subsidiary Repurchase and retirement of shares Repurchase and retirement of shares, shares Net loss attributable to non controlling interest in discontinued operations Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities Net loss Less: Loss from discontinued operations, net of tax Adjustments to reconcile net loss to net cash used in operating activities: Unrealized loss (gain) on marketable securities Realized gain on marketable securities Unrealized loss on designated assets Realized loss on designated assets Gain on sale of SRAXmd Interest income Change in fair value of preferred stock Change in fair value of derivative liabilities Forgiveness of payroll protection program loan Warrants issued by FVPD for SRAX, Inc. debenture holders Loss on extinguishment of debt Warrant inducement charge Marketable securities received for accounts receivable previously written off Amortization of debt issue costs Stock based compensation Provision for bad debts Depreciation expense Amortization of intangibles Net change in right of use asset and liability Non-cash financing expense Changes in operating assets and liabilities Accounts receivable Prepaid expenses and other current assets Accounts payable and accrued expenses Deferred revenue Other current liabilities Deferred tax liability Net cash used in continuing operations Net cash used in discontinued operations Net cash used in operating activities Cash flows from investing activities Proceeds from the sale of marketable securities Proceeds from the sale of designated assets Purchase of marketable securities Proceeds from sale of SRAXmd, net Acquisition of LD Micro, net of cash acquired Payment for deferred consideration to LD Micro Acquisition of property and equipment Acquisition of intangible assets Other assets Net cash from continuing operations Net cash from (used in) discontinued operations Net cash from investing activities Cash flows from financing activities Proceeds from the issuance of common stock units Proceeds from the exercise of warrants Repurchase of shares Proceeds from OID notes payable, less issuance costs Redemption of OID notes payable Proceeds from issuance of short-term notes payable, less issuance costs Repayment of short-term notes payable Proceeds from payroll protection program Proceeds from the issuance of notes payable Repayment of notes payable Net cash from continuing operations Net cash from discontinued operations Net cash from financing activities Net increase in cash from continuing operations Net decrease in cash from discontinued operations Cash, cash equivalents and board designated restricted cash beginning of year Cash, cash equivalents and board designated restricted cash end of year Less: Cash from discontinued operations Cash, cash equivalents and board designated restricted cash from continuing operations Cash reserved for designated asset for return of capital Cash and cash equivalents Supplemental schedule of cash flow information Cash paid for interest Cash paid for taxes Supplemental schedule of noncash investing and financing activities Common stock received in lieu of cash for accounts receivable Convertible notes converted into shares Designation of marketable securities for dividend distribution Dividends on preferred stock Vesting of common stock award Relative fair value of warrants issued with term loan Derivative liabilities transferred to equity Shares of common stock issued for extension agreement Fair value of BCF for debt financings Fair value of warrants issued for debt financings Premium on debt financings Original issue discount recorded on OID convertible debentures Shares issued for the acquisition of a subsidiary Common stock issued to settle liability Organization, Consolidation and Presentation of Financial Statements [Abstract] ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Discontinued Operations and Disposal Groups [Abstract] DISCONTINUED OPERATIONS Business Combination and Asset Acquisition [Abstract] ACQUISITIONS Credit Loss [Abstract] SALE AND PURCHASE OF ACCOUNTS RECEIVABLE CONTRACTS RECEIVABLE Cash and Cash Equivalents [Abstract] MARKETABLE SECURITIES Designated Assets For Return Of Capital DESIGNATED ASSETS FOR RETURN OF CAPITAL Receivables [Abstract] NOTES RECEIVABLE Property, Plant and Equipment [Abstract] PROPERTY AND EQUIPMENT Goodwill and Intangible Assets Disclosure [Abstract] INTANGIBLE ASSETS Right To Use Asset RIGHT TO USE ASSET Payables and Accruals [Abstract] ACCOUNTS PAYABLE AND ACCRUED EXPENSES Revenue from Contract with Customer [Abstract] DEFERRED REVENUE Other Liabilities Disclosure [Abstract] OTHER CURRENT LIABILITIES Paycheck Protection Program Loan PAYCHECK PROTECTION PROGRAM LOAN Debt Disclosure [Abstract] SHORT TERM PROMISSORY NOTES TERM LOAN NOTE Oid Convertible Debentures OID CONVERTIBLE DEBENTURES Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Schedule of Stock by Class [Table] Class of Stock [Line Items] SERIES A PREFERRED STOCK Equity [Abstract] STOCKHOLDERS’ EQUITY Share-Based Payment Arrangement [Abstract] STOCK OPTIONS, AWARDS AND WARRANTS Related Party Transactions [Abstract] RELATED PARTY TRANSACTIONS Income Tax Disclosure [Abstract] INCOME TAXES Fair Value Disclosures [Abstract] FAIR VALUE OF FINANCIAL INSTRUMENTS Revenue Disaggregation REVENUE DISAGGREGATION Subsequent Events [Abstract] SUBSEQUENT EVENTS Organization Liquidity and Going Concern Principles of Consolidation Business Segments Business Combinations Use of Estimates Fair Value of Financial Instruments Cash and Cash Equivalents Accounts Receivable Concentration of Credit and Significant Customer Risk Long-lived Assets Property and equipment Intangible assets Right of Use Assets and Lease Obligations Goodwill Derivatives Warrant Liability Debt Discounts Revenue Recognition Stock-Based Compensation Income Taxes Earnings Per Share Recently Issued Accounting Standards SCHEDULE OF DECONSOLIDATION OF BUSINESS SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS SCHEDULE OF CALCULATIONS OF PURCHASE PRICE SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS SUMMARY OF PRO FORMA ADJUSTMENTS SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES SCHEDULE OF DESIGNATED ASSETS SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE SCHEDULE OF COMPONENT OF LEASE EXPENSE SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES SCHEDULE OF OTHER CURRENT LIABILITIES SCHEDULE OF OID CONVERTIBLE DEBENTURES SCHEDULE OF STOCK OPTION ACTIVITY SCHEDULE OF WARRANT ACTIVITY SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE SCHEDULE OF EFFECTIVE TAX RATE SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES SCHEDULE OF ASSETS MEASURED AT FAIR VALUE SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE SCHEDULE OF FAIR VALUE AT ASSETS SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS SCHEDULE OF REVENUE BY BUSINESS UNIT Schedule of Product Information [Table] Product Information [Line Items] Cash Equivalents, at Carrying Value FDIC amount Excess of federal insurance limit Allowance for doubtful accounts Concentration risk percentage Capitalized software development costs Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Consideration received Fair value of Series D Stock and Common stock Carrying amount of non-controlling interest of BIGToken Previous equity adjustments of non-controlling interest Total consolidations Book basis of investment in BIGToken Loss on disposal of subsidiary Cash and cash equivalents Accounts receivable, net Prepaid expenses and other current assets Property and equipment, net Goodwill Intangible assets, net Total assets classified as discontinued operations in the consolidated balance sheet Accounts payable and accrued expenses Other current liabilities Total liabilities classified as discontinued operations in the consolidated balance sheet Revenues Cost of revenue Gross profit Employee related costs Marketing and selling expenses Platform costs Depreciation and amortization General and administrative expenses Total operating expense Loss from operations of discontinued operations Financing costs Realized loss on marketable securities Impairment of goodwill Total other expense Loss from discontinued operations before provision for income taxes Provision for income taxes Loss from discontinued operations, net of income taxes Stock Issued During Period, Shares, Acquisitions [custom:ExchangedNumberOfSharesforCommonStock] Conversion of Stock, Shares Converted [custom:IssuedAndOutstandingOfCommonStock] Conversion of Stock, Shares Issued Beneficial Ownership Percenatge Conversion of Stock, Amount Issued [custom:IssuanceOfAcquisitionSharesDescription] Gain (Loss) on Sale of Equity Investments Business Combination, Contingent Consideration, Liability [custom:BusinessCombinationContingentConsiderationLiabilityRelated-0] Debt Instrument, Convertible, Beneficial Conversion Feature Fair Value Adjustment of Warrants Other Expenses Schedule of Business Acquisitions, by Acquisition [Table] Business Acquisition [Line Items] Fair value of stock at closing Cash at closing Deferred payments Less cash received Transaction expenses Working capital adjustment Purchase price Accounts receivable, net Intangibles Accounts payable and accrued liabilities Payroll protection loan Other current liabilities Deferred tax liability Net assets acquired Fair value Life in years, description Nety income (loss) Revenues Cost of revenues Operating expenses Other expense Provision for income taxes Net loss Amortization of intangibles acquired Employee related costs Financing costs Net income (loss) Business Acquisition, Date of Acquisition Agreement Business combination, cash payable by entity Number of shares issued in acquisition Deferred payments discounted under CCC rated corporate debt Amortization of payments Employee related costs Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table] Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items] Accounts receivable Accounts receivable purchase [custom:PercentageOfReceivablesUponExerciseOfPutOption] Description of sale of accounts receivable Sale of stock number of share Sale of stock, value Converted debt Converted debt Fair value of debentures Loss on extinguishment Difference between face value and fair value Conversion premium Fair value of warrants Right to future subscription revenues Subscription revenues Accounts Receivable, Related Parties Proceeds from accounts receivable Debt Instrument, Unused Borrowing Capacity, Amount Proceeds from additional borrowing [custom:AccountsReceivables-0] [custom:PurchasePrice-0] Debt Instrument, Redemption Price, Percentage [custom:AccountsReceivable-0] Balances at beginning of year Additions Sale of marketable securities Designation for dividend distribution Change in fair value Balances at end of year [custom:ProceedFromSaleAndMaturityOfMarketableSecurities] Marketable Securities [custom:GainOnMarketableSecurities] Cash Marketable securities Balance Designated assets at beginning balance Sales Proceeds from sale of other assets Change in fair value of designated assets Designated assets at ending balance Sale of marketable securities Marketable Securities Gain on marketable securities. Redemption of class A units Price to be paid for all of the units Price to be paid upon earlier Total consideration Excess amount for each unit Deferred payments of notes receivable Discount on notes receivable Debt instrument term Implied discount Note receivable Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Office equipment Accumulated depreciation Depreciation Schedule of Finite-Lived Intangible Assets [Table] Finite-Lived Intangible Assets [Line Items] Total cost Accumulated amortization 2022 2023 2024 Intangible assets Amortization of finite-lived intangible assets Goodwill Acquisition Impairment loss Schedule Of Component Of Lease Expense Operating lease expense Short-term lease expense Total lease expense Schedule Of Operating Lease Assets And Liabilities Operating lease right-of-use assets - non-current Operating lease liabilities - current Operating lease liabilities - non-current Total operating lease liabilities Weighted Average Remaining Lease Term Weighted Average Discount Rate 2022 2023 Total future lease payments, undiscounted Less: Implied interest Present value of operating lease payments Lessee, Operating Lease, Remaining Lease Term Variable lease cost and sublease Cash paid for operating lease Accounts payable, trade Accrued expenses Accrued compensation Accrued commissions Accrued interest Contract with Customer, Liability Other current liabilities Total other current liabilities Collaborative Arrangement and Arrangement Other than Collaborative [Table] Collaborative Arrangement and Arrangement Other than Collaborative [Line Items] Other Sundry Liabilities, Current Deferred payments related to acquisition Deferred contractual payments Schedule of Short-Term Debt [Table] Short-Term Debt [Line Items] Unsecured loan Term loan Interest rate Payroll protection loan in connection with acquisition Forgiveness of payroll protection program loan Loans Payable Debt instrument, face amount Debt instrument, description Number of shares of common stock Debt instrument, original issue discount Security shares Repayment of short-term note payable Convertible debt Fair value of debenture Outstanding loan Term loan, maximum borrowing capacity Debt instrument, unused borrowing capacity, amount Proceeds from notes payable Debt instrument, additional borrowing capacity Debt instrument, interest rate Debt instrument, maturity date Debt instrument, payment term description Debt instrument origination fee Attorneys fees Class of warrant issued Warrant exercise price percentage Exercise price of warrant Warrant expire date Proceeds from issuance of warrant Repayment of loan principal and interest Principal Debt discount Net book value Debt face amount Debt discount Original issue discount percentage Warrant to purchase common stock, shares Proceeds from warrants exercise Accounts receivable Short term promissory notes Debt Instrument, Maturity Date Debt Instrument, Interest Rate, Stated Percentage Debt Instrument, Convertible, Conversion Price Debt Instrument, Description Debt instrument, restrictive covenants Warrants exercise price per share Warrant or Right, Reason for Issuance, Description Payment of outstanding debt Class of warrant or right, unissued Warrants and rights outstanding, measurement input Warrants and rights outstanding, Term Payments of Debt Issuance Costs Proceeds from warrants percentage Proceeds from issuance of debt Proceeds from issuance Initial public offering Net proceeds from issuance of Initial public offering Legal Fees Amortization expenses Debt conversion, converted instrument, amount Debt conversion, converted instrument, shares issued Additional principal balance Additional principal percentage Current principal balance fee amount Dividend description Preferred stock authorized Preferred stock, shares issued Preferred stock, shares outstanding Warrant to purchase common stock, shares Conversion of convertible securities Stock issued during period, shares, conversion of convertible securities Fair value of preferred stock Preferred stock shares authorized Preferred stock par value Common stock shares authorized Common stock par value Common stock shares issued Common stock shares outstanding Proceeds from sale of non-performing receivables Purchase price of receivables Receivable description Number of shares pledged for repurchase of receivables Shares issued for extension agreement Repurchase of common stock Proceeds from issuanceor sale of equity Sale of stock Sale of stock, consideration received on transaction Number of repurchased shares Number of repurchased value Number of Shares, Outstanding Beginning balance Weighted Average Strike Price/Share, Outstanding Beginning balance Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance Aggregate Intrinsic Value, Outstanding Beginning balance Weighted Average Grant Date Fair Value, Outstanding Beginning balance Number of Shares, Granted Weighted Average Strike Price/Share, Granted Weighted Average Remaining Contractual Term (Years), Granted Aggregate Intrinsic Value, Granted Weighted Average Grant Date Fair Value, Granted Number of Shares, Exercised Weighted Average Strike Price/Share, Exercised Aggregate Intrinsic Value, Exercised Weighted Average Grant Date Fair Value, Exercised Number of Shares, Forfeited Weighted Average Strike Price/Share, Forfeited Aggregate Intrinsic Value, Forfeited Weighted Average Grant Date Fair Value, Forfeited Number of Shares, Outstanding Ending balance Weighted Average Strike Price/Share, Outstanding Ending balance Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance Aggregate Intrinsic Value, Outstanding Ending balance Weighted Average Grant Date Fair Value, Outstanding Ending balance Number of Shares, Vested and exercisable Ending balance Weighted Average Strike Price/Share, Vested and exercisable Ending balance Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance Aggregate Intrinsic Value, Vested and exercisable Ending balance Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance Number of Shares, Unvested and non-exercisable Ending balance Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance Weighted Average Remaining Contractual Term (Years), Exercised Weighted Average Remaining Contractual Term (Years), Forfeited Number of Shares, Warrants Outstanding Beginning balance Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance Aggregate Intrinsic Value, Warrants Outstanding Beginning balance Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance Number of Shares, Warrants Granted Weighted Average Strike Price/Share, Warrants Granted Weighted Average Remaining Contractual Term (Years), Warrants Granted Aggregate Intrinsic Value, Aggregate Intrinsic Value, Warrants Granted Weighted Average Grant Date Fair Value, Warrants Granted Number of Shares, Warrants Exercised Weighted Average Strike Price/Share, Warrants Exercised Aggregate Intrinsic Value, Warrants Exercised Weighted Average Grant Date Fair Value, Warrants Exercised Number of Shares, Warrants Forfeiture Weighted Average Strike Price/Share, Warrants Forfeiture Aggregate Intrinsic Value, Warrants Forfeitures Weighted Average Grant Date Fair Value, Warrants Forfeiture Number of Shares, Warrants Outstanding Ending balance Weighted Average Strike Price/Share, Warrants Outstanding Ending balance Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance Aggregate Intrinsic Value, Warrants Outstanding Ending balance Weighted Average Grant Date Fair Value, Warrants Outstanding Ending balance Number of Shares, Warrants Vested and Exercisable Weighted Average Strike Price/Share, Warrants Vested and Exercisable Weighted Average Remaining Contractual Term (Years), Warrants Vested and exercisable Ending balance Aggregate Intrinsic Value, Warrants Vested and Exercisable Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable Number of Shares, Warrants Unvested and Non-Exercisable Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance Aggregate Intrinsic Value, Warrants Unvested and Non Exercisable Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable Weighted Average Remaining Contractual Term (Years), Warrants Exercised Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Number of shares authorized Number of shares reserved for grants Minimum percentage of fair market value Threshold of employee ownership for increase in fair market value and decrease in maximum life Minimum percentage of fair market value for eligible employee Maximum fair market value underlying options exercisable by any option holder during any calendar year Maximum option life Maximum option life for 10% holder Number of common shares option to purchase Shares issued price per share Number of option vested Option expiration date Share-based payment award, fair value of options Option term Implied volatility Risk free equivalent yield Share price Class of warrant or right, number of securities called by warrants or rights Fair value of warrant option grant date Option vesting period Share-Based Payment Arrangement, Expense Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term Warrants and Rights Outstanding, Term Warrants and Rights Outstanding, Measurement Input Warrants and rights outstanding, maturity date Proceeds from issuance of warrants Proceeds from warrant exercises Solicitation Fees [custom:NumberOfWarrantsCancelled] Shares issued upon exercise of warrants Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table] Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items] Lease term Lease amount Payments for Rent Related party payments Current Federal Deferred Federal Federal Current State Deferred State State Current Subtotal Deferred Subtotal Subtotal Current Valuation allowance Deferred Valuation allowance Valuation allowance Current Total Deferred Total Total Taxes calculated at federal rate Stock based compensation Permanent differences Change in valuation allowance Fair market adjustment derivatives Prior year true-ups Other adjustments Provision for income tax benefit (expense) Deferred Tax Assets Net operating loss carryforwards Bad debt expense Fixed assets Accrued interest Stock based compensation Interest expense limitation carryover Contribution carryover Lease liability Unrealized gain on marketable securities Other accruals Total Deferred Tax Assets Deferred Tax Liabilities Fixed assets Right-of-use asset Intangibles Interest expense limitation carryover Prepaid expenses Total Deferred Tax Liabilities Net Deferred Tax Assets Valuation Allowance Net deferred tax / (liabilities) Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Operating Loss Carryforwards, Limitations on Use Deferred Tax Assets, Operating Loss Carryforwards, Domestic Deferred Tax Assets, Operating Loss Carryforwards, State and Local Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued NOL carryforwards, description Operating Loss Carryforwards Fair Value, Recurring and Nonrecurring [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Total assets Total liabilities Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Beginning Balance Acquisitions Sales and dispositions Transfers intoLevel 3 Transfers out of Level 3 Realized & Unrealized Gains (Losses) Ending Balance Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 Fair Value Measurement Inputs and Valuation Techniques [Table] Fair Value Measurement Inputs and Valuation Techniques [Line Items] Range Range, maturity Notes Receivable, Fair Value Disclosure Deferred payment fair value Corporate debt Implied discount Fair value notes receivable Contracts asset Total revenues Revenue from contract liabilities Subsequent Event [Table] Subsequent Event [Line Items] Investments Debt amount Proceeds from sale of securities Principal amount exchange Loan amount Expiration date Additional amount Credit facility, description Payment percentage Payment description Conversion, description Number of shares issued Number of common stock and warrants shares Shares issued for debt extinguishment. Stock issued during period value warrants exercised. Non controlling interest increase from warrants issued. Non controlling interest series B convertible preferred stock issued. Non controlling interest increase from convertible debt with conversion feature . Shares issued for debt extinguishment shares. Stock issued during period shares warrants exercised. Description of sale of accounts receivable. Agreements to Sell Accounts Receivable Ammended [Member] Receivable Purchase and Sale Agreement [Member] Accounts receivable. Proceeds from accounts receivable. Lease costs. LD Micro [Member] Series 1 Preferred Stock [Member] Class B Common Stock [Member] Term loan, maximum borrowing capacity. Term Loan [Member] Debt instrument, additional borrowing capacity. Second Drawdown [Member] OID Convertible Debentures [Member] Original issue discount percentage. OID Convertible Debentures [Member] Securities Purchase Agreement [Member] Placement Agent [Member] Proceeds from warrants percentage. Prior To Closing Date [Member] After The Closing Date [Member] Number of shares pledged for repurchase of receivables. Proceeds from offering, net. Increase in additional paid in capital. Debenture Holders [Member] Current Principal Balance Fee Percentage. Designated assets for return of capital. Long term assets of discontinued operations. Oid notes payable. Platform costs. Financing costs. Unrealized loss on designated assets. Gain loss on fair value in preferred stock. Loss on disposal of subsidiary. Retirement of shares. Disposition of shares. Warrants issued as inducement to exercise warrants. Common stock issued for acquisition of subsidiary shares. Retirement of shares of value. Additions [Member] Repurchase of authorized common stock. Board of Directors [Member] At the Market Sales Agreement [Member] Extension [Member] Conversion [Member] Amortization [Member] 2012 Equity Compensation Plan [Member] 2014 Equity Compensation Plan [Member] 2016 Equity Compensation Plan [Member] Oid convertible debentures short term. Two Remaining Note Holders [Member] Principal. Debt discount. Issuance Beginning of Year [Member] Repayments of short term notes payable. Additional principal percentage. Warrant exercise price percentage. Maximum option life for eligible employees. Previous equity adjustments of noncontrolling interest. Book basis of investment in bigtoken. Schedule of Deconsolidation of Business [Table Text Block] Disposal group including discontinued operation employee releated cost. Disposal group including discontinued operation selling and marketing expense. Force Protection Video Equipment Corp [Member] Marketable Securities [Member] Employees and Members of Management Team [Member] Non-Executive Directors [Member] Current valuation allowance. Deferred valuation allowance. Valuation allowance, deferred tax assets. Amount of state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations. Fair value of warrant option grant date. Effective income tax rate reconciliation, fair market adjustment derivatives. Effective income tax rate reconciliation, permanent differences. Deferred tax assets, bad debt expense. Deferred Tax Assets: Contribution carryover. Deferred Tax Assets: Lease liability. Deferred tax liabilities, fixed assets. Deferred Tax Liabilities: Right-of-use asset. Weighted Average Remaining Contractual Term (Years), Granted. Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Remaining Exercised Contractual Term. Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Remaining Forfeited Contractual Term. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance. NOL carryforwards, description. Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance. Weighted Average Grant Date Fair Value, Outstanding Beginning balance. Consulting Agreement [Member] Weighted Average Grant Date Fair Value,Exercised. Weighted Average Grant Date Fair Value, Forfeited. Weighted Average Grant Date Fair Value, Outstanding Ending balance. Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance. Expiration date of each operating loss carryforward from state and local included in operating loss carryforward, in CCYY-MM-DD format. Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Exercised Remaining Contractual Term. New Warrant [Member] Solicitation fees. BIG Tokens [Member] Issuance of acquisition shares description. Adjustments to additional paid in capital reclassification of warrants from liability to equity. Retirement of shares share. Marketable securities received for accounts receivable previously written off. Increase decrease deferred revenues. Designation of marketable securities for dividend distribution. Dividends on preferred stock. Relative fair value of warrants issued with term loan. Derivative liabilities transferred to equity. Shares of common stock issued for extension agreement. Fair value of warrants issued for debt financings. Premium on debt financings. Original issue discount recorded on oid convertible debentures. LD Micro Inc [Member] Forecast [Member] Class A common stock [Member] Business combination working capital adjustment. Business combination transaction expenses. Business combination less cash received. Business combination deferred payments. Proceeds from oid notes payable less issuance costs. Business combination deferred payments discounted. Amortization of payments. Schedule of Intangible Assets Acquired as Part of Business Combination [Table Text Block] Summary of amounts of revenue and earnings of acquiree since the acquisition date. Vesting of common stock award. Summary of pro forma adjustments. Business acquisitions pro forma financing costs. Business acquisitions pro forma employee related costs. Business acquisitions pro forma amortization of intangibles acquired. Business acquisitions pro forma other expense. Business acquisitions pro forma operating expenses. Business acquisitions pro forma cost of revenues. Pro Forma Combined [Member] Intangible assets life in years description. Noncompete [Member] Domain Name [Member] Trademark [Member] Customer List [Member] Liquidity and Going Concern [Policy Text Block] Employee related costs. Redemption of oid notes payable. Common stock received in lieu of cash for account received. Customer One [Member] Customer Two [Member] Customer Three [Member] Revenue [Member] Warrant Liability [Policy Text Block] Percentage of receivables upon exercise of put option. Agreements to Sell Accounts Receivable [Member] Debentures [Member] Sale of stock number of value issued in transaction. Sale of stock number of values issued in transaction. Right to future subscription revenues. Movement Marketable Securities [Text Block] Marketable securities addition. Convertible Debentures [Member] Marketable securities designation for dividend distribution. Convertible Debentures and Preferred Stock [Member] Proceed from sale and maturity of marketable securities. Gain on marketable securities. Designated Assets [Text Block] Designated Assets [Member] Assets designated. Designated Assets [Table Text Block] Designated Marketable Assets [Member] CCC Rated Corporate Debt [Member] Rated Corporate Debt [Member] Discount on notes receivable. Haylard MDLLC [Member] Price to be paid upon earliar. Excess amount for each unit. MD CoInvest, LLC [Member] Software [Member] Internally Developed Software [Member] Ten Percent [Member] Twenty Percent [Member] Thirty Six Percent [Member] Subscription revenues. PIPE Technologies [Member] Purchase price. FPVD [Member] Accounts receivables. Schedule of Operating Lease Assets and Liabilities [Table Text Block] Schedule of Weighted Average Remaining Lease Term and Discount Rate [Table Text Block] Paycheck Protection Program Loan [Text Block] Accrued commissions current. Paycheck Protection Program Loan [Member] Short-Term Promissory Notes [Member] Original Issue Discount Convertible Debentures [Text Block] Common stock issued for acquisition of subsidiary value. Loss on unrealized designated assets. Forgiveness of payroll protection program loan. Losses on extinguishment of debt. Non cash financing expense. Acquisition of LD Micro net of cash acquired. Payments to acquire other assets. Minimum percentage of fair market value of underying share. 2012, 2014 and 2016 Equity Compensation Plans [Member] Threshold of employee ownership for increase in fair market value. Minimum percentage of fair market value of underying shares for eligible employee. Maximum fair market value threshhold in calendar year for single holder. Maximum option life. Disposal group including discontinued operation platform cost. Disposal group including discontinued operation financing costs. Disposal group including discontinued operation realized loss on marketable securities. Disposal group including discontinued operation impairment of goodwill. Schedule of Vested and Non vested Stock Option [Table Text Block] SEQUIRE [Member] Platform Revenue [Member] Conference Revenue [Member] Other Revenues [Member] Big Token Inc [Member] Safe Agreement [Member] Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Forfeited Remaining Contractual Term. Brite Pool Inc [Member] Issued and Outstanding of Common Stock. Revenue Disaggregation [Text Block] Right to Use Asset Leases [Text Block] Fair Value of Stock [Member] Cash At Closing [Member] Deferred Payments [Member] Cash Received [Member] Transaction Expenses [Member] Working Capital Adjustment [Member] Purchase Price [Member] Proceeds from payments for acquire other assets. Net Change In Right Of Use Asset And Liability. Noncontrolling Interest Increase From Warrant Issued. Schedule Of Movement In Designated Assets [Table Text Block] Disposal Group Including Discontinued Operation Fair Value Of Series D Stock. Carrying Amount Of Noncontrolling Interest Of Bigtoken. Previous Equity Adjustment Of Noncontrolling Interest. Exchanged Number Of Shares for CommonStock. Series D Convertible Preferred Stock [Member] Number Of Warrants Cancelled. Beneficial Ownership Percenatge. Business Combination Contingent Consideration Liability Related. Pro Forma Adjustment [Member] Share Based Compensation Arrangement By Share Based Payment Award Non Options Vested And Expected To Vest Outstanding Number. Share based Compensation Arrangement By Share based Payment Award Non Options Nonvested Number Of Shares. Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average Exercise Price. Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price. Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises InPeriod Weighted Average Exercise Price. Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures InPeriod Weighted Average Exercise Price. Share Based Compensation Arrangement By Share Based Payment Award Non Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price. Share based Compensation Arrangement By Share based Payment Award Non Options Non vested Weighted Average Grant Date Fair Value. Share based Compensation Arrangement By Share based Payment Award Non Options OutstandingWeighted Average Remaining Contractual Term2. Share based Compensation Arrangement By Share based Payment Award Non Options Exercisable Weighted Average Exercised Remaining Contractual Term. Share based Compensation Arrangement By Share based Payment Award Non Options Exercisable Weighted Average Forfeited Remaining Contractual Term. Share based Compensation Arrangement By Share based Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term1. Share based Compensation Arrangement By Share based Payment Award Non Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1. Share based Compensation Arrangement By Share based Payment Award Non Options Outstanding Nonvested Weighted Average Remaining Contractual Term1. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value. Share based Compensation Arrangement By Share based Payment Award Non Options Nonvested Instrictic Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average Grant Date Fair Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average Grant Date Fair Value1. Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Weighted Average Grant Date Fair Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercised In Period Weighted Average Grant Date Fair Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeited In Period Weighted Average Grant Date Fair Value. Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Vested Weighted Average Grant Date Fair Value. Share based Compensation Arrangement By Share based Payment Award Options Non vested Non Options Forfeited Weighted Average Grant Date Fair Value. Share based Compensation Arrangement By Share based Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term. Sequire Platform Revenue [Member] Business acquisitions pro forma income tax expense benefit. Cash and Cash Equivalents Discontinued Operations Cash and Cash Equivalents Continuing Operations. Contracts receivable. Repurchase and retirement of shares. Repurchase and retirement of shares,share Repurchase of shares. Deferred tax liabilities interest expense limitation carryover. Common stock issued to settle liability. Fair value of Series D Stock and Common stock. BIGtoken [Member] Share Buy-Back Program [Member] Notional amount. Deferred payments. Deferred payments discount. Fair value amortization period. Holders [Member] Bridge Note [Member] Exchange of principal amount. Fair value of preferred stock. Cost and expenses. Series D Convertible Preferred Stock and Common Stock [Member] Factoring Facility [Member] Contracts Receivable [Member] CVR Agreement [Member] Institutional Investor [Member] Credit Agreement and Revolving Note [Member] Line of credit facility payment percentage. Tranche One [Member] Tranche Two [Member] Tranche Three [Member] Line of credit facility payment description. Security Agreements [Member] Credit Agreement [Member] Cash, cash equivalents and restricted cash from continuing operations. Cash restricted for designated assets for return of capital. Amortization of finite-lived intangible assets. Deferred payments related to acquisition. Deferred payments discounted under CCC rated corporate debt. Cash reserved for designated asset for return of capital. Proceeds from sale of designated assets. Deferred payment fair value. Put Option Pricing Model [Member] Derivative asset maturity measurement input. OID Convertible Debentures [Member] [Default Label] Assets, Current Assets [Default Label] Liabilities, Current Liabilities Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity CostAndOperatingExpenses Operating Income (Loss) FinancingCosts UnrealizedLossOnDesignatedAssets Nonoperating Income (Expense) Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent LossOnDisposalOfSubsidiary Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent Stockholders' Equity Attributable to Parent Shares, Outstanding Noncontrolling Interest, Increase from Business Combination Dividends, Preferred Stock, Stock Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest Interest Income, Other NoncontrollingInterestIncreaseFromWarrantIssued MarketableSecuritiesReceivedForAccountsReceivablePreviouslyWrittenOff Share-Based Payment Arrangement, Noncash Expense NetChangeInRightOfUseAssetAndLiability Increase (Decrease) in Accounts Receivable Increase (Decrease) in Prepaid Expense and Other Assets Increase (Decrease) in Accounts Payable and Accrued Liabilities IncreaseDecreaseDeferredRevenues Increase (Decrease) in Other Current Liabilities Increase (Decrease) in Deferred Liabilities Net Cash Provided by (Used in) Operating Activities, Continuing Operations Net Cash Provided by (Used in) Operating Activities Payments to Acquire Marketable Securities AcquisitionOfLdMicroNetOfCashAcquired Payments to Acquire Property, Plant, and Equipment Payments to Acquire Intangible Assets ProceedsFromPaymentsForAcquireOtherAssets Net Cash Provided by (Used in) Investing Activities, Continuing Operations Net Cash Provided by (Used in) Investing Activities RepurchaseOfShares RedemptionOfOidNotesPayable RepaymentsOfShortTermNotesPayable Net Cash Provided by (Used in) Financing Activities, Continuing Operations Net Cash Provided by (Used in) Financing Activities Net Cash Provided by (Used in) Continuing Operations Net Cash Provided by (Used in) Discontinued Operations Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations CashAndCashEquivalentsDiscontinuedOperations CashCashEquivalentsAndRestrictedCashFromContinuingOperations CashReservedForDesignatedAssetForReturnOfCapital Cash and Cash Equivalents, at Carrying Value DesignationOfMarketableSecuritiesForDividendDistribution Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block] Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent Disposal Group, Including Discontinued Operation, Assets Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current Disposal Group, Including Discontinued Operation, Other Liabilities, Current Disposal Group, Including Discontinued Operation, Revenue Disposal Group, Including Discontinued Operation, Costs of Goods Sold Disposal Group, Including Discontinued Operation, Gross Profit (Loss) DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense DisposalGroupIncludingDiscontinuedOperationPlatformCost Disposal Group, Including Discontinued Operation, Depreciation and Amortization Disposal Group, Including Discontinued Operation, General and Administrative Expense Disposal Group, Including Discontinued Operation, Operating Expense Disposal Group, Including Discontinued Operation, Operating Income (Loss) DisposalGroupIncludingDiscontinuedOperationFinancingCosts DisposalGroupIncludingDiscontinuedOperationRealizedLossOnMarketableSecurities DisposalGroupIncludingDiscontinuedOperationImpairmentOfGoodwill Disposal Group, Including Discontinued Operation, Other Expense Business Combination, Consideration Transferred Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net Business Acquisition, Pro Forma Revenue BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit Business Acquisition, Pro Forma Net Income (Loss) BusinessAcquisitionsProFormaEmployeeRelatedCosts EmployeeRelatedCosts Proceeds from Sale and Maturity of Marketable Securities MarketableSecuritiesDesignationforDividendDistribution AssetsDesignated Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Finite-Lived Intangible Assets, Net Lessee, Operating Lease, Liability, to be Paid, Year One Lessee, Operating Lease, Liability, to be Paid, Year Two Lessee, Operating Lease, Liability, to be Paid Lessee, Operating Lease, Liability, Undiscounted Excess Amount Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Effective Income Tax Rate Reconciliation, Percent Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost Deferred Tax Assets, Gross DeferredTaxLiabilitiesFixedAssets DeferredTaxLiabilitiesRightofuseAsset Deferred Tax Liabilities, Intangible Assets DeferredTaxLiabilitiesInterestExpenseLimitationCarryover Deferred Tax Liabilities, Prepaid Expenses Deferred Tax Liabilities, Gross Deferred Tax Assets, Net of Valuation Allowance Deferred Tax Assets, Valuation Allowance Deferred Tax Assets, Net Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Amortization of Debt Issuance Costs and Discounts EX-101.PRE 15 srax-20211231_pre.xml INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 16 R1.htm IDEA: XBRL DOCUMENT v3.22.2.2
Cover - USD ($)
 12 Months Ended
Dec. 31, 2021
Sep. 23, 2022
Jun. 30, 2021
Cover [Abstract]      
Document Type 10-K    
Amendment Flag false    
Document Annual Report true    
Document Transition Report false    
Document Period End Date Dec. 31, 2021    
Document Fiscal Period Focus FY    
Document Fiscal Year Focus 2021    
Current Fiscal Year End Date --12-31    
Entity File Number 001-37916    
Entity Registrant Name SRAX, INC.    
Entity Central Index Key 0001538217    
Entity Tax Identification Number 45-2925231    
Entity Incorporation, State or Country Code DE    
Entity Address, Address Line One 2629 Townsgate Road #215    
Entity Address, City or Town Westlake Village    
Entity Address, State or Province CA    
Entity Address, Postal Zip Code 91361    
City Area Code (323)    
Local Phone Number 694-9800    
Title of 12(b) Security Class A Common Stock, $0.001 par value    
Trading Symbol SRAX    
Security Exchange Name NASDAQ    
Entity Well-known Seasoned Issuer No    
Entity Voluntary Filers No    
Entity Current Reporting Status No    
Entity Interactive Data Current No    
Entity Filer Category Non-accelerated Filer    
Entity Small Business true    
Entity Emerging Growth Company false    
Entity Shell Company false    
Entity Public Float     $ 121,972,024
Entity Common Stock, Shares Outstanding   26,315,178  
Documents Incorporated By Reference None    
ICFR Auditor Attestation Flag false    
Auditor Name RBSM LLP    
Auditor Location New York, NY    
Auditor Firm ID 587    
XML 17 R2.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Current assets    
Cash and cash equivalents $ 1,348,000 $ 450,000
Accounts receivable, net 821,000 1,409,000
Contracts receivable 844,000
Marketable securities 15,617,000 8,447,000
Designated assets for return of capital 3,925,000
Prepaid expenses and other current assets 430,000 361,000
Current assets of discontinued operations 1,206,000
Total current assets 22,985,000 11,873,000
Notes receivable 935,000 893,000
Property and equipment, net 114,000 117,000
Intangible assets, net 1,443,000 1,492,000
Right of use assets 257,000 366,000
Other assets 36,000 2,000
Goodwill 17,906,000 17,906,000
Long-term assets of discontinued operations 6,364,000
Total assets 43,676,000 39,013,000
Current liabilities    
Accounts payable and accrued expenses 4,095,000 2,708,000
Deferred revenue 12,859,000 4,842,000
Other current liabilities 763,000 3,417,000
Payroll protection loan - current portion 10,000 747,000
OID notes payable 1,164,000 6,016,000
Series A preferred stock, authorized 36,462,417 shares, $0.001 par value, 36,462,417 shares and none issued and outstanding, respectively 3,925,000
Current liabilities of discontinued operations 1,305,000
Total current liabilities 22,816,000 19,035,000
Right of use liability - long term 114,000 243,000
Payroll protection loan - long term 379,000
Deferred tax liability 131,000
Total liabilities 22,930,000 19,788,000
Commitments and contingencies (Note 19)
Stockholders’ equity    
Class A common stock, authorized 250,000,000 shares, $0.001 par value, 25,995,172 and 16,145,778 shares issued and outstanding, respectively 26,000 16,000
Additional paid in capital 51,075,000 69,551,000
Accumulated deficit (30,355,000) (50,342,000)
Total stockholders’ equity 20,746,000 19,225,000
Total liabilities and stockholders’ equity $ 43,676,000 $ 39,013,000
XML 18 R3.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Balance Sheets (Parenthetical) - $ / shares
Dec. 31, 2021
Dec. 31, 2020
Common stock, shares authorized 259,000,000  
Common stock, shares issued 25,995,172 16,145,778
Common stock, shares outstanding 25,995,172 16,145,778
Series A Preferred Stock [Member]    
Temporary equity, shares authorized 36,462,417 36,462,417
Temporary equity, par value $ 0.001 $ 0.001
Temporary equity, shares outstanding 36,462,417 0
Temporary Equity, Shares Outstanding 36,462,417 0
Class A common stock [Member]    
Common stock, shares authorized 250,000,000 250,000,000
Common stock, par value $ 0.001 $ 0.001
Common stock, shares issued 25,995,172 16,145,778
Common stock, shares outstanding 25,995,172 16,145,778
XML 19 R4.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Statement [Abstract]    
Revenues $ 26,707,000 $ 6,479,000
Cost and expenses    
Cost of revenue 6,521,000 1,789,000
Employee related costs 7,533,000 4,683,000
Marketing and selling expenses 6,330,000 1,717,000
Platform costs 214,000 960,000
Depreciation and amortization 842,000 772,000
General and administrative expenses 5,352,000 3,590,000
Total cost and expenses 26,792,000 13,511,000
Income (loss) from operations (85,000) (7,032,000)
Other income (expense)    
Financing costs (10,295,000) (12,150,000)
Realized gain on marketable securities 804,000 684,000
Unrealized gain (loss) on marketable securities (7,904,000) 261,000
Realized loss on designated assets (84,000)
Unrealized loss on designated assets (2,378,000)
Gain on sale of SRAXmd, net 7,873,000
Interest income 42,000
Other income 1,144,000
Change in fair value of preferred stock 2,462,000
Change in fair value of derivative liabilities 321,000
Total other expense (16,209,000) (3,011,000)
Loss before provision for income taxes (16,294,000) (10,043,000)
Provision for income tax benefit (expense) 127,000 (21,000)
Loss from continuing operations (16,167,000) (10,064,000)
Discontinued operations    
Loss before income tax benefits (14,376,000) (4,641,000)
Loss on disposal of subsidiary (10,684,000)
Income tax benefit
Loss from discontinued operations (25,060,000) (4,641,000)
Net loss (41,227,000) (14,705,000)
Net loss attributable to non-controlling interest in discontinued operations 6,465,000
Net loss attributable to SRAX, Inc. $ (34,762,000) $ (14,705,000)
Basic and diluted loss per share    
Continuing operations $ (0.69) $ (0.69)
Discontinued operations attributable to SRAX, Inc. (0.79) (0.32)
Net loss per share, basic and diluted $ (1.48) $ (1.01)
Weighted average shares outstanding, basic and diluted 23,550,744 14,649,788
XML 20 R5.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2019 $ 14,000 $ 48,129,000 $ (35,637,000) $ 12,506,000
Balance, shares at Dec. 31, 2019 13,997,452        
Stock based compensation 1,710,000 1,710,000
Relative fair value of warrants issued with notes payable 4,331,000 4,331,000
Shares issued for extension agreement 71,000 71,000
Shares issued for extension agreement, shares 36,700        
Shares issued for debt extinguishment 181,000 181,000
Shares issued for debt extinguishment, shares 100,000        
Conversion of convertible debt to equity 434,000 434,000
Conversion of convertible debt to equity, shares 411,626        
Common stock issued for the acquisition of a subsidiary $ 2,000 4,262,000 4,264,000
Common stock issued for the acquisition of a subsidiary, shares 1,600,000        
Reclassification of warrants from liability to equity 4,076,000 4,076,000
Premium on debt extinguishment 46,000 46,000
Beneficial conversion feature 6,311,000 6,311,000
Net loss attributable to SRAX, Inc. (14,705,000) (14,705,000)
Net loss attributable to non controlling interest in discontinued operations        
Balance at Dec. 31, 2020 $ 16,000 69,551,000 (50,342,000) 19,225,000
Balance, shares at Dec. 31, 2020 16,145,778        
Stock based compensation 1,006,000 1,006,000
Conversion of convertible debt to equity $ 3,000 5,971,000 5,974,000
Conversion of convertible debt to equity, shares 3,122,167        
Net loss attributable to SRAX, Inc. (34,762,000) (34,762,000)
Shares issued for cash 284,000 284,000
Shares issued for cash, shares 53,616        
Shares issued for exercise of warrants, net of offering costs $ 7,000 15,945,000 15,952,000
Shares issued for exercise of warrants, net of offering costs, shares 6,828,611        
Warrants issued as an inducement to exercise warrants 7,737,000 7,737,000
Acquisition of noncontrolling interest of FVPD (95,000) (95,000)
Warrants issued by FVPD for SRAX, Inc. debenture holders 885,000 885,000
Series B convertible preferred stock issued by FPVD 5,860,000 5,860,000
Beneficial conversion feature FPVD series B convertible preferred stock 5,860,000 5,860,000
Dividends on preferred stock (6,387,000) (6,387,000)
Disposition of subsidiary (42,239,000) 54,749,000 (6,045,000) 6,465,000
Repurchase and retirement of shares (793,000) (793,000)
Repurchase and retirement of shares, shares (155,000)        
Net loss attributable to non controlling interest in discontinued operations (6,465,000) (6,465,000)
Balance at Dec. 31, 2021 $ 26,000 $ 51,075,000 $ (30,355,000) $ 20,746,000
Balance, shares at Dec. 31, 2021 25,995,172        
XML 21 R6.htm IDEA: XBRL DOCUMENT v3.22.2.2
Consolidated Statements of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net loss $ (41,227,000) $ (14,705,000)
Less: Loss from discontinued operations, net of tax (25,060,000) (4,641,000)
Loss from continuing operations (16,167,000) (10,064,000)
Adjustments to reconcile net loss to net cash used in operating activities:    
Unrealized loss (gain) on marketable securities 7,904,000 (261,000)
Realized gain on marketable securities (804,000) (684,000)
Unrealized loss on designated assets 2,378,000
Realized loss on designated assets 84,000
Gain on sale of SRAXmd (7,873,000)
Interest income (42,000)
Change in fair value of preferred stock (2,462,000)
Change in fair value of derivative liabilities (321,000)
Forgiveness of payroll protection program loan (1,116,000)
Warrants issued by FVPD for SRAX, Inc. debenture holders 885,000
Loss on extinguishment of debt 1,103,000
Warrant inducement charge 7,737,000
Marketable securities received for accounts receivable previously written off (409,000)
Amortization of debt issue costs 854,000 9,128,000
Stock based compensation 1,006,000 1,615,000
Provision for bad debts (20,000) 17,000
Depreciation expense 72,000 28,000
Amortization of intangibles 847,000 744,000
Net change in right of use asset and liability (20,000) (19,000)
Non-cash financing expense 268,000
Changes in operating assets and liabilities    
Accounts receivable 1,680,000 (1,439,000)
Prepaid expenses and other current assets (820,000) 400,000
Accounts payable and accrued expenses 3,278,000 1,521,000
Deferred revenue (20,669,000)
Other current liabilities 350,000 (3,049,000)
Deferred tax liability (131,000)
Net cash used in continuing operations (15,317,000) (9,154,000)
Net cash used in discontinued operations (8,118,000) (4,335,000)
Net cash used in operating activities (23,435,000) (13,489,000)
Cash flows from investing activities    
Proceeds from the sale of marketable securities 8,666,000 519,000
Proceeds from the sale of designated assets 686,000
Purchase of marketable securities (1,450,000)
Proceeds from sale of SRAXmd, net 7,000,000
Acquisition of LD Micro, net of cash acquired (697,000)
Payment for deferred consideration to LD Micro (3,004,000)
Acquisition of property and equipment (69,000)
Acquisition of intangible assets (798,000) (633,000)
Other assets (33,000) 32,000
Net cash from continuing operations 3,998,000 6,221,000
Net cash from (used in) discontinued operations 841,000 (175,000)
Net cash from investing activities 4,839,000 6,046,000
Cash flows from financing activities    
Proceeds from the issuance of common stock units 284,000
Proceeds from the exercise of warrants 15,952,000
Repurchase of shares (793,000)  
Proceeds from OID notes payable, less issuance costs 11,988,000
Redemption of OID notes payable (6,070,000)
Proceeds from issuance of short-term notes payable, less issuance costs 960,000
Repayment of short-term notes payable (100,000)
Proceeds from payroll protection program 1,084,000
Proceeds from the issuance of notes payable 2,130,000
Repayment of notes payable (2,130,000)
Net cash from continuing operations 15,443,000 7,862,000
Net cash from discontinued operations 4,736,000
Net cash from financing activities 20,179,000 7,862,000
Net increase in cash from continuing operations 4,124,000 4,929,000
Net decrease in cash from discontinued operations (2,541,000) (4,510,000)
Cash, cash equivalents and board designated restricted cash beginning of year 451,000 32,000
Cash, cash equivalents and board designated restricted cash end of year 2,034,000 451,000
Less: Cash from discontinued operations 1,000
Cash, cash equivalents and board designated restricted cash from continuing operations 2,034,000 450,000
Cash reserved for designated asset for return of capital (686,000)
Cash and cash equivalents 1,348,000 450,000
Supplemental schedule of cash flow information    
Cash paid for interest 176,000
Cash paid for taxes
Supplemental schedule of noncash investing and financing activities    
Common stock received in lieu of cash for accounts receivable 27,842,000 8,406,000
Convertible notes converted into shares 5,974,000 434,000
Designation of marketable securities for dividend distribution 6,387,000
Dividends on preferred stock 6,387,000
Vesting of common stock award 94,000
Relative fair value of warrants issued with term loan 83,000
Derivative liabilities transferred to equity 4,076,000
Shares of common stock issued for extension agreement 71,000
Fair value of BCF for debt financings 6,311,000
Fair value of warrants issued for debt financings 4,248,000
Premium on debt financings 46,000
Original issue discount recorded on OID convertible debentures 1,931,000
Shares issued for the acquisition of a subsidiary 4,264,000
Common stock issued to settle liability $ 181,000
XML 22 R7.htm IDEA: XBRL DOCUMENT v3.22.2.2
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

NOTE 1 – ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 

Organization

 

SRAX, Inc. (“SRAX”, “we”, “us”, “our” or the “Company”) is a Delaware corporation formed on August 2, 2011. We are headquartered in Westlake Village, California but work as a distributed virtual Company. The Consolidated Financial Statements consist of SRAX and its wholly owned subsidiary LD Micro, Inc. (“LD Micro”).

 

We are a technology firm focused on enhancing communications between public companies and their shareholders and investors. We currently have two distinct business units, which we consider to be one reporting unit:

 

  ● Our unique SaaS platform, Sequire provides users many features which allow issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels.
  ● Through LD Micro, we organize and host investor conferences within the micro and small- cap markets, and plan to create several more niche events for the investor community.

 

Each of SRAX’s business units deliver valuable insights that assist our clients with their investor relations and communications initiatives.

 

On December 29, 2021, we deconsolidated our majority owned subsidiary BIG Token, Inc. (“BIGToken”) (formerly known as Force Protection Video Equipment Corporation). After the deconsolidation, we do not beneficially own controlling interest in BIGtoken, and no longer consolidate BIGtoken into our financial results for periods ending after December 31, 2021. The financial results of BIGtoken for the years ended December 31, 2021 and 2020 are presented as income from discontinued operations, net of taxes on the consolidated statements of operations and its assets and liabilities as of December 31, 2021 are presented as assets and liabilities of discontinued operations on the consolidated balance sheets. The historical consolidated statement of cash flows has also been revised to reflect the effect of the deconsolidation. See Note 2 – Discontinued Operations. Unless noted otherwise, discussion in the notes to the consolidated financial statements pertain to continuing operations.

 

Liquidity and Going Concern

 

The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. As of December 31, 2021, the Company had cash and cash equivalents of $1,348,000 which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited Consolidated Financial Statements are issued.

 

The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

 

In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flow and cash usage forecasts, and obligations and debts. Although management has a long history of successful capital raises, the analysis used to determine the Company’s ability as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next 12 months.

 

We expect that our existing cash and cash equivalents, our accounts receivable and marketable securities as of December 31, 2021, will not be sufficient to enable us to fund our anticipated level of operations through one year from the date these financial statements are issued.  We anticipate raising additional capital through the private and public sales of our equity or debt securities and selling our marketable securities, or a combination thereof. Although management believes that such capital sources will be available, there can be no assurances that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. If we do not raise sufficient capital in a timely manner, among other things, we may be forced to scale back our operations or cease operations altogether.

 

 

The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, and uncertain. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.

 

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.

 

The consolidated financial statements include the accounts of the Company and its subsidiaries from the acquisition date of majority voting control of the subsidiary.

 

Business Segments

 

The Company uses the “management approach” to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics.

 

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition.

 

Use of Estimates

 

The consolidated financial statements have been prepared in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) and requires management of the Company to make estimates and assumptions in the preparation of these consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.

 

The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company’s revenue recognition, allowance for doubtful accounts and sales credits, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisition, goodwill, other intangible assets, put rights and valuation of other assets and liabilities.

 

Fair Value of Financial Instruments

 

The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

 

In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels:

 

  ● Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.;
  ● Level 2 - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly.; and
  ● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. Therefore, even when market assumptions are not readily available, the fund’s own assumptions reflect those that market participants would use in pricing the asset or liability at the measurement date.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fund’s level is based on the lowest significant level input to the fair value measurement.

 

 

Valuation Techniques and Inputs

 

Investments in securities and securities sold short that are both freely tradable and listed on major securities exchanges are valued at their last reported sales price as of the valuation date.

 

Many over-the-counter contracts have bid and ask prices that are observable in the marketplace. Bid prices reflect the highest price that the marketplace participants are willing to pay for an asset. Ask prices represent the lowest price that the marketplace participants are willing to accept for an asset.

 

An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. The Company initially classifies securities between debt securities, equity securities, warrants, convertible debt, or preferred stock. The Company does not have any debt securities as of December 31, 2021 and 2020. Warrants are initially valued at cost, if acquired for cash, or at intrinsic value. For convertible debt securities the investor generally should evaluate the security in its current “all-in” form as convertible debt and not use the “if converted” value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities are valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity.

 

The Company considers there to be an active market based on the guidance in ASC 820-10-35-54C. In an active market, transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. An orderly transaction assumes exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities. Whether transactions take place with sufficient frequency and volume to constitute an active market is a matter of judgement and depends on the facts and circumstances of the market for the asset or liability. If the Company determines that the trading market for a security is not an active market the Company evaluates the stock price based on other observable or unobservable inputs. A market with limited activity may still provide relevant pricing information when there is no contrary evidence that the pricing information is not relevant to the fair value of the asset. In certain situations, the Company’s security holdings represent share quantities that materially exceed the average daily trading volume of the securities in their primary market. Thus, the Company considers a discount due to the lack of liquidity. If the Company determines it can liquidate its position within 180 days based on 10% of the securities average daily trading volume, no discount is applied. Rule 144 also has an alternative volume limit for affiliates of up to 10% of the tranche (or class) outstanding for debt securities. We believe this provides a reasonable basis to suggest this 10% of trading volume should have minimal impact on market prices.

 

Securities with a marketability holding period in excess of 180 days is subjected to a discount for marketability. If a security has both a marketability holding period over 180 days and a liquidation period of over 180 days the Company will evaluate the impact of both the marketability and liquidity discounts. The Company utilizes the quoted market price on the date of valuation calculates a discount for marketability and liquidity based on a protective put option pricing model that factors in both the lack of marketability and liquidity.

 

Independent Valuation Expert

 

The Company uses a third party specialist to provide guidance around the assumptions, inputs, pricing models utilized valuation calculations into the various Put Option Pricing Models (POPMs) used in the calculations to determine discounts at contract inceptions date and each of the respective balance sheet dates.

 

If the Company has access to material non-public information regarding an investee, it will consider this information as an input for purposes of valuing the security. In these situations, the Company will consider the impact this information will have on the valuation of the securities on a case-by-case basis. These situations could arise due to the Company being an affiliate of the issuer or an officer or director of the Company is an affiliate of the issuer.

 

These securities are categorized in Level 1 of the fair value hierarchy to the extent these securities are actively traded. Securities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 of the fair value hierarchy.

 

Investments in Restricted Securities of Public Companies

 

Investments in restricted securities of public companies cannot be offered for sale to the public until the company complies with certain statutory requirements. The valuation will not exceed the listed price on any major securities exchange. Investments in restricted securities of public companies are generally categorized in Level 2 of the fair value hierarchy. However, investments in public companies may be categorized in Level 3 of the fair value hierarchy depending on the level of observable liquidity. Specifically, if the Company determines the market activity is not sufficient to conclude the market activity represents an Active Market pursuant to ASC 820 -10 -35 36B.

 

The Company evaluates the trading activity of each listed security to determine if the trading market is an Active Market for purposes of evaluating Fair Value under ASC 820. The Company evaluated the number of trade observations during the year, the percentage of the total trading days the security traded on its listed market during the full year or the portion of the year if the security was initially listed during the year, and at the dollar value of the trading activity for the full year as a percentage of the market capitalization of the security. If the Company determines the listed securities trading market is not an active market it looks at other transactions reported by the listed company including private equity transactions, non-cash equity transactions, the trading price and other factors. The Company determines a fair value of the stock price based on this analysis. This price is the lower of the listed price or the fair value based on the analysis. The Company also considers the marketability and liquidity discounts on the listed security in determining fair value.

 

Cash and Cash Equivalents

 

The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are recorded at cost, which approximates its fair value. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. As of December 31, 2021 and 2020, the Company had $1,098,000 and $200,000 in excess of the federal insurance limit, respectively.

 

 

Accounts Receivable

 

Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company usually does not require collateral. Allowance for doubtful accounts was approximately $130,000 and $15,000 as of December 31, 2021 and 2020, respectively.

 

Concentration of Credit and Significant Customer Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any loss on these accounts.

 

As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately 11%. As of December 31, 2020, the Company had three customers with accounts receivable balances of approximately 43.41%, 11.60%, and 10.53%.

 

For the year ended December 31, 2021, the Company had no customers that account for a significant percentage of total revenue. For the year ended December 31, 2020, the Company had one customer that accounted for 18.1% of total revenue.

 

Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the years ended December 31, 2021 or 2020, respectively.

 

Property and equipment

 

Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years.

 

Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment.

 

Intangible assets

 

Intangible assets consist of intellectual property, trademarks, trade names, and non-compete agreements, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years.

 

 

Costs incurred to develop computer software for internal use are capitalized once: (1) the preliminary project stage is completed, (2) management authorizes and commits to funding a specific software project, and (3) it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred prior to meeting the qualifications are expensed as incurred. Capitalization of costs ceases when the project is substantially complete and ready for its intended use. Post-implementation costs related to the internal use computer software, are expensed as incurred. Internal use software development costs are amortized using the straight-line method over its estimated useful life which ranges up to three years. Software development costs may become impaired in situations where development efforts are abandoned due to the viability of the planned project becoming doubtful or due to technological obsolescence of the planned software product. For the years ended December 31, 2021, and 2020 there has been no impairment associated with internal use software. For the years ended December 31, 2021, and 2020, the Company capitalized software development costs of $798,000 and $633,000, respectively.

 

During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use.

 

The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred.

 

Right of Use Assets and Lease Obligations

 

The Right of Use Asset and Lease Liability reflect the present value of the Company’s estimated future minimum lease payments over the lease term, which may include options that are reasonably assured of being exercised, discounted using a collateralized incremental borrowing rate.

 

Typically, renewal options are considered reasonably assured of being exercised if the associated asset lives of the building or leasehold improvements exceed that of the initial lease term. Therefore, the Right of Use Asset and Lease Liability may include an assumption on renewal options that have not yet been exercised by the Company.

 

As the rate implicit in leases are not readily determinable, the Company uses an incremental borrowing rate to calculate the lease liability that represents an estimate of the interest rate the Company would incur to borrow on a collateralized basis over the term of a lease within a particular currency environment.

 

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur or circumstances indicate the fair value of a reporting unit is below its carrying value. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. The Company performed its most recent annual goodwill impairment test as of December 31, 2021 using market data and discounted cash flow analysis. Based on this analysis, it was determined that the fair value exceeded the carrying value of its reporting units. The Company concluded the fair value of the goodwill exceed the carrying value accordingly there were no indicators of impairment for the years ended December 31, 2021 and 2020.

 

The Company had historically performed its annual goodwill and impairment assessment on December 31st of each year. This aligns the Company with other advertising sales companies who also generally conduct this annual analysis in the fourth quarter.

 

 

When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the impairment testing methodology primarily using the income approach (discounted cash flow method).

 

We compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows if the carrying value of a reporting unit exceeds its fair value, then the amount by which it exceeds its fair value will be recognized as an impairment.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.

 

Derivatives

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, Distinguishing Liabilities From Equity and FASB ASC Topic No. 815, Derivatives and Hedging. Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments.

 

The Company has adopted ASU 2017-11, Earnings per share (Topic 260), provided that when determining whether certain financial instruments should be classified as liability or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. If a down round feature on the conversion option embedded in the note is triggered, the Company will evaluate whether a beneficial conversion feature exists, the Company will record the amount as a debt discount and will amortize it over the remaining term of the debt.

 

If the down round feature in the warrants that are classified as equity is triggered, the Company will recognize the effect of the down round as a deemed dividend, which will reduce the income available to common stockholders.

 

Warrant Liability

 

The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black-Scholes option pricing model, at each measurement date.

 

Debt Discounts

 

The Company accounts for debt discounts originating in connection with conversion features that remain embedded in the related notes in accordance with ASC 470-20, Debt with Conversion and Other Options. These costs are classified on the consolidated balance sheet as a direct deduction from the debt liability. The Company amortizes these costs over the term of its debt agreements as interest expense-debt discount in the consolidated statement of operations.

 

 

Revenue Recognition

 

On January 1, 2018, we adopted ASU 2014-09, “Revenue from Contracts with Customers” (Topic 606) (“ASC 606”) and applied this guidance to those contracts which were not completed at the date of adoption using the modified retrospective method. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods (ASC 605). The adoption did not have a significant impact to the nature and timing of our revenues, results of operations, cash flows and statement of financial position. 

 

Revenue from all sale types is recognized at transaction price, the amount we expect to be entitled to in exchange for transferring goods or providing services. Transaction price is calculated as selling price net of variable consideration which may include estimates for future returns, sales incentives and price protection related to current period product revenue. Our standard obligation to our direct customers generally provides for a full refund in the event that such product is not merchantable or is found to be damaged or defective. In determining estimates for future returns, we estimate variable consideration at the expected value amount which is based on management’s analysis of historical data, channel inventory levels, current economic trends and changes in customer demand for our products. Sales incentives and price protection are determined based on a combination of the actual amounts committed and through estimating future expenditure based upon historical customary business practice. We continue to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur.

 

We enter into contracts to sell our products and services, and while some of our sales agreements contain standard terms and conditions, there are agreements that contain non-standard terms and conditions and include promises to transfer multiple goods or services. As a result, significant interpretation and judgment is sometimes required to determine the appropriate accounting for these transactions including: (1) whether performance obligations are considered distinct and required to be accounted for separately or combined, including allocation of transaction price; (2) developing an estimate of the stand-alone selling price, or SSP, of each distinct performance obligation; (3) combining contracts that may impact the allocation of the transaction price between product and services; and (4) estimating and accounting for variable consideration, including rights of return, rebates, price protection, expected penalties or other price concessions as a reduction of the transaction price.

 

Revenue from contracts with customers is recognized when the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to be entitled to in exchange for those goods or services.

 

The Company derives its revenue primarily from the licensing of our Sequire Platform and Services associated with our customer’s use of the platform, consisting of data insights, marketing, creative, and paid media advertising Revenue is recognized at a point in time when control of the goods is transferred to the customer, generally occurring ratably over the contract period. The amount recognized reflects the consideration the Company expects to be entitled to in exchange for the transferred services.

 

Licensing and Service revenue is generally recognized over time on a ratable basis over the contract term beginning on the date that the service is expected to begin. Service contracts are generally for 12 months in length, billed either monthly or annually and generally in advance. Services revenue are typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. 

 

Deferred Revenue

 

Deferred revenue consists of platform and services fees that the Company has received consideration in advance of satisfying performance under the associated contract. The majority of the Company’s deferred revenue balance consists of the unrecognized portion of Service revenue that the Company has received consideration in marketable securities, which is recognized as revenue ratably over the contractual service period.

 

 

ASC Topic 606 is a comprehensive revenue recognition model that requires revenue to be recognized when control of the promised goods or services are transferred to our customers at an amount that reflects the consideration that we expect to receive. Application of ASC Topic 606 requires us to use more judgment and make more estimates than under former guidance. Application of ASC Topic 606 requires a five-step model applicable to all product offering revenue streams as follows:

 

Identification of the contract, or contracts, with a customer

 

A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration.

 

We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit or financial information pertaining to the customer.

 

Identification of the performance obligations in the contract

 

Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract.

 

When a contract includes multiple promised goods or services, we apply judgment to determine whether the promised goods or services are capable of being distinct and are distinct within the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. The Company has identified three distinct services promised within its contracts: (1) subscription to the Platform for a fixed monthly fee (Platform revenue), (2) Managed Services (including, data and marketing campaigns for a fixed monthly fee (managed services), and (3) Ancillary data, which consists of various data attributes that supplement the data available within the Sequire platform. The Managed Services to be delivered to the customer are within the discretion of the Company, and there are no minimum or maximum guaranties to be delivered.

 

Determination of the transaction price

 

The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods or services to our customer. We estimate any variable consideration included in the transaction price using the expected value method that requires the use of significant estimates for discounts, cancellation periods, refunds and returns. In cases which the Company receives marketable securities as payment the transaction price is determined to be the lower of the fair market value of the securities received or the contract amount.

 

Allocation of the transaction price to the performance obligations in the contract

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. We determine SSP based on the price at which the performance obligation would be sold separately.

 

During the second quarter of 2020, the Company provided its customers the ability to pay for the Sequire services with the issuance of the customers’ common stock or other securities. For contacts paid with any type of security, Management considers whether there is any marketability of liquidity discounts in determining the fair value of the security on the contract date.

 

The Company’s contract with its customers is for a period of one year or less than one year and the Company is applying the practical expedient, therefore, the transaction price is not adjusted for any significant financing component. The Company evaluates whether there is an existence of a significant financing component in the contract. This is evaluated based on the marketability holding period and liquidity issues than can extend the ability to sale the securities. For any marketability restrictions over 180 days the Company provides a marketability discount. For any liquidity issues that would take the Company in excess of 180 days to liquidate the security the Company applies a liquidity discount. Where there is both a marketability and liquidity issue the Company provides a discount considering both. ASC 606-10-32-23 The fair value of the noncash consideration may vary after contract inception because of the form of the consideration (for example, a change in the price of a share to which an entity is entitled to receive from a customer). Changes in the fair value of noncash consideration after contract inception that are due to the form of the consideration are not included in the transaction price.

 

 

Recognition of revenue when, or as, we satisfy a performance obligation

 

We recognize revenue at the point in time that the related performance obligation is satisfied by transferring the promised goods or services to our customer. The Company has performed a limited analysis of the performance efforts and has determined that the effort for the managed services is typically front loaded and as a result of performing services for SEC reporting companies’ additional efforts are maintained throughout the year. The Company considers the services to be delivered ratably during any service period and as such is amortizing the contract price on a straight line method over the contract period.

 

Principal versus Agent Considerations

 

When another party is involved in providing goods or services to our customer, we apply the principal versus agent guidance in ASC Topic 606 to determine if we are the principal or an agent to the transaction. When we control the specified goods or services before they are transferred to our customer, we report revenue gross, as principal. If we do not control the goods or services before they are transferred to our customer, revenue is reported net of the fees paid to the other party, as agent. Our evaluation to determine if we control the goods or services within ASC Topic 606 includes the following indicators:

 

We are primarily responsible for fulfilling the promise to provide the specified good or service.

 

When we are primarily responsible for providing the goods and services, such as when the other party is acting on our behalf, we have indication that we are the principal to the transaction. We consider if we may terminate our relationship with the other party at any time without penalty or without permission from our customer.

 

We have risk before the specified good or service have been transferred to a customer or after transfer of control to the customer.

 

We may commit to obtaining the services of another party with or without an existing contract with our customer. In these situations, we have risk of loss as principal for any amount due to the other party regardless of the amount(s) we earn as revenue from our customer.

 

The entity has discretion in establishing the price for the specified good or service.

 

We have discretion in establishing the price our customer pays for the specified goods or services.

 

Contract Liabilities

 

Contract liabilities consist of customer advance payments and billings in excess of revenue recognized. We may receive payments from our customers in advance of completing our performance obligations. We record contract liabilities equal to the amount of payments received in excess of revenue recognized, including payments that are refundable if the customer cancels the contract according to the contract terms. Contract liabilities have been historically low historically recorded as current liabilities on our consolidated financial statements when the time to fulfill the performance obligations under terms of our contracts is less than one year. We have no long-term contract liabilities which would represent the amount of payments received in excess of revenue earned, including those that are refundable, when the time to fulfill the performance obligation is greater than one year.

 

Practical Expedients and Exemptions

 

We have elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:

 

  ● We adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception;
     
  ● We made the accounting policy election to not assess promised goods or services as performance obligations if they are immaterial in the context of the contract with the customer;
     
  ● We made the accounting policy election to exclude any sales and similar taxes from the transaction price; and
     
  ● We adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

 

 

Stock-Based Compensation

 

We account for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Common stock awards

 

The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded in accordance with ASC 718 on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.

 

Warrants

 

In connection with certain financing, and consulting arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period.

 

Income Taxes

 

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.

 

Earnings Per Share

 

We use ASC 260, “Earnings Per Share” for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share are the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.

 

There were 11,867,520 common share equivalents at December 31, 2021 and 15,366,426 at December 31, 2020. For the year ended December 31, 2021 and 2020 these potential shares were excluded from the computation of diluted net earnings per share as their effect would have been antidilutive.

 

 

Recently Issued Accounting Standards

 

In January 2020, the FASB issued ASU 2020-01, which clarifies the interactions between Topics 321, 323 and 815. This ASU clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, the amendments clarify the accounting for certain forward contracts and purchased options accounted for under Topic 815. Our adoption of this ASU did not impact our consolidated financial statements or disclosures.

 

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a limited period of time to ease the potential burden in accounting treatments related to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. Adoption of the expedients and exceptions is elective and is permitted upon issuance of the guidance through December 31, 2022. The adoption had no material impact on the Company’s financial position, results of operations and cash flows.

 

In May 2020, the SEC adopted amendments to the financial disclosure requirements in Regulation S-X including the significance tests in the “significant subsidiary” definition in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 to improve their application and to assist registrants in making more meaningful determinations of whether a subsidiary or an acquired or disposed business is significant. In addition, to address the unique attributes of investment companies and business development companies, the SEC updated the significance tests in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 by (i) revising the investment test to compare the registrant’s investments in and advances to the acquired or disposed business to the registrant’s aggregate worldwide market value if available; (ii) revising the income test by adding a revenue component; (iii) expanding the use of pro forma financial information in measuring significance; and (iv) conforming, to the extent applicable, the significance threshold and tests for disposed businesses to those used for acquired businesses. The amendment became effective January 1, 2021.

 

In August 2020, the FASB issued ASU 2020-06, which simplifies the accounting for convertible instruments by removing certain separation models (including the cash conversion model and the beneficial conversion feature model) for convertible instruments. As a result, for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815 or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features are no longer separated from the host contract. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost as long as no other features require bifurcation and recognition as derivatives. This ASU is effective for fiscal years beginning after December 15, 2021.

 

In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables–Nonrefundable Fees and Other Costs, (“ASU 2020-08”). This ASU clarifies that an entity should reevaluate whether a callable debt security is within the scope of ASC paragraph 310-20-35-33 for each reporting period. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of ASU 2020-08 did not have a material impact on its consolidated financial statements since the Company does not have any convertible debt.

 

On November 15, 2019, the FASB delayed the effective date of FASB ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments.” This ASU amends several aspects of the measurement of credit losses on certain financial instruments, including replacing the existing incurred credit loss model and other models with the Current Expected Credit Losses (CECL) model and amending certain aspects of accounting for purchased financial assets with deterioration in credit quality since origination.

 

Rule 2a-5 under the 1940 Act was adopted by the SEC in December 2020 and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. As noted above, the if the Company were determined to be an Investment Company we would be required to comply with the rule. We are evaluating the impact of adopting Rule 2a-5 on the consolidated financial statements and intend to comply with the new rule’s requirements should we be required to do so on or before the compliance date in September 2022.

 

The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.

 
XML 23 R8.htm IDEA: XBRL DOCUMENT v3.22.2.2
DISCONTINUED OPERATIONS
 12 Months Ended
Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]  
DISCONTINUED OPERATIONS

NOTE 2 – DISCONTINUED OPERATIONS

 

On December 29, 2021, The Company’s wholly owned subsidiary BIGToken completed a merger transaction with BritePool, Inc. (“BritePool”) (the “Merger”). As a result of the Merger, BIGToken issued 183,445,351,631 shares of its common stock (“Acquisition Shares”) for all of the issued and outstanding equity shares of BritePool. On December 29, 2021, as a condition for the closing of the Merger, the Company exchanged 149,562,566,584 shares of BIGToken common stock for 242,078 shares of BIGToken’s Series D Convertible Preferred Stock (“Series D Stock”) (the “Exchange”). Simultaneously with the Exchange, the Company converted 22,162 shares of the Series D Stock into 13,692,304,136 shares of BIGToken’s common stock, or approximately 4.99% of the issued and outstanding shares of BIGToken’s common stock.

 

The Series D Stock is non-redeemable, non-voting with liquidation preference being the same as if the Series D Stock had been converted into shares of FVPD common stock. Each share of the Series D Stock is convertible into 617,828 shares of BIGToken’s common stock, subject to a conversion limitation such that the number of shares of the BIGToken common stock outstanding immediately after giving effect to the issuance of BIGToken common stock to the Company upon conversion of the Series D Stock shall not be more than 4.99% (“Beneficial Ownership Limitation”). However, the Company upon not less than sixty-one days’ prior notice to BIGToken, may increase or decrease the Beneficial Ownership Limitation amount provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of BIGToken’s common stock outstanding immediately after giving effect to the issuance of the common stock upon conversion of the Series D Stock. As of the Exchange date, the Series D Stock and common stock of BIGtoken had a fair value of approximately $31,000.

 

 

BIGToken’s issuance of the Acquisition Share and the Exchange caused the Company’s BIGToken common stock holdings to decrease from approximately 66% to approximately 4.99%; Therefore, the Company no longer controlled the operations of BIGToken. Given the Company’s loss of control over the operations of BIGToken, the Company deconsolidated BIGToken, as of December 29, 2021, in accordance with ASC 810 Consolidations. Based on the deconsolidation of BIGToken, the Company recognized a loss of $10,684,000 calculated, as follows:

 

SCHEDULE OF DECONSOLIDATION OF BUSINESS

      
Consideration received  $- 
Fair value of Series D Stock and Common stock   31,000 
Carrying amount of non-controlling interest of BIGToken   6,045,000 
Previous equity adjustments of non-controlling interest   (12,510,000)
Total consolidations   (6,434,000)
      
Book basis of investment in BIGToken   4,250,000 
Loss on disposal of subsidiary  $(10,684,000)

 

As the transaction causing the deconsolidation of BIGToken, was a result of BIGToken issuing additional shares of its common stock for acquisition of BritePool, the Company received no cash or other consideration.

 

In accordance with ASC 820 – Fair Value Measurement, the Company determined the Series D Stock would be classified as level 3 asset consistent with the account policy for determining the fair value of an asset or liability. As there is no observable market for quoted market price for an identical asset. The Company engaged an independent third party valuation expert to estimate the fair value of the Series D Stock.

 

As of the Exchange date, the carrying basis of the non-controlling interest was approximately $6,465,000, which included approximately $12,510,000 related to BIGToken’s recording of a $5,860,000 Beneficial conversion feature for convertible preferred stock, issuance of convertible preferred stock in the amount of $5,860,000, $885,000 for the fair value of warrants issued to the Company’s debenture holders and less other amounts of approximately $95,000. These transactions were recognized in equity outside of the accumulated other comprehensive income (loss) related to ownership interest, which did not result in a loss of control, so they would not be included in the calculation of the gain or loss from deconsolidation because these amounts resulted from transactions among shareholders and are not directly attributable to the non-controlling interest.

 

The following table presents the aggregate carrying amounts of assets and liabilities of discontinued operations of BIGToken in the consolidated balance sheet as of December 31, 2020:

 

     
Carrying amounts of assets included as part of discontinued operations:    
Cash and cash equivalents  $1,000 
Accounts receivable, net   1,199,000 
Prepaid expenses and other current assets   6,000 
Property and equipment, net   1,000 
Goodwill   5,445,000 
Intangible assets, net   917,000 
Total assets classified as discontinued operations in the consolidated balance sheet  $7,569,000 
      
Carrying amounts of liabilities included as part of discontinued operations:     
Accounts payable and accrued expenses  $853,000 
Other current liabilities   452,000 
Total liabilities classified as discontinued operations in the consolidated balance sheet  $1,305,000 

 

 

The financial results of BIGToken are presented as income from discontinued operations, net of income taxes on our consolidated income through December 29, 2021, when our deconsolidation occurred. The following table presents the financial results of BIGToken:

 

           
   Year ended December 31, 
   2021   2020 
Revenues  $3,431,000   $2,168,000 
Cost of revenue   1,090,000    800,000 
Gross profit   2,341,000    1,368,000 
           
Operating expense          
Employee related costs   2,419,000    3,212,000 
Marketing and selling expenses   1,136,000    958,000 
Platform costs   1,350,000    707,000 
Depreciation and amortization   530,000    531,000 
General and administrative expenses   4,152,000    530,000 
Total operating expense   9,587,000    5,938,000 
           
Loss from operations of discontinued operations   (7,246,000)   (4,570,000)
           
Other expense          
Financing costs   (5,872,000)   - 
Realized loss on marketable securities   -    (71,000)
Impairment of goodwill   (1,258,000)   - 
Total other expense   (7,130,000)   (71,000)
           
Loss from discontinued operations before provision for income taxes   (14,376,000)   (4,641,000)
Provision for income taxes   -     
Loss from discontinued operations, net of income taxes  $(14,376,000)  $(4,641,000)

 

 
XML 24 R9.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACQUISITIONS
 12 Months Ended
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
ACQUISITIONS

NOTE 3 – ACQUISITIONS

 

On September 15, 2020 (“Closing Date”), an Agreement and Plan of Merger (the “Agreement”) was entered into by and among SRAX, Inc. a Delaware corporation (“Parent”), Townsgate Merger Sub 1, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub 1”), LD Micro, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub 2”), LD Micro, Inc., a California corporation (the “Acquiree”, “LD Micro”), and Christopher Lahiji, the sole stockholder of the Acquiree (the “Stockholder”). Merger Sub 1 and Merger Sub 2 are sometimes collectively referred to as “Merger Sub.”

 

The parties intend that Merger Sub 1 will be merged with and into the Acquiree (the “First Merger”), with the Acquiree surviving the First Merger, and then the Acquiree will be merged with and into Merger Sub 2 (the “Second Merger,” and together with the First Merger, the “Merger”), with Merger Sub 2 surviving the Second Merger.

 

As consideration, the Company will pay cash payable as follows: (i) $1,000,000 at the Closing, (ii) $1,000,000 on January 1, 2021, (iii) $1,000,000 on April 1, 2021, and (iv) $1,000,000 on July 1, 2021 and subject to adjustment or off-set. Additionally, the Company issued 1,600,000 shares of its Class A common stock. The total consideration to be paid by the Company is $7,610,000, as adjusted, as follows:

 

      
Calculation of the purchase price:    
Fair value of stock at closing  $4,264,000 
Cash at closing   1,000,000 
Deferred payments   2,771,000 
Less cash received   (303,000)
Transaction expenses   10,000 
Working capital adjustment   (132,000)
Purchase price  $7,610,000 

 

The transaction was accounted for using the acquisition method. Accordingly, goodwill has been measured as the excess of the total consideration over the amounts assigned to the identifiable assets acquired and liabilities assumed.

 

The deferred payments of $3,000,000 were discounted using the yield on a CCC rated corporate debt for 3-month, 6-month and 9-month maturities, respectively. The implied discount is approximately $229,000, which will be amortized over the term on the payments.

 

The purchase price includes working capital adjustments that are based on our preliminary estimates and assumptions that are subject to change.

 

 

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed:

 

      
Accounts receivable, net  $30,000 
Intangibles   468,000 
Goodwill   7,706,000 
Accounts payable and accrued liabilities   (324,000)
Payroll protection loan   (42,000)
Other current liabilities   (97,000)
Deferred tax liability   (131,000)
Net assets acquired  $7,610,000 

 

Intangible assets consisted of the following:

 

    Fair Value     Life in Years
Trademark   $ 271,000     Indefinite
Domain name     3,000     Indefinite
Noncompete     8,000     5 years
Customer list     186,000     3 years
    $ 468,000      

 

The estimated fair values for the trademark and domain name were determined by using the relief-from-royalty method. The estimated fair value for the customer list and noncompete were determined using the excess earnings and differential method of comparing having an asset in-place versus not having the asset in place, respectively.

 

The Company has estimated the preliminary purchase price allocations based on historical inputs and data as of September 15, 2020. The preliminary allocation of the purchase price is based on the best information available and is pending, amongst other things: (i) the finalization of the valuation of the fair values and useful lives of tangible assets acquired; (ii) the finalization of the valuations and intangible assets acquired; (iii) finalization of the valuation of accounts payable and accrued expenses; and (iv) finalization of the fair value of non-cash consideration.

 

During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date.

 

The amounts of revenue and earnings of the Acquiree since the acquisition date included in the consolidated statements of operations for the year ended December 31, 2020 follows:

 

Revenues $ -  
Net loss $   (51,000 )

 

The following pro forma information presents the combined results of operations as if the acquisitions had been completed on January 1, 2020. The pro forma results include the amortization associated with the preliminary estimates for the acquired intangible assets.

 

The pro forma results do not reflect any cost saving synergies from operating efficiencies, or the effect of the incremental costs incurred in integrating the two companies. Accordingly, these pro forma results are presented for informational purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations.

 

 

Pro Forma Consolidated Statements of Operations

For the Year ended December 31, 2020

 

    SRAX, Inc.     LD Micro, Inc.     Pro Forma Adjustment     Pro Forma Combined  
Revenues   $ 6,479,000     $ 937,000     $ -     $ 7,416,000  
Cost of revenues     (1,789,000 )     (98,000 )     -       (1,887,000 )
Operating expenses     (11,722,000 )     (858,000 )     171,000       (12,409,000 )
Other expense     (3,011,000 )     (1,000 )     -       (3,012,000 )
Provision for income taxes     (21,000 )     -       -       (21,000 )
Net loss   $ (10,064,000 )   $ (20,000 )   $ 171,000     $ (9,913,000 )

 

The following summarizes the pro forma adjustments made for the year ended December 31, 2020:

 

         
Amortization of intangibles acquired   $ 64,000  
Employee related costs     (235,000 )
Financing costs     -  
Net income (loss)   $ (171,000 )

 

Amortization relates to the acquired noncompete and customer list amounting to $2,000 and $62,000, respectively for the year ended December 31, 2020.

 

Employee related cost are contracted cost amounting to $235,000 for the year ended December 31, 2020.

 
XML 25 R10.htm IDEA: XBRL DOCUMENT v3.22.2.2
SALE AND PURCHASE OF ACCOUNTS RECEIVABLE
 12 Months Ended
Dec. 31, 2021
Credit Loss [Abstract]  
SALE AND PURCHASE OF ACCOUNTS RECEIVABLE

NOTE 4 – SALE AND PURCHASE OF ACCOUNTS RECEIVABLE

 

On January 22, 2020 and January 30, 2020, the Company entered into financing agreements, with a single unrelated purchaser to sell, with full recourse, certain accounts receivable with a face value of $454,000 and $75,000, respectively, for a purchase price of $454,000 and $56,000, respectively. Transactions under these agreements were accounted for as financing of accounts receivable and the related accounts receivable was not removed from our consolidated balance sheet at the time of the sales transactions, a liability was recorded for the proceeds received. The terms of the agreements are as follows:

 

Pursuant to the initial purchase agreement, commencing on March 24, 2020, the purchaser may, at its sole discretion, exercise a put option, to cause the Company to purchase from purchaser, any of the outstanding January 22, 2020 receivables which were not collected by the purchaser. Effective April 9, 2020, the put option was extended until June 23, 2020.

 

The purchase price payable by Company to the Purchaser for the receivables upon exercise of the Put Option shall be equal to one hundred and thirty-six percent (136%) of the then remaining outstanding balance of the applicable receivables.

 

Upon the occurrence of a payment made on the applicable receivables, the Company is required to pay a true up amount as follows:

 

a. ten percent (10%) of the portion of the receivables which are paid on or before the 30th day following the effective date of the agreement;

b. twenty percent (20%) of the portion of the receivables which are paid after the 30th day but on or before the 60th day following the effective date of the agreement; and

c. thirty-six percent (36%) of the portion of the receivables which are paid after the 60th day following the effective date of the agreement.

 

In order to secure performance by the Company, the purchaser was granted a security interest in: (i) 239,029 shares of the Company’s Class A common stock in connection with the sale of the $454,000 receivable and (ii) 29,519 shares of the Company’s Class A common stock in connection with the sale of the $75,000 receivable. The shares have been issued and are being held by the Company’s transfer agent. Since the shares are not outstanding, the Company has treated them as shares reserved for collateral.

 

 

Since the purchaser of the receivables has recourse, the Company accounted for the purchase price as a liability. Upon the purchaser’s election of the put option or the true up, as applicable the Company will treat the put option price or the true up amounts as interest.

 

On April 9, 2020 the Company entered into an agreement to amend the January 22 and 30 accounts receivable agreements. The purchaser agreed to amend the put option date as described above to June 23, 2020 and June 30, 2020 for the sale of receivables originating on January 22, 2020 and January 30, 2020, respectively. As consideration for the extension the Company agreed to issue the purchaser 32,668 and 4,032 shares of Class A common stock for the receivable sale originating on January 22, 2020 and January 30, 2020, respectively.

 

On June 30, 2020, the Purchaser converted the payable of $510,000 and accrued interest of $184,000 (“Old Debt”) into approximately $788,000 of the OID Convertible Notes payable (“Debentures”) (See Note 17 - OID Convertible Debentures). The conversion was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. At the date of issuance, the Debenture had a fair market value of approximately $815,000. The transaction created a loss on extinguishment of approximately $546,000, which consisted of (i) the difference of value between the Old Debt and the fair value of the new debt of approximately $95,000, (ii) the difference between the face value of the debenture and the fair value of the Debenture of approximately $27,000 and (iii) $424,000 for fair value of warrants issued with the Debenture. Also, since the Debenture was convertible into the Company’s common stock, a $27,000 premium associated with the conversion feature was recorded as additional paid in capital.

 

Since the purchaser of the receivables has recourse, the Company accounted for the purchase price as a liability. Upon the purchaser’s election of the put option or the true up, as applicable the Company will treat the put option price or the true up amounts as interest.

 

In December 2020, the Company entered into an agreement with a third-party lender whereby it sold the Company’s right to future subscription revenues of $570,000 for net proceeds of $528,000. Under the terms of the agreement, the Company may borrow funds collateralized by the right to the revenues from Sequire platform contracts. The third party lender receives a discount on the amount sold and remits the net amount to the Company. The Company bears the risk of credit loss on the contracts. These transactions are accounted for as secured borrowing arrangements and not as a sale of financial assets. In December 2021, the Company entered into another agreement through which it sold future subscriptions amounting to $625,000 for net proceeds of $576,000.

 

The amount of borrowings outstanding was approximately $631,000 as of December 31, 2021 and $570,000 at December 31, 2020. As of December 31, 2021, our availability to draw additional funds through this agreement was approximately $1,000,000. These balances are included with Accounts Payable and Accrued Expenses within our consolidated balance sheet.

 

On October 29, 2021, the Company (“Purchaser”) and BIGtoken (“Seller”) entered into a receivable purchase and sale agreement whereby BIGtoken sell, assign, transfer, convey and deliver to the Company all rights, title and interest for its receivable aggregating $352,000 for a purchase price of $327,000, sup representing a 7% discount. As of December 31, 2021, the outstanding receivable amounts to $352,000.

 
XML 26 R11.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONTRACTS RECEIVABLE
 12 Months Ended
Dec. 31, 2021
Credit Loss [Abstract]  
CONTRACTS RECEIVABLE

NOTE 5 – CONTRACTS RECEIVABLE

 

Contracts receivable represents amounts for which non-cancellable revenue contracts with customers have been finalized but the payment in the form of securities issued by the customer which could be a common stock, preferred stock or convertible debentures have not been received by the Company. Contracts receivable that will be received during the succeeding 12-month period is recorded as current contracts receivable, and the remaining portion, if any, is recorded as long-term contracts receivable. As of December 31, 2021 and 2020, contracts receivable amounted to $844,000 and none, respectively.

 
XML 27 R12.htm IDEA: XBRL DOCUMENT v3.22.2.2
MARKETABLE SECURITIES
 12 Months Ended
Dec. 31, 2021
Cash and Cash Equivalents [Abstract]  
MARKETABLE SECURITIES

NOTE 6 – MARKETABLE SECURITIES

 

During the second quarter of 2020, the Company began offering customers of its Sequire segment who purchase services on the Company’s proprietary SaaS platform the option to pay the contract price in securities issued by the Customer which could be a common stock, preferred stock or convertible debentures. The customer’s securities must be trading on a United States securities exchange. In accordance with ASC 606 - Revenue Recognition, the Company will value the shares received at the fair market value of the date the contract is executed. The shares received will be accounted for in accordance with ASC 320 and ASC 321 – Investments – Debt and Equity Securities, as such the shares will be classified as available-for-sale securities and will be measured at each reporting period at fair value with the unrealized gain or (loss) as a component of other income (expense). Upon the sale of the shares, the Company will record the final gain or (loss) in the consolidated statement of operations as a component of net income (loss).

 

 

The movement in this account is as follows:

 

   Balance as of                 
   December 31,   Common   Convertible   Preferred     
   2021   Stock   Debentures   Stock   Warrants 
Balances at beginning of year  $8,447,000   $7,764,000   $

683,000

   $-   $- 
Additions   34,914,000    29,281,000    4,602,000    1,031,000    - 
Sale of marketable securities   (8,666,000)   (8,156,000)   (510,000)   -   - 
Designation for dividend distribution   (10,790,000)   (10,577,000)   

(213,000

)   -   - 
Change in fair value   (8,288,000)   (7,577,000)   

(375,000

)   (432,000)   96,000 
Balances at end of year  $15,617,000   $10,735,000   $4,187,000   $599,000   $96,000 

 

   Balance as of         
   December 31,   Common   Convertible 
   2020   Stock   Debentures 
Balances at beginning of year  $83,000   $83,000   $— 
Additions   8,406,000    7,496,000    910,000 
Sale of marketable securities   (916,000)   (916,000)   — 
Change in fair value   874,000    1,101,000    (227,000)
Balances at end of year  $8,447,000   $7,764,000   $683,000 

 

The Company’s sales of securities for the year ended December 31, 2021, were approximately $8,666,000, with a book basis of approximately $7,862,000 which represented a gain of $804,000, which the Company recorded as other income included in the gains from marketable securities.

 

The Company accounts for its investments in equity securities in accordance with ASC 321-10 Investments - Equity Securities. The equity securities may be classified into two categories and accounted for as follows:

 

● Equity securities with a readily determinable fair value are reported at fair value, with unrealized gains and losses included in earnings. Any dividends received are recorded in interest income, the fair value of equity investments with fair values is primarily obtained from third-party pricing services.
   
● Equity securities without a readily determinable fair value are reported at their cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer and their impact on fair value. Any dividends received are recorded in interest income. For equity investments without readily determinable fair values, when an orderly transaction for the identical or similar investment of the same issuer is identified, we use the valuation techniques permitted under ASC 820 Fair Value Measurement to evaluate the observed transaction(s) and adjust the fair value of the equity investment. See discussion of the Company’s valuation policy in Note 1 – Fair Value of Financial Instruments.

 
XML 28 R13.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESIGNATED ASSETS FOR RETURN OF CAPITAL
 12 Months Ended
Dec. 31, 2021
Designated Assets For Return Of Capital  
DESIGNATED ASSETS FOR RETURN OF CAPITAL

NOTE 7 – DESIGNATED ASSETS FOR RETURN OF CAPITAL

 

On August 17, 2021, the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock to shareholders, debenture holders, and certain warrant holders (“Recipients”) as of record on September 20, 2021. The board designated certain of the Company’s marketable securities (“Designated Assets”) to be used when liquidated, as a return of capital to the Recipients. See Note 19 - Series A Preferred Stock for more details.

 

As of December 31, 2021, designated assets consist of the following:

 

      
Cash  $686,000 
Marketable securities   3,239,000 
Balance  $

3,925,000

 

 

 

The movement in designated assets is as follows:

 

Designated assets as of September 20, 2021  $6,387,000 
Sale of designated assets   (770,000)
Proceeds from sale of designated assets   686,000 
Change in fair value of designated assets   (2,378,000)
Balances as of December 31, 2021  $3,925,000 

 

The Company’s sale of the designated marketable securities for the year ended December 31, 2021, were approximately $686,000, with a book basis of approximately $770,000 which represented a loss of $84,000, which the Company recorded as other expense included in the loss from designated assets.

 
XML 29 R14.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTES RECEIVABLE
 12 Months Ended
Dec. 31, 2021
Receivables [Abstract]  
NOTES RECEIVABLE

NOTE 8 – NOTES RECEIVABLE

 

On October 30, 2020, a unit redemption agreement was entered into by and between the Company and Haylard MD, LLC (“Haylard”). The Company owns 10,000,000 Class A Units of Haylard. The Company desires to sell and transfer to Haylard, and Haylard desires to redeem and purchase from the Company. The price to be paid for all of the Units shall be $6,718,000 at closing and $960,000 upon the earlier of (a) the third anniversary of the closing and (b) a Sale of Haylard, for a total consideration of $7,678,000, provided that if Haylard consummates a Sale of Haylard within one hundred and eighty (180) calendar days after the closing, and the amount to be paid in respect of a Class A Unit in connection with such transaction after taking into account all fees, costs, expenses, escrows, indemnities, purchase price adjustments, repayments of indebtedness and other holdbacks as reasonably determined and calculated in good faith by Haylard is greater than $0.7677543, then Haylard shall pay to the Company an amount equal to such excess for each Unit redeemed and purchased hereunder by wire transfer of immediately available funds to the account specified by the Company.

 

On October 30, 2020, a unit redemption agreement was entered into by and between the Company and MD CoInvest, LLC, (“CoInvest”). The Company owns 420,000 Units of CoInvest. The Company desires to sell and transfer to CoInvest, and CoInvest desires to redeem and purchase from the Company. The price to be paid for all of the Units shall be $282,000 at closing and $40,000 upon the earlier of (a) the third anniversary of the closing and (b) a Sale of CoInvest, for a total consideration of $322,000, provided that if CoInvest consummates a Sale of CoInvest within one hundred and eighty (180) calendar days after the closing, and the amount to be paid in respect of a Class A Unit in connection with such transaction after taking into account all fees, costs, expenses, escrows, indemnities, purchase price adjustments, repayments of indebtedness and other holdbacks as reasonably determined and calculated in good faith by CoInvest is greater than $0.7677543, then CoInvest shall pay to the Company an amount equal to such excess for each Unit redeemed and purchased hereunder by wire transfer of immediately available funds to the account specified by the Company.

 

The deferred payments of $960,000 and $40,000 were discounted using the yield on a CCC rated corporate debt for 3-year maturity. The implied discount is approximately $107,000, which will be amortized over 3 years. Notes receivable as of December 31, 2021 and 2020 amounted to $935,000 and $893,000, respectively.

 
XML 30 R15.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY AND EQUIPMENT
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
PROPERTY AND EQUIPMENT

NOTE 9 – PROPERTY AND EQUIPMENT

 

Property and equipment consist of the following as of December 31:

 

    2021     2020  
Office equipment   $ 471,000     $ 402,000  
Accumulated depreciation     (357,000 )     (285,000 )
Property and equipment, net   $ 114,000     $ 117,000  

 

Depreciation expense for the years ended December 31, 2021 and 2020 was $72,000 and $28,000, respectively.

 

 
XML 31 R16.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
INTANGIBLE ASSETS

NOTE 10 – INTANGIBLE ASSETS

 

Intangible assets consist of the following as of December 31:

 

    2021     2020  
Non-compete agreement   $ 1,258,000     $ 1,258,000  
Intellectual property     756,000       756,000  
Acquired Software     756,000       617,000  
Internally developed software     2,726,000       2,048,000  
Trademark     271,000       271,000  
Customer list     186,000       186,000  
Domain name     17,000       36,000  
Total cost     5,970,000       5,172,000  
Accumulated amortization     (4,527,000 )     (3,680,000 )
Intangible assets, net   $ 1,443,000     $ 1,492,000  

 

Amortization expenses amounted to $847,000 and $744,000 for the years ended December 31, 2021 and 2020, respectively.

 

Trademark has indefinite life and not subject to amortization. The estimated future amortization expense for the years ended December 31, are as follows:

 

      
2022  $632,000 
2023   404,000 
2024   136,000 
Intangible assets  $1,172,000 

 

As of December 31, 2021 and 2020, goodwill amounted to $17,906,000, an addition of $7,706,000 in 2020 was due to acquisition of LD Micro (see Note 3 - Acquisitions). There were no impairments during the years ended December 31, 2021 and 2020.

 
XML 32 R17.htm IDEA: XBRL DOCUMENT v3.22.2.2
RIGHT TO USE ASSET
 12 Months Ended
Dec. 31, 2021
Right To Use Asset  
RIGHT TO USE ASSET

NOTE 11 – RIGHT TO USE ASSET

 

We determine whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if we obtain the rights to direct the use of and to obtain substantially all of the economic benefit from the use of the underlying asset. Some of our leases include both lease and non-lease components which are accounted for as a single lease component as we have elected the practical expedient. Some of our operating lease agreements include variable lease costs, primarily taxes, insurance, common area maintenance or increases in rental costs related to inflation. Substantially all of our equipment leases and some of our real estate leases have terms of less than one year and, as such, are accounted for as short-term leases as we have elected the practical expedient.

 

Operating leases are included in the right-of-use lease assets, other current liabilities and long-term lease liabilities on the Consolidated Balance Sheet. Right-of-use assets and lease liabilities are recognized at each lease’s commencement date based on the present values of its lease payments over its respective lease term. When a borrowing rate is not explicitly available for a lease, our incremental borrowing rate is used based on information available at the lease’s commencement date to determine the present value of its lease payments. Operating lease payments are recognized on a straight-line basis over the lease term. We had no financing leases as of December 31, 2021.

 

We have operating leases for office space. Our leases have remaining lease terms of approximately 1.75 years. We consider renewal options in determining the lease term used to establish our right-of-use assets and lease liabilities when it is determined that it is reasonably certain that the renewal option will be exercised.

 

 

As of December 31, 2021, there were no material variable lease costs or sublease income. Cash paid for operating leases are classified in operating expenses and were $175,000 and $192,000 for the years ended December 31, 2021 and 2020, respectively. The following tables summarize the lease expense for the year ended December 31:

 

   2021   2020 
Operating lease expense  $163,000   $163,000 
Short-term lease expense   12,000    29,000 
Total lease expense  $175,000   $192,000 

 

The below table summarizes these lease asset and liability accounts presented on our accompanying Consolidated Balance Sheets for the year ended December 31:

 

Operating Leases*  Consolidated Balance Sheet Caption  2021   2020 
Operating lease right-of-use assets - non-current  Right of use asset  $257,000   $366,000 
              
Operating lease liabilities – current  Other current liabilities  $130,000   $109,000 
Operating lease liabilities - non-current  Right to use liability - long term   114,000    243,000 
Total operating lease liabilities     $244,000   $352,000 

 

Components of Lease Expense

 

We recognize lease expense on a straight-line basis over the term of our operating leases, as reported within “selling, general and administrative” expense on the accompanying consolidated statement of operations.

 

Weighted Average Remaining Lease Term and Applied Discount Rate

 

  

Weighted

Average

Remaining

Lease Term

 

Weighted

Average

Discount Rate

 
Operating leases as of December 31, 2021  1.75 years   18%

 

Future Contractual Lease Payments as of December 31, 2021

 

The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest,

 

and (iii) present value of future lease payments for the years ending December 31:

 

Operating Leases - future payments    
2022   163,000 
2023   123,000 
Total future lease payments, undiscounted   286,000 
Less: Implied interest   (42,000)
Present value of operating lease payments   244,000 

 
XML 33 R18.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTS PAYABLE AND ACCRUED EXPENSES
 12 Months Ended
Dec. 31, 2021
Payables and Accruals [Abstract]  
ACCOUNTS PAYABLE AND ACCRUED EXPENSES

NOTE 12 – ACCOUNTS PAYABLE AND ACCRUED EXPENSES

 

Accounts payable and accrued expenses as of December 31, are comprised of the following:

 

   2021   2020 
Accounts payable, trade  $1,938,000   $1,900,000 
Accrued expenses   1,518,000    537,000 
Accrued compensation   213,000    232,000 
Accrued commissions   303,000    32,000 
Accrued interest   123,000    7,000 
Accounts payable and accrued expenses  $4,095,000   $2,708,000 

 

 
XML 34 R19.htm IDEA: XBRL DOCUMENT v3.22.2.2
DEFERRED REVENUE
 12 Months Ended
Dec. 31, 2021
Revenue from Contract with Customer [Abstract]  
DEFERRED REVENUE

NOTE 13 – DEFERRED REVENUE

 

Deferred revenue represents amounts billed for which revenue has not yet been recognized. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue, and the remaining portion, if any, is recorded as long-term deferred revenue. As of December 31, 2021, deferred revenue was $12,859,000, as compared to $4,842,000 as of December 31, 2020.

 
XML 35 R20.htm IDEA: XBRL DOCUMENT v3.22.2.2
OTHER CURRENT LIABILITIES
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
OTHER CURRENT LIABILITIES

NOTE 14 – OTHER CURRENT LIABILITIES

 

The following table summarizes the composition of other current liabilities presented on our accompanying Consolidated Balance Sheets:

   December 31,
2021		   December 31,
2020		 
Operating lease liabilities - current  $130,000   $109,000 
Other current liabilities   633,000    3,308,000 
Total other current liabilities  $763,000   $3,417,000 

 

As of December 31, 2021 and 2020, other current liabilities consist of amounts payable on a factoring facility amounting to $633,000 and $573,000, respectively (See Note 4 – Sale and Purchases of Accounts Receivable) and deferred payments amounting to $2,735,000 related to the acquisition of LD Micro (See Note 3 – Acquisitions) as of December 31, 2020.

 

During the year ended December 31, 2021, the Company made $3,004,000 in deferred contractual payments related to the LD Micro acquisition.

 
XML 36 R21.htm IDEA: XBRL DOCUMENT v3.22.2.2
PAYCHECK PROTECTION PROGRAM LOAN
 12 Months Ended
Dec. 31, 2021
Paycheck Protection Program Loan  
PAYCHECK PROTECTION PROGRAM LOAN

NOTE 15 - PAYCHECK PROTECTION PROGRAM LOAN

 

On April 17, 2020, we entered into a promissory note evidencing an unsecured approximately $1,084,000 loan under the Paycheck Protection Program (PPP). The loan is being made through Cross River Bank. The term of the loan is two years with an interest rate of 1%, which shall be deferred for the first six months of the term of the loan. The promissory note evidencing the loan contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the promissory note. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, and/or filing suit and obtaining judgment against the Company.

 

On September 15, 2020, $42,000 of the payroll protection loan of LD Micro was assumed in connection with the acquisition. This amount is expected to be forgiven, otherwise the Company will be reimbursed by Sellers of LD Micro. This is classified under current liabilities.

 

During the year ended December 31, 2021, the PPP loan in the of $1,116,000 was forgiven. As of December 31, 2021 and 2020, PPP loans outstanding amounted to $10,000 and $1,126,000, respectively.

 
XML 37 R22.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHORT TERM PROMISSORY NOTES
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
SHORT TERM PROMISSORY NOTES

NOTE 16 – SHORT TERM PROMISSORY NOTES

 

In February 2020, the Company entered into three separate short-term promissory notes with an aggregate principal value of $450,000 (the “Notes”), of which $100,000 was borrowed from the Company’s Chief Financial Officer.

 

The notes are due and payable on May 12, 2020 (“Maturity Date”). The notes will accrue interest as follows: (i) on the origination date, ten percent (10%) of the principal amount was added to each note, (ii) on March 12, 2020, an additional ten percent (10%) of the principal amount was added to each note, and (iii) on April 12, 2020, an additional sixteen percent (16%) of the principal amount was added to each notes.

 

 

The note holders were granted security interests (in amounts equal to the face value of their investments on a dollar for share basis) in an aggregate of 450,000 shares of the Company’s Class A common stock (“Security Shares”). The shares have been issued and are being held by the Company’s transfer agent. Since the shares are not outstanding, the Company has treated them as shares reserved for collateral.

 

The interest imputed on the origination date was treated as an original issue discount with the $45,000 amortized over the term of the Notes. On each of the interest date, the Company accrued and expensed the related interest.

 

On the Maturity Date, one of the Note’s was amended to (i) extend the maturity date to December 31, 2020 and (ii) to release 100,000 shares of the Security Shares. The modification was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. Based on the amended terms the fair value of the amended note approximated the book value of the old Note. The fair value of the Security Shares was approximately $181,000, which was expensed as a loss on the extinguishment.

 

On June 30, 2020, the short-term note payable to the Company’s Chief Financial Officer in the amount of approximately $136,000 was repaid from the proceeds of the OID Convertible Notes Payable.

 

On June 30, 2020, the two remaining Note Holders converted the Notes of approximately $350,000 and accrued interest of approximately $126,000 (“Old Debt”) into approximately $541,000 of the OID Convertible Debentures (See Note 17 - OID Convertible Debentures). The conversion was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. At the date of issuance, the Debentures had a fair market value of approximately $560,000. The transaction created a loss on extinguishment of approximately $375,000, which consisted of (i) the difference of value between the Old Debt and the fair value of the Debentures of approximately $65,000, (ii) the difference between the face value of the debenture and the fair value of the Debenture of approximately $19,000 and (iii) $291,000 for fair value of warrants issued with the Debenture. Also, since the Debenture was convertible into the Company’s common stock, a $18,000 premium associated with the conversion feature was recorded as additional paid in capital.

 

As of December 31, 2020, there is no outstanding loan balance on this account.

 
XML 38 R23.htm IDEA: XBRL DOCUMENT v3.22.2.2
TERM LOAN NOTE
 12 Months Ended
Dec. 31, 2021
Debt Disclosure [Abstract]  
TERM LOAN NOTE

NOTE 17 – TERM LOAN NOTE

 

On February 28, 2020, the Company entered into a term loan and security agreement with a BRF Finance Co. LLC as lender. Pursuant to the loan agreement, the Company can borrow up to $5,000,000, subject to the conditions described below.

 

Under the loan: (i) the Company received an initial draw of $2,500,000 on February 28, 2020 and (ii) the Company is eligible to receive an additional $2,500,000 loan within (30) days of the Company entering into an at the market sales agreement with the lender and the filing of an at the market offering on Form S-3 with the SEC registering the shares to be sold pursuant to the at the market sales agreement. The Company agreed to file the ATM by May 1, 2020. Additionally, the Company will be required to increase the dollar amount authorized under the at the market sales agreement each time additional capacity of at least $1,000,000 is available under our shelf registration statement.

 

The loan is secured by substantially all of the assets of the Company pursuant to the loan agreement and the intellectual property security agreement entered into in connection with the transaction.

 

The loan bears interest at ten percent (10%) per annum and has a maturity date of March 1, 2022. Beginning on August 1, 2020 and continuing on the first day of each month thereafter until the maturity date, the Company will make monthly payments of principal and interest on an eighteen (18) month straight line amortization schedule, based on the principal outstanding on July 31, 2020. Additionally, the Company will have the option of a one (1) time payment-in-kind payment for a monthly required payment of principal and interest, which will defer such payments and result in a recalculation of the amortization schedule. In the event that the Company is late on any payments under the Loan, a late charge of three percent (3%) of the amount of the payment due will be assessed.

 

 

At origination the Company paid lender: (i) an origination fee of $300,000, (ii) $35,000 in attorneys’ fees reimbursement, and (iii) certain other costs and expenses associated with the completion of the loan, including but not limited to escrow fees and recording fees. Accordingly, the Company received net proceeds of approximately $2,164,000 as of May 1, 2020.

 

The Loan may be prepaid in whole or in part at any time at the discretion of the Company. The loan also provides for mandatory prepayments of all of the net cash received upon (i) a sale of the company’ assets, (ii) raising additional capital through the issuance of equity or debt securities, or (iii) sales under the at the market sales agreement described above.

 

As part of the loan the Company agreed to issue to Lender: (i) 500,000 Common Stock purchase warrants on the date of the origination date and (ii) 500,000 Common Stock purchase warrants on the date of the second drawdown. The warrants have an exercise price equal to a 25% premium of the closing price of the Common Stock on their respective date of issue (provided that the exercise price of the warrants cannot be less than $2.50 per share, subject to adjustment contained therein). The initial warrant has an exercise price of $3.60. The warrants will expire on October 31, 2022. The warrants allow for cashless exercise in the event that they are not subject to a registration statement on the six (6) month anniversary of their respective issuances. The warrants do not contain any price protection or non-standard anti-dilution provisions.

 

In accordance with ASC 470 - Debt, the Company has allocated the cash proceeds to the loan and the warrants. The relative fair value of the initial warrant issued was $83,000, which is being amortized and expensed over the term of the Notes.

 

The Company evaluated the loan and warrant agreements in accordance with ASC 815 Derivatives and Hedging. Based on this evaluation, the Company has determined that no provisions required derivative accounting.

 

On June 30, 2020, the principal and interest of approximately $2,585,000 was paid from the proceeds from the OID Convertible Debentures.

 

As of December 31, 2020, there is no outstanding loan balance on this account.

 
XML 39 R24.htm IDEA: XBRL DOCUMENT v3.22.2.2
OID CONVERTIBLE DEBENTURES
 12 Months Ended
Dec. 31, 2021
Oid Convertible Debentures  
OID CONVERTIBLE DEBENTURES

NOTE 18 – OID CONVERTIBLE DEBENTURES

 

On June 25, 2020, the Company entered into a definitive securities purchase agreement (the “Securities Purchase Agreement or Transaction”) with certain accredited and institutional investors (the “Purchasers”) for the purchase and sale of an aggregate of: (i) $16,101,000 in principal amount of Original Issue Discount Senior Secured Convertible Debenture (the “Debentures”) for $14,169,000 (representing a 12% original issue discount) (“Purchase Price”) and (ii) warrants to purchase up to 6,440,561 shares of the Company’s Class A common stock (the “Warrants”) in a private placement (the “Offering”). The Purchase Price consists of (a) $13,000,000 in cash and (b) the cancellation of $1,169,000 in outstanding debt, consisting of the accounts receivable loans of $510,000 with accrued interest of $184,000, and the short-term promissory notes of $350,000 with accrued interest of $125,000.

 

The Debentures, which mature on December 31, 2021, pay interest in cash at the rate of 12.0% per annum commencing on June 30, 2021, with such interest payable quarterly, beginning on October 1, 2021. Commencing after the six-month anniversary of the issuance of the Debentures, the Company will be required to make amortization payments (“Amortization Payments”) with each Purchaser having the right to delay such Amortization Payments by a six month period up to three separate times (each, an “Extension”) in exchange for five percent in principal being added to the balance of such applicable Debenture on each such Extension. Accordingly, upon a Purchaser exercising three Extensions, such Purchaser’s Debenture will mature and be due and payable on June 30, 2023. Beginning on the date that the first Amortization Payment is due, and on a monthly basis thereafter, the Company will be required to pay one hundred fifteen percent of the value of one-twelfth of the outstanding principal plus any additional accrued interest due.

 

In the event a Purchaser converts a portion of its Debenture into shares of the Company’s Common Stock, such amount will be deducted from the next applicable Amortization Payment. In the event such conversion exceeds the next applicable Amortization Payment, such excess amount will be deducted, in reverse order, from future Amortization Payments. The Company’s obligations under the Debentures are secured by substantially all of the assets of the Company pursuant to a security agreement (the “Security Agreement”).

 

 

The Debentures are convertible at the option of the holder into shares of the Company’s common stock at an initial conversion price of $2.69 per share, subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Debentures do not have any price protection or price reset provisions with respect to future issuances of securities.

 

Subject to the Company’s compliance with certain equity conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that (i) the Company sells or reprices any securities (each, a “Redemption Financing”), or (ii) the Company disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to cause the Company (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures.

 

The Debentures also contain certain customary events of default provisions, including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, failure to register the shares underlying the Debentures in Warrants (as described below), changes in control of the Company, delisting of its securities from its trading market, and the entering or filing of certain monetary judgments against the Company. Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the Purchaser’s election, immediately due and payable in cash. The Company is also subject to certain negative covenants (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser) under the Debentures, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends.

 

The Warrants are initially exercisable at 2.50 per share and, are subject to cashless exercise after six months if the shares underlying the Warrants are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities.

 

Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company.

 

The Company also agreed to use proceeds from the Offering to pay (i) $2,500,000 in outstanding principal plus accrued interest pursuant to the Company’s Term Loan and Security Agreement entered into on February 28, 2020 with BRF Finance Co., LLC (the “Term Loan”) and (ii) $136,000 in outstanding short-term promissory notes and accrued interest (collectively, the “Debt Repayments”).

 

In connection with Securities Purchase Agreement, the Company will issue to the Placement Agent (as defined below), an aggregate of 478,854 Common Stock purchase warrants (“PA Warrants”). The PA Warrants are substantially similar to the Warrants, except that the PA Warrants have an exercise price of $3.3625 per share. The fair value of the PA Warrants at issuance was estimated to be $360,000 based on a risk-free interest rate of .11%, an expected term of 2.417 years, an expected volatility of 96% and a 0% dividend yield.

 

 

Pursuant to a registration rights agreement (“Registration Rights Agreement”), the Company has agreed to file a registration statement registering the resale of the shares of the common stock underlying the Debentures and the Warrants within forty-five days from the date of the Registration Rights Agreement. The Company also agrees to have the registration statement declared effective within 90 days from the date of the Registration Rights Agreement and keep the registration statement continuously effective until the earlier of (i) the date after which all of the securities to be registered thereunder have been sold, or (ii) the date on which all the securities to be registered thereunder may be sold without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 under the Securities Act. The Company is also obligated to pay the Investors, as partial liquidated damages, a fee of 2.0% of each Purchaser’s subscription amount per month in cash upon the occurrence of certain events, including our failure to file and(or) have the registration statement declared effective within the time periods provided.

 

Bradley Woods & Co. Ltd. (“Placement Agent”) acted as the placement agent, in connection with the sale of the securities pursuant to the Securities Purchase Agreement. Pursuant to an engagement agreement entered into by and between the Company and the Placement Agent, the Company agreed to pay the Placement Agent a cash commission of $1,040,000. Pursuant to the discussion above, the Company also issued an aggregate of 478,854 PA Warrants to the Placement Agent. The Company has agreed to include the shares of our common stock underlying the PA Warrants to be included in the registration statement to be filed. Additionally, upon the exercise of Warrants issued in the Offering, the Placement Agent will be entitled to eight percent (8%) of the cash proceeds received from such exercises.

 

The Transaction closed on June 30, 2020 (the “Closing Date”), with approximately $3,800,000 cash proceeds received prior to Closing date, $4,200,000 received on the closing date and $5,000,000 received after the closing date. The gross proceeds received from the Offering were approximately $13,000,000 and net proceeds of approximately $9,100,000 after deducting the Placement Agent fees, the Debt Repayments and other offering expenses. Also, the Company reimbursed the lead Purchaser $75,000 for legal fees, which was deducted from the required subscription amount to be paid.

 

The Company evaluated all of the associated financial instruments in accordance with ASC 815 Derivatives and Hedging. Based on this evaluation, the Company has determined that no provisions required derivative accounting.

 

In accordance with ASC 470 - Debt, the Company first allocated the cash proceeds to the loan and the warrants on a relative fair value basis, secondly, the proceeds were allocated to the beneficial conversion feature.

 

During the year ended December 31, 2020, the Company recognized amortization expense of $5,639,000.

 

During the year ended December 31, 2020, holders of debenture principal converted $1,118,000 debenture into 411,626 shares of the Company’s class A common stock. As a result of these conversions and issuance of common stock, the Company wrote-off debt discount and increased additional paid in capital by $434,000.

 

During the year ended December 31, 2020, majority of the debenture holders exercise their rights to delay amortization payment by six months in exchange for 5% additional principal. Total additional principal due to extension amounted to $472,000.

 

During the year ended December 31, 2021, certain Debenture holders converted $8,387,000 of principal into 3,122,167 shares of the Company’s class A common stock shares. As a result of these conversions, the Company reduced the principal balance by approximately $8,387,000 and reduced the debt discount by approximately $2,413,000 for a net book value of $5,974,000, which was transferred to additional paid-in capital.

 

During the year ended December 31, 2021, the holders of the remaining Debentures notified the Company of their election to defer the inception of amortization payments due under the Debentures until June 30, 2022. As a result of their election, the holders are entitled to a 5% increase of their then current principal balance as a fee. The Company recorded this fee as a financing cost during the year ended December 31, 2021.

 

 

The table below summarizes the transactions during the year end December 31, 2021:

   Principal   Debt discount   Net book value 
Balance at beginning of year  $9,386,000   $(3,370,000)  $6,016,000 
Extension   268,000    -    268,000 
Conversion   (8,387,000)   2,413,000    (5,974,000)
Amortization   -    854,000    854,000 
Total  $1,267,000   $(103,000)  $1,164,000 

 

As of December 31, 2021, the Company has classified the debt as current liability because the management intends to redeem the remaining convertible debentures within the following 12 months.

 

The table below summarizes the transactions during the year   end December 31, 2020:

 

   Principal   Debt discount   Net book value 
Issuance during the year  $16,101,000   $(12,731,000)  $3,370,000 
Extension   472,000    -    472,000 
Redemption   (6,069,000)   3,037,000    (3,032,000)
Conversion   (1,118,000)   685,000    (433,000)
Amortization   -    5,639,000    5,639,000 
Total  $9,386,000   $(3,370,000)  $6,016,000 

 
XML 40 R25.htm IDEA: XBRL DOCUMENT v3.22.2.2
COMMITMENTS AND CONTINGENCIES
 12 Months Ended
Dec. 31, 2021
Commitments and Contingencies Disclosure [Abstract]  
COMMITMENTS AND CONTINGENCIES

NOTE 19 – COMMITMENTS AND CONTINGENCIES

 

Other Commitments

 

In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise due to their status or service as directors, officers or employees. The Company has also agreed to indemnify certain former officers, directors and employees of acquired companies in connection with the acquisition of such companies. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors and employees of acquired companies, in certain circumstances.

 

It is not possible to determine the maximum potential amount of exposure under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each agreement. Such indemnification agreements may not be subject to maximum loss clauses.

 

Employment agreements

 

We have entered employment agreements with key employees. These agreements may include provisions for base salary, guaranteed and discretionary bonuses and option grants. The agreements may contain severance provisions if the employees are terminated without cause, as defined in the agreements.

 

Litigation

 

From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. In addition, the Company may receive letters alleging infringement of patent or other intellectual property rights. The Company is not currently a party to any material legal proceedings, nor is the Company aware of any pending or threatened litigation that would have a material adverse effect on the Company’s business, operating results, cash flows or financial condition should such litigation be resolved unfavorably.

 

Business Interruption

 

The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.

 

 
XML 41 R26.htm IDEA: XBRL DOCUMENT v3.22.2.2
SERIES A PREFERRED STOCK
 12 Months Ended
Dec. 31, 2021
Series A Preferred Stock [Member]  
Class of Stock [Line Items]  
SERIES A PREFERRED STOCK

NOTE 20 – SERIES A PREFERRED STOCK

 

On August 17, 2021, the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock (“Preferred Stock”) to certain Qualified Recipients (as defined below) on a 1-for-1 as converted to common stock basis (the “Dividend”). The record date for the Dividend is September 20, 2021 (the “Record Date”). The preferred stock entitles the Qualified Recipients with the right to receive the net proceeds from sales of certain securities of issuers that the Company received through its Sequire Platform services.

 

On September 20, 2021, the Company filed a certificate of designation (the “COD”) of preferences, rights, and limitations of Series A Non-Voting Preferred Stock (“Series A Preferred Stock”) with the Secretary of State of Delaware. Pursuant to the COD, the Company is authorized to issue up to 36,462,417 shares of Series A Preferred Stock (the “Dividend Shares”).

 

As of the Record Date, the following holders of securities were entitled to receive the Dividend (collectively, the “Qualified Recipients):

 

  i. each outstanding share of Class A common stock (the “Common Stock”), of which 25,160,504 shares were issued and outstanding,
  ii. each share of Common Stock underlying outstanding common stock purchase warrants containing a contractual right to receive the Dividend (“Warrants”) of which, 10,327,645 were outstanding, and
  iii. each original issue discount senior convertible debenture (the “Debentures”) issued on June 30, 2021, containing a contractual right to receive the Dividend on an as converted to Common Stock basis, of which $2,486,275 of Debentures were outstanding in principal and interest, convertible into 974,268 shares of Common Stock.

 

Accordingly, the Company issued 36,462,417 shares of Series A Preferred Stock to the Qualified Recipients on an as converted to Common Stock basis. The Dividend was delivered on September 27, 2021.

 

The Company’s management has evaluated the Preferred Stock in accordance with ASC 480 – Distinguishing Liabilities from Equity. Management has determined that the cancellation clause of the Preferred Stock deemed it to be mandatorily redeemable and should be classified as a liability. The fair value of the Preferred stock as of December 31, 2021 amounted to $3,925,000.

 
XML 42 R27.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY
 12 Months Ended
Dec. 31, 2021
Equity [Abstract]  
STOCKHOLDERS’ EQUITY

NOTE 21 – STOCKHOLDERS’ EQUITY

 

Authorized Shares

 

Preferred Stock

 

We are authorized to issue 50,000,000 of preferred stock, par value $0.001, of which 200,000 shares were designated as Series 1 Preferred Stock. Our board of directors, without further stockholder approval, may issue preferred stock in one or more series from time to time and fix or alter the designations, relative rights, priorities, preferences, qualifications, limitations and restrictions of the shares of each series. The rights, preferences, limitations and restrictions of different series of preferred stock may differ with respect to dividend rates, amounts payable on liquidation, voting rights, conversion rights, redemption provisions, sinking fund provisions and other matters. Our board of directors may authorize the issuance of preferred stock, which ranks senior to our common stock for the payment of dividends and the distribution of assets on liquidation. In addition, our board of directors can fix limitations and restrictions, if any, upon the payment of dividends on both classes of our common stock to be effective while any shares of preferred stock are outstanding.

 

 

Common Stock

 

We are authorized to issue an aggregate of 259,000,000 shares of common stock. Our certificate of incorporation provides that we will have two classes of common stock: Class A common stock (authorized 250,000,000 shares, par value $0.001), which has one vote per share, and Class B common stock (authorized 9,000,000 shares, par value $0.001), which has ten votes per share. Any holder of Class B common stock may convert his or her shares at any time into shares of Class A common stock on a share-for-share basis. Otherwise, the rights of the two classes of common stock are identical. As of December 31, 2021, the Company had 25,995,172 shares issued and outstanding. As of December 31, 2020, the Company had 16,145,778 shares issued and outstanding.

 

In January 2020, we sold non-performing receivables in the aggregate amount of $529,000 for a purchase price of $510,000 whereby in the event of payment on the receivables being received, we agreed to provide a true-up to the purchaser of the receivable of between 10% and 36% depending on the payment date. In the event of nonpayment of the receivables by March 24, 2020 and March 30, 2020, as applicable to the receivables, the purchaser may require us to purchase any outstanding portion of the receivables for 136% of its outstanding balance (“Payment Date”). In order to secure our performance to repurchase the receivables, we pledged 239,029 shares of our Class A common stock. The purchaser and Company agreed to extend the Payment Date until June 23 and June 30, 2020, as applicable, in exchange for an aggregate of 36,700 Class A common shares.

 

In August 2021, our Board of Directors approved a share repurchase program pursuant to which we are authorized to repurchase up to $10,000,000 of our Class A Common Stock in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices. The total remaining authorization for future common share repurchases under our share repurchase program was $10.0 million as of September 30, 2021. Under the program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable law and regulation. This includes purchases pursuant to Rule 10b5-1 plans, including accelerated share repurchases. The program does not have an expiration date.

 

During the year ended December 31, 2021, the Company sold 53,616 shares of common stock, resulting in proceeds of approximately $284,000, through sales under its At the Market (ATM) offering.

 

During the year ended December 31, 2021, the Company repurchased 155,000 shares of Common Stock, for an aggregate purchase price of $793,000 pursuant to the Company’s Share Buy-Back program. The shares were retired as of December 31, 2021.

 
XML 43 R28.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK OPTIONS, AWARDS AND WARRANTS
 12 Months Ended
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]  
STOCK OPTIONS, AWARDS AND WARRANTS

NOTE 22 – STOCK OPTIONS, AWARDS AND WARRANTS

 

2012, 2014 and 2016 Equity Compensation Plans

 

In January 2012, our board of directors and stockholders authorized the 2012 Equity Compensation Plan, which we refer to as the 2012 Plan, covering 600,000 shares of our Class A common stock. On November 5, 2014, our board of directors approved the adoption of our 2014 Equity Compensation Plan (the “2014 Plan”) and reserved 600,000 shares of our Class A common stock for grants under this plan. On February 23, 2016, our board of directors approved the adoption of our 2016 Equity Compensation Plan (the “2016 Plan”) and reserved 600,000 shares of our Class A common stock for grants under this plan. The purpose of the 2012, 2014 and 2016 Plans is to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our employees, directors and consultants and to promote the success of our company’s business. The 2012, 2014 and 2016 Plans are administered by our board of directors. Plan options may either be:

 

  ● incentive stock options (ISOs),
  ● non-qualified options (NSOs),
  ● awards of our common stock,
  ● stock appreciation rights (SARs),
  ● restricted stock units (RSUs),
  ● performance units,
  ● performance shares, and
  ● other stock-based awards.

 

Any option granted under the 2012, 2014 and 2016 Plans must provide for an exercise price of not less than 100% of the fair market value of the underlying shares on the date of grant, but the exercise price of any ISO granted to an eligible employee owning more than 10% of our outstanding common stock must not be less than 110% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $100,000. The exercise price of any NSO granted under the 2012, 2014 or 2016 Plans is determined by the Board at the time of grant but must be at least equal to fair market value on the date of grant. The term of each plan option and the manner in which it may be exercised is determined by the board of directors or the compensation committee, provided that no option may be exercisable more than 10 years after the date of its grant and, in the case of an incentive option granted to an eligible employee owning more than 10% of the common stock, no more than five years after the date of the grant. The terms of grants of any other type of award under the 2012, 2014 or 2016 Plans is determined by the Board at the time of grant. Subject to the limitation on the aggregate number of shares issuable under the plans, there is no maximum or minimum number of shares as to which a stock grant or plan option may be granted to any person.

 

 

Transactions involving our stock options for the years ended December 31, 2021 and 2020, respectively, are summarized as follows:

 

In April 2020 the Company issued 36,172 options to purchase the Company’s common stock at a price of $1.95 to our non-executive directors. Each of our four non-executive directors received 9,043 options that vest 1/4th quarterly over the next year with an expiration date of April 15, 2027. The options were valued using the Black Scholes option pricing model at a total of $60,000 based on the seven-year term, implied volatility of 100% and a risk-free equivalent yield of 0.24%, stock price of $1.95.

 

In August 2020, 430,000 common stock options having an exercise price of $2.70 per share with an option value as of the grant date of $859,000 calculated using the Black-Scholes option pricing model were granted to several employees and members of our management team. The expense associated with this option award will be recognized in operating expenses ratably over the vesting period of five years.

 

In November 2020, 300,000 common stock options having an exercise price of $2.97 per share with an option value as of the grant date of $649,000 calculated using the Black-Scholes option pricing model were granted to an employee. The expense associated with this option award will be recognized in operating expenses at date of grant.

 

   Number of Shares   Weighted Average Strike Price/Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding — December 31, 2019   1,192,519   $4.14    2.17   $—   $— 
Granted   766,172    2.77    3.00    521,000    2.72 
Exercised   —    —    —    —    — 
Forfeited   (316,367)   5.14    —    —    3.14 
Outstanding — December 31, 2020   1,642,324    3.30    2.81    —    — 
Vested and exercisable — December 31, 2020   844,742    3.54    2.62    333,000    3.54 
Unvested and non-exercisable - December 31, 2020   797,582    2.81    3.00    207,000    2.09 
                          
Outstanding — December 31, 2020   1,642,324    3.30    2.81    —    — 
Granted   21,627    4.38    6.29    2,000    3.60 
Exercised   (12,500)   2.70    3.63    —    2.00 
Forfeited   (319,671)   4.60    0.65    —    3.49 
Outstanding — December 31, 2021   1,331,780    3.02    2.39    1,969,000    2.13 
Vested and exercisable — December 31, 2021   870,750    3.05    2.27    1,265,000    2.15 
Unvested and non-exercisable - December 31, 2021   461,030   $2.96    2.62   $703,000   $2.10 

 

 

During the years ended December 31, 2021 and 2020, we recorded compensation expense of $1,006,000 and $1,615,000, respectively, related to stock-based compensation.

 

As of December 31, 2021, compensation cost related to the unvested options not yet recognized was approximately $811,000. The weighted average period over which the $811,000 will vest is estimated to be 2.83 years.

 

Transactions involving our warrants for the years ended December 31, 2021 and 2020, respectively, are summarized as follows:

 

As part of the Company’s Convertible Debenture offering in June 2020 (as described in Note 17 – OID Convertible Debentures), the Company negotiated the ability to release the BIGToken business, as security for the OID Convertible Debentures, for the purposes of selling BIGToken. As consideration for the release, the Company agreed to require the purchaser of BIGToken to issue warrants in the new entity. The warrants were to represent 13% of the new entities issued and outstanding on a fully diluted basis upon closing. As disclosed in Note 3 – Acquisitions, the Company entered into an agreement to merge BIGToken with FPVD on February 4, 2021, which required the issuance of 25,568,064,462 warrants. Based on a valuation from an independent third-party, the fair-market value of the warrants required to be issued was determined to be $885,000 based on implied 3-year volatility of 92.30%, a risk-free equivalent yield of 18% and stock price of $0.00006552.

 

On February 21, 2021 the Company entered into an agreement with the certain Debenture holders to exercise 4,545,440 of the Warrants issued in the June 2020 Debenture offering. As an inducement for the Warrant holders to exercise the Warrants, the holders receive a new registered warrant (“New Warrant”) to purchase an aggregate of 4,545,440 shares of the Company’s common stock at an exercise price of $7.50 per share. The New Warrants expire on January 31, 2022. Each holder agreed to pay $0.125 for each New Warrant. The Company received net proceeds of approximately $11,022,000, consisted of the exercise price of $11,363,000, $568,000 for the purchase of the New Warrant less solicitation fees of approximately $909,000.

 

The New Warrants were valued using the Black Scholes option pricing model at a total of $7,737,000 based on a one-year term, implied volatility of 96%, a risk-free equivalent yield of 11%, and stock price of $5.83. The fair value of the New Warrants was expensed and included in Financing Costs.

 

During the quarter ended March 31, 2021, the Company: (i) received cash of approximately $4,930,000, (ii) cancelled 349,197 warrants (as a result of cashless exercises) and (iii) issued an aggregate of 2,283,171 shares of Common Stock, in connection with the exercise of outstanding warrants.

 

In total the Company issued a total of 6,828,611 shares of common stock, for the exercise of warrants, with net proceeds of $15,952,000.

 

 

   Number of Shares   Weighted Average Strike Price/Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding — December 31, 2019   6,237,430   $3.57    2.68   $—   $— 
Granted   7,421,054    2.63    1.82    3,929,000    1.38 
Exercised   —    —    —    —    — 
Forfeited   (1,073,201)   —    —    —    — 
Outstanding — December 31, 2020   12,585,283    2.98    1.78    4,460,000    1.38 
Vested and exercisable — December 31, 2020   12,285,283    2.94    1.74    4,460,000    1.38 
Unvested and non-exercisable - December 31, 2020   300,000    4.75    3.37    —    — 
                          
Outstanding — December 31, 2020   12,585,283    2.98    1.78    4,460,000    1.38 
Granted   4,582,345    7.48    0.11    —    1.70 
Exercised   (7,148,501)   2.74    0.78    —    — 
Forfeited   —    —    —    —    — 
Outstanding — December 31, 2021   10,019,127    5.21    0.47    6,779,000    1.70 
Vested and exercisable — December 31, 2021   9,719,127    5.22    0.41    6,779,000    1.70 
Unvested and non-exercisable - December 31, 2021   300,000   $4.75    2.37   $—   $— 

 
XML 44 R29.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS
 12 Months Ended
Dec. 31, 2021
Related Party Transactions [Abstract]  
RELATED PARTY TRANSACTIONS

NOTE 23 – RELATED PARTY TRANSACTIONS

 

The Company has subleased a suite at the Sofi Stadium in Los Angeles from an entity wholly owned by Christopher Miglino, our CEO. The sublease is for a period of one (1) year, at a rate of $382,500, and commencing on the date that the stadium opens to the general public (“Sublease”). We believe that such annual rate is a discount from prevailing market rates and is less than the master lease rate. In September 2021, the Company started paying $39,000 for the monthly lease payment for the 2nd year lease. The total amount paid during 2021 pursuant to the arrangement was $477,000.

 

The Sublease entitles the Company to game tickets, optional tickets for other stadium events, and suite and conference room access during business days. The Company determined that the sublease agreement does not meet the definition of a lease in accordance with ASC 842, Leases.

 
XML 45 R30.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
INCOME TAXES

NOTE 24 – INCOME TAXES

 

Income tax (benefit) expense from continuing operations for the year ended December 31, 2021 consisted of the following:

 

   Current   Deferred   Total 
Federal  $—   $(132,000)  $(132,000)
State   5,000    —   5,000
Subtotal   5,000    (132,000)   (127,000)
Valuation allowance   —    —    — 
Total  $5,000   $(132,000)  $(127,000)

 

Income tax expense from continuing operations for the year ended December 31, 2020 consisted of the following:

   Current   Deferred   Total 
Federal  $—   $—    - 
State   21,000    —    21,000 
Subtotal   21,000    —    21,000 
Valuation allowance   —    —    — 
Total  $21,000   $—   $21,000 

 

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

   2021   2020 
Taxes calculated at federal rate   21.0%   21.0%
Stock based compensation   0.0%   (2.7)%
Permanent differences   (1.0)%   

(13.4

)%
Change in valuation allowance   (15.1)%   (2.1)%
Fair market adjustment derivatives   0.0%   0.5%
Prior year true-ups   0.0%   (3.3)%
Other adjustments   (4.1)%   (0.1)%
Provision for income tax benefit (expense)   0.8%   

(0.1

)%

 

 

The tax effects, rounded to thousands, of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at December 31, are presented below:

 

   2021   2020 
Deferred Tax Assets          
Net operating loss carryforwards  $10,003,000   $9,040,000 
Bad debt expense   33,000    136,000 
Fixed assets   -    

9,000

 
Accrued interest   -    - 
Stock based compensation   525,000    567,000 
Interest expense limitation carryover   220,000    

629,000

 
Contribution carryover   5,000    

5,000

 
Lease liability   62,000    

97,000

 
Unrealized gain on marketable securities   2,668,000    120,000 
Other accruals   124,000    173,000 
Total Deferred Tax Assets   13,640,000    10,776,000 
           
Deferred Tax Liabilities          
Fixed assets   

(29,000

)   -
Right-of-use asset   (66,000)   

(101,000

)
Intangibles   (455,000)   (690,000)
Interest expense limitation carryover   (59,000)   - 
Prepaid expenses   (15,000)   (17,000)
Total Deferred Tax Liabilities   (624,000)   (808,000)
           
Net Deferred Tax Assets   13,016,000    9,968,000 
Valuation Allowance   (13,016,000)   (9,968,000)
           
Net deferred tax / (liabilities)  $—   $— 

 

Deferred tax assets and liabilities are computed by applying the federal and state income tax rates in effect to the gross amounts of temporary differences and other tax attributes, such as net operating loss carry-forwards. In assessing if the deferred tax assets will be realized, the Company considers whether it is more likely than not that some or all of these deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which these deductible temporary differences reverse.

 

During the years ended December 31, 2021 and 2020, the valuation allowance increased by $2,996,000 and $2,375,000, respectively. The increase for both years was attributable to the increase in our net operating loss carryforwards. The total valuation allowance results from the Company’s estimate of its inability to recover its net deferred tax assets.

 

At December 31, 2021, the Company has federal and state net operating loss carry forwards, which are available to offset future taxable income, of approximately $34,933,000 and $73,733,000 respectively, both of which begin to expire in 2032 and 2032 respectively. These carry forwards may be subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code of 1986, and similar state provisions if the Company experienced one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382 and 383, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percentage points over a three-year period. The Company has not completed an IRC Section 382/383 analysis. If a change in ownership were to have occurred, NOL and tax credit carryforwards could be eliminated or restricted. If eliminated, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, will not impact the Company’s effective tax rate.

 

The Company files income tax returns in the United States and various state jurisdictions. Due to the Company’s net operating loss posture all tax years are open and subject to income tax examination by tax authorities. The Company’s policy is to recognize interest expense and penalties related to income tax matters as tax expense. As of December 31, 2021 and 2020, there are no unrecognized tax benefits, and there are no significant accruals for interest related to unrecognized tax benefits or tax penalties.

 

The Company is in the process of analyzing their NOL and has not determined if the company has had any change of control issues that could limit the future use of NOL. NOL carryforwards that were generated after 2017 of approximately $29.4 million may only be used to offset 80% of taxable income and are carried forward indefinitely.

 

 
XML 46 R31.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE OF FINANCIAL INSTRUMENTS
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
FAIR VALUE OF FINANCIAL INSTRUMENTS

NOTE 25 – FAIR VALUE OF FINANCIAL INSTRUMENTS

 

The carrying amounts of certain financial instruments, including cash and cash equivalents and accounts payable and accrued expenses, approximate their respective fair values due to the short-term nature of such instruments.

 

Additionally, the Company has a deferred note receivable with a notional amount of $1,000,000. The deferred payments of $960,000 and $40,000 were discounted using the yield on a CCC rated corporate debt for 3-year maturity. The implied discount is approximately $107,000, which will be amortized over 3 years. Notes receivable as of December 31, 2021 and 2020 amounted to $935,000 and $893,000, respectively.

 

Assets and Liabilities Measured at Fair Value on a Recurring Basis

 

The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The Company had the following financial assets and liabilities as of December 31, 2021 and 2020:

 

 

       Quoted Prices   Significant     
   Balance as of   in Active
Markets for		   Other
Observable		   Significant
Unobservable		 
   December 31   Identical Assets   Inputs   Inputs 

  2021   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Marketable securities  $15,617,000   $6,134,000   $2,448,000   $7,035,000 
Designated assets   3,925,000    259,000    3,666,000    — 
Contract assets   

844,000

    

—

    —    

844,000

 
Total assets  $20,386,000   $6,393,000   $6,114,000   $

7,879,000

 

 

       Quoted Prices   Significant     
   Balance as of  

in Active

Markets for

   Other
Observable		   Significant Unobservable 
   December 31,   Identical Assets   Inputs   Inputs 
  2020   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Marketable securities  $8,447,000   $7,764,000   $683,000   $— 
Total assets  $8,447,000   $7,764,000   $683,000   $— 

 

The Contract assets represent a forward contractual right of to receive securities pursuant to a revenue contract. As of December 31, 2021, the Company determined the value of the securities underlying the Contract asset to have a fair value of $844,000.

 

 

             
   As of Dec. 31, 2021   
   Level 1   Level 2   Level 3   Fair Value 
Liabilities:                    
Series A Preferred Stock  $—   $3,925,000    -   $3,925,000 
Total liabilities  $—   $3,925,000    -    $3,925,000 

 

             
   As of December 31, 2020  
   Level 1   Level 2   Level 3   Fair Value 
Liabilities:                    
Series A Preferred Stock  $—   $—   $      -   $- 
Total liabilities  $—   $—   $-   $ - 

 

 

Changes in level 3 assets measured at fair value

 

The following table presents additional information about Level 3 assets measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of assets classified within the Level 3 category. As a result, the unrealized gains and losses for the assets and liabilities within the Level 3 category may include changes in fair value that were attributable to both observable and unobservable inputs. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Changes in Level 3 assets measured at fair value for the year ended December 31, 2021 were as follows:

 

Assets  Beginning
Balance January 1, 2021		   Acquisitions   Sales and dispositions  

Transfers into

Level 3

   Transfers out of Level 3 (a)   Realized &
Unrealized Gains (Losses)(b)		   Ending Balance Dec 31, 2021 
                             
Common stocks   -   $2,665,000   $-   $400,000   $(534,000)  $(377,000)  $2,154,000 
Convertible Debt   -   $4,267,000   $-   $410,000   $(213,000)  $(278,000)  $4,186,000 
Warrants   -   $-   $-   $-   $-   $96,000   $96,000 
Preferred stocks   -   $1,031,000   $(510,000)  $500,000   $-   $(422,000)  $599,000 
Total Investments   -   $7,963,000   $(510,000)  $1,310,000   $(747,000)  $(981,000)  $7,035,000 

 

a.Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital.
  
b.Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations.

 

Valuation processes for Level 2 and 3 Fair Value Measurements

 

Fair value measurement of certain of our marketable securities fall within Level 2 and 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.

 

The Company classifies certain assets as Level 3 assets if the estimated fair value was derived from level 3 inputs. The Company utilizes a put option pricing model to arrive at a discount for lack of marketability and liquidity associated with restrictions on sales into the public market. The Company generally classifies restricted securities in public companies as level 2, however in circumstances where the observed level of liquidity is low and the quoted market price is deemed unreliable they may be categorized in Level 3 of the fair value hierarchy. The Company considers marketable securities without sufficient liquidity to sell within 6 months of the date of acquisition and securities that will not be eligible for resale in the public markets through Rule 144 for 1 year from the date acquisition to be valued with Level 2 inputs.

 

The fair value of the Company’s Series A Preferred Stock may change significantly, impacting the Company’s assumptions used to estimate its fair value. The valuation of the Series A Preferred Stock is primarily based on the valuation of its underlying marketable securities. The marketable securities that are underlying the Series A Preferred Stock are classified as Designated Assets on the Company’s balance sheet and include Level 1 and Level 2 marketable securities and cash.

 

The following table lists the significant unobservable inputs used to value assets classified as Level 3 of December 31, 2021. The table is not intended to be all-inclusive, but instead identifies the significant unobservable inputs relevant to the determination of fair values. The other Level 3 assets have been valued using unadjusted third-party transactions and, unadjusted historical third-party information, or the unadjusted net asset values of the securities’ issuer. No unobservable inputs internally developed by the Company have been applied to these assets, and therefore are omitted from the following table.

Assets   Valuation technique   Unobservable inputs   Range
             
Common stocks   Put option pricing model   Discount for lack of marketability   0% - 54%
             
Convertible preferred stock   Put option pricing model   Discount for lack of marketability   0% - 54%
             
 Convertible Debt    Discounted cash flow   Maturity   0 - 35 months
        Risk adjusted discount factor   26%
             
    Option pricing model   Volatility   100%
        Risk-free interest rate   0.78 % 1.04%
        Dividend yield   0%
        Time to maturity   0 - 35 months

 

Sensitivity of Level 3 measurements to changes in significant unobservable inputs

 

The process of estimating the fair value of securities without active markets involves significant estimates and judgement on behalf of management. These estimated fair values may not be realized in a current sale or immediate settlement of the asset or liability. Additionally, there are inherent uncertainties in any fair value measurement techniques, and changes in the underlying assumptions used could significantly affect the fair value measurement amounts.

 

Changes in each of these significant unobservable valuation inputs will impact the fair value measurement of the financial instrument generally as follows:

 

●An increase or decrease in the volatility of the common stock that underlies our holdings in convertible debt would result in a directionally similar change in the estimated fair value.
   
●An increase or decrease in the risk-free interest rate or risk adjusted discount factor would result in an inverse change in the estimated fair value of our convertible debt.
   
●An increase in the dividend yield would increase the estimated value of the convertible debt.
   
●A change in the maturity may result in either an increase or decrease in estimated fair value of the convertible debt.
   
 ●An increase or decrease in the discount for lack of marketability of our common stock holdings and the common stock that underlies our preferred stock would generally result in an inverse change in the estimated fair value.

 

Instruments for which unobservable inputs are significant to their fair value measurement (i.e., Level 3) include securities in which we deem their market to be inactive or unreliable. The Company reviews and updates the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next that are related to the observable inputs to a fair value measurement may result in a reclassification from one hierarchy level to another.

 

 

Valuation technique refinements

 

During the year-ended December 31, 2021, the Company refined its valuation techniques to enhance consideration of unobservable inputs for the valuation of Level 2 and Level 3 marketable securities.

 

If quoted market prices are not available for the specific security, or if the observed quoted market price is deemed unreliable, then fair values are estimated by using pricing models, considering third-party transactions, unadjusted historical third-party information, and the unadjusted net asset values of the issuer. The pricing models primarily use market-based or independently sourced market parameters as inputs, including, but not limited to, yield curves, interest rates, equity or debt prices, and credit spreads. In addition to market information, models also incorporate transaction details, such as maturity and cash flow assumptions. Securities valued in this manner would generally be classified within Level 2 and Level 3 of the valuation hierarchy and primarily include such instruments as convertible debt.

 

The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.

 
XML 47 R32.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE DISAGGREGATION
 12 Months Ended
Dec. 31, 2021
Revenue Disaggregation  
REVENUE DISAGGREGATION

NOTE 26 – REVENUE DISAGGREGATION

 

The Company has two operating units and one reportable segment. The Sequire segment includes the licensing of the Company’s proprietary SaaS platform and associated data analysis technologies. Additionally, the Sequire segment comprises consumer and investor targeted marketing solutions to allow users of our SaaS platform to act on the insights obtained through our technologies. Lastly, reported under Sequire is our business unit LD Micro, which is in the business of hosting events and conference for microcap public companies.

 

The following table summarizes revenue by business unit:

 

   2021   2020 
Sequire platform revenue  $24,514,000   $5,976,000 
Conference revenue   1,229,000    503,000 
Other revenues   964,000    - 
Total revenues  $26,707,000   $6,479,000 

 

As of December 31, 2021 and 2020, revenue contract liabilities were approximately $12,859,000 and $4,842,000, respectively.

 

 
XML 48 R33.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS
 12 Months Ended
Dec. 31, 2021
Subsequent Events [Abstract]  
SUBSEQUENT EVENTS

NOTE 27 – SUBSEQUENT EVENTS

 

The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The management of the Company determined the following reportable events:

 

SAFE agreement

 

On February 15, 2022 The Company entered into a simple agreement for future equity (the “SAFE”) with BIGtoken, Inc. (BIGToken), its former subsidiary. Pursuant to the SAFE, SRAX has agreed to invest $1,000,000 in the SAFE. The amount funded into the SAFE at a given time is referred to herein as the “SAFE Amount”.

 

Pursuant to the terms of the SAFE, at any time that the Company sells its securities (a “Financing”) prior to the termination of the SAFE, the Company may, at its option, convert the SAFE into: (i) the number of shares of non-voting Series D Convertible Preferred Stock (“Series D Preferred Stock”) equal to such (a) SAFE Amount divided by (b) the lowest price per share of equity securities sold in any Financing (prior to the termination of the SAFE) multiplied by eighty percent (80%) (the “Conversion Price”) and (ii) such number of warrants to purchase Series D Preferred Stock (the “Warrants”) equal to the SAFE Amount divided by the Conversion Price. Upon issuance, the Warrants will (i) have a term of five (5) years, (ii) an exercise price equal to the Conversion Price, and (iii) contain price protection provisions for subsequent financings.

 

CVR Agreement

 

On June 13, 2022, the Company entered into an agreement with an institutional investor whereby in exchange for the payment of $404,513.40 (the “Purchase Price”), the investor received (i) the right to receive the net proceeds upon the sale of certain securities of the Company (“CVR Payments”) with a quoted price equal to $674,190 (with a guaranteed minimum return of 120% of such Purchase Price and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the CVR Payments.

 

Extension of Outstanding Original Issue Discount Senior Secured Convertible Debentures

 

On July 1, 2022, the holders (“Holders”) of $1,102,682 in principal of the Company’s Original Issue Discount Senior Secured Convertible Debentures (“Debentures”), representing all of the outstanding Debentures that were originally issued on June 30, 2020, entered into an agreement with the Company to (i) extend the maturity date of the Debentures until December 31, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures. The Debentures, including the additional principal added to the Debentures are secured by substantially all of the assets of the Company pursuant to a security agreement entered into between the Company and Holders contemporaneous with the original issuance of the Debentures (the “Security Agreement”).

 

Bridge Note

 

On July 1, 2022, the Company issued an original issue discount bridge note in principal amount of $650,000 (“Bridge Note”) to an institutional investor in exchange for $500,000 in cash. The bridge note was non-interest bearing and had a maturity date of August 15, 2022. The Company’s obligations pursuant to the bridge note were secured by substantially all of the assets of the Company pursuant to the terms of the Security Agreement.

 

On August 8, 2022, as described below, the Bridge Note was exchanged for a revolving note in the Senior Secured Revolving Credit Facility.

 

RBSM LLP Declining to Stand for Reappointment

 

On June 30, 2022, RBSM LLP (“RBSM”), the independent registered public accounting firm to the Company, informed the Company of its decision not to stand for re-appointment as the independent registered public accounting firm of the Company. RBSM will cease its services as the Company’s independent registered accountants effective with the filing of the Company’s annual report on Form 10-K with the United States Securities and Exchange Commission. The Company’s Audit Committee accepted the resignation of RBSM and has selected a new independent public accounting firm.

 

Revolving Credit Facility

 

On August 8, 2022 (“Effective Date”), the Company entered into a senior secured revolving credit facility agreement (the “Credit Agreement”) with an institutional investor (the “Lender”) to initially borrow up to $9,450,000 (“Loan Amount”) in the aggregate from time to time, subject to certain conditions (each a “Revolving Loan”). The Revolving Loan is secured by all the assets of the Company and is guaranteed by LD Micro, Inc. (collectively, Company and LD Micro are referred to as the “Credit Parties”). In addition to the Credit Agreement, the Credit Parties, as applicable, also entered into a: (i) Revolving Note, (ii) Security Agreements, (iii) Fee Agreement and (iv) Registration Rights Agreement (collectively the “Loan Documents”). As part of the transaction, the Company also amended and restated Lender’s outstanding warrants to extend the maturity date of a total of 2,590,358 Common Stock purchase warrants until September 30, 2023.

 

For the Company enter into the Credit Agreement , we were required to issue 33,000 shares of the Company’s common stock as a breakup fee to an unrelated lender as a result of a failed offering.

 

 

Credit Agreement and Revolving Note

 

On the Effective Date, the Lender advanced $5,580,000 consisting of $4,930,000 in cash and the exchange of the $650,000 bridge note entered into on June 28, 2022, which was previously disclosed on the Company’s Current Report on Form 8-K filed on July 7, 2022 with the SEC. Provided that no event of default has occurred under the Loan Documents, upon the Company becoming current with its filing obligations under the Securities Exchange Act of 1934, as amended, as well as any other obligations of its principal trading market, Lender will advance up to an additional $3,870,000. Future Revolving Loan amounts (but not in excess of the Loan Amount) are subject to a borrowing base calculation.

 

The principal balance of each Revolving Loan will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%. The Revolving Loans have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents.

 

Commencing on the first day of each month after the Effective Date (each a “Payment Date”), the outstanding balance of the Revolving Loan will be paid as follows:

 

a.With respect to the first, second and third months, 10% of the monthly collections from the sale of securities received by the Company from its customers during the prior month;

 

b.With respect to the fourth, fifth and sixth months, 15% of the monthly collections from the sale of securities received by the Company from its customers during the prior month; and

 

c.With respect to each successive Payment Date, 20% of the monthly collections from the sale of securities received by the Company from its customers during the prior month.

 

Additionally, with respect to any Payment Date where the applicable monthly collection from the sale of securities received by the Company from its customers during the prior month exceeds $2,000,000, the Company will make an additional payment equal to 30% of any amounts in excess of $2,000,000.

 

The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends and fundamental transactions. Moreover, in the event the Company is deemed to have issued or sold shares of its Common Stock while the Revolving Loan is outstanding at a price equal to or less than $5.00 per share, the conversion price will adjust to such lower applicable price.

 

Security Agreements

 

In order to perfect Lender’s security interest, the Credit Parties entered into: (i) Security Agreements, (ii) Guaranty Agreements, (iii) Pledge Agreements and (iv) Security Account Control Agreements and Deposit Account Control Agreements (collectively “Security Agreements”). The Security Agreements provide for a general lien on all of the Credit Parties’ assets, including each party’s respective intellectual property.

 

Extension of Warrants

 

As part of the transactions contemplated by the Loan Documents, the Company additionally agreed to extend the expiration dates of the following outstanding Common Stock purchase warrants held by the Lender or its affiliated entities until September 30, 2023:

 

(a)a warrant to purchase 1,363,636 shares of Common Stock issued on June 30, 2020, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2020;

 

(b)a warrant to purchase 166,667 shares of Common Stock issued on November 29, 2018, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on November 30, 2018; and

 

(c)a warrant to purchase 530,027 shares of Common Stock issued on November 29, 2018, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on November 30, 2018;

 

(d)a warrant to purchase 530,028 shares of Common Stock issued on October 27, 2017 that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on October 27, 2017.

 

Fee Agreement

 

As consideration for Lender entering into the Loan Documents, Lender will be entitled to receive, in addition to any payment made under the Credit Agreement, 10% of the net proceeds received by the Company from the sales of securities received during the term of the Revolving Loan.

 

Common stock issue for Options and Warrants

 

Subsequent to December 31, 2021, the Company issued approximately 287,000 shares of the Company’s common stock for the exercise of warrants and/or stock options.
XML 49 R34.htm IDEA: XBRL DOCUMENT v3.22.2.2
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)
 12 Months Ended
Dec. 31, 2021
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization

Organization

 

SRAX, Inc. (“SRAX”, “we”, “us”, “our” or the “Company”) is a Delaware corporation formed on August 2, 2011. We are headquartered in Westlake Village, California but work as a distributed virtual Company. The Consolidated Financial Statements consist of SRAX and its wholly owned subsidiary LD Micro, Inc. (“LD Micro”).

 

We are a technology firm focused on enhancing communications between public companies and their shareholders and investors. We currently have two distinct business units, which we consider to be one reporting unit:

 

  ● Our unique SaaS platform, Sequire provides users many features which allow issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels.
  ● Through LD Micro, we organize and host investor conferences within the micro and small- cap markets, and plan to create several more niche events for the investor community.

 

Each of SRAX’s business units deliver valuable insights that assist our clients with their investor relations and communications initiatives.

 

On December 29, 2021, we deconsolidated our majority owned subsidiary BIG Token, Inc. (“BIGToken”) (formerly known as Force Protection Video Equipment Corporation). After the deconsolidation, we do not beneficially own controlling interest in BIGtoken, and no longer consolidate BIGtoken into our financial results for periods ending after December 31, 2021. The financial results of BIGtoken for the years ended December 31, 2021 and 2020 are presented as income from discontinued operations, net of taxes on the consolidated statements of operations and its assets and liabilities as of December 31, 2021 are presented as assets and liabilities of discontinued operations on the consolidated balance sheets. The historical consolidated statement of cash flows has also been revised to reflect the effect of the deconsolidation. See Note 2 – Discontinued Operations. Unless noted otherwise, discussion in the notes to the consolidated financial statements pertain to continuing operations.

 
Liquidity and Going Concern

Liquidity and Going Concern

 

The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. As of December 31, 2021, the Company had cash and cash equivalents of $1,348,000 which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited Consolidated Financial Statements are issued.

 

The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.

 

In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flow and cash usage forecasts, and obligations and debts. Although management has a long history of successful capital raises, the analysis used to determine the Company’s ability as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next 12 months.

 

We expect that our existing cash and cash equivalents, our accounts receivable and marketable securities as of December 31, 2021, will not be sufficient to enable us to fund our anticipated level of operations through one year from the date these financial statements are issued.  We anticipate raising additional capital through the private and public sales of our equity or debt securities and selling our marketable securities, or a combination thereof. Although management believes that such capital sources will be available, there can be no assurances that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. If we do not raise sufficient capital in a timely manner, among other things, we may be forced to scale back our operations or cease operations altogether.

 

 

The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, and uncertain. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.

 
Principles of Consolidation

Principles of Consolidation

 

The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.

 

The consolidated financial statements include the accounts of the Company and its subsidiaries from the acquisition date of majority voting control of the subsidiary.

 
Business Segments

Business Segments

 

The Company uses the “management approach” to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics.

 
Business Combinations

Business Combinations

 

For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition.

 
Use of Estimates

Use of Estimates

 

The consolidated financial statements have been prepared in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) and requires management of the Company to make estimates and assumptions in the preparation of these consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.

 

The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company’s revenue recognition, allowance for doubtful accounts and sales credits, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisition, goodwill, other intangible assets, put rights and valuation of other assets and liabilities.

 
Fair Value of Financial Instruments

Fair Value of Financial Instruments

 

The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.

 

In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels:

 

  ● Level 1 - Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.;
  ● Level 2 - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly.; and
  ● Level 3 - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.

 

Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. Therefore, even when market assumptions are not readily available, the fund’s own assumptions reflect those that market participants would use in pricing the asset or liability at the measurement date.

 

The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fund’s level is based on the lowest significant level input to the fair value measurement.

 

 

Valuation Techniques and Inputs

 

Investments in securities and securities sold short that are both freely tradable and listed on major securities exchanges are valued at their last reported sales price as of the valuation date.

 

Many over-the-counter contracts have bid and ask prices that are observable in the marketplace. Bid prices reflect the highest price that the marketplace participants are willing to pay for an asset. Ask prices represent the lowest price that the marketplace participants are willing to accept for an asset.

 

An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. The Company initially classifies securities between debt securities, equity securities, warrants, convertible debt, or preferred stock. The Company does not have any debt securities as of December 31, 2021 and 2020. Warrants are initially valued at cost, if acquired for cash, or at intrinsic value. For convertible debt securities the investor generally should evaluate the security in its current “all-in” form as convertible debt and not use the “if converted” value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities are valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity.

 

The Company considers there to be an active market based on the guidance in ASC 820-10-35-54C. In an active market, transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. An orderly transaction assumes exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities. Whether transactions take place with sufficient frequency and volume to constitute an active market is a matter of judgement and depends on the facts and circumstances of the market for the asset or liability. If the Company determines that the trading market for a security is not an active market the Company evaluates the stock price based on other observable or unobservable inputs. A market with limited activity may still provide relevant pricing information when there is no contrary evidence that the pricing information is not relevant to the fair value of the asset. In certain situations, the Company’s security holdings represent share quantities that materially exceed the average daily trading volume of the securities in their primary market. Thus, the Company considers a discount due to the lack of liquidity. If the Company determines it can liquidate its position within 180 days based on 10% of the securities average daily trading volume, no discount is applied. Rule 144 also has an alternative volume limit for affiliates of up to 10% of the tranche (or class) outstanding for debt securities. We believe this provides a reasonable basis to suggest this 10% of trading volume should have minimal impact on market prices.

 

Securities with a marketability holding period in excess of 180 days is subjected to a discount for marketability. If a security has both a marketability holding period over 180 days and a liquidation period of over 180 days the Company will evaluate the impact of both the marketability and liquidity discounts. The Company utilizes the quoted market price on the date of valuation calculates a discount for marketability and liquidity based on a protective put option pricing model that factors in both the lack of marketability and liquidity.

 

Independent Valuation Expert

 

The Company uses a third party specialist to provide guidance around the assumptions, inputs, pricing models utilized valuation calculations into the various Put Option Pricing Models (POPMs) used in the calculations to determine discounts at contract inceptions date and each of the respective balance sheet dates.

 

If the Company has access to material non-public information regarding an investee, it will consider this information as an input for purposes of valuing the security. In these situations, the Company will consider the impact this information will have on the valuation of the securities on a case-by-case basis. These situations could arise due to the Company being an affiliate of the issuer or an officer or director of the Company is an affiliate of the issuer.

 

These securities are categorized in Level 1 of the fair value hierarchy to the extent these securities are actively traded. Securities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 of the fair value hierarchy.

 

Investments in Restricted Securities of Public Companies

 

Investments in restricted securities of public companies cannot be offered for sale to the public until the company complies with certain statutory requirements. The valuation will not exceed the listed price on any major securities exchange. Investments in restricted securities of public companies are generally categorized in Level 2 of the fair value hierarchy. However, investments in public companies may be categorized in Level 3 of the fair value hierarchy depending on the level of observable liquidity. Specifically, if the Company determines the market activity is not sufficient to conclude the market activity represents an Active Market pursuant to ASC 820 -10 -35 36B.

 

The Company evaluates the trading activity of each listed security to determine if the trading market is an Active Market for purposes of evaluating Fair Value under ASC 820. The Company evaluated the number of trade observations during the year, the percentage of the total trading days the security traded on its listed market during the full year or the portion of the year if the security was initially listed during the year, and at the dollar value of the trading activity for the full year as a percentage of the market capitalization of the security. If the Company determines the listed securities trading market is not an active market it looks at other transactions reported by the listed company including private equity transactions, non-cash equity transactions, the trading price and other factors. The Company determines a fair value of the stock price based on this analysis. This price is the lower of the listed price or the fair value based on the analysis. The Company also considers the marketability and liquidity discounts on the listed security in determining fair value.

 
Cash and Cash Equivalents

Cash and Cash Equivalents

 

The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are recorded at cost, which approximates its fair value. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $250,000 per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. As of December 31, 2021 and 2020, the Company had $1,098,000 and $200,000 in excess of the federal insurance limit, respectively.

 

 
Accounts Receivable

Accounts Receivable

 

Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company usually does not require collateral. Allowance for doubtful accounts was approximately $130,000 and $15,000 as of December 31, 2021 and 2020, respectively.

 
Concentration of Credit and Significant Customer Risk

Concentration of Credit and Significant Customer Risk

 

Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any loss on these accounts.

 

As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately 11%. As of December 31, 2020, the Company had three customers with accounts receivable balances of approximately 43.41%, 11.60%, and 10.53%.

 

For the year ended December 31, 2021, the Company had no customers that account for a significant percentage of total revenue. For the year ended December 31, 2020, the Company had one customer that accounted for 18.1% of total revenue.

 
Long-lived Assets

Long-lived Assets

 

Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the years ended December 31, 2021 or 2020, respectively.

 
Property and equipment

Property and equipment

 

Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years.

 

Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment.

 
Intangible assets

Intangible assets

 

Intangible assets consist of intellectual property, trademarks, trade names, and non-compete agreements, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years.

 

 

Costs incurred to develop computer software for internal use are capitalized once: (1) the preliminary project stage is completed, (2) management authorizes and commits to funding a specific software project, and (3) it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred prior to meeting the qualifications are expensed as incurred. Capitalization of costs ceases when the project is substantially complete and ready for its intended use. Post-implementation costs related to the internal use computer software, are expensed as incurred. Internal use software development costs are amortized using the straight-line method over its estimated useful life which ranges up to three years. Software development costs may become impaired in situations where development efforts are abandoned due to the viability of the planned project becoming doubtful or due to technological obsolescence of the planned software product. For the years ended December 31, 2021, and 2020 there has been no impairment associated with internal use software. For the years ended December 31, 2021, and 2020, the Company capitalized software development costs of $798,000 and $633,000, respectively.

 

During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use.

 

The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred.

 
Right of Use Assets and Lease Obligations

Right of Use Assets and Lease Obligations

 

The Right of Use Asset and Lease Liability reflect the present value of the Company’s estimated future minimum lease payments over the lease term, which may include options that are reasonably assured of being exercised, discounted using a collateralized incremental borrowing rate.

 

Typically, renewal options are considered reasonably assured of being exercised if the associated asset lives of the building or leasehold improvements exceed that of the initial lease term. Therefore, the Right of Use Asset and Lease Liability may include an assumption on renewal options that have not yet been exercised by the Company.

 

As the rate implicit in leases are not readily determinable, the Company uses an incremental borrowing rate to calculate the lease liability that represents an estimate of the interest rate the Company would incur to borrow on a collateralized basis over the term of a lease within a particular currency environment.

 
Goodwill

Goodwill

 

Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur or circumstances indicate the fair value of a reporting unit is below its carrying value. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. The Company performed its most recent annual goodwill impairment test as of December 31, 2021 using market data and discounted cash flow analysis. Based on this analysis, it was determined that the fair value exceeded the carrying value of its reporting units. The Company concluded the fair value of the goodwill exceed the carrying value accordingly there were no indicators of impairment for the years ended December 31, 2021 and 2020.

 

The Company had historically performed its annual goodwill and impairment assessment on December 31st of each year. This aligns the Company with other advertising sales companies who also generally conduct this annual analysis in the fourth quarter.

 

 

When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the impairment testing methodology primarily using the income approach (discounted cash flow method).

 

We compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows if the carrying value of a reporting unit exceeds its fair value, then the amount by which it exceeds its fair value will be recognized as an impairment.

 

When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.

 
Derivatives

Derivatives

 

The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, Distinguishing Liabilities From Equity and FASB ASC Topic No. 815, Derivatives and Hedging. Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments.

 

The Company has adopted ASU 2017-11, Earnings per share (Topic 260), provided that when determining whether certain financial instruments should be classified as liability or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. If a down round feature on the conversion option embedded in the note is triggered, the Company will evaluate whether a beneficial conversion feature exists, the Company will record the amount as a debt discount and will amortize it over the remaining term of the debt.

 

If the down round feature in the warrants that are classified as equity is triggered, the Company will recognize the effect of the down round as a deemed dividend, which will reduce the income available to common stockholders.

 
Warrant Liability

Warrant Liability

 

The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black-Scholes option pricing model, at each measurement date.

 
Debt Discounts

Debt Discounts

 

The Company accounts for debt discounts originating in connection with conversion features that remain embedded in the related notes in accordance with ASC 470-20, Debt with Conversion and Other Options. These costs are classified on the consolidated balance sheet as a direct deduction from the debt liability. The Company amortizes these costs over the term of its debt agreements as interest expense-debt discount in the consolidated statement of operations.

 

 
Revenue Recognition

Revenue Recognition

 

On January 1, 2018, we adopted ASU 2014-09, “Revenue from Contracts with Customers” (Topic 606) (“ASC 606”) and applied this guidance to those contracts which were not completed at the date of adoption using the modified retrospective method. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods (ASC 605). The adoption did not have a significant impact to the nature and timing of our revenues, results of operations, cash flows and statement of financial position. 

 

Revenue from all sale types is recognized at transaction price, the amount we expect to be entitled to in exchange for transferring goods or providing services. Transaction price is calculated as selling price net of variable consideration which may include estimates for future returns, sales incentives and price protection related to current period product revenue. Our standard obligation to our direct customers generally provides for a full refund in the event that such product is not merchantable or is found to be damaged or defective. In determining estimates for future returns, we estimate variable consideration at the expected value amount which is based on management’s analysis of historical data, channel inventory levels, current economic trends and changes in customer demand for our products. Sales incentives and price protection are determined based on a combination of the actual amounts committed and through estimating future expenditure based upon historical customary business practice. We continue to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur.

 

We enter into contracts to sell our products and services, and while some of our sales agreements contain standard terms and conditions, there are agreements that contain non-standard terms and conditions and include promises to transfer multiple goods or services. As a result, significant interpretation and judgment is sometimes required to determine the appropriate accounting for these transactions including: (1) whether performance obligations are considered distinct and required to be accounted for separately or combined, including allocation of transaction price; (2) developing an estimate of the stand-alone selling price, or SSP, of each distinct performance obligation; (3) combining contracts that may impact the allocation of the transaction price between product and services; and (4) estimating and accounting for variable consideration, including rights of return, rebates, price protection, expected penalties or other price concessions as a reduction of the transaction price.

 

Revenue from contracts with customers is recognized when the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to be entitled to in exchange for those goods or services.

 

The Company derives its revenue primarily from the licensing of our Sequire Platform and Services associated with our customer’s use of the platform, consisting of data insights, marketing, creative, and paid media advertising Revenue is recognized at a point in time when control of the goods is transferred to the customer, generally occurring ratably over the contract period. The amount recognized reflects the consideration the Company expects to be entitled to in exchange for the transferred services.

 

Licensing and Service revenue is generally recognized over time on a ratable basis over the contract term beginning on the date that the service is expected to begin. Service contracts are generally for 12 months in length, billed either monthly or annually and generally in advance. Services revenue are typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. 

 

Deferred Revenue

 

Deferred revenue consists of platform and services fees that the Company has received consideration in advance of satisfying performance under the associated contract. The majority of the Company’s deferred revenue balance consists of the unrecognized portion of Service revenue that the Company has received consideration in marketable securities, which is recognized as revenue ratably over the contractual service period.

 

 

ASC Topic 606 is a comprehensive revenue recognition model that requires revenue to be recognized when control of the promised goods or services are transferred to our customers at an amount that reflects the consideration that we expect to receive. Application of ASC Topic 606 requires us to use more judgment and make more estimates than under former guidance. Application of ASC Topic 606 requires a five-step model applicable to all product offering revenue streams as follows:

 

Identification of the contract, or contracts, with a customer

 

A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration.

 

We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit or financial information pertaining to the customer.

 

Identification of the performance obligations in the contract

 

Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract.

 

When a contract includes multiple promised goods or services, we apply judgment to determine whether the promised goods or services are capable of being distinct and are distinct within the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. The Company has identified three distinct services promised within its contracts: (1) subscription to the Platform for a fixed monthly fee (Platform revenue), (2) Managed Services (including, data and marketing campaigns for a fixed monthly fee (managed services), and (3) Ancillary data, which consists of various data attributes that supplement the data available within the Sequire platform. The Managed Services to be delivered to the customer are within the discretion of the Company, and there are no minimum or maximum guaranties to be delivered.

 

Determination of the transaction price

 

The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods or services to our customer. We estimate any variable consideration included in the transaction price using the expected value method that requires the use of significant estimates for discounts, cancellation periods, refunds and returns. In cases which the Company receives marketable securities as payment the transaction price is determined to be the lower of the fair market value of the securities received or the contract amount.

 

Allocation of the transaction price to the performance obligations in the contract

 

If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. We determine SSP based on the price at which the performance obligation would be sold separately.

 

During the second quarter of 2020, the Company provided its customers the ability to pay for the Sequire services with the issuance of the customers’ common stock or other securities. For contacts paid with any type of security, Management considers whether there is any marketability of liquidity discounts in determining the fair value of the security on the contract date.

 

The Company’s contract with its customers is for a period of one year or less than one year and the Company is applying the practical expedient, therefore, the transaction price is not adjusted for any significant financing component. The Company evaluates whether there is an existence of a significant financing component in the contract. This is evaluated based on the marketability holding period and liquidity issues than can extend the ability to sale the securities. For any marketability restrictions over 180 days the Company provides a marketability discount. For any liquidity issues that would take the Company in excess of 180 days to liquidate the security the Company applies a liquidity discount. Where there is both a marketability and liquidity issue the Company provides a discount considering both. ASC 606-10-32-23 The fair value of the noncash consideration may vary after contract inception because of the form of the consideration (for example, a change in the price of a share to which an entity is entitled to receive from a customer). Changes in the fair value of noncash consideration after contract inception that are due to the form of the consideration are not included in the transaction price.

 

 

Recognition of revenue when, or as, we satisfy a performance obligation

 

We recognize revenue at the point in time that the related performance obligation is satisfied by transferring the promised goods or services to our customer. The Company has performed a limited analysis of the performance efforts and has determined that the effort for the managed services is typically front loaded and as a result of performing services for SEC reporting companies’ additional efforts are maintained throughout the year. The Company considers the services to be delivered ratably during any service period and as such is amortizing the contract price on a straight line method over the contract period.

 

Principal versus Agent Considerations

 

When another party is involved in providing goods or services to our customer, we apply the principal versus agent guidance in ASC Topic 606 to determine if we are the principal or an agent to the transaction. When we control the specified goods or services before they are transferred to our customer, we report revenue gross, as principal. If we do not control the goods or services before they are transferred to our customer, revenue is reported net of the fees paid to the other party, as agent. Our evaluation to determine if we control the goods or services within ASC Topic 606 includes the following indicators:

 

We are primarily responsible for fulfilling the promise to provide the specified good or service.

 

When we are primarily responsible for providing the goods and services, such as when the other party is acting on our behalf, we have indication that we are the principal to the transaction. We consider if we may terminate our relationship with the other party at any time without penalty or without permission from our customer.

 

We have risk before the specified good or service have been transferred to a customer or after transfer of control to the customer.

 

We may commit to obtaining the services of another party with or without an existing contract with our customer. In these situations, we have risk of loss as principal for any amount due to the other party regardless of the amount(s) we earn as revenue from our customer.

 

The entity has discretion in establishing the price for the specified good or service.

 

We have discretion in establishing the price our customer pays for the specified goods or services.

 

Contract Liabilities

 

Contract liabilities consist of customer advance payments and billings in excess of revenue recognized. We may receive payments from our customers in advance of completing our performance obligations. We record contract liabilities equal to the amount of payments received in excess of revenue recognized, including payments that are refundable if the customer cancels the contract according to the contract terms. Contract liabilities have been historically low historically recorded as current liabilities on our consolidated financial statements when the time to fulfill the performance obligations under terms of our contracts is less than one year. We have no long-term contract liabilities which would represent the amount of payments received in excess of revenue earned, including those that are refundable, when the time to fulfill the performance obligation is greater than one year.

 

Practical Expedients and Exemptions

 

We have elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:

 

  ● We adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception;
     
  ● We made the accounting policy election to not assess promised goods or services as performance obligations if they are immaterial in the context of the contract with the customer;
     
  ● We made the accounting policy election to exclude any sales and similar taxes from the transaction price; and
     
  ● We adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.

 

 
Stock-Based Compensation

Stock-Based Compensation

 

We account for our stock-based compensation under ASC 718 “Compensation – Stock Compensation” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.

 

We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.

 

Common stock awards

 

The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded in accordance with ASC 718 on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.

 

Warrants

 

In connection with certain financing, and consulting arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period.

 
Income Taxes

Income Taxes

 

We utilize ASC 740 “Income Taxes” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.

 

The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.

 
Earnings Per Share

Earnings Per Share

 

We use ASC 260, “Earnings Per Share” for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share are the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.

 

There were 11,867,520 common share equivalents at December 31, 2021 and 15,366,426 at December 31, 2020. For the year ended December 31, 2021 and 2020 these potential shares were excluded from the computation of diluted net earnings per share as their effect would have been antidilutive.

 

 
Recently Issued Accounting Standards

Recently Issued Accounting Standards

 

In January 2020, the FASB issued ASU 2020-01, which clarifies the interactions between Topics 321, 323 and 815. This ASU clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, the amendments clarify the accounting for certain forward contracts and purchased options accounted for under Topic 815. Our adoption of this ASU did not impact our consolidated financial statements or disclosures.

 

In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a limited period of time to ease the potential burden in accounting treatments related to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. Adoption of the expedients and exceptions is elective and is permitted upon issuance of the guidance through December 31, 2022. The adoption had no material impact on the Company’s financial position, results of operations and cash flows.

 

In May 2020, the SEC adopted amendments to the financial disclosure requirements in Regulation S-X including the significance tests in the “significant subsidiary” definition in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 to improve their application and to assist registrants in making more meaningful determinations of whether a subsidiary or an acquired or disposed business is significant. In addition, to address the unique attributes of investment companies and business development companies, the SEC updated the significance tests in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 by (i) revising the investment test to compare the registrant’s investments in and advances to the acquired or disposed business to the registrant’s aggregate worldwide market value if available; (ii) revising the income test by adding a revenue component; (iii) expanding the use of pro forma financial information in measuring significance; and (iv) conforming, to the extent applicable, the significance threshold and tests for disposed businesses to those used for acquired businesses. The amendment became effective January 1, 2021.

 

In August 2020, the FASB issued ASU 2020-06, which simplifies the accounting for convertible instruments by removing certain separation models (including the cash conversion model and the beneficial conversion feature model) for convertible instruments. As a result, for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815 or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features are no longer separated from the host contract. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost as long as no other features require bifurcation and recognition as derivatives. This ASU is effective for fiscal years beginning after December 15, 2021.

 

In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables–Nonrefundable Fees and Other Costs, (“ASU 2020-08”). This ASU clarifies that an entity should reevaluate whether a callable debt security is within the scope of ASC paragraph 310-20-35-33 for each reporting period. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of ASU 2020-08 did not have a material impact on its consolidated financial statements since the Company does not have any convertible debt.

 

On November 15, 2019, the FASB delayed the effective date of FASB ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments.” This ASU amends several aspects of the measurement of credit losses on certain financial instruments, including replacing the existing incurred credit loss model and other models with the Current Expected Credit Losses (CECL) model and amending certain aspects of accounting for purchased financial assets with deterioration in credit quality since origination.

 

Rule 2a-5 under the 1940 Act was adopted by the SEC in December 2020 and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. As noted above, the if the Company were determined to be an Investment Company we would be required to comply with the rule. We are evaluating the impact of adopting Rule 2a-5 on the consolidated financial statements and intend to comply with the new rule’s requirements should we be required to do so on or before the compliance date in September 2022.

 

The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.

 
XML 50 R35.htm IDEA: XBRL DOCUMENT v3.22.2.2
DISCONTINUED OPERATIONS (Tables)
 12 Months Ended
Dec. 31, 2021
Discontinued Operations and Disposal Groups [Abstract]  
SCHEDULE OF DECONSOLIDATION OF BUSINESS

SCHEDULE OF DECONSOLIDATION OF BUSINESS

      
Consideration received  $- 
Fair value of Series D Stock and Common stock   31,000 
Carrying amount of non-controlling interest of BIGToken   6,045,000 
Previous equity adjustments of non-controlling interest   (12,510,000)
Total consolidations   (6,434,000)
      
Book basis of investment in BIGToken   4,250,000 
Loss on disposal of subsidiary  $(10,684,000)
SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS

The following table presents the aggregate carrying amounts of assets and liabilities of discontinued operations of BIGToken in the consolidated balance sheet as of December 31, 2020:

 

     
Carrying amounts of assets included as part of discontinued operations:    
Cash and cash equivalents  $1,000 
Accounts receivable, net   1,199,000 
Prepaid expenses and other current assets   6,000 
Property and equipment, net   1,000 
Goodwill   5,445,000 
Intangible assets, net   917,000 
Total assets classified as discontinued operations in the consolidated balance sheet  $7,569,000 
      
Carrying amounts of liabilities included as part of discontinued operations:     
Accounts payable and accrued expenses  $853,000 
Other current liabilities   452,000 
Total liabilities classified as discontinued operations in the consolidated balance sheet  $1,305,000 

 

 

The financial results of BIGToken are presented as income from discontinued operations, net of income taxes on our consolidated income through December 29, 2021, when our deconsolidation occurred. The following table presents the financial results of BIGToken:

 

           
   Year ended December 31, 
   2021   2020 
Revenues  $3,431,000   $2,168,000 
Cost of revenue   1,090,000    800,000 
Gross profit   2,341,000    1,368,000 
           
Operating expense          
Employee related costs   2,419,000    3,212,000 
Marketing and selling expenses   1,136,000    958,000 
Platform costs   1,350,000    707,000 
Depreciation and amortization   530,000    531,000 
General and administrative expenses   4,152,000    530,000 
Total operating expense   9,587,000    5,938,000 
           
Loss from operations of discontinued operations   (7,246,000)   (4,570,000)
           
Other expense          
Financing costs   (5,872,000)   - 
Realized loss on marketable securities   -    (71,000)
Impairment of goodwill   (1,258,000)   - 
Total other expense   (7,130,000)   (71,000)
           
Loss from discontinued operations before provision for income taxes   (14,376,000)   (4,641,000)
Provision for income taxes   -     
Loss from discontinued operations, net of income taxes  $(14,376,000)  $(4,641,000)
XML 51 R36.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACQUISITIONS (Tables)
 12 Months Ended
Dec. 31, 2021
Business Combination and Asset Acquisition [Abstract]  
SCHEDULE OF CALCULATIONS OF PURCHASE PRICE

 

      
Calculation of the purchase price:    
Fair value of stock at closing  $4,264,000 
Cash at closing   1,000,000 
Deferred payments   2,771,000 
Less cash received   (303,000)
Transaction expenses   10,000 
Working capital adjustment   (132,000)
Purchase price  $7,610,000 
SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED

The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed:

 

      
Accounts receivable, net  $30,000 
Intangibles   468,000 
Goodwill   7,706,000 
Accounts payable and accrued liabilities   (324,000)
Payroll protection loan   (42,000)
Other current liabilities   (97,000)
Deferred tax liability   (131,000)
Net assets acquired  $7,610,000 
SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION

Intangible assets consisted of the following:

 

    Fair Value     Life in Years
Trademark   $ 271,000     Indefinite
Domain name     3,000     Indefinite
Noncompete     8,000     5 years
Customer list     186,000     3 years
    $ 468,000      
SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE

The amounts of revenue and earnings of the Acquiree since the acquisition date included in the consolidated statements of operations for the year ended December 31, 2020 follows:

 

Revenues $ -  
Net loss $   (51,000 )
SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS

Pro Forma Consolidated Statements of Operations

For the Year ended December 31, 2020

 

    SRAX, Inc.     LD Micro, Inc.     Pro Forma Adjustment     Pro Forma Combined  
Revenues   $ 6,479,000     $ 937,000     $ -     $ 7,416,000  
Cost of revenues     (1,789,000 )     (98,000 )     -       (1,887,000 )
Operating expenses     (11,722,000 )     (858,000 )     171,000       (12,409,000 )
Other expense     (3,011,000 )     (1,000 )     -       (3,012,000 )
Provision for income taxes     (21,000 )     -       -       (21,000 )
Net loss   $ (10,064,000 )   $ (20,000 )   $ 171,000     $ (9,913,000 )
SUMMARY OF PRO FORMA ADJUSTMENTS

The following summarizes the pro forma adjustments made for the year ended December 31, 2020:

 

         
Amortization of intangibles acquired   $ 64,000  
Employee related costs     (235,000 )
Financing costs     -  
Net income (loss)   $ (171,000 )
XML 52 R37.htm IDEA: XBRL DOCUMENT v3.22.2.2
MARKETABLE SECURITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Cash and Cash Equivalents [Abstract]  
SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES

The movement in this account is as follows:

 

   Balance as of                 
   December 31,   Common   Convertible   Preferred     
   2021   Stock   Debentures   Stock   Warrants 
Balances at beginning of year  $8,447,000   $7,764,000   $

683,000

   $-   $- 
Additions   34,914,000    29,281,000    4,602,000    1,031,000    - 
Sale of marketable securities   (8,666,000)   (8,156,000)   (510,000)   -   - 
Designation for dividend distribution   (10,790,000)   (10,577,000)   

(213,000

)   -   - 
Change in fair value   (8,288,000)   (7,577,000)   

(375,000

)   (432,000)   96,000 
Balances at end of year  $15,617,000   $10,735,000   $4,187,000   $599,000   $96,000 

 

   Balance as of         
   December 31,   Common   Convertible 
   2020   Stock   Debentures 
Balances at beginning of year  $83,000   $83,000   $— 
Additions   8,406,000    7,496,000    910,000 
Sale of marketable securities   (916,000)   (916,000)   — 
Change in fair value   874,000    1,101,000    (227,000)
Balances at end of year  $8,447,000   $7,764,000   $683,000 
XML 53 R38.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables)
 12 Months Ended
Dec. 31, 2021
Designated Assets For Return Of Capital  
SCHEDULE OF DESIGNATED ASSETS

As of December 31, 2021, designated assets consist of the following:

 

      
Cash  $686,000 
Marketable securities   3,239,000 
Balance  $

3,925,000

 
SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS

The movement in designated assets is as follows:

 

Designated assets as of September 20, 2021  $6,387,000 
Sale of designated assets   (770,000)
Proceeds from sale of designated assets   686,000 
Change in fair value of designated assets   (2,378,000)
Balances as of December 31, 2021  $3,925,000 
XML 54 R39.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY AND EQUIPMENT (Tables)
 12 Months Ended
Dec. 31, 2021
Property, Plant and Equipment [Abstract]  
SCHEDULE OF PROPERTY AND EQUIPMENT

Property and equipment consist of the following as of December 31:

 

    2021     2020  
Office equipment   $ 471,000     $ 402,000  
Accumulated depreciation     (357,000 )     (285,000 )
Property and equipment, net   $ 114,000     $ 117,000  
XML 55 R40.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS (Tables)
 12 Months Ended
Dec. 31, 2021
Goodwill and Intangible Assets Disclosure [Abstract]  
SCHEDULE OF INTANGIBLE ASSETS

Intangible assets consist of the following as of December 31:

 

    2021     2020  
Non-compete agreement   $ 1,258,000     $ 1,258,000  
Intellectual property     756,000       756,000  
Acquired Software     756,000       617,000  
Internally developed software     2,726,000       2,048,000  
Trademark     271,000       271,000  
Customer list     186,000       186,000  
Domain name     17,000       36,000  
Total cost     5,970,000       5,172,000  
Accumulated amortization     (4,527,000 )     (3,680,000 )
Intangible assets, net   $ 1,443,000     $ 1,492,000  
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE

Trademark has indefinite life and not subject to amortization. The estimated future amortization expense for the years ended December 31, are as follows:

 

      
2022  $632,000 
2023   404,000 
2024   136,000 
Intangible assets  $1,172,000 
XML 56 R41.htm IDEA: XBRL DOCUMENT v3.22.2.2
RIGHT TO USE ASSET (Tables)
 12 Months Ended
Dec. 31, 2021
Right To Use Asset  
SCHEDULE OF COMPONENT OF LEASE EXPENSE

 

   2021   2020 
Operating lease expense  $163,000   $163,000 
Short-term lease expense   12,000    29,000 
Total lease expense  $175,000   $192,000 
SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES

The below table summarizes these lease asset and liability accounts presented on our accompanying Consolidated Balance Sheets for the year ended December 31:

 

Operating Leases*  Consolidated Balance Sheet Caption  2021   2020 
Operating lease right-of-use assets - non-current  Right of use asset  $257,000   $366,000 
              
Operating lease liabilities – current  Other current liabilities  $130,000   $109,000 
Operating lease liabilities - non-current  Right to use liability - long term   114,000    243,000 
Total operating lease liabilities     $244,000   $352,000 
SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE

Weighted Average Remaining Lease Term and Applied Discount Rate

 

  

Weighted

Average

Remaining

Lease Term

 

Weighted

Average

Discount Rate

 
Operating leases as of December 31, 2021  1.75 years   18%
SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS

The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest,

 

and (iii) present value of future lease payments for the years ending December 31:

 

Operating Leases - future payments    
2022   163,000 
2023   123,000 
Total future lease payments, undiscounted   286,000 
Less: Implied interest   (42,000)
Present value of operating lease payments   244,000 
XML 57 R42.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)
 12 Months Ended
Dec. 31, 2021
Payables and Accruals [Abstract]  
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES

Accounts payable and accrued expenses as of December 31, are comprised of the following:

 

   2021   2020 
Accounts payable, trade  $1,938,000   $1,900,000 
Accrued expenses   1,518,000    537,000 
Accrued compensation   213,000    232,000 
Accrued commissions   303,000    32,000 
Accrued interest   123,000    7,000 
Accounts payable and accrued expenses  $4,095,000   $2,708,000 
XML 58 R43.htm IDEA: XBRL DOCUMENT v3.22.2.2
OTHER CURRENT LIABILITIES (Tables)
 12 Months Ended
Dec. 31, 2021
Other Liabilities Disclosure [Abstract]  
SCHEDULE OF OTHER CURRENT LIABILITIES

The following table summarizes the composition of other current liabilities presented on our accompanying Consolidated Balance Sheets:

   December 31,
2021		   December 31,
2020		 
Operating lease liabilities - current  $130,000   $109,000 
Other current liabilities   633,000    3,308,000 
Total other current liabilities  $763,000   $3,417,000 
XML 59 R44.htm IDEA: XBRL DOCUMENT v3.22.2.2
OID CONVERTIBLE DEBENTURES (Tables)
 12 Months Ended
Dec. 31, 2021
Oid Convertible Debentures  
SCHEDULE OF OID CONVERTIBLE DEBENTURES

The table below summarizes the transactions during the year end December 31, 2021:

   Principal   Debt discount   Net book value 
Balance at beginning of year  $9,386,000   $(3,370,000)  $6,016,000 
Extension   268,000    -    268,000 
Conversion   (8,387,000)   2,413,000    (5,974,000)
Amortization   -    854,000    854,000 
Total  $1,267,000   $(103,000)  $1,164,000 

 

As of December 31, 2021, the Company has classified the debt as current liability because the management intends to redeem the remaining convertible debentures within the following 12 months.

 

The table below summarizes the transactions during the year   end December 31, 2020:

 

   Principal   Debt discount   Net book value 
Issuance during the year  $16,101,000   $(12,731,000)  $3,370,000 
Extension   472,000    -    472,000 
Redemption   (6,069,000)   3,037,000    (3,032,000)
Conversion   (1,118,000)   685,000    (433,000)
Amortization   -    5,639,000    5,639,000 
Total  $9,386,000   $(3,370,000)  $6,016,000 
XML 60 R45.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK OPTIONS, AWARDS AND WARRANTS (Tables)
 12 Months Ended
Dec. 31, 2021
Share-Based Payment Arrangement [Abstract]  
SCHEDULE OF STOCK OPTION ACTIVITY

 

   Number of Shares   Weighted Average Strike Price/Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding — December 31, 2019   1,192,519   $4.14    2.17   $—   $— 
Granted   766,172    2.77    3.00    521,000    2.72 
Exercised   —    —    —    —    — 
Forfeited   (316,367)   5.14    —    —    3.14 
Outstanding — December 31, 2020   1,642,324    3.30    2.81    —    — 
Vested and exercisable — December 31, 2020   844,742    3.54    2.62    333,000    3.54 
Unvested and non-exercisable - December 31, 2020   797,582    2.81    3.00    207,000    2.09 
                          
Outstanding — December 31, 2020   1,642,324    3.30    2.81    —    — 
Granted   21,627    4.38    6.29    2,000    3.60 
Exercised   (12,500)   2.70    3.63    —    2.00 
Forfeited   (319,671)   4.60    0.65    —    3.49 
Outstanding — December 31, 2021   1,331,780    3.02    2.39    1,969,000    2.13 
Vested and exercisable — December 31, 2021   870,750    3.05    2.27    1,265,000    2.15 
Unvested and non-exercisable - December 31, 2021   461,030   $2.96    2.62   $703,000   $2.10 
SCHEDULE OF WARRANT ACTIVITY

 

   Number of Shares   Weighted Average Strike Price/Share   Weighted Average Remaining Contractual Term (Years)   Aggregate Intrinsic Value   Weighted Average Grant Date Fair Value 
Outstanding — December 31, 2019   6,237,430   $3.57    2.68   $—   $— 
Granted   7,421,054    2.63    1.82    3,929,000    1.38 
Exercised   —    —    —    —    — 
Forfeited   (1,073,201)   —    —    —    — 
Outstanding — December 31, 2020   12,585,283    2.98    1.78    4,460,000    1.38 
Vested and exercisable — December 31, 2020   12,285,283    2.94    1.74    4,460,000    1.38 
Unvested and non-exercisable - December 31, 2020   300,000    4.75    3.37    —    — 
                          
Outstanding — December 31, 2020   12,585,283    2.98    1.78    4,460,000    1.38 
Granted   4,582,345    7.48    0.11    —    1.70 
Exercised   (7,148,501)   2.74    0.78    —    — 
Forfeited   —    —    —    —    — 
Outstanding — December 31, 2021   10,019,127    5.21    0.47    6,779,000    1.70 
Vested and exercisable — December 31, 2021   9,719,127    5.22    0.41    6,779,000    1.70 
Unvested and non-exercisable - December 31, 2021   300,000   $4.75    2.37   $—   $— 
XML 61 R46.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES (Tables)
 12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE

Income tax (benefit) expense from continuing operations for the year ended December 31, 2021 consisted of the following:

 

   Current   Deferred   Total 
Federal  $—   $(132,000)  $(132,000)
State   5,000    —   5,000
Subtotal   5,000    (132,000)   (127,000)
Valuation allowance   —    —    — 
Total  $5,000   $(132,000)  $(127,000)

 

Income tax expense from continuing operations for the year ended December 31, 2020 consisted of the following:

   Current   Deferred   Total 
Federal  $—   $—    - 
State   21,000    —    21,000 
Subtotal   21,000    —    21,000 
Valuation allowance   —    —    — 
Total  $21,000   $—   $21,000 
SCHEDULE OF EFFECTIVE TAX RATE

A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:

 

   2021   2020 
Taxes calculated at federal rate   21.0%   21.0%
Stock based compensation   0.0%   (2.7)%
Permanent differences   (1.0)%   

(13.4

)%
Change in valuation allowance   (15.1)%   (2.1)%
Fair market adjustment derivatives   0.0%   0.5%
Prior year true-ups   0.0%   (3.3)%
Other adjustments   (4.1)%   (0.1)%
Provision for income tax benefit (expense)   0.8%   

(0.1

)%
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES

The tax effects, rounded to thousands, of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at December 31, are presented below:

 

   2021   2020 
Deferred Tax Assets          
Net operating loss carryforwards  $10,003,000   $9,040,000 
Bad debt expense   33,000    136,000 
Fixed assets   -    

9,000

 
Accrued interest   -    - 
Stock based compensation   525,000    567,000 
Interest expense limitation carryover   220,000    

629,000

 
Contribution carryover   5,000    

5,000

 
Lease liability   62,000    

97,000

 
Unrealized gain on marketable securities   2,668,000    120,000 
Other accruals   124,000    173,000 
Total Deferred Tax Assets   13,640,000    10,776,000 
           
Deferred Tax Liabilities          
Fixed assets   

(29,000

)   -
Right-of-use asset   (66,000)   

(101,000

)
Intangibles   (455,000)   (690,000)
Interest expense limitation carryover   (59,000)   - 
Prepaid expenses   (15,000)   (17,000)
Total Deferred Tax Liabilities   (624,000)   (808,000)
           
Net Deferred Tax Assets   13,016,000    9,968,000 
Valuation Allowance   (13,016,000)   (9,968,000)
           
Net deferred tax / (liabilities)  $—   $— 
XML 62 R47.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)
 12 Months Ended
Dec. 31, 2021
Fair Value Disclosures [Abstract]  
SCHEDULE OF ASSETS MEASURED AT FAIR VALUE

 

       Quoted Prices   Significant     
   Balance as of   in Active
Markets for		   Other
Observable		   Significant
Unobservable		 
   December 31   Identical Assets   Inputs   Inputs 

  2021   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Marketable securities  $15,617,000   $6,134,000   $2,448,000   $7,035,000 
Designated assets   3,925,000    259,000    3,666,000    — 
Contract assets   

844,000

    

—

    —    

844,000

 
Total assets  $20,386,000   $6,393,000   $6,114,000   $

7,879,000

 

 

       Quoted Prices   Significant     
   Balance as of  

in Active

Markets for

   Other
Observable		   Significant Unobservable 
   December 31,   Identical Assets   Inputs   Inputs 
  2020   (Level 1)   (Level 2)   (Level 3) 
Assets:                
Marketable securities  $8,447,000   $7,764,000   $683,000   $— 
Total assets  $8,447,000   $7,764,000   $683,000   $— 
SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE

 

             
   As of Dec. 31, 2021   
   Level 1   Level 2   Level 3   Fair Value 
Liabilities:                    
Series A Preferred Stock  $—   $3,925,000    -   $3,925,000 
Total liabilities  $—   $3,925,000    -    $3,925,000 

 

             
   As of December 31, 2020  
   Level 1   Level 2   Level 3   Fair Value 
Liabilities:                    
Series A Preferred Stock  $—   $—   $      -   $- 
Total liabilities  $—   $—   $-   $ - 
SCHEDULE OF FAIR VALUE AT ASSETS

The following table presents additional information about Level 3 assets measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of assets classified within the Level 3 category. As a result, the unrealized gains and losses for the assets and liabilities within the Level 3 category may include changes in fair value that were attributable to both observable and unobservable inputs. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Changes in Level 3 assets measured at fair value for the year ended December 31, 2021 were as follows:

 

Assets  Beginning
Balance January 1, 2021		   Acquisitions   Sales and dispositions  

Transfers into

Level 3

   Transfers out of Level 3 (a)   Realized &
Unrealized Gains (Losses)(b)		   Ending Balance Dec 31, 2021 
                             
Common stocks   -   $2,665,000   $-   $400,000   $(534,000)  $(377,000)  $2,154,000 
Convertible Debt   -   $4,267,000   $-   $410,000   $(213,000)  $(278,000)  $4,186,000 
Warrants   -   $-   $-   $-   $-   $96,000   $96,000 
Preferred stocks   -   $1,031,000   $(510,000)  $500,000   $-   $(422,000)  $599,000 
Total Investments   -   $7,963,000   $(510,000)  $1,310,000   $(747,000)  $(981,000)  $7,035,000 

 

a.Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital.
  
b.Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations.
SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS

Assets   Valuation technique   Unobservable inputs   Range
             
Common stocks   Put option pricing model   Discount for lack of marketability   0% - 54%
             
Convertible preferred stock   Put option pricing model   Discount for lack of marketability   0% - 54%
             
 Convertible Debt    Discounted cash flow   Maturity   0 - 35 months
        Risk adjusted discount factor   26%
             
    Option pricing model   Volatility   100%
        Risk-free interest rate   0.78 % 1.04%
        Dividend yield   0%
        Time to maturity   0 - 35 months
XML 63 R48.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE DISAGGREGATION (Tables)
 12 Months Ended
Dec. 31, 2021
Revenue Disaggregation  
SCHEDULE OF REVENUE BY BUSINESS UNIT

 

   2021   2020 
Sequire platform revenue  $24,514,000   $5,976,000 
Conference revenue   1,229,000    503,000 
Other revenues   964,000    - 
Total revenues  $26,707,000   $6,479,000 
XML 64 R49.htm IDEA: XBRL DOCUMENT v3.22.2.2
ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Product Information [Line Items]    
Cash Equivalents, at Carrying Value $ 1,348,000 $ 450,000
FDIC amount 250,000  
Excess of federal insurance limit 1,098,000 200,000
Allowance for doubtful accounts 130,000 15,000
Capitalized software development costs $ 798,000 $ 633,000
Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount 11,867,520 15,366,426
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer One [Member]    
Product Information [Line Items]    
Concentration risk percentage 11.00% 43.41%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Two [Member]    
Product Information [Line Items]    
Concentration risk percentage   11.60%
Customer Concentration Risk [Member] | Accounts Receivable [Member] | Customer Three [Member]    
Product Information [Line Items]    
Concentration risk percentage   10.53%
Customer Concentration Risk [Member] | Revenue Benchmark [Member] | Revenue [Member]    
Product Information [Line Items]    
Concentration risk percentage   18.10%
XML 65 R50.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details)
Dec. 29, 2021
USD ($)
Discontinued Operations and Disposal Groups [Abstract]  
Consideration received
Fair value of Series D Stock and Common stock 31,000
Carrying amount of non-controlling interest of BIGToken 6,045,000
Previous equity adjustments of non-controlling interest (12,510,000)
Total consolidations (6,434,000)
Book basis of investment in BIGToken 4,250,000
Loss on disposal of subsidiary $ (10,684,000)
XML 66 R51.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Discontinued Operations and Disposal Groups [Abstract]    
Cash and cash equivalents   $ 1,000
Accounts receivable, net   1,199,000
Prepaid expenses and other current assets   6,000
Property and equipment, net   1,000
Goodwill   5,445,000
Intangible assets, net   917,000
Total assets classified as discontinued operations in the consolidated balance sheet   7,569,000
Accounts payable and accrued expenses   853,000
Other current liabilities   452,000
Total liabilities classified as discontinued operations in the consolidated balance sheet 1,305,000
Revenues 3,431,000 2,168,000
Cost of revenue 1,090,000 800,000
Gross profit 2,341,000 1,368,000
Employee related costs 2,419,000 3,212,000
Marketing and selling expenses 1,136,000 958,000
Platform costs 1,350,000 707,000
Depreciation and amortization 530,000 531,000
General and administrative expenses 4,152,000 530,000
Total operating expense 9,587,000 5,938,000
Loss from operations of discontinued operations (7,246,000) (4,570,000)
Financing costs (5,872,000)
Realized loss on marketable securities (71,000)
Impairment of goodwill (1,258,000)
Total other expense (7,130,000) (71,000)
Loss from discontinued operations before provision for income taxes (14,376,000) (4,641,000)
Provision for income taxes  
Loss from discontinued operations, net of income taxes $ (14,376,000) $ (4,641,000)
XML 67 R52.htm IDEA: XBRL DOCUMENT v3.22.2.2
DISCONTINUED OPERATIONS (Details Narrative)
Dec. 29, 2021
USD ($)
shares
[custom:IssuanceOfAcquisitionSharesDescription] BIGToken’s issuance of the Acquisition Share and the Exchange caused the Company’s BIGToken common stock holdings to decrease from approximately 66% to approximately 4.99%; Therefore, the Company no longer controlled the operations of BIGToken. Given the Company’s loss of control over the operations of BIGToken, the Company deconsolidated BIGToken, as of December 29, 2021, in accordance with ASC 810 Consolidations
Gain (Loss) on Sale of Equity Investments $ 10,684,000
BIG Tokens [Member]  
Conversion of Stock, Amount Issued 5,860,000
Business Combination, Contingent Consideration, Liability 6,465,000
[custom:BusinessCombinationContingentConsiderationLiabilityRelated-0] 12,510,000
Debt Instrument, Convertible, Beneficial Conversion Feature 5,860,000
Fair Value Adjustment of Warrants 885,000
Other Expenses $ 95,000
Common Stock [Member]  
Conversion of Stock, Shares Converted | shares 13,692,304,136
[custom:IssuedAndOutstandingOfCommonStock] 4.99%
Series D Convertible Preferred Stock [Member]  
Conversion of Stock, Shares Converted | shares 22,162
Conversion of Stock, Shares Issued | shares 617,828
Beneficial Ownership Percenatge 4.99%
Series D Convertible Preferred Stock and Common Stock [Member]  
Conversion of Stock, Amount Issued $ 31,000
Brite Pool Inc [Member]  
Stock Issued During Period, Shares, Acquisitions | shares 183,445,351,631
[custom:ExchangedNumberOfSharesforCommonStock] | shares 149,562,566,584
Brite Pool Inc [Member] | Series D Convertible Preferred Stock [Member]  
[custom:ExchangedNumberOfSharesforCommonStock] | shares 242,078
XML 68 R53.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF CALCULATIONS OF PURCHASE PRICE (Details) - USD ($)
 12 Months Ended
Jan. 02, 2021
Sep. 15, 2020
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]        
Cash at closing     $ 3,004,000
LD Micro Inc [Member]        
Business Acquisition [Line Items]        
Fair value of stock at closing   $ 4,264,000    
Cash at closing $ 1,000,000 1,000,000 $ 7,610,000  
Deferred payments   2,771,000    
Less cash received   (303,000)    
Transaction expenses   10,000    
Working capital adjustment   (132,000)    
Purchase price   $ 7,610,000    
XML 69 R54.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Sep. 15, 2020
Business Acquisition [Line Items]      
Intangibles     $ 468,000
Goodwill $ 17,906,000 $ 17,906,000  
LD Micro Inc [Member]      
Business Acquisition [Line Items]      
Accounts receivable, net     30,000
Intangibles     468,000
Goodwill     7,706,000
Accounts payable and accrued liabilities     (324,000)
Payroll protection loan     (42,000)
Other current liabilities     (97,000)
Deferred tax liability     (131,000)
Net assets acquired     $ 7,610,000
XML 70 R55.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION (Details)
Sep. 15, 2020
USD ($)
Business Acquisition [Line Items]  
Fair value $ 468,000
Trademark [Member]  
Business Acquisition [Line Items]  
Fair value $ 271,000
Life in years, description Indefinite
Domain Name [Member]  
Business Acquisition [Line Items]  
Fair value $ 3,000
Life in years, description Indefinite
Noncompete [Member]  
Business Acquisition [Line Items]  
Fair value $ 8,000
Life in years, description 5 years
Customer List [Member]  
Business Acquisition [Line Items]  
Fair value $ 186,000
Life in years, description 3 years
XML 71 R56.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]    
Revenues $ 26,707,000 $ 6,479,000
Nety income (loss) $ (34,762,000) (14,705,000)
LD Micro Inc [Member]    
Business Acquisition [Line Items]    
Revenues  
Nety income (loss)   $ (51,000)
XML 72 R57.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS (Details)
 12 Months Ended
Dec. 31, 2020
USD ($)
Business Acquisition [Line Items]  
Revenues $ 6,479,000
Cost of revenues (1,789,000)
Operating expenses (11,722,000)
Other expense (3,011,000)
Provision for income taxes (21,000)
Net loss (10,064,000)
Pro Forma Adjustment [Member]  
Business Acquisition [Line Items]  
Revenues (0)
Cost of revenues (0)
Operating expenses 171,000
Other expense (0)
Provision for income taxes 0
Net loss 171,000
Pro Forma Combined [Member]  
Business Acquisition [Line Items]  
Revenues 7,416,000
Cost of revenues (1,887,000)
Operating expenses (12,409,000)
Other expense (3,012,000)
Provision for income taxes (21,000)
Net loss (9,913,000)
LD Micro Inc [Member]  
Business Acquisition [Line Items]  
Revenues 937,000
Cost of revenues (98,000)
Operating expenses (858,000)
Other expense (1,000)
Provision for income taxes 0
Net loss $ (20,000)
XML 73 R58.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUMMARY OF PRO FORMA ADJUSTMENTS (Details)
 12 Months Ended
Dec. 31, 2020
USD ($)
Net income (loss) $ 10,064,000
Scenario, Adjustment [Member]  
Amortization of intangibles acquired 64,000
Employee related costs (235,000)
Financing costs
Net income (loss) $ (171,000)
XML 74 R59.htm IDEA: XBRL DOCUMENT v3.22.2.2
ACQUISITIONS (Details Narrative) - USD ($)
 12 Months Ended
Jul. 01, 2021
Apr. 01, 2021
Jan. 02, 2021
Sep. 15, 2020
Sep. 15, 2020
Dec. 31, 2021
Dec. 31, 2020
Business Acquisition [Line Items]              
Business combination, cash payable by entity           $ 3,004,000
Employee related costs             235,000
LD Micro Inc [Member]              
Business Acquisition [Line Items]              
Business Acquisition, Date of Acquisition Agreement       Sep. 15, 2020      
Business combination, cash payable by entity     $ 1,000,000   $ 1,000,000 $ 7,610,000  
Deferred payments discounted under CCC rated corporate debt         3,000,000    
Amortization of payments         $ 229,000    
LD Micro Inc [Member] | Class A common stock [Member]              
Business Acquisition [Line Items]              
Number of shares issued in acquisition         1,600,000    
LD Micro Inc [Member] | Forecast [Member]              
Business Acquisition [Line Items]              
Business combination, cash payable by entity $ 1,000,000 $ 1,000,000          
Noncompete [Member]              
Business Acquisition [Line Items]              
Amortization of payments             2,000
Customer List [Member]              
Business Acquisition [Line Items]              
Amortization of payments             $ 62,000
XML 75 R60.htm IDEA: XBRL DOCUMENT v3.22.2.2
SALE AND PURCHASE OF ACCOUNTS RECEIVABLE (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Oct. 29, 2021
Jun. 30, 2020
Apr. 09, 2020
Mar. 24, 2020
Jan. 30, 2020
Jan. 22, 2020
Dec. 31, 2021
Dec. 31, 2020
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Accounts receivable           $ 75,000 $ 454,000    
Accounts receivable purchase           $ 56,000 $ 454,000    
Converted debt                 $ 1,118,000
Loss on extinguishment               (1,103,000)
Conversion premium $ 51,075,000             51,075,000 69,551,000
Debt Instrument, Unused Borrowing Capacity, Amount 631,000             $ 631,000 570,000
Proceeds from additional borrowing 1,000,000               472,000
Accounts Payable [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Converted debt     $ 510,000            
Accrued Liabilities [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Converted debt     184,000            
Debentures [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Converted debt     788,000            
Fair value of debentures     815,000            
Loss on extinguishment     546,000            
Difference between face value and fair value     95,000            
Conversion premium     27,000            
Fair value of warrants     $ 424,000            
Common Class A [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Sale of stock number of share           29,519 239,029    
Sale of stock, value           $ 75,000 $ 454,000    
Ten Percent [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Description of sale of accounts receivable               ten percent (10%) of the portion of the receivables which are paid on or before the 30th day following the effective date of the agreement;  
Twenty Percent [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Description of sale of accounts receivable               twenty percent (20%) of the portion of the receivables which are paid after the 30th day but on or before the 60th day following the effective date of the agreement; and  
Thirty Six Percent [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Description of sale of accounts receivable               thirty-six  
Agreements to Sell Accounts Receivable [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
[custom:PercentageOfReceivablesUponExerciseOfPutOption]         136.00%        
Agreements to Sell Accounts Receivable Ammended [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Description of sale of accounts receivable       On April 9, 2020 the Company entered into an agreement to amend the January 22 and 30 accounts receivable agreements. The purchaser agreed to amend the put option date as described above to June 23, 2020 and June 30, 2020 for the sale of receivables originating on January 22, 2020 and January 30, 2020, respectively. As consideration for the extension the Company agreed to issue the purchaser 32,668 and 4,032 shares of Class A common stock for the receivable sale originating on January 22, 2020 and January 30, 2020, respectively.          
Sale of stock number of share           4,032 32,668    
PIPE Technologies [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
Right to future subscription revenues                 570,000
Subscription revenues                 $ 528,000
Accounts Receivable, Related Parties 625,000             $ 625,000  
Proceeds from accounts receivable               576,000  
Receivable Purchase and Sale Agreement [Member] | BIGtoken [Member]                  
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]                  
[custom:AccountsReceivables-0]   $ 352,000              
[custom:PurchasePrice-0]   $ 327,000              
Debt Instrument, Redemption Price, Percentage   7.00%              
[custom:AccountsReceivable-0] $ 352,000             $ 352,000  
XML 76 R61.htm IDEA: XBRL DOCUMENT v3.22.2.2
CONTRACTS RECEIVABLE (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Credit Loss [Abstract]    
Contracts receivable $ 844,000
XML 77 R62.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Balances at beginning of year $ 8,447,000 $ 83,000
Additions 34,914,000 8,406,000
Sale of marketable securities (8,666,000) (916,000)
Designation for dividend distribution (10,790,000)  
Change in fair value (8,288,000) 874,000
Balances at end of year 15,617,000 8,447,000
Convertible Debentures [Member]    
Balances at beginning of year 683,000
Additions 4,602,000 910,000
Sale of marketable securities (510,000)
Designation for dividend distribution (213,000)  
Change in fair value (375,000) (227,000)
Balances at end of year 4,187,000 683,000
Common Stock [Member]    
Balances at beginning of year 7,764,000 83,000
Additions 29,281,000 7,496,000
Sale of marketable securities (8,156,000) (916,000)
Designation for dividend distribution (10,577,000)  
Change in fair value (7,577,000) 1,101,000
Balances at end of year 10,735,000 7,764,000
Preferred Stock [Member]    
Balances at beginning of year  
Additions 1,031,000  
Sale of marketable securities  
Designation for dividend distribution  
Change in fair value (432,000)  
Balances at end of year 599,000
Warrant [Member]    
Balances at beginning of year  
Additions  
Sale of marketable securities  
Designation for dividend distribution  
Change in fair value 96,000  
Balances at end of year $ 96,000
XML 78 R63.htm IDEA: XBRL DOCUMENT v3.22.2.2
MARKETABLE SECURITIES (Details Narrative)
 12 Months Ended
Dec. 31, 2021
USD ($)
Cash and Cash Equivalents [Abstract]  
[custom:ProceedFromSaleAndMaturityOfMarketableSecurities] $ 8,666,000
Marketable Securities 7,862,000
[custom:GainOnMarketableSecurities] $ 804,000
XML 79 R64.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF DESIGNATED ASSETS (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Marketable securities $ 7,862,000  
Balance 3,925,000
Designated Assets [Member]    
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]    
Cash 686,000  
Marketable securities 3,239,000  
Balance $ 3,925,000  
XML 80 R65.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS (Details) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]      
Sales   $ (8,666,000) $ (916,000)
Change in fair value of designated assets   8,288,000 $ (874,000)
Designated Assets [Member]      
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]      
Designated assets at beginning balance $ 6,387,000    
Sales (770,000) (770,000)  
Proceeds from sale of other assets 686,000    
Change in fair value of designated assets (2,378,000)    
Designated assets at ending balance $ 3,925,000 $ 3,925,000  
XML 81 R66.htm IDEA: XBRL DOCUMENT v3.22.2.2
DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative) - USD ($)
 3 Months Ended 12 Months Ended
Dec. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]      
Sale of marketable securities   $ 8,666,000  
Marketable Securities   8,666,000 $ 916,000
Gain on marketable securities.   804,000  
Designated Assets [Member]      
Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]      
Sale of marketable securities   686,000  
Marketable Securities $ 770,000 770,000  
Gain on marketable securities.   $ 84,000  
XML 82 R67.htm IDEA: XBRL DOCUMENT v3.22.2.2
NOTES RECEIVABLE (Details Narrative) - USD ($)
 12 Months Ended
Oct. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Implied discount     $ 5,639,000
Note receivable   $ 935,000 $ 893,000
Rated Corporate Debt [Member]      
Deferred payments of notes receivable   960,000  
Discount on notes receivable   $ 40,000  
Debt instrument term   3 years  
Implied discount   $ 107,000  
Maximum [Member] | Rated Corporate Debt [Member]      
Debt instrument term   3 years  
Haylard MDLLC [Member]      
Redemption of class A units 10,000,000    
Price to be paid for all of the units $ 6,718,000    
Price to be paid upon earlier 960,000    
Total consideration $ 7,678,000    
Haylard MDLLC [Member] | Maximum [Member]      
Excess amount for each unit 0.7677543    
MD CoInvest, LLC [Member]      
Redemption of class A units 420,000    
Price to be paid for all of the units $ 282,000    
Price to be paid upon earlier 40,000    
Total consideration $ 322,000    
MD CoInvest, LLC [Member] | Maximum [Member]      
Excess amount for each unit 0.7677543    
XML 83 R68.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF PROPERTY AND EQUIPMENT (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Line Items]    
Accumulated depreciation $ (357,000) $ (285,000)
Property and equipment, net 114,000 117,000
Office Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Office equipment $ 471,000 $ 402,000
XML 84 R69.htm IDEA: XBRL DOCUMENT v3.22.2.2
PROPERTY AND EQUIPMENT (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Property, Plant and Equipment [Abstract]    
Depreciation $ 72,000 $ 28,000
XML 85 R70.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF INTANGIBLE ASSETS (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Finite-Lived Intangible Assets [Line Items]    
Total cost $ 5,970,000 $ 5,172,000
Accumulated amortization (4,527,000) (3,680,000)
Intangible assets, net 1,443,000 1,492,000
Noncompete Agreements [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost 1,258,000 1,258,000
Intellectual Property [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost 756,000 756,000
Software [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost 756,000 617,000
Internally Developed Software [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost 2,726,000 2,048,000
Trademarks [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost 271,000 271,000
Customer Lists [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost 186,000 186,000
Internet Domain Names [Member]    
Finite-Lived Intangible Assets [Line Items]    
Total cost $ 17,000 $ 36,000
XML 86 R71.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details)
Dec. 31, 2021
USD ($)
Goodwill and Intangible Assets Disclosure [Abstract]  
2022 $ 632,000
2023 404,000
2024 136,000
Intangible assets $ 1,172,000
XML 87 R72.htm IDEA: XBRL DOCUMENT v3.22.2.2
INTANGIBLE ASSETS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Goodwill and Intangible Assets Disclosure [Abstract]    
Amortization of finite-lived intangible assets $ 847,000 $ 744,000
Goodwill 17,906,000 17,906,000
Goodwill Acquisition   7,706,000
Impairment loss $ 0 $ 0
XML 88 R73.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF COMPONENT OF LEASE EXPENSE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Right To Use Asset    
Operating lease expense $ 163,000 $ 163,000
Short-term lease expense 12,000 29,000
Total lease expense $ 175,000 $ 192,000
XML 89 R74.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Right To Use Asset    
Operating lease right-of-use assets - non-current $ 257,000 $ 366,000
Operating lease liabilities - current 130,000 109,000
Operating lease liabilities - non-current 114,000 243,000
Total operating lease liabilities $ 244,000 $ 352,000
XML 90 R75.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE (Details)
Dec. 31, 2021
Right To Use Asset  
Weighted Average Remaining Lease Term 1 year 9 months
Weighted Average Discount Rate 18.00%
XML 91 R76.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Right To Use Asset    
2022 $ 163,000  
2023 123,000  
Total future lease payments, undiscounted 286,000  
Less: Implied interest (42,000)  
Present value of operating lease payments $ 244,000 $ 352,000
XML 92 R77.htm IDEA: XBRL DOCUMENT v3.22.2.2
RIGHT TO USE ASSET (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Right To Use Asset    
Lessee, Operating Lease, Remaining Lease Term 1 year 9 months  
Variable lease cost and sublease $ 0  
Cash paid for operating lease $ 175,000 $ 192,000
XML 93 R78.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Payables and Accruals [Abstract]    
Accounts payable, trade $ 1,938,000 $ 1,900,000
Accrued expenses 1,518,000 537,000
Accrued compensation 213,000 232,000
Accrued commissions 303,000 32,000
Accrued interest 123,000 7,000
Accounts payable and accrued expenses $ 4,095,000 $ 2,708,000
XML 94 R79.htm IDEA: XBRL DOCUMENT v3.22.2.2
DEFERRED REVENUE (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Revenue from Contract with Customer [Abstract]    
Contract with Customer, Liability $ 12,859,000 $ 4,842,000
XML 95 R80.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF OTHER CURRENT LIABILITIES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Other Liabilities Disclosure [Abstract]    
Operating lease liabilities - current $ 130,000 $ 109,000
Other current liabilities 633,000 3,308,000
Total other current liabilities $ 763,000 $ 3,417,000
XML 96 R81.htm IDEA: XBRL DOCUMENT v3.22.2.2
OTHER CURRENT LIABILITIES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Other Sundry Liabilities, Current $ 633,000 $ 3,308,000
LD Micro [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Deferred payments related to acquisition   2,735,000
Deferred contractual payments 3,004,000  
Factoring Facility [Member]    
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]    
Other Sundry Liabilities, Current $ 633,000 $ 573,000
XML 97 R82.htm IDEA: XBRL DOCUMENT v3.22.2.2
PAYCHECK PROTECTION PROGRAM LOAN (Details Narrative) - USD ($)
 12 Months Ended
Apr. 17, 2020
Dec. 31, 2021
Dec. 31, 2020
Sep. 15, 2020
Short-Term Debt [Line Items]        
Forgiveness of payroll protection program loan   $ 1,116,000  
LD Micro Inc [Member]        
Short-Term Debt [Line Items]        
Payroll protection loan in connection with acquisition       $ 42,000
Paycheck Protection Program Loan [Member]        
Short-Term Debt [Line Items]        
Unsecured loan $ 1,084,000      
Term loan 2 years      
Interest rate 1.00%      
Loans Payable   $ 10,000 $ 1,126,000  
XML 98 R83.htm IDEA: XBRL DOCUMENT v3.22.2.2
SHORT TERM PROMISSORY NOTES (Details Narrative) - USD ($)
 12 Months Ended
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Feb. 28, 2020
Short-Term Debt [Line Items]        
Loss on extinguishment   $ (1,103,000)  
Repayment of short-term note payable   2,130,000  
Converted debt     1,118,000  
Conversion premium   $ 51,075,000 $ 69,551,000  
Accrued Liabilities [Member]        
Short-Term Debt [Line Items]        
Converted debt $ 184,000      
Debentures [Member]        
Short-Term Debt [Line Items]        
Loss on extinguishment 546,000      
Convertible debt 788,000      
Fair value of debenture 815,000      
Difference between face value and fair value 95,000      
Fair value of warrants 424,000      
Conversion premium 27,000      
Short-Term Promissory Notes [Member]        
Short-Term Debt [Line Items]        
Debt instrument, face amount       $ 450,000
Debt instrument, description   The notes are due and payable on May 12, 2020 (“Maturity Date”). The notes will accrue interest as follows: (i) on the origination date, ten percent (10%) of the principal amount was added to each note, (ii) on March 12, 2020, an additional ten percent (10%) of the principal amount was added to each note, and (iii) on April 12, 2020, an additional sixteen percent (16%) of the principal amount was added to each notes    
Number of shares of common stock   450,000    
Debt instrument, original issue discount   $ 45,000    
Security shares     100,000  
Loss on extinguishment     $ 181,000  
Difference between face value and fair value 65,000      
Outstanding loan     $ 0  
Short-Term Promissory Notes [Member] | Accrued Liabilities [Member]        
Short-Term Debt [Line Items]        
Converted debt 126,000      
Short-Term Promissory Notes [Member] | Accrued Liabilities [Member] | Two Remaining Note Holders [Member]        
Short-Term Debt [Line Items]        
Converted debt 350,000      
Short-Term Promissory Notes [Member] | Debentures [Member]        
Short-Term Debt [Line Items]        
Loss on extinguishment 375,000      
Convertible debt 541,000      
Fair value of debenture 560,000      
Difference between face value and fair value 19,000      
Fair value of warrants 291,000      
Conversion premium 18,000      
Short-Term Promissory Notes [Member] | Chief Financial Officer [Member]        
Short-Term Debt [Line Items]        
Debt instrument, face amount       $ 100,000
Repayment of short-term note payable $ 136,000      
XML 99 R84.htm IDEA: XBRL DOCUMENT v3.22.2.2
TERM LOAN NOTE (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
May 02, 2020
Feb. 28, 2020
Jun. 30, 2020
Dec. 31, 2021
Dec. 31, 2020
Feb. 21, 2021
Short-Term Debt [Line Items]            
Debt instrument, unused borrowing capacity, amount       $ 631,000 $ 570,000  
Proceeds from notes payable       2,130,000  
Debt instrument origination fee   $ 300,000        
Class of warrant issued       6,828,611    
Exercise price of warrant           $ 5.83
Proceeds from issuance of warrant       $ 15,952,000  
Warrant [Member]            
Short-Term Debt [Line Items]            
Class of warrant issued   500,000        
Exercise price of warrant   $ 3.60        
Warrant expire date   Oct. 31, 2022        
Proceeds from issuance of warrant   $ 83,000        
Warrant [Member] | Maximum [Member]            
Short-Term Debt [Line Items]            
Exercise price of warrant   $ 2.50        
Warrant [Member] | Second Drawdown [Member]            
Short-Term Debt [Line Items]            
Class of warrant issued   500,000        
Warrant exercise price percentage   25.00%        
Term Loan [Member]            
Short-Term Debt [Line Items]            
Term loan, maximum borrowing capacity   $ 5,000,000        
Debt instrument, unused borrowing capacity, amount   2,500,000        
Proceeds from notes payable $ 2,164,000 2,500,000        
Debt instrument, additional borrowing capacity   $ 1,000,000        
Debt instrument, interest rate   10.00%        
Debt instrument, maturity date   Mar. 01, 2022        
Debt instrument, payment term description   the Company will make monthly payments of principal and interest on an eighteen (18) month straight line amortization schedule, based on the principal outstanding on July 31, 2020. Additionally, the Company will have the option of a one (1) time payment-in-kind payment for a monthly required payment of principal and interest, which will defer such payments and result in a recalculation of the amortization schedule. In the event that the Company is late on any payments under the Loan, a late charge of three percent (3%) of the amount of the payment due will be assessed        
Attorneys fees   $ 35,000        
Repayment of loan principal and interest     $ 2,585,000      
Outstanding loan         $ 0  
XML 100 R85.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Short-Term Debt [Line Items]    
Principal $ 1,267,000 $ 9,386,000
Debt discount (103,000) (3,370,000)
Net book value 1,164,000 6,016,000
Issuance Beginning of Year [Member]    
Short-Term Debt [Line Items]    
Principal 9,386,000 16,101,000
Debt discount (3,370,000) (12,731,000)
Net book value 6,016,000 3,370,000
Extension [Member]    
Short-Term Debt [Line Items]    
Principal 268,000 472,000
Debt discount
Net book value 268,000 472,000
Conversion [Member]    
Short-Term Debt [Line Items]    
Principal (8,387,000) (1,118,000)
Debt discount 2,413,000 685,000
Net book value (5,974,000) (433,000)
Amortization [Member]    
Short-Term Debt [Line Items]    
Principal
Debt discount 854,000 5,639,000
Net book value $ 854,000 5,639,000
Redemption [Member]    
Short-Term Debt [Line Items]    
Principal   (6,069,000)
Debt discount   3,037,000
Net book value   $ (3,032,000)
XML 101 R86.htm IDEA: XBRL DOCUMENT v3.22.2.2
OID CONVERTIBLE DEBENTURES (Details Narrative)
 12 Months Ended
Dec. 31, 2021
USD ($)
$ / shares
shares
Jun. 30, 2020
USD ($)
Jun. 25, 2020
USD ($)
$ / shares
shares
Feb. 28, 2020
USD ($)
Dec. 31, 2021
USD ($)
$ / shares
shares
Dec. 31, 2020
USD ($)
shares
Feb. 21, 2021
$ / shares
Warrant to purchase common stock, shares | shares 6,828,611       6,828,611    
Accounts receivable $ 821,000       $ 821,000 $ 1,409,000  
Accrued interest 123,000       123,000 7,000  
Warrants exercise price per share | $ / shares             $ 5.83
Repayment of short-term note payable         2,130,000  
Proceeds from issuance of debt 1,000,000         472,000  
Amortization expenses           5,639,000  
Debt conversion, converted instrument, amount           1,118,000  
Additional principal balance           $ 434,000  
Additional principal percentage           5.00%  
Current principal balance fee amount         5.00%    
Debenture Holders [Member]              
Debt face amount 5,974,000       $ 5,974,000    
Debt discount 2,413,000       2,413,000    
Debt conversion, converted instrument, amount         8,387,000    
Additional principal balance $ 8,387,000       $ 8,387,000    
Class A common stock [Member]              
Debt conversion, converted instrument, shares issued | shares           411,626  
Class A common stock [Member] | Debenture Holders [Member]              
Debt conversion, converted instrument, shares issued | shares         3,122,167    
Securities Purchase Agreement [Member] | Placement Agent [Member]              
Proceeds from warrants percentage         8.00%    
OID Convertible Debentures [Member]              
Debt face amount     $ 16,101,000        
Debt discount     $ 14,169,000        
Original issue discount percentage     12.00%        
Warrant to purchase common stock, shares | shares     6,440,561        
Proceeds from warrants exercise     $ 13,000,000        
Outstanding loan     1,169,000        
Accounts receivable     510,000        
Accrued interest     125,000        
Short term promissory notes     $ 350,000        
Debt Instrument, Maturity Date     Dec. 31, 2021        
Debt Instrument, Interest Rate, Stated Percentage     12.00%        
Debt Instrument, Convertible, Conversion Price | $ / shares     $ 2.69        
Debt Instrument, Description     Subject to the Company’s compliance with certain equity conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that (i) the Company sells or reprices any securities (each, a “Redemption Financing”), or (ii) the Company disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to cause the Company (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures        
Debt instrument, restrictive covenants     The Company is also subject to certain negative covenants (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser) under the Debentures, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends        
Warrants exercise price per share | $ / shares     $ 2.50        
Warrant or Right, Reason for Issuance, Description     Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company        
Proceeds from issuance of debt   $ 4,200,000          
Proceeds from issuance Initial public offering   13,000,000          
Net proceeds from issuance of Initial public offering   9,100,000          
Legal Fees   75,000          
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member]              
Warrant to purchase common stock, shares | shares 478,854       478,854    
Warrants exercise price per share | $ / shares $ 3.3625       $ 3.3625    
Class of warrant or right, unissued | shares 360,000       360,000    
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member] | Placement Agent [Member]              
Warrant to purchase common stock, shares | shares 478,854       478,854    
Payments of Debt Issuance Costs         $ 1,040,000    
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member] | Measurement Input, Risk Free Interest Rate [Member]              
Warrants and rights outstanding, measurement input 0.11       0.11    
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member] | Measurement Input, Expected Term [Member]              
Warrants and rights outstanding, Term 2 years 5 months       2 years 5 months    
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member] | Measurement Input, Price Volatility [Member]              
Warrants and rights outstanding, measurement input 96       96    
OID Convertible Debentures [Member] | Securities Purchase Agreement [Member] | Measurement Input, Expected Dividend Rate [Member]              
Warrants and rights outstanding, measurement input 0       0    
OID Convertible Debentures [Member] | Prior To Closing Date [Member]              
Proceeds from issuance of debt   3,800,000          
OID Convertible Debentures [Member] | After The Closing Date [Member]              
Proceeds from issuance of debt   $ 5,000,000          
OID Convertible Debentures [Member] | Accounts Receivable [Member]              
Accrued interest     $ 184,000        
OID Convertible Debentures [Member]              
Payment of outstanding debt       $ 2,500,000      
Repayment of short-term note payable       $ 136,000      
XML 102 R87.htm IDEA: XBRL DOCUMENT v3.22.2.2
SERIES A PREFERRED STOCK (Details Narrative) - USD ($)
Sep. 20, 2021
Aug. 17, 2021
Dec. 31, 2021
Mar. 31, 2021
Class of Stock [Line Items]        
Preferred stock authorized     50,000,000  
Warrant to purchase common stock, shares       2,283,171
Fair value of preferred stock     $ 3,925,000  
Series A Preferred Stock [Member]        
Class of Stock [Line Items]        
Dividend description   the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock (“Preferred Stock”) to certain Qualified Recipients (as defined below) on a 1-for-1 as converted to common stock basis (the “Dividend”).    
Preferred stock authorized 36,462,417      
Preferred stock, shares issued 25,160,504      
Preferred stock, shares outstanding 25,160,504      
Warrant to purchase common stock, shares 10,327,645      
Conversion of convertible securities $ 2,486,275      
Stock issued during period, shares, conversion of convertible securities 974,268      
Series A Preferred Stock [Member] | Maximum [Member]        
Class of Stock [Line Items]        
Preferred stock authorized 36,462,417      
XML 103 R88.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCKHOLDERS’ EQUITY (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Jun. 30, 2020
Jan. 30, 2020
Jan. 22, 2020
Aug. 31, 2021
Jan. 31, 2021
Jan. 31, 2020
Dec. 31, 2021
Dec. 31, 2020
Class of Stock [Line Items]                
Preferred stock shares authorized             50,000,000  
Preferred stock par value             $ 0.001  
Common stock shares authorized             259,000,000  
Common stock shares issued             25,995,172 16,145,778
Common stock shares outstanding             25,995,172 16,145,778
Receivable description           we agreed to provide a true-up to the purchaser of the receivable of between 10% and 36% depending on the payment date. In the event of nonpayment of the receivables by March 24, 2020 and March 30, 2020, as applicable to the receivables, the purchaser may require us to purchase any outstanding portion of the receivables for 136% of its outstanding balance (“Payment Date”).    
At the Market Sales Agreement [Member]                
Class of Stock [Line Items]                
Sale of stock             53,616  
Sale of stock, consideration received on transaction             $ 284,000  
Share Buy-Back Program [Member]                
Class of Stock [Line Items]                
Number of repurchased shares             155,000  
Number of repurchased value             $ 793,000  
Common Stock [Member]                
Class of Stock [Line Items]                
Shares issued for extension agreement               36,700
Board of Directors [Member] | Common Stock [Member]                
Class of Stock [Line Items]                
Proceeds from issuanceor sale of equity       $ 10,000,000.0        
Nonperforming Financial Instruments [Member]                
Class of Stock [Line Items]                
Proceeds from sale of non-performing receivables         $ 529,000      
Purchase price of receivables           $ 510,000    
Series 1 Preferred Stock [Member]                
Class of Stock [Line Items]                
Preferred stock shares authorized             200,000  
Class A common stock [Member]                
Class of Stock [Line Items]                
Common stock shares authorized             250,000,000 250,000,000
Common stock par value             $ 0.001 $ 0.001
Common stock shares issued             25,995,172 16,145,778
Common stock shares outstanding             25,995,172 16,145,778
Class A common stock [Member] | Board of Directors [Member]                
Class of Stock [Line Items]                
Repurchase of common stock       $ 10,000,000        
Class B Common Stock [Member]                
Class of Stock [Line Items]                
Common stock shares authorized             9,000,000  
Common stock par value             $ 0.001  
Common Class A [Member]                
Class of Stock [Line Items]                
Sale of stock   29,519 239,029          
Common Class A [Member] | Nonperforming Financial Instruments [Member]                
Class of Stock [Line Items]                
Number of shares pledged for repurchase of receivables           239,029    
Shares issued for extension agreement 36,700              
XML 104 R89.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF STOCK OPTION ACTIVITY (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Outstanding Beginning balance 1,642,324 1,192,519
Weighted Average Strike Price/Share, Outstanding Beginning balance $ 3.30 $ 4.14
Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance 2 years 9 months 21 days 2 years 2 months 1 day
Aggregate Intrinsic Value, Outstanding Beginning balance
Weighted Average Grant Date Fair Value, Outstanding Beginning balance
Number of Shares, Granted 21,627 766,172
Weighted Average Strike Price/Share, Granted $ 4.38 $ 2.77
Weighted Average Remaining Contractual Term (Years), Granted 6 years 3 months 14 days 3 years
Aggregate Intrinsic Value, Granted $ 2,000 $ 521,000
Weighted Average Grant Date Fair Value, Granted $ 3.60 $ 2.72
Number of Shares, Exercised (12,500)
Weighted Average Strike Price/Share, Exercised $ 2.70
Aggregate Intrinsic Value, Exercised
Weighted Average Grant Date Fair Value, Exercised $ 2.00
Number of Shares, Forfeited (319,671) (316,367)
Weighted Average Strike Price/Share, Forfeited $ 4.60 $ 5.14
Aggregate Intrinsic Value, Forfeited
Weighted Average Grant Date Fair Value, Forfeited $ 3.49 $ 3.14
Number of Shares, Outstanding Ending balance 1,331,780 1,642,324
Weighted Average Strike Price/Share, Outstanding Ending balance $ 3.02 $ 3.30
Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance 2 years 4 months 20 days 2 years 9 months 21 days
Aggregate Intrinsic Value, Outstanding Ending balance $ 1,969,000
Weighted Average Grant Date Fair Value, Outstanding Ending balance $ 2.13
Number of Shares, Vested and exercisable Ending balance 870,750 844,742
Weighted Average Strike Price/Share, Vested and exercisable Ending balance $ 3.05 $ 3.54
Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance 2 years 3 months 7 days 2 years 7 months 13 days
Aggregate Intrinsic Value, Vested and exercisable Ending balance $ 1,265,000 $ 333,000
Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance $ 2.15 $ 3.54
Number of Shares, Unvested and non-exercisable Ending balance 461,030 797,582
Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance $ 2.96 $ 2.81
Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance 2 years 7 months 13 days 3 years
Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance $ 703,000 $ 207,000
Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance $ 2.10 $ 2.09
Weighted Average Remaining Contractual Term (Years), Exercised 3 years 7 months 17 days  
Weighted Average Remaining Contractual Term (Years), Forfeited 7 months 24 days  
XML 105 R90.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF WARRANT ACTIVITY (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Share-Based Payment Arrangement [Abstract]    
Number of Shares, Warrants Outstanding Beginning balance 12,585,283 6,237,430
Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance $ 2.98 $ 3.57
Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance 1 year 9 months 10 days 2 years 8 months 4 days
Aggregate Intrinsic Value, Warrants Outstanding Beginning balance $ 4,460,000
Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance $ 1.38
Number of Shares, Warrants Granted 4,582,345 7,421,054
Weighted Average Strike Price/Share, Warrants Granted $ 7.48 $ 2.63
Weighted Average Remaining Contractual Term (Years), Warrants Granted 1 month 9 days 1 year 9 months 25 days
Aggregate Intrinsic Value, Aggregate Intrinsic Value, Warrants Granted $ 3,929,000
Weighted Average Grant Date Fair Value, Warrants Granted $ 1.70 $ 1.38
Number of Shares, Warrants Exercised (7,148,501)
Weighted Average Strike Price/Share, Warrants Exercised $ 2.74
Aggregate Intrinsic Value, Warrants Exercised
Weighted Average Grant Date Fair Value, Warrants Exercised
Number of Shares, Warrants Forfeiture (1,073,201)
Weighted Average Strike Price/Share, Warrants Forfeiture
Aggregate Intrinsic Value, Warrants Forfeitures
Weighted Average Grant Date Fair Value, Warrants Forfeiture
Number of Shares, Warrants Outstanding Ending balance 10,019,127 12,585,283
Weighted Average Strike Price/Share, Warrants Outstanding Ending balance $ 5.21 $ 2.98
Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance 5 months 19 days 1 year 9 months 10 days
Aggregate Intrinsic Value, Warrants Outstanding Ending balance $ 6,779,000 $ 4,460,000
Weighted Average Grant Date Fair Value, Warrants Outstanding Ending balance $ 1.70 $ 1.38
Number of Shares, Warrants Vested and Exercisable 9,719,127 12,285,283
Weighted Average Strike Price/Share, Warrants Vested and Exercisable $ 5.22 $ 2.94
Weighted Average Remaining Contractual Term (Years), Warrants Vested and exercisable Ending balance 4 months 28 days 1 year 8 months 26 days
Aggregate Intrinsic Value, Warrants Vested and Exercisable $ 6,779,000 $ 4,460,000
Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable $ 1.70 $ 1.38
Number of Shares, Warrants Unvested and Non-Exercisable 300,000 300,000
Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable $ 4.75 $ 4.75
Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance 2 years 4 months 13 days 3 years 4 months 13 days
Aggregate Intrinsic Value, Warrants Unvested and Non Exercisable $ 0
Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable
Weighted Average Remaining Contractual Term (Years), Warrants Exercised 9 months 10 days  
XML 106 R91.htm IDEA: XBRL DOCUMENT v3.22.2.2
STOCK OPTIONS, AWARDS AND WARRANTS (Details Narrative)
 1 Months Ended 3 Months Ended 12 Months Ended
Feb. 21, 2021
USD ($)
$ / shares
shares
Feb. 04, 2021
USD ($)
shares
Nov. 30, 2020
USD ($)
$ / shares
shares
Aug. 31, 2020
USD ($)
$ / shares
shares
Feb. 28, 2020
USD ($)
$ / shares
shares
Feb. 23, 2016
USD ($)
shares
Apr. 30, 2020
USD ($)
$ / shares
shares
Mar. 31, 2021
USD ($)
shares
Dec. 31, 2021
USD ($)
shares
Dec. 31, 2020
USD ($)
Nov. 05, 2014
shares
Jan. 31, 2012
shares
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Share-based payment award, fair value of options             $ 60,000          
Option term             7 years          
Implied volatility 96.00%           100.00%          
Risk free equivalent yield 11.00%           0.24%          
Share price | $ / shares             $ 1.95          
Class of warrant or right, number of securities called by warrants or rights | shares               2,283,171        
Warrants exercise price per share | $ / shares $ 5.83                      
Share-Based Payment Arrangement, Expense                 $ 1,006,000 $ 1,615,000    
Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount                 811,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value                 $ 811,000      
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term                 2 years 9 months 29 days      
Proceeds from issuance of warrants               $ 4,930,000        
Proceeds from warrant exercises                 $ 15,952,000    
[custom:NumberOfWarrantsCancelled] | shares               349,197        
Shares issued upon exercise of warrants | shares                 6,828,611      
Warrant [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Class of warrant or right, number of securities called by warrants or rights | shares 4,545,440 25,568,064,462                    
Warrants exercise price per share | $ / shares         $ 3.60              
Fair value of warrants   $ 885,000                    
Proceeds from issuance of warrants $ 11,022,000                      
Proceeds from warrant exercises         $ 83,000              
Shares issued upon exercise of warrants | shares         500,000              
Warrant [Member] | Measurement Input, Expected Term [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Warrants and Rights Outstanding, Term   3 years                    
Warrant [Member] | Measurement Input, Option Volatility [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Warrants and Rights Outstanding, Measurement Input   92.30                    
Warrant [Member] | Measurement Input, Risk Free Interest Rate [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Warrants and Rights Outstanding, Measurement Input   18                    
New Warrant [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Share price | $ / shares $ 0.125                      
Class of warrant or right, number of securities called by warrants or rights | shares 4,545,440                      
Warrants exercise price per share | $ / shares $ 7.50                      
Fair value of warrants $ 7,737,000                      
Warrants and rights outstanding, maturity date Jan. 31, 2022                      
Proceeds from issuance of warrants $ 568,000                      
Proceeds from warrant exercises 11,363,000                      
Solicitation Fees $ 909,000                      
Non-Executive Directors [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of common shares option to purchase | shares             36,172          
Shares issued price per share | $ / shares             $ 1.95          
Number of option vested | shares             9,043          
Option expiration date             Apr. 15, 2027          
Employees and Members of Management Team [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Class of warrant or right, number of securities called by warrants or rights | shares     300,000 430,000                
Warrants exercise price per share | $ / shares     $ 2.97 $ 2.70                
Fair value of warrant option grant date     $ 649,000 $ 859,000                
Option vesting period       5 years                
2012 Equity Compensation Plan [Member] | Common Class A [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares authorized | shares                       600,000
2014 Equity Compensation Plan [Member] | Common Class A [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares reserved for grants | shares                     600,000  
2016 Equity Compensation Plan [Member] | Common Class A [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Number of shares reserved for grants | shares           600,000            
2012, 2014 and 2016 Equity Compensation Plans [Member]                        
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]                        
Minimum percentage of fair market value           100.00%            
Threshold of employee ownership for increase in fair market value and decrease in maximum life           10.00%            
Minimum percentage of fair market value for eligible employee           110.00%            
Maximum fair market value underlying options exercisable by any option holder during any calendar year           $ 100,000            
Maximum option life           10 years            
Maximum option life for 10% holder           5 years            
XML 107 R92.htm IDEA: XBRL DOCUMENT v3.22.2.2
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Lease term 1 year  
Lease amount $ 175,000 $ 192,000
Chief Executive Officer [Member]    
Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]    
Lease amount 382,500  
Payments for Rent 39,000  
Related party payments $ 477,000  
XML 108 R93.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Income Tax Disclosure [Abstract]    
Current Federal
Deferred Federal (132,000)
Federal (132,000)
Current State 5,000 21,000
Deferred State
State 5,000 21,000
Current Subtotal 5,000 21,000
Deferred Subtotal (132,000)
Subtotal (127,000) 21,000
Current Valuation allowance
Deferred Valuation allowance
Valuation allowance
Current Total 5,000 21,000
Deferred Total (132,000)
Total $ (127,000) $ 21,000
XML 109 R94.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF EFFECTIVE TAX RATE (Details)
 12 Months Ended
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]    
Taxes calculated at federal rate 21.00% 21.00%
Stock based compensation 0.00% (2.70%)
Permanent differences (1.00%) (13.40%)
Change in valuation allowance (15.10%) (2.10%)
Fair market adjustment derivatives 0.00% 0.50%
Prior year true-ups 0.00% (3.30%)
Other adjustments (4.10%) (0.10%)
Provision for income tax benefit (expense) 0.80% (0.10%)
XML 110 R95.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($)
Dec. 31, 2020
Dec. 31, 2019
Deferred Tax Assets    
Net operating loss carryforwards $ 10,003,000 $ 9,040,000
Bad debt expense 33,000 136,000
Fixed assets 9,000
Accrued interest
Stock based compensation 525,000 567,000
Interest expense limitation carryover 220,000 629,000
Contribution carryover 5,000 5,000
Lease liability 62,000 97,000
Unrealized gain on marketable securities 2,668,000 120,000
Other accruals 124,000 173,000
Total Deferred Tax Assets 13,640,000 10,776,000
Deferred Tax Liabilities    
Fixed assets 29,000
Right-of-use asset 66,000 101,000
Intangibles (455,000) (690,000)
Interest expense limitation carryover (59,000)
Prepaid expenses (15,000) (17,000)
Total Deferred Tax Liabilities (624,000) (808,000)
Net Deferred Tax Assets 13,016,000 9,968,000
Valuation Allowance (13,016,000) (9,968,000)
Net deferred tax / (liabilities)
XML 111 R96.htm IDEA: XBRL DOCUMENT v3.22.2.2
INCOME TAXES (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Income Tax Disclosure [Abstract]      
Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount   $ 2,996,000 $ 2,375,000
Operating Loss Carryforwards, Limitations on Use   which are available to offset future taxable income, of approximately $  
Deferred Tax Assets, Operating Loss Carryforwards, Domestic   $ 34,933,000  
Deferred Tax Assets, Operating Loss Carryforwards, State and Local   73,733,000  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense $ 0 $ 0  
Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued     $ 0
NOL carryforwards, description   The Company is in the process of analyzing their NOL and has not determined if the company has had any change of control issues that could limit the future use of NOL. NOL carryforwards that were generated after 2017 of approximately $  
Operating Loss Carryforwards $ 29,400,000    
XML 112 R97.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 20,386,000 $ 8,447,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 6,393,000 7,764,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 6,114,000 683,000
Fair Value, Recurring [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 7,879,000
Fair Value, Recurring [Member] | Marketable Securities [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 15,617,000 8,447,000
Fair Value, Recurring [Member] | Marketable Securities [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 6,134,000 7,764,000
Fair Value, Recurring [Member] | Marketable Securities [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 2,448,000 683,000
Fair Value, Recurring [Member] | Marketable Securities [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 7,035,000
Fair Value, Recurring [Member] | Designated Assets [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 3,925,000  
Fair Value, Recurring [Member] | Designated Assets [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 259,000  
Fair Value, Recurring [Member] | Designated Assets [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 3,666,000  
Fair Value, Recurring [Member] | Designated Assets [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets  
Fair Value, Recurring [Member] | Contracts Receivable [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets 844,000  
Fair Value, Recurring [Member] | Contracts Receivable [Member] | Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets  
Fair Value, Recurring [Member] | Contracts Receivable [Member] | Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets  
Fair Value, Recurring [Member] | Contracts Receivable [Member] | Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total assets $ 844,000  
XML 113 R98.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details) - USD ($)
Dec. 31, 2022
Dec. 31, 2021
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities $ 3,925,000
Series A Preferred Stock [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities 3,925,000
Fair Value, Inputs, Level 1 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities
Fair Value, Inputs, Level 1 [Member] | Series A Preferred Stock [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities
Fair Value, Inputs, Level 2 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities 3,925,000
Fair Value, Inputs, Level 2 [Member] | Series A Preferred Stock [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities 3,925,000
Fair Value, Inputs, Level 3 [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities  
Fair Value, Inputs, Level 3 [Member] | Series A Preferred Stock [Member]    
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]    
Total liabilities  
XML 114 R99.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF FAIR VALUE AT ASSETS (Details)
 12 Months Ended
Dec. 31, 2021
USD ($)
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning Balance
Acquisitions 7,963,000
Sales and dispositions (510,000)
Transfers intoLevel 3 1,310,000
Transfers out of Level 3 (747,000) [1]
Realized & Unrealized Gains (Losses) (981,000) [2]
Ending Balance 7,035,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 747,000 [1]
Common Stock [Member]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning Balance
Acquisitions 2,665,000
Sales and dispositions
Transfers intoLevel 3 400,000
Transfers out of Level 3 (534,000) [1]
Realized & Unrealized Gains (Losses) (377,000) [2]
Ending Balance 2,154,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 534,000 [1]
Convertible Debt Securities [Member]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning Balance
Acquisitions 4,267,000
Sales and dispositions
Transfers intoLevel 3 410,000
Transfers out of Level 3 (213,000) [1]
Realized & Unrealized Gains (Losses) (278,000) [2]
Ending Balance 4,186,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 213,000 [1]
Warrant [Member]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning Balance
Acquisitions
Sales and dispositions
Transfers intoLevel 3
Transfers out of Level 3 [1]
Realized & Unrealized Gains (Losses) 96,000 [2]
Ending Balance 96,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 [1]
Preferred Stock [Member]  
Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]  
Beginning Balance
Acquisitions 1,031,000
Sales and dispositions (510,000)
Transfers intoLevel 3 500,000
Transfers out of Level 3 [1]
Realized & Unrealized Gains (Losses) (422,000) [2]
Ending Balance 599,000
Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3 [1]
[1] Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations.
[2] Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital.
XML 115 R100.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details) - Fair Value, Inputs, Level 3 [Member]
 12 Months Ended
Dec. 31, 2021
Dec. 30, 2021
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Maturity [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range, maturity 0 months  
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Maturity [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range, maturity 35 months  
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Price Volatility [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range   100
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range   0.78
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Risk Free Interest Rate [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range   1.04
Valuation Technique, Option Pricing Model [Member] | Measurement Input, Expected Dividend Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range   0
Common Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range 0  
Common Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range 54  
Convertible Preferred Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range 0  
Convertible Preferred Stock [Member] | Put Option Pricing Model [Member] | Measurement Input, Discount for Lack of Marketability [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range 54  
Convertible Debt Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Maturity [Member] | Minimum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range, maturity 0 months  
Convertible Debt Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Maturity [Member] | Maximum [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range, maturity 35 months  
Convertible Debt Securities [Member] | Valuation Technique, Discounted Cash Flow [Member] | Measurement Input, Discount Rate [Member]    
Fair Value Measurement Inputs and Valuation Techniques [Line Items]    
Range   26
XML 116 R101.htm IDEA: XBRL DOCUMENT v3.22.2.2
FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Fair Value Disclosures [Abstract]    
Notes Receivable, Fair Value Disclosure $ 1,000,000  
Deferred payment fair value 960,000  
Corporate debt 40,000  
Implied discount 107,000  
Fair value notes receivable 935,000 $ 893,000
Contracts asset $ 844,000
XML 117 R102.htm IDEA: XBRL DOCUMENT v3.22.2.2
SCHEDULE OF REVENUE BY BUSINESS UNIT (Details) - USD ($)
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Total revenues $ 26,707,000 $ 6,479,000
Sequire Platform Revenue [Member]    
Total revenues 24,514,000 5,976,000
Conference Revenue [Member]    
Total revenues 1,229,000 503,000
Other Revenues [Member]    
Total revenues $ 964,000
XML 118 R103.htm IDEA: XBRL DOCUMENT v3.22.2.2
REVENUE DISAGGREGATION (Details Narrative) - USD ($)
Dec. 31, 2021
Dec. 31, 2020
Revenue Disaggregation    
Revenue from contract liabilities $ 12,859,000 $ 4,842,000
XML 119 R104.htm IDEA: XBRL DOCUMENT v3.22.2.2
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
 1 Months Ended 12 Months Ended
Aug. 08, 2022
Jul. 01, 2022
Jun. 13, 2022
Feb. 15, 2022
Nov. 29, 2018
Oct. 27, 2017
Jun. 30, 2020
Dec. 31, 2021
Sep. 27, 2022
Jun. 28, 2022
Mar. 31, 2021
Subsequent Event [Line Items]                      
Class of warrant issued               6,828,611      
Number of common stock and warrants shares                     2,283,171
Common Stock [Member]                      
Subsequent Event [Line Items]                      
Number of shares issued               53,616      
Security Agreements [Member] | Common Stock [Member]                      
Subsequent Event [Line Items]                      
Number of shares issued         166,667 530,028 1,363,636        
Security Agreements [Member] | Tranche One [Member] | Common Stock [Member]                      
Subsequent Event [Line Items]                      
Number of shares issued         530,027            
Subsequent Event [Member] | Warrant [Member]                      
Subsequent Event [Line Items]                      
Number of common stock and warrants shares                 287,000    
Subsequent Event [Member] | Bridge Note [Member]                      
Subsequent Event [Line Items]                      
Debt amount   $ 650,000                  
Principal amount exchange   $ 500,000                  
Debt Instrument, Maturity Date   Aug. 15, 2022                  
Subsequent Event [Member] | Institutional Investor [Member] | Revolving Credit Facility [Member]                      
Subsequent Event [Line Items]                      
Loan amount $ 9,450,000                    
Class of warrant issued 2,590,358                    
Expiration date Sep. 30, 2023                    
Additional amount $ 3,870,000                    
Credit facility, description The principal balance of each Revolving Loan will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%. The Revolving Loans have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents.                    
Payment description Additionally, with respect to any Payment Date where the applicable monthly collection from the sale of securities received by the Company from its customers during the prior month exceeds $2,000,000, the Company will make an additional payment equal to 30% of any amounts in excess of $2,000,000.                    
Conversion, description The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends and fundamental transactions. Moreover, in the event the Company is deemed to have issued or sold shares of its Common Stock while the Revolving Loan is outstanding at a price equal to or less than $5.00 per share, the conversion price will adjust to such lower applicable price.                    
Subsequent Event [Member] | Institutional Investor [Member] | Revolving Credit Facility [Member] | Tranche One [Member]                      
Subsequent Event [Line Items]                      
Payment percentage 10.00%                    
Subsequent Event [Member] | Institutional Investor [Member] | Revolving Credit Facility [Member] | Tranche Two [Member]                      
Subsequent Event [Line Items]                      
Payment percentage 15.00%                    
Subsequent Event [Member] | Institutional Investor [Member] | Revolving Credit Facility [Member] | Tranche Three [Member]                      
Subsequent Event [Line Items]                      
Payment percentage 20.00%                    
Subsequent Event [Member] | Holders [Member]                      
Subsequent Event [Line Items]                      
Debt amount   $ 1,102,682                  
Debt instrument, description   (i) extend the maturity date of the Debentures until December 31, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures.                  
Subsequent Event [Member] | CVR Agreement [Member] | Institutional Investor [Member]                      
Subsequent Event [Line Items]                      
Debt amount     $ 404,513.40                
Debt instrument, description     the investor received (i) the right to receive the net proceeds upon the sale of certain securities of the Company (“CVR Payments”) with a quoted price equal to $674,190 (with a guaranteed minimum return of 120% of such Purchase Price and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the CVR Payments.                
Proceeds from sale of securities     $ 674,190                
Subsequent Event [Member] | Credit Agreement [Member]                      
Subsequent Event [Line Items]                      
Class of warrant issued 33,000                    
Subsequent Event [Member] | Credit Agreement and Revolving Note [Member] | Institutional Investor [Member]                      
Subsequent Event [Line Items]                      
Loan amount $ 5,580,000                    
Subsequent Event [Member] | Credit Agreement and Revolving Note [Member] | Institutional Investor [Member] | Cash [Member]                      
Subsequent Event [Line Items]                      
Loan amount $ 4,930,000                    
Subsequent Event [Member] | Credit Agreement and Revolving Note [Member] | Institutional Investor [Member] | Bridge Note [Member]                      
Subsequent Event [Line Items]                      
Debt amount                   $ 650,000  
Subsequent Event [Member] | Big Token Inc [Member] | Safe Agreement [Member]                      
Subsequent Event [Line Items]                      
Investments       $ 1,000,000              
XML 120 form10-k_htm.xml IDEA: XBRL DOCUMENT 0001538217 2021-01-01 2021-12-31 0001538217 2021-06-30 0001538217 2022-09-23 0001538217 2021-12-31 0001538217 2020-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2021-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2020-12-31 0001538217 SRAX:ClassACommonStockMember 2021-12-31 0001538217 SRAX:ClassACommonStockMember 2020-12-31 0001538217 2020-01-01 2020-12-31 0001538217 us-gaap:CommonStockMember 2019-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001538217 us-gaap:RetainedEarningsMember 2019-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2019-12-31 0001538217 2019-12-31 0001538217 us-gaap:CommonStockMember 2020-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001538217 us-gaap:RetainedEarningsMember 2020-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2020-12-31 0001538217 us-gaap:CommonStockMember 2020-01-01 2020-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-12-31 0001538217 us-gaap:RetainedEarningsMember 2020-01-01 2020-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2020-01-01 2020-12-31 0001538217 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-12-31 0001538217 us-gaap:RetainedEarningsMember 2021-01-01 2021-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2021-01-01 2021-12-31 0001538217 us-gaap:CommonStockMember 2021-12-31 0001538217 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001538217 us-gaap:RetainedEarningsMember 2021-12-31 0001538217 us-gaap:NoncontrollingInterestMember 2021-12-31 0001538217 SRAX:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2021-01-01 2021-12-31 0001538217 SRAX:CustomerOneMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001538217 SRAX:CustomerTwoMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001538217 SRAX:CustomerThreeMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001538217 SRAX:RevenueMember us-gaap:SalesRevenueNetMember us-gaap:CustomerConcentrationRiskMember 2020-01-01 2020-12-31 0001538217 SRAX:BritePoolIncMember 2021-12-28 2021-12-29 0001538217 SRAX:BritePoolIncMember SRAX:SeriesDConvertiblePreferredStockMember 2021-12-28 2021-12-29 0001538217 SRAX:SeriesDConvertiblePreferredStockMember 2021-12-28 2021-12-29 0001538217 us-gaap:CommonStockMember 2021-12-28 2021-12-29 0001538217 SRAX:SeriesDConvertiblePreferredStockAndCommonStockMember 2021-12-28 2021-12-29 0001538217 2021-12-28 2021-12-29 0001538217 SRAX:BIGTokensMember 2021-12-29 0001538217 SRAX:BIGTokensMember 2021-12-28 2021-12-29 0001538217 2021-12-29 0001538217 SRAX:LDMicroIncMember 2020-09-14 2020-09-15 0001538217 SRAX:LDMicroIncMember 2020-09-13 2020-09-15 0001538217 SRAX:LDMicroIncMember 2020-12-30 2021-01-02 0001538217 SRAX:ForecastMember SRAX:LDMicroIncMember 2021-03-30 2021-04-01 0001538217 SRAX:ForecastMember SRAX:LDMicroIncMember 2021-06-29 2021-07-01 0001538217 SRAX:LDMicroIncMember SRAX:ClassACommonStockMember 2020-09-13 2020-09-15 0001538217 SRAX:LDMicroIncMember 2021-01-01 2021-12-31 0001538217 SRAX:NoncompeteMember 2020-01-01 2020-12-31 0001538217 SRAX:CustomerListMember 2020-01-01 2020-12-31 0001538217 SRAX:LDMicroIncMember 2020-09-15 0001538217 SRAX:TrademarkMember 2020-09-15 0001538217 SRAX:TrademarkMember 2020-09-13 2020-09-15 0001538217 SRAX:DomainNameMember 2020-09-15 0001538217 SRAX:DomainNameMember 2020-09-13 2020-09-15 0001538217 SRAX:NoncompeteMember 2020-09-15 0001538217 SRAX:NoncompeteMember 2020-09-13 2020-09-15 0001538217 SRAX:CustomerListMember 2020-09-15 0001538217 SRAX:CustomerListMember 2020-09-13 2020-09-15 0001538217 2020-09-15 0001538217 SRAX:LDMicroIncMember 2020-01-01 2020-12-31 0001538217 SRAX:ProFormaAdjustmentMember 2020-01-01 2020-12-31 0001538217 SRAX:ProFormaCombinedMember 2020-01-01 2020-12-31 0001538217 us-gaap:ScenarioAdjustmentMember 2020-01-01 2020-12-31 0001538217 2020-01-22 0001538217 2020-01-30 0001538217 2020-01-20 2020-01-22 0001538217 2020-01-28 2020-01-30 0001538217 SRAX:AgreementsToSellAccountsReceivableMember 2020-03-22 2020-03-24 0001538217 SRAX:TenPercentMember 2021-01-01 2021-12-31 0001538217 SRAX:TwentyPercentMember 2021-01-01 2021-12-31 0001538217 SRAX:ThirtySixPercentMember 2021-01-01 2021-12-31 0001538217 us-gaap:CommonClassAMember 2020-01-20 2020-01-22 0001538217 us-gaap:CommonClassAMember 2020-01-28 2020-01-30 0001538217 SRAX:AgreementsToSellAccountsReceivableAmmendedMember 2020-04-08 2020-04-09 0001538217 SRAX:AgreementsToSellAccountsReceivableAmmendedMember 2020-01-20 2020-01-22 0001538217 SRAX:AgreementsToSellAccountsReceivableAmmendedMember 2020-01-28 2020-01-30 0001538217 us-gaap:AccountsPayableMember 2020-06-28 2020-06-30 0001538217 us-gaap:AccruedLiabilitiesMember 2020-06-28 2020-06-30 0001538217 SRAX:DebenturesMember 2020-06-28 2020-06-30 0001538217 SRAX:DebenturesMember 2020-06-30 0001538217 SRAX:PIPETechnologiesMember 2020-01-01 2020-12-31 0001538217 SRAX:PIPETechnologiesMember 2021-12-31 0001538217 SRAX:PIPETechnologiesMember 2021-01-01 2021-12-31 0001538217 2021-12-27 2021-12-31 0001538217 SRAX:ReceivablePurchaseAndSaleAgreementMember SRAX:BIGtokenMember 2021-10-29 0001538217 SRAX:ReceivablePurchaseAndSaleAgreementMember SRAX:BIGtokenMember 2021-10-28 2021-10-29 0001538217 SRAX:ReceivablePurchaseAndSaleAgreementMember SRAX:BIGtokenMember 2021-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2020-12-31 0001538217 us-gaap:PreferredStockMember 2020-12-31 0001538217 us-gaap:WarrantMember 2020-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2021-01-01 2021-12-31 0001538217 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2021-12-31 0001538217 us-gaap:PreferredStockMember 2021-12-31 0001538217 us-gaap:WarrantMember 2021-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2019-12-31 0001538217 SRAX:ConvertibleDebenturesMember 2020-01-01 2020-12-31 0001538217 SRAX:DesignatedAssetsMember 2021-12-31 0001538217 SRAX:DesignatedAssetsMember 2021-09-20 0001538217 SRAX:DesignatedAssetsMember 2021-09-21 2021-12-31 0001538217 SRAX:DesignatedAssetsMember 2021-01-01 2021-12-31 0001538217 SRAX:HaylardMDLLCMember 2020-10-30 0001538217 SRAX:HaylardMDLLCMember 2020-10-29 2020-10-30 0001538217 srt:MaximumMember SRAX:HaylardMDLLCMember 2020-10-29 2020-10-30 0001538217 SRAX:MDCoInvestLLCMember 2020-10-30 0001538217 SRAX:MDCoInvestLLCMember 2020-10-29 2020-10-30 0001538217 srt:MaximumMember SRAX:MDCoInvestLLCMember 2020-10-29 2020-10-30 0001538217 SRAX:RatedCorporateDebtMember 2021-01-01 2021-12-31 0001538217 SRAX:RatedCorporateDebtMember 2021-12-31 0001538217 srt:MaximumMember SRAX:RatedCorporateDebtMember 2021-01-01 2021-12-31 0001538217 us-gaap:OfficeEquipmentMember 2021-12-31 0001538217 us-gaap:OfficeEquipmentMember 2020-12-31 0001538217 us-gaap:NoncompeteAgreementsMember 2021-12-31 0001538217 us-gaap:NoncompeteAgreementsMember 2020-12-31 0001538217 us-gaap:IntellectualPropertyMember 2021-12-31 0001538217 us-gaap:IntellectualPropertyMember 2020-12-31 0001538217 SRAX:SoftwareMember 2021-12-31 0001538217 SRAX:SoftwareMember 2020-12-31 0001538217 SRAX:InternallyDevelopedSoftwareMember 2021-12-31 0001538217 SRAX:InternallyDevelopedSoftwareMember 2020-12-31 0001538217 us-gaap:TrademarksMember 2021-12-31 0001538217 us-gaap:TrademarksMember 2020-12-31 0001538217 us-gaap:CustomerListsMember 2021-12-31 0001538217 us-gaap:CustomerListsMember 2020-12-31 0001538217 us-gaap:InternetDomainNamesMember 2021-12-31 0001538217 us-gaap:InternetDomainNamesMember 2020-12-31 0001538217 SRAX:FactoringFacilityMember 2021-12-31 0001538217 SRAX:FactoringFacilityMember 2020-12-31 0001538217 SRAX:LDMicroMember 2020-01-01 2020-12-31 0001538217 SRAX:LDMicroMember 2021-01-01 2021-12-31 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2020-04-17 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2020-04-16 2020-04-17 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2021-12-31 0001538217 SRAX:PaycheckProtectionProgramLoanMember 2020-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-02-28 0001538217 srt:ChiefFinancialOfficerMember SRAX:ShortTermPromissoryNotesMember 2020-02-28 0001538217 SRAX:ShortTermPromissoryNotesMember 2021-01-01 2021-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2021-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-12-31 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-01-01 2020-12-31 0001538217 srt:ChiefFinancialOfficerMember SRAX:ShortTermPromissoryNotesMember 2020-06-28 2020-06-30 0001538217 SRAX:TwoRemainingNoteHoldersMember SRAX:ShortTermPromissoryNotesMember us-gaap:AccruedLiabilitiesMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember us-gaap:AccruedLiabilitiesMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember SRAX:DebenturesMember 2020-06-28 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember SRAX:DebenturesMember 2020-06-30 0001538217 SRAX:ShortTermPromissoryNotesMember 2020-06-30 0001538217 SRAX:TermloanMember 2020-02-28 0001538217 SRAX:TermloanMember 2020-02-26 2020-02-28 0001538217 2020-02-28 0001538217 SRAX:TermloanMember 2020-04-29 2020-05-02 0001538217 us-gaap:WarrantMember 2020-02-28 0001538217 us-gaap:WarrantMember SRAX:SecondDrawdownMember 2020-02-28 0001538217 us-gaap:WarrantMember SRAX:SecondDrawdownMember 2020-02-26 2020-02-28 0001538217 srt:MaximumMember us-gaap:WarrantMember 2020-02-28 0001538217 us-gaap:WarrantMember 2020-02-26 2020-02-28 0001538217 SRAX:TermloanMember 2020-05-28 2020-06-30 0001538217 SRAX:TermloanMember 2020-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember 2020-06-25 0001538217 SRAX:OIDConvertibleDebenturesMember us-gaap:AccountsReceivableMember 2020-06-25 0001538217 SRAX:OIDConvertibleDebenturesMember 2020-06-24 2020-06-25 0001538217 SRAX:OIDConvertibleDebenturesMembersMember 2020-02-27 2020-02-28 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember us-gaap:MeasurementInputRiskFreeInterestRateMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember us-gaap:MeasurementInputExpectedTermMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember us-gaap:MeasurementInputPriceVolatilityMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember us-gaap:MeasurementInputExpectedDividendRateMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:PlacementAgentMember SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001538217 SRAX:PlacementAgentMember SRAX:OIDConvertibleDebenturesMember SRAX:SecuritiesPurchaseAgreementMember 2021-12-31 0001538217 SRAX:PlacementAgentMember SRAX:SecuritiesPurchaseAgreementMember 2021-01-01 2021-12-31 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:PriorToClosingDateMember 2020-06-29 2020-06-30 0001538217 SRAX:OIDConvertibleDebenturesMember 2020-06-29 2020-06-30 0001538217 SRAX:OIDConvertibleDebenturesMember SRAX:AfterTheClosingDateMember 2020-06-29 2020-06-30 0001538217 SRAX:ClassACommonStockMember 2020-01-01 2020-12-31 0001538217 SRAX:DebentureHoldersMember 2021-01-01 2021-12-31 0001538217 SRAX:DebentureHoldersMember SRAX:ClassACommonStockMember 2021-01-01 2021-12-31 0001538217 SRAX:DebentureHoldersMember 2021-12-31 0001538217 SRAX:IssuanceDuringTheYearMember 2021-12-31 0001538217 SRAX:ExtensionMember 2021-12-31 0001538217 SRAX:ConversionMember 2021-12-31 0001538217 SRAX:AmortizationMember 2021-12-31 0001538217 SRAX:IssuanceDuringTheYearMember 2020-12-31 0001538217 SRAX:ExtensionMember 2020-12-31 0001538217 SRAX:RedemptionMember 2020-12-31 0001538217 SRAX:ConversionMember 2020-12-31 0001538217 SRAX:AmortizationMember 2020-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2021-08-16 2021-08-17 0001538217 srt:MaximumMember us-gaap:SeriesAPreferredStockMember 2021-09-20 0001538217 us-gaap:SeriesAPreferredStockMember 2021-09-20 0001538217 us-gaap:SeriesAPreferredStockMember 2021-09-19 2021-09-20 0001538217 SRAX:SeriesOnePreferredStockMember 2021-12-31 0001538217 SRAX:ClassBCommonStockMember 2021-12-31 0001538217 us-gaap:NonperformingFinancingReceivableMember 2021-01-01 2021-01-31 0001538217 us-gaap:NonperformingFinancingReceivableMember 2020-01-31 0001538217 2020-01-01 2020-01-31 0001538217 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommonClassAMember 2020-01-01 2020-01-31 0001538217 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommonClassAMember 2020-06-29 2020-06-30 0001538217 SRAX:BoardOfDirectorsMember SRAX:ClassACommonStockMember 2021-08-02 2021-08-31 0001538217 SRAX:BoardOfDirectorsMember us-gaap:CommonStockMember 2021-08-02 2021-08-31 0001538217 SRAX:AtTheMarketSalesAgreementMember 2021-01-01 2021-12-31 0001538217 SRAX:ShareBuyBackProgramMember 2021-01-01 2021-12-31 0001538217 SRAX:TwoThousandAndTwelveEquityCompensationPlanMember us-gaap:CommonClassAMember 2012-01-31 0001538217 SRAX:TwoThousandAndFourteenteenEquityCompensationPlanMember us-gaap:CommonClassAMember 2014-11-05 0001538217 SRAX:TwoThousandAndSixteenEquityCompensationPlanMember us-gaap:CommonClassAMember 2016-02-23 0001538217 SRAX:TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember 2016-02-22 2016-02-23 0001538217 SRAX:NonExecutiveDirectorsMember 2020-04-01 2020-04-30 0001538217 SRAX:NonExecutiveDirectorsMember 2020-04-30 0001538217 2020-04-01 2020-04-30 0001538217 2020-04-30 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-08-31 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-08-28 2020-08-31 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-11-30 0001538217 SRAX:EmployeesAndMembersOfManagementTeamMember 2020-11-28 2020-11-30 0001538217 us-gaap:WarrantMember 2021-02-04 0001538217 us-gaap:WarrantMember 2021-02-03 2021-02-04 0001538217 us-gaap:MeasurementInputExpectedTermMember us-gaap:WarrantMember 2021-02-04 0001538217 us-gaap:MeasurementInputOptionVolatilityMember us-gaap:WarrantMember 2021-02-04 0001538217 us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:WarrantMember 2021-02-04 0001538217 us-gaap:WarrantMember 2021-02-21 0001538217 SRAX:NewWarrantMember 2021-02-21 0001538217 us-gaap:WarrantMember 2021-02-20 2021-02-21 0001538217 SRAX:NewWarrantMember 2021-02-20 2021-02-21 0001538217 2021-02-20 2021-02-21 0001538217 2021-02-21 0001538217 2021-01-01 2021-03-31 0001538217 2021-03-31 0001538217 srt:ChiefExecutiveOfficerMember 2021-01-01 2021-12-31 0001538217 2019-01-01 2019-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SRAX:DesignatedAssetsMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SRAX:ContractsReceivableMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2021-12-31 0001538217 us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember SRAX:MarketableSecuritiesMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsRecurringMember 2020-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:SeriesAPreferredStockMember 2022-12-31 0001538217 us-gaap:FairValueInputsLevel1Member 2022-12-31 0001538217 us-gaap:FairValueInputsLevel2Member 2022-12-31 0001538217 us-gaap:FairValueInputsLevel3Member 2022-12-31 0001538217 2022-12-31 0001538217 us-gaap:FairValueInputsLevel1Member us-gaap:SeriesAPreferredStockMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member us-gaap:SeriesAPreferredStockMember 2021-12-31 0001538217 us-gaap:FairValueInputsLevel1Member 2021-12-31 0001538217 us-gaap:FairValueInputsLevel2Member 2021-12-31 0001538217 us-gaap:CommonStockMember 2020-12-31 0001538217 us-gaap:CommonStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:CommonStockMember 2021-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember 2020-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember 2021-01-01 2021-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember 2021-12-31 0001538217 us-gaap:WarrantMember 2020-12-31 0001538217 us-gaap:WarrantMember 2021-01-01 2021-12-31 0001538217 us-gaap:WarrantMember 2021-12-31 0001538217 us-gaap:PreferredStockMember 2020-12-31 0001538217 us-gaap:PreferredStockMember 2021-01-01 2021-12-31 0001538217 us-gaap:PreferredStockMember 2021-12-31 0001538217 srt:MinimumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember SRAX:PutOptionPricingModelMember 2021-12-31 0001538217 srt:MaximumMember us-gaap:CommonStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember SRAX:PutOptionPricingModelMember 2021-12-31 0001538217 srt:MinimumMember us-gaap:ConvertiblePreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember SRAX:PutOptionPricingModelMember 2021-12-31 0001538217 srt:MaximumMember us-gaap:ConvertiblePreferredStockMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountForLackOfMarketabilityMember SRAX:PutOptionPricingModelMember 2021-12-31 0001538217 srt:MinimumMember us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMaturityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2021-01-01 2021-12-31 0001538217 srt:MaximumMember us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMaturityMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2021-01-01 2021-12-31 0001538217 us-gaap:ConvertibleDebtSecuritiesMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputDiscountRateMember us-gaap:ValuationTechniqueDiscountedCashFlowMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputPriceVolatilityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-12-30 0001538217 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-12-30 0001538217 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputRiskFreeInterestRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-12-30 0001538217 us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputExpectedDividendRateMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-12-30 0001538217 srt:MinimumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMaturityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-01-01 2021-12-31 0001538217 srt:MaximumMember us-gaap:FairValueInputsLevel3Member us-gaap:MeasurementInputMaturityMember us-gaap:ValuationTechniqueOptionPricingModelMember 2021-01-01 2021-12-31 0001538217 SRAX:SequirePlatformRevenueMember 2021-01-01 2021-12-31 0001538217 SRAX:SequirePlatformRevenueMember 2020-01-01 2020-12-31 0001538217 SRAX:ConferenceRevenueMember 2021-01-01 2021-12-31 0001538217 SRAX:ConferenceRevenueMember 2020-01-01 2020-12-31 0001538217 SRAX:OtherRevenuesMember 2021-01-01 2021-12-31 0001538217 SRAX:OtherRevenuesMember 2020-01-01 2020-12-31 0001538217 us-gaap:SubsequentEventMember SRAX:SafeAgreementMember SRAX:BigTokenIncMember 2022-02-13 2022-02-15 0001538217 SRAX:InstitutionalInvestorMember us-gaap:SubsequentEventMember SRAX:CVRAgreementMember 2022-06-13 0001538217 SRAX:InstitutionalInvestorMember us-gaap:SubsequentEventMember SRAX:CVRAgreementMember 2022-06-12 2022-06-13 0001538217 SRAX:HoldersMember us-gaap:SubsequentEventMember 2022-07-01 0001538217 SRAX:HoldersMember us-gaap:SubsequentEventMember 2022-06-29 2022-07-01 0001538217 SRAX:BridgeNoteMember us-gaap:SubsequentEventMember 2022-07-01 0001538217 SRAX:BridgeNoteMember us-gaap:SubsequentEventMember 2022-06-29 2022-07-01 0001538217 SRAX:InstitutionalInvestorMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2022-08-08 0001538217 SRAX:InstitutionalInvestorMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember 2022-08-07 2022-08-08 0001538217 us-gaap:SubsequentEventMember SRAX:CreditAgreementMember 2022-08-08 0001538217 SRAX:InstitutionalInvestorMember us-gaap:SubsequentEventMember SRAX:CreditAgreementAndRevolvingNoteMember 2022-08-08 0001538217 SRAX:InstitutionalInvestorMember us-gaap:CashMember us-gaap:SubsequentEventMember SRAX:CreditAgreementAndRevolvingNoteMember 2022-08-08 0001538217 SRAX:InstitutionalInvestorMember SRAX:BridgeNoteMember us-gaap:SubsequentEventMember SRAX:CreditAgreementAndRevolvingNoteMember 2022-06-28 0001538217 SRAX:InstitutionalInvestorMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:TrancheOneMember 2022-08-08 0001538217 SRAX:InstitutionalInvestorMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:TrancheTwoMember 2022-08-08 0001538217 SRAX:InstitutionalInvestorMember us-gaap:RevolvingCreditFacilityMember us-gaap:SubsequentEventMember SRAX:TrancheThreeMember 2022-08-08 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember 2020-06-01 2020-06-30 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember 2018-11-29 2018-11-29 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember SRAX:TrancheOneMember 2018-11-29 2018-11-29 0001538217 us-gaap:CommonStockMember SRAX:SecurityAgreementsMember 2017-10-27 2017-10-27 0001538217 us-gaap:WarrantMember us-gaap:SubsequentEventMember 2022-09-27 iso4217:USD shares iso4217:USD shares pure SRAX:segment 0001538217 false FY P7Y 10-K true 2021-12-31 --12-31 2021 false 001-37916 SRAX, INC. DE 45-2925231 2629 Townsgate Road #215 Westlake Village CA 91361 (323) 694-9800 Class A Common Stock, $0.001 par value SRAX NASDAQ No No No No Non-accelerated Filer true false false false 121972024 26315178 None RBSM LLP New York, NY 587 1348000 450000 821000 1409000 844000 15617000 8447000 3925000 430000 361000 1206000 22985000 11873000 935000 893000 114000 117000 1443000 1492000 257000 366000 36000 2000 17906000 17906000 6364000 43676000 39013000 4095000 2708000 12859000 4842000 763000 3417000 10000 747000 1164000 6016000 36462417 36462417 0.001 0.001 36462417 36462417 0 0 3925000 1305000 22816000 19035000 114000 243000 379000 131000 22930000 19788000 250000000 250000000 0.001 0.001 25995172 25995172 16145778 16145778 26000 16000 51075000 69551000 -30355000 -50342000 20746000 19225000 43676000 39013000 26707000 6479000 6521000 1789000 7533000 4683000 6330000 1717000 214000 960000 842000 772000 5352000 3590000 26792000 13511000 -85000 -7032000 10295000 12150000 804000 684000 -7904000 261000 -84000 2378000 7873000 42000 1144000 2462000 321000 -16209000 -3011000 -16294000 -10043000 -127000 21000 -16167000 -10064000 -14376000 -4641000 10684000 -25060000 -4641000 -41227000 -14705000 -6465000 -34762000 -14705000 -0.69 -0.69 -0.79 -0.32 -1.48 -1.01 23550744 14649788 13997452 14000 48129000 -35637000 12506000 1710000 1710000 4331000 4331000 36700 71000 71000 100000 181000 181000 411626 434000 434000 1600000 2000 4262000 4264000 4076000 4076000 46000 46000 6311000 6311000 -14705000 -14705000 16145778 16000 69551000 -50342000 19225000 16145778 16000 69551000 -50342000 19225000 1006000 1006000 53616 284000 284000 3122167 3000 5971000 5974000 6828611 7000 15945000 15952000 7737000 7737000 95000 95000 885000 885000 5860000 5860000 5860000 5860000 6387000 6387000 -42239000 54749000 -6045000 6465000 -155000 -793000 -793000 -34762000 -34762000 -6465000 -6465000 25995172 26000 51075000 -30355000 20746000 25995172 26000 51075000 -30355000 20746000 -41227000 -14705000 25060000 4641000 -16167000 -10064000 -7904000 261000 804000 684000 2378000 -84000 7873000 42000 2462000 321000 1116000 885000 -1103000 7737000 409000 854000 9128000 1006000 1615000 -20000 17000 72000 28000 847000 744000 20000 19000 268000 -1680000 1439000 820000 -400000 3278000 1521000 20669000 350000 -3049000 -131000 -15317000 -9154000 -8118000 -4335000 -23435000 -13489000 8666000 519000 686000 1450000 7000000 697000 3004000 69000 798000 633000 33000 -32000 3998000 6221000 841000 -175000 4839000 6046000 284000 15952000 793000 11988000 6070000 960000 100000 1084000 2130000 2130000 15443000 7862000 4736000 20179000 7862000 4124000 4929000 -2541000 -4510000 451000 32000 2034000 451000 1000 2034000 450000 -686000 1348000 450000 176000 27842000 8406000 5974000 434000 -6387000 6387000 94000 83000 4076000 71000 6311000 4248000 46000 1931000 4264000 181000 <p id="xdx_80F_eus-gaap--OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock_zvjT2tqekYSj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 1 – <span id="xdx_82C_zokES99Hh84c">ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zSr624Mamrlg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z5LqlP69AuJ5">Organization</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRAX, Inc. (“SRAX”, “we”, “us”, “our” or the “Company”) is a Delaware corporation formed on August 2, 2011. We are headquartered in Westlake Village, California but work as a distributed virtual Company. The Consolidated Financial Statements consist of SRAX and its wholly owned subsidiary LD Micro, Inc. (“LD Micro”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are a technology firm focused on enhancing communications between public companies and their shareholders and investors. We currently have two distinct business units, which we consider to be one reporting unit:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our unique SaaS platform, Sequire provides users many features which allow issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through LD Micro, we organize and host investor conferences within the micro and small- cap markets, and plan to create several more niche events for the investor community.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of SRAX’s business units deliver valuable insights that assist our clients with their investor relations and communications initiatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 29, 2021, we deconsolidated our majority owned subsidiary BIG Token, Inc. (“BIGToken”) (formerly known as Force Protection Video Equipment Corporation). After the deconsolidation, we do not beneficially own controlling interest in BIGtoken, and no longer consolidate BIGtoken into our financial results for periods ending after December 31, 2021. The financial results of BIGtoken for the years ended December 31, 2021 and 2020 are presented as income from discontinued operations, net of taxes on the consolidated statements of operations and its assets and liabilities as of December 31, 2021 are presented as assets and liabilities of discontinued operations on the consolidated balance sheets. The historical consolidated statement of cash flows has also been revised to reflect the effect of the deconsolidation. See Note 2 – Discontinued Operations. Unless noted otherwise, discussion in the notes to the consolidated financial statements pertain to continuing operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zIK5b2p0D09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zhalS9HEf5Rk">Liquidity and Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. As of December 31, 2021, the Company had cash and cash equivalents of $<span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20211231_zPB3M5V09CNc">1,348,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited Consolidated Financial Statements are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flow and cash usage forecasts, and obligations and debts. Although management has a long history of successful capital raises, the analysis used to determine the Company’s ability as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expect that our existing cash and cash equivalents, our accounts receivable and marketable securities as of December 31, 2021, will not be sufficient to enable us to fund our anticipated level of operations through one year from the date these financial statements are issued.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We anticipate raising additional capital through the private and public sales of our equity or debt securities and selling our marketable securities, or a combination thereof. Although management believes that such capital sources will be available, there can be no assurances that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. If we do not raise sufficient capital in a timely manner, among other things, we may be forced to scale back our operations or cease operations altogether.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, and uncertain. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zndG9RQOZvr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z7Gu3fEJwudg">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its subsidiaries from the acquisition date of majority voting control of the subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zj5breqCwVFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zv2yunblewLk">Business Segments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the “management approach” to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--BusinessCombinationsPolicy_zP2QNQGOPrL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z3qalWJghSR4">Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UseOfEstimates_zTvQE8W6QlPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zSG1zxqUqixk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements have been prepared in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) and requires management of the Company to make estimates and assumptions in the preparation of these consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company’s revenue recognition, allowance for doubtful accounts and sales credits, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisition, goodwill, other intangible assets, put rights and valuation of other assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9xCQVunDHyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zuXn9Pq0pka2">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 1 </b>- Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 2</b> - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly.; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 3</b> - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. Therefore, even when market assumptions are not readily available, the fund’s own assumptions reflect those that market participants would use in pricing the asset or liability at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fund’s level is based on the lowest significant level input to the fair value measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation Techniques and Inputs</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in securities and securities sold short that are both freely tradable and listed on major securities exchanges are valued at their last reported sales price as of the valuation date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many over-the-counter contracts have bid and ask prices that are observable in the marketplace. Bid prices reflect the highest price that the marketplace participants are willing to pay for an asset. Ask prices represent the lowest price that the marketplace participants are willing to accept for an asset. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. The Company initially classifies securities between debt securities, equity securities, warrants, convertible debt, or preferred stock. The Company does not have any debt securities as of December 31, 2021 and 2020. Warrants are initially valued at cost, if acquired for cash, or at intrinsic value. For convertible debt securities the investor generally should evaluate the security in its current “all-in” form as convertible debt and not use the “if converted” value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities are valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers there to be an active market based on the guidance in ASC 820-10-35-54C. In an active market, transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. An orderly transaction assumes exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities. Whether transactions take place with sufficient frequency and volume to constitute an active market is a matter of judgement and depends on the facts and circumstances of the market for the asset or liability. If the Company determines that the trading market for a security is not an active market the Company evaluates the stock price based on other observable or unobservable inputs. A market with limited activity may still provide relevant pricing information when there is no contrary evidence that the pricing information is not relevant to the fair value of the asset. In certain situations, the Company’s security holdings represent share quantities that materially exceed the average daily trading volume of the securities in their primary market. Thus, the Company considers a discount due to the lack of liquidity. If the Company determines it can liquidate its position within 180 days based on 10% of the securities average daily trading volume, no discount is applied. Rule 144 also has an alternative volume limit for affiliates of up to 10% of the tranche (or class) outstanding for debt securities. We believe this provides a reasonable basis to suggest this 10% of trading volume should have minimal impact on market prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities with a marketability holding period in excess of 180 days is subjected to a discount for marketability. If a security has both a marketability holding period over 180 days and a liquidation period of over 180 days the Company will evaluate the impact of both the marketability and liquidity discounts. The Company utilizes the quoted market price on the date of valuation calculates a discount for marketability and liquidity based on a protective put option pricing model that factors in both the lack of marketability and liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Valuation Expert</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses a third party specialist to provide guidance around the assumptions, inputs, pricing models utilized valuation calculations into the various Put Option Pricing Models (POPMs) used in the calculations to determine discounts at contract inceptions date and each of the respective balance sheet dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company has access to material non-public information regarding an investee, it will consider this information as an input for purposes of valuing the security. In these situations, the Company will consider the impact this information will have on the valuation of the securities on a case-by-case basis. These situations could arise due to the Company being an affiliate of the issuer or an officer or director of the Company is an affiliate of the issuer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These securities are categorized in Level 1 of the fair value hierarchy to the extent these securities are actively traded. Securities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 of the fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investments in Restricted Securities of Public Companies</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in restricted securities of public companies cannot be offered for sale to the public until the company complies with certain statutory requirements. The valuation will not exceed the listed price on any major securities exchange. Investments in restricted securities of public companies are generally categorized in Level 2 of the fair value hierarchy. However, investments in public companies may be categorized in Level 3 of the fair value hierarchy depending on the level of observable liquidity. Specifically, if the Company determines the market activity is not sufficient to conclude the market activity represents an Active Market pursuant to ASC 820 -10 -35 36B.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates the trading activity of each listed security to determine if the trading market is an Active Market for purposes of evaluating Fair Value under ASC 820. The Company evaluated the number of trade observations during the year, the percentage of the total trading days the security traded on its listed market during the full year or the portion of the year if the security was initially listed during the year, and at the dollar value of the trading activity for the full year as a percentage of the market capitalization of the security. If the Company determines the listed securities trading market is not an active market it looks at other transactions reported by the listed company including private equity transactions, non-cash equity transactions, the trading price and other factors. The Company determines a fair value of the stock price based on this analysis. This price is the lower of the listed price or the fair value based on the analysis. The Company also considers the marketability and liquidity discounts on the listed security in determining fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVPBMwkzbH3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zeQsWSPbtsy9">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are recorded at cost, which approximates its fair value. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20211231_zoRe2YNDgfI5" title="FDIC amount">250,000</span> per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. As of December 31, 2021 and 2020, the Company had $<span id="xdx_906_eus-gaap--TimeDepositsAtOrAboveFDICInsuranceLimit_iI_c20211231_zUBNPwDt7oTi" title="Excess of federal insurance limit">1,098,000</span> and $<span id="xdx_904_eus-gaap--TimeDepositsAtOrAboveFDICInsuranceLimit_iI_c20201231_zh4U4OcPXoMi">200,000</span> in excess of the federal insurance limit, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zZ9kYNZOz5uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_z8WrabEqEMB5">Accounts Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company usually does not require collateral. Allowance for doubtful accounts was approximately $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20211231_zepxpm0VawI8" title="Allowance for doubtful accounts">130,000</span> and $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20201231_zrWkDxp1NWHc" title="Allowance for doubtful accounts">15,000</span> as of December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zahNcFOLfUCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zk5ApwfmJvQl">Concentration of Credit and Significant Customer Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any loss on these accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z72pAZFeZgXk">11</span>%.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2020, the Company had three customers with accounts receivable balances of approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zKo5f8aV55F3">43.41</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zXiQ3Jo2QNMb">11.60</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z6enNxwDeYFg">10.53</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2021, the Company had no customers that account for a significant percentage of total revenue. For the year ended December 31, 2020, the Company had one customer that accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z98YAdWWXah1" title="Concentration risk percentage">18.1</span>% of total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ztdceYuw2pWe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zizmUm4Kwga3">Long-lived Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the years ended December 31, 2021 or 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z1diTxoBnGVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zIlXa1YOfBce">Property and equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zKFLZtbw4zp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zB6R3MxEBvE3">Intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of intellectual property, trademarks, trade names, and non-compete agreements, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs incurred to develop computer software for internal use are capitalized once: (1) the preliminary project stage is completed, (2) management authorizes and commits to funding a specific software project, and (3) it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred prior to meeting the qualifications are expensed as incurred. Capitalization of costs ceases when the project is substantially complete and ready for its intended use. Post-implementation costs related to the internal use computer software, are expensed as incurred. Internal use software development costs are amortized using the straight-line method over its estimated useful life which ranges up to three years. Software development costs may become impaired in situations where development efforts are abandoned due to the viability of the planned project becoming doubtful or due to technological obsolescence of the planned software product. For the years ended December 31, 2021, and 2020 there has been no impairment associated with internal use software. For the years ended December 31, 2021, and 2020, the Company capitalized software development costs of $<span id="xdx_904_eus-gaap--CapitalizedComputerSoftwareNet_iI_c20211231_zYmuklPw4Gs3" title="Capitalized software development costs">798,000</span> and $<span id="xdx_90D_eus-gaap--CapitalizedComputerSoftwareNet_iI_c20201231_znskKYpXGYxa" title="Capitalized software development costs">633,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zwI4mlftjbAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zMMGLTTl4MWj">Right of Use Assets and Lease Obligations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Right of Use Asset and Lease Liability reflect the present value of the Company’s estimated future minimum lease payments over the lease term, which may include options that are reasonably assured of being exercised, discounted using a collateralized incremental borrowing rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Typically, renewal options are considered reasonably assured of being exercised if the associated asset lives of the building or leasehold improvements exceed that of the initial lease term. Therefore, the Right of Use Asset and Lease Liability may include an assumption on renewal options that have not yet been exercised by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the rate implicit in leases are not readily determinable, the Company uses an incremental borrowing rate to calculate the lease liability that represents an estimate of the interest rate the Company would incur to borrow on a collateralized basis over the term of a lease within a particular currency environment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zEcqSTMQvyr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z1ahOLG9KzRd">Goodwill</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur or circumstances indicate the fair value of a reporting unit is below its carrying value. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. The Company performed its most recent annual goodwill impairment test as of December 31, 2021 using market data and discounted cash flow analysis. Based on this analysis, it was determined that the fair value exceeded the carrying value of its reporting units. The Company concluded the fair value of the goodwill exceed the carrying value accordingly there were no indicators of impairment for the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had historically performed its annual goodwill and impairment assessment on December 31<sup>st</sup> of each year. This aligns the Company with other advertising sales companies who also generally conduct this annual analysis in the fourth quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the impairment testing methodology primarily using the income approach (discounted cash flow method).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows if the carrying value of a reporting unit exceeds its fair value, then the amount by which it exceeds its fair value will be recognized as an impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--DerivativesPolicyTextBlock_z7SL3osNY4Ub" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKpTS4TzjMLg">Derivatives</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, <i>Distinguishing Liabilities From Equity</i> and FASB ASC Topic No. 815, <i>Derivatives and Hedging</i>. Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted ASU 2017-11, Earnings per share (Topic 260), provided that when determining whether certain financial instruments should be classified as liability or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. If a down round feature on the conversion option embedded in the note is triggered, the Company will evaluate whether a beneficial conversion feature exists, the Company will record the amount as a debt discount and will amortize it over the remaining term of the debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the down round feature in the warrants that are classified as equity is triggered, the Company will recognize the effect of the down round as a deemed dividend, which will reduce the income available to common stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--WarrantLiabilityPolicyTextBlock_zjDrOzdScgj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zYWo88iItqFl">Warrant Liability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black-Scholes option pricing model, at each measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--DebtPolicyTextBlock_zIfPFbY6QCK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zA1p7XORmtUe">Debt Discounts</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for debt discounts originating in connection with conversion features that remain embedded in the related notes in accordance with ASC 470-20, <i>Debt with Conversion and Other Options</i>. These costs are classified on the consolidated balance sheet as a direct deduction from the debt liability. The Company amortizes these costs over the term of its debt agreements as interest expense-debt discount in the consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zP2mbV8D15A8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zPfjSLBmVzy5">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, we adopted ASU 2014-09, “Revenue from Contracts with Customers” (Topic 606) (“ASC 606”) and applied this guidance to those contracts which were not completed at the date of adoption using the modified retrospective method. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods (ASC 605). The adoption did not have a significant impact to the nature and timing of our revenues, results of operations, cash flows and statement of financial position. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from all sale types is recognized at transaction price, the amount we expect to be entitled to in exchange for transferring goods or providing services. Transaction price is calculated as selling price net of variable consideration which may include estimates for future returns, sales incentives and price protection related to current period product revenue. Our standard obligation to our direct customers generally provides for a full refund in the event that such product is not merchantable or is found to be damaged or defective. In determining estimates for future returns, we estimate variable consideration at the expected value amount which is based on management’s analysis of historical data, channel inventory levels, current economic trends and changes in customer demand for our products. Sales incentives and price protection are determined based on a combination of the actual amounts committed and through estimating future expenditure based upon historical customary business practice. We continue to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We enter into contracts to sell our products and services, and while some of our sales agreements contain standard terms and conditions, there are agreements that contain non-standard terms and conditions and include promises to transfer multiple goods or services. As a result, significant interpretation and judgment is sometimes required to determine the appropriate accounting for these transactions including: (1) whether performance obligations are considered distinct and required to be accounted for separately or combined, including allocation of transaction price; (2) developing an estimate of the stand-alone selling price, or SSP, of each distinct performance obligation; (3) combining contracts that may impact the allocation of the transaction price between product and services; and (4) estimating and accounting for variable consideration, including rights of return, rebates, price protection, expected penalties or other price concessions as a reduction of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from contracts with customers is recognized when the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to be entitled to in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company derives its revenue primarily from the licensing of our Sequire Platform and Services associated with our customer’s use of the platform, consisting of data insights, marketing, creative, and paid media advertising Revenue is recognized at a point in time when control of the goods is transferred to the customer, generally occurring ratably over the contract period. The amount recognized reflects the consideration the Company expects to be entitled to in exchange for the transferred services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensing and Service revenue is generally recognized over time on a ratable basis over the contract term beginning on the date that the service is expected to begin. Service contracts are generally for 12 months in length, billed either monthly or annually and generally in advance. Services revenue are typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Deferred Revenue</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue consists of platform and services fees that the Company has received consideration in advance of satisfying performance under the associated contract. The majority of the Company’s deferred revenue balance consists of the unrecognized portion of Service revenue that the Company has received consideration in marketable securities, which is recognized as revenue ratably over the contractual service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 606 is a comprehensive revenue recognition model that requires revenue to be recognized when control of the promised goods or services are transferred to our customers at an amount that reflects the consideration that we expect to receive. Application of ASC Topic 606 requires us to use more judgment and make more estimates than under former guidance. Application of ASC Topic 606 requires a five-step model applicable to all product offering revenue streams as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identification of the contract, or contracts, with a customer</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit or financial information pertaining to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identification of the performance obligations in the contract</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When a contract includes multiple promised goods or services, we apply judgment to determine whether the promised goods or services are capable of being distinct and are distinct within the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. The Company has identified three distinct services promised within its contracts: (1) subscription to the Platform for a fixed monthly fee (Platform revenue), (2) Managed Services (including, data and marketing campaigns for a fixed monthly fee (managed services), and (3) Ancillary data, which consists of various data attributes that supplement the data available within the Sequire platform. The Managed Services to be delivered to the customer are within the discretion of the Company, and there are no minimum or maximum guaranties to be delivered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination of the transaction price</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods or services to our customer. We estimate any variable consideration included in the transaction price using the expected value method that requires the use of significant estimates for discounts, cancellation periods, refunds and returns. In cases which the Company receives marketable securities as payment the transaction price is determined to be the lower of the fair market value of the securities received or the contract amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of the transaction price to the performance obligations in the contract</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. We determine SSP based on the price at which the performance obligation would be sold separately. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the second quarter of 2020, the Company provided its customers the ability to pay for the Sequire services with the issuance of the customers’ common stock or other securities. For contacts paid with any type of security, Management considers whether there is any marketability of liquidity discounts in determining the fair value of the security on the contract date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s contract with its customers is for a period of one year or less than one year and the Company is applying the practical expedient, therefore, the transaction price is not adjusted for any significant financing component. The Company evaluates whether there is an existence of a significant financing component in the contract. This is evaluated based on the marketability holding period and liquidity issues than can extend the ability to sale the securities. For any marketability restrictions over 180 days the Company provides a marketability discount. For any liquidity issues that would take the Company in excess of 180 days to liquidate the security the Company applies a liquidity discount. Where there is both a marketability and liquidity issue the Company provides a discount considering both. ASC 606-10-32-23 The fair value of the noncash consideration may vary after contract inception because of the form of the consideration (for example, a change in the price of a share to which an entity is entitled to receive from a customer). Changes in the fair value of noncash consideration after contract inception that are due to the form of the consideration are not included in the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition of revenue when, or as, we satisfy a performance obligation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue at the point in time that the related performance obligation is satisfied by transferring the promised goods or services to our customer. The Company has performed a limited analysis of the performance efforts and has determined that the effort for the managed services is typically front loaded and as a result of performing services for SEC reporting companies’ additional efforts are maintained throughout the year. The Company considers the services to be delivered ratably during any service period and as such is amortizing the contract price on a straight line method over the contract period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principal versus Agent Considerations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When another party is involved in providing goods or services to our customer, we apply the principal versus agent guidance in ASC Topic 606 to determine if we are the principal or an agent to the transaction. When we control the specified goods or services before they are transferred to our customer, we report revenue gross, as principal. If we do not control the goods or services before they are transferred to our customer, revenue is reported net of the fees paid to the other party, as agent. Our evaluation to determine if we control the goods or services within ASC Topic 606 includes the following indicators:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We are primarily responsible for fulfilling the promise to provide the specified good or service.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When we are primarily responsible for providing the goods and services, such as when the other party is acting on our behalf, we have indication that we are the principal to the transaction. We consider if we may terminate our relationship with the other party at any time without penalty or without permission from our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We have risk before the specified good or service have been transferred to a customer or after transfer of control to the customer.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may commit to obtaining the services of another party with or without an existing contract with our customer. In these situations, we have risk of loss as principal for any amount due to the other party regardless of the amount(s) we earn as revenue from our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The entity has discretion in establishing the price for the specified good or service.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have discretion in establishing the price our customer pays for the specified goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract Liabilities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of customer advance payments and billings in excess of revenue recognized. We may receive payments from our customers in advance of completing our performance obligations. We record contract liabilities equal to the amount of payments received in excess of revenue recognized, including payments that are refundable if the customer cancels the contract according to the contract terms. Contract liabilities have been historically low historically recorded as current liabilities on our consolidated financial statements when the time to fulfill the performance obligations under terms of our contracts is less than one year. We have no long-term contract liabilities which would represent the amount of payments received in excess of revenue earned, including those that are refundable, when the time to fulfill the performance obligation is greater than one year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Practical Expedients and Exemptions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We made the accounting policy election to not assess promised goods or services as performance obligations if they are immaterial in the context of the contract with the customer; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We made the accounting policy election to exclude any sales and similar taxes from the transaction price; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3XwVXqQICk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zwHOCBq28nId">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our stock-based compensation under ASC 718 “<i>Compensation – Stock Compensation</i>” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common stock awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded in accordance with ASC 718 on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with certain financing, and consulting arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zCIdE7RzpDi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zTqcnaxo63M8">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We utilize ASC 740 “<i>Income Taxes</i>” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zj3bXkesGUPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zsvxG98maiTc">Earnings Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use ASC 260, “<i>Earnings Per Share</i>” for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share are the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_znMChTwSzCWk">11,867,520 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common share equivalents at December 31, 2021 and <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_zAtepslmU9I7">15,366,426 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at December 31, 2020. For the year ended December 31, 2021 and 2020 these potential shares were excluded from the computation of diluted net earnings per share as their effect would have been antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zQP3ENG2piQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zkaTKJagE9l5">Recently Issued Accounting Standards</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the FASB issued ASU 2020-01, which clarifies the interactions between Topics 321, 323 and 815. This ASU clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, the amendments clarify the accounting for certain forward contracts and purchased options accounted for under Topic 815. Our adoption of this ASU did not impact our consolidated financial statements or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 32.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a limited period of time to ease the potential burden in accounting treatments related to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. Adoption of the expedients and exceptions is elective and is permitted upon issuance of the guidance through December 31, 2022. <span style="background-color: white">The adoption had no material impact on the Company’s financial position, results of operations and cash flows.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2020, the SEC adopted amendments to the financial disclosure requirements in Regulation S-X including the significance tests in the “significant subsidiary” definition in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 to improve their application and to assist registrants in making more meaningful determinations of whether a subsidiary or an acquired or disposed business is significant. In addition, to address the unique attributes of investment companies and business development companies, the SEC updated the significance tests in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 by (i) revising the investment test to compare the registrant’s investments in and advances to the acquired or disposed business to the registrant’s aggregate worldwide market value if available; (ii) revising the income test by adding a revenue component; (iii) expanding the use of pro forma financial information in measuring significance; and (iv) conforming, to the extent applicable, the significance threshold and tests for disposed businesses to those used for acquired businesses. The amendment became effective January 1, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, which simplifies the accounting for convertible instruments by removing certain separation models (including the cash conversion model and the beneficial conversion feature model) for convertible instruments. As a result, for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815 or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features are no longer separated from the host contract. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost as long as no other features require bifurcation and recognition as derivatives. This ASU is effective for fiscal years beginning after December 15, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables–Nonrefundable Fees and Other Costs, (“ASU 2020-08”). This ASU clarifies that an entity should reevaluate whether a callable debt security is within the scope of ASC paragraph 310-20-35-33 for each reporting period. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of ASU 2020-08 did not have a material impact on its consolidated financial statements since the Company does not have any convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 15, 2019, the FASB delayed the effective date of FASB ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments.” This ASU amends several aspects of the measurement of credit losses on certain financial instruments, including replacing the existing incurred credit loss model and other models with the Current Expected Credit Losses (CECL) model and amending certain aspects of accounting for purchased financial assets with deterioration in credit quality since origination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 2a-5 under the 1940 Act was adopted by the SEC in December 2020 and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. As noted above, the if the Company were determined to be an Investment Company we would be required to comply with the rule. We are evaluating the impact of adopting Rule 2a-5 on the consolidated financial statements and intend to comply with the new rule’s requirements should we be required to do so on or before the compliance date in September 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84C_eus-gaap--BasisOfAccountingPolicyPolicyTextBlock_zSr624Mamrlg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_z5LqlP69AuJ5">Organization</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRAX, Inc. (“SRAX”, “we”, “us”, “our” or the “Company”) is a Delaware corporation formed on August 2, 2011. We are headquartered in Westlake Village, California but work as a distributed virtual Company. The Consolidated Financial Statements consist of SRAX and its wholly owned subsidiary LD Micro, Inc. (“LD Micro”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are a technology firm focused on enhancing communications between public companies and their shareholders and investors. We currently have two distinct business units, which we consider to be one reporting unit:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Our unique SaaS platform, Sequire provides users many features which allow issuers to track their shareholders’ behaviors and trends, then use data-driven insights to engage with shareholders across marketing channels.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Through LD Micro, we organize and host investor conferences within the micro and small- cap markets, and plan to create several more niche events for the investor community.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Each of SRAX’s business units deliver valuable insights that assist our clients with their investor relations and communications initiatives.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 29, 2021, we deconsolidated our majority owned subsidiary BIG Token, Inc. (“BIGToken”) (formerly known as Force Protection Video Equipment Corporation). After the deconsolidation, we do not beneficially own controlling interest in BIGtoken, and no longer consolidate BIGtoken into our financial results for periods ending after December 31, 2021. The financial results of BIGtoken for the years ended December 31, 2021 and 2020 are presented as income from discontinued operations, net of taxes on the consolidated statements of operations and its assets and liabilities as of December 31, 2021 are presented as assets and liabilities of discontinued operations on the consolidated balance sheets. The historical consolidated statement of cash flows has also been revised to reflect the effect of the deconsolidation. See Note 2 – Discontinued Operations. Unless noted otherwise, discussion in the notes to the consolidated financial statements pertain to continuing operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_ecustom--LiquidityAndGoingConcernPolicyTextBlock_zIK5b2p0D09g" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zhalS9HEf5Rk">Liquidity and Going Concern</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has incurred significant losses since its inception and has not demonstrated an ability to generate cash in excess of its operating expenses for a sustained period of time. As of December 31, 2021, the Company had cash and cash equivalents of $<span id="xdx_908_eus-gaap--CashEquivalentsAtCarryingValue_iI_c20211231_zPB3M5V09CNc">1,348,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which is not sufficient to fund the Company’s planned operations through one year after the date the consolidated financial statements are issued. These factors create substantial doubt about the Company’s ability to continue as a going concern for at least one year after the date that our audited Consolidated Financial Statements are issued.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. Accordingly, the consolidated financial statements have been prepared on a basis that assumes the Company will continue as a going concern and which contemplates the realization of assets and satisfaction of liabilities and commitments in the ordinary course of business.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In making this assessment we performed a comprehensive analysis of our current circumstances including: our financial position, our cash flow and cash usage forecasts, and obligations and debts. Although management has a long history of successful capital raises, the analysis used to determine the Company’s ability as a going concern does not include cash sources outside the Company’s direct control that management expects to be available within the next 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We expect that our existing cash and cash equivalents, our accounts receivable and marketable securities as of December 31, 2021, will not be sufficient to enable us to fund our anticipated level of operations through one year from the date these financial statements are issued.</span><span style="font-family: Times New Roman, Times, Serif; font-size: 8pt"> </span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We anticipate raising additional capital through the private and public sales of our equity or debt securities and selling our marketable securities, or a combination thereof. Although management believes that such capital sources will be available, there can be no assurances that financing will be available to us when needed in order to allow us to continue our operations, or if available, on terms acceptable to us. If we do not raise sufficient capital in a timely manner, among other things, we may be forced to scale back our operations or cease operations altogether.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, and uncertain. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 1348000 <p id="xdx_843_eus-gaap--ConsolidationPolicyTextBlock_zndG9RQOZvr3" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z7Gu3fEJwudg">Principles of Consolidation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its wholly owned subsidiaries. All material intercompany transactions and balances have been eliminated in consolidation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements include the accounts of the Company and its subsidiaries from the acquisition date of majority voting control of the subsidiary.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_847_eus-gaap--SegmentReportingPolicyPolicyTextBlock_zj5breqCwVFj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zv2yunblewLk">Business Segments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses the “management approach” to identify its reportable segments. The management approach designates the internal organization used by management for making operating decisions and assessing performance as the basis for identifying the Company’s reportable segments. Using the management approach, the Company determined that it has one operating segment due to business similarities and similar economic characteristics.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_849_eus-gaap--BusinessCombinationsPolicy_zP2QNQGOPrL5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_z3qalWJghSR4">Business Combinations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For all business combinations (whether partial, full or step acquisitions), the Company records 100% of all assets and liabilities of the acquired business, including goodwill, generally at their fair values; contingent consideration, if any, is recognized at its fair value on the acquisition date and, for certain arrangements, changes in fair value are recognized in earnings until settlement and acquisition-related transaction and restructuring costs are expensed rather than treated as part of the cost of the acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84A_eus-gaap--UseOfEstimates_zTvQE8W6QlPh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_864_zSG1zxqUqixk">Use of Estimates</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The consolidated financial statements have been prepared in conformity with generally accepted accounting principles accepted in the United States of America (“GAAP”) and requires management of the Company to make estimates and assumptions in the preparation of these consolidated financial statements that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from these estimates and assumptions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The most significant areas that require management judgment and which are susceptible to possible change in the near term include the Company’s revenue recognition, allowance for doubtful accounts and sales credits, valuation of marketable investment securities, stock-based compensation, income taxes, purchase price for acquisition, goodwill, other intangible assets, put rights and valuation of other assets and liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--FairValueOfFinancialInstrumentsPolicy_z9xCQVunDHyb" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zuXn9Pq0pka2">Fair Value of Financial Instruments</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The accounting standard for fair value measurements provides a framework for measuring fair value and requires disclosures regarding fair value measurements. Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date, based on the Company’s principal or, in absence of a principal, most advantageous market for the specific asset or liability.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In determining fair value, the Company uses various valuation techniques. A fair value hierarchy for inputs is used in measuring fair value. It maximizes observable inputs and minimizes unobservable inputs. Valuation techniques consistent with the market or income approach are used to measure fair value. The fair value hierarchy is categorized into three levels:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 1 </b>- Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that the Company has the ability to access.; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 2</b> - Valuations based on inputs, other than quoted prices included in Level 1, that are observable either directly or indirectly.; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Level 3</b> - Valuations based on inputs that are unobservable and significant to the overall fair value measurement.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair value is a market-based measure that is based on assumptions of prices and inputs considered from the perspective of a market participant on the measurement date. Therefore, even when market assumptions are not readily available, the fund’s own assumptions reflect those that market participants would use in pricing the asset or liability at the measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The availability of valuation techniques and observable inputs can vary from investment to investment and are affected by a wide variety of factors. The determination of fair value requires prudent judgment. Due to the inherent uncertainty of valuation, estimated values may be materially different from values were a ready market available. Inputs used to measure fair value may fall into different levels of the fair value hierarchy. In such cases, the fund’s level is based on the lowest significant level input to the fair value measurement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Valuation Techniques and Inputs</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in securities and securities sold short that are both freely tradable and listed on major securities exchanges are valued at their last reported sales price as of the valuation date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Many over-the-counter contracts have bid and ask prices that are observable in the marketplace. Bid prices reflect the highest price that the marketplace participants are willing to pay for an asset. Ask prices represent the lowest price that the marketplace participants are willing to accept for an asset. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An integral part of the Company’s fair value measurement process is the assessment of the type of securities as well as the securities’ liquidity and marketability. The Company initially classifies securities between debt securities, equity securities, warrants, convertible debt, or preferred stock. The Company does not have any debt securities as of December 31, 2021 and 2020. Warrants are initially valued at cost, if acquired for cash, or at intrinsic value. For convertible debt securities the investor generally should evaluate the security in its current “all-in” form as convertible debt and not use the “if converted” value. Convertible debt is valued based on an analysis of the implied call option and a discounted cash flow analysis of the debt component. Equity securities are valued using the quoted prices times the number of shares acquired. The securities are then evaluated based on their marketability (usually based on the restrictions on resale into the securities primary market) and liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers there to be an active market based on the guidance in ASC 820-10-35-54C. In an active market, transactions for the asset or liability take place with sufficient frequency and volume to provide pricing information on an ongoing basis. An orderly transaction assumes exposure to the market for a period before the measurement date to allow for marketing activities that are usual and customary for transactions involving such assets or liabilities. Whether transactions take place with sufficient frequency and volume to constitute an active market is a matter of judgement and depends on the facts and circumstances of the market for the asset or liability. If the Company determines that the trading market for a security is not an active market the Company evaluates the stock price based on other observable or unobservable inputs. A market with limited activity may still provide relevant pricing information when there is no contrary evidence that the pricing information is not relevant to the fair value of the asset. In certain situations, the Company’s security holdings represent share quantities that materially exceed the average daily trading volume of the securities in their primary market. Thus, the Company considers a discount due to the lack of liquidity. If the Company determines it can liquidate its position within 180 days based on 10% of the securities average daily trading volume, no discount is applied. Rule 144 also has an alternative volume limit for affiliates of up to 10% of the tranche (or class) outstanding for debt securities. We believe this provides a reasonable basis to suggest this 10% of trading volume should have minimal impact on market prices.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Securities with a marketability holding period in excess of 180 days is subjected to a discount for marketability. If a security has both a marketability holding period over 180 days and a liquidation period of over 180 days the Company will evaluate the impact of both the marketability and liquidity discounts. The Company utilizes the quoted market price on the date of valuation calculates a discount for marketability and liquidity based on a protective put option pricing model that factors in both the lack of marketability and liquidity.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Independent Valuation Expert</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company uses a third party specialist to provide guidance around the assumptions, inputs, pricing models utilized valuation calculations into the various Put Option Pricing Models (POPMs) used in the calculations to determine discounts at contract inceptions date and each of the respective balance sheet dates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the Company has access to material non-public information regarding an investee, it will consider this information as an input for purposes of valuing the security. In these situations, the Company will consider the impact this information will have on the valuation of the securities on a case-by-case basis. These situations could arise due to the Company being an affiliate of the issuer or an officer or director of the Company is an affiliate of the issuer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">These securities are categorized in Level 1 of the fair value hierarchy to the extent these securities are actively traded. Securities traded on inactive markets or valued by reference to similar instruments are generally categorized in Level 2 of the fair value hierarchy.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Investments in Restricted Securities of Public Companies</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Investments in restricted securities of public companies cannot be offered for sale to the public until the company complies with certain statutory requirements. The valuation will not exceed the listed price on any major securities exchange. Investments in restricted securities of public companies are generally categorized in Level 2 of the fair value hierarchy. However, investments in public companies may be categorized in Level 3 of the fair value hierarchy depending on the level of observable liquidity. Specifically, if the Company determines the market activity is not sufficient to conclude the market activity represents an Active Market pursuant to ASC 820 -10 -35 36B.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company evaluates the trading activity of each listed security to determine if the trading market is an Active Market for purposes of evaluating Fair Value under ASC 820. The Company evaluated the number of trade observations during the year, the percentage of the total trading days the security traded on its listed market during the full year or the portion of the year if the security was initially listed during the year, and at the dollar value of the trading activity for the full year as a percentage of the market capitalization of the security. If the Company determines the listed securities trading market is not an active market it looks at other transactions reported by the listed company including private equity transactions, non-cash equity transactions, the trading price and other factors. The Company determines a fair value of the stock price based on this analysis. This price is the lower of the listed price or the fair value based on the analysis. The Company also considers the marketability and liquidity discounts on the listed security in determining fair value.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_849_eus-gaap--CashAndCashEquivalentsPolicyTextBlock_zVPBMwkzbH3h" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_868_zeQsWSPbtsy9">Cash and Cash Equivalents</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company considers all short-term highly liquid investments with a remaining maturity at the date of purchase of three months or less to be cash equivalents. Cash and cash equivalents are recorded at cost, which approximates its fair value. The Company maintains its cash and cash equivalents in banks insured by the Federal Deposit Insurance Corporation (“FDIC”) in accounts that at times may be in excess of the federally insured limit of $<span id="xdx_908_eus-gaap--CashFDICInsuredAmount_iI_c20211231_zoRe2YNDgfI5" title="FDIC amount">250,000</span> per bank. The Company minimizes this risk by placing its cash deposits with major financial institutions. As of December 31, 2021 and 2020, the Company had $<span id="xdx_906_eus-gaap--TimeDepositsAtOrAboveFDICInsuranceLimit_iI_c20211231_zUBNPwDt7oTi" title="Excess of federal insurance limit">1,098,000</span> and $<span id="xdx_904_eus-gaap--TimeDepositsAtOrAboveFDICInsuranceLimit_iI_c20201231_zh4U4OcPXoMi">200,000</span> in excess of the federal insurance limit, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 250000 1098000 200000 <p id="xdx_847_eus-gaap--TradeAndOtherAccountsReceivablePolicy_zZ9kYNZOz5uh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_z8WrabEqEMB5">Accounts Receivable</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Credit is extended to customers based on an evaluation of their financial condition and other factors. Management periodically assesses the Company’s accounts receivable and, if necessary, establishes an allowance for estimated uncollectible amounts. Accounts determined to be uncollectible are charged to operations when that determination is made. The Company usually does not require collateral. Allowance for doubtful accounts was approximately $<span id="xdx_90A_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20211231_zepxpm0VawI8" title="Allowance for doubtful accounts">130,000</span> and $<span id="xdx_905_eus-gaap--AllowanceForDoubtfulAccountsReceivable_iI_c20201231_zrWkDxp1NWHc" title="Allowance for doubtful accounts">15,000</span> as of December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 130000 15000 <p id="xdx_84D_eus-gaap--ConcentrationRiskCreditRisk_zahNcFOLfUCh" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86E_zk5ApwfmJvQl">Concentration of Credit and Significant Customer Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments that potentially subject the Company to concentration of credit risk consist of cash and cash equivalents and accounts receivable. Cash and cash equivalents are deposited with financial institutions within the United States. The balances maintained at these financial institutions are generally more than the Federal Deposit Insurance Corporation insurance limits. The Company has not experienced any loss on these accounts.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company had one customer with an accounts receivable balance of approximately <span id="xdx_90F_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20210101__20211231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__srt--MajorCustomersAxis__custom--CustomerOneMember_z72pAZFeZgXk">11</span>%.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2020, the Company had three customers with accounts receivable balances of approximately <span id="xdx_908_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerOneMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zKo5f8aV55F3">43.41</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, <span id="xdx_900_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerTwoMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_zXiQ3Jo2QNMb">11.60</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, and <span id="xdx_907_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--MajorCustomersAxis__custom--CustomerThreeMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember_z6enNxwDeYFg">10.53</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the year ended December 31, 2021, the Company had no customers that account for a significant percentage of total revenue. For the year ended December 31, 2020, the Company had one customer that accounted for <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_c20200101__20201231__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--RevenueMember__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember_z98YAdWWXah1" title="Concentration risk percentage">18.1</span>% of total revenue.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 0.11 0.4341 0.1160 0.1053 0.181 <p id="xdx_841_eus-gaap--ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock_ztdceYuw2pWe" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86B_zizmUm4Kwga3">Long-lived Assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Management evaluates the recoverability of the Company’s identifiable intangible assets and other long-lived assets when events or circumstances indicate a potential impairment exists. Events and circumstances considered by the Company in determining whether the carrying value of identifiable intangible assets and other long-lived assets may not be recoverable include, but are not limited to: significant changes in performance relative to expected operating results; significant changes in the use of the assets; significant negative industry or economic trends; a significant decline in the Company’s stock price for a sustained period of time; and changes in the Company’s business strategy. In determining if impairment exists, the Company estimates the undiscounted cash flows to be generated from the use and ultimate disposition of these assets. If impairment is indicated based on a comparison of the assets’ carrying values and the undiscounted cash flows, the impairment loss is measured as the amount by which the carrying amount of the assets exceeds the fair value of the assets. No impairments have been recorded regarding its identifiable intangible assets or other long-lived assets during the years ended December 31, 2021 or 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_841_eus-gaap--PropertyPlantAndEquipmentPolicyTextBlock_z1diTxoBnGVg" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zIlXa1YOfBce">Property and equipment</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment is stated at cost less accumulated depreciation. Depreciation is provided on the straight-line basis over the estimated useful lives of the assets of three to seven years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Expenditures for repair and maintenance which do not materially extend the useful lives of property and equipment are charged to operations. When property or equipment is sold or otherwise disposed of, the cost and related accumulated depreciation are removed from the respective accounts with the resulting gain or loss reflected in operations. Management periodically reviews the carrying value of its property and equipment for impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_845_eus-gaap--IntangibleAssetsFiniteLivedPolicy_zKFLZtbw4zp1" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_863_zB6R3MxEBvE3">Intangible assets</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of intellectual property, trademarks, trade names, and non-compete agreements, and internally developed software and are stated at cost less accumulated amortization. Amortization is provided for on the straight-line basis over the estimated useful lives of the assets of five years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Costs incurred to develop computer software for internal use are capitalized once: (1) the preliminary project stage is completed, (2) management authorizes and commits to funding a specific software project, and (3) it is probable that the project will be completed and the software will be used to perform the function intended. Costs incurred prior to meeting the qualifications are expensed as incurred. Capitalization of costs ceases when the project is substantially complete and ready for its intended use. Post-implementation costs related to the internal use computer software, are expensed as incurred. Internal use software development costs are amortized using the straight-line method over its estimated useful life which ranges up to three years. Software development costs may become impaired in situations where development efforts are abandoned due to the viability of the planned project becoming doubtful or due to technological obsolescence of the planned software product. For the years ended December 31, 2021, and 2020 there has been no impairment associated with internal use software. For the years ended December 31, 2021, and 2020, the Company capitalized software development costs of $<span id="xdx_904_eus-gaap--CapitalizedComputerSoftwareNet_iI_c20211231_zYmuklPw4Gs3" title="Capitalized software development costs">798,000</span> and $<span id="xdx_90D_eus-gaap--CapitalizedComputerSoftwareNet_iI_c20201231_znskKYpXGYxa" title="Capitalized software development costs">633,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During 2016, the Company began capitalizing the costs of developing internal-use computer software, including directly related payroll costs. The Company amortizes costs associated with its internally developed software over periods up to three years, beginning when the software is ready for its intended use.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company capitalizes costs incurred during the application development stage of internal-use software and amortize these costs over the estimated useful life. Upgrades and enhancements are capitalized if they result in added functionality which enable the software to perform tasks it was previously incapable of performing. Software maintenance, training, data conversion, and business process reengineering costs are expensed in the period in which they are incurred.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 798000 633000 <p id="xdx_845_eus-gaap--LesseeLeasesPolicyTextBlock_zwI4mlftjbAl" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zMMGLTTl4MWj">Right of Use Assets and Lease Obligations</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Right of Use Asset and Lease Liability reflect the present value of the Company’s estimated future minimum lease payments over the lease term, which may include options that are reasonably assured of being exercised, discounted using a collateralized incremental borrowing rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Typically, renewal options are considered reasonably assured of being exercised if the associated asset lives of the building or leasehold improvements exceed that of the initial lease term. Therefore, the Right of Use Asset and Lease Liability may include an assumption on renewal options that have not yet been exercised by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.25in; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As the rate implicit in leases are not readily determinable, the Company uses an incremental borrowing rate to calculate the lease liability that represents an estimate of the interest rate the Company would incur to borrow on a collateralized basis over the term of a lease within a particular currency environment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--GoodwillAndIntangibleAssetsGoodwillPolicy_zEcqSTMQvyr5" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_z1ahOLG9KzRd">Goodwill</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Goodwill is comprised of the purchase price of business combinations in excess of the fair value assigned at acquisition to the net tangible and identifiable intangible assets acquired. Goodwill is not amortized. The Company tests goodwill for impairment for its reporting units on an annual basis, or when events occur or circumstances indicate the fair value of a reporting unit is below its carrying value. If the fair value of a reporting unit is less than its carrying value, an impairment loss is recorded to the extent that implied fair value of the goodwill within the reporting unit is less than its carrying value. The Company performed its most recent annual goodwill impairment test as of December 31, 2021 using market data and discounted cash flow analysis. Based on this analysis, it was determined that the fair value exceeded the carrying value of its reporting units. The Company concluded the fair value of the goodwill exceed the carrying value accordingly there were no indicators of impairment for the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company had historically performed its annual goodwill and impairment assessment on December 31<sup>st</sup> of each year. This aligns the Company with other advertising sales companies who also generally conduct this annual analysis in the fourth quarter.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When evaluating the potential impairment of goodwill, management first assess a range of qualitative factors, including but not limited to, macroeconomic conditions, industry conditions, the competitive environment, changes in the market for the Company’s products and services, regulatory and political developments, entity specific factors such as strategy and changes in key personnel, and the overall financial performance for each of the Company’s reporting units. If, after completing this assessment, it is determined that it is more likely than not that the fair value of a reporting unit is less than its carrying value, we then proceed to the impairment testing methodology primarily using the income approach (discounted cash flow method).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We compare the carrying value of the reporting unit, including goodwill, with its fair value, as determined by its estimated discounted cash flows if the carrying value of a reporting unit exceeds its fair value, then the amount by which it exceeds its fair value will be recognized as an impairment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When required, we arrive at our estimates of fair value using a discounted cash flow methodology which includes estimates of future cash flows to be generated by specifically identified assets, as well as selecting a discount rate to measure the present value of those anticipated cash flows. Estimating future cash flows requires significant judgment and includes making assumptions about projected growth rates, industry-specific factors, working capital requirements, weighted average cost of capital, and current and anticipated operating conditions. The use of different assumptions or estimates for future cash flows could produce different results.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_845_eus-gaap--DerivativesPolicyTextBlock_z7SL3osNY4Ub" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zKpTS4TzjMLg">Derivatives</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company analyzes all financial instruments with features of both liabilities and equity under FASB ASC Topic No. 480, <i>Distinguishing Liabilities From Equity</i> and FASB ASC Topic No. 815, <i>Derivatives and Hedging</i>. Derivative liabilities are adjusted to reflect fair value at each period end, with any increase or decrease in the fair value being recorded in results of operations as adjustments to fair value of derivatives. The effects of interactions between embedded derivatives are calculated and accounted for in arriving at the overall fair value of the financial instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has adopted ASU 2017-11, Earnings per share (Topic 260), provided that when determining whether certain financial instruments should be classified as liability or equity instruments, a down round feature no longer precludes equity classification when assessing whether the instrument is indexed to an entity’s own stock. If a down round feature on the conversion option embedded in the note is triggered, the Company will evaluate whether a beneficial conversion feature exists, the Company will record the amount as a debt discount and will amortize it over the remaining term of the debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the down round feature in the warrants that are classified as equity is triggered, the Company will recognize the effect of the down round as a deemed dividend, which will reduce the income available to common stockholders.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_840_ecustom--WarrantLiabilityPolicyTextBlock_zjDrOzdScgj8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zYWo88iItqFl">Warrant Liability</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for certain common stock warrants outstanding as a liability at fair value and adjusts the instruments to fair value at each reporting period. This liability is subject to re-measurement at each balance sheet date until exercised, and any change in fair value is recognized in the Company’s consolidated statements of operations. The fair value of the warrants issued by the Company has been estimated using a Black-Scholes option pricing model, at each measurement date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 0.55in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_84B_eus-gaap--DebtPolicyTextBlock_zIfPFbY6QCK2" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_860_zA1p7XORmtUe">Debt Discounts</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for debt discounts originating in connection with conversion features that remain embedded in the related notes in accordance with ASC 470-20, <i>Debt with Conversion and Other Options</i>. These costs are classified on the consolidated balance sheet as a direct deduction from the debt liability. The Company amortizes these costs over the term of its debt agreements as interest expense-debt discount in the consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_840_eus-gaap--RevenueRecognitionPolicyTextBlock_zP2mbV8D15A8" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_865_zPfjSLBmVzy5">Revenue Recognition</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 1, 2018, we adopted ASU 2014-09, “Revenue from Contracts with Customers” (Topic 606) (“ASC 606”) and applied this guidance to those contracts which were not completed at the date of adoption using the modified retrospective method. The comparative information was not restated and continued to be reported under the accounting standards in effect for those periods (ASC 605). The adoption did not have a significant impact to the nature and timing of our revenues, results of operations, cash flows and statement of financial position. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from all sale types is recognized at transaction price, the amount we expect to be entitled to in exchange for transferring goods or providing services. Transaction price is calculated as selling price net of variable consideration which may include estimates for future returns, sales incentives and price protection related to current period product revenue. Our standard obligation to our direct customers generally provides for a full refund in the event that such product is not merchantable or is found to be damaged or defective. In determining estimates for future returns, we estimate variable consideration at the expected value amount which is based on management’s analysis of historical data, channel inventory levels, current economic trends and changes in customer demand for our products. Sales incentives and price protection are determined based on a combination of the actual amounts committed and through estimating future expenditure based upon historical customary business practice. We continue to assess variable consideration estimates such that it is probable that a significant reversal of revenue will not occur.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We enter into contracts to sell our products and services, and while some of our sales agreements contain standard terms and conditions, there are agreements that contain non-standard terms and conditions and include promises to transfer multiple goods or services. As a result, significant interpretation and judgment is sometimes required to determine the appropriate accounting for these transactions including: (1) whether performance obligations are considered distinct and required to be accounted for separately or combined, including allocation of transaction price; (2) developing an estimate of the stand-alone selling price, or SSP, of each distinct performance obligation; (3) combining contracts that may impact the allocation of the transaction price between product and services; and (4) estimating and accounting for variable consideration, including rights of return, rebates, price protection, expected penalties or other price concessions as a reduction of the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenue from contracts with customers is recognized when the promised goods or services is transferred to the customers, in an amount that reflects the consideration that the Company expects to be entitled to in exchange for those goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company derives its revenue primarily from the licensing of our Sequire Platform and Services associated with our customer’s use of the platform, consisting of data insights, marketing, creative, and paid media advertising Revenue is recognized at a point in time when control of the goods is transferred to the customer, generally occurring ratably over the contract period. The amount recognized reflects the consideration the Company expects to be entitled to in exchange for the transferred services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Licensing and Service revenue is generally recognized over time on a ratable basis over the contract term beginning on the date that the service is expected to begin. Service contracts are generally for 12 months in length, billed either monthly or annually and generally in advance. Services revenue are typically recognized using an output measure of progress by looking at the time elapsed as the contracts generally provide the customer equal benefit throughout the contract period because the Company transfers control evenly by providing a stand-ready service. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i>Deferred Revenue</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue consists of platform and services fees that the Company has received consideration in advance of satisfying performance under the associated contract. The majority of the Company’s deferred revenue balance consists of the unrecognized portion of Service revenue that the Company has received consideration in marketable securities, which is recognized as revenue ratably over the contractual service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ASC Topic 606 is a comprehensive revenue recognition model that requires revenue to be recognized when control of the promised goods or services are transferred to our customers at an amount that reflects the consideration that we expect to receive. Application of ASC Topic 606 requires us to use more judgment and make more estimates than under former guidance. Application of ASC Topic 606 requires a five-step model applicable to all product offering revenue streams as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identification of the contract, or contracts, with a customer</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A contract with a customer exists when (i) we enter into an enforceable contract with a customer that defines each party’s rights regarding the goods or services to be transferred and identifies the payment terms related to these goods or services, (ii) the contract has commercial substance and, (iii) we determine that collection of substantially all consideration for goods or services that are transferred is probable based on the customer’s intent and ability to pay the promised consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We apply judgment in determining the customer’s ability and intention to pay, which is based on a variety of factors including the customer’s historical payment experience or, in the case of a new customer, published credit or financial information pertaining to the customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 24.45pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Identification of the performance obligations in the contract</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Performance obligations promised in a contract are identified based on the goods or services that will be transferred to the customer that are both capable of being distinct, whereby the customer can benefit from the goods or service either on its own or together with other resources that are readily available from third parties or from us, and are distinct in the context of the contract, whereby the transfer of the goods or services is separately identifiable from other promises in the contract.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When a contract includes multiple promised goods or services, we apply judgment to determine whether the promised goods or services are capable of being distinct and are distinct within the context of the contract. If these criteria are not met, the promised goods or services are accounted for as a combined performance obligation. The Company has identified three distinct services promised within its contracts: (1) subscription to the Platform for a fixed monthly fee (Platform revenue), (2) Managed Services (including, data and marketing campaigns for a fixed monthly fee (managed services), and (3) Ancillary data, which consists of various data attributes that supplement the data available within the Sequire platform. The Managed Services to be delivered to the customer are within the discretion of the Company, and there are no minimum or maximum guaranties to be delivered.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Determination of the transaction price</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction price is determined based on the consideration to which we will be entitled to receive in exchange for transferring goods or services to our customer. We estimate any variable consideration included in the transaction price using the expected value method that requires the use of significant estimates for discounts, cancellation periods, refunds and returns. In cases which the Company receives marketable securities as payment the transaction price is determined to be the lower of the fair market value of the securities received or the contract amount.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Allocation of the transaction price to the performance obligations in the contract</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">If the contract contains a single performance obligation, the entire transaction price is allocated to the single performance obligation. Contracts that contain multiple performance obligations require an allocation of the transaction price to each performance obligation based on a relative Stand-Alone Selling Price (“SSP,”) basis. We determine SSP based on the price at which the performance obligation would be sold separately. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the second quarter of 2020, the Company provided its customers the ability to pay for the Sequire services with the issuance of the customers’ common stock or other securities. For contacts paid with any type of security, Management considers whether there is any marketability of liquidity discounts in determining the fair value of the security on the contract date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s contract with its customers is for a period of one year or less than one year and the Company is applying the practical expedient, therefore, the transaction price is not adjusted for any significant financing component. The Company evaluates whether there is an existence of a significant financing component in the contract. This is evaluated based on the marketability holding period and liquidity issues than can extend the ability to sale the securities. For any marketability restrictions over 180 days the Company provides a marketability discount. For any liquidity issues that would take the Company in excess of 180 days to liquidate the security the Company applies a liquidity discount. Where there is both a marketability and liquidity issue the Company provides a discount considering both. ASC 606-10-32-23 The fair value of the noncash consideration may vary after contract inception because of the form of the consideration (for example, a change in the price of a share to which an entity is entitled to receive from a customer). Changes in the fair value of noncash consideration after contract inception that are due to the form of the consideration are not included in the transaction price.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Recognition of revenue when, or as, we satisfy a performance obligation</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize revenue at the point in time that the related performance obligation is satisfied by transferring the promised goods or services to our customer. The Company has performed a limited analysis of the performance efforts and has determined that the effort for the managed services is typically front loaded and as a result of performing services for SEC reporting companies’ additional efforts are maintained throughout the year. The Company considers the services to be delivered ratably during any service period and as such is amortizing the contract price on a straight line method over the contract period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Principal versus Agent Considerations</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When another party is involved in providing goods or services to our customer, we apply the principal versus agent guidance in ASC Topic 606 to determine if we are the principal or an agent to the transaction. When we control the specified goods or services before they are transferred to our customer, we report revenue gross, as principal. If we do not control the goods or services before they are transferred to our customer, revenue is reported net of the fees paid to the other party, as agent. Our evaluation to determine if we control the goods or services within ASC Topic 606 includes the following indicators:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We are primarily responsible for fulfilling the promise to provide the specified good or service.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">When we are primarily responsible for providing the goods and services, such as when the other party is acting on our behalf, we have indication that we are the principal to the transaction. We consider if we may terminate our relationship with the other party at any time without penalty or without permission from our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>We have risk before the specified good or service have been transferred to a customer or after transfer of control to the customer.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We may commit to obtaining the services of another party with or without an existing contract with our customer. In these situations, we have risk of loss as principal for any amount due to the other party regardless of the amount(s) we earn as revenue from our customer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>The entity has discretion in establishing the price for the specified good or service.</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have discretion in establishing the price our customer pays for the specified goods or services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><i> </i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Contract Liabilities</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Contract liabilities consist of customer advance payments and billings in excess of revenue recognized. We may receive payments from our customers in advance of completing our performance obligations. We record contract liabilities equal to the amount of payments received in excess of revenue recognized, including payments that are refundable if the customer cancels the contract according to the contract terms. Contract liabilities have been historically low historically recorded as current liabilities on our consolidated financial statements when the time to fulfill the performance obligations under terms of our contracts is less than one year. We have no long-term contract liabilities which would represent the amount of payments received in excess of revenue earned, including those that are refundable, when the time to fulfill the performance obligation is greater than one year.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Practical Expedients and Exemptions</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have elected certain practical expedients and policy elections as permitted under ASC Topic 606 as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We adopted the practical expedient related to not adjusting the promised amount of consideration for the effects of a significant financing component if the period between transfer of product and customer payment is expected to be less than one year at the time of contract inception; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We made the accounting policy election to not assess promised goods or services as performance obligations if they are immaterial in the context of the contract with the customer; </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We made the accounting policy election to exclude any sales and similar taxes from the transaction price; and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: justify"><span style="font-family: Times New Roman, Times, Serif">We adopted the practical expedient not to disclose the value of unsatisfied performance obligations for contracts with an original expected length of one year or less.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span/></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_84A_eus-gaap--ShareBasedCompensationOptionAndIncentivePlansPolicy_z3XwVXqQICk4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_866_zwHOCBq28nId">Stock-Based Compensation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We account for our stock-based compensation under ASC 718 “<i>Compensation – Stock Compensation</i>” using the fair value based method. Under this method, compensation cost is measured at the grant date based on the value of the award and is recognized over the service period, which is usually the vesting period. This guidance establishes standards for the accounting for transactions in which an entity exchanges it equity instruments for goods or services. It also addresses transactions in which an entity incurs liabilities in exchange for goods or services that are based on the fair value of the entity’s equity instruments or that may be settled by the issuance of those equity instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use the fair value method for equity instruments granted to non-employees and use the Black-Scholes model for measuring the fair value of options. The stock based fair value compensation is determined as of the date of the grant or the date at which the performance of the services is completed (measurement date) and is recognized over the vesting periods.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common stock awards</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company grants common stock awards to non-employees in exchange for services provided. The Company measures the fair value of these awards using the fair value of the services provided or the fair value of the awards granted, whichever is more reliably measurable. The fair value measurement date of these awards is generally the date the performance of services is complete. The fair value of the awards is recognized on a straight-line basis as services are rendered. The share-based payments related to common stock awards for the settlement of services provided by non-employees is recorded in accordance with ASC 718 on the consolidated statement of comprehensive loss in the same manner and charged to the same account as if such settlements had been made in cash.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with certain financing, and consulting arrangements, the Company has issued warrants to purchase shares of its common stock. The outstanding warrants are standalone instruments that are not puttable or mandatorily redeemable by the holder and are classified as equity awards. The Company measures the fair value of the awards using the Black-Scholes option pricing model as of the measurement date. Warrants issued in conjunction with the issuance of common stock are initially recorded at fair value as a reduction in additional paid-in capital of the common stock issued. All other warrants are recorded at fair value as expense over the requisite service period or at the date of issuance, if there is not a service period.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_842_eus-gaap--IncomeTaxPolicyTextBlock_zCIdE7RzpDi3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_867_zTqcnaxo63M8">Income Taxes</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We utilize ASC 740 “<i>Income Taxes</i>” which requires the recognition of deferred tax assets and liabilities for the expected future tax consequences of events that have been included in the consolidated financial statements or tax returns. Under this method, deferred income taxes are recognized for the tax consequences in future years of differences between the tax bases of assets and liabilities and their financial reporting amounts at year-end based on enacted laws and statutory tax rates applicable to the periods in which the differences are expected to affect taxable income.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company recognizes the impact of a tax position in the financial statements only if that position is more likely than not of being sustained upon examination by taxing authorities, based on the technical merits of the position. Our practice is to recognize interest and/or penalties related to income tax matters in income tax expense.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p id="xdx_84B_eus-gaap--EarningsPerSharePolicyTextBlock_zj3bXkesGUPa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86F_zsvxG98maiTc">Earnings Per Share</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We use ASC 260, “<i>Earnings Per Share</i>” for calculating the basic and diluted earnings (loss) per share. We compute basic earnings (loss) per share by dividing net income (loss) by the weighted average number of common shares outstanding. Diluted earnings (loss) per share is computed based on the weighted average number of shares of common stock plus the effect of dilutive potential common shares outstanding during the period using the treasury stock method. Dilutive potential common shares include outstanding stock options and warrants and stock awards. For periods with a net loss, basic and diluted loss per share are the same, in that any potential common stock equivalents would have the effect of being anti-dilutive in the computation of net loss per share.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">There were <span id="xdx_904_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20210101__20211231_znMChTwSzCWk">11,867,520 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">common share equivalents at December 31, 2021 and <span id="xdx_905_eus-gaap--AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_c20200101__20201231_zAtepslmU9I7">15,366,426 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at December 31, 2020. For the year ended December 31, 2021 and 2020 these potential shares were excluded from the computation of diluted net earnings per share as their effect would have been antidilutive.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 11867520 15366426 <p id="xdx_847_eus-gaap--NewAccountingPronouncementsPolicyPolicyTextBlock_zQP3ENG2piQ7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_862_zkaTKJagE9l5">Recently Issued Accounting Standards</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, the FASB issued ASU 2020-01, which clarifies the interactions between Topics 321, 323 and 815. This ASU clarifies that an entity should consider observable transactions that require it to either apply or discontinue the equity method of accounting for the purposes of applying the measurement alternative in accordance with Topic 321 immediately before applying or upon discontinuing the equity method. In addition, the amendments clarify the accounting for certain forward contracts and purchased options accounted for under Topic 815. Our adoption of this ASU did not impact our consolidated financial statements or disclosures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify; text-indent: 32.05pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In March 2020, the FASB issued ASU 2020-04, “Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting”, which provides optional expedients and exceptions for a limited period of time to ease the potential burden in accounting treatments related to contracts, hedging relationships and other transactions affected by reference rate reform if certain criteria are met. Adoption of the expedients and exceptions is elective and is permitted upon issuance of the guidance through December 31, 2022. <span style="background-color: white">The adoption had no material impact on the Company’s financial position, results of operations and cash flows.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In May 2020, the SEC adopted amendments to the financial disclosure requirements in Regulation S-X including the significance tests in the “significant subsidiary” definition in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 to improve their application and to assist registrants in making more meaningful determinations of whether a subsidiary or an acquired or disposed business is significant. In addition, to address the unique attributes of investment companies and business development companies, the SEC updated the significance tests in Rule 1-02(w), Securities Act Rule 405, and Exchange Act Rule 12b-2 by (i) revising the investment test to compare the registrant’s investments in and advances to the acquired or disposed business to the registrant’s aggregate worldwide market value if available; (ii) revising the income test by adding a revenue component; (iii) expanding the use of pro forma financial information in measuring significance; and (iv) conforming, to the extent applicable, the significance threshold and tests for disposed businesses to those used for acquired businesses. The amendment became effective January 1, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, the FASB issued ASU 2020-06, which simplifies the accounting for convertible instruments by removing certain separation models (including the cash conversion model and the beneficial conversion feature model) for convertible instruments. As a result, for convertible instruments with conversion features that are not required to be accounted for as derivatives under Topic 815 or that do not result in substantial premiums accounted for as paid-in capital, the embedded conversion features are no longer separated from the host contract. Consequently, a convertible debt instrument will be accounted for as a single liability measured at its amortized cost, and convertible preferred stock will be accounted for as a single equity instrument measured at its historical cost as long as no other features require bifurcation and recognition as derivatives. This ASU is effective for fiscal years beginning after December 15, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In October 2020, the FASB issued ASU 2020-08, Codification Improvements to Subtopic 310-20, Receivables–Nonrefundable Fees and Other Costs, (“ASU 2020-08”). This ASU clarifies that an entity should reevaluate whether a callable debt security is within the scope of ASC paragraph 310-20-35-33 for each reporting period. The guidance is effective for public business entities for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The adoption of ASU 2020-08 did not have a material impact on its consolidated financial statements since the Company does not have any convertible debt.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On November 15, 2019, the FASB delayed the effective date of FASB ASC Topic 326 for certain small public companies and other private companies. As amended, the effective date of ASC Topic 326 was delayed until fiscal years beginning after December 15, 2022 for SEC filers that are eligible to be smaller reporting companies under the SEC’s definition, as well as private companies and not-for-profit entities Credit Losses (Topic 326) — Measurement of Credit Losses on Financial Instruments.” This ASU amends several aspects of the measurement of credit losses on certain financial instruments, including replacing the existing incurred credit loss model and other models with the Current Expected Credit Losses (CECL) model and amending certain aspects of accounting for purchased financial assets with deterioration in credit quality since origination.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Rule 2a-5 under the 1940 Act was adopted by the SEC in December 2020 and establishes requirements for determining fair value in good faith for purposes of the 1940 Act. As noted above, the if the Company were determined to be an Investment Company we would be required to comply with the rule. We are evaluating the impact of adopting Rule 2a-5 on the consolidated financial statements and intend to comply with the new rule’s requirements should we be required to do so on or before the compliance date in September 2022.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management reviewed all recently issued accounting standard updates (“ASU’s”) not yet adopted by the Company and does not believe the future adoptions of any such ASU’s may be expected to cause a material impact on the Company’s consolidated financial condition or the results of its operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_80D_eus-gaap--DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock_z3oStuTseqel" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 2 – <span style="font-variant: small-caps"><span id="xdx_821_zA6DlERBUQEl">DISCONTINUED OPERATIONS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On December 29, 2021, The Company’s wholly owned subsidiary BIGToken completed a merger transaction with BritePool, Inc. (“BritePool”) (the “Merger”). As a result of the Merger, BIGToken issued <span id="xdx_902_eus-gaap--StockIssuedDuringPeriodSharesAcquisitions_c20211228__20211229__us-gaap--BusinessAcquisitionAxis__custom--BritePoolIncMember_zAPVD42wuLFd">183,445,351,631 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of its common stock (“Acquisition Shares”) for all of the issued and outstanding equity shares of BritePool. On December 29, 2021, as a condition for the closing of the Merger, the Company exchanged <span id="xdx_903_ecustom--ExchangedNumberOfSharesforCommonStock_c20211228__20211229__us-gaap--BusinessAcquisitionAxis__custom--BritePoolIncMember_zMuY1UfooR83">149,562,566,584 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of BIGToken common stock for <span id="xdx_90F_ecustom--ExchangedNumberOfSharesforCommonStock_c20211228__20211229__us-gaap--BusinessAcquisitionAxis__custom--BritePoolIncMember__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zSLx6C3HGWB5">242,078 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of BIGToken’s Series D Convertible Preferred Stock (“Series D Stock”) (the “Exchange”). Simultaneously with the Exchange, the Company converted <span id="xdx_903_eus-gaap--ConversionOfStockSharesConverted1_c20211228__20211229__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zYTvX1cB3wqb">22,162 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of the Series D Stock into <span id="xdx_905_eus-gaap--ConversionOfStockSharesConverted1_c20211228__20211229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zyhlp1ipMd32">13,692,304,136 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of BIGToken’s common stock, or approximately <span id="xdx_90C_ecustom--IssuedAndOutstandingOfCommonStock_dp_uPure_c20211228__20211229__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zivSPbNNcu6b">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% of the issued and outstanding shares of BIGToken’s common stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The Series D Stock is non-redeemable, non-voting with liquidation preference being the same as if the Series D Stock had been converted into shares of FVPD common stock. Each share of the Series D Stock is convertible into <span id="xdx_90F_eus-gaap--ConversionOfStockSharesIssued1_c20211228__20211229__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zp9DmeBM0Nzk">617,828 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">shares of BIGToken’s common stock, subject to a conversion limitation such that the number of shares of the BIGToken common stock outstanding immediately after giving effect to the issuance of BIGToken common stock to the Company upon conversion of the Series D Stock shall not be more than <span id="xdx_909_ecustom--BeneficialOwnershipPercenatge_pid_dp_uPure_c20211228__20211229__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockMember_zU7IGrEWw039">4.99</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">% (“Beneficial Ownership Limitation”). However, the Company upon not less than sixty-one days’ prior notice to BIGToken, may increase or decrease the Beneficial Ownership Limitation amount provided that the Beneficial Ownership Limitation in no event exceeds 9.99% of the number of shares of BIGToken’s common stock outstanding immediately after giving effect to the issuance of the common stock upon conversion of the Series D Stock. As of the Exchange date, the Series D Stock and common stock of BIGtoken had a fair value of approximately $<span id="xdx_903_eus-gaap--ConversionOfStockAmountIssued1_c20211228__20211229__us-gaap--StatementClassOfStockAxis__custom--SeriesDConvertiblePreferredStockAndCommonStockMember_zekkVr9psQQ9">31,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span id="xdx_908_ecustom--IssuanceOfAcquisitionSharesDescription_c20211228__20211229_zV19JR9e1No6" style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">BIGToken’s issuance of the Acquisition Share and the Exchange caused the Company’s BIGToken common stock holdings to decrease from approximately 66% to approximately 4.99%; Therefore, the Company no longer controlled the operations of BIGToken. Given the Company’s loss of control over the operations of BIGToken, the Company deconsolidated BIGToken, as of December 29, 2021, in accordance with ASC 810 Consolidations</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">. Based on the deconsolidation of BIGToken, the Company recognized a loss of $<span id="xdx_901_eus-gaap--GainLossOnSaleOfEquityInvestments_c20211228__20211229_zstq98NFXoKh">10,684,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">calculated, as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p id="xdx_899_ecustom--ScheduleOfDeconsolidationOfBusinessTableTextBlock_z36muXbLH8pd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_znfbpApG3At2">SCHEDULE OF DECONSOLIDATION OF BUSINESS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Consideration received</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20211229_zrmtcp5nwrkb" style="width: 16%; text-align: right" title="Consideration received"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Fair value of Series D Stock and Common stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock_c20211228__20211229_z9rO2RTcmZTi" style="text-align: right" title="Fair value of Series D Stock and Common stock">31,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Carrying amount of non-controlling interest of BIGToken</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--CarryingAmountOfNoncontrollingInterestOfBigtoken_c20211228__20211229_zerFAesigPZa" style="text-align: right" title="Carrying amount of non-controlling interest of BIGToken">6,045,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Previous equity adjustments of non-controlling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--PreviousEquityAdjustmentOfNoncontrollingInterest_c20211228__20211229_zhIniO61dB81" style="border-bottom: Black 1.5pt solid; text-align: right" title="Previous equity adjustments of non-controlling interest">(12,510,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total consolidations</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--DeconsolidationGainOrLossAmount_c20211228__20211229_zc16fYxaQKq8" style="text-align: right" title="Total consolidations">(6,434,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Book basis of investment in BIGToken</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--BookBasisOfInvestmentInBigtoken_iI_c20211229_zJF9IgARZFme" style="border-bottom: Black 1.5pt solid; text-align: right" title="Book basis of investment in BIGToken">4,250,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Loss on disposal of subsidiary</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--GainOrLossOnSaleOfStockInSubsidiary_c20211228__20211229_zBPb0jSmrMrh" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss on disposal of subsidiary">(10,684,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8A2_zYKyj9bJI08e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As the transaction causing the deconsolidation of BIGToken, was a result of BIGToken issuing additional shares of its common stock for acquisition of BritePool, the Company received no cash or other consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">In accordance with ASC 820 – Fair Value Measurement, the Company determined the Series D Stock would be classified as level 3 asset consistent with the account policy for determining the fair value of an asset or liability. As there is no observable market for quoted market price for an identical asset. The Company engaged an independent third party valuation expert to estimate the fair value of the Series D Stock.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">As of the Exchange date, the carrying basis of the non-controlling interest was approximately $<span id="xdx_90B_eus-gaap--BusinessCombinationContingentConsiderationLiability_iI_c20211229__srt--TitleOfIndividualAxis__custom--BIGTokensMember_zI4qWG1WRTEi">6,465,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">which included approximately $<span id="xdx_900_ecustom--BusinessCombinationContingentConsiderationLiabilityRelated_iI_c20211229__srt--TitleOfIndividualAxis__custom--BIGTokensMember_z2IxujqZIAe2">12,510,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">related to BIGToken’s recording of a $<span id="xdx_903_eus-gaap--DebtInstrumentConvertibleBeneficialConversionFeature_c20211228__20211229__srt--TitleOfIndividualAxis__custom--BIGTokensMember_zse9lsBQz3yk">5,860,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">Beneficial conversion feature for convertible preferred stock, issuance of convertible preferred stock in the amount of $<span id="xdx_907_eus-gaap--ConversionOfStockAmountIssued1_c20211228__20211229__srt--TitleOfIndividualAxis__custom--BIGTokensMember_zZo0EAW2Lzag">5,860,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">, $<span id="xdx_907_eus-gaap--FairValueAdjustmentOfWarrants_c20211228__20211229__srt--TitleOfIndividualAxis__custom--BIGTokensMember_zgSGnudIV1s4">885,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">for the fair value of warrants issued to the Company’s debenture holders and less other amounts of approximately $<span id="xdx_909_eus-gaap--OtherExpenses_c20211228__20211229__srt--TitleOfIndividualAxis__custom--BIGTokensMember_zMBU34yHgnte">95,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">. These transactions were recognized in equity outside of the accumulated other comprehensive income (loss) related to ownership interest, which did not result in a loss of control, so they would not be included in the calculation of the gain or loss from deconsolidation because these amounts resulted from transactions among shareholders and are not directly attributable to the non-controlling interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zf09g8WFD2Zd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The following table presents the aggregate carrying amounts of assets and liabilities of discontinued operations of BIGToken in the consolidated balance sheet as of December 31, 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zdZTKgbRSzD2" style="display: none">SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_496_20201231_zZLKA7bTtNN2" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Carrying amounts of assets included as part of discontinued operations:</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzI6Z_zRDHR8Czpdi" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzI6Z_ztprZq1z58ti" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accounts receivable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,199,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzI6Z_zVMkINROum8f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses and other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maAODGIzI6Z_z9ZG2c68AIv2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maAODGIzI6Z_zGk58XQgU0qi" style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,445,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maAODGIzI6Z_zkMAjvEdgYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Intangible assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">917,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperation_iTI_mtAODGIzI6Z_zRtW0hxMPoJg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets classified as discontinued operations in the consolidated balance sheet</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,569,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Carrying amounts of liabilities included as part of discontinued operations:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIz5fz_zO0258akVBLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accounts payable and accrued expenses</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">853,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIz5fz_z97W8LvgWwm7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other current liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">452,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIz5fz_zXwJ5Zwa0H63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities classified as discontinued operations in the consolidated balance sheet</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,305,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The financial results of BIGToken are presented as income from discontinued operations, net of income taxes on our consolidated income through December 29, 2021, when our deconsolidation occurred. The following table presents the financial results of BIGToken:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101__20211231_za8Wq3gouuE" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20200101__20201231_zKtzJVoN468" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzIg1_zK4BYSirl3Eh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,431,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,168,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzIg1_zEruUZ5c3Knj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,090,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">800,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzIg1_maDGIDOz7cg_zzBT2qmycBa9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,341,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,368,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost_maDGIDOzFBL_zReUbZaYh777" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Employee related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,419,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,212,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_maDGIDOzFBL_zhz4doOPqIc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Marketing and selling expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,136,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">958,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationPlatformCost_maDGIDOzFBL_zsYTSvjsSNle" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Platform costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">707,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_maDGIDOzFBL_zTtd3GHLtiVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">530,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">531,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_maDGIDOzFBL_zmyn73ucSLdg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">General and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,152,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">530,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzFBL_msDGIDOz7cg_zCXCS847Rih7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,587,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,938,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_iT_mtDGIDOz7cg_maDOGLFzG62_z6unla8u2V42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations of discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,246,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,570,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationFinancingCosts_iN_di_maDGIDOz6hB_z4yTLjE6vHbc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Financing costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,872,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRealizedLossOnMarketableSecurities_iN_di_maDGIDOz6hB_zGur33tPhswg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Realized loss on marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(71,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationImpairmentOfGoodwill_iN_di_maDGIDOz6hB_zAQdMpgy3MLg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Impairment of goodwill</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,258,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherExpense_iNT_di_mtDGIDOz6hB_msDOGLFzG62_zn8RCvj4rRgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total other expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,130,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(71,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_mtDOGLFzG62_maDOGLOzpGb_zEEmo4aUSIb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from discontinued operations before provision for income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,376,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,641,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_msDOGLOzpGb_z0Vk0AgwRci2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Provision for income taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0943">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_mtDOGLOzpGb_zPCIGphXZGdl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss from discontinued operations, net of income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(14,376,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,641,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p id="xdx_8AD_zAq6uSYCKcj4" style="margin-top: 0; margin-bottom: 0"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 183445351631 149562566584 242078 22162 13692304136 0.0499 617828 0.0499 31000 BIGToken’s issuance of the Acquisition Share and the Exchange caused the Company’s BIGToken common stock holdings to decrease from approximately 66% to approximately 4.99%; Therefore, the Company no longer controlled the operations of BIGToken. Given the Company’s loss of control over the operations of BIGToken, the Company deconsolidated BIGToken, as of December 29, 2021, in accordance with ASC 810 Consolidations 10684000 <p id="xdx_899_ecustom--ScheduleOfDeconsolidationOfBusinessTableTextBlock_z36muXbLH8pd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B8_znfbpApG3At2">SCHEDULE OF DECONSOLIDATION OF BUSINESS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 80%; text-align: left">Consideration received</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--DisposalGroupIncludingDiscontinuedOperationConsideration_iI_c20211229_zrmtcp5nwrkb" style="width: 16%; text-align: right" title="Consideration received"><span style="-sec-ix-hidden: xdx2ixbrl0856">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Fair value of Series D Stock and Common stock</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_ecustom--DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock_c20211228__20211229_z9rO2RTcmZTi" style="text-align: right" title="Fair value of Series D Stock and Common stock">31,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Carrying amount of non-controlling interest of BIGToken</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_ecustom--CarryingAmountOfNoncontrollingInterestOfBigtoken_c20211228__20211229_zerFAesigPZa" style="text-align: right" title="Carrying amount of non-controlling interest of BIGToken">6,045,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Previous equity adjustments of non-controlling interest</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_983_ecustom--PreviousEquityAdjustmentOfNoncontrollingInterest_c20211228__20211229_zhIniO61dB81" style="border-bottom: Black 1.5pt solid; text-align: right" title="Previous equity adjustments of non-controlling interest">(12,510,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Total consolidations</span></td><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--DeconsolidationGainOrLossAmount_c20211228__20211229_zc16fYxaQKq8" style="text-align: right" title="Total consolidations">(6,434,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Book basis of investment in BIGToken</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--BookBasisOfInvestmentInBigtoken_iI_c20211229_zJF9IgARZFme" style="border-bottom: Black 1.5pt solid; text-align: right" title="Book basis of investment in BIGToken">4,250,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Loss on disposal of subsidiary</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_981_eus-gaap--GainOrLossOnSaleOfStockInSubsidiary_c20211228__20211229_zBPb0jSmrMrh" style="border-bottom: Black 2.5pt double; text-align: right" title="Loss on disposal of subsidiary">(10,684,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 31000 6045000 -12510000 -6434000 4250000 -10684000 6465000 12510000 5860000 5860000 885000 95000 <p id="xdx_89D_eus-gaap--ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock_zf09g8WFD2Zd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The following table presents the aggregate carrying amounts of assets and liabilities of discontinued operations of BIGToken in the consolidated balance sheet as of December 31, 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zdZTKgbRSzD2" style="display: none">SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="display: none"> </td><td style="display: none"> </td> <td style="display: none; text-align: left"> </td><td id="xdx_496_20201231_zZLKA7bTtNN2" style="display: none; text-align: right"> </td><td style="display: none; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Carrying amounts of assets included as part of discontinued operations:</td><td> </td> <td colspan="2"> </td><td> </td></tr> <tr id="xdx_406_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents_iI_maAODGIzI6Z_zRDHR8Czpdi" style="vertical-align: bottom; background-color: White"> <td style="width: 80%; text-align: left">Cash and cash equivalents</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 16%; text-align: right">1,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet_iI_maAODGIzI6Z_ztprZq1z58ti" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accounts receivable, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,199,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent_iI_maAODGIzI6Z_zVMkINROum8f" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Prepaid expenses and other current assets</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">6,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent_iI_maAODGIzI6Z_z9ZG2c68AIv2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Property and equipment, net</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent_iI_maAODGIzI6Z_zGk58XQgU0qi" style="vertical-align: bottom; background-color: White"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">5,445,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent_iI_maAODGIzI6Z_zkMAjvEdgYf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Intangible assets, net</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">917,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--AssetsOfDisposalGroupIncludingDiscontinuedOperation_iTI_mtAODGIzI6Z_zRtW0hxMPoJg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total assets classified as discontinued operations in the consolidated balance sheet</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,569,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Carrying amounts of liabilities included as part of discontinued operations:</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent_iI_maLODGIz5fz_zO0258akVBLh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Accounts payable and accrued expenses</td><td> </td> <td style="text-align: left">$</td><td style="text-align: right">853,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities_iI_maLODGIz5fz_z97W8LvgWwm7" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Other current liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">452,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent_iTI_mtLODGIz5fz_zXwJ5Zwa0H63" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total liabilities classified as discontinued operations in the consolidated balance sheet</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">1,305,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; background-color: white">The financial results of BIGToken are presented as income from discontinued operations, net of income taxes on our consolidated income through December 29, 2021, when our deconsolidation occurred. The following table presents the financial results of BIGToken:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49F_20210101__20211231_za8Wq3gouuE" style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49A_20200101__20201231_zKtzJVoN468" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="6" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Year ended December 31,</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2020</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr id="xdx_40A_eus-gaap--DisposalGroupIncludingDiscontinuedOperationRevenue_maDGIDOzIg1_zK4BYSirl3Eh" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 64%">Revenues</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">3,431,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 14%; text-align: right">2,168,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold_msDGIDOzIg1_zEruUZ5c3Knj" style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 1.5pt">Cost of revenue</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,090,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">800,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss_iT_mtDGIDOzIg1_maDGIDOz7cg_zzBT2qmycBa9" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Gross profit</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">2,341,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">1,368,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Operating expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_406_ecustom--DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost_maDGIDOzFBL_zReUbZaYh777" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Employee related costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,419,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">3,212,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense_maDGIDOzFBL_zhz4doOPqIc2" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Marketing and selling expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,136,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">958,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--DisposalGroupIncludingDiscontinuedOperationPlatformCost_maDGIDOzFBL_zsYTSvjsSNle" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Platform costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,350,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">707,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization_maDGIDOzFBL_zTtd3GHLtiVf" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Depreciation and amortization</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">530,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">531,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense_maDGIDOzFBL_zmyn73ucSLdg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">General and administrative expenses</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">4,152,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">530,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingExpense_iT_mtDGIDOzFBL_msDGIDOz7cg_zCXCS847Rih7" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total operating expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">9,587,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">5,938,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_403_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss_iT_mtDGIDOz7cg_maDOGLFzG62_z6unla8u2V42" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from operations of discontinued operations</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(7,246,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,570,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Other expense</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DisposalGroupIncludingDiscontinuedOperationFinancingCosts_iN_di_maDGIDOz6hB_z4yTLjE6vHbc" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Financing costs</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(5,872,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0929">-</span></td><td style="text-align: left"> </td></tr> <tr id="xdx_40B_ecustom--DisposalGroupIncludingDiscontinuedOperationRealizedLossOnMarketableSecurities_iN_di_maDGIDOz6hB_zGur33tPhswg" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Realized loss on marketable securities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0931">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(71,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40E_ecustom--DisposalGroupIncludingDiscontinuedOperationImpairmentOfGoodwill_iN_di_maDGIDOz6hB_zAQdMpgy3MLg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt">Impairment of goodwill</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(1,258,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0935">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DisposalGroupIncludingDiscontinuedOperationOtherExpense_iNT_di_mtDGIDOz6hB_msDOGLFzG62_zn8RCvj4rRgi" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Total other expense</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(7,130,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(71,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_40C_eus-gaap--DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax_mtDOGLFzG62_maDOGLOzpGb_zEEmo4aUSIb1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loss from discontinued operations before provision for income taxes</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(14,376,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(4,641,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation_msDOGLOzpGb_z0Vk0AgwRci2" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Provision for income taxes</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0943">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"/><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax_mtDOGLOzpGb_zPCIGphXZGdl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt">Loss from discontinued operations, net of income taxes</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(14,376,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">(4,641,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> 1000 1199000 6000 1000 5445000 917000 7569000 853000 452000 1305000 3431000 2168000 1090000 800000 2341000 1368000 2419000 3212000 1136000 958000 1350000 707000 530000 531000 4152000 530000 9587000 5938000 -7246000 -4570000 5872000 71000 1258000 7130000 71000 -14376000 -4641000 -14376000 -4641000 <p id="xdx_805_eus-gaap--BusinessCombinationDisclosureTextBlock_z6kXeecPzvq4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 3 – <span style="font-variant: small-caps"><span id="xdx_827_z82IrGA7JZDk">ACQUISITIONS</span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On <span id="xdx_907_eus-gaap--BusinessAcquisitionDateOfAcquisitionAgreement1_c20200914__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember">September 15, 2020</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(“Closing Date”), an Agreement and Plan of Merger (the “Agreement”) was entered into by and among SRAX, Inc. a Delaware corporation (“Parent”), Townsgate Merger Sub 1, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub 1”), LD Micro, Inc., a Delaware corporation and a direct wholly-owned subsidiary of Parent (“Merger Sub 2”), LD Micro, Inc., a California corporation (the “Acquiree”, “LD Micro”), and Christopher Lahiji, the sole stockholder of the Acquiree (the “Stockholder”). Merger Sub 1 and Merger Sub 2 are sometimes collectively referred to as “Merger Sub.”</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The parties intend that Merger Sub 1 will be merged with and into the Acquiree (the “First Merger”), with the Acquiree surviving the First Merger, and then the Acquiree will be merged with and into Merger Sub 2 (the “Second Merger,” and together with the First Merger, the “Merger”), with Merger Sub 2 surviving the Second Merger.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As consideration, the Company will pay cash payable as follows: (i) $<span id="xdx_90F_eus-gaap--PaymentsToAcquireBusinessesGross_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zafbiNQzTCi7" title="Business combination, cash payable by entity">1,000,000</span> at the Closing, (ii) $<span id="xdx_903_eus-gaap--PaymentsToAcquireBusinessesGross_c20201230__20210102__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_z4gtoyvJlwDf" title="Business combination, cash payable by entity">1,000,000</span> on January 1, 2021, (iii) $<span id="xdx_907_eus-gaap--PaymentsToAcquireBusinessesGross_c20210330__20210401__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember__srt--StatementScenarioAxis__custom--ForecastMember_z09GxVmyCtDl" title="Business combination, cash payable by entity">1,000,000</span> on April 1, 2021, and (iv) $<span id="xdx_90A_eus-gaap--PaymentsToAcquireBusinessesGross_c20210629__20210701__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember__srt--StatementScenarioAxis__custom--ForecastMember_zgZT49Fw9VIe" title="Business combination, cash payable by entity">1,000,000</span> on July 1, 2021 and subject to adjustment or off-set. Additionally, the Company issued <span id="xdx_907_eus-gaap--BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zJVzpD9KOjdk" title="Number of shares issued in acquisition">1,600,000</span> shares of its Class A common stock. The total consideration to be paid by the Company is $<span id="xdx_90E_eus-gaap--PaymentsToAcquireBusinessesGross_c20210101__20211231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zqUkUbvUptC8" title="Business combination, cash payable by entity">7,610,000</span>, as adjusted, as follows:</span></p> <p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_z7f26b0YDGBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zDubH89hDaL" style="display: none">SCHEDULE OF CALCULATIONS OF PURCHASE PRICE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_z8G6rV8FN9f7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Calculation of the purchase price:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_maBCCTzg13_zCYBXKAszmj6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 79%; text-align: left">Fair value of stock at closing</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">4,264,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PaymentsToAcquireBusinessesGross_maBCCTzg13_zLIEIbRmDaxd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Cash at closing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationContractWithCustomerLiability_maBCCTzg13_z3XEdiOMqd7f" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Deferred payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,771,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BusinessCombinationLessCashReceived_maBCCTzg13_z1VNsV0LFqBl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Less cash received</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(303,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--BusinessCombinationTransactionExpenses_maBCCTzg13_ze5nbhcag5d1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Transaction expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--BusinessCombinationWorkingCapitalAdjustment_maBCCTzg13_zHTQoRgOvC15" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Working capital adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(132,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationConsiderationTransferred1_iT_mtBCCTzg13_zvTmxUCeu0Eg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,610,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A9_zlHmweMvcE1j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The transaction was accounted for using the acquisition method. Accordingly, goodwill has been measured as the excess of the total consideration over the amounts assigned to the identifiable assets acquired and liabilities assumed.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The deferred payments of $<span id="xdx_902_ecustom--BusinessCombinationContractWithCustomerLiabilityDiscounted_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zxa15gIHJH93" title="Deferred payments discounted under CCC rated corporate debt">3,000,000</span> were discounted using the yield on a CCC rated corporate debt for 3-month, 6-month and 9-month maturities, respectively. The implied discount is approximately $<span id="xdx_904_ecustom--AmortizationOfPayments_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zXenaspWDIs6" title="Amortization of payments">229,000</span>, which will be amortized over the term on the payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price includes working capital adjustments that are based on our preliminary estimates and assumptions that are subject to change.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_892_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zBoij1coZPsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zLnvc4D5b4s1" style="display: none">SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_z4wtP7FPMPTh" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zSHxaje7wed8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 79%; text-align: left">Accounts receivable, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">30,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zUdTeXW1aCM7" style="vertical-align: bottom; background-color: White"> <td>Intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--Goodwill_iI_zNFIEIvZGKR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,706,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zWu2Kej9Msie" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(324,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zEh1gImntYQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payroll protection loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(42,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iNI_di_zrBj5jUN5RRj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(97,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_zWX8cuyJIIi1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_zj99brFMnCHi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,610,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zfN5XigvFg3i" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89B_ecustom--ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_zhx9ccma07bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zTTOHuUUaJ7l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life in Years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--TrademarkMember_z6OjkfEeXuQi" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--TrademarkMember_zRhb0reA1g2l" title="Life in years, description">Indefinite</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--DomainNameMember_zM2HQzzaFQRj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--DomainNameMember_zG87xfApRQTl" title="Life in years, description">Indefinite</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncompete</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--NoncompeteMember_zDkSUkdx5pIg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--NoncompeteMember_zKDEkhrqghl8" title="Life in years, description">5 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer list</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--CustomerListMember_zcCE1P0qC6N1" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--CustomerListMember_zysNAb31SMUj" title="Life in years, description">3 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915_zq9LXcFgr5Y5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">468,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_z8xcKHNQhPfc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The estimated fair values for the trademark and domain name were determined by using the relief-from-royalty method. The estimated fair value for the customer list and noncompete were determined using the excess earnings and differential method of comparing having an asset in-place versus not having the asset in place, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has estimated the preliminary purchase price allocations based on historical inputs and data as of September 15, 2020. The preliminary allocation of the purchase price is based on the best information available and is pending, amongst other things: (i) the finalization of the valuation of the fair values and useful lives of tangible assets acquired; (ii) the finalization of the valuations and intangible assets acquired; (iii) finalization of the valuation of accounts payable and accrued expenses; and (iv) finalization of the fair value of non-cash consideration.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the measurement period (which is the period required to obtain all necessary information that existed at the acquisition date, or to conclude that such information is unavailable, not to exceed one year), additional assets or liabilities may be recognized, or there could be changes to the amounts of assets or liabilities previously recognized on a preliminary basis, if new information is obtained about facts and circumstances that existed as of the acquisition date that, if known, would have resulted in the recognition of these assets or liabilities as of that date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_ecustom--SummaryOfAmountsOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateTableTextBlock_ziLOnQuvSyGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts of revenue and earnings of the Acquiree since the acquisition date included in the consolidated statements of operations for the year ended December 31, 2020 follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zcTvj2kF3VEe" style="display: none">SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td colspan="2" id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zFspuUppWmcc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zZghyX0v6dH7" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Nety income (loss)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8AC_zoBmId6BeDP6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following pro forma information presents the combined results of operations as if the acquisitions had been completed on January 1, 2020. The pro forma results include the amortization associated with the preliminary estimates for the acquired intangible assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The pro forma results do not reflect any cost saving synergies from operating efficiencies, or the effect of the incremental costs incurred in integrating the two companies. Accordingly, these pro forma results are presented for informational purpose only and are not necessarily indicative of what the actual results of operations of the combined company would have been if the acquisition had occurred at the beginning of the period presented, nor are they indicative of future results of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_890_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zFDVLLA0Wpgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Consolidated Statements of Operations</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Year ended December 31, 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BB_zloITPBP4OHc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRAX, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LD Micro, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Adjustment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Combined</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_zvBb0Xcr8vB" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,479,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zezfVvOz1bp8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">937,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_d0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zaI9HZvJbvhg" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zFs66ogWAoY7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,416,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_c20200101__20201231_zK3a5ai9iqG4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,789,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zZ4sktCmzrC4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_d0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zirADgEPpLL" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zILR41gTBTod" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,887,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_zRzAn1wsAd5c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,722,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zBqWb7OICKoh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(858,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zuZLemgqme3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zn8dPOOM51k6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,409,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--BusinessAcquisitionsProFormaOtherExpense_c20200101__20201231_zQdCklDgfvOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,011,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--BusinessAcquisitionsProFormaOtherExpense_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zQWkxCPw3lB" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherExpense_d0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zUAKxl4Ol2ae" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaOtherExpense_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zcNp6916fbbe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,012,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for income taxes</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di_c20200101__20201231_z880ShoLrmh5" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di0_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zhOOfr2jZ2Fl" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zHjnpbtXidmb" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zKdXnk3LoKUd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_za2tSLKqOb1k" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,064,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zygNyDia763k" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zbHJzkBps8r8" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_z3MAzIQzBfqf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,913,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8AC_zpM9CCuv6oV5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_895_ecustom--ScheduleOfProFormaAdjustmentsTextBlock_z97OETbySDG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the pro forma adjustments made for the year ended December 31, 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zGKwToDftgna" style="display: none">SUMMARY OF PRO FORMA ADJUSTMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_49E_20200101__20201231__srt--StatementScenarioAxis__us-gaap--ScenarioAdjustmentMember_zcj7VUNDwwYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_ecustom--BusinessAcquisitionsProFormaAmortizationOfIntangiblesAcquired_msBAPFNz0xk_zldLRfjNUli" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of intangibles acquired</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaEmployeeRelatedCosts_msBAPFNz0xk_zzd9pahw0m64" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee related costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(235,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaFinancingCosts_msBAPFNz0xk_z19OG9ir1j53" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_iNT_di_mtBAPFNz0xk_zJoJ9EYhfaw2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(171,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> <p id="xdx_8A5_zVU3JHnspGF1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization relates to the acquired noncompete and customer list amounting to $<span id="xdx_90C_ecustom--AmortizationOfPayments_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--NoncompeteMember_z9LvXuLknxna" title="Amortization of payments">2,000</span> and $<span id="xdx_90A_ecustom--AmortizationOfPayments_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--CustomerListMember_zG8ybqTJAk67" title="Amortization of payments">62,000</span>, respectively for the year ended December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee related cost are contracted cost amounting to $<span id="xdx_90D_ecustom--EmployeeRelatedCosts_c20200101__20201231_zqRr9nQd1Ka5" title="Employee related costs">235,000</span> for the year ended December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 2020-09-15 1000000 1000000 1000000 1000000 1600000 7610000 <p id="xdx_89F_eus-gaap--ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock_z7f26b0YDGBe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BC_zDubH89hDaL" style="display: none">SCHEDULE OF CALCULATIONS OF PURCHASE PRICE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_z8G6rV8FN9f7" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Calculation of the purchase price:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr id="xdx_400_eus-gaap--BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable_maBCCTzg13_zCYBXKAszmj6" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; width: 79%; text-align: left">Fair value of stock at closing</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">4,264,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--PaymentsToAcquireBusinessesGross_maBCCTzg13_zLIEIbRmDaxd" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Cash at closing</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">1,000,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_403_ecustom--BusinessCombinationContractWithCustomerLiability_maBCCTzg13_z3XEdiOMqd7f" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Deferred payments</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">2,771,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_40E_ecustom--BusinessCombinationLessCashReceived_maBCCTzg13_z1VNsV0LFqBl" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left">Less cash received</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(303,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_403_ecustom--BusinessCombinationTransactionExpenses_maBCCTzg13_ze5nbhcag5d1" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; text-align: left">Transaction expenses</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">10,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_400_ecustom--BusinessCombinationWorkingCapitalAdjustment_maBCCTzg13_zHTQoRgOvC15" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Working capital adjustment</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(132,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationConsiderationTransferred1_iT_mtBCCTzg13_zvTmxUCeu0Eg" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 2.5pt">Purchase price</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,610,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 4264000 1000000 2771000 -303000 10000 -132000 7610000 3000000 229000 <p id="xdx_892_eus-gaap--ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock_zBoij1coZPsk" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the allocation of the purchase price to the assets acquired and liabilities assumed:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zLnvc4D5b4s1" style="display: none">SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; width: 70%; border-collapse: collapse; margin-right: auto"> <tr style="display: none; vertical-align: bottom; background-color: White"> <td> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_49E_20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_z4wtP7FPMPTh" style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables_iI_zSHxaje7wed8" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 79%; text-align: left">Accounts receivable, net</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 18%; text-align: right">30,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_zUdTeXW1aCM7" style="vertical-align: bottom; background-color: White"> <td>Intangibles</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">468,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_401_eus-gaap--Goodwill_iI_zNFIEIvZGKR6" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Goodwill</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">7,706,000</td><td style="text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable_iNI_di_zWu2Kej9Msie" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Accounts payable and accrued liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(324,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt_iNI_di_zEh1gImntYQ5" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Payroll protection loan</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(42,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther_iNI_di_zrBj5jUN5RRj" style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Other current liabilities</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">(97,000</td><td style="text-align: left">)</td></tr> <tr id="xdx_40B_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities_iNI_di_zWX8cuyJIIi1" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Deferred tax liability</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">(131,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_409_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet_iTI_zj99brFMnCHi" style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Net assets acquired</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; text-align: right">7,610,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 30000 468000 7706000 324000 42000 97000 131000 7610000 <p id="xdx_89B_ecustom--ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock_zhx9ccma07bh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B4_zTTOHuUUaJ7l" style="display: none">SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fair Value</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Life in Years</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98A_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--TrademarkMember_z6OjkfEeXuQi" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--TrademarkMember_zRhb0reA1g2l" title="Life in years, description">Indefinite</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--DomainNameMember_zM2HQzzaFQRj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">3,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--DomainNameMember_zG87xfApRQTl" title="Life in years, description">Indefinite</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Noncompete</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_985_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--NoncompeteMember_zDkSUkdx5pIg" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--NoncompeteMember_zKDEkhrqghl8" title="Life in years, description">5 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer list</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915__us-gaap--BusinessAcquisitionAxis__custom--CustomerListMember_zcCE1P0qC6N1" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_ecustom--IntangibleAssetsLifeInYearsDescription_c20200913__20200915__us-gaap--BusinessAcquisitionAxis__custom--CustomerListMember_zysNAb31SMUj" title="Life in years, description">3 years</span></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98D_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill_iI_c20200915_zq9LXcFgr5Y5" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Fair value"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">468,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 271000 Indefinite 3000 Indefinite 8000 5 years 186000 3 years 468000 <p id="xdx_891_ecustom--SummaryOfAmountsOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateTableTextBlock_ziLOnQuvSyGl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amounts of revenue and earnings of the Acquiree since the acquisition date included in the consolidated statements of operations for the year ended December 31, 2020 follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zcTvj2kF3VEe" style="display: none">SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td colspan="2" id="xdx_98A_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zFspuUppWmcc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1024">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 77%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_983_eus-gaap--NetIncomeLoss_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zZghyX0v6dH7" style="font: 10pt Times New Roman, Times, Serif; width: 20%; text-align: right" title="Nety income (loss)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(51,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> -51000 <p id="xdx_890_eus-gaap--BusinessAcquisitionProFormaInformationTextBlock_zFDVLLA0Wpgb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Consolidated Statements of Operations</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Year ended December 31, 2020</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span id="xdx_8BB_zloITPBP4OHc" style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">SRAX, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">LD Micro, Inc.</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Adjustment</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pro Forma Combined</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 45%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231_zvBb0Xcr8vB" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">6,479,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_983_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zezfVvOz1bp8" style="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">937,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_989_eus-gaap--BusinessAcquisitionsProFormaRevenue_d0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zaI9HZvJbvhg" style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaRevenue_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zFs66ogWAoY7" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,416,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Cost of revenues</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98B_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_c20200101__20201231_zK3a5ai9iqG4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,789,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zZ4sktCmzrC4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(98,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_988_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_d0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zirADgEPpLL" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaCostOfRevenues_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zILR41gTBTod" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Cost of revenues"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,887,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating expenses</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_986_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231_zRzAn1wsAd5c" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(11,722,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zBqWb7OICKoh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(858,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zuZLemgqme3g" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_984_ecustom--BusinessAcquisitionsProFormaOperatingExpenses_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zn8dPOOM51k6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating expenses"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(12,409,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other expense</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_987_ecustom--BusinessAcquisitionsProFormaOtherExpense_c20200101__20201231_zQdCklDgfvOb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,011,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--BusinessAcquisitionsProFormaOtherExpense_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zQWkxCPw3lB" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98E_ecustom--BusinessAcquisitionsProFormaOtherExpense_d0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zUAKxl4Ol2ae" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_98C_ecustom--BusinessAcquisitionsProFormaOtherExpense_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zcNp6916fbbe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Other expense"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,012,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Provision for income taxes</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di_c20200101__20201231_z880ShoLrmh5" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di0_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zhOOfr2jZ2Fl" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_982_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di0_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zHjnpbtXidmb" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td id="xdx_981_ecustom--BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit_iN_di_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_zKdXnk3LoKUd" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Provision for income taxes"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(21,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net loss</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231_za2tSLKqOb1k" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(10,064,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_987_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_zygNyDia763k" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(20,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaAdjustmentMember_zbHJzkBps8r8" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">171,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td id="xdx_98B_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_c20200101__20201231__srt--StatementScenarioAxis__custom--ProFormaCombinedMember_z3MAzIQzBfqf" style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net loss"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(9,913,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 6479000 937000 -0 7416000 -1789000 -98000 -0 -1887000 -11722000 -858000 171000 -12409000 -3011000 -1000 -0 -3012000 21000 0 0 21000 -10064000 -20000 171000 -9913000 <p id="xdx_895_ecustom--ScheduleOfProFormaAdjustmentsTextBlock_z97OETbySDG8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following summarizes the pro forma adjustments made for the year ended December 31, 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B9_zGKwToDftgna" style="display: none">SUMMARY OF PRO FORMA ADJUSTMENTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 60%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td> <td id="xdx_49E_20200101__20201231__srt--StatementScenarioAxis__us-gaap--ScenarioAdjustmentMember_zcj7VUNDwwYc" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr id="xdx_40A_ecustom--BusinessAcquisitionsProFormaAmortizationOfIntangiblesAcquired_msBAPFNz0xk_zldLRfjNUli" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 73%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization of intangibles acquired</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 22%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">64,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_ecustom--BusinessAcquisitionsProFormaEmployeeRelatedCosts_msBAPFNz0xk_zzd9pahw0m64" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Employee related costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(235,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">) </span></td></tr> <tr id="xdx_401_ecustom--BusinessAcquisitionsProFormaFinancingCosts_msBAPFNz0xk_z19OG9ir1j53" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financing costs</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl1083">-</span></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--BusinessAcquisitionsProFormaNetIncomeLoss_iNT_di_mtBAPFNz0xk_zJoJ9EYhfaw2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Net income (loss)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(171,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> </table> 64000 -235000 171000 2000 62000 235000 <p id="xdx_800_eus-gaap--CreditLossFinancialInstrumentTextBlock_zRnkPChr10U5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 4 – <span style="font-variant: small-caps"><span><span id="xdx_82E_z6xRBSbbY8z1">SALE AND PURCHASE OF ACCOUNTS RECEIVABLE</span></span></span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On January 22, 2020 and January 30, 2020, the Company entered into financing agreements, with a single unrelated purchaser to sell, with full recourse, certain accounts receivable with a face value of $<span title="Accounts receivable"><span id="xdx_905_eus-gaap--AccountsReceivableNet_iI_c20200122_ztkqc1ht6ukf" title="Accounts receivable">454,000</span></span> and $<span title="Accounts receivable"><span id="xdx_902_eus-gaap--AccountsReceivableNet_iI_c20200130_zGjqVu5xjBn1" title="Accounts receivable">75,000</span></span>, respectively, for a purchase price of $<span><span id="xdx_902_eus-gaap--AccountsReceivablePurchase_c20200120__20200122_z3NyY8fNNSw3" title="Accounts receivable purchase">454,000</span></span> and $<span><span id="xdx_903_eus-gaap--AccountsReceivablePurchase_c20200128__20200130_z6v1TGmqZNR4" title="Accounts receivable purchase">56,000</span></span>, respectively. Transactions under these agreements were accounted for as financing of accounts receivable and the related accounts receivable was not removed from our consolidated balance sheet at the time of the sales transactions, a liability was recorded for the proceeds received. The terms of the agreements are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the initial purchase agreement, commencing on March 24, 2020, the purchaser may, at its sole discretion, exercise a put option, to cause the Company to purchase from purchaser, any of the outstanding January 22, 2020 receivables which were not collected by the purchaser. Effective April 9, 2020, the put option was extended until June 23, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The purchase price payable by Company to the Purchaser for the receivables upon exercise of the Put Option shall be equal to one hundred and thirty-six percent (<span id="xdx_90D_ecustom--PercentageOfReceivablesUponExerciseOfPutOption_dp_uPure_c20200322__20200324__us-gaap--TypeOfArrangementAxis__custom--AgreementsToSellAccountsReceivableMember_zwy2MoY07eRi">136</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%) of the then remaining outstanding balance of the applicable receivables.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Upon the occurrence of a payment made on the applicable receivables, the Company is required to pay a true up amount as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"> </p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a. <span id="xdx_90C_ecustom--DescriptionOfSaleOfAccountsReceivable_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__custom--TenPercentMember_zAaaC1pIGYCg" title="Description of sale of accounts receivable">ten percent (10%) of the portion of the receivables which are paid on or before the 30th day following the effective date of the agreement;</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b. <span id="xdx_90A_ecustom--DescriptionOfSaleOfAccountsReceivable_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__custom--TwentyPercentMember_zYZhI47r9dId" title="Description of sale of accounts receivable">twenty percent (20%) of the portion of the receivables which are paid after the 30<sup>th</sup> day but on or before the 60<sup>th</sup> day following the effective date of the agreement; and</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0 0 0 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c. <span id="xdx_90A_ecustom--DescriptionOfSaleOfAccountsReceivable_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__custom--ThirtySixPercentMember_z2EGop7hNFld">thirty-six </span>percent (36%) of the portion of the receivables which are paid after the 60<sup>th</sup> day following the effective date of the agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0 0.25in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to secure performance by the Company, the purchaser was granted a security interest in: (i) <span id="xdx_908_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200120__20200122__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z9IPqpovRjL2" title="Sale of stock, shares">239,029</span> shares of the Company’s Class A common stock in connection with the sale of the $<span id="xdx_90A_ecustom--SaleOfStockNumberOfValueIssuedInTransaction_c20200120__20200122__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zkPJ7xtvttBb" title="Sale of stock, value">454,000</span> receivable and (ii) <span id="xdx_902_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200128__20200130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zvlwAhvi8Awg" title="Sale of stock, shares">29,519</span> shares of the Company’s Class A common stock in connection with the sale of the $<span id="xdx_902_ecustom--SaleOfStockNumberOfValueIssuedInTransaction_c20200128__20200130__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zjeHOhL1r2Xl" title="Sale of stock, value">75,000</span> receivable. The shares have been issued and are being held by the Company’s transfer agent. Since the shares are not outstanding, the Company has treated them as shares reserved for collateral.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the purchaser of the receivables has recourse, the Company accounted for the purchase price as a liability. Upon the purchaser’s election of the put option or the true up, as applicable the Company will treat the put option price or the true up amounts as interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_904_ecustom--DescriptionOfSaleOfAccountsReceivable_c20200408__20200409__us-gaap--TypeOfArrangementAxis__custom--AgreementsToSellAccountsReceivableAmmendedMember_z7rZD0ACdzxb" title="Description of sale of accounts receivable">On April 9, 2020 the Company entered into an agreement to amend the January 22 and 30 accounts receivable agreements. The purchaser agreed to amend the put option date as described above to June 23, 2020 and June 30, 2020 for the sale of receivables originating on January 22, 2020 and January 30, 2020, respectively. As consideration for the extension the Company agreed to issue the purchaser <span id="xdx_901_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200120__20200122__us-gaap--TypeOfArrangementAxis__custom--AgreementsToSellAccountsReceivableAmmendedMember_zn6v0kSK2cRl" title="Sale of stock number of shares">32,668</span> and <span id="xdx_909_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_c20200128__20200130__us-gaap--TypeOfArrangementAxis__custom--AgreementsToSellAccountsReceivableAmmendedMember_zHdHIFPE6nuf" title="Sale of stock number of share">4,032</span> shares of Class A common stock for the receivable sale originating on January 22, 2020 and January 30, 2020, respectively.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2020, the Purchaser converted the payable of $<span id="xdx_908_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200628__20200630__us-gaap--FinancialInstrumentAxis__us-gaap--AccountsPayableMember_zLqUlG4LUch7" title="Converted debt">510,000</span> and accrued interest of $<span id="xdx_902_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200628__20200630__us-gaap--FinancialInstrumentAxis__us-gaap--AccruedLiabilitiesMember_zPkkoJy6CfZg" title="Converted debt">184,000</span> (“Old Debt”) into approximately $<span id="xdx_904_eus-gaap--DebtConversionOriginalDebtAmount1_c20200628__20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_z6gB0PjIRtk6" title="Converted debt">788,000</span> of the OID Convertible Notes payable (“Debentures”) (See Note 17 - OID Convertible Debentures). The conversion was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. At the date of issuance, the Debenture had a fair market value of approximately $<span id="xdx_90F_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations_iI_c20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_zkXgDy3yEHPg" title="Fair value of debentures">815,000</span>. The transaction created a loss on extinguishment of approximately $<span id="xdx_900_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200628__20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_z2PYkvO1lxcd" title="Loss on extinguishment">546,000</span>, which consisted of (i) the difference of value between the Old Debt and the fair value of the new debt of approximately $<span id="xdx_905_eus-gaap--FairValueOptionAggregateDifferencesLongTermDebtInstruments_iI_c20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_zJN75CZuL0n5" title="Difference between face value and fair value">95,000</span>, (ii) the difference between the face value of the debenture and the fair value of the Debenture of approximately $<span id="xdx_904_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_c20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_zu4GxnsGDFs1" title="Conversion premium">27,000</span> and (iii) $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_c20200628__20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_zI3yPsSHEjcf" title="Fair value of warrants">424,000</span> for fair value of warrants issued with the Debenture. Also, since the Debenture was convertible into the Company’s common stock, a $<span id="xdx_90F_eus-gaap--AdditionalPaidInCapitalCommonStock_iI_c20200630__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_zJQXsuhDW8Bl" title="Conversion premium">27,000</span> premium associated with the conversion feature was recorded as additional paid in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Since the purchaser of the receivables has recourse, the Company accounted for the purchase price as a liability. Upon the purchaser’s election of the put option or the true up, as applicable the Company will treat the put option price or the true up amounts as interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In December 2020, the Company entered into an agreement with a third-party lender whereby it sold the Company’s right to future subscription revenues of $<span id="xdx_902_ecustom--RightToFutureSubscriptionRevenues_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--PIPETechnologiesMember_zArNrXGG2A13">570,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_90B_ecustom--SubscriptionRevenues_c20200101__20201231__us-gaap--TypeOfArrangementAxis__custom--PIPETechnologiesMember_zKOPlEzl4vSk">528,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the terms of the agreement, the Company may borrow funds collateralized by the right to the revenues from Sequire platform contracts. The third party lender receives a discount on the amount sold and remits the net amount to the Company. The Company bears the risk of credit loss on the contracts. These transactions are accounted for as secured borrowing arrangements and not as a sale of financial assets. In December 2021, the Company entered into another agreement through which it sold future subscriptions amounting to $<span id="xdx_905_eus-gaap--AccountsReceivableRelatedParties_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--PIPETechnologiesMember_z08iRzfepHCc">625,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for net proceeds of $<span id="xdx_90B_ecustom--ProceedsFromAccountsReceivable_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--PIPETechnologiesMember_zCJL6Ny9e6ng">576,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The amount of borrowings outstanding was approximately $<span id="xdx_907_eus-gaap--DebtInstrumentUnusedBorrowingCapacityAmount_iI_c20211231_zztVGacA1Mqa">631,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2021 and $<span id="xdx_90B_eus-gaap--DebtInstrumentUnusedBorrowingCapacityAmount_iI_c20201231_zSXVqqpsooKk">570,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">at December 31, 2020. As of December 31, 2021, our availability to draw additional funds through this agreement was approximately $<span id="xdx_902_eus-gaap--ProceedsFromIssuanceOfDebt_c20211227__20211231_zvQW63Dm3Dmc" title="Proceeds from additional borrowing">1,000,000</span>. These balances are included with Accounts Payable and Accrued Expenses within our consolidated balance sheet.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 29, 2021, the Company (“Purchaser”) and BIGtoken (“Seller”) entered into a receivable purchase and sale agreement whereby BIGtoken sell, assign, transfer, convey and deliver to the Company all rights, title and interest for its receivable aggregating $<span id="xdx_90B_ecustom--AccountsReceivables_iI_c20211029__us-gaap--TypeOfArrangementAxis__custom--ReceivablePurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--BIGtokenMember_zMDtBJX4NUhf">352,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for a purchase price of $<span id="xdx_900_ecustom--PurchasePrice_iI_c20211029__us-gaap--TypeOfArrangementAxis__custom--ReceivablePurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--BIGtokenMember_zIDySSJiGJK2">327,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, sup representing a <span id="xdx_909_eus-gaap--DebtInstrumentRedemptionPricePercentage_pid_dp_uPure_c20211028__20211029__us-gaap--TypeOfArrangementAxis__custom--ReceivablePurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--BIGtokenMember_zuW5shf5VB79">7</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% discount. As of December 31, 2021, the outstanding receivable amounts to $<span id="xdx_900_ecustom--AccountsReceivable_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--ReceivablePurchaseAndSaleAgreementMember__dei--LegalEntityAxis__custom--BIGtokenMember_zR2OnBs4oQxk">352,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> 454000 75000 454000 56000 1.36 ten percent (10%) of the portion of the receivables which are paid on or before the 30th day following the effective date of the agreement; twenty percent (20%) of the portion of the receivables which are paid after the 30th day but on or before the 60th day following the effective date of the agreement; and thirty-six 239029 454000 29519 75000 On April 9, 2020 the Company entered into an agreement to amend the January 22 and 30 accounts receivable agreements. The purchaser agreed to amend the put option date as described above to June 23, 2020 and June 30, 2020 for the sale of receivables originating on January 22, 2020 and January 30, 2020, respectively. As consideration for the extension the Company agreed to issue the purchaser 32,668 and 4,032 shares of Class A common stock for the receivable sale originating on January 22, 2020 and January 30, 2020, respectively. 32668 4032 510000 184000 788000 815000 546000 95000 27000 424000 27000 570000 528000 625000 576000 631000 570000 1000000 352000 327000 0.07 352000 <p id="xdx_80A_eus-gaap--AccountsAndNontradeReceivableTextBlock_zS6PsAAYosbj" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 5 – <span style="font-variant: small-caps"><span id="xdx_820_zFNeH4kAp7Ff">CONTRACTS RECEIVABLE</span></span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Contracts receivable represents amounts for which non-cancellable revenue contracts with customers have been finalized but the payment in the form of securities issued by the customer which could be a common stock, preferred stock or convertible debentures have not been received by the Company. Contracts receivable that will be received during the succeeding 12-month period is recorded as current contracts receivable, and the remaining portion, if any, is recorded as long-term contracts receivable. As of December 31, 2021 and 2020, contracts receivable amounted to $<span id="xdx_905_ecustom--ContractsReceivable_iI_c20211231_zgrCFT97cWh5" title="Contracts receivable">844,000</span> and <span id="xdx_904_ecustom--ContractsReceivable_iI_doxL_c20201231_zqaq5dabkzod" title="::XDX::-"><span style="-sec-ix-hidden: xdx2ixbrl1156">no</span></span>ne, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 844000 <p id="xdx_807_eus-gaap--CashCashEquivalentsAndMarketableSecuritiesTextBlock_zDQamGH5zsvl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 6 – <span id="xdx_829_zehHw0otici1" style="font-variant: small-caps">MARKETABLE SECURITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the second quarter of 2020, the Company began offering customers of its Sequire segment who purchase services on the Company’s proprietary SaaS platform the option to pay the contract price in securities issued by the Customer which could be a common stock, preferred stock or convertible debentures. The customer’s securities must be trading on a United States securities exchange. In accordance with ASC 606 - Revenue Recognition, the Company will value the shares received at the fair market value of the date the contract is executed. The shares received will be accounted for in accordance with ASC 320 and ASC 321 – Investments – Debt and Equity Securities, as such the shares will be classified as available-for-sale securities and will be measured at each reporting period at fair value with the unrealized gain or (loss) as a component of other income (expense). Upon the sale of the shares, the Company will record the final gain or (loss) in the consolidated statement of operations as a component of net income (loss).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--MarketableSecuritiesTextBlock_zET4jmHT6hE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The movement in this account is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zEbN82HGFH68" style="display: none">SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Balance as of</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Common</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Convertible</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Preferred</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Debentures</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left">Balances at beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231_zpbp7cYxU0I4" style="width: 14%; text-align: right" title="Balances at beginning of year">8,447,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOlyQoZUTIH6" style="width: 9%; text-align: right" title="Balances at beginning of year">7,764,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><p id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zXCDobU4KhA3" style="margin: 0" title="Balances at beginning of year">683,000</p></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z3wO7zMahPt4" style="width: 9%; text-align: right" title="Balances at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z775Fg4M75kj" style="width: 9%; text-align: right" title="Balances at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Additions</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231_z8DUPrSR52m9" style="text-align: right" title="Additions">34,914,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCuvuZZjKve" style="text-align: right">29,281,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zvPJMNZgNFrj" style="text-align: right">4,602,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zn4O4cPTQa72" style="text-align: right">1,031,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4X9PWhBff6k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1176">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of marketable securities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231_z3odHfXPaief" style="text-align: right" title="Sale of marketable securities">(8,666,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRYqDxs4Lb89" style="text-align: right">(8,156,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zbgFxaiAWsJ9" style="text-align: right">(510,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zWT7vuHohiq7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1181">-</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI6Ypvb0Ukr1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Designation for dividend distribution</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231_zD2K3XZ8eW56" style="text-align: right" title="Designation for dividend distribution">(10,790,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziFeHUK8k9l3" style="text-align: right">(10,577,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_98D_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_z6t957bELJw7" style="margin: 0">(213,000</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z6jYyFnXHDX6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfapZNUXuld2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231_zKS5JNNUmNxe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(8,288,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbLR4Mvkh1f3" style="border-bottom: Black 1.5pt solid; text-align: right">(7,577,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p id="xdx_987_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zGf5jyXRnLgg" style="margin: 0">(375,000</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zgbjePruSjqh" style="border-bottom: Black 1.5pt solid; text-align: right">(432,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3tF2iBo2KV4" style="border-bottom: Black 1.5pt solid; text-align: right">96,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balances at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231_zvWEOkrkVc34" style="border-bottom: Black 2.5pt double; text-align: right" title="Balances at end of year">15,617,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8cYfurLoD6g" style="border-bottom: Black 2.5pt double; text-align: right">10,735,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zRZWKHpAYXAg" style="border-bottom: Black 2.5pt double; text-align: right">4,187,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zHC8VoTXXbhg" style="border-bottom: Black 2.5pt double; text-align: right">599,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhjIWvTyGY1l" style="border-bottom: Black 2.5pt double; text-align: right">96,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Balance as of</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Convertible</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Debentures</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Balances at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20200101__20201231_zPnqOd5iVzK3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Balances at beginning of year">83,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXDugseLel5g" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Balances at beginning of year">83,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_z5bsCvgHjgFe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Balances at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1206">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Additions</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--MarketableSecuritiesAddition_pp0p0_c20200101__20201231_zomU44D3UcM3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions">8,406,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--MarketableSecuritiesAddition_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZTn0rK4Sxt8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions">7,496,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--MarketableSecuritiesAddition_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zOQBOU2KLj44" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions">910,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sale of marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20200101__20201231_zSrLk9aoy3xc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sale of marketable securities">(916,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn3ywfFX6Kei" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sale of marketable securities">(916,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zuIQ6tJ39CXl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sale of marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1218">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20200101__20201231_z9dOU77Qnfsb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value">874,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsPne6aee4Za" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value">1,101,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_z8d3G1eExFmi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value">(227,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balances at end of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20200101__20201231_zP1q8OOVdVRb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balances at end of year">8,447,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE3OQoYKDVYj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balances at end of year">7,764,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zOg3JbzB5FBj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balances at end of year">683,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zcra4XHFw7Dl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sales of securities for the year ended December 31, 2021, were approximately $<span id="xdx_90D_ecustom--ProceedFromSaleAndMaturityOfMarketableSecurities_c20210101__20211231_z4Q1dWQhPHJd">8,666,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">with a book basis of approximately $<span id="xdx_90C_eus-gaap--MarketableSecurities_iI_c20211231_zBnK4y55iMF">7,862,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">which represented a gain of $<span id="xdx_902_ecustom--GainOnMarketableSecurities_c20210101__20211231_zguPydLNtmr1">804,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, which the Company recorded as other income included in the gains from marketable securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company accounts for its investments in equity securities in accordance with ASC 321-10 Investments - Equity Securities. The equity securities may be classified into two categories and accounted for as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity securities with a readily determinable fair value are reported at fair value, with unrealized gains and losses included in earnings. Any dividends received are recorded in interest income, the fair value of equity investments with fair values is primarily obtained from third-party pricing services.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Equity securities without a readily determinable fair value are reported at their cost minus impairment, if any, plus or minus changes resulting from observable price changes in orderly transactions for the identical or similar investment of the same issuer and their impact on fair value. Any dividends received are recorded in interest income. For equity investments without readily determinable fair values, when an orderly transaction for the identical or similar investment of the same issuer is identified, we use the valuation techniques permitted under ASC 820 Fair Value Measurement to evaluate the observed transaction(s) and adjust the fair value of the equity investment. See discussion of the Company’s valuation policy in Note 1 – Fair Value of Financial Instruments.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--MarketableSecuritiesTextBlock_zET4jmHT6hE8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The movement in this account is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BE_zEbN82HGFH68" style="display: none">SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Balance as of</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">December 31,</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Common</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Convertible</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">Preferred</td><td style="text-align: center; font-weight: bold"> </td><td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td><td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">2021</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Debentures</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Stock</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Warrants</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 31%; text-align: left">Balances at beginning of year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231_zpbp7cYxU0I4" style="width: 14%; text-align: right" title="Balances at beginning of year">8,447,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zOlyQoZUTIH6" style="width: 9%; text-align: right" title="Balances at beginning of year">7,764,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right"><p id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zXCDobU4KhA3" style="margin: 0" title="Balances at beginning of year">683,000</p></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z3wO7zMahPt4" style="width: 9%; text-align: right" title="Balances at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1168">-</span></td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_98F_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z775Fg4M75kj" style="width: 9%; text-align: right" title="Balances at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1170">-</span></td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Additions</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231_z8DUPrSR52m9" style="text-align: right" title="Additions">34,914,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zCuvuZZjKve" style="text-align: right">29,281,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zvPJMNZgNFrj" style="text-align: right">4,602,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zn4O4cPTQa72" style="text-align: right">1,031,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--MarketableSecuritiesAddition_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z4X9PWhBff6k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1176">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sale of marketable securities</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231_z3odHfXPaief" style="text-align: right" title="Sale of marketable securities">(8,666,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zRYqDxs4Lb89" style="text-align: right">(8,156,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_987_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zbgFxaiAWsJ9" style="text-align: right">(510,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_986_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zWT7vuHohiq7" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1181">-</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td id="xdx_98A_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zI6Ypvb0Ukr1" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1182">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left">Designation for dividend distribution</td><td> </td> <td style="text-align: left"> </td><td id="xdx_982_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231_zD2K3XZ8eW56" style="text-align: right" title="Designation for dividend distribution">(10,790,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_983_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_ziFeHUK8k9l3" style="text-align: right">(10,577,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"><p id="xdx_98D_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_z6t957bELJw7" style="margin: 0">(213,000</p></td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_989_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_z6jYyFnXHDX6" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1187">-</span></td><td style="text-align: left"/><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--MarketableSecuritiesDesignationforDividendDistribution_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zfapZNUXuld2" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1188">-</span></td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_987_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231_zKS5JNNUmNxe" style="border-bottom: Black 1.5pt solid; text-align: right" title="Change in fair value">(8,288,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zbLR4Mvkh1f3" style="border-bottom: Black 1.5pt solid; text-align: right">(7,577,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><p id="xdx_987_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zGf5jyXRnLgg" style="margin: 0">(375,000</p></td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98D_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zgbjePruSjqh" style="border-bottom: Black 1.5pt solid; text-align: right">(432,000</td><td style="padding-bottom: 1.5pt; text-align: left">)</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_986_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_z3tF2iBo2KV4" style="border-bottom: Black 1.5pt solid; text-align: right">96,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 2.5pt">Balances at end of year</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98D_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231_zvWEOkrkVc34" style="border-bottom: Black 2.5pt double; text-align: right" title="Balances at end of year">15,617,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98E_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_z8cYfurLoD6g" style="border-bottom: Black 2.5pt double; text-align: right">10,735,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_988_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zRZWKHpAYXAg" style="border-bottom: Black 2.5pt double; text-align: right">4,187,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--PreferredStockMember_zHC8VoTXXbhg" style="border-bottom: Black 2.5pt double; text-align: right">599,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20210101__20211231__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zhjIWvTyGY1l" style="border-bottom: Black 2.5pt double; text-align: right">96,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Balance as of</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Common</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Convertible</td><td style="font: bold 10pt Times New Roman, Times, Serif"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Debentures</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 44%; text-align: left">Balances at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20200101__20201231_zPnqOd5iVzK3" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Balances at beginning of year">83,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zXDugseLel5g" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Balances at beginning of year">83,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--MarketableSecuritiesCurrent_iS_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_z5bsCvgHjgFe" style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Balances at beginning of year"><span style="-sec-ix-hidden: xdx2ixbrl1206">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Additions</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--MarketableSecuritiesAddition_pp0p0_c20200101__20201231_zomU44D3UcM3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions">8,406,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--MarketableSecuritiesAddition_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zZTn0rK4Sxt8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions">7,496,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--MarketableSecuritiesAddition_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zOQBOU2KLj44" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Additions">910,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sale of marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20200101__20201231_zSrLk9aoy3xc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sale of marketable securities">(916,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zn3ywfFX6Kei" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sale of marketable securities">(916,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_pp0p0_di_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zuIQ6tJ39CXl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sale of marketable securities"><span style="-sec-ix-hidden: xdx2ixbrl1218">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Change in fair value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20200101__20201231_z9dOU77Qnfsb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value">874,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zsPne6aee4Za" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value">1,101,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--MarketableSecuritiesGainLoss_iN_pp0p0_di_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_z8d3G1eExFmi" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value">(227,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Balances at end of year</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20200101__20201231_zP1q8OOVdVRb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balances at end of year">8,447,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20200101__20201231__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zE3OQoYKDVYj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balances at end of year">7,764,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--MarketableSecuritiesCurrent_iE_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ConvertibleDebenturesMember_zOg3JbzB5FBj" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Balances at end of year">683,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 8447000 7764000 683000 34914000 29281000 4602000 1031000 8666000 8156000 510000 10790000 10577000 213000 8288000 7577000 375000 432000 -96000 15617000 10735000 4187000 599000 96000 83000 83000 8406000 7496000 910000 916000 916000 -874000 -1101000 227000 8447000 7764000 683000 8666000 7862000 804000 <p id="xdx_80E_ecustom--DesignatedAssetsTextBlock_zd8BgWlMuNv1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 7 – <span id="xdx_829_zQ8dahJYpfDc" style="font-variant: small-caps">DESIGNATED ASSETS FOR RETURN OF CAPITAL</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 17, 2021, the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock to shareholders, debenture holders, and certain warrant holders (“Recipients”) as of record on September 20, 2021. The board designated certain of the Company’s marketable securities (“Designated Assets”) to be used when liquidated, as a return of capital to the Recipients. See Note 19 - Series A Preferred Stock for more details.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_ecustom--DesignatedAssetsTableTextBlock_zc4thWsWUdG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, designated assets consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zakitFVuinb3" style="display: none">SCHEDULE OF DESIGNATED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20211231_zI4nCvSV5nqi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Cash_iI_pp0p0_hus-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_maADzOU9_zagZiU6cpK89" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">686,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_pp0p0_hus-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_maADzOU9_zJtZNu3AVowd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,239,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DesignatedAssetsForReturnOfCapital_iI_pp0p0_hus-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_maADzOU9_zWKQGfoswdW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">3,925,000</span></p> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AA_zK4C4wIOKz46" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfMovementInDesignatedAssetsTableTextBlock_zLKy04XoVHbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The movement in designated assets is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zaWNajbFq8Dk" style="display: none">SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%">Designated assets as of September 20, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--AssetsDesignated_iS_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zZDni4o1bZTf" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Designated assets at beginning balance">6,387,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sale of designated assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_di_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zNp3cv0aEsA" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sales">(770,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds from sale of designated assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ProceedsFromSaleOfOtherAssets1_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zpDoyDkhesqd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds from sale of other assets">686,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Change in fair value of designated assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--MarketableSecuritiesGainLoss_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zLhl0EgGIeRk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value of designated assets">(2,378,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balances as of December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--AssetsDesignated_iE_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_z1d0MUWScQZ9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Designated assets at ending balance">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zTeNF4FHzdzj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s sale of the designated marketable securities for the year ended December 31, 2021, were approximately $<span id="xdx_90B_ecustom--ProceedFromSaleAndMaturityOfMarketableSecurities_c20210101__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zZt4qwNrLQT4" title="Sale of marketable securities">686,000</span>, with a book basis of approximately $<span id="xdx_90C_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_c20210101__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zsUXZxP7T6Bg" title="Marketable Securities">770,000</span> which represented a loss of $<span id="xdx_90F_ecustom--GainOnMarketableSecurities_c20210101__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zxqH2LibAcZ1" title="Gain on marketable securities.">84,000</span>, which the Company recorded as other expense included in the loss from designated assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_ecustom--DesignatedAssetsTableTextBlock_zc4thWsWUdG3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, designated assets consist of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zakitFVuinb3" style="display: none">SCHEDULE OF DESIGNATED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_497_20211231_zI4nCvSV5nqi" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--Cash_iI_pp0p0_hus-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_maADzOU9_zagZiU6cpK89" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%">Cash</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right">686,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--MarketableSecurities_iI_pp0p0_hus-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_maADzOU9_zJtZNu3AVowd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,239,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40D_ecustom--DesignatedAssetsForReturnOfCapital_iI_pp0p0_hus-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_maADzOU9_zWKQGfoswdW2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"> <p style="margin: 0; font-family: Times New Roman, Times, Serif"><span style="font-size: 10pt">3,925,000</span></p> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 686000 3239000 3925000 <p id="xdx_897_ecustom--ScheduleOfMovementInDesignatedAssetsTableTextBlock_zLKy04XoVHbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The movement in designated assets is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B7_zaWNajbFq8Dk" style="display: none">SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 60%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 70%">Designated assets as of September 20, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 10%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--AssetsDesignated_iS_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zZDni4o1bZTf" style="font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Designated assets at beginning balance">6,387,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Sale of designated assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ProceedsFromSaleAndMaturityOfMarketableSecurities_iN_di_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zNp3cv0aEsA" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sales">(770,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Proceeds from sale of designated assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ProceedsFromSaleOfOtherAssets1_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zpDoyDkhesqd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Proceeds from sale of other assets">686,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Change in fair value of designated assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--MarketableSecuritiesGainLoss_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_zLhl0EgGIeRk" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Change in fair value of designated assets">(2,378,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Balances as of December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--AssetsDesignated_iE_c20210921__20211231__us-gaap--FinancialInstrumentAxis__custom--DesignatedAssetsMember_z1d0MUWScQZ9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Designated assets at ending balance">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 6387000 770000 686000 -2378000 3925000 686000 770000 84000 <p id="xdx_80C_eus-gaap--LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock_zWFPSfhp8Tmi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 8 – <span id="xdx_827_zCwWq1sGqj15" style="font-variant: small-caps">NOTES RECEIVABLE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 30, 2020, a unit redemption agreement was entered into by and between the Company and Haylard MD, LLC (“Haylard”). The Company owns <span id="xdx_907_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20201030__dei--LegalEntityAxis__custom--HaylardMDLLCMember_z92FXCgOUGa8" title="Redemption of class A units">10,000,000</span> Class A Units of Haylard. The Company desires to sell and transfer to Haylard, and Haylard desires to redeem and purchase from the Company. The price to be paid for all of the Units shall be $<span id="xdx_90B_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_iI_c20201030__dei--LegalEntityAxis__custom--HaylardMDLLCMember_zmSiF8hA7MAl">6,718,000</span> at closing and $<span id="xdx_905_ecustom--PriceToBePaidUponEarliar_iI_c20201030__dei--LegalEntityAxis__custom--HaylardMDLLCMember_zg0TlCiBOBM3" title="Price to be paid upon earlier">960,000</span> upon the earlier of (a) the third anniversary of the closing and (b) a Sale of Haylard, for a total consideration of $<span id="xdx_909_eus-gaap--ProceedsFromDivestitureOfBusinesses_c20201029__20201030__dei--LegalEntityAxis__custom--HaylardMDLLCMember_zessMPHxsej9" title="Total consideration">7,678,000</span>, provided that if Haylard consummates a Sale of Haylard within one hundred and eighty (180) calendar days after the closing, and the amount to be paid in respect of a Class A Unit in connection with such transaction after taking into account all fees, costs, expenses, escrows, indemnities, purchase price adjustments, repayments of indebtedness and other holdbacks as reasonably determined and calculated in good faith by Haylard is greater than $<span id="xdx_90F_ecustom--ExcessAmountForEachUnit_c20201029__20201030__dei--LegalEntityAxis__custom--HaylardMDLLCMember__srt--RangeAxis__srt--MaximumMember_zvyna8oqGrO5" title="Excess amount for each unit">0.7677543</span>, then Haylard shall pay to the Company an amount equal to such excess for each Unit redeemed and purchased hereunder by wire transfer of immediately available funds to the account specified by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On October 30, 2020, a unit redemption agreement was entered into by and between the Company and MD CoInvest, LLC, (“CoInvest”). The Company owns <span id="xdx_905_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares_iI_c20201030__dei--LegalEntityAxis__custom--MDCoInvestLLCMember_zaY2v2zK4xVl" title="Redemption of class A units">420,000</span> Units of CoInvest. The Company desires to sell and transfer to CoInvest, and CoInvest desires to redeem and purchase from the Company. The price to be paid for all of the Units shall be $<span id="xdx_90C_eus-gaap--SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares_iI_c20201030__dei--LegalEntityAxis__custom--MDCoInvestLLCMember_zJALMHHCO3p7" title="Price to be paid for all of the units">282,000</span> at closing and $<span id="xdx_902_ecustom--PriceToBePaidUponEarliar_iI_c20201030__dei--LegalEntityAxis__custom--MDCoInvestLLCMember_zgBzy5XGE6Af" title="Price to be paid upon earlier">40,000</span> upon the earlier of (a) the third anniversary of the closing and (b) a Sale of CoInvest, for a total consideration of $<span id="xdx_90F_eus-gaap--ProceedsFromDivestitureOfBusinesses_c20201029__20201030__dei--LegalEntityAxis__custom--MDCoInvestLLCMember_zlTJHGPonT85" title="Total consideration">322,000</span>, provided that if CoInvest consummates a Sale of CoInvest within one hundred and eighty (180) calendar days after the closing, and the amount to be paid in respect of a Class A Unit in connection with such transaction after taking into account all fees, costs, expenses, escrows, indemnities, purchase price adjustments, repayments of indebtedness and other holdbacks as reasonably determined and calculated in good faith by CoInvest is greater than $<span id="xdx_906_ecustom--ExcessAmountForEachUnit_c20201029__20201030__dei--LegalEntityAxis__custom--MDCoInvestLLCMember__srt--RangeAxis__srt--MaximumMember_zJLSz01fdIC5" title="Excess amount for each unit">0.7677543</span>, then CoInvest shall pay to the Company an amount equal to such excess for each Unit redeemed and purchased hereunder by wire transfer of immediately available funds to the account specified by the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The deferred payments of $<span id="xdx_901_eus-gaap--PaymentsToAcquireNotesReceivable_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RatedCorporateDebtMember_zhQRAsrbXDr5" title="Deferred payments of notes receivable">960,000</span> and $<span id="xdx_901_ecustom--DiscountOnNotesReceivable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--RatedCorporateDebtMember_zUm5FJQ8F6y5" title="Discount on notes receivable">40,000</span> were discounted using the yield on a CCC rated corporate debt for <span id="xdx_905_eus-gaap--DebtInstrumentTerm_dtY_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RatedCorporateDebtMember_z6PMidFikyFc" title="Debt instrument term">3</span>-year maturity. The implied discount is approximately $<span id="xdx_90F_eus-gaap--AmortizationOfDebtDiscountPremium_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RatedCorporateDebtMember_zqYwPBJThTj8" title="Implied discount">107,000</span>, which will be amortized over <span id="xdx_907_eus-gaap--DebtInstrumentTerm_dtY_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--RatedCorporateDebtMember__srt--RangeAxis__srt--MaximumMember_z75Xh7c5og8e" title="Debt instrument term">3</span> years. Notes receivable as of December 31, 2021 and 2020 amounted to $<span id="xdx_901_eus-gaap--AccountsReceivableNetNoncurrent_iI_c20211231_ziCfv8n1VR07" title="Note receivable">935,000</span> and $<span id="xdx_906_eus-gaap--AccountsReceivableNetNoncurrent_iI_c20201231_zPwTTPKiLVCg" title="Note receivable">893,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 10000000 6718000 960000 7678000 0.7677543 420000 282000 40000 322000 0.7677543 960000 40000 P3Y 107000 P3Y 935000 893000 <p id="xdx_802_eus-gaap--PropertyPlantAndEquipmentDisclosureTextBlock_zBl8gLucP1kj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 9 – <span id="xdx_829_zslbsPMBhoEc" style="font-variant: small-caps">PROPERTY AND EQUIPMENT</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zlJscYdux2Ie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B6_zwTUXYM4USo6" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49A_20211231_zi7MJfavlztj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20201231_zNKc0Ver9KTe" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zFaZOPNrLo3b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">402,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zURKM0tzWhs6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(357,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(285,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iI_zr3FUdxHyCTk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AA_zjyFeIT51Kb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Depreciation expense for the years ended December 31, 2021 and 2020 was $<span id="xdx_90F_eus-gaap--Depreciation_c20210101__20211231_zsMFcNDc0j3e" title="Depreciation">72,000</span> and $<span id="xdx_902_eus-gaap--Depreciation_c20200101__20201231_zXoqML3YUdfl" title="Depreciation">28,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_895_eus-gaap--PropertyPlantAndEquipmentTextBlock_zlJscYdux2Ie" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment consist of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B6_zwTUXYM4USo6" style="display: none">SCHEDULE OF PROPERTY AND EQUIPMENT</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_49A_20211231_zi7MJfavlztj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_490_20201231_zNKc0Ver9KTe" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_40B_eus-gaap--PropertyPlantAndEquipmentGross_iI_hus-gaap--PropertyPlantAndEquipmentByTypeAxis__us-gaap--OfficeEquipmentMember_zFaZOPNrLo3b" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Office equipment</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">471,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">402,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_iNI_di_zURKM0tzWhs6" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated depreciation</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(357,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(285,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_40E_eus-gaap--PropertyPlantAndEquipmentNet_iI_zr3FUdxHyCTk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Property and equipment, net</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">114,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">117,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 471000 402000 357000 285000 114000 117000 72000 28000 <p id="xdx_809_eus-gaap--IntangibleAssetsDisclosureTextBlock_z3W9KgekoHv4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 10 – <span id="xdx_826_zmMLfhscZEFd">INTANGIBLE ASSETS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zwZuwGNc7Y8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zphPe0vXaApk" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_493_20211231_zytl0OOxMnj9" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_499_20201231_zAZCasOkL1nj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zJkbTpxzuth9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-compete agreement</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,258,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,258,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zsa8FH7vcdw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zFpEWMYHLzH3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquired Software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">617,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zZTXLyF5XnF7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internally developed software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,726,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,048,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjoubt41ABxa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zDaKf8nrdLy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer list</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InternetDomainNamesMember_z15hUW20wL12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_z3lAfNXAbc38" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cost</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,970,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,172,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_z0wUPEaW3CE2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,527,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,680,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zgyuD45gdrmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,443,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,492,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8AD_zU2zzMhRWf9d" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Amortization expenses amounted to $<span id="xdx_903_ecustom--AmortizationOfFiniteLivedIntangibleAssets_c20210101__20211231_zZnWa3y5QE41" title="Amortization of finite-lived intangible assets">847,000</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_903_ecustom--AmortizationOfFiniteLivedIntangibleAssets_c20200101__20201231_zPzl2P3Krt7i" title="Amortization of finite-lived intangible assets">744,000</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">for the years ended December 31, 2021 and 2020, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdC2rWgGxdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark has indefinite life and not subject to amortization. The estimated future amortization expense for the years ended December 31, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zK06cXbV2qW4" style="display: none">SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20211231_zh31cqlwi4u1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_z0XjJEFXpC2a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">632,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zTi1sjZq7cNe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2023</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">404,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zMrfY2SH7LO1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">136,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zRfYaf0b7eKk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,172,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AF_z6WeB6RFkcLi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, goodwill amounted to $<span id="xdx_904_eus-gaap--Goodwill_iI_c20211231_z3T9i4lTZM1c" title="Goodwill"><span id="xdx_90B_eus-gaap--Goodwill_iI_c20201231_zbg13fMWGis" title="Goodwill">17,906,000</span></span>, an addition of $<span id="xdx_90C_eus-gaap--GoodwillAcquiredDuringPeriod_c20200101__20201231_zT1MAzKo1m7h" title="Goodwill Acquisition">7,706,000</span> in 2020 was due to acquisition of LD Micro (see Note 3 - Acquisitions). There were <span id="xdx_908_eus-gaap--GoodwillImpairmentLoss_do_c20210101__20211231_zbNAUgMxk2fl" title="Impairment loss"><span id="xdx_90D_eus-gaap--GoodwillImpairmentLoss_do_c20200101__20201231_zqgEb4i58os7" title="Impairment loss">no</span></span> impairments during the years ended December 31, 2021 and 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock_zwZuwGNc7Y8f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets consist of the following as of December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B3_zphPe0vXaApk" style="display: none">SCHEDULE OF INTANGIBLE ASSETS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_493_20211231_zytl0OOxMnj9" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2021</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td> <td colspan="2" id="xdx_499_20201231_zAZCasOkL1nj" style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>2020</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--NoncompeteAgreementsMember_zJkbTpxzuth9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif; width: 72%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Non-compete agreement</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,258,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 11%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,258,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40E_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--IntellectualPropertyMember_zsa8FH7vcdw" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intellectual property</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_40D_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--SoftwareMember_zFpEWMYHLzH3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquired Software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">756,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">617,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_403_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__custom--InternallyDevelopedSoftwareMember_zZTXLyF5XnF7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Internally developed software</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,726,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,048,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_405_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--TrademarksMember_zjoubt41ABxa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">271,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_402_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--CustomerListsMember_zDaKf8nrdLy8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: white"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Customer list</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">186,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_401_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_hus-gaap--FiniteLivedIntangibleAssetsByMajorClassAxis__us-gaap--InternetDomainNamesMember_z15hUW20wL12" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Domain name</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">17,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">36,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_407_eus-gaap--FiniteLivedIntangibleAssetsGross_iI_z3lAfNXAbc38" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total cost</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,970,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">5,172,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr id="xdx_409_eus-gaap--FiniteLivedIntangibleAssetsAccumulatedAmortization_iI_z0wUPEaW3CE2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: #CCEEFF"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accumulated amortization</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4,527,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3,680,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td></tr> <tr id="xdx_400_eus-gaap--IntangibleAssetsNetExcludingGoodwill_iI_zgyuD45gdrmd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets, net</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,443,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td> <td style="border-bottom: black 2.25pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,492,000</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 1258000 1258000 756000 756000 756000 617000 2726000 2048000 271000 271000 186000 186000 17000 36000 5970000 5172000 -4527000 -3680000 1443000 1492000 847000 744000 <p id="xdx_89C_eus-gaap--ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock_zdC2rWgGxdl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Trademark has indefinite life and not subject to amortization. The estimated future amortization expense for the years ended December 31, are as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BD_zK06cXbV2qW4" style="display: none">SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 50%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; display: none; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_493_20211231_zh31cqlwi4u1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths_iI_z0XjJEFXpC2a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: left">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">632,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo_iI_zTi1sjZq7cNe" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">2023</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">404,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--FiniteLivedIntangibleAssetsAmortizationExpenseYearThree_iI_zMrfY2SH7LO1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">2024</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">136,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--FiniteLivedIntangibleAssetsNet_iI_zRfYaf0b7eKk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt">Intangible assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">1,172,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 632000 404000 136000 1172000 17906000 17906000 7706000 0 0 <p id="xdx_80F_ecustom--RighttoUseAssetLeasesTextBlock_zVNGwVULjZQc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 11 – <span id="xdx_827_zckK7wqHqoad" style="font-variant: small-caps">RIGHT TO USE ASSET</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We determine whether an arrangement is a lease at inception. This determination generally depends on whether the arrangement conveys the right to control the use of an identified fixed asset explicitly or implicitly for a period of time in exchange for consideration. Control of an underlying asset is conveyed if we obtain the rights to direct the use of and to obtain substantially all of the economic benefit from the use of the underlying asset. Some of our leases include both lease and non-lease components which are accounted for as a single lease component as we have elected the practical expedient. Some of our operating lease agreements include variable lease costs, primarily taxes, insurance, common area maintenance or increases in rental costs related to inflation. Substantially all of our equipment leases and some of our real estate leases have terms of less than one year and, as such, are accounted for as short-term leases as we have elected the practical expedient.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Operating leases are included in the right-of-use lease assets, other current liabilities and long-term lease liabilities on the Consolidated Balance Sheet. Right-of-use assets and lease liabilities are recognized at each lease’s commencement date based on the present values of its lease payments over its respective lease term. When a borrowing rate is not explicitly available for a lease, our incremental borrowing rate is used based on information available at the lease’s commencement date to determine the present value of its lease payments. Operating lease payments are recognized on a straight-line basis over the lease term. We had no financing leases as of December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have operating leases for office space. Our leases have remaining lease terms of approximately <span id="xdx_90E_eus-gaap--LesseeOperatingLeaseRemainingLeaseTerm_iI_dtY_c20211231_zgr72JpA0M4l">1.75 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years. We consider renewal options in determining the lease term used to establish our right-of-use assets and lease liabilities when it is determined that it is reasonably certain that the renewal option will be exercised.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, there were <span id="xdx_90B_eus-gaap--VariableLeaseCost_pp0p0_do_c20210101__20211231_zAniaQ8X6vnj" title="Variable lease cost and sublease">no</span> material variable lease costs or sublease income. Cash paid for operating leases are classified in operating expenses and were $<span id="xdx_900_eus-gaap--OperatingLeaseLeaseIncomeLeasePayments_c20210101__20211231_zQJiw7IDTljf" title="Cash paid for operating lease">175,000</span> and $<span id="xdx_903_eus-gaap--OperatingLeaseLeaseIncomeLeasePayments_c20200101__20201231_zr3dz4V9n1E2" title="Cash paid for operating lease">192,000</span> for the years ended December 31, 2021 and 2020, respectively. The following tables summarize the lease expense for the year ended December 31:</span></p> <p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_zixPU4jOE8ue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zaSQuH14MlB6" style="display: none">SCHEDULE OF COMPONENT OF LEASE EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20210101__20211231_zMBLrKpAIVg3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231_zfbh5RZzg56i" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseCost_maLCzgyJ_zb1U1XfVER0a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Operating lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">163,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">163,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCzgyJ_zlueDQw0e0ha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Short-term lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LeaseCost_iT_pp0p0_mtLCzgyJ_zOmgjneL6MQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">175,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">192,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A3_zUdyW8TtFGwc" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_ecustom--ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock_zhwZoxiuZYff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below table summarizes these lease asset and liability accounts presented on our accompanying Consolidated Balance Sheets for the year ended December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zasy4u3if3r7" style="display: none">SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">Operating Leases*</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Consolidated Balance Sheet Caption</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; width: 32%">Operating lease right-of-use assets - non-current</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-bottom: 2.5pt">Right of use asset</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20211231_ziQyKhaZuKb8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating lease right-of-use assets - non-current">257,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z5g4hKPVuk9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating lease right-of-use assets - non-current">366,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease liabilities – current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20211231_zGDSsAJVkWsh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - current">130,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20201231_zltGgCpQ0xTa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - current">109,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Operating lease liabilities - non-current</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Right to use liability - long term</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20211231_z2uX7Ci8WwO6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - non-current">114,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20201231_zC9JKAAtm76e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - non-current">243,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20211231_zB6zcsUfUg8l" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total operating lease liabilities">244,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20201231_z1sxJ7Rg42l1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total operating lease liabilities">352,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A5_zSrYPXTxsfk1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Components of Lease Expense</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We recognize lease expense on a straight-line basis over the term of our operating leases, as reported within “selling, general and administrative” expense on the accompanying consolidated statement of operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_zd5qK2H0yFrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Weighted Average Remaining Lease Term and Applied Discount Rate</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B8_zt4Fh1jpl2Ia" style="display: none">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discount Rate</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 66%">Operating leases as of December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231_zHHCdEg9LpBh" title="Weighted Average Remaining Lease Term">1.75</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20211231_zVgoKPK7OQ6h" title="Weighted Average Discount Rate">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> </table> <p id="xdx_8A5_zwFu9wYThFQd" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Future Contractual Lease Payments as of December 31, 2021</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_894_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zaprHojVHlH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (iii) present value of future lease payments for the years ending December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zfHX92Drcngi" style="display: none">SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">Operating Leases - future payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20211231_zoTGEkOZOqC3" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzv0x_zmaa07tkbeDd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: right">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">163,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzv0x_zbt62tmgiWbg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">123,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzv0x_zi4FktIY7kL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total future lease payments, undiscounted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">286,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zFrZcPcUeB78" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: Implied interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(42,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Present value of operating lease payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">244,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A6_zOXGUims4P57" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> P1Y9M 0 175000 192000 <p id="xdx_899_eus-gaap--LeaseCostTableTextBlock_zixPU4jOE8ue" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zaSQuH14MlB6" style="display: none">SCHEDULE OF COMPONENT OF LEASE EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_490_20210101__20211231_zMBLrKpAIVg3" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_496_20200101__20201231_zfbh5RZzg56i" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseCost_maLCzgyJ_zb1U1XfVER0a" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Operating lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">163,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">163,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--ShortTermLeaseCost_maLCzgyJ_zlueDQw0e0ha" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Short-term lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">12,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">29,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_40E_eus-gaap--LeaseCost_iT_pp0p0_mtLCzgyJ_zOmgjneL6MQl" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total lease expense</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">175,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">192,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 163000 163000 12000 29000 175000 192000 <p id="xdx_897_ecustom--ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock_zhwZoxiuZYff" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below table summarizes these lease asset and liability accounts presented on our accompanying Consolidated Balance Sheets for the year ended December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_8BA_zasy4u3if3r7" style="display: none">SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 85%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">Operating Leases*</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Consolidated Balance Sheet Caption</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt; width: 32%">Operating lease right-of-use assets - non-current</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 30%; text-align: left; padding-bottom: 2.5pt">Right of use asset</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20211231_ziQyKhaZuKb8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating lease right-of-use assets - non-current">257,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_eus-gaap--OperatingLeaseRightOfUseAsset_iI_pp0p0_c20201231_z5g4hKPVuk9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Operating lease right-of-use assets - non-current">366,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Operating lease liabilities – current</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20211231_zGDSsAJVkWsh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - current">130,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseLiabilityCurrent_iI_pp0p0_c20201231_zltGgCpQ0xTa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - current">109,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Operating lease liabilities - non-current</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Right to use liability - long term</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20211231_z2uX7Ci8WwO6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - non-current">114,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--OperatingLeaseLiabilityNoncurrent_iI_pp0p0_c20201231_zC9JKAAtm76e" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Operating lease liabilities - non-current">243,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total operating lease liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20211231_zB6zcsUfUg8l" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total operating lease liabilities">244,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98F_eus-gaap--OperatingLeaseLiability_iI_pp0p0_c20201231_z1sxJ7Rg42l1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total operating lease liabilities">352,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 257000 366000 130000 109000 114000 243000 244000 352000 <p id="xdx_892_ecustom--ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock_zd5qK2H0yFrh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Weighted Average Remaining Lease Term and Applied Discount Rate</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span id="xdx_8B8_zt4Fh1jpl2Ia" style="display: none">SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Remaining</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Lease Term</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Weighted</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Average</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Discount Rate</b></span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; width: 66%">Operating leases as of December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90B_eus-gaap--OperatingLeaseWeightedAverageRemainingLeaseTerm1_iI_dtY_c20211231_zHHCdEg9LpBh" title="Weighted Average Remaining Lease Term">1.75</span> years</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right"><span id="xdx_90E_eus-gaap--OperatingLeaseWeightedAverageDiscountRatePercent_iI_pid_dp_c20211231_zVgoKPK7OQ6h" title="Weighted Average Discount Rate">18</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> </table> P1Y9M 0.18 <p id="xdx_894_eus-gaap--LesseeOperatingLeaseLiabilityMaturityTableTextBlock_zaprHojVHlH5" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The below table summarizes our (i) minimum lease payments over the next five years, (ii) lease arrangement implied interest,</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and (iii) present value of future lease payments for the years ending December 31:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BF_zfHX92Drcngi" style="display: none">SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-left: auto; border-collapse: collapse; width: 60%; margin-right: auto"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif">Operating Leases - future payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20211231_zoTGEkOZOqC3" style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_401_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_iI_pp0p0_maLOLLPzv0x_zmaa07tkbeDd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 80%; text-align: right">2022</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">163,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_iI_pp0p0_maLOLLPzv0x_zbt62tmgiWbg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: right; padding-bottom: 1.5pt">2023</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">123,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--LesseeOperatingLeaseLiabilityPaymentsDue_iTI_pp0p0_mtLOLLPzv0x_zi4FktIY7kL4" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Total future lease payments, undiscounted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">286,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_iNI_pp0p0_di_zFrZcPcUeB78" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Less: Implied interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(42,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_40F_eus-gaap--OperatingLeaseLiability_iI_pp0p0" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Present value of operating lease payments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">244,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 163000 123000 286000 42000 244000 <p id="xdx_800_eus-gaap--AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock_zMKnpgk6xpWl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 12 – <span id="xdx_828_zsNwt3kbbTvh">ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z9LrV70OVUb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued expenses as of December 31, are comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zZwSRMsdcOlk" style="display: none">SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20211231_zl3OW4DxlZ7l" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20201231_zrosxoy65QWd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableTradeCurrent_iI_z0iUhtuM731g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Accounts payable, trade</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,938,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccruedLiabilitiesCurrent_iI_zSpYKAjeTpq" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,518,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">537,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zeD7nXOKtLok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">213,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">232,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedCommissionsCurrent_iI_zrd8ugXumiK8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued commissions</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">303,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">32,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InterestPayableCurrent_iI_zMeB52gG8uB8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">123,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_zL2BRQaam7s3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,095,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,708,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zQtoM88pn9ng" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_897_eus-gaap--ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock_z9LrV70OVUb2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accounts payable and accrued expenses as of December 31, are comprised of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8BA_zZwSRMsdcOlk" style="display: none">SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_499_20211231_zl3OW4DxlZ7l" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20201231_zrosxoy65QWd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_407_eus-gaap--AccountsPayableTradeCurrent_iI_z0iUhtuM731g" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 64%; text-align: left">Accounts payable, trade</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,938,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right">1,900,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--AccruedLiabilitiesCurrent_iI_zSpYKAjeTpq" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,518,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">537,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--EmployeeRelatedLiabilitiesCurrent_iI_zeD7nXOKtLok" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">213,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">232,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_ecustom--AccruedCommissionsCurrent_iI_zrd8ugXumiK8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Accrued commissions</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">303,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">32,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_409_eus-gaap--InterestPayableCurrent_iI_zMeB52gG8uB8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">123,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">7,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--AccountsPayableAndAccruedLiabilitiesCurrent_iI_zL2BRQaam7s3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Accounts payable and accrued expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">4,095,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">2,708,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1938000 1900000 1518000 537000 213000 232000 303000 32000 123000 7000 4095000 2708000 <p id="xdx_809_eus-gaap--ContractWithCustomerAssetAndLiabilityTableTextBlock_z4YK3bE14Mbl" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 13 – <span id="xdx_820_zoGgIzDmqqPg" style="font-variant: small-caps">DEFERRED REVENUE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred revenue represents amounts billed for which revenue has not yet been recognized. Deferred revenue that will be recognized during the succeeding 12-month period is recorded as current deferred revenue, and the remaining portion, if any, is recorded as long-term deferred revenue. As of December 31, 2021, deferred revenue was $<span id="xdx_90A_eus-gaap--ContractWithCustomerLiability_iI_c20211231_zMEMGsnQlPZ5">12,859,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as compared to $<span id="xdx_903_eus-gaap--ContractWithCustomerLiability_iI_c20201231_z6c8RS4w4LUe">4,842,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">as of December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 12859000 4842000 <p id="xdx_801_eus-gaap--OtherLiabilitiesDisclosureTextBlock_zkMieYBuCvS1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 14 – <span id="xdx_820_zbuL6sb752qe" style="font-variant: small-caps">OTHER CURRENT LIABILITIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p id="xdx_894_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zAdX4cAFveW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the composition of other current liabilities presented on our accompanying Consolidated Balance Sheets:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zkem0WjuonF4" style="display: none">SCHEDULE OF OTHER CURRENT LIABILITIES</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20211231_zU43ZF0ULnya" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20201231_z1FtGBQFGpDi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maOLCzHMI_ziExBad7OSg3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease liabilities - current</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">130,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">109,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzHMI_zxur5fuT2t74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">633,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,308,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzHMI_zER8ZhxU4r1d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">763,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,417,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A1_zKb7lp7IYTR6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, other current liabilities consist of amounts payable on a factoring facility amounting to $<span id="xdx_904_eus-gaap--OtherSundryLiabilitiesCurrent_iI_c20211231__us-gaap--TypeOfArrangementAxis__custom--FactoringFacilityMember_zVTbYOeI9Ji6">633,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90A_eus-gaap--OtherSundryLiabilitiesCurrent_iI_c20201231__us-gaap--TypeOfArrangementAxis__custom--FactoringFacilityMember_znwqazQDqGLa">573,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively (See Note 4 – Sale and Purchases of Accounts Receivable) and deferred payments amounting to $<span id="xdx_902_ecustom--BusinessCombinationContractWithCustomerLiability_c20200101__20201231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LDMicroMember_zf4G7t3kitbf" title="Deferred payments related to acquisition">2,735,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">related to the acquisition of LD Micro (See Note 3 – Acquisitions) as of December 31, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company made $<span id="xdx_901_eus-gaap--DeferredRevenueRefundPayments1_c20210101__20211231__us-gaap--RelatedPartyTransactionsByRelatedPartyAxis__custom--LDMicroMember_zJszID4Cqt5c" title="Deferred contractual payments">3,004,000</span> in deferred contractual payments related to the LD Micro acquisition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p id="xdx_894_eus-gaap--OtherCurrentLiabilitiesTableTextBlock_zAdX4cAFveW9" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes the composition of other current liabilities presented on our accompanying Consolidated Balance Sheets:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BE_zkem0WjuonF4" style="display: none">SCHEDULE OF OTHER CURRENT LIABILITIES</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20211231_zU43ZF0ULnya" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_495_20201231_z1FtGBQFGpDi" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31,<br/> 2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_40B_eus-gaap--OperatingLeaseLiabilityCurrent_iI_maOLCzHMI_ziExBad7OSg3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 60%; text-align: left">Operating lease liabilities - current</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">130,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 16%; text-align: right">109,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherSundryLiabilitiesCurrent_iI_maOLCzHMI_zxur5fuT2t74" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">633,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">3,308,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_408_eus-gaap--OtherLiabilitiesCurrent_iTI_mtOLCzHMI_zER8ZhxU4r1d" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 2.5pt">Total other current liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">763,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">3,417,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 130000 109000 633000 3308000 763000 3417000 633000 573000 2735000 3004000 <p id="xdx_80D_ecustom--PaycheckProtectionProgramLoanTextBlock_zC3aWSyE8Ag3" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 15 - <span id="xdx_827_zF5DbE90klHk">PAYCHECK PROTECTION PROGRAM LOAN</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On April 17, 2020, we entered into a promissory note evidencing an unsecured approximately $<span id="xdx_907_eus-gaap--UnsecuredDebt_iI_pp0p0_c20200417__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_zpP46IYIiu8j" title="Unsecured loan">1,084,000</span> loan under the Paycheck Protection Program (PPP). The loan is being made through Cross River Bank. The term of the loan is <span id="xdx_906_eus-gaap--DebtInstrumentTerm_c20200416__20200417__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_zaf6JiHiQUr6" title="Term loan">two years</span> with an interest rate of <span id="xdx_900_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200417__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_ziYGOgdAbEZ7" title="Interest rate">1</span>%, which shall be deferred for the first six months of the term of the loan. The promissory note evidencing the loan contains customary events of default relating to, among other things, payment defaults, breach of representations and warranties, or provisions of the promissory note. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, and/or filing suit and obtaining judgment against the Company.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 15, 2020, $<span id="xdx_90F_eus-gaap--BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets_c20200915__us-gaap--BusinessAcquisitionAxis__custom--LDMicroIncMember_pp0p0" title="Payroll protection loan in connection with acquisition">42,000</span> of the payroll protection loan of LD Micro was assumed in connection with the acquisition. This amount is expected to be forgiven, otherwise the Company will be reimbursed by Sellers of LD Micro. This is classified under current liabilities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the PPP loan in the of $<span id="xdx_909_ecustom--ForgivenessOfPayrollProtectionProgramLoan_c20210101__20211231_zRk8MvsnMh0f">1,116,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">was forgiven. As of December 31, 2021 and 2020, PPP loans outstanding amounted to $<span id="xdx_907_eus-gaap--LoansPayable_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_zAooyPeNTqJe">10,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_905_eus-gaap--LoansPayable_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--PaycheckProtectionProgramLoanMember_z5eL33Kg55y3">1,126,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 1084000 P2Y 0.01 42000 1116000 10000 1126000 <p id="xdx_80B_eus-gaap--ShortTermDebtTextBlock_zlcDAmh898Rh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 16 – <span id="xdx_82E_zRpXvxR34aRe" style="font-variant: small-caps">SHORT TERM PROMISSORY NOTES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In February 2020, the Company entered into three separate short-term promissory notes with an aggregate principal value of $<span id="xdx_902_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20200228__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_zcADzRaCDsdb" title="Debt instrument, face amount">450,000</span> (the “Notes”), of which $<span id="xdx_908_eus-gaap--DebtInstrumentFaceAmount_c20200228__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_pp0p0" title="Debt instrument, face amount">100,000</span> was borrowed from the Company’s Chief Financial Officer.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_901_eus-gaap--DebtInstrumentDescription_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_zHVkM7P21p7f" title="Debt instrument, description">The notes are due and payable on May 12, 2020 (“Maturity Date”). The notes will accrue interest as follows: (i) on the origination date, ten percent (10%) of the principal amount was added to each note, (ii) on March 12, 2020, an additional ten percent (10%) of the principal amount was added to each note, and (iii) on April 12, 2020, an additional sixteen percent (16%) of the principal amount was added to each notes</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The note holders were granted security interests (in amounts equal to the face value of their investments on a dollar for share basis) in an aggregate of <span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_z6koud0AMIac" title="Number of shares of common stock">450,000</span> shares of the Company’s Class A common stock (“Security Shares”). The shares have been issued and are being held by the Company’s transfer agent. Since the shares are not outstanding, the Company has treated them as shares reserved for collateral.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The interest imputed on the origination date was treated as an original issue discount with the $<span id="xdx_90F_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_zlnXEHh8sGeb" title="Debt instrument, original issue discount">45,000</span> amortized over the term of the Notes. On each of the interest date, the Company accrued and expensed the related interest.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Maturity Date, one of the Note’s was amended to (i) extend the maturity date to December 31, 2020 and (ii) to release <span id="xdx_908_eus-gaap--SharesIssued_c20201231__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_pdd" title="Security shares">100,000</span> shares of the Security Shares. The modification was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. Based on the amended terms the fair value of the amended note approximated the book value of the old Note. The fair value of the Security Shares was approximately $<span id="xdx_908_eus-gaap--GainsLossesOnExtinguishmentOfDebt_pp0p0_c20200101__20201231__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_zyV38CihWb3g" title="Loss on extinguishment">181,000</span>, which was expensed as a loss on the extinguishment.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2020, the short-term note payable to the Company’s Chief Financial Officer in the amount of approximately $<span id="xdx_904_eus-gaap--RepaymentsOfNotesPayable_c20200628__20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__srt--TitleOfIndividualAxis__srt--ChiefFinancialOfficerMember_pp0p0" title="Repayment of short-term note payable">136,000</span> was repaid from the proceeds of the OID Convertible Notes Payable.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2020, the two remaining Note Holders converted the Notes of approximately $<span id="xdx_904_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200628__20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__us-gaap--AccruedLiabilitiesMember__us-gaap--AwardTypeAxis__custom--TwoRemainingNoteHoldersMember_zrxlyYGmkQ9d">350,000</span> and accrued interest of approximately $<span id="xdx_90E_eus-gaap--DebtConversionConvertedInstrumentAmount1_c20200628__20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__us-gaap--AccruedLiabilitiesMember_pp0p0" title="Converted debt">126,000</span> (“Old Debt”) into approximately $<span id="xdx_902_eus-gaap--DebtConversionOriginalDebtAmount1_c20200628__20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_pp0p0" title="Convertible debt">541,000</span> of the OID Convertible Debentures (See Note 17 - OID Convertible Debentures). The conversion was treated as an extinguishment of debt as prescribed by ASC 470-50 – Debt Modification and Extinguishment. At the date of issuance, the Debentures had a fair market value of approximately $<span id="xdx_907_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations_c20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_pp0p0" title="Fair value of debenture">560,000</span>. The transaction created a loss on extinguishment of approximately $<span id="xdx_908_eus-gaap--GainsLossesOnExtinguishmentOfDebt_c20200628__20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_pp0p0" title="Loss on extinguishment">375,000</span>, which consisted of (i) the difference of value between the Old Debt and the fair value of the Debentures of approximately $<span id="xdx_904_eus-gaap--FairValueOptionAggregateDifferencesLongTermDebtInstruments_c20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_pp0p0" title="Difference between face value and fair value">65,000</span>, (ii) the difference between the face value of the debenture and the fair value of the Debenture of approximately $<span id="xdx_90D_eus-gaap--FairValueOptionAggregateDifferencesLongTermDebtInstruments_c20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_pp0p0" title="Difference between face value and fair value">19,000</span> and (iii) $<span id="xdx_909_eus-gaap--FairValueAdjustmentOfWarrants_c20200628__20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_pp0p0" title="Fair value of warrants">291,000</span> for fair value of warrants issued with the Debenture. Also, since the Debenture was convertible into the Company’s common stock, a $<span id="xdx_900_eus-gaap--AdditionalPaidInCapitalCommonStock_c20200630__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember__us-gaap--FinancialInstrumentAxis__custom--DebenturesMember_pp0p0" title="Conversion premium">18,000</span> premium associated with the conversion feature was recorded as additional paid in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2020, there is <span id="xdx_90C_eus-gaap--LoansPayable_iI_pp0p0_do_c20201231__us-gaap--DebtInstrumentAxis__custom--ShortTermPromissoryNotesMember_z6J8E57QAnAj" title="Outstanding loan">no</span> outstanding loan balance on this account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 450000 100000 The notes are due and payable on May 12, 2020 (“Maturity Date”). The notes will accrue interest as follows: (i) on the origination date, ten percent (10%) of the principal amount was added to each note, (ii) on March 12, 2020, an additional ten percent (10%) of the principal amount was added to each note, and (iii) on April 12, 2020, an additional sixteen percent (16%) of the principal amount was added to each notes 450000 45000 100000 181000 136000 350000 126000 541000 560000 375000 65000 19000 291000 18000 0 <p id="xdx_807_eus-gaap--DebtDisclosureTextBlock_zu5homWATvE2" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 17 – <span id="xdx_827_zpG2SgxWKW61" style="font-variant: small-caps">TERM LOAN NOTE</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 28, 2020, the Company entered into a term loan and security agreement with a BRF Finance Co. LLC as lender. Pursuant to the loan agreement, the Company can borrow up to $<span id="xdx_90A_ecustom--TermLoanMaximumBorrowingCapacity_iI_pp0p0_c20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_zNcyJNMgHza5" title="Term loan, maximum borrowing capacity">5,000,000</span>, subject to the conditions described below.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Under the loan: (i) the Company received an initial draw of $<span id="xdx_907_eus-gaap--DebtInstrumentUnusedBorrowingCapacityAmount_c20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_pp0p0" title="Debt instrument, unused borrowing capacity, amount">2,500,000</span> on February 28, 2020 and (ii) the Company is eligible to receive an additional $<span id="xdx_90E_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20200226__20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_zFSzfqO4KqMf" title="Proceeds from notes payable">2,500,000</span> loan within (30) days of the Company entering into an at the market sales agreement with the lender and the filing of an at the market offering on Form S-3 with the SEC registering the shares to be sold pursuant to the at the market sales agreement. The Company agreed to file the ATM by May 1, 2020. Additionally, the Company will be required to increase the dollar amount authorized under the at the market sales agreement each time additional capacity of at least $<span id="xdx_90B_ecustom--DebtInstrumentAdditionalBorrowingCapacity_c20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_pp0p0" title="Debt instrument, additional borrowing capacity">1,000,000</span> is available under our shelf registration statement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loan is secured by substantially all of the assets of the Company pursuant to the loan agreement and the intellectual property security agreement entered into in connection with the transaction.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The loan bears interest at ten percent (<span id="xdx_90D_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_z72uCxT0ltc4" title="Debt instrument, interest rate">10</span>%) per annum and has a maturity date of <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20200226__20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_zoeZOLCXDyM8" title="Debt instrument, maturity date">March 1, 2022</span>. Beginning on August 1, 2020 and continuing on the first day of each month thereafter until the maturity date, <span id="xdx_90B_eus-gaap--DebtInstrumentPaymentTerms_c20200226__20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_zFwz02XN4BA3" title="Debt instrument, payment term description">the Company will make monthly payments of principal and interest on an eighteen (18) month straight line amortization schedule, based on the principal outstanding on July 31, 2020. Additionally, the Company will have the option of a one (1) time payment-in-kind payment for a monthly required payment of principal and interest, which will defer such payments and result in a recalculation of the amortization schedule. In the event that the Company is late on any payments under the Loan, a late charge of three percent (3%) of the amount of the payment due will be assessed</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At origination the Company paid lender: (i) an origination fee of $<span id="xdx_901_eus-gaap--DeferredFinanceCostsNet_iI_c20200228_zBhaKJWjNci" title="Debt instrument origination fee">300,000</span>, (ii) $<span id="xdx_908_eus-gaap--ProfessionalFees_pp0p0_c20200226__20200228__us-gaap--DebtInstrumentAxis__custom--TermloanMember_z0liGZdafWo3" title="Attorneys fees">35,000</span> in attorneys’ fees reimbursement, and (iii) certain other costs and expenses associated with the completion of the loan, including but not limited to escrow fees and recording fees. Accordingly, the Company received net proceeds of approximately $<span id="xdx_901_eus-gaap--ProceedsFromNotesPayable_pp0p0_c20200429__20200502__us-gaap--DebtInstrumentAxis__custom--TermloanMember_ztN2DSARvz3g" title="Proceeds from notes payable">2,164,000</span> as of May 1, 2020.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Loan may be prepaid in whole or in part at any time at the discretion of the Company. The loan also provides for mandatory prepayments of all of the net cash received upon (i) a sale of the company’ assets, (ii) raising additional capital through the issuance of equity or debt securities, or (iii) sales under the at the market sales agreement described above.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the loan the Company agreed to issue to Lender: (i) <span id="xdx_90F_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_pdd" title="Class of warrant issued">500,000</span> Common Stock purchase warrants on the date of the origination date and (ii) <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--SecondDrawdownMember_pdd" title="Class of warrant issued">500,000</span> Common Stock purchase warrants on the date of the second drawdown. The warrants have an exercise price equal to a <span id="xdx_904_ecustom--WarrantExercisePricePercentage_dp_uPure_c20200226__20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--TypeOfArrangementAxis__custom--SecondDrawdownMember_z4rOI5k8a9ic" style="font: 10pt Times New Roman, Times, Serif">25</span>% premium of the closing price of the Common Stock on their respective date of issue (provided that the exercise price of the warrants cannot be less than $<span id="xdx_90A_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__srt--RangeAxis__srt--MaximumMember_zq3vRnssCKCh" title="Exercise price of warrant">2.50</span> per share, subject to adjustment contained therein). The initial warrant has an exercise price of $<span id="xdx_903_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_za2OxgaB9g55" title="Exercise price of warrant">3.60</span>. The warrants will expire on <span id="xdx_904_eus-gaap--ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable_dd_c20200226__20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrvlGpQl9tif" title="Warrant expire date">October 31, 2022</span>. The warrants allow for cashless exercise in the event that they are not subject to a registration statement on the six (6) month anniversary of their respective issuances. The warrants do not contain any price protection or non-standard anti-dilution provisions.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 470 - <i>Debt</i>, the Company has allocated the cash proceeds to the loan and the warrants. The relative fair value of the initial warrant issued was $<span id="xdx_904_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20200226__20200228__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zmG7NedwEJl4" title="Proceeds from issuance of warrant">83,000</span>, which is being amortized and expensed over the term of the Notes.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated the loan and warrant agreements in accordance with ASC 815 <i>Derivatives and Hedging.</i> Based on this evaluation, the Company has determined that no provisions required derivative accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2020, the principal and interest of approximately $<span id="xdx_904_eus-gaap--RepaymentsOfShortTermDebt_pp0p0_c20200528__20200630__us-gaap--DebtInstrumentAxis__custom--TermloanMember_zk4qNluD01z7" title="Repayment of loan principal and interest">2,585,000</span> was paid from the proceeds from the OID Convertible Debentures.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2020, there is <span id="xdx_900_eus-gaap--LoansPayable_iI_pp0p0_do_c20201231__us-gaap--DebtInstrumentAxis__custom--TermloanMember_z5OU0DLyceje" title="Outstanding loan">no</span> outstanding loan balance on this account.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 5000000 2500000 2500000 1000000 0.10 2022-03-01 the Company will make monthly payments of principal and interest on an eighteen (18) month straight line amortization schedule, based on the principal outstanding on July 31, 2020. Additionally, the Company will have the option of a one (1) time payment-in-kind payment for a monthly required payment of principal and interest, which will defer such payments and result in a recalculation of the amortization schedule. In the event that the Company is late on any payments under the Loan, a late charge of three percent (3%) of the amount of the payment due will be assessed 300000 35000 2164000 500000 500000 0.25 2.50 3.60 2022-10-31 83000 2585000 0 <p id="xdx_80A_ecustom--OriginalIssueDiscountConvertibleDebenturesTextBlock_zmtZC7YRaJOb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 18 – <span id="xdx_82C_zAW1f1wwtf8d" style="font-variant: small-caps">OID CONVERTIBLE DEBENTURES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 25, 2020, the Company entered into a definitive securities purchase agreement (the “Securities Purchase Agreement or Transaction”) with certain accredited and institutional investors (the “Purchasers”) for the purchase and sale of an aggregate of: (i) $<span id="xdx_909_eus-gaap--DebtInstrumentFaceAmount_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Debt instrument, face amount">16,101,000</span> in principal amount of Original Issue Discount Senior Secured Convertible Debenture (the “Debentures”) for $<span id="xdx_90C_eus-gaap--DebtInstrumentUnamortizedDiscount_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Debt discount">14,169,000</span> (representing a <span id="xdx_903_ecustom--DebtDiscountPercentage_iI_dp_uPure_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_z685Tfz7t6h8" title="Original issue discount percentage">12</span>% original issue discount) (“Purchase Price”) and (ii) warrants to purchase up to <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pdd" title="Warrant to purchase common stock, shares">6,440,561</span> shares of the Company’s Class A common stock (the “Warrants”) in a private placement (the “Offering”). The Purchase Price consists of (a) $<span id="xdx_90E_eus-gaap--WarrantsAndRightsOutstanding_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Proceeds from warrants exercise">13,000,000</span> in cash and (b) the cancellation of $<span id="xdx_903_eus-gaap--LoansPayable_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Outstanding loan">1,169,000</span> in outstanding debt, consisting of the accounts receivable loans of $<span id="xdx_907_eus-gaap--AccountsReceivableNetCurrent_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Accounts receivable">510,000</span> with accrued interest of $<span id="xdx_90E_eus-gaap--InterestPayableCurrent_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--FinancialInstrumentAxis__us-gaap--AccountsReceivableMember_pp0p0" title="Accrued interest">184,000</span>, and the short-term promissory notes of $<span id="xdx_90E_eus-gaap--ShortTermBankLoansAndNotesPayable_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Short term promissory notes">350,000</span> with accrued interest of $<span id="xdx_900_eus-gaap--InterestPayableCurrent_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Accrued interest">125,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Debentures, which mature on <span id="xdx_903_eus-gaap--DebtInstrumentMaturityDate_c20200624__20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_zmrDI5IuSLgf">December 31, 2021</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, pay interest in cash at the rate of <span id="xdx_901_eus-gaap--DebtInstrumentInterestRateStatedPercentage_iI_pid_dp_uPure_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_zyIobszbH81f">12.0</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% per annum commencing on June 30, 2021, with such interest payable quarterly, beginning on October 1, 2021. Commencing after the six-month anniversary of the issuance of the Debentures, the Company will be required to make amortization payments (“Amortization Payments”) with each Purchaser having the right to delay such Amortization Payments by a six month period up to three separate times (each, an “Extension”) in exchange for five percent in principal being added to the balance of such applicable Debenture on each such Extension. Accordingly, upon a Purchaser exercising three Extensions, such Purchaser’s Debenture will mature and be due and payable on June 30, 2023. Beginning on the date that the first Amortization Payment is due, and on a monthly basis thereafter, the Company will be required to pay one hundred fifteen percent of the value of one-twelfth of the outstanding principal plus any additional accrued interest due.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the event a Purchaser converts a portion of its Debenture into shares of the Company’s Common Stock, such amount will be deducted from the next applicable Amortization Payment. In the event such conversion exceeds the next applicable Amortization Payment, such excess amount will be deducted, in reverse order, from future Amortization Payments. The Company’s obligations under the Debentures are secured by substantially all of the assets of the Company pursuant to a security agreement (the “Security Agreement”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Debentures are convertible at the option of the holder into shares of the Company’s common stock at an initial conversion price of $<span id="xdx_904_eus-gaap--DebtInstrumentConvertibleConversionPrice1_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pdd" title="Debt Instrument, Convertible, Conversion Price">2.69</span> per share, subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Debentures do not have any price protection or price reset provisions with respect to future issuances of securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DebtInstrumentDescription_c20200624__20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_zPtMDlM3NJc9" title="Debt Instrument, Description">Subject to the Company’s compliance with certain equity conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that (i) the Company sells or reprices any securities (each, a “Redemption Financing”), or (ii) the Company disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to cause the Company (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Debentures also contain certain customary events of default provisions, including, but not limited to, default in payment of principal or interest thereunder, breaches of covenants, agreements, representations or warranties thereunder, the occurrence of an event of default under certain material contracts of the Company, failure to register the shares underlying the Debentures in Warrants (as described below), changes in control of the Company, delisting of its securities from its trading market, and the entering or filing of certain monetary judgments against the Company. Upon the occurrence of any such event of default, the outstanding principal amount of the Debenture plus liquidated damages, interest and other amounts owing in respect thereof through the date of acceleration, shall become, at the Purchaser’s election, immediately due and payable in cash. <span id="xdx_90D_eus-gaap--DebtInstrumentRestrictiveCovenants_c20200624__20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_z4hmvCSpM61h" title="Debt instrument, restrictive covenants">The Company is also subject to certain negative covenants (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser) under the Debentures, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Warrants are initially exercisable at <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_zMFUXqi3wqF5" title="Warrants exercise price per share">2.50</span> per share and, are subject to cashless exercise after six months if the shares underlying the Warrants are not subject to an effective resale registration statement. The Warrants are also subject to adjustment in the event of (i) stock splits and dividends, (ii) subsequent rights offerings, (iii) pro-rata distributions, and (iv) certain fundamental transactions, including but not limited to the sale of the Company, business combinations, and reorganizations. The Warrants do not have any price protection or price reset provisions with respect to future issuances of securities.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightReasonForIssuingToNonemployees_c20200624__20200625__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_ze4py3iPLLzg" title="Warrant or Right, Reason for Issuance, Description">Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company also agreed to use proceeds from the Offering to pay (i) $<span id="xdx_90C_eus-gaap--RepaymentsOfDebt_c20200227__20200228__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMembersMember_pp0p0" title="Payment of outstanding debt">2,500,000</span> in outstanding principal plus accrued interest pursuant to the Company’s Term Loan and Security Agreement entered into on February 28, 2020 with BRF Finance Co., LLC (the “Term Loan”) and (ii) $<span id="xdx_90C_eus-gaap--RepaymentsOfNotesPayable_c20200227__20200228__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMembersMember_pp0p0" title="Repayment of short-term note payable">136,000</span> in outstanding short-term promissory notes and accrued interest (collectively, the “Debt Repayments”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In connection with Securities Purchase Agreement, the Company will issue to the Placement Agent (as defined below), an aggregate of <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4IFpBZJJ6R7" title="Warrant to purchase common stock, shares">478,854</span> Common Stock purchase warrants (“PA Warrants”). The PA Warrants are substantially similar to the Warrants, except that the PA Warrants have an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_z4KsMsq7j4Lj" title="Warrants exercise price per share">3.3625</span> per share. The fair value of the PA Warrants at issuance was estimated to be $<span id="xdx_90E_eus-gaap--ClassOfWarrantOrRightUnissued_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember_zAUEYqS3xPc3" title="Class of warrant or right, unissued">360,000</span> based on a risk-free interest rate of <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zETyHGMnZMi8" title="Warrants and rights outstanding, measurement input">.11</span>%, an expected term of <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zHND1AXfGoS5" title="Warrants and rights outstanding, Term">2.417</span> years, an expected volatility of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zuBCoXJODIYd" title="Warrants and rights outstanding, measurement input">96</span>% and a <span id="xdx_900_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zbDd7mdG1vye" title="Warrants and rights outstanding, measurement input">0</span>% dividend yield.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to a registration rights agreement (“Registration Rights Agreement”), the Company has agreed to file a registration statement registering the resale of the shares of the common stock underlying the Debentures and the Warrants within forty-five days from the date of the Registration Rights Agreement. The Company also agrees to have the registration statement declared effective within 90 days from the date of the Registration Rights Agreement and keep the registration statement continuously effective until the earlier of (i) the date after which all of the securities to be registered thereunder have been sold, or (ii) the date on which all the securities to be registered thereunder may be sold without volume or manner-of-sale restrictions and without current public information pursuant to Rule 144 under the Securities Act. The Company is also obligated to pay the Investors, as partial liquidated damages, a fee of 2.0% of each Purchaser’s subscription amount per month in cash upon the occurrence of certain events, including our failure to file and(or) have the registration statement declared effective within the time periods provided.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Bradley Woods &amp; Co. Ltd. (“Placement Agent”) acted as the placement agent, in connection with the sale of the securities pursuant to the Securities Purchase Agreement. Pursuant to an engagement agreement entered into by and between the Company and the Placement Agent, the Company agreed to pay the Placement Agent a cash commission of $<span id="xdx_90F_eus-gaap--PaymentsOfDebtIssuanceCosts_pp0p0_c20210101__20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ProductOrServiceAxis__custom--PlacementAgentMember_zXfeEqhfK987" title="Payments of Debt Issuance Costs">1,040,000</span>. Pursuant to the discussion above, the Company also issued an aggregate of <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ProductOrServiceAxis__custom--PlacementAgentMember_zovHHUgVUnPc" title="Warrant to purchase common stock, shares">478,854</span> PA Warrants to the Placement Agent. The Company has agreed to include the shares of our common stock underlying the PA Warrants to be included in the registration statement to be filed. Additionally, upon the exercise of Warrants issued in the Offering, the Placement Agent will be entitled to eight percent (<span id="xdx_90B_ecustom--ProceedsFromWarrantsPercentage_pid_dp_uPure_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--SecuritiesPurchaseAgreementMember__srt--ProductOrServiceAxis__custom--PlacementAgentMember_zXhuuaw2Itp7" title="Proceeds from warrants percentage">8</span>%) of the cash proceeds received from such exercises.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Transaction closed on June 30, 2020 (the “Closing Date”), with approximately $<span id="xdx_909_eus-gaap--ProceedsFromIssuanceOfDebt_pp0p0_c20200629__20200630__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--PriorToClosingDateMember_zgra1YdvqJKk" title="Proceeds from Issuance of Debt">3,800,000</span> cash proceeds received prior to Closing date, $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfDebt_c20200629__20200630__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Proceeds from Issuance of Debt">4,200,000</span> received on the closing date and $<span id="xdx_901_eus-gaap--ProceedsFromIssuanceOfDebt_c20200629__20200630__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember__us-gaap--TypeOfArrangementAxis__custom--AfterTheClosingDateMember_pp0p0" title="Proceeds from Issuance of Debt">5,000,000</span> received after the closing date. The gross proceeds received from the Offering were approximately $<span id="xdx_90F_eus-gaap--ProceedsFromIssuanceInitialPublicOffering_pp0p0_c20200629__20200630__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_zseksNZEHaU4" title="Proceeds from issuance Initial public offering">13,000,000</span> and net proceeds of approximately $<span id="xdx_904_ecustom--ProceedsFromIssuanceInitialPublicOfferingNet_pp0p0_c20200629__20200630__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_zbFXvQZeLph" title="Net proceeds from issuance of Initial public offering">9,100,000</span> after deducting the Placement Agent fees, the Debt Repayments and other offering expenses. Also, the Company reimbursed the lead Purchaser $<span id="xdx_90E_eus-gaap--LegalFees_c20200629__20200630__us-gaap--DebtInstrumentAxis__custom--OIDConvertibleDebenturesMember_pp0p0" title="Legal Fees">75,000</span> for legal fees, which was deducted from the required subscription amount to be paid.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluated all of the associated financial instruments in accordance with ASC 815 <i>Derivatives and Hedging.</i> Based on this evaluation, the Company has determined that no provisions required derivative accounting.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In accordance with ASC 470 - <i>Debt</i>, the Company first allocated the cash proceeds to the loan and the warrants on a relative fair value basis, secondly, the proceeds were allocated to the beneficial conversion feature.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, the Company recognized amortization expense of $<span id="xdx_90B_eus-gaap--AmortizationOfDebtDiscountPremium_pp0p0_c20200101__20201231_zIzczwYA4ux3" title="Amortization expenses">5,639,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, holders of debenture principal converted $<span id="xdx_90C_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20200101__20201231_zGjiWQamnhpf" title="Debenture principal converted into common stock">1,118,000</span> debenture into <span id="xdx_90A_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20200101__20201231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_pdd" title="Debt instrument, no. of shares issued upon conversion">411,626</span> shares of the Company’s class A common stock. As a result of these conversions and issuance of common stock, the Company wrote-off debt discount and increased additional paid in capital by $<span id="xdx_90A_ecustom--IncreaseDecreaseInAdditionalPaidInCapital_c20201231_pp0p0" title="Increase in additional paid in capital">434,000</span><b>.</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2020, majority of the debenture holders exercise their rights to delay amortization payment by six months in exchange for <span id="xdx_908_ecustom--AdditionalPrincipalPercentage_pid_dp_uPure_c20200101__20201231_z0Q4itwouakc" title="Additional principal percentage">5</span>% additional principal. Total additional principal due to extension amounted to $<span id="xdx_90B_eus-gaap--ProceedsFromIssuanceOfDebt_c20200101__20201231_pp0p0" title="Proceeds from issuance of debt">472,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, certain Debenture holders converted $<span id="xdx_900_eus-gaap--DebtConversionConvertedInstrumentAmount1_pp0p0_c20210101__20211231__srt--TitleOfIndividualAxis__custom--DebentureHoldersMember_zxZaBpAMw4e9" title="Debt conversion, converted instrument, amount">8,387,000</span> of principal into <span id="xdx_905_eus-gaap--DebtConversionConvertedInstrumentSharesIssued1_c20210101__20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember__srt--TitleOfIndividualAxis__custom--DebentureHoldersMember_zwdr0SldXoI1" title="Debt conversion, converted instrument, shares issued">3,122,167 </span>shares of the Company’s class A common stock shares. As a result of these conversions, the Company reduced the principal balance by approximately $<span id="xdx_900_ecustom--IncreaseDecreaseInAdditionalPaidInCapital_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DebentureHoldersMember_zFPgGfA7k0el" title="Additional principal balance">8,387,000</span> and reduced the debt discount by approximately $<span id="xdx_901_eus-gaap--DebtInstrumentUnamortizedDiscount_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DebentureHoldersMember_zywxBhAIQCn4" title="Debt discount">2,413,000</span> for a net book value of $<span id="xdx_904_eus-gaap--DebtInstrumentFaceAmount_iI_pp0p0_c20211231__srt--TitleOfIndividualAxis__custom--DebentureHoldersMember_zbUCaKk7hMN3" title="Debt face amount">5,974,000</span>, which was transferred to additional paid-in capital.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the holders of the remaining Debentures notified the Company of their election to defer the inception of amortization payments due under the Debentures until June 30, 2022. As a result of their election, the holders are entitled to a <span id="xdx_90E_ecustom--CurrentPrincipalBalanceFeePercentage_pid_dp_uPure_c20210101__20211231_zOMxQshETKSa" title="Current principal balance fee amount">5</span>% increase of their then current principal balance as a fee. The Company recorded this fee as a financing cost during the year ended December 31, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zFNcj2t1YYH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below summarizes the transactions during the year end December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zdqsEsDu3oRj" style="display: none">SCHEDULE OF OID CONVERTIBLE DEBENTURES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Debt discount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net book value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left">Balance at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--OIDConvertibleDebenturesFaceAmount_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zGbcvmMoDqH7" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Principal">9,386,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--OIDConvertibleDebenturesDiscount_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zHUMJvdY7z94" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Debt discount">(3,370,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zSdzmYfSih03" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Net book value">6,016,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Extension</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zOlAy2GHlqmj" style="font: 10pt Times New Roman, Times, Serif; text-align: right">268,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_z2uEHBgYScRb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1665">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zdfKpYdHzjO6" style="font: 10pt Times New Roman, Times, Serif; text-align: right">268,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Conversion</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zxZChkgQV5xg" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(8,387,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zzxdRhqfp3Jc" style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,413,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zdrgho7GePMf" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,974,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zagSaOtLxrw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1670">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zp4MQdoqa2Ob" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">854,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zSHSJ7kzV3X8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">854,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231_zy8OPkHg1Hmi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">1,267,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231_zCKoH25063Ie" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount">(103,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231_zWFk3zV98s6g" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net book value">1,164,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company has classified the debt as current liability because the management intends to redeem the remaining convertible debentures within the following 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The table below summarizes the transactions during the year</span><span style="font-size: 8pt">  </span> <span style="font-size: 10pt">end December 31, 2020:</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Principal</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Debt discount</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net book value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Issuance during the year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--OIDConvertibleDebenturesFaceAmount_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zYIF3eDxQw5e" style="width: 14%; text-align: right">16,101,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--OIDConvertibleDebenturesDiscount_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zOPFtBj3SHu4" style="width: 14%; text-align: right">(12,731,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--OidConvertibleDebenturesShortTerm_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_z8PqQWiKrkqf" style="width: 14%; text-align: right">3,370,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Extension</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zDhgSaZncFtg" style="text-align: right">472,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zfQ028FPQ8u9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1683">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zdQ4OwnUSNYc" style="text-align: right">472,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Redemption</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--RedemptionMember_z4jPwGEsCOHl" style="text-align: right">(6,069,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--RedemptionMember_zsWFZNUgHHGh" style="text-align: right">3,037,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--RedemptionMember_zoYvIkt9fBca" style="text-align: right">(3,032,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Conversion</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zCdlEoPGNawl" style="text-align: right">(1,118,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_znGOeJ3i7HS3" style="text-align: right">685,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zDuXHotroQ74" style="text-align: right">(433,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zorjVLewhFA2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1691">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zzTFxQvZNN0b" style="border-bottom: Black 1.5pt solid; text-align: right">5,639,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_z3Rg2OgfOiKb" style="border-bottom: Black 1.5pt solid; text-align: right">5,639,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231_zGWn7JFNNt4h" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal">9,386,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231_zJsLAIsNLa1j" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt discount">(3,370,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231_zmcru6o7Lmkb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value">6,016,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_8AF_zqPD41iiei81" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> 16101000 14169000 0.12 6440561 13000000 1169000 510000 184000 350000 125000 2021-12-31 0.120 2.69 Subject to the Company’s compliance with certain equity conditions, upon ten trading days’ notice to the Purchasers, the Company has the right to redeem the Debentures in cash at 115% of their outstanding principal, plus accrued interest. Additionally, in the event that (i) the Company sells or reprices any securities (each, a “Redemption Financing”), or (ii) the Company disposes of assets (except those sold or transferred in the ordinary course of business) (each, an “Asset Sale”), then the Purchasers shall have the right to cause the Company (a) in the event of a Redemption Financing at a price per Common Stock equivalent of $2.50 or less per share, the Purchasers may mandate that 100% of the proceeds be used to redeem the Debentures (b) in the event of a Redemption Financing at a price per Common Stock equivalent of greater than $2.50 per share, the Purchasers may mandate that up to 50% of the proceeds be used to redeem the Debentures, and (c) in the event of an Asset Sale, the Purchasers may mandate that up to 100% of the proceeds be used to redeem the Debentures The Company is also subject to certain negative covenants (unless waived by 67% of the then outstanding Purchasers, and including the lead Purchaser) under the Debentures, including but not limited to, the creation of certain debt obligations, liens on Company assets, amending its charter documents, repayment or repurchase of securities or certain debt of the Company, or the payment of dividends 2.50 Pursuant to the terms of the Debentures and Warrants, a Purchaser will not have the right to convert any portion of the Debentures or exercise any portion of the Warrants if the holder (together with its affiliates) would beneficially own in excess of 4.99% or 9.99% (at the Purchaser’s option) of the number of shares of Common Stock outstanding immediately after giving effect to such conversion or exercise, as such percentage ownership is determined in accordance with the terms of the Debentures and the Warrants; provided that at the election of a holder and notice to us such percentage ownership limitation may be increased to 9.99%; provided that any increase will not be effective until the 61st day after such notice is delivered from the holder to the Company 2500000 136000 478854 3.3625 360000 0.11 P2Y5M 96 0 1040000 478854 0.08 3800000 4200000 5000000 13000000 9100000 75000 5639000 1118000 411626 434000 0.05 472000 8387000 3122167 8387000 2413000 5974000 0.05 <p id="xdx_896_eus-gaap--ConvertibleDebtTableTextBlock_zFNcj2t1YYH6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The table below summarizes the transactions during the year end December 31, 2021:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B5_zdqsEsDu3oRj" style="display: none">SCHEDULE OF OID CONVERTIBLE DEBENTURES</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Principal</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Debt discount</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: center">Net book value</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 46%; text-align: left">Balance at beginning of year</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_986_ecustom--OIDConvertibleDebenturesFaceAmount_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zGbcvmMoDqH7" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Principal">9,386,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--OIDConvertibleDebenturesDiscount_iI_c20211231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zHUMJvdY7z94" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Debt discount">(3,370,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98C_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zSdzmYfSih03" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Net book value">6,016,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Extension</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zOlAy2GHlqmj" style="font: 10pt Times New Roman, Times, Serif; text-align: right">268,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_z2uEHBgYScRb" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1665">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zdfKpYdHzjO6" style="font: 10pt Times New Roman, Times, Serif; text-align: right">268,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Conversion</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zxZChkgQV5xg" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(8,387,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zzxdRhqfp3Jc" style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,413,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zdrgho7GePMf" style="font: 10pt Times New Roman, Times, Serif; text-align: right">(5,974,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Amortization</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zagSaOtLxrw" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1670">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zp4MQdoqa2Ob" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">854,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zSHSJ7kzV3X8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">854,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20211231_zy8OPkHg1Hmi" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Principal">1,267,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_981_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20211231_zCKoH25063Ie" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Debt discount">(103,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_984_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20211231_zWFk3zV98s6g" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Net book value">1,164,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, the Company has classified the debt as current liability because the management intends to redeem the remaining convertible debentures within the following 12 months.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><span style="font-size: 10pt">The table below summarizes the transactions during the year</span><span style="font-size: 8pt">  </span> <span style="font-size: 10pt">end December 31, 2020:</span></p> <p style="font: 12pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="vertical-align: bottom"> <td> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Principal</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Debt discount</td><td style="padding-bottom: 1.5pt"> </td><td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Net book value</td><td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 46%; text-align: left">Issuance during the year</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_989_ecustom--OIDConvertibleDebenturesFaceAmount_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zYIF3eDxQw5e" style="width: 14%; text-align: right">16,101,000</td><td style="width: 1%; text-align: left"> </td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--OIDConvertibleDebenturesDiscount_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_zOPFtBj3SHu4" style="width: 14%; text-align: right">(12,731,000</td><td style="width: 1%; text-align: left">)</td><td style="width: 2%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_981_ecustom--OidConvertibleDebenturesShortTerm_iI_c20201231__us-gaap--DebtInstrumentAxis__custom--IssuanceDuringTheYearMember_z8PqQWiKrkqf" style="width: 14%; text-align: right">3,370,000</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Extension</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zDhgSaZncFtg" style="text-align: right">472,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_98B_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zfQ028FPQ8u9" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1683">-</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_985_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ExtensionMember_zdQ4OwnUSNYc" style="text-align: right">472,000</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Redemption</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--RedemptionMember_z4jPwGEsCOHl" style="text-align: right">(6,069,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98E_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--RedemptionMember_zsWFZNUgHHGh" style="text-align: right">3,037,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--RedemptionMember_zoYvIkt9fBca" style="text-align: right">(3,032,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td>Conversion</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zCdlEoPGNawl" style="text-align: right">(1,118,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_980_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_znGOeJ3i7HS3" style="text-align: right">685,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--ConversionMember_zDuXHotroQ74" style="text-align: right">(433,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Amortization</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_988_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zorjVLewhFA2" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl1691">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_zzTFxQvZNN0b" style="border-bottom: Black 1.5pt solid; text-align: right">5,639,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98A_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231__us-gaap--DebtInstrumentAxis__custom--AmortizationMember_z3Rg2OgfOiKb" style="border-bottom: Black 1.5pt solid; text-align: right">5,639,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_987_ecustom--OIDConvertibleDebenturesFaceAmount_iI_pp0p0_c20201231_zGWn7JFNNt4h" style="border-bottom: Black 2.5pt double; text-align: right" title="Principal">9,386,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_982_ecustom--OIDConvertibleDebenturesDiscount_iI_pp0p0_c20201231_zJsLAIsNLa1j" style="border-bottom: Black 2.5pt double; text-align: right" title="Debt discount">(3,370,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_ecustom--OidConvertibleDebenturesShortTerm_iI_pp0p0_c20201231_zmcru6o7Lmkb" style="border-bottom: Black 2.5pt double; text-align: right" title="Net book value">6,016,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> 9386000 -3370000 6016000 268000 268000 -8387000 2413000 -5974000 854000 854000 1267000 -103000 1164000 16101000 -12731000 3370000 472000 472000 -6069000 3037000 -3032000 -1118000 685000 -433000 5639000 5639000 9386000 -3370000 6016000 <p id="xdx_80E_eus-gaap--CommitmentsAndContingenciesDisclosureTextBlock_zlZ07iyhMvS7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 19 – <span id="xdx_822_zaZa5sFquWU1" style="font-variant: small-caps">COMMITMENTS AND CONTINGENCIES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Other Commitments</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In the ordinary course of business, the Company may provide indemnifications of varying scope and terms to customers, vendors, lessors, business partners, and other parties with respect to certain matters, including, but not limited to, losses arising out of the Company’s breach of such agreements, services to be provided by the Company, or from intellectual property infringement claims made by third parties. In addition, the Company has entered indemnification agreements with its directors and certain of its officers and employees that will require the Company to, among other things, indemnify them against certain liabilities that may arise due to their status or service as directors, officers or employees. The Company has also agreed to indemnify certain former officers, directors and employees of acquired companies in connection with the acquisition of such companies. The Company maintains director and officer insurance, which may cover certain liabilities arising from its obligation to indemnify its directors and certain of its officers and employees, and former officers, directors and employees of acquired companies, in certain circumstances.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">It is not possible to determine the maximum potential amount of exposure under these indemnification agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each agreement. Such indemnification agreements may not be subject to maximum loss clauses.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Employment agreements</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We have entered employment agreements with key employees. These agreements may include provisions for base salary, guaranteed and discretionary bonuses and option grants. The agreements may contain severance provisions if the employees are terminated without cause, as defined in the agreements.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Litigation</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">From time to time, the Company may become subject to legal proceedings, claims and litigation arising in the ordinary course of business. In addition, the Company may receive letters alleging infringement of patent or other intellectual property rights. The Company is not currently a party to any material legal proceedings, nor is the Company aware of any pending or threatened litigation that would have a material adverse effect on the Company’s business, operating results, cash flows or financial condition should such litigation be resolved unfavorably.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Business Interruption</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The continuing COVID-19 global pandemic has caused significant disruption to the economy and financial markets globally, and the full extent of the potential impacts of COVID-19 are not yet known. Circumstances caused by the COVID-19 pandemic are complex, uncertain and rapidly evolving. The impact of COVID-19 has not been significant to the Company’s results of operations, financial condition, and liquidity and capital resources. Although no material impairment or other effects have been identified to date, there is substantial uncertainty in the nature and degree of its continued effects over time. That uncertainty affects management’s accounting estimates and assumptions, which could result in greater variability in a variety of areas that depend on these estimates and assumptions as additional events and information become known. The Company will continue to consider the potential impact of the COVID-19 pandemic on its business operations.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_80A_eus-gaap--PreferredStockTextBlock_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zNH5kiaKLjB" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 20 – <span id="xdx_820_zFT8PcbkJOs5" style="font-variant: small-caps">SERIES A PREFERRED STOCK</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span title="Dividends description">On August 17, 2021, <span id="xdx_901_eus-gaap--DividendsPayableNature_c20210816__20210817__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zj6rTcy0Fooj" title="Dividend description">the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock (“Preferred Stock”) to certain Qualified Recipients (as defined below) on a 1-for-1 as converted to common stock basis (the “Dividend”).</span></span> The record date for the Dividend is September 20, 2021 (the “Record Date”). The preferred stock entitles the Qualified Recipients with the right to receive the net proceeds from sales of certain securities of issuers that the Company received through its Sequire Platform services.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On September 20, 2021, the Company filed a certificate of designation (the “COD”) of preferences, rights, and limitations of Series A Non-Voting Preferred Stock (“Series A Preferred Stock”) with the Secretary of State of Delaware. Pursuant to the COD, the Company is authorized to issue up to <span id="xdx_908_eus-gaap--PreferredStockSharesAuthorized_iI_c20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember__srt--RangeAxis__srt--MaximumMember_ztB7ulUSoo7d" title="Preferred stock authorized">36,462,417</span> shares of Series A Preferred Stock (the “Dividend Shares”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of the Record Date, the following holders of securities were entitled to receive the Dividend (collectively, the “Qualified Recipients):</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">i.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each outstanding share of Class A common stock (the “Common Stock”), of which <span id="xdx_907_eus-gaap--PreferredStockSharesIssued_iI_c20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zaUslAggeixj" title="Preferred stock, shares issued"><span id="xdx_905_eus-gaap--PreferredStockSharesOutstanding_iI_c20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zbBJqixyFHQ3" title="Preferred stock, shares outstanding">25,160,504</span></span> shares were issued and outstanding,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">ii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each share of Common Stock underlying outstanding common stock purchase warrants containing a contractual right to receive the Dividend (“Warrants”) of which, <span id="xdx_905_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zZLAcDp22fr" title="Warrant to purchase common stock, shares">10,327,645</span> were outstanding, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">iii.</span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">each original issue discount senior convertible debenture (the “Debentures”) issued on June 30, 2021, containing a contractual right to receive the Dividend on an as converted to Common Stock basis, of which $<span id="xdx_90D_eus-gaap--DebtInstrumentConvertibleConversionPrice1_iI_c20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_ztk1MghrcSjg" title="Conversion of convertible securities">2,486,275</span> of Debentures were outstanding in principal and interest, convertible into <span id="xdx_909_eus-gaap--StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities_c20210919__20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zMcelbcRT1Ch" title="Stock issued during period, shares, conversion of convertible securities">974,268</span> shares of Common Stock.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Accordingly, the Company issued <span id="xdx_90A_eus-gaap--PreferredStockSharesAuthorized_iI_c20210920__us-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBqdVGEbW865">36,462,417</span> shares of Series A Preferred Stock to the Qualified Recipients on an as converted to Common Stock basis. The Dividend was delivered on September 27, 2021.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company’s management has evaluated the Preferred Stock in accordance with ASC 480 – Distinguishing Liabilities from Equity. Management has determined that the cancellation clause of the Preferred Stock deemed it to be mandatorily redeemable and should be classified as a liability. The fair value of the Preferred stock as of December 31, 2021 amounted to $<span id="xdx_90B_ecustom--FairValueOfPreferredStock_iI_c20211231_zyEvsj9H751a" title="Fair value of preferred stock">3,925,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> the Company announced that it will be issuing a one-time dividend consisting of a share of series A preferred stock (“Preferred Stock”) to certain Qualified Recipients (as defined below) on a 1-for-1 as converted to common stock basis (the “Dividend”). 36462417 25160504 25160504 10327645 2486275 974268 36462417 3925000 <p id="xdx_809_eus-gaap--StockholdersEquityNoteDisclosureTextBlock_zMuKwnACtSAi" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 21 – <span id="xdx_822_z2KtTkLNeq2a" style="font-variant: small-caps">STOCKHOLDERS’ EQUITY</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">Authorized Shares</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Preferred Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue <span id="xdx_903_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231_zSRZ31rQX7Yg" title="Preferred stock shares authorized">50,000,000</span> of preferred stock, par value $<span id="xdx_900_eus-gaap--PreferredStockParOrStatedValuePerShare_iI_c20211231_zEbqw612t8hk" title="Preferred stock par value">0.001</span>, of which <span id="xdx_902_eus-gaap--PreferredStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--SeriesOnePreferredStockMember_z8wGdf94Hs9a" title="Preferred stock shares authorized">200,000</span> shares were designated as Series 1 Preferred Stock. Our board of directors, without further stockholder approval, may issue preferred stock in one or more series from time to time and fix or alter the designations, relative rights, priorities, preferences, qualifications, limitations and restrictions of the shares of each series. The rights, preferences, limitations and restrictions of different series of preferred stock may differ with respect to dividend rates, amounts payable on liquidation, voting rights, conversion rights, redemption provisions, sinking fund provisions and other matters. Our board of directors may authorize the issuance of preferred stock, which ranks senior to our common stock for the payment of dividends and the distribution of assets on liquidation. In addition, our board of directors can fix limitations and restrictions, if any, upon the payment of dividends on both classes of our common stock to be effective while any shares of preferred stock are outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common Stock</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">We are authorized to issue an aggregate of <span id="xdx_90F_eus-gaap--CommonStockSharesAuthorized_iI_c20211231_zBrGCpGY2Tnb" title="Common stock shares authorized">259,000,000</span> shares of common stock. Our certificate of incorporation provides that we will have two classes of common stock: Class A common stock (authorized <span id="xdx_90C_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zfG3F7DuBuk4" title="Common stock shares authorized">250,000,000</span> shares, par value $<span id="xdx_90D_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_zXCBUgFvn5j" title="Common stock par value">0.001</span>), which has one vote per share, and Class B common stock (authorized <span id="xdx_901_eus-gaap--CommonStockSharesAuthorized_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zCTiVBccgp4e" title="Common stock shares authorized">9,000,000</span> shares, par value $<span id="xdx_90F_eus-gaap--CommonStockParOrStatedValuePerShare_iI_c20211231__us-gaap--StatementClassOfStockAxis__custom--ClassBCommonStockMember_zreECEOispEh" title="Common stock par value">0.001</span>), which has ten votes per share. Any holder of Class B common stock may convert his or her shares at any time into shares of Class A common stock on a share-for-share basis. Otherwise, the rights of the two classes of common stock are identical. As of December 31, 2021, the Company had <span id="xdx_907_eus-gaap--CommonStockSharesIssued_iI_c20211231_zm6CUlpMSo12" title="Common stock shares issued"><span id="xdx_905_eus-gaap--CommonStockSharesOutstanding_iI_c20211231_zmWLqyWOImfb" title="Common stock shares outstanding">25,995,172</span></span> shares issued and outstanding. As of December 31, 2020, the Company had <span id="xdx_900_eus-gaap--CommonStockSharesIssued_c20201231_pdd" title="Common stock shares issued"><span id="xdx_903_eus-gaap--CommonStockSharesOutstanding_c20201231_pdd" title="Common stock shares outstanding">16,145,778</span></span> shares issued and outstanding.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2020, we sold non-performing receivables in the aggregate amount of $<span id="xdx_90C_eus-gaap--ProceedsFromSaleOfNotesReceivable_pp0p0_c20210101__20210131__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember_zEqgg6tWNEtj" title="Proceeds from sale of non-performing receivables">529,000</span> for a purchase price of $<span id="xdx_90C_eus-gaap--TradeReceivablesHeldForSaleAmount_iI_pp0p0_c20200131__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember_z2XXZgMwcCT2" title="Purchase price of receivables">510,000</span> whereby in the event of payment on the receivables being received, <span id="xdx_90E_eus-gaap--ReceivableWithImputedInterestDescription_c20200101__20200131_zXityRmviRub" title="Receivable description">we agreed to provide a true-up to the purchaser of the receivable of between 10% and 36% depending on the payment date. In the event of nonpayment of the receivables by March 24, 2020 and March 30, 2020, as applicable to the receivables, the purchaser may require us to purchase any outstanding portion of the receivables for 136% of its outstanding balance (“Payment Date”).</span> In order to secure our performance to repurchase the receivables, we pledged <span id="xdx_908_ecustom--NumberOfSharesPledgedForRepurchaseOfReceivables_c20200101__20200131__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zpeCzWgCy0wi" title="Number of shares pledged for repurchase of receivables">239,029</span> shares of our Class A common stock. The purchaser and Company agreed to extend the Payment Date until June 23 and June 30, 2020, as applicable, in exchange for an aggregate of <span id="xdx_903_eus-gaap--StockIssuedDuringPeriodSharesOther_c20200629__20200630__us-gaap--FinancialInstrumentPerformanceStatusAxis__us-gaap--NonperformingFinancingReceivableMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zDPB0ANm0TI9" title="Shares issued for extension agreement">36,700</span> Class A common shares.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2021, our Board of Directors approved a share repurchase program pursuant to which we are authorized to repurchase up to $<span id="xdx_900_ecustom--RepurchaseOfAuthorizedCommonStock_c20210802__20210831__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--StatementClassOfStockAxis__custom--ClassACommonStockMember_z8LTuVnCZcMd" title="Repurchase of common stock">10,000,000</span> of our Class A Common Stock in privately negotiated transactions or in the open market at prices per share not exceeding the then-current market prices. The total remaining authorization for future common share repurchases under our share repurchase program was $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOrSaleOfEquity_pn5n6_c20210802__20210831__srt--TitleOfIndividualAxis__custom--BoardOfDirectorsMember__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember_zxy0tXtyFcHh" title="Proceeds from issuanceor sale of equity">10.0</span> million as of September 30, 2021. Under the program, management has discretion to determine the dollar amount of shares to be repurchased and the timing of any repurchases in compliance with applicable law and regulation. This includes purchases pursuant to Rule 10b5-1 plans, including accelerated share repurchases. The program does not have an expiration date.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the year ended December 31, 2021, the Company sold <span id="xdx_90F_eus-gaap--SaleOfStockNumberOfSharesIssuedInTransaction_pid_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember_zKT08CxWHAe" title="Sale of stock">53,616</span> shares of common stock, resulting in proceeds of approximately $<span id="xdx_90F_eus-gaap--SaleOfStockConsiderationReceivedOnTransaction_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--AtTheMarketSalesAgreementMember_zIEVusBUOsW3" title="Sale of stock, consideration received on transaction">284,000</span>, through sales under its At the Market (ATM) offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year ended December 31, 2021, the Company repurchased <span id="xdx_905_eus-gaap--StockRepurchasedDuringPeriodShares_pid_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareBuyBackProgramMember_zcPMQR5WRms2" title="Number of repurchased shares">155,000</span> shares of Common Stock, for an aggregate purchase price of $<span id="xdx_902_eus-gaap--StockRepurchasedDuringPeriodValue_pid_c20210101__20211231__us-gaap--TypeOfArrangementAxis__custom--ShareBuyBackProgramMember_z4P0AoN8MJs" title="Number of repurchased value">793,000</span> pursuant to the Company’s Share Buy-Back program. The shares were retired as of December 31, 2021.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 50000000 0.001 200000 259000000 250000000 0.001 9000000 0.001 25995172 25995172 16145778 16145778 529000 510000 we agreed to provide a true-up to the purchaser of the receivable of between 10% and 36% depending on the payment date. In the event of nonpayment of the receivables by March 24, 2020 and March 30, 2020, as applicable to the receivables, the purchaser may require us to purchase any outstanding portion of the receivables for 136% of its outstanding balance (“Payment Date”). 239029 36700 10000000 10000000.0 53616 284000 155000 793000 <p id="xdx_806_eus-gaap--DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock_zfiS5MoUTqt4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 22 – <span id="xdx_824_zfkHmCj89Ttg">STOCK OPTIONS, AWARDS AND WARRANTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="text-decoration: underline">2012, 2014 and 2016 Equity Compensation Plans</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In January 2012, our board of directors and stockholders authorized the 2012 Equity Compensation Plan, which we refer to as the 2012 Plan, covering <span id="xdx_905_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized_iI_c20120131__us-gaap--PlanNameAxis__custom--TwoThousandAndTwelveEquityCompensationPlanMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z5MKIFjboRo4" title="Number of shares authorized">600,000</span> shares of our Class A common stock. On November 5, 2014, our board of directors approved the adoption of our 2014 Equity Compensation Plan (the “2014 Plan”) and reserved <span id="xdx_904_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20141105__us-gaap--PlanNameAxis__custom--TwoThousandAndFourteenteenEquityCompensationPlanMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_zltunBGhuy53" title="Number of shares reserved for grants">600,000</span> shares of our Class A common stock for grants under this plan. On February 23, 2016, our board of directors approved the adoption of our 2016 Equity Compensation Plan (the “2016 Plan”) and reserved <span id="xdx_908_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant_iI_c20160223__us-gaap--PlanNameAxis__custom--TwoThousandAndSixteenEquityCompensationPlanMember__us-gaap--StatementClassOfStockAxis__us-gaap--CommonClassAMember_z1VuBNlY6ZEe" title="Number of shares reserved for grants">600,000</span> shares of our Class A common stock for grants under this plan. The purpose of the 2012, 2014 and 2016 Plans is to attract and retain the best available personnel for positions of substantial responsibility, to provide additional incentive to our employees, directors and consultants and to promote the success of our company’s business. The 2012, 2014 and 2016 Plans are administered by our board of directors. Plan options may either be:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">incentive stock options (ISOs),</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">non-qualified options (NSOs),</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">awards of our common stock,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">stock appreciation rights (SARs),</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">restricted stock units (RSUs),</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance units,</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">performance shares, and</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">other stock-based awards.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Any option granted under the 2012, 2014 and 2016 Plans must provide for an exercise price of not less than <span id="xdx_903_ecustom--MinimumPercentageOfFairMarketValueOfUnderyingShare_dp_c20160222__20160223__us-gaap--PlanNameAxis__custom--TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember_z4Pg27R3qmMh" title="Minimum percentage of fair market value">100</span>% of the fair market value of the underlying shares on the date of grant, but the exercise price of any ISO granted to an eligible employee owning more than <span id="xdx_903_ecustom--ThresholdOfEmployeeOwnershipForIncreaseInFairMarketValue_dp_c20160222__20160223__us-gaap--PlanNameAxis__custom--TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember_z1nL7V9Z4Mqd" title="Threshold of employee ownership for increase in fair market value and decrease in maximum life">10</span>% of our outstanding common stock must not be less than <span id="xdx_905_ecustom--MinimumPercentageOfFairMarketValueOfUnderyingSharesForEligibleEmployee_dp_c20160222__20160223__us-gaap--PlanNameAxis__custom--TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember_zmrQffS40Uia" title="Minimum percentage of fair market value for eligible employee">110</span>% of fair market value on the date of the grant. The plans further provide that with respect to ISOs the aggregate fair market value of the common stock underlying the options which are exercisable by any option holder during any calendar year cannot exceed $<span id="xdx_90C_ecustom--MaximumFairMarketValueThreshholdInCalendarYearForSingleHolder_c20160222__20160223__us-gaap--PlanNameAxis__custom--TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember_zSBOplyAWjoa" title="Maximum fair market value underlying options exercisable by any option holder during any calendar year">100,000</span>. The exercise price of any NSO granted under the 2012, 2014 or 2016 Plans is determined by the Board at the time of grant but must be at least equal to fair market value on the date of grant. The term of each plan option and the manner in which it may be exercised is determined by the board of directors or the compensation committee, provided that no option may be exercisable more than <span id="xdx_900_ecustom--MaximumOptionLife_dtY_c20160222__20160223__us-gaap--PlanNameAxis__custom--TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember_zS8V7sWPhKG4" title="Maximum option life">10</span> years after the date of its grant and, in the case of an incentive option granted to an eligible employee owning more than 10% of the common stock, no more than <span id="xdx_906_ecustom--MaximumOptionLifeForEligibleEmployees_dc_c20160222__20160223__us-gaap--PlanNameAxis__custom--TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember_z5k86ZDOtx47" title="Maximum option life for 10% holder">five years</span> after the date of the grant. The terms of grants of any other type of award under the 2012, 2014 or 2016 Plans is determined by the Board at the time of grant. Subject to the limitation on the aggregate number of shares issuable under the plans, there is no maximum or minimum number of shares as to which a stock grant or plan option may be granted to any person.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving our stock options for the years ended December 31, 2021 and 2020, respectively, are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In April 2020 the Company issued <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200401__20200430__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember_zKqIZ9RvHflb" title="Number of common shares option to purchase">36,172</span> options to purchase the Company’s common stock at a price of $<span id="xdx_90C_eus-gaap--SharesIssuedPricePerShare_iI_c20200430__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember_zfWWGBeu4S05" title="Shares issued price per share">1.95</span> to our non-executive directors. Each of our four non-executive directors received <span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares_c20200401__20200430__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember_z9KaMvWNC39l" title="Number of option vested">9,043</span> options that vest 1/4<sup>th</sup> quarterly over the next year with an expiration date of <span id="xdx_909_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate_c20200401__20200430__srt--TitleOfIndividualAxis__custom--NonExecutiveDirectorsMember_zt0f4PVCJoO" title="Option expiration date">April 15, 2027</span>. The options were valued using the Black Scholes option pricing model at a total of $<span id="xdx_908_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1_pp0p0_c20200401__20200430_zo9ezDNBbeA3" title="Share-based payment award, fair value of options">60,000</span> based on the <span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1_dxL_c20200401__20200430_zIfj03IKMRd1" title="Option term::XDX::P7Y"><span style="-sec-ix-hidden: xdx2ixbrl1800">seven-year</span></span> term, implied volatility of <span id="xdx_90E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20200401__20200430_zADx695bgeLi" title="Implied volatility">100</span>% and a risk-free equivalent yield of <span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20200401__20200430_zpCZsV8uiAcb" title="Risk free equivalent yield">0.24</span>%, stock price of $<span id="xdx_907_eus-gaap--SharePrice_iI_c20200430_zCXblJWJUQx1" title="Share price">1.95</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In August 2020, <span id="xdx_908_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20200831__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_zfAP96iEvEv8" title="Warrants to purchase common stock shares">430,000</span> common stock options having an exercise price of $<span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20200831__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_zdfN9WqMV887" title="Warrants exercise price per share">2.70</span> per share with an option value as of the grant date of $<span id="xdx_905_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedDate_pp0p0_c20200828__20200831__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_ztTVVs5obQk" title="Fair value of warrant option grant date">859,000</span> calculated using the Black-Scholes option pricing model were granted to several employees and members of our management team. The expense associated with this option award will be recognized in operating expenses ratably over the vesting period of <span id="xdx_900_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1_dc_c20200828__20200831__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_zvdCa6noWLOb" title="Option vesting period">five years</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In November 2020, <span id="xdx_90C_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20201130__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_zqA4NfvjjfX" title="Warrants to purchase common stock shares">300,000</span> common stock options having an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20201130__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_zxRtfwy5pfnf" title="Warrants exercise price per share">2.97</span> per share with an option value as of the grant date of $<span id="xdx_90D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedDate_c20201128__20201130__srt--TitleOfIndividualAxis__custom--EmployeesAndMembersOfManagementTeamMember_pp0p0" title="Fair value of warrant option grant date">649,000</span> calculated using the Black-Scholes option pricing model were granted to an employee. The expense associated with this option award will be recognized in operating expenses at date of grant.</span></p> <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKZ0zMtPIw7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zVw1IC2Qg7Hg" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Strike Price/Share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Term (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Grant Date Fair Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%">Outstanding — December 31, 2019</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231_ziLnS9LY93hj" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Number of Shares, Outstanding Beginning balance">1,192,519</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_z1R3DTx0zCUd" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Beginning balance">4.14</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_zQIIHsjEcO3" title="Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance">2.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20200101__20201231_zaWvLIbo8hed" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1830">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_c20200101__20201231_zauj2hIEhZk9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1832">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231_zmlsKqb5NDG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Granted">766,172</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_zCGF1Egmhxa9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Granted">2.77</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231_zEXRCCDC1NS6" title="Weighted Average Remaining Contractual Term (Years), Granted">3.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20200101__20201231_zB1VNCBzOefj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Granted">521,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zgxWubltQHh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted">2.72</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200101__20201231_zll5Q7sR0w31" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1844">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231_zRcyPtSNupY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1846">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span>—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20200101__20201231_zws7bhC8FN21" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1848">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_z6K6gc33gNyh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1850">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200101__20201231_zFi24J0nb4ei" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited">(316,367</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231_zggK7UwYDCUf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Forfeited">5.14</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span>—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20200101__20201231_zsmpCa9Oavud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1856">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zBxkrSv98XE7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited">3.14</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231_zoBN4BztmA13" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Ending balance">1,642,324</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_z9RiR20lXKP" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Ending balance">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zwVGDhEVY545" title="Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance">2.81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20200101__20201231_zzbOf8D4i3j7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1866">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue1_c20200101__20201231_z82St5A4LuM1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1868">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Vested and exercisable — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231_zEAjHAJzVu5l" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested and exercisable Ending balance">844,742</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20201231_zVDWd10Uw092" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Vested and exercisable Ending balance">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zVe5F9HC68C4" title="Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance">2.62</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20201231_zfoygjj75iLb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Vested and exercisable Ending balance">333,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20200101__20201231_zboUKc0qGsS4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Unvested and non-exercisable - December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231_zkk9BHI1ilg9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Unvested and non-exercisable Ending balance">797,582</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20201231_zJ8dXlQtB1q6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance">2.81</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNOnvestedWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_z8M1ItjnUpa9" title="Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance">3.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedInstricticValue_iI_pdp0_c20201231_zQ8Res8srQ1a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance">207,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231_zw4G6CvORRG4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance">2.09</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zXj8Jic03Utb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Beginning balance">1,642,324</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zx7M9CKHkWKa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Beginning balance">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zzjSpE6LqZSh" title="Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance">2.81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20211231_zRjXWgzvgBV6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1896">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_c20210101__20211231_zBqAseh5upPi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1898">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zqgz9exkh9t5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Granted">21,627</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zqJL38wlbg4k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Granted">4.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_zx8sngMvp6G5" title="Weighted Average Remaining Contractual Term (Years), Granted">6.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20211231_z6KQHQGaSIn" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Granted">2,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zMUI8U3NEbc1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_zGb3GCCpRXy6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Exercised">(12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zsZGdRJ9lTW5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Exercised">2.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageExercisedRemainingContractualTerm_dtY_c20210101__20211231_z2zTZ9I5YnG2" title="Weighted Average Remaining Contractual Term (Years), Exercised">3.63</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20210101__20211231_zlpxyIr8ecQ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1916">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zYcAKWN9rtW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Exercised">2.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231_zNXiRvkQvoUa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited">(319,671</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_zlUsFasnOmmk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Forfeited">4.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageForfeitedRemainingContractualTerm_dtY_c20210101__20211231_za0MNHwNc6xf" title="Weighted Average Remaining Contractual Term (Years), Forfeited">0.65</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20211231_zjZRyp1AR9Rh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1926">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z0wjef5WcSek" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited">3.49</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_ztSa1ElCjhhd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Ending balance">1,331,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zZERFkFiJ6ji" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Ending balance">3.02</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_z4ebH9KTnj3e" title="Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance">2.39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20211231_zysJpc7D0Ce2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending balance">1,969,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue1_c20210101__20211231_zTD6DLHFToH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Ending balance">2.13</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Vested and exercisable — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231_zaJrMNAkxQIg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested and exercisable Ending balance">870,750</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20211231_z3oHtqbdzroe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Vested and exercisable Ending balance">3.05</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zHyXudCQRmB8" title="Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance">2.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20211231_z2VGUYNVTds1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Vested and exercisable Ending balance">1,265,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20210101__20211231_zfBfZP205bj9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance">2.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Unvested and non-exercisable - December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231_znTvxqYlYxad" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Unvested and non-exercisable Ending balance">461,030</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20211231_zxK4QCSoKI62" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance">2.96</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNOnvestedWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zTHfVgYX3aG4" title="Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance">2.62</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedInstricticValue_iI_pdp0_c20211231_zeuEVtbQh0Fa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance">703,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231_z6YfiEDtMiJ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance">2.10</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zDLRSMyvASol" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2021 and 2020, we recorded compensation expense of $<span id="xdx_90F_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20210101__20211231_ztoczWkRcGf5">1,006,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--AllocatedShareBasedCompensationExpense_pp0p0_c20200101__20201231_zFUYBPpIAZi3">1,615,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively, related to stock-based compensation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021, compensation cost related to the unvested options not yet recognized was approximately $<span id="xdx_90B_eus-gaap--EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions_iI_pp0p0_c20211231_zR6QaqPjmbx4">811,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">. The weighted average period over which the $<span id="xdx_90A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue_iI_pp0p0_c20211231_zjboGFzhlBv">811,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">will vest is estimated to be <span id="xdx_907_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zAl2Bk0GTY6a">2.83 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">years.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font: small-caps 10pt Times New Roman, Times, Serif"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transactions involving our warrants for the years ended December 31, 2021 and 2020, respectively, are summarized as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the Company’s Convertible Debenture offering in June 2020 (as described in Note 17 – OID Convertible Debentures), the Company negotiated the ability to release the BIGToken business, as security for the OID Convertible Debentures, for the purposes of selling BIGToken. As consideration for the release, the Company agreed to require the purchaser of BIGToken to issue warrants in the new entity. The warrants were to represent 13% of the new entities issued and outstanding on a fully diluted basis upon closing. As disclosed in Note 3 – Acquisitions, the Company entered into an agreement to merge BIGToken with FPVD on February 4, 2021, which required the issuance of <span id="xdx_904_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210204__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrxD5QRBXZr8">25,568,064,462 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants. Based on a valuation from an independent third-party, the fair-market value of the warrants required to be issued was determined to be $<span id="xdx_90C_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20210203__20210204__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zcsnMaNCOdt2">885,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">based on implied <span id="xdx_903_eus-gaap--WarrantsAndRightsOutstandingTerm_iI_dtY_c20210204__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedTermMember_zNTaE2jCB5P5">3</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">-year volatility of <span id="xdx_908_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210204__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputOptionVolatilityMember_zFbPLpZkbO72">92.30</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">%, a risk-free equivalent yield of <span id="xdx_90C_eus-gaap--WarrantsAndRightsOutstandingMeasurementInput_iI_pid_uPure_c20210204__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember_zyd5JJG0hzci">18</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">% and stock price of $<span style="font: 10pt Times New Roman, Times, Serif" title="Warrants exercise price per share">0.00006552</span>.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 21, 2021 the Company entered into an agreement with the certain Debenture holders to exercise <span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210221__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zrg86TQ88d2c" title="Class of warrant or right, number of securities called by warrants or rights">4,545,440</span> of the Warrants issued in the June 2020 Debenture offering. As an inducement for the Warrant holders to exercise the Warrants, the holders receive a new registered warrant (“New Warrant”) to purchase an aggregate of <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_pid_c20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zJYcjdA76oql" title="Class of warrant or right, number of securities called by warrants or rights">4,545,440</span> shares of the Company’s common stock at an exercise price of $<span id="xdx_901_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_pid_c20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zPux3onM1FM" title="Class of warrant or right, exercise price of warrants or rights">7.50</span> per share. The New Warrants expire on <span id="xdx_906_eus-gaap--WarrantsAndRightsOutstandingMaturityDate_iI_dd_c20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_znTazoSAVlUk" title="Warrants and rights outstanding, maturity date">January 31, 2022</span>. Each holder agreed to pay $<span id="xdx_90F_eus-gaap--SharePrice_iI_pid_c20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zhFdIMuoM5O1" title="Share price">0.125</span> for each New Warrant. The Company received net proceeds of approximately $<span id="xdx_903_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20210220__20210221__us-gaap--StatementEquityComponentsAxis__us-gaap--WarrantMember_zIHa00eWuiyl" title="Proceeds from issuance of warrants">11,022,000</span>, consisted of the exercise price of $<span id="xdx_902_eus-gaap--ProceedsFromWarrantExercises_pp0p0_c20210220__20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zyZxkRkfF4Ki">11,363,000</span>, $<span id="xdx_904_eus-gaap--ProceedsFromIssuanceOfWarrants_pp0p0_c20210220__20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zeamzj6Bv8Tb">568,000</span> for the purchase of the New Warrant less solicitation fees of approximately $<span id="xdx_90E_ecustom--SolicitationFees_pp0p0_c20210220__20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zDJ18bOY0F6b" title="Solicitation Fees">909,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The New Warrants were valued using the Black Scholes option pricing model at a total of $<span id="xdx_90E_eus-gaap--FairValueAdjustmentOfWarrants_pp0p0_c20210220__20210221__us-gaap--StatementEquityComponentsAxis__custom--NewWarrantMember_zhRvQkAkYJY6" title="Fair value of warrants">7,737,000</span> based on a <span title="Warrants term">one</span>-year term, implied volatility of <span id="xdx_907_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_dp_uPure_c20210220__20210221_zhqaZvwXIerf" title="Implied volatility">96</span>%, a risk-free equivalent yield of <span id="xdx_90D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_dp_uPure_c20210220__20210221_zDcn7IamrMW3" title="Risk free equivalent yield">11</span>%, and stock price of $<span id="xdx_90D_eus-gaap--ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1_iI_c20210221_zLilCLvW7Qg7" title="Warrants exercise price per share">5.83</span>. The fair value of the New Warrants was expensed and included in Financing Costs.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the quarter ended March 31, 2021, the Company: (i) received cash of approximately $<span id="xdx_908_eus-gaap--ProceedsFromIssuanceOfWarrants_c20210101__20210331_z3UcEsTSR5Tb">4,930,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, (ii) cancelled <span id="xdx_908_ecustom--NumberOfWarrantsCancelled_c20210101__20210331_zlXFdRnEdCN2">349,197</span></span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">warrants (as a result of cashless exercises) and (iii) issued an aggregate of <span id="xdx_90B_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20210331_zVbTuTBZ5YAa">2,283,171 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">shares of Common Stock, in connection with the exercise of outstanding warrants.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In total the Company issued a total of <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20211231_zuMOCJCryUAf" title="Shares issued upon exercise of warrants">6,828,611 </span>shares of common stock, for the exercise of warrants, with net proceeds of $<span id="xdx_90E_eus-gaap--ProceedsFromWarrantExercises_c20210101__20211231_zk3S7PUk1tKb" title="Proceeds from warrant exercises">15,952,000</span>.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_899_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zn3n2uMnffO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span> </span></span><span id="xdx_8B9_znkpVThwd5Fb" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span></p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Strike Price/Share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Term (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Grant Date Fair Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%">Outstanding — December 31, 2019</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200101__20201231_ztun458cdCp6" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Number of Shares, Warrants Outstanding Beginning balance">6,237,430</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_zEr2IqlJmfc9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance">3.57</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_z0ioONfTnGXk" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance">2.68</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iS_pdp0_c20200101__20201231_zsEuWzo8iFs9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2009">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue_c20200101__20201231_zlxCkyWwUal9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2011">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20200101__20201231_zNhVhk0WCZ4k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Granted">7,421,054</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_z95UoMKhA9P6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Granted">2.63</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231_zcHKdlEjcMkg" title="Weighted Average Remaining Contractual Term (Years), Warrants Granted">1.82</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue_c20200101__20201231_zYumkHofeQEh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Granted">3,929,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zBqX10wYKmu8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Granted">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200101__20201231_zKROaCztnEgb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2023">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231_zZaB8DZVRZ5b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2025">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20200101__20201231_zGcoD1C3VXQi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2027">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zWY6cRFpyLM3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2029">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20200101__20201231_zpNP6vVJ87C5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Forfeiture">(1,073,201</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231_z9Wp8tYTHZte" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2033">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20200101__20201231_z6d97nzcrIUi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2035">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zo2lHRAu4WAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2037">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200101__20201231_z44iWMxdEIo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Outstanding Beginning balance">12,585,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zCdTMnRXlEF4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance">2.98</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zd4IB7QCMPel" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance">1.78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iE_pdp0_c20200101__20201231_z1AKOJTrQdfd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Beginning balance">4,460,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue1_c20200101__20201231_zMZuFIdYL5P9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Vested and exercisable — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231_zc7CvsNFdB1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Vested and Exercisable">12,285,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20201231_zycxCBnTzes1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Vested and Exercisable">2.94</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zfHK0MFdtS3g" title="Weighted Average Remaining Contractual Term (Years), Warrants Vested and Exercisable">1.74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20201231_zMqOeVUTZrEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Vested and Exercisable">4,460,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20200101__20201231_zef9wjWX95H2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Unvested and non-exercisable - December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares_iI_c20201231_zHZLYVsB2z96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Unvested and Non-Exercisable">300,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20201231_zpoffiVuCr9a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable">4.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zNoaVBMhu1u5" title="Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance">3.37</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedInstricticValue_iI_pdp0_d0_c20201231_zwfqVj13krO5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Unvested and Non-Exercisable">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231_zLWbSfGKMmMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2067">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210101__20211231_zNbujCB2mqlb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Outstanding Beginning balance">12,585,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_z9wH7xHyulXk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance">2.98</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zLSRFaZm4R6e" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance">1.78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20211231_zPIrbVBDiV9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Beginning balance">4,460,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue_c20210101__20211231_zNuqHf9Sn2Tl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210101__20211231_zjTNFU2mzbw1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Granted">4,582,345</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zsF3C7jfXSN2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Granted">7.48</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_zHJeM8wKCsmk" title="Weighted Average Remaining Contractual Term (Years), Warrants Granted">0.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20211231_zdQxdo769Bwf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Aggregate Intrinsic Value, Warrants Granted"><span style="-sec-ix-hidden: xdx2ixbrl2085">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zzJbAKntdN1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Granted">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231_zdo0orbryGf1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Exercised">(7,148,501</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zry9XLqxnS0i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Exercised">2.74</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageExercisedRemainingContractualTerm_dtY_c20210101__20211231_zqqrA0F4l7M2" title="Weighted Average Remaining Contractual Term (Years), Warrants Exercised">0.78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20210101__20211231_zDsHz0IJdTy3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2095">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z6W7WmeflLN1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2097">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20210101__20211231_zBgkrECqwLei" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2099">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_zP2WiPEVmugd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2101">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20211231_zLvywkze6143" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Forfeitures"><span style="-sec-ix-hidden: xdx2ixbrl2103">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z7d0f6tj2BQ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2105">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210101__20211231_z1lKzJA0Vfa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Outstanding Ending balance">10,019,127</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zzu5UasjvVah" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Ending balance">5.21</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_z2O3G4mTsDM9" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance">0.47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20211231_zYbF9NGwYTd8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Ending balance">6,779,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue1_c20210101__20211231_zVKxKXL3LKLe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Ending balance">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Vested and exercisable — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231_zDtj5S9xxkU6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Vested and Exercisable">9,719,127</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20211231_zNjncuFFV5eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Vested and Exercisable">5.22</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zHw4y4hq4iv8" title="Weighted Average Remaining Contractual Term (Years), Warrants Vested and exercisable Ending balance">0.41</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20211231_zwZ1O66T5vN2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Vested and Exercisable">6,779,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20210101__20211231_zigSDs5jIe7f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Unvested and non-exercisable - December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares_iI_c20211231_zKin6DOlDVT3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Unvested and Non-Exercisable">300,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20211231_zeuIsUCGCIk5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable">4.75</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zA8lY1bZgrH9" title="Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance">2.37</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedInstricticValue_iI_pdp0_c20211231_zxTQCvLXFbr4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Unvested and Non Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2133">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231_zpp69YbQcJ2j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2135">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </div><p id="xdx_8A1_z4jWdttolW2f" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> 600000 600000 600000 1 0.10 1.10 100000 P10Y P5Y 36172 1.95 9043 2027-04-15 60000 1 0.0024 1.95 430000 2.70 859000 P5Y 300000 2.97 649000 <p id="xdx_89E_eus-gaap--ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock_zKZ0zMtPIw7e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B5_zVw1IC2Qg7Hg" style="display: none">SCHEDULE OF STOCK OPTION ACTIVITY</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Strike Price/Share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Term (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Grant Date Fair Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%">Outstanding — December 31, 2019</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20200101__20201231_ziLnS9LY93hj" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Number of Shares, Outstanding Beginning balance">1,192,519</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_z1R3DTx0zCUd" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Beginning balance">4.14</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_zQIIHsjEcO3" title="Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance">2.17</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20200101__20201231_zaWvLIbo8hed" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1830">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_c20200101__20201231_zauj2hIEhZk9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1832">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20200101__20201231_zmlsKqb5NDG6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Granted">766,172</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_zCGF1Egmhxa9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Granted">2.77</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231_zEXRCCDC1NS6" title="Weighted Average Remaining Contractual Term (Years), Granted">3.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20200101__20201231_zB1VNCBzOefj" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Granted">521,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zgxWubltQHh3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted">2.72</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20200101__20201231_zll5Q7sR0w31" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1844">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231_zRcyPtSNupY8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1846">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span>—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20200101__20201231_zws7bhC8FN21" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1848">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_z6K6gc33gNyh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1850">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20200101__20201231_zFi24J0nb4ei" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited">(316,367</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231_zggK7UwYDCUf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Forfeited">5.14</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span>—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20200101__20201231_zsmpCa9Oavud" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1856">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zBxkrSv98XE7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited">3.14</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20200101__20201231_zoBN4BztmA13" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Ending balance">1,642,324</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_z9RiR20lXKP" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Ending balance">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zwVGDhEVY545" title="Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance">2.81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20200101__20201231_zzbOf8D4i3j7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1866">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue1_c20200101__20201231_z82St5A4LuM1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Ending balance"><span style="-sec-ix-hidden: xdx2ixbrl1868">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Vested and exercisable — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231_zEAjHAJzVu5l" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested and exercisable Ending balance">844,742</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20201231_zVDWd10Uw092" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Vested and exercisable Ending balance">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_901_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zVe5F9HC68C4" title="Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance">2.62</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20201231_zfoygjj75iLb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Vested and exercisable Ending balance">333,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20200101__20201231_zboUKc0qGsS4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance">3.54</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Unvested and non-exercisable - December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20201231_zkk9BHI1ilg9" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Unvested and non-exercisable Ending balance">797,582</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20201231_zJ8dXlQtB1q6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance">2.81</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNOnvestedWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_z8M1ItjnUpa9" title="Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance">3.00</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedInstricticValue_iI_pdp0_c20201231_zQ8Res8srQ1a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance">207,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231_zw4G6CvORRG4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance">2.09</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20210101__20211231_zXj8Jic03Utb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Beginning balance">1,642,324</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_zx7M9CKHkWKa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Beginning balance">3.30</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_909_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zzjSpE6LqZSh" title="Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance">2.81</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20211231_zRjXWgzvgBV6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1896">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue_c20210101__20211231_zBqAseh5upPi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl1898">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_c20210101__20211231_zqgz9exkh9t5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Granted">21,627</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zqJL38wlbg4k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Granted">4.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_zx8sngMvp6G5" title="Weighted Average Remaining Contractual Term (Years), Granted">6.29</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20211231_z6KQHQGaSIn" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Granted">2,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zMUI8U3NEbc1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Granted">3.60</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--StockIssuedDuringPeriodSharesStockOptionsExercised_iN_di_c20210101__20211231_zGb3GCCpRXy6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Exercised">(12,500</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zsZGdRJ9lTW5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Exercised">2.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageExercisedRemainingContractualTerm_dtY_c20210101__20211231_z2zTZ9I5YnG2" title="Weighted Average Remaining Contractual Term (Years), Exercised">3.63</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20210101__20211231_zlpxyIr8ecQ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Exercised"><span style="-sec-ix-hidden: xdx2ixbrl1916">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zYcAKWN9rtW4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Exercised">2.00</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod_iN_di_c20210101__20211231_zNXiRvkQvoUa" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Forfeited">(319,671</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_zlUsFasnOmmk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Forfeited">4.60</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90B_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageForfeitedRemainingContractualTerm_dtY_c20210101__20211231_za0MNHwNc6xf" title="Weighted Average Remaining Contractual Term (Years), Forfeited">0.65</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20211231_zjZRyp1AR9Rh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Forfeited"><span style="-sec-ix-hidden: xdx2ixbrl1926">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z0wjef5WcSek" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Forfeited">3.49</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20210101__20211231_ztSa1ElCjhhd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Ending balance">1,331,780</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zZERFkFiJ6ji" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Ending balance">3.02</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_z4ebH9KTnj3e" title="Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance">2.39</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20211231_zysJpc7D0Ce2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Ending balance">1,969,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue1_c20210101__20211231_zTD6DLHFToH1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Ending balance">2.13</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Vested and exercisable — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231_zaJrMNAkxQIg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Vested and exercisable Ending balance">870,750</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20211231_z3oHtqbdzroe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Vested and exercisable Ending balance">3.05</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_906_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zHyXudCQRmB8" title="Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance">2.27</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20211231_z2VGUYNVTds1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Vested and exercisable Ending balance">1,265,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20210101__20211231_zfBfZP205bj9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance">2.15</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Unvested and non-exercisable - December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares_iI_c20211231_znTvxqYlYxad" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Unvested and non-exercisable Ending balance">461,030</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20211231_zxK4QCSoKI62" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance">2.96</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90E_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNOnvestedWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zTHfVgYX3aG4" title="Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance">2.62</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedInstricticValue_iI_pdp0_c20211231_zeuEVtbQh0Fa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance">703,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231_z6YfiEDtMiJ3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance">2.10</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 1192519 4.14 P2Y2M1D 766172 2.77 P3Y 521000 2.72 316367 5.14 3.14 1642324 3.30 P2Y9M21D 844742 3.54 P2Y7M13D 333000 3.54 797582 2.81 P3Y 207000 2.09 1642324 3.30 P2Y9M21D 21627 4.38 P6Y3M14D 2000 3.60 12500 2.70 P3Y7M17D 2.00 319671 4.60 P0Y7M24D 3.49 1331780 3.02 P2Y4M20D 1969000 2.13 870750 3.05 P2Y3M7D 1265000 2.15 461030 2.96 P2Y7M13D 703000 2.10 1006000 1615000 811000 811000 P2Y9M29D 25568064462 885000 P3Y 92.30 18 4545440 4545440 7.50 2022-01-31 0.125 11022000 11363000 568000 909000 7737000 0.96 0.11 5.83 4930000 349197 2283171 6828611 15952000 <p id="xdx_899_eus-gaap--ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock_zn3n2uMnffO4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span> </span></span><span id="xdx_8B9_znkpVThwd5Fb" style="display: none">SCHEDULE OF WARRANT ACTIVITY</span></p> <div><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number of Shares</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Strike Price/Share</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Remaining Contractual Term (Years)</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Aggregate Intrinsic Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Weighted Average Grant Date Fair Value</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 35%">Outstanding — December 31, 2019</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20200101__20201231_ztun458cdCp6" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Number of Shares, Warrants Outstanding Beginning balance">6,237,430</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20200101__20201231_zEr2IqlJmfc9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance">3.57</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right"><span id="xdx_909_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20200101__20201231_z0ioONfTnGXk" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance">2.68</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iS_pdp0_c20200101__20201231_zsEuWzo8iFs9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2009">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue_c20200101__20201231_zlxCkyWwUal9" style="font: 10pt Times New Roman, Times, Serif; width: 9%; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance"><span style="-sec-ix-hidden: xdx2ixbrl2011">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20200101__20201231_zNhVhk0WCZ4k" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Granted">7,421,054</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20200101__20201231_z95UoMKhA9P6" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Granted">2.63</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_907_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20200101__20201231_zcHKdlEjcMkg" title="Weighted Average Remaining Contractual Term (Years), Warrants Granted">1.82</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue_c20200101__20201231_zYumkHofeQEh" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Granted">3,929,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zBqX10wYKmu8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Granted">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20200101__20201231_zKROaCztnEgb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2023">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_c20200101__20201231_zZaB8DZVRZ5b" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2025">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20200101__20201231_zGcoD1C3VXQi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2027">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zWY6cRFpyLM3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2029">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20200101__20201231_zpNP6vVJ87C5" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Forfeiture">(1,073,201</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20200101__20201231_z9Wp8tYTHZte" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2033">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">—</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20200101__20201231_z6d97nzcrIUi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2035">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20200101__20201231_zo2lHRAu4WAc" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2037">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20200101__20201231_z44iWMxdEIo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Outstanding Beginning balance">12,585,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20200101__20201231_zCdTMnRXlEF4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance">2.98</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zd4IB7QCMPel" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance">1.78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iE_pdp0_c20200101__20201231_z1AKOJTrQdfd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Beginning balance">4,460,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue1_c20200101__20201231_zMZuFIdYL5P9" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Vested and exercisable — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20201231_zc7CvsNFdB1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Vested and Exercisable">12,285,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20201231_zycxCBnTzes1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Vested and Exercisable">2.94</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zfHK0MFdtS3g" title="Weighted Average Remaining Contractual Term (Years), Warrants Vested and Exercisable">1.74</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20201231_zMqOeVUTZrEb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Vested and Exercisable">4,460,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20200101__20201231_zef9wjWX95H2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Unvested and non-exercisable - December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares_iI_c20201231_zHZLYVsB2z96" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Unvested and Non-Exercisable">300,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20201231_zpoffiVuCr9a" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable">4.75</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_904_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm1_dtY_c20200101__20201231_zNoaVBMhu1u5" title="Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance">3.37</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedInstricticValue_iI_pdp0_d0_c20201231_zwfqVj13krO5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Unvested and Non-Exercisable">—</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue_c20200101__20201231_zLWbSfGKMmMi" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2067">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Outstanding Beginning balance"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2020</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iS_c20210101__20211231_zNbujCB2mqlb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Outstanding Beginning balance">12,585,283</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iS_c20210101__20211231_z9wH7xHyulXk" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance">2.98</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2_dtY_c20210101__20211231_zLSRFaZm4R6e" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance">1.78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iS_pdp0_c20210101__20211231_zPIrbVBDiV9i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Beginning balance">4,460,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue_c20210101__20211231_zNuqHf9Sn2Tl" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance">1.38</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif">Granted</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted_c20210101__20211231_zjTNFU2mzbw1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Granted">4,582,345</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice_c20210101__20211231_zsF3C7jfXSN2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Granted">7.48</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_903_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm_dtY_c20210101__20211231_zHJeM8wKCsmk" title="Weighted Average Remaining Contractual Term (Years), Warrants Granted">0.11</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue_c20210101__20211231_zdQxdo769Bwf" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Aggregate Intrinsic Value, Warrants Granted"><span style="-sec-ix-hidden: xdx2ixbrl2085">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_989_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_zzJbAKntdN1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Granted">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Exercised</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised_iN_di_c20210101__20211231_zdo0orbryGf1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Exercised">(7,148,501</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice_c20210101__20211231_zry9XLqxnS0i" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Exercised">2.74</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageExercisedRemainingContractualTerm_dtY_c20210101__20211231_zqqrA0F4l7M2" title="Weighted Average Remaining Contractual Term (Years), Warrants Exercised">0.78</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue_pdp0_c20210101__20211231_zDsHz0IJdTy3" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2095">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_984_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z6W7WmeflLN1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Exercised"><span style="-sec-ix-hidden: xdx2ixbrl2097">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Forfeited</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures_iN_di_c20210101__20211231_zBgkrECqwLei" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2099">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_ecustom--ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice_c20210101__20211231_zP2WiPEVmugd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2101">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue_c20210101__20211231_zLvywkze6143" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Forfeitures"><span style="-sec-ix-hidden: xdx2ixbrl2103">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue_c20210101__20211231_z7d0f6tj2BQ1" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Forfeiture"><span style="-sec-ix-hidden: xdx2ixbrl2105">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Outstanding — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber_iE_c20210101__20211231_z1lKzJA0Vfa7" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Outstanding Ending balance">10,019,127</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_980_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice_iE_c20210101__20211231_zzu5UasjvVah" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Outstanding Ending balance">5.21</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_902_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_z2O3G4mTsDM9" title="Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance">0.47</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue_iE_pdp0_c20210101__20211231_zYbF9NGwYTd8" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Outstanding Ending balance">6,779,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_986_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue1_c20210101__20211231_zVKxKXL3LKLe" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Outstanding Ending balance">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt">Vested and exercisable — December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingNumber_iI_c20211231_zDtj5S9xxkU6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Vested and Exercisable">9,719,127</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98A_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice_iI_c20211231_zNjncuFFV5eb" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Vested and Exercisable">5.22</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90C_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zHw4y4hq4iv8" title="Weighted Average Remaining Contractual Term (Years), Warrants Vested and exercisable Ending balance">0.41</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue_iI_pdp0_c20211231_zwZ1O66T5vN2" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Vested and Exercisable">6,779,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_ecustom--ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingVestedWeightedAverageGrantDateFairValue_c20210101__20211231_zigSDs5jIe7f" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable">1.70</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Unvested and non-exercisable - December 31, 2021</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares_iI_c20211231_zKin6DOlDVT3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Number of Shares, Warrants Unvested and Non-Exercisable">300,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_987_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue_iI_c20211231_zeuIsUCGCIk5" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable">4.75</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span id="xdx_90A_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm1_dtY_c20210101__20211231_zA8lY1bZgrH9" title="Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance">2.37</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedInstricticValue_iI_pdp0_c20211231_zxTQCvLXFbr4" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Aggregate Intrinsic Value, Warrants Unvested and Non Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2133">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_ecustom--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue_c20210101__20211231_zpp69YbQcJ2j" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable"><span style="-sec-ix-hidden: xdx2ixbrl2135">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> </div> 6237430 3.57 P2Y8M4D 7421054 2.63 P1Y9M25D 3929000 1.38 1073201 12585283 2.98 P1Y9M10D 4460000 1.38 12285283 2.94 P1Y8M26D 4460000 1.38 300000 4.75 P3Y4M13D 0 12585283 2.98 P1Y9M10D 4460000 1.38 4582345 7.48 P0Y1M9D 1.70 7148501 2.74 P0Y9M10D 10019127 5.21 P0Y5M19D 6779000 1.70 9719127 5.22 P0Y4M28D 6779000 1.70 300000 4.75 P2Y4M13D <p id="xdx_800_eus-gaap--RelatedPartyTransactionsDisclosureTextBlock_zzAYDg24NfEk" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>NOTE 23 – <span id="xdx_822_z35CmWLF2OVb">RELATED PARTY TRANSACTIONS</span></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b> </b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has subleased a suite at the Sofi Stadium in Los Angeles from an entity wholly owned by Christopher Miglino, our CEO. The sublease is for a period of one (<span id="xdx_904_eus-gaap--LesseeOperatingLeaseTermOfContract_iI_dtY_c20211231_zu7sdOpXrV2a" title="Lease term">1</span>) year, at a rate of $<span id="xdx_90D_eus-gaap--LeaseCost_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zr8xMWO1BXJl" title="Lease amount">382,500</span>, and commencing on the date that the stadium opens to the general public (“Sublease”). We believe that such annual rate is a discount from prevailing market rates and is less than the master lease rate. In September 2021, the Company started paying $<span id="xdx_90F_eus-gaap--PaymentsForRent_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zjwxxJbBKkwe">39,000</span> for the monthly lease payment for the 2<sup>nd </sup>year lease. The total amount paid during 2021 pursuant to the arrangement was $<span id="xdx_90E_eus-gaap--RepaymentsOfRelatedPartyDebt_c20210101__20211231__srt--TitleOfIndividualAxis__srt--ChiefExecutiveOfficerMember_zFfhBenE9kad" title="Related party payments">477,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Sublease entitles the Company to game tickets, optional tickets for other stadium events, and suite and conference room access during business days. The Company determined that the sublease agreement does not meet the definition of a lease in accordance with ASC 842, <i>Leases</i>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> P1Y 382500 39000 477000 <p id="xdx_800_eus-gaap--IncomeTaxDisclosureTextBlock_zjP0h2C4e3w1" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 24 – <span id="xdx_82A_zeOyHO3ijq94">INCOME TAXES</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCVrxuNppUxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax (benefit) expense from continuing operations for the year ended December 31, 2021 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zDalKUw1e2H3" style="display: none">SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Current</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deferred</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Federal</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CurrentFederalTaxExpenseBenefit_pdp0_c20210101__20211231_zyLp1kdJme1k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2149">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pdp0_c20210101__20211231_zUFuRk6OztLl" style="text-align: right">(132,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pdp0_c20210101__20211231_zN7mvNc0cHK7" style="text-align: right">(132,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; padding-bottom: 1.5pt">State</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_c20210101__20211231_zQTNMzvkHTpe" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">5,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pdp0_c20210101__20211231_zEldIUq4nqA4" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2153">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"/><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pp0p0_c20210101__20211231_z5hY5PHIesK3" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">5,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_pp0p0_c20210101__20211231_zXzPdyJYUtYd" style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_pdp0_c20210101__20211231_zrT4KnuBWhnk" style="text-align: right">(132,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--FederalStateAndLocalTaxExpenseBenefitContinuingOperations_pp0p0_c20210101__20211231_z3BjFePSTZWg" style="text-align: right">(127,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--CurrentValuationAllowance_pdp0_c20210101__20211231_zBXjzlFd1Ihf" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2158">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--DeferredValuationAllowance_pdp0_c20210101__20211231_z8zNR97yS0Lc" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2159">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ValuationAllowanceIncomeTaxBenefitContinuingOperations_pdp0_c20210101__20211231_zWc50SmCEEz1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--CurrentIncomeTaxExpenseBenefit_pp0p0_c20210101__20211231_zB4kyHJycH5c" style="border-bottom: Black 2.5pt double; text-align: right">5,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxExpenseBenefit_pdp0_c20210101__20211231_zIWOPqAOb0sl" style="border-bottom: Black 2.5pt double; text-align: right">(132,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20210101__20211231_zMPzfOnindIg" style="border-bottom: Black 2.5pt double; text-align: right">(127,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense from continuing operations for the year ended December 31, 2020 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deferred</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Federal"><span style="-sec-ix-hidden: xdx2ixbrl2165">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Federal"><span style="-sec-ix-hidden: xdx2ixbrl2167">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; padding-bottom: 1.5pt">State</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Current State">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Deferred State"><span style="-sec-ix-hidden: xdx2ixbrl2173">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="State">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Subtotal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_c20200101__20201231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Subtotal">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl2179">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--FederalStateAndLocalTaxExpenseBenefitContinuingOperations_c20200101__20201231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subtotal">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--CurrentValuationAllowance_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Valuation allowance"><span style="-sec-ix-hidden: xdx2ixbrl2183">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--DeferredValuationAllowance_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Valuation allowance"><span style="-sec-ix-hidden: xdx2ixbrl2185">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ValuationAllowanceIncomeTaxBenefitContinuingOperations_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="-sec-ix-hidden: xdx2ixbrl2187">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Total">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxExpenseBenefit_c20200101__20201231_pdp0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Total"><span style="-sec-ix-hidden: xdx2ixbrl2191">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_8A9_zvR0B7BXOoY" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zHZCEhcfai84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="text-transform: uppercase"><span id="xdx_8B6_zgvMeg9jaM43" style="display: none">SCHEDULE OF EFFECTIVE TAX RATE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20200101_20201231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20190101_20191231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zl9tm3D8JqU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Taxes calculated at federal rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_iN_pid_dpi_uPure_zKSREEth4xQ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences_pid_dp_uPure_zoVwuFibFdQ" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(13.4</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_uPure_zXZ7khZXt9if" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(15.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationFairMarketAdjustmentDerivatives_pid_dp_uPure_zTPfHEBb3vak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair market adjustment derivatives</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iN_pid_dpi_uPure_zOftX5Gx73mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prior year true-ups</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_iN_pid_dpi_uPure_zVsE6KkOP0vc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other adjustments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4.1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iN_pid_dpi_uPure_zao1Z2En8LRk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Provision for income tax benefit (expense)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.8</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(0.1</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)%</td></tr> </table> <p id="xdx_8A0_z75vfPJSYjOj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zS5qfJ3EYY15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effects, rounded to thousands, of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at December 31, are presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_8BA_zuO7YkpNALOl" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20201231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20191231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_z5eKLT4fiQg2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzqKj_z7kok0WlC6y5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Net operating loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">10,003,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9,040,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--DeferredTaxAssetsTaxDeferredExpenseBadDebtExpenses_iI_pp0p0_maDTAGzqKj_z6g8iFfslIOk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Bad debt expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">136,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iI_pp0p0_maDTAGzqKj_zUGv67lhOyA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2232">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">9,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzqKj_zsZ3m36Wxx13" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2235">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2236">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzqKj_zuotmkNk5rOj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">525,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">567,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_maDTAGzqKj_zbZ1vIHuau51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Interest expense limitation carryover</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">220,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">629,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DeferredTaxAssetsContributionCarryover_iI_pp0p0_maDTAGzqKj_zCqX0XQ61qPa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Contribution carryover</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">5,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsLeaseLiability_iI_pp0p0_maDTAGzqKj_zSHn51QlIUx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Lease liability</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">97,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_iI_pp0p0_zqxJHvnQVudd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Unrealized gain on marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,668,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">120,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_maDTAGzqKj_zGawozv7Edy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other accruals</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">124,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">173,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzqKj_maDTANzW9r_ztPD4bkix744" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,640,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,776,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zv6fmLZBxPf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxLiabilitiesFixedAssets_iNI_pp0p0_maDITLzNhQ_zvw338YVRYLb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(29,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2263">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/></tr> <tr id="xdx_409_ecustom--DeferredTaxLiabilitiesRightofuseAsset_iNI_pp0p0_maDITLzNhQ_zIl9JZgB7Cmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Right-of-use asset</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(66,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(101,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pp0p0_di_maDITLzNhQ_zcRmSQ2gvOLb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intangibles</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(455,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(690,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DeferredTaxLiabilitiesInterestExpenseLimitationCarryover_iI_pp0p0_z7PeERkAKI9i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Interest expense limitation carryover</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(59,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2272">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_pp0p0_di_maDITLzNhQ_zVgkDFsRply3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(15,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(17,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzNhQ_msDTANzW9r_zfhU8Rp4w6p9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(624,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(808,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzW9r_maDTALNzZ2J_zD12lD9JJ4va" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,016,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,968,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzZ2J_zlJSxXpF1IFf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(13,016,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,968,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzZ2J_zX8dp4qYIxY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax / (liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2286">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2287">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8A2_zjVkwcoGeMJb" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Deferred tax assets and liabilities are computed by applying the federal and state income tax rates in effect to the gross amounts of temporary differences and other tax attributes, such as net operating loss carry-forwards. In assessing if the deferred tax assets will be realized, the Company considers whether it is more likely than not that some or all of these deferred tax assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the period in which these deductible temporary differences reverse.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">During the years ended December 31, 2021 and 2020, the valuation allowance increased by $<span id="xdx_90C_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20200101__20201231_pp0p0">2,996,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_90D_eus-gaap--ValuationAllowanceDeferredTaxAssetChangeInAmount_c20190101__20191231_pp0p0">2,375,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively. The increase for both years was attributable to the increase in our net operating loss carryforwards. The total valuation allowance results from the Company’s estimate of its inability to recover its net deferred tax assets.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">At December 31, 2021, the Company has federal and state net operating loss carry forwards, <span id="xdx_905_eus-gaap--OperatingLossCarryforwardsLimitationsOnUse_dd_c20200101__20201231_zeEGG2OEjm7a">which are available to offset future taxable income, of approximately $</span></span><span id="xdx_90C_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsDomestic_iI_pp0p0_c20201231_zn6dwgBh1y5g" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">34,933,000 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_906_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal_iI_pp0p0_c20201231_zLTOVo6TB8Z9">73,733,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">respectively, both of which begin to expire in 2032 and 2032 respectively. These carry forwards may be subject to an annual limitation under Section 382 and 383 of the Internal Revenue Code of 1986, and similar state provisions if the Company experienced one or more ownership changes which would limit the amount of NOL and tax credit carryforwards that can be utilized to offset future taxable income and tax, respectively. In general, an ownership change, as defined by Section 382 and 383, results from transactions increasing ownership of certain stockholders or public groups in the stock of the corporation by more than 50 percentage points over a three-year period. The Company has not completed an IRC Section 382/383 analysis. If a change in ownership were to have occurred, NOL and tax credit carryforwards could be eliminated or restricted. If eliminated, the related asset would be removed from the deferred tax asset schedule with a corresponding reduction in the valuation allowance. Due to the existence of the valuation allowance, limitations created by future ownership changes, if any, will not impact the Company’s effective tax rate.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company files income tax returns in the United States and various state jurisdictions. Due to the Company’s net operating loss posture all tax years are open and subject to income tax examination by tax authorities. The Company’s policy is to recognize interest expense and penalties related to income tax matters as tax expense. As of December 31, 2021 and 2020, there are <span id="xdx_903_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_pdp0_do_c20210101__20211231_zsJ5RrFcKI0a"><span id="xdx_907_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense_pdp0_do_c20200101__20201231_zI7M5b5HDHvi">no</span> </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">unrecognized tax benefits, and there are <span id="xdx_90A_eus-gaap--UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued_iI_pdp0_do_c20191231_zxuN4t9uJ2Za">no </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">significant accruals for interest related to unrecognized tax benefits or tax penalties.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span id="xdx_90B_ecustom--NolCarryforwardsDescription_c20200101__20201231_zIzSvc5aU3ai" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company is in the process of analyzing their NOL and has not determined if the company has had any change of control issues that could limit the future use of NOL. NOL carryforwards that were generated after 2017 of approximately $</span><span id="xdx_90B_eus-gaap--OperatingLossCarryforwards_iI_pn5n6_c20211231_zKzloOxWRWq7" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">29.4 </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">million may only be used to offset 80% of taxable income and are carried forward indefinitely</span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b/></span></p> <p id="xdx_891_eus-gaap--ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock_zCVrxuNppUxj" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax (benefit) expense from continuing operations for the year ended December 31, 2021 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B7_zDalKUw1e2H3" style="display: none">SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Current</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Deferred</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td><td style="text-align: center; font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: center">Total</td><td style="text-align: center; padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Federal</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--CurrentFederalTaxExpenseBenefit_pdp0_c20210101__20211231_zyLp1kdJme1k" style="text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2149">—</span></td><td style="text-align: left"> </td><td> </td> <td style="text-align: left">$</td><td id="xdx_98D_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_pdp0_c20210101__20211231_zUFuRk6OztLl" style="text-align: right">(132,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left">$</td><td id="xdx_981_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_pdp0_c20210101__20211231_zN7mvNc0cHK7" style="text-align: right">(132,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="width: 52%; padding-bottom: 1.5pt">State</td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_982_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_pp0p0_c20210101__20211231_zQTNMzvkHTpe" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">5,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_pdp0_c20210101__20211231_zEldIUq4nqA4" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2153">—</span></td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"/><td style="width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td id="xdx_986_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_pp0p0_c20210101__20211231_z5hY5PHIesK3" style="border-bottom: Black 1.5pt solid; width: 12%; text-align: right">5,000</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"/></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Subtotal</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98F_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_pp0p0_c20210101__20211231_zXzPdyJYUtYd" style="text-align: right">5,000</td><td style="text-align: left"> </td><td> </td> <td style="text-align: left"> </td><td id="xdx_981_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_pdp0_c20210101__20211231_zrT4KnuBWhnk" style="text-align: right">(132,000</td><td style="text-align: left">)</td><td> </td> <td style="text-align: left"> </td><td id="xdx_98D_ecustom--FederalStateAndLocalTaxExpenseBenefitContinuingOperations_pp0p0_c20210101__20211231_z3BjFePSTZWg" style="text-align: right">(127,000</td><td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_982_ecustom--CurrentValuationAllowance_pdp0_c20210101__20211231_zBXjzlFd1Ihf" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2158">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_98C_ecustom--DeferredValuationAllowance_pdp0_c20210101__20211231_z8zNR97yS0Lc" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2159">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td id="xdx_989_ecustom--ValuationAllowanceIncomeTaxBenefitContinuingOperations_pdp0_c20210101__20211231_zWc50SmCEEz1" style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2160">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 2.5pt">Total</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_984_eus-gaap--CurrentIncomeTaxExpenseBenefit_pp0p0_c20210101__20211231_zB4kyHJycH5c" style="border-bottom: Black 2.5pt double; text-align: right">5,000</td><td style="padding-bottom: 2.5pt; text-align: left"> </td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxExpenseBenefit_pdp0_c20210101__20211231_zIWOPqAOb0sl" style="border-bottom: Black 2.5pt double; text-align: right">(132,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td><td style="padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; text-align: left">$</td><td id="xdx_983_eus-gaap--IncomeTaxExpenseBenefit_pp0p0_c20210101__20211231_zMPzfOnindIg" style="border-bottom: Black 2.5pt double; text-align: right">(127,000</td><td style="padding-bottom: 2.5pt; text-align: left">)</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Income tax expense from continuing operations for the year ended December 31, 2020 consisted of the following:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"/> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Current</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Deferred</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Federal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_980_eus-gaap--CurrentFederalTaxExpenseBenefit_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Federal"><span style="-sec-ix-hidden: xdx2ixbrl2165">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_985_eus-gaap--DeferredFederalIncomeTaxExpenseBenefit_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Federal"><span style="-sec-ix-hidden: xdx2ixbrl2167">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_988_eus-gaap--FederalIncomeTaxExpenseBenefitContinuingOperations_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Federal"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2169">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 52%; padding-bottom: 1.5pt">State</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_983_eus-gaap--CurrentStateAndLocalTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Current State">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_980_eus-gaap--DeferredStateAndLocalIncomeTaxExpenseBenefit_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Deferred State"><span style="-sec-ix-hidden: xdx2ixbrl2173">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td id="xdx_98B_eus-gaap--StateAndLocalIncomeTaxExpenseBenefitContinuingOperations_c20200101__20201231_pp0p0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="State">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif">Subtotal</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--CurrentFederalStateAndLocalTaxExpenseBenefit_c20200101__20201231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Subtotal">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98E_eus-gaap--DeferredFederalStateAndLocalTaxExpenseBenefit_c20200101__20201231_pdp0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Subtotal"><span style="-sec-ix-hidden: xdx2ixbrl2179">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98B_ecustom--FederalStateAndLocalTaxExpenseBenefitContinuingOperations_c20200101__20201231_pp0p0" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Subtotal">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_982_ecustom--CurrentValuationAllowance_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Valuation allowance"><span style="-sec-ix-hidden: xdx2ixbrl2183">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98D_ecustom--DeferredValuationAllowance_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Valuation allowance"><span style="-sec-ix-hidden: xdx2ixbrl2185">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_987_ecustom--ValuationAllowanceIncomeTaxBenefitContinuingOperations_c20200101__20201231_pdp0" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Valuation allowance"><span style="-sec-ix-hidden: xdx2ixbrl2187">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt">Total</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_986_eus-gaap--CurrentIncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Current Total">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_989_eus-gaap--DeferredIncomeTaxExpenseBenefit_c20200101__20201231_pdp0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Deferred Total"><span style="-sec-ix-hidden: xdx2ixbrl2191">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98E_eus-gaap--IncomeTaxExpenseBenefit_c20200101__20201231_pp0p0" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total">21,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> -132000 -132000 5000 5000 5000 -132000 -127000 5000 -132000 -127000 21000 21000 21000 21000 21000 21000 <p id="xdx_892_eus-gaap--ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock_zHZCEhcfai84" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A reconciliation of the federal statutory income tax rate to the Company’s effective income tax rate is as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="text-transform: uppercase"><span id="xdx_8B6_zgvMeg9jaM43" style="display: none">SCHEDULE OF EFFECTIVE TAX RATE</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20200101_20201231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49C_20190101_20191231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_408_eus-gaap--EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate_pid_dp_uPure_zl9tm3D8JqU9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: left">Taxes calculated at federal rate</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">21.0</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</td></tr> <tr id="xdx_402_eus-gaap--EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost_iN_pid_dpi_uPure_zKSREEth4xQ1" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2.7</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences_pid_dp_uPure_zoVwuFibFdQ" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Permanent differences</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(1.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(13.4</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_407_eus-gaap--EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance_iN_pid_dpi_uPure_zXZ7khZXt9if" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Change in valuation allowance</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(15.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(2.1</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_40E_ecustom--EffectiveIncomeTaxRateReconciliationFairMarketAdjustmentDerivatives_pid_dp_uPure_zTPfHEBb3vak" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Fair market adjustment derivatives</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.5</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes_iN_pid_dpi_uPure_zOftX5Gx73mg" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Prior year true-ups</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">0.0</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(3.3</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)%</td></tr> <tr id="xdx_40A_eus-gaap--EffectiveIncomeTaxRateReconciliationOtherAdjustments_iN_pid_dpi_uPure_zVsE6KkOP0vc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Other adjustments</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(4.1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(0.1</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)%</td></tr> <tr id="xdx_406_eus-gaap--EffectiveIncomeTaxRateContinuingOperations_iN_pid_dpi_uPure_zao1Z2En8LRk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Provision for income tax benefit (expense)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">0.8</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">%</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(0.1</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left">)%</td></tr> </table> 0.210 0.210 -0.000 0.027 -0.010 -0.134 0.151 0.021 0.000 0.005 -0.000 0.033 0.041 0.001 -0.008 0.001 <p id="xdx_89A_eus-gaap--ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock_zS5qfJ3EYY15" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The tax effects, rounded to thousands, of temporary differences that give rise to significant portions of the deferred tax assets and liabilities at December 31, are presented below:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt; text-transform: uppercase"><span id="xdx_8BA_zuO7YkpNALOl" style="display: none">SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_494_20201231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20191231" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGrossAbstract_iB_z5eKLT4fiQg2" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_405_eus-gaap--DeferredTaxAssetsOperatingLossCarryforwards_iI_pp0p0_maDTAGzqKj_z7kok0WlC6y5" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; width: 68%; text-align: left">Net operating loss carryforwards</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">10,003,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">9,040,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr id="xdx_404_ecustom--DeferredTaxAssetsTaxDeferredExpenseBadDebtExpenses_iI_pp0p0_maDTAGzqKj_z6g8iFfslIOk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Bad debt expense</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">33,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">136,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsPropertyPlantAndEquipment_iI_pp0p0_maDTAGzqKj_zUGv67lhOyA7" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2232">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">9,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities_iI_pp0p0_maDTAGzqKj_zsZ3m36Wxx13" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Accrued interest</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2235">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2236">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_402_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost_iI_pp0p0_maDTAGzqKj_zuotmkNk5rOj" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Stock based compensation</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">525,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">567,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetInterestCarryforward_iI_pp0p0_maDTAGzqKj_zbZ1vIHuau51" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Interest expense limitation carryover</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">220,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">629,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_401_ecustom--DeferredTaxAssetsContributionCarryover_iI_pp0p0_maDTAGzqKj_zCqX0XQ61qPa" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Contribution carryover</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">5,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">5,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_ecustom--DeferredTaxAssetsLeaseLiability_iI_pp0p0_maDTAGzqKj_zSHn51QlIUx8" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Lease liability</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">62,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">97,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross_iI_pp0p0_zqxJHvnQVudd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Unrealized gain on marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">2,668,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">120,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther_iI_pp0p0_maDTAGzqKj_zGawozv7Edy9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Other accruals</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">124,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">173,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr id="xdx_404_eus-gaap--DeferredTaxAssetsGross_iTI_pp0p0_mtDTAGzqKj_maDTANzW9r_ztPD4bkix744" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">13,640,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">10,776,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--DeferredTaxLiabilitiesAbstract_iB_zv6fmLZBxPf9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_ecustom--DeferredTaxLiabilitiesFixedAssets_iNI_pp0p0_maDITLzNhQ_zvw338YVRYLb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Fixed assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(29,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2263">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"/></tr> <tr id="xdx_409_ecustom--DeferredTaxLiabilitiesRightofuseAsset_iNI_pp0p0_maDITLzNhQ_zIl9JZgB7Cmk" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left">Right-of-use asset</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(66,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><p style="margin: 0">(101,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_407_eus-gaap--DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets_iNI_pp0p0_di_maDITLzNhQ_zcRmSQ2gvOLb" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Intangibles</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(455,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(690,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td></tr> <tr id="xdx_402_ecustom--DeferredTaxLiabilitiesInterestExpenseLimitationCarryover_iI_pp0p0_z7PeERkAKI9i" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt">Interest expense limitation carryover</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">(59,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2272">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_400_eus-gaap--DeferredTaxLiabilitiesPrepaidExpenses_iNI_pp0p0_di_maDITLzNhQ_zVgkDFsRply3" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 10pt; text-align: left; padding-bottom: 1.5pt">Prepaid expenses</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(15,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(17,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr id="xdx_408_eus-gaap--DeferredIncomeTaxLiabilities_iNTI_pp0p0_di_mtDITLzNhQ_msDTANzW9r_zfhU8Rp4w6p9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-left: 20pt; text-align: left; padding-bottom: 1.5pt">Total Deferred Tax Liabilities</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(624,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(808,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsNet_iTI_pp0p0_mtDTANzW9r_maDTALNzZ2J_zD12lD9JJ4va" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Net Deferred Tax Assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">13,016,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">9,968,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40F_eus-gaap--DeferredTaxAssetsValuationAllowance_iNI_pp0p0_di_msDTALNzZ2J_zlJSxXpF1IFf" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Valuation Allowance</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(13,016,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">(9,968,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr id="xdx_40D_eus-gaap--DeferredTaxAssetsLiabilitiesNet_iTI_pp0p0_mtDTALNzZ2J_zX8dp4qYIxY9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Net deferred tax / (liabilities)</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2286">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2287">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 10003000 9040000 33000 136000 9000 525000 567000 220000 629000 5000 5000 62000 97000 2668000 120000 124000 173000 13640000 10776000 -29000 -66000 -101000 455000 690000 -59000 15000 17000 624000 808000 13016000 9968000 13016000 9968000 2996000 2375000 which are available to offset future taxable income, of approximately $ 34933000 73733000 0 0 0 The Company is in the process of analyzing their NOL and has not determined if the company has had any change of control issues that could limit the future use of NOL. NOL carryforwards that were generated after 2017 of approximately $ 29400000 <p id="xdx_809_eus-gaap--FairValueDisclosuresTextBlock_zqbjbuCCNZO6" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 25 – <span id="xdx_822_zoOcxUfAnZdg" style="font-variant: small-caps">FAIR VALUE OF FINANCIAL INSTRUMENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 27.8pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The carrying amounts of certain financial instruments, including cash and cash equivalents and accounts payable and accrued expenses, approximate their respective fair values due to the short-term nature of such instruments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Additionally, the Company has a deferred note receivable with a notional amount of $<span id="xdx_902_eus-gaap--NotesReceivableFairValueDisclosure_iI_c20211231_zpwiwqr2gzT2">1,000,000</span>. The deferred payments of $<span id="xdx_90B_ecustom--DeferredPaymentFairValue_c20210101__20211231_z0uzz9If3sRk" title="Deferred payment fair value">960,000</span> and $<span id="xdx_90B_eus-gaap--DebtInstrumentFairValue_iI_c20211231_zWhBgGQZxYKk" title="Corporate debt">40,000</span> were discounted using the yield on a CCC rated corporate debt for 3-year maturity. The implied discount is approximately $<span id="xdx_905_eus-gaap--AmortizationOfFinancingCostsAndDiscounts_c20210101__20211231_zFjfcx1N3p28" title="Implied discount">107,000</span>, which will be amortized over 3 years. Notes receivable as of December 31, 2021 and 2020 amounted to $<span id="xdx_90D_eus-gaap--FairValueConcentrationOfRiskNotesReceivable_iI_c20211231_z1NsDRFWxJo4" title="Fair value notes receivable">935,000</span> and $<span id="xdx_90D_eus-gaap--FairValueConcentrationOfRiskNotesReceivable_iI_c20201231_zcDnhEtjKBn4" title="Fair value notes receivable">893,000</span>, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 20.4pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Assets and Liabilities Measured at Fair Value on a Recurring Basis</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company evaluates its financial assets and liabilities subject to fair value measurements on a recurring basis to determine the appropriate level in which to classify them for each reporting period. This determination requires significant judgments to be made. The Company had the following financial assets and liabilities as of December 31, 2021 and 2020:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_891_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zSbP4CQ476D8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zPWZTIR2PSkf" style="display: none">SCHEDULE OF ASSETS MEASURED AT FAIR VALUE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Quoted Prices</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Significant</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Balance as of</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">in Active <br/> Markets for</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other<br/> Observable</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Significant<br/> Unobservable</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Identical Assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Inputs</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Inputs</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Level 1)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Level 2)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Level 3)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>Assets:</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">Marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zObhNM7xuG07" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">15,617,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zyQmdO3x3bO5" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">6,134,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zpSy8oaxoZm4" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">2,448,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_z8wpENv95SQ7" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">7,035,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Designated assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember_zPLPbNSJNhma" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbAgFCO61Fib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">259,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbMc1iM1NUQa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">3,666,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvGxe07BwXPd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl2328">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contract assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember_z3OZNqVLL1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0">844,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKZztQospIh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl2330">—</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvVMgdts8HQb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2331">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzD6idZmvVrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">844,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231_zEUOYJTbf18f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">20,386,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAWPDauHOymb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">6,393,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlIPLeGrRHWl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">6,114,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdrqVGMLwQpe" style="margin: 0" title="Total assets">7,879,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted Prices</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<br/> Observable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Unobservable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identical Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"/><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>Assets:</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zEb2Z2Jb3Hlc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,447,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zUqDfUcqjOJ2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,764,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zG8ruGj6MSp2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zchvjQ8QlpRe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231_zvSuMN3DVnYk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,447,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zW5SwldJz9q3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,764,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4wdkQD0d9O8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEquRlrYQM1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2356">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p id="xdx_8A9_zyNlSV9u6nBh" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">The Contract assets represent a forward contractual right of to receive securities pursuant to a revenue contract. As of December 31, 2021, the Company determined the value of the securities underlying the Contract asset to have a fair value of $<span id="xdx_90A_ecustom--ContractsReceivable_iI_c20211231_zyKHlJ2thFK3" title="Contracts asset">844,000</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zqOoqtNXIpci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <span id="xdx_8B1_zK1XZqeObnb9" style="display: none">SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z10GG0Hd7K3a" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 1</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLeod9MKGWq9" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 2</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbYzdPoT42dc" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 3</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20221231_zWkaQR5u0AUd" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Fair Value</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>As of Dec. 31, 2021</b></span><b> <span style="color: #222222"> </span></b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 1</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 2</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; color: #222222; font-weight: bold">Level 3</td><td style="padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Liabilities:</td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBooQtZhCs31" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; width: 40%; text-align: left">Series A Preferred Stock</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2362">—</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2364">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_zWP772ZlXSgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2367">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9o9igrWBYue" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 1</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zY9hQ1w7b8bf" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 2</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcgLNLBDBhQ5" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 3</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20211231_zSrfvzDnoT8c" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Fair Value</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>As of December 31, 2020 </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 1</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 2</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 3</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Liabilities:</td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z4wmS8dvYEz" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; width: 40%; text-align: left">Series A Preferred Stock</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2372">—</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; color: #222222; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2373">—</span></td><td style="padding-bottom: 1.5pt; width: 1%; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; color: #222222; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl2374">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_zIT1eVuVRwwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2377">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2378">—</span></td><td style="padding-bottom: 1.5pt; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2379">-</span></td><td style="padding-bottom: 1.5pt; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"> <span style="-sec-ix-hidden: xdx2ixbrl2380">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p id="xdx_8AB_zfZXUYzUIZP4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="letter-spacing: 0.2pt"><b><i>Changes in level 3 assets measured at fair value</i></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_899_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zLSKN9jxhNA" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #222222">The following table presents additional information about Level 3 assets measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of assets classified within the Level 3 category. As a result, the unrealized gains and losses for the assets and liabilities within the Level 3 category may include changes in fair value that were attributable to both observable and unobservable inputs. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Changes in Level 3 assets measured at fair value for the year ended December 31, 2021 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_z0ZEsBgi9G46" style="display: none">SCHEDULE OF FAIR VALUE AT ASSETS</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 7pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning<br/> Balance January 1, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales and dispositions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">Transfers into</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_F53_zPwSNqt20Sgc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfers out of Level 3 (a)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_F5D_zxuFS0zmf05a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized &amp;<br/> Unrealized Gains (Losses)(b)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending Balance Dec 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stocks</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zEE7zoi5qJC2" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2383">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zgNXS8rOXFcj" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zb1motLQ9ntb" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2385">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zy0kGDe2pht4" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_iN_di_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_fYi4___z7l7eYGF9Ajj" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(534,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_fYS4___zYninpceD4Ac" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(377,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zJgpyETX85d" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,154,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zdAU7RmYePSf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2390">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zpLLo5hxwo8a" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,267,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zcBFVwXyDOSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2392">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_z5GrLa1OD1H8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">410,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_iN_di_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_fYi4___zRtS7kM2D7x6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(213,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_fYS4___zXSgPXHSyJec" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(278,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zIb2N3lP3bjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,186,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zoArFp1hqKLl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_z49GE2REVdo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2398">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zGX2v6SDjcJk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zO01mWDKkQJj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_fYi4___zyIsQr6Iybcl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2401">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_fYS4___zoIu7cp0nMC3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zy8PzxFhI8d3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred stocks</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zg9uGOd0mCVf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2404">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zyWHlYo9f4kg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zCZnVCR8DfW6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zx2JHDrhWiZ8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_fYi4___z5h6F04N0m01" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2408">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_fYS4___zcWN7D6N3tPe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(422,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zsAsDFAof2tc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">599,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Investments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231_zUzY5ufXAJeb" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2412">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231_z792IkncMzs8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisitions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,963,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231_za7yJ9JrTRq7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sales and dispositions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231_zuMRQXsVF67c" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transfers intoLevel 3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_iN_di_c20210101__20211231_fYi4___z4VRGqPh8Ukf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transfers out of Level 3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(747,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231_fYS4___z092cAGmKjZf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Realized &amp; Unrealized Gains (Losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(981,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231_zo8KfkqjHVdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,035,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td id="xdx_F0F_zex55tmzePs5" style="text-align: left; width: 0.25in">a.</td><td id="xdx_F10_zOZwgfcilNce" style="text-align: justify">Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital.</td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: left"> </td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: left"><span id="xdx_F08_zy3SLj3Ah0x8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="text-align: justify"><span id="xdx_F1D_zWIlKIJFSyl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations.</span></td> </tr> </table> <p id="xdx_8A0_z2laf2dEsBK6" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><b><i>Valuation processes for Level 2 and 3 Fair Value Measurements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify">Fair value measurement of certain of our marketable securities fall within Level 2 and 3 of the fair value hierarchy. The fair value measurements are evaluated by management to ensure that changes are consistent with expectations of management based upon the sensitivity and nature of the inputs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company classifies certain assets as Level 3 assets if the estimated fair value was derived from level 3 inputs. The Company utilizes a put option pricing model to arrive at a discount for lack of marketability and liquidity associated with restrictions on sales into the public market. The Company generally classifies restricted securities in public companies as level 2, however in circumstances where the observed level of liquidity is low and the quoted market price is deemed unreliable they may be categorized in Level 3 of the fair value hierarchy. The Company considers marketable securities without sufficient liquidity to sell within 6 months of the date of acquisition and securities that will not be eligible for resale in the public markets through Rule 144 for 1 year from the date acquisition to be valued with Level 2 inputs.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt/12.5pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="letter-spacing: 0.2pt">The fair value of the Company’s Series A Preferred Stock may change significantly, impacting the Company’s assumptions used to estimate its fair value. The valuation of the Series A Preferred Stock is primarily based on the valuation of its underlying marketable securities. The marketable securities that are underlying the Series A Preferred Stock are classified as Designated Assets on the Company’s balance sheet and include Level 1 and Level 2 marketable securities and cash. </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table lists the significant unobservable inputs used to value assets classified as Level 3 of December 31, 2021. The table is not intended to be all-inclusive, but instead identifies the significant unobservable inputs relevant to the determination of fair values. The other Level 3 assets have been valued using unadjusted third-party transactions and, unadjusted historical third-party information, or the unadjusted net asset values of the securities’ issuer. No unobservable inputs internally developed by the Company have been applied to these assets, and therefore are omitted from the following table.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zZQZ8bYyat1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zKuZRCvk9G4f" style="display: none">SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation technique</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable inputs</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Range</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stocks</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Put option pricing model </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount for lack of marketability</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zyp1A3utwbKe" title="Range">0</span>% - <span id="xdx_903_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_zzk8s2jbMuIb" title="Range">54</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible preferred stock</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Put option pricing model </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount for lack of marketability</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zluXoYfZfBF4">0</span>% - <span id="xdx_90A_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_zVdQbH7c2Big">54</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Convertible Debt </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Discounted cash flow </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueDiscountedCashFlowMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MinimumMember_zoybfltNepG7">0</span> - <span id="xdx_905_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueDiscountedCashFlowMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MaximumMember_zRmJ1W8BhWz4" title="Range, maturity">35</span> months</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk adjusted discount factor</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueDiscountedCashFlowMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zRu4Eh67FwA5">26</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option pricing model</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zU891zf08lra">100</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_z62RAtQRPSq4">0.78</span> % <span id="xdx_90F_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zWEp8je8mj7k">1.04</span>% </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zfBP9Qji5HCg">0</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time to maturity</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MinimumMember_zNjqa2ECUHeh">0</span> - <span id="xdx_90F_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MaximumMember_zSLpejtLvck2">35</span> months </span></td></tr> </table> <p id="xdx_8AE_z09tSsdnmsSe" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"><b><i>Sensitivity of Level 3 measurements to changes in significant unobservable inputs</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The process of estimating the fair value of securities without active markets involves significant estimates and judgement on behalf of management. These estimated fair values may not be realized in a current sale or immediate settlement of the asset or liability. Additionally, there are inherent uncertainties in any fair value measurement techniques, and changes in the underlying assumptions used could significantly affect the fair value measurement amounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0 0 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Changes in each of these significant unobservable valuation inputs will impact the fair value measurement of the financial instrument generally as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; background-color: white"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An increase or decrease in the volatility of the common stock that underlies our holdings in convertible debt would result in a directionally similar change in the estimated fair value.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An increase or decrease in the risk-free interest rate or risk adjusted discount factor would result in an inverse change in the estimated fair value of our convertible debt.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An increase in the dividend yield would increase the estimated value of the convertible debt.</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"/><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">A change in the maturity may result in either an increase or decrease in estimated fair value of the convertible debt.</span></td></tr><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">●</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">An increase or decrease in the discount for lack of marketability of our common stock holdings and the common stock that underlies our preferred stock would generally result in an inverse change in the estimated fair value.</span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Instruments for which unobservable inputs are significant to their fair value measurement (i.e., Level 3) include securities in which we deem their market to be inactive or unreliable. The Company reviews and updates the fair value hierarchy classifications on a quarterly basis. Changes from one quarter to the next that are related to the observable inputs to a fair value measurement may result in a reclassification from one hierarchy level to another.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Valuation technique refinements</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the year-ended December 31, 2021, the Company refined its valuation techniques to enhance consideration of unobservable inputs for the valuation of Level 2 and Level 3 marketable securities.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If quoted market prices are not available for the specific security, or if the observed quoted market price is deemed unreliable, then fair values are estimated by using pricing models, considering third-party transactions, unadjusted historical third-party information, and the unadjusted net asset values of the issuer. The pricing models primarily use market-based or independently sourced market parameters as inputs, including, but not limited to, yield curves, interest rates, equity or debt prices, and credit spreads. In addition to market information, models also incorporate transaction details, such as maturity and cash flow assumptions. Securities valued in this manner would generally be classified within Level 2 and Level 3 of the valuation hierarchy and primarily include such instruments as convertible debt.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The methods described above may produce a fair value calculation that may not be indicative of net realizable value or reflective of future fair values. Furthermore, while the Company believes its valuation methods are appropriate and consistent with those of other market participants, the use of different methodologies or assumptions to determine the fair value of certain financial instruments could result in a different estimate of fair value at the reporting date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> 1000000 960000 40000 107000 935000 893000 <p id="xdx_891_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisTextBlock_zSbP4CQ476D8" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BC_zPWZTIR2PSkf" style="display: none">SCHEDULE OF ASSETS MEASURED AT FAIR VALUE</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Quoted Prices</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Significant</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Balance as of</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">in Active <br/> Markets for</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Other<br/> Observable</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Significant<br/> Unobservable</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">December 31</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Identical Assets</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Inputs</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center">Inputs</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0"/></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Level 1)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Level 2)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">(Level 3)</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>Assets:</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; width: 28%; text-align: left">Marketable securities</td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zObhNM7xuG07" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">15,617,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_984_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zyQmdO3x3bO5" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">6,134,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zpSy8oaxoZm4" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">2,448,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">$</td><td id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_z8wpENv95SQ7" style="font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets">7,035,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left">Designated assets</td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember_zPLPbNSJNhma" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">3,925,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zbAgFCO61Fib" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">259,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zbMc1iM1NUQa" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">3,666,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_985_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--DesignatedAssetsMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zvGxe07BwXPd" style="font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="-sec-ix-hidden: xdx2ixbrl2328">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt">Contract assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember_z3OZNqVLL1i" style="font: 10pt Times New Roman, Times, Serif; margin: 0">844,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_98B_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zKZztQospIh5" style="font: 10pt Times New Roman, Times, Serif; margin: 0"><span style="-sec-ix-hidden: xdx2ixbrl2330">—</span></p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zvVMgdts8HQb" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2331">—</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--ContractsReceivableMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zzD6idZmvVrd" style="font: 10pt Times New Roman, Times, Serif; margin: 0">844,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 2.5pt">Total assets</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_983_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231_zEUOYJTbf18f" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">20,386,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zAWPDauHOymb" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">6,393,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zlIPLeGrRHWl" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets">6,114,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><p id="xdx_98C_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20211231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zdrqVGMLwQpe" style="margin: 0" title="Total assets">7,879,000</p></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Quoted Prices</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Balance as of</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>in Active</b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Markets for</b></span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Other<br/> Observable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Significant Unobservable</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">December 31,</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Identical Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Inputs</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"/><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2020</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 1)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 2)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Level 3)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><b>Assets:</b></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td> <td colspan="2" style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: center"> </td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 28%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Marketable securities</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zEb2Z2Jb3Hlc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 14%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,447,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zUqDfUcqjOJ2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 18%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,764,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zG8ruGj6MSp2" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--InvestmentTypeAxis__custom--MarketableSecuritiesMember_zchvjQ8QlpRe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2348">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total assets</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231_zvSuMN3DVnYk" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">8,447,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zW5SwldJz9q3" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,764,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_z4wdkQD0d9O8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">683,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--AssetsFairValueDisclosure_iI_pp0p0_c20201231__us-gaap--FairValueByMeasurementFrequencyAxis__us-gaap--FairValueMeasurementsRecurringMember__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zCEquRlrYQM1" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Total assets"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2356">—</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> 15617000 6134000 2448000 7035000 3925000 259000 3666000 844000 844000 20386000 6393000 6114000 7879000 8447000 7764000 683000 8447000 7764000 683000 844000 <p id="xdx_89D_eus-gaap--FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock_zqOoqtNXIpci" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> <span id="xdx_8B1_zK1XZqeObnb9" style="display: none">SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE</span> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_490_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z10GG0Hd7K3a" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 1</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_491_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zLeod9MKGWq9" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 2</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20221231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member_zbYzdPoT42dc" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 3</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49A_20221231_zWkaQR5u0AUd" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Fair Value</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>As of Dec. 31, 2021</b></span><b> <span style="color: #222222"> </span></b></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 1</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 2</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; color: #222222; font-weight: bold">Level 3</td><td style="padding-bottom: 1.5pt; text-align: center; color: #222222; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Liabilities:</td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr id="xdx_40B_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_zBooQtZhCs31" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; width: 40%; text-align: left">Series A Preferred Stock</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2362">—</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2364">-</span></span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_407_eus-gaap--LiabilitiesFairValueDisclosure_iI_zWP772ZlXSgk" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2367">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2369">-</span></span> </td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right">3,925,000</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="display: none; vertical-align: bottom"> <td style="display: none; padding-bottom: 1.5pt; text-align: center; font-size: 12pt"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_499_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_z9o9igrWBYue" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 1</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_496_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel2Member_zY9hQ1w7b8bf" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 2</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel1Member_zcgLNLBDBhQ5" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Level 3</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td> <td colspan="2" id="xdx_49C_20211231_zSrfvzDnoT8c" style="border-bottom: Black 1.5pt solid; display: none; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif; font-size: 10pt"><b style="display: none">Fair Value</b></span></td><td style="display: none; padding-bottom: 1.5pt; text-align: center; font-weight: bold"><span style="display: none; font-family: Times New Roman, Times, Serif"> </span></td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="14" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>As of December 31, 2020 </b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt; text-align: center; font-size: 12pt"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 1</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 2</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold"><span style="font-size: 10pt"><b>Level 3</b></span></td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center; font-weight: bold">Fair Value</td><td style="padding-bottom: 1.5pt; text-align: center; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold">Liabilities:</td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="color: #222222"> </td> <td style="color: #222222; text-align: left"> </td><td style="color: #222222; text-align: right"> </td><td style="color: #222222; text-align: left"> </td><td style="font-size: 12pt"> </td> <td style="font-size: 12pt; text-align: left"> </td><td style="font-size: 12pt; text-align: right"> </td><td style="font-size: 12pt; text-align: left"> </td></tr> <tr id="xdx_40A_eus-gaap--LiabilitiesFairValueDisclosure_iI_hus-gaap--StatementClassOfStockAxis__us-gaap--SeriesAPreferredStockMember_z4wmS8dvYEz" style="vertical-align: bottom; background-color: White"> <td style="padding-left: 10pt; padding-bottom: 1.5pt; width: 40%; text-align: left">Series A Preferred Stock</td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2372">—</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; color: #222222; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2373">—</span></td><td style="padding-bottom: 1.5pt; width: 1%; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; color: #222222; text-align: right">      <span style="-sec-ix-hidden: xdx2ixbrl2374">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt; width: 2%"> </td> <td style="border-bottom: Black 1.5pt solid; width: 1%; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; width: 11%; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2375">-</span></td><td style="padding-bottom: 1.5pt; width: 1%; text-align: left"> </td></tr> <tr id="xdx_406_eus-gaap--LiabilitiesFairValueDisclosure_iI_zIT1eVuVRwwe" style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt; text-align: left">Total liabilities</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2377">—</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td><td style="padding-bottom: 1.5pt; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2378">—</span></td><td style="padding-bottom: 1.5pt; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt; color: #222222"> </td> <td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; color: #222222; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2379">-</span></td><td style="padding-bottom: 1.5pt; color: #222222; text-align: left"> </td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="border-bottom: Black 1.5pt solid; text-align: right"> <span style="-sec-ix-hidden: xdx2ixbrl2380">-</span></td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> </table> 3925000 3925000 3925000 3925000 <p id="xdx_899_eus-gaap--FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock_zLSKN9jxhNA" style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white; color: #222222">The following table presents additional information about Level 3 assets measured at fair value. Both observable and unobservable inputs may be used to determine the fair value of assets classified within the Level 3 category. As a result, the unrealized gains and losses for the assets and liabilities within the Level 3 category may include changes in fair value that were attributable to both observable and unobservable inputs. Transfers to/from Levels 1, 2 and 3 are recognized at the beginning of the reporting period in which a change in valuation technique or methodology occurs. Changes in Level 3 assets measured at fair value for the year ended December 31, 2021 were as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> <span id="xdx_8B8_z0ZEsBgi9G46" style="display: none">SCHEDULE OF FAIR VALUE AT ASSETS</span> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <table cellpadding="0" cellspacing="0" style="font: 7pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Assets</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Beginning<br/> Balance January 1, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Acquisitions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Sales and dispositions</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><p style="margin-top: 0; margin-bottom: 0"><span style="font-size: 10pt">Transfers into</span></p> <p style="margin-top: 0; margin-bottom: 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Level 3</span></p></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_F53_zPwSNqt20Sgc" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Transfers out of Level 3 (a)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span id="xdx_F5D_zxuFS0zmf05a" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized &amp;<br/> Unrealized Gains (Losses)(b)</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Ending Balance Dec 31, 2021</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: center; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td colspan="2" style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 37%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stocks</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zEE7zoi5qJC2" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2383">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zgNXS8rOXFcj" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,665,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zb1motLQ9ntb" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2385">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_984_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zy0kGDe2pht4" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">400,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_iN_di_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_fYi4___z7l7eYGF9Ajj" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(534,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_fYS4___zYninpceD4Ac" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(377,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember_zJgpyETX85d" style="font: 10pt Times New Roman, Times, Serif; width: 5%; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">2,154,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible Debt</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zdAU7RmYePSf" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2390">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zpLLo5hxwo8a" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,267,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zcBFVwXyDOSe" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2392">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_z5GrLa1OD1H8" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">410,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_983_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_iN_di_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_fYi4___zRtS7kM2D7x6" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(213,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_fYS4___zXSgPXHSyJec" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(278,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98D_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember_zIb2N3lP3bjk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">4,186,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Warrants</span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_98E_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zoArFp1hqKLl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2397">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_z49GE2REVdo1" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2398">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_985_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zGX2v6SDjcJk" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2399">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zO01mWDKkQJj" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2400">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_fYi4___zyIsQr6Iybcl" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2401">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_fYS4___zoIu7cp0nMC3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--WarrantMember_zy8PzxFhI8d3" style="font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">96,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preferred stocks</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zg9uGOd0mCVf" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2404">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zyWHlYo9f4kg" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,031,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zCZnVCR8DfW6" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_980_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zx2JHDrhWiZ8" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">500,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_fYi4___z5h6F04N0m01" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2408">-</span></span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_988_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_fYS4___zcWN7D6N3tPe" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(422,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98A_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231__us-gaap--FairValueByAssetClassAxis__us-gaap--PreferredStockMember_zsAsDFAof2tc" style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">599,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: bold 10pt Times New Roman, Times, Serif; padding-left: 0pt; text-align: left; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Total Investments</span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td id="xdx_987_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iS_c20210101__20211231_zUzY5ufXAJeb" style="border-bottom: Black 2.5pt double; font: bold 10pt Times New Roman, Times, Serif; text-align: right" title="Beginning Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span style="-sec-ix-hidden: xdx2ixbrl2412">-</span></span></td><td style="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_989_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases_c20210101__20211231_z792IkncMzs8" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Acquisitions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,963,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_982_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales_c20210101__20211231_za7yJ9JrTRq7" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Sales and dispositions"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(510,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_986_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_c20210101__20211231_zuMRQXsVF67c" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transfers intoLevel 3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">1,310,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98F_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_iN_di_c20210101__20211231_fYi4___z4VRGqPh8Ukf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Transfers out of Level 3"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(747,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_981_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1_c20210101__20211231_fYS4___z092cAGmKjZf" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Realized &amp; Unrealized Gains (Losses)"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(981,000</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">)</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">$</span></td><td id="xdx_98C_eus-gaap--FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue_iE_c20210101__20211231_zo8KfkqjHVdd" style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right" title="Ending Balance"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">7,035,000</span></td><td style="padding-bottom: 2.5pt; text-align: left"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; width: 100%"> <tr style="vertical-align: top; text-align: justify"> <td id="xdx_F0F_zex55tmzePs5" style="text-align: left; width: 0.25in">a.</td><td id="xdx_F10_zOZwgfcilNce" style="text-align: justify">Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital.</td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: left"> </td><td style="text-align: justify"> </td></tr> <tr style="vertical-align: top; text-align: justify"> <td style="text-align: left"><span id="xdx_F08_zy3SLj3Ah0x8" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="text-align: justify"><span id="xdx_F1D_zWIlKIJFSyl2" style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations.</span></td> </tr> </table> 2665000 400000 534000 -377000 2154000 4267000 410000 213000 -278000 4186000 96000 96000 1031000 -510000 500000 -422000 599000 7963000 -510000 1310000 747000 -981000 7035000 <p id="xdx_892_eus-gaap--FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock_zZQZ8bYyat1e" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8BB_zKuZRCvk9G4f" style="display: none">SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS</span></span></p> <table cellpadding="0" cellspacing="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Assets </b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Valuation technique</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 25%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Unobservable inputs</b></span></td> <td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; width: 2%"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; width: 23%; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>Range</b></span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Common stocks</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Put option pricing model </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount for lack of marketability</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_906_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zyp1A3utwbKe" title="Range">0</span>% - <span id="xdx_903_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--CommonStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_zzk8s2jbMuIb" title="Range">54</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Convertible preferred stock</span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: bottom"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Put option pricing model </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Discount for lack of marketability</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MinimumMember_zluXoYfZfBF4">0</span>% - <span id="xdx_90A_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertiblePreferredStockMember__us-gaap--ValuationTechniqueAxis__custom--PutOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountForLackOfMarketabilityMember__srt--RangeAxis__srt--MaximumMember_zVdQbH7c2Big">54</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Convertible Debt </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> Discounted cash flow </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Maturity</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueDiscountedCashFlowMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MinimumMember_zoybfltNepG7">0</span> - <span id="xdx_905_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueDiscountedCashFlowMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MaximumMember_zRmJ1W8BhWz4" title="Range, maturity">35</span> months</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk adjusted discount factor</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90D_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--FairValueByAssetClassAxis__us-gaap--ConvertibleDebtSecuritiesMember__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueDiscountedCashFlowMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputDiscountRateMember_zRu4Eh67FwA5">26</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Option pricing model</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Volatility</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_902_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputPriceVolatilityMember_zU891zf08lra">100</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Risk-free interest rate</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_903_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MinimumMember_z62RAtQRPSq4">0.78</span> % <span id="xdx_90F_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputRiskFreeInterestRateMember__srt--RangeAxis__srt--MaximumMember_zWEp8je8mj7k">1.04</span>% </span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; vertical-align: top"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Dividend yield</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90F_eus-gaap--DerivativeAssetMeasurementInput_iI_pid_uPure_c20211230__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputExpectedDividendRateMember_zfBP9Qji5HCg">0</span>%</span></td></tr> <tr style="font: 10pt Times New Roman, Times, Serif; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Time to maturity</span></td> <td style="font: 10pt Times New Roman, Times, Serif"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></td> <td style="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_900_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MinimumMember_zNjqa2ECUHeh">0</span> - <span id="xdx_90F_ecustom--DerivativeAssetMaturityMeasurementInput_dtM_c20210101__20211231__us-gaap--FairValueByFairValueHierarchyLevelAxis__us-gaap--FairValueInputsLevel3Member__us-gaap--ValuationTechniqueAxis__us-gaap--ValuationTechniqueOptionPricingModelMember__us-gaap--MeasurementInputTypeAxis__us-gaap--MeasurementInputMaturityMember__srt--RangeAxis__srt--MaximumMember_zSLpejtLvck2">35</span> months </span></td></tr> </table> 0 54 0 54 P0M P35M 26 100 0.78 1.04 0 P0M P35M <p id="xdx_804_ecustom--RevenueDisaggregationTextBlock_zZXe2eAV0GG4" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 26 – <span id="xdx_826_zj8wKxN79HC" style="font-variant: small-caps">REVENUE DISAGGREGATION</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has two operating units and one reportable segment. The Sequire segment includes the licensing of the Company’s proprietary SaaS platform and associated data analysis technologies. Additionally, the Sequire segment comprises consumer and investor targeted marketing solutions to allow users of our SaaS platform to act on the insights obtained through our technologies. Lastly, reported under Sequire is our business unit LD Micro, which is in the business of hosting events and conference for microcap public companies.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The following table summarizes revenue by business unit:</span></p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6UbqI9Kqz7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zBruqtzfeWti" style="display: none">SCHEDULE OF REVENUE BY BUSINESS UNIT</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20211231_zPNw8e8SW5Uf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20200101__20201231_zpO5zdoUe1jd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SequirePlatformRevenueMember_zWjRwRiYISYc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Sequire platform revenue</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">24,514,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">5,976,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConferenceRevenueMember_zFRBrd1Jzehd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Conference revenue</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,229,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">503,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OtherRevenuesMember_zKsjG64u4HM9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Other revenues</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">964,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2457">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z2UDPgyECjD9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total revenues</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: justify">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">26,707,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: justify">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,479,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"> </td></tr> </table> <p id="xdx_8A6_zYat1ZHYwQle" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b> </b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As of December 31, 2021 and 2020, revenue contract liabilities were approximately $<span id="xdx_903_eus-gaap--DeferredRevenueCurrent_iI_c20211231_zlPk7MffVqji" title="Revenue from contract liabilities">12,859,000</span> </span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">and $<span id="xdx_907_eus-gaap--DeferredRevenueCurrent_iI_c20201231_z2D6fcSUNL43" title="Revenue from contract liabilities">4,842,000</span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">, respectively.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p id="xdx_89F_eus-gaap--DisaggregationOfRevenueTableTextBlock_z6UbqI9Kqz7j" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_8B3_zBruqtzfeWti" style="display: none">SCHEDULE OF REVENUE BY BUSINESS UNIT</span> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%"> <tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_492_20210101__20211231_zPNw8e8SW5Uf" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2021</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td colspan="2" id="xdx_49D_20200101__20201231_zpO5zdoUe1jd" style="border-bottom: Black 1.5pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">2020</td><td style="font: bold 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td></tr> <tr id="xdx_400_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--SequirePlatformRevenueMember_zWjRwRiYISYc" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; width: 68%; text-align: justify">Sequire platform revenue</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">24,514,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 2%"> </td> <td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify">$</td><td style="font: 10pt Times New Roman, Times, Serif; width: 12%; text-align: right">5,976,000</td><td style="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: justify"> </td></tr> <tr id="xdx_401_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--ConferenceRevenueMember_zFRBrd1Jzehd" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify">Conference revenue</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">1,229,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: right">503,000</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td></tr> <tr id="xdx_40D_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_hsrt--ProductOrServiceAxis__custom--OtherRevenuesMember_zKsjG64u4HM9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt">Other revenues</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right">964,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: justify"> </td><td style="border-bottom: Black 1.5pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl2457">-</span></td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1.5pt; text-align: justify"> </td></tr> <tr id="xdx_403_eus-gaap--RevenueFromContractWithCustomerExcludingAssessedTax_z2UDPgyECjD9" style="font: 10pt Times New Roman, Times, Serif; vertical-align: bottom; background-color: White"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt">Total revenues</td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: justify">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">26,707,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"> </td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; padding-bottom: 2.5pt"> </td> <td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: justify">$</td><td style="border-bottom: Black 2.5pt double; font: 10pt Times New Roman, Times, Serif; text-align: right">6,479,000</td><td style="font: 10pt Times New Roman, Times, Serif; padding-bottom: 2.5pt; text-align: justify"> </td></tr> </table> 24514000 5976000 1229000 503000 964000 26707000 6479000 12859000 4842000 <p id="xdx_80D_eus-gaap--SubsequentEventsTextBlock_zkQx7SEdAEIa" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b>NOTE 27 – <span id="xdx_82E_zYKgCGfWcNMg" style="font-variant: small-caps">SUBSEQUENT EVENTS</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The Company has evaluated all events that occurred after the balance sheet date through the date when the financial statements were issued to determine if they must be reported. The management of the Company determined the following reportable events:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>SAFE agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On February 15, 2022 The Company entered into a simple agreement for future equity (the “SAFE”) with BIGtoken, Inc. (BIGToken), its former subsidiary. Pursuant to the SAFE, SRAX has agreed to invest $<span id="xdx_90E_eus-gaap--PaymentsForProceedsFromInvestments_c20220213__20220215__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__dei--LegalEntityAxis__custom--BigTokenIncMember__us-gaap--TypeOfArrangementAxis__custom--SafeAgreementMember_ziSx5DC7MKec" title="Investments">1,000,000</span> in the SAFE. The amount funded into the SAFE at a given time is referred to herein as the “SAFE Amount”.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Pursuant to the terms of the SAFE, at any time that the Company sells its securities (a “Financing”) prior to the termination of the SAFE, the Company may, at its option, convert the SAFE into: (i) the number of shares of non-voting Series D Convertible Preferred Stock (“Series D Preferred Stock”) equal to such (a) SAFE Amount divided by (b) the lowest price per share of equity securities sold in any Financing (prior to the termination of the SAFE) multiplied by eighty percent (80%) (the “Conversion Price”) and (ii) such number of warrants to purchase Series D Preferred Stock (the “Warrants”) equal to the SAFE Amount divided by the Conversion Price. Upon issuance, the Warrants will (i) have a term of five (5) years, (ii) an exercise price equal to the Conversion Price, and (iii) contain price protection provisions for subsequent financings.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i>CVR Agreement</i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify">On June 13, 2022, the Company entered into an agreement with an institutional investor whereby in exchange for the payment of $<span id="xdx_905_eus-gaap--DebtInstrumentFaceAmount_iI_pp2d_c20220613__us-gaap--TypeOfArrangementAxis__custom--CVRAgreementMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zdTXr0ixr2Z4" title="Purchase price">404,513.40</span> (the “Purchase Price”), <span id="xdx_903_eus-gaap--DebtInstrumentDescription_c20220612__20220613__us-gaap--TypeOfArrangementAxis__custom--CVRAgreementMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zO7PZwJZFgYa" title="Debt instrument, description">the investor received (i) the right to receive the net proceeds upon the sale of certain securities of the Company (“CVR Payments”) with a quoted price equal to $<span id="xdx_90D_eus-gaap--ProceedsFromSaleOfAvailableForSaleSecuritiesDebt_c20220612__20220613__us-gaap--TypeOfArrangementAxis__custom--CVRAgreementMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember_zh5sezK0620l" title="Proceeds from sale of securities">674,190</span> (with a guaranteed minimum return of 120% of such Purchase Price and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the CVR Payments.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Extension of Outstanding Original Issue Discount Senior Secured Convertible Debentures</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0pt; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2022, the holders (“Holders”) of $<span id="xdx_90C_eus-gaap--DebtInstrumentFaceAmount_iI_c20220701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--HoldersMember_ztDkMJen4sia" title="Principal amount">1,102,682</span> in principal of the Company’s Original Issue Discount Senior Secured Convertible Debentures (“Debentures”), representing all of the outstanding Debentures that were originally issued on June 30, 2020, entered into an agreement with the Company to <span id="xdx_902_eus-gaap--DebtInstrumentDescription_c20220629__20220701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--HoldersMember_zx3Vghefyui6" title="Debt instrument, description">(i) extend the maturity date of the Debentures until December 31, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures.</span> The Debentures, including the additional principal added to the Debentures are secured by substantially all of the assets of the Company pursuant to a security agreement entered into between the Company and Holders contemporaneous with the original issuance of the Debentures (the “Security Agreement”).</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Bridge Note</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On July 1, 2022, the Company issued an original issue discount bridge note in principal amount of $<span id="xdx_901_eus-gaap--DebtInstrumentFaceAmount_iI_c20220701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--BridgeNoteMember_z3EGu8tgXlo2">650,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(“Bridge Note”) to an institutional investor in exchange for $<span id="xdx_90E_ecustom--PrincipalAmountExchange_iI_c20220701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--BridgeNoteMember_zFmSb0jWmKrg" title="Principal amount exchange">500,000 </span></span><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">in cash. The bridge note was non-interest bearing and had a maturity date of <span id="xdx_909_eus-gaap--DebtInstrumentMaturityDate_c20220629__20220701__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--DebtInstrumentAxis__custom--BridgeNoteMember_zJT2n9eFyqTg">August 15, 2022</span>.</span> <span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> The Company’s obligations pursuant to the bridge note were secured by substantially all of the assets of the Company pursuant to the terms of the Security Agreement.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white">On August 8, 2022, as described below, the Bridge Note was exchanged for a revolving note in the Senior Secured Revolving Credit Facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; background-color: white"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>RBSM LLP Declining to Stand for Reappointment</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify; background-color: white"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On June 30, 2022, RBSM LLP (“RBSM”), the independent registered public accounting firm to the Company, informed the Company of its decision not to stand for re-appointment as the independent registered public accounting firm of the Company. RBSM will cease its services as the Company’s independent registered accountants effective with the filing of the Company’s annual report on Form 10-K with the United States Securities and Exchange Commission. The Company’s Audit Committee accepted the resignation of RBSM and has selected a new independent public accounting firm.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Revolving Credit Facility</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On August 8, 2022 (“Effective Date”), the Company entered into a senior secured revolving credit facility agreement (the “Credit Agreement”) with an institutional investor </span> (the “Lender”) to initially borrow up to $<span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_zmkHpHxNFM7b" title="Loan amount">9,450,000</span> (“Loan Amount”) in the aggregate from time to time, subject to certain conditions (each a “Revolving Loan”). The Revolving Loan is secured by all the assets of the Company and is guaranteed by LD Micro, Inc. (collectively, Company and LD Micro are referred to as the “Credit Parties”). In addition to the Credit Agreement, the Credit Parties, as applicable, also entered into a: (i) Revolving Note, (ii) Security Agreements, (iii) Fee Agreement and (iv) Registration Rights Agreement (collectively the “Loan Documents”). As part of the transaction, the Company also amended and restated Lender’s outstanding warrants to extend the maturity date of a total of <span id="xdx_900_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_zgqxjJirY3lc" title="Warrant to purchase common stock, shares">2,590,358</span> Common Stock purchase warrants until <span id="xdx_90F_eus-gaap--LineOfCreditFacilityExpirationDate1_dd_c20220807__20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_zZkyCFlTHm9l" title="Expiration date">September 30, 2023</span>.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">For the Company enter into the Credit Agreement , we were required to issue <span id="xdx_907_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight_iI_c20220808__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementMember_zNjyWQG4GMib" title="Warrants issue shares">33,000</span> shares of the Company’s common stock as a breakup fee to an unrelated lender as a result of a failed offering.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Credit Agreement and Revolving Note</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">On the Effective Date, the Lender advanced $<span id="xdx_904_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20220808__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementAndRevolvingNoteMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_zKeaG5JAH8ge">5,580,000</span> consisting of $<span id="xdx_906_eus-gaap--LineOfCreditFacilityMaximumBorrowingCapacity_iI_c20220808__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementAndRevolvingNoteMember__us-gaap--CashAndCashEquivalentsAxis__us-gaap--CashMember_zyAv4YVdMhkk">4,930,000</span> in cash and the exchange of the $<span id="xdx_90E_eus-gaap--DebtInstrumentFaceAmount_iI_c20220628__us-gaap--TypeOfArrangementAxis__custom--CreditAgreementAndRevolvingNoteMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--DebtInstrumentAxis__custom--BridgeNoteMember_z7yjpNOqESVh" title="Debt amount">650,000</span> bridge note entered into on June 28, 2022, which was previously disclosed on the Company’s Current Report on Form 8-K filed on July 7, 2022 with the SEC. Provided that no event of default has occurred under the Loan Documents, upon the Company becoming current with its filing obligations under the Securities Exchange Act of 1934, as amended, as well as any other obligations of its principal trading market, Lender will advance up to an additional $<span id="xdx_900_eus-gaap--LineOfCreditFacilityRemainingBorrowingCapacity_iI_c20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_zZE2XY80a4A4" title="Additional amount">3,870,000</span>. Future Revolving Loan amounts (but not in excess of the Loan Amount) are subject to a borrowing base calculation.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--LineOfCreditFacilityDescription_c20220807__20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_zxzGSmPSeSpi" title="Credit facility, description">The principal balance of each Revolving Loan will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%. The Revolving Loans have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Commencing on the first day of each month after the Effective Date (each a “Payment Date”), the outstanding balance of the Revolving Loan will be paid as follows:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to the first, second and third months, <span id="xdx_90C_ecustom--LineOfCreditFacilityPaymentPercentage_iI_pid_dp_c20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--VestingAxis__custom--TrancheOneMember_zOdHnJOFlzwl" title="Payment percentage">10</span>% of the monthly collections from the sale of securities received by the Company from its customers during the prior month;</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.75in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">b.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to the fourth, fifth and sixth months, <span id="xdx_90F_ecustom--LineOfCreditFacilityPaymentPercentage_iI_pid_dp_c20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--VestingAxis__custom--TrancheTwoMember_zRfGJHRP3ESa">15</span>% of the monthly collections from the sale of securities received by the Company from its customers during the prior month; and</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.5in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">c.</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">With respect to each successive Payment Date, <span id="xdx_909_ecustom--LineOfCreditFacilityPaymentPercentage_iI_pid_dp_c20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember__us-gaap--VestingAxis__custom--TrancheThreeMember_zAhbx4gDgYL1">20</span>% of the monthly collections from the sale of securities received by the Company from its customers during the prior month. </span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0 0pt 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90B_ecustom--LineOfCreditFacilityPaymentDescription_c20220807__20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_ziu9I85AcEMk" title="Payment description">Additionally, with respect to any Payment Date where the applicable monthly collection from the sale of securities received by the Company from its customers during the prior month exceeds $2,000,000, the Company will make an additional payment equal to 30% of any amounts in excess of $2,000,000.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><span id="xdx_90E_eus-gaap--DebtConversionDescription_c20220807__20220808__us-gaap--CreditFacilityAxis__us-gaap--RevolvingCreditFacilityMember__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__srt--TitleOfIndividualAxis__custom--InstitutionalInvestorMember_z0i4DouG1Qc8" title="Conversion, description">The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends and fundamental transactions. Moreover, in the event the Company is deemed to have issued or sold shares of its Common Stock while the Revolving Loan is outstanding at a price equal to or less than $5.00 per share, the conversion price will adjust to such lower applicable price.</span></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Security Agreements</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">In order to perfect Lender’s security interest, the Credit Parties entered into: (i) Security Agreements, (ii) Guaranty Agreements, (iii) Pledge Agreements and (iv) Security Account Control Agreements and Deposit Account Control Agreements (collectively “Security Agreements”). The Security Agreements provide for a general lien on all of the Credit Parties’ assets, including each party’s respective intellectual property.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; text-align: justify; margin: 0pt 0"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Extension of Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As part of the transactions contemplated by the Loan Documents, the Company additionally agreed to extend the expiration dates of the following outstanding Common Stock purchase warrants held by the Lender or its affiliated entities until September 30, 2023:</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(a)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a warrant to purchase <span id="xdx_90B_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20200601__20200630__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementsMember_zDs6Ndoj1uUh" title="Number of shares issued">1,363,636</span> shares of Common Stock issued on June 30, 2020, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on June 30, 2020;</span></td></tr></table> <p style="text-align: justify; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(b)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a warrant to purchase <span id="xdx_90A_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20181129__20181129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementsMember_zz76VoZv4y5d">166,667</span> shares of Common Stock issued on November 29, 2018, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on November 30, 2018; and</span></td></tr></table> <p style="text-align: justify; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(c)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a warrant to purchase <span id="xdx_900_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20181129__20181129__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementsMember__us-gaap--VestingAxis__custom--TrancheOneMember_zlNojsfXaUEk">530,027</span> shares of Common Stock issued on November 29, 2018, that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on November 30, 2018; </span></td></tr></table> <p style="text-align: justify; margin-top: 0; margin-bottom: 0"> </p> <table cellpadding="0" cellspacing="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0; margin-bottom: 0"><tr style="font: 10pt Times New Roman, Times, Serif; vertical-align: top"> <td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"/><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify; width: 0.25in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">(d)</span></td><td style="font: 10pt Times New Roman, Times, Serif; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">a warrant to purchase <span id="xdx_907_eus-gaap--StockIssuedDuringPeriodSharesNewIssues_c20171027__20171027__us-gaap--StatementEquityComponentsAxis__us-gaap--CommonStockMember__us-gaap--TypeOfArrangementAxis__custom--SecurityAgreementsMember_zlHjXjFMTgQi">530,028</span> shares of Common Stock issued on October 27, 2017 that was initially disclosed on the Company’s Current Report on Form 8-K filed with the SEC on October 27, 2017.</span></td></tr></table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Fee Agreement</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i> </i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">As consideration for Lender entering into the Loan Documents, Lender will be entitled to receive, in addition to any payment made under the Credit Agreement, 10% of the net proceeds received by the Company from the sales of securities received during the term of the Revolving Loan.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"/> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"/></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><i>Common stock issue for Options and Warrants</i></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"> </p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Subsequent to December 31, 2021, the Company issued approximately <span id="xdx_906_eus-gaap--ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights_iI_c20220927__us-gaap--SubsequentEventTypeAxis__us-gaap--SubsequentEventMember__us-gaap--ClassOfWarrantOrRightAxis__us-gaap--WarrantMember_zCZYEFFkoEt5" title="Number of common stock and warrants shares">287,000</span> shares of the Company’s common stock for the exercise of warrants and/or stock options.</span></p> 1000000 404513.40 the investor received (i) the right to receive the net proceeds upon the sale of certain securities of the Company (“CVR Payments”) with a quoted price equal to $674,190 (with a guaranteed minimum return of 120% of such Purchase Price and (ii) the right after 90 days but before 120 days to demand payment of 120% of the Purchase Price in cash less amounts previously paid from the CVR Payments. 674190 1102682 (i) extend the maturity date of the Debentures until December 31, 2023 and (ii) extend the first date that monthly redemptions are required to be made by the Company to begin on January 1, 2023 (the “Debenture Extension”). As consideration for the Debenture Extension, the Company increased the principal amount outstanding on the Debentures by five percent (5%). Additionally, the holders of the Debentures have the unilateral right to extend the maturity date and monthly redemption period by an additional six (6) month period at any time prior to January 1, 2023 for an additional five percent (5%) to be added to the outstanding principal of such Debentures. 650000 500000 2022-08-15 9450000 2590358 2023-09-30 33000 5580000 4930000 650000 3870000 The principal balance of each Revolving Loan will reflect an original issue discount of ten percent (10%); provided that beginning on the date that is twelve (12) months from the Effective Date, such original issue discount will increase to twelve percent (12%) in the event the Prime borrowing rate increases to 6.75%. The Revolving Loans have a maturity date of the earlier of (i) twenty-four (24) months from the Effective Date or (ii) the occurrence of an event of default, as described in the Loan Documents. 0.10 0.15 0.20 Additionally, with respect to any Payment Date where the applicable monthly collection from the sale of securities received by the Company from its customers during the prior month exceeds $2,000,000, the Company will make an additional payment equal to 30% of any amounts in excess of $2,000,000. The Revolving Note is initially convertible into shares of Common Stock at a conversion price of $15.00 per share (“Conversion Price”). The Conversion Price is subject to adjustment in the event of stock splits, dividends and fundamental transactions. Moreover, in the event the Company is deemed to have issued or sold shares of its Common Stock while the Revolving Loan is outstanding at a price equal to or less than $5.00 per share, the conversion price will adjust to such lower applicable price. 1363636 166667 530027 530028 287000 Transfers out of Level 3 relate to investments that have been transferred to level 2 and designed assets for return of capital. Realized and unrealized gains and losses are included in the gain / (loss) line in the statement of operations. EXCEL 121 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx M4$L#!!0 ( -6 3%4'04UB@0 +$ 0 9&]C4')O<',O87!P+GAM M;$V./0L",1!$_\IQO;=!P4)B0-!2L+(/>QLOD&1#LD)^OCG!CVX>;QA&WPIG M*N*I#BV&5(_C(I(/ !47BK9.7:=N')=HI6-Y #OGDK7A.YNJQ<&4GPZ4A!0W_J=0U[R;UEA_6\#MI7E!+ P04 M " #5@$Q5+%%I*>T K @ $0 &1O8U!R;W!S+V-O&ULS9+! M:L,P#(9?9?B>R':A!Y/FLK)3"X,5-G8SMMJ:Q8ZQ-9*^_1*O31G; ^QHZ?>G M3Z#&1&7ZA,^ICYC(87X8?1>R,G'#SD11 61S1J]S/27"U#SVR6N:GND$49L/ M?4*0G*_!(VFK2<,,K.)"9&UCC3()-?7IBK=FP@R40=0"6#M/ MC)>Q:^ .F&&$R>?O MJ%6*I_8DL'V#4Y9K>DAF&HAU7)33L(>-OO7LJZE0N9 M=# X_MX1!&PO=&AE M;64O=&AE;64Q+GAM;.U:6W/:.!1^[Z_0>&?V;0O&-H&VM!-S:7;;M)F$[4X? MA1%8C6QY9)&$?[]'-A#+E@WMDDVZFSP$+.G[SD5'Y^@X>?/N+F+HAHB4\GA@ MV2_;UKNW+][@5S(D$4$P&:>O\, *I4Q>M5II ,,X?+&A T%116F]?(+3E'S/X%/F7/Z3H=,H%N,!M8('_.;Z?D3EJ(X53"Q,!J9S]6:\?1 MTDB @LE]E 6Z2?:CTQ4(,@T[.IU8SG9\]L3MGXS*VG0T;1K@X_%X.+;+THMP M' 3@4;N>PIWT;+^D00FTHVG09-CVVJZ1IJJ-4T_3]WW?ZYMHG J-6T_3:W?= MTXZ)QJW0> V^\4^'PZZ)QJO0=.MI)B?]KFNDZ19H0D;CZWH2%;7E0-,@ %AP M=M;,T@.67BGZ=90:V1V[W4%<\%CN.8D1_L;%!-9ITAF6-$9RG9 %#@ WQ-%, M4'RO0;:*X,*2TER0UL\IM5 :")K(@?5'@B'%W*_]]9>[R:0S>IU].LYKE']I MJP&G[;N;SY/\<^CDGZ>3UTU"SG"\+ GQ^R-;88C'(CN]WV6'WV3T=N(]>IP+,BUY1&)$6?R"VZ MY!$XM4D-,A,_")V&F&I0' *D"3&6H8;XM,:L$> 3?;>^",C?C8CWJV^:/5>A M6$G:A/@01AKBG'/F<]%L^P>E1M'V5;SC MFED)O816:I^JAS0^J!XR"@7QN1X^Y7IX"C>6QKQ0KH)[ ?_1VC?"J_B"P#E_ M+GW/I>^Y]#VATK\>WZV22$KYI9+2,6D$N!LT$DN/R+RO JQ GH9%LE" M0AMNZ5/U2I77Y:^Y*+@\6^3IKZ%T/BS/^3Q?Y[3-"S-#MW)+ZK:4OK4F.$KT ML@'37[]EUVY".E,%.70[@:0KX#;;J=W#HXGIB1N0K3 M4I!OP_GIQ7@:XCG9!+E]F%=MY]C1T?OGP5&PH^\\EAW'B/*B(>ZAAIC/PT.' M>7M?F&>5QE T%&ULK"0L1K=@N-?Q+!3@9& MH >#KU$"\E)58#%;Q@,KD*)\ M3(Q%Z'#GEUQ?X]&2X]NF9;5NKREW&6TB4CG":9@39ZO*WF6QP54=SU5;\K"^ M:CVT%4[/_EFMR)\,$4X6"Q)(8Y07IDJB\QE3ON>;G*YZ(G;ZEW?! M8/+]<,E'#^4[YU_T74.N?O;=X_INDSM(3)QYQ1$!=$4"(Y4U#VT%SU&\Z.9X!ZSAW.;>KC"1:S_6-8>^3+?.7#;.MX#7N83 M+$.D?L%]BHJ $:MBOKJO3_DEG#NT>_&!()O\UMND]MW@#'S4JUJE9"L1/TL' M?!^2!F.,6_0T7X\48JVFL:W&VC$,>8!8\PRA9CC?AT6:&C/5BZPYC0IO0=5 MY3_;U UH]@TT')$%7C&9MC:CY$X*/-S^[PVPPL2.X>V+OP%02P,$% @ MU8!,53,#LUN!!P R#$ !@ !X;"]W;W)K_S*S2TL]/.A&#+0$(W889 V&6;IMF0MMO=V0O%%N");;&2G(]_ MOY(Q.,[(K_&,DHO$!K\'ZXEDGV.)TT?&[\6*4HF>XB@19ZV5E.M/G8[P5S0F MXHBM::+>63 >$ZEV^;(CUIR2("N*HPYVG'XG)F'2&IYFKUWSX2E+910F])HC MD<8QX<_G-&*/9RVWM7WA)ERNI'ZA,SQ=DR6=4_EM?G$H0Q343($L3I MXJPU-58^Z(H&,6_0@#N3IKG;100!0->_R=Y@WJ M:3V?12+[C1XWQW:[+>2G0K(X+U9G$(?)YB]YRD&\+/ J"G!>@%\5N%6?X.4% MWKX%W;R@FY'9-"7C,"&2#$\Y>T1<'ZW4]$8&,ZM6S0\3_7^?2Z[>#56='([9 M ^6HC;[-)^C#^X^G':E$]5L=/QM H25(2H1NZ9ER: M2,$ZDJ=&4&!54U"6Q$J@CG>@CO<<:IRH6WIV1ZZ&!6M5=BNPK"DM2V(E6B<[ M6B?[T;JF/&2!OO$A=?,U7J-JE+:WNLI['5C?%)HEL1*TP0[:8#]HTU#X:BSF M[*;J96$"!ZM-?YI@@35-85D2*\%RG<*6.8UP_:2$5\.J$:OJ7'!94V"VU,K$ M7AA9%VSD..7\-3!H9-;(M=LN;GMF;&!E8VR6U,K8<($-@^V\2&0HGQ6UB**K M-+ZCW @+%G$*ZH\$N\=&:E:]O2VU,K7"W;NP/<^IW9(G- L4NG 1^B1S9L PA26[O38> MX!ZNN*Q9]?VVU,KT"N?OPI8]IS=+?,:5C\W ':*Y5#<#Q#@:LU1U1M4G66 > MO#7!XL((T&H>L*56!E@D A>V\3G 41 H=7&XW4"7ZCCT-3%3@R5Q'P\.;MEC M(I;ZWW##2(#>8;=G9&DU+=A2*[,L\H(+V_S7+,=Z3_5"S<+($9;[086,R#T] M^!Y&*OD;PQ8LT9C?6R0'MX@.+NSV7_/;#>-KSA["Q#=W1EAS/#)BLQHA;*F5 M'Z,6&0+#MO\UMFLFI+K__AVN*Z][-8H#U^N;'\E:31*VU,K1E]7L M8$NMS*O(#GBO[/"#1E'[/E$>38U6(M1E+D S(=**ZQRL><6,V*PF!EMJ96Q% M8L![)8;O+%+9BO#-,R5N?%Y9HU0!RVHDL*56AE5$ KQ7)-@^M-Q,MF27,N5M MS0]Y:Q0KH%G- ;;4RM"*'(#WR@&S1%*^63"BG^Z2+44C-%BQ IK5%&!+K;S\ MH$@!WEXI(!N,:*R"TY)QH^VHT;EB29OX/E4R2B38"!H7(%C- K;4RO2*+.#! M5CZG-X])%*'S5*BWA7%TUNA432'#98UAO44B\(I$X.TUEW 14[[4U[+?E()< M:9.Z)HFYS\&"E7/)<%UC;&\1#;P7*X3VFE.8KY3A &'!,M6P["X)>@O+[Q66 MW]MK,N$ZO8M"'TTC1HS7?5BE\9HJJW$@5^ME:GIAYL/0Q>[@&#NX>]IY,.$I MO+ZWUZQ!.1?.5T2=%OJ:2B%)HA.3$9E-#S_.U?HO&HG[GMMSCT]V;K;M^66IE3X?8]V)MO.>GGC+I7&5G5V'OZ>/"3<74)O#(N&(++ M&_-Z"Z/?+8Q^%S;H6U[3D,=H-C'AJE'HG1BGU>&JQDMFK1KZSHNE[]IV9E\A M$,C7\[N;5?"[5W=?4QAEB_,[Q>&;[SA\(=JU"A31A2IUCH[5?8EOOC:PV9%L MG2VDOV-2LCC;7%$24*X/4.\O&)/;'?T!NR]O#/\'4$L#!!0 ( -6 3%7! M!#2&PO=V]R:W-H965T&ULK5EM;]LV M$/XKA%L4'>#$(JG7-C&0)MA68%V#9MT^,Q)M"Y%%EZ3RLE^_H^Q8-G1B["X? MVDCR\?0<>;SG.>KL0>D[LY#2DL=E59OST<+:U8?)Q.0+N13F5*UD#;_,E%X* M"[=Z/C$K+471#EI6$Q8$\60IRGHT/6N?7>OIF6IL5=;R6A/3+)="/WV2E7HX M']'1\X-OY7QAW8/)]&PEYO)&VN^K:PUWDZV7HES*VI2J)EK.SD<7],,E3]V MUN+O4CZ8G6OB0KE5ZL[=?"[.1X%#)"N96^="P)][>2FKRGD"'#\V3D?;=[J! MN]?/WG]M@X=@;H61EZKZIRSLXGR4CD@A9Z*I[#?U\+O=C8 M!B.2-\:JY68P(%B6]?JO>-Q,Q,X &@X,8)L![- !?#. MX&ND;5A70DKIF=: M/1#MK,&;NVCGIAT-T92U6\8;J^'7$L;9Z:6JC:K*0EA9D$^B$G4NR8US9\@) M^7YS1=Z__>5L8N%5;L DW[C]M';+!MQ>R?R4<#HF+& 4&7YY^/!@?_@$ MQ& MR;91LM8?'XJRT5K6E@AC(# LG/7X$!_O]M('LQ*Y/!_!9C%2W\O1]-T;&@!>R=E>J'P;*O=YGUX*LR"B+DCN+N2/IKP7%<2.1KUV%;6NW(:_GU(>ID$ MI'GJ@%D4 YR"3!O*SDFM;08TK6G> =!RF@? M:-^,AD$VB#3:(HW\DZIJJZ'B[$+%4$9]E&'81^E]&9X?Q),:\3:*V!O%%Z'O MI'78B9%YHTM;2C0MXOXL1C%-^H'T#2'>9'"ZDRW0Q OT2IIR7KL:B/W O@^"5(MY&EWLBNM5R)LB#R$7C82-/N M5&474D.Q?ZE&I;W80A[T0^N;\9@.KDFV19[YM\ >/+<*16ERV!=EW< Z@:[0 MPA$SBMSK^J#97H>6]1.3!?%@;#3H6##P1O>7@GPZ8 DV;G81,):E2((AEI2F M"1\&NT/9U OV3V7E2Y5HXV+W]1G'8/;MTLP#LF-_%Q;4<]+5QS7RS\,E2,D$W($*V:8L6&P M'7%2/W.V:MOMP<9(7[;VZ9!%2!E'['CLV58=;5(_;WYM*YL'8)\P>8S@ZYMY M9K&C0^KGP]^4*A[*"N41BG!@D@48N ,L]P%V-$C]//B'JNR]M^O]01(O,3XE:;K\13JQA=&1=YKEW:/:L7M)'J\QXH<(1Y M$$.6!.G@>K&.'YF?'Z_D3,**%4"1]Q+V"0JSSWN4I5&&X.Q;AFDX7'_83E/J MI\BO>[KOA>QB?>)+8H1T$#L>>AB2=0S)_ QY+9ZTJBJRTJ _UHKGM#Y M0>@:[:[\01[?7K&.TYF?TY%:?21K^E]P!&LR1!CP(!I.DDX7,+\NV.]67BH< M??)F+*4(A2*6- NX!W''\\S/\WN"]1GP$Y2."B0.<1('A=[G=+0I0.Q8.,S\ MK&-^YF]ZATN>'_=K];NLW_#R9/@XBW?TSOWTOJ5(*QZ[]4"/"+V.CHB%(PTQ M'SZ7X!W=DN:QS5Z;>N[Z>T P];O=[/F89_K^C_>AW#J:Y5T;?.!Y;J*J0VKQ[DS*: M?&P/!@;RSBM&CE73K^5M/_1.?7"_^KBLH,4!4L\A :"&]!D=2'0,">;^>2B= M1>,LB\8T86WZT'A,PVB<).DSP_\LL7/DH A",3,(WIX)WJX7_1<%$7IBBML MX_9TM*Q]1[R\KT(B&B2(#$$LXRR*/$6GTQG41=R5N8E>E;$ M^QK@A .E8F 1TRC@GDZ#=X*!'R(8S'$;$-$-01)B:8'I!L:&=0/O= ,_Y'Q@ M5\RYW#XRD+3_]0H_0T L!\X0)CM?7-WG[B]"S\O:D$K.8&APFH /O?Z"O+ZQ M:M5^A+U5UJIE>[F0 @)P!O#[3$'QW]RX[[K;[_C3_P!02P,$% @ U8!, M50EGL%@V P -PT !@ !X;"]W;W)KQ$"2/081XF8&J&4Z:5I"C^$F(@>2R%15Y:,QT2J M(5^9(N5 @CPICDS;LAPS)C0QO$E^;LZ]"#[X&4\/21!"!+[4$43]KF$$4:27%\5"*&M6<.G'W^%G]F;DC M F8L^D4#&4Z-D8$"6)(LDK=L\P5*0T.MY[-(Y-]H4\0.70/YF9 L+I,504R3 MXI<\EC=B)T$9;4ZPRP2[:T*_3.CG1@NRW-9'(HDWX6R#N(Y6:OH@OS=YMG)# M$_T8%Y*KJU3E26_&$L$B&A ) ;HF$4E\0 LM)]#;.>&0R! D]4GT#KU'KY&) M1*C.BHDIU>Q:P_3+F:Z+F>P#,WT$OX?Z^ +9EHT;TF?=TZUZNJD\5\;MRKB= MZPT.&H]C]3=2-]B_ORA-(9+)D''Z%X(F?X6@DPOJ\EA[]G!LY9^)N=ZUTCJU MKLQ+D1(?IH8J/0%\#8;WYA5VK \MQOJ5L?[IQJ@06;.I?I.I\1"[]@M/^X'8 MP8.AZXZJP!KOH.(=G,ZK%APA21+09-4$/>@*O1_8#CVLH(>MT O@5&%>H;E: M=8!S53P+;0#]OH'X#OB?)NI6R>[_BL+9F<1J[IW*O=/J_CO$*>-JU4?PD%'Y MU+%^G+V'T7<&CCW [HNGUB&PQNU6W.Z)W"GA:$VB#)IX"S%W!\/J619^ 7LL MJD8ZJDA'_W>'CQ3&J.LMW@^TFHG'%?&X(_&GDGA1$']K)QYW)=X//$",K6WO ML]J7GH@(7<3^SA+46L'M>J>6\+G4ZNYW.C\^=PL+K]78 CN%ULFWK1N? MTKM;:[A4.E;$1\/JI-M>C,_:C''G;MP0V=[9\+8?X_,W9-RY(S=$'@ W=W:U M^I7BAO 5302*8*E2K9ZK6B O=NG%0+(TW^C>,:FVS?EAJ-YL@.L =7W)F'P> MZ+US]:[D_0-02P,$% @ U8!,5=AK+K\S!P :"( !@ !X;"]W;W)K MQY*.KOGXDZN*%7@ MH3Y8*;4^'8WD?$4+(D_XFI;ZEP47!5'Z4BQ'I!13Y"01"/"L+* MP>2L_NY:3,[X1N6LI-<"R$U1$/'MDN;\_GP ![LO;MARI:HO1I.S-5G26ZJ^ MK*^%OAIU7C)6T%(R7@)!%^>#"W@Z#>L!M<6?C-[+O<^@"F7&^5UU\2$['P05 M(IK3N:I<$/UG2Z_K=-!-V M*J%_97JP5>_?SZ;*3T MI-70T;R=X+*9 /5, !'XQ$NUDN!MF='LT,%(H^T@HQWD2^3U>$7G)P##-P % M"#H 39\^//# P=T*XMH?[O'WH9SS@IJU W]?S*02NC[_<:U6XRQT.ZLV[:E< MDSD]'^A=*:G8TL'DEY]@'/SJBO2%G!W$'79QAS[ODQNZI>6&2E>0S\.U^ +9A'";C?;L#;%&'+?+F9,JE J3, 'W0_4ZZ048OF8D7 MK-ZQH,N**M7$0[Z]SA*"=#]L.)FE_/I(.8>)%^+98Y_P; MI1IB7G>:N8;L3$IB 4@BC&V@MET8I[@7:-H!3;U /Q%Q1Q4KEW7U:+;)J\^^ M*DKME:WQ/@9LV\$$)KV QQW@L1?PM5[/BLS[5W1L38Q@:..SS<9QT L/!H9? M B_ *ZHK?LY(0]IZ44G!A6+?ZR^<=!)82-(0V8 ==DF"^A'O,2+T(GY/2TU\ M>0,VTYS+JG9>J0UO(;1>]_%$.'(!MPUQ-/:L-3+(D1?Y'UQIW/.G-+_64WS8 MHLVH\U7.I7P-%H(7@'>BPXD:6UB&:>3 [+!+ NRI M#L-Z,/12RV>UH@*P%GF[Q&Y=Y.7/8PGFI;P=AFT(%7H9;/*.E:2<5\VPM]&T M'@X6'09H[,J/RQ3!R+,)#!E"/QO>4)*S[YICEOH0 W33*>J>3F8YU0U]OA%, ML9X]8;-?&CA:I<,N3L-^Z(8EH9\FOY3B 'R[,8Z*P2;&H194KBAL2Q1[=K6A M4.CGT"X!%?H*?$8E6Y8U[Q,I:4_UV 0Y3%VPO9.[]P'P;0'#M-!/M7O9.2XR MFUJ'"">I(S8O@.-C0X:ED9^EW[=[11)=85I*WMY<_%5D;T!)E2LDO[C8-/YYGA&"H7CDI_CIBI1+JF, "\($V))\4Q>8GF=!A= ;1RH^OW-&9Y,X M"F-7@IYQ#/9&9\0 \I^!^Z++J&#;1C+FC,Q8WMNO_1,C7],A!_#"&L0NVRS0(XG[MA0R[ MH[%7UU\QV4+6/>D'B)]!T_W"_J6\'=Z\-,R/_[?-_W\3*6;]3NT*F3 N2*"*<&PUYM MF^K)^6%U.I\"!O8:PY,P??P, MT&D6P![<1B"$?H'PM7Z$7]V:V>J%U\>T&KO6#!LEE8:N*^NI@=C" >$H"I(P M?!R+;0DUZ8R3-'T4SFCOF7U!Q;)^E4%JV;PI5?,LO/NV>UWBHGY)X-'WE_!T MVKST8-PT[V!\(F+)=+7E=*%=ZHK1C4HTKS4T%XJOZS<#9EPI7M0?5Y3HPVME MH']?<*YV%]4$W&PO=V]R:W-H965T&ULQ5QM;^(Z%OXK%KO:%VD8$CLO,-M6 MFI)$.Q_N5=7NG;O2:C^88(HU(>'&IIWY]^N$E&!L#.D<:;^TA-C/.?:38_L\ M=KAYK>IO8LV81-\W12EN1VLIMY\F$Y&OV8:*C]66E>K.JJHW5*K+^GDBMC6C MR[;2IIA@SXLF&\K+T=U-^]U#?7=3[63!2_90([';;&C]XYX5U>OMR!^]??'( MG]>R^6)R=[.ES^R)R=^V#[6ZFAQ0EGS#2L&K$M5L=3OZ['_* J^IT);XRMFK M./J,FJ8LJNI;<_%E>3OR&H]8P7+90%#U[X7-65$T2,J//SK0T<%F4_'X\QMZ MUC9>-69!!9M7Q>]\*=>WH^D(+=F*[@KY6+W^DW4-"AN\O"I$^Q>][LO&\0CE M.R&K35=9>;#AY?X__=YUQ%$%C,]4P%T%?%*!1&4=V45FC-AY:NMK;J8%XV3]:3 MK-5=KNK)NWE5BJK@2RK9$CU)]4\]-E*@:H7F:UH^,X%XJ6Y4^;=U52Q9+?Z* MTC]V7/Y 8_3;4X+^]N>_WTRD\J3!F^2=U?N]57S6ZF93=;#H/[^PS8+5_[7 MS-TPGY=+WCR?M$ /E"_'RM,YW7*IKAV@B1OTD4D5D*HW4EJ7O'P6+JS4C?5K M5>95*>NJ4'>>T9=2LIH)Z4+,W(C_JE3K]&H31?F!=WS@';UK0,F>( M2I2P_",B_@>$/7]FXW*/%+9(S4CU20R>2:SKQ Q)K MJCRXJC/WB-&Q+V0VBX,0G_2GT[2]\7_YDQ]Y_[ ]\I!@*218!@2F\1<<^ N< M_.W'GV9B6J*\VJC96M!F/+'QYD2Z_EF^940)D+P7"R2[[K5$0'B@( MG10\LH(V:PNTHKQ&+[38L6;N>:5U39MYB NQ4^R\0.D_WHUE&A5K.(?9?=XI(^UZQ= M,MCX<,(.X",RVA5;V "RE@+A9)>\UKB(#US$/\_%VX1DXR0VO")1;$SF3B>& M3CZ08"DD6 8$IC$Y/3 Y'G]-Z3C)5 M4ONB,M5F3%1KB;R]DEPM&O:DR@JQ-H6U)JY.Z 'AU0'IL[&9-R50!E,HH.RR MYSHO1UJ##\*+*\XZ$YISOA_AZ"30W*X,C310M!04+8-"TTGMA03?K21T6HYH ME9OBF+!!X<62)12@] PHHN\)U MG:9>TO#=FL9#S39\MT&*H"N7]&[ (7Q8) ;&U#*!110=M%QG8M>NO#=VL4] M*YD*%TZ+;KW1KCY6C,I=;=60W'A#J##S_XCXE@0+RF(*!91=X;I.1Z]>^&[Y MXE(L,:4*E^,]+/ZVA\75Z,9%WY'XGX\&4+04%"V#0M-I[/4+[-8OANP7NJ$&3%G8%#Q4P%@6=5 6 M4RB@[ K7=2:.3B]<$AW>K_!A4V4@EN,,9JH>SFS;3FY/AW0[V'$'J^OG50;< MJPSXDLKP\P(>-F4%XF/L1_$I Z"R BA:"HJ60:'IK/:R G;+"N]ZRST$@(>>ORA8<$YQ)GYJ MAQ^:8'7.A7;6Z ,JU4"HOJA6*U8WN6Y>"6DG.#:6$.;QQ3DV\W4_G 6F1)"X M_1\235!:@]WWT#&J]5(#'GKP80 ;SK SCP9$4SR-?/^4&%#Y !0M!47+H-!T MJGL- ;LUA-]/CO%1M<8H$2^7N[P]J-2N&-_(?V/>2BU0DC_'9I(?QY:SQPF4 MQ10**+O"=?T4_(XNW$ M 0$E4$ I,36;,\1=+J@3UXL4Q"U2)/R%+UFY%,VV^C5L0*D3Q)+@1V1J63) MF4RA@+)K?-?YZ+4)XM8F$BZV5;]FO]$KGIW+,ICQMU M2,>:DL4XGIFZ> )E,84"RJYP72>EUPV(6S>X@A17/DIL^_6A^5C-W6X,?MR/_WE(/;_)!P! )*H(!28HHKX].QK^/XBI(Z?[V>0-YU M)L&W2<"6,PF68J'OQ1:1SE)R3#QB">C4W8PA8YNE$5[L.!D7]$E_\%-G M$JQ]&I@Y+@YGL]"/3]]>=AL?.J2!HJ6@:!D4VI[&R=%/.30_[?$+K9]Y*5#! M5@K>^QBK1Z'>_UK&_D)6V_;7'1:5E-6F_;AF5.7_30%U?U55\NVB^<&(PV^6 MW/T/4$L#!!0 ( -6 3%6R8/=[BPT ')- 8 >&PO=V]R:W-H965T M&ULK9QO;]LX$H>_BI ['':!9B.*$B7WV@!I+Y=Q)4UK79C[8 MMK%7:S5Y:;KQ44G]UUQ?IZYOJ[*NBCSC2F3>H]+_Z3Y2M5?-O%M>+[S/NI]K M[]+[[?'.^^GO/W^X4OJFYM*KM+W!I^8&P< -2.!]JTJUJ+U_E9G(NA5<:6NW M)@<;DS\%:(UW(OW%H^2=%_@! 0RZ/?YR'S&';EN0VOKH4 N:9IK99IK):NGI M)TQRE9?SQD5SE8L::K:FUA"NU3R][^L53\7'"_UXUD(^B8OK?_R-,/^?D.0S M5=9I@'#; "%6^_5W/=@450V*;*Z,[)5F1'FZO@Q)$,2^KYO^:5?4/$?K6G=*7H(/T7M( M87S.I^A,E77:*=FV4X+V[F^ECL)%_I?6;UOEI[F.P3][.M+I\/I#*#[5;5:+ M="T'1Y2DUX?QQ _[?=TO=QFP8?^<;!5,4 4/&_N-Y:,,G_0-2B##@7(L&791 MXKL@Z(]J?&U\)NI\7MJPR.M:*-#PMMI=BP(:)WW+\?O#KN4A7D5VXCLYKE?& M"2,]80G0(?B]3Y 5.%D!*NO?K8_57'N7'K4?'V[^N\Q *6A%1]G8B@WZ[ASH49 MO6<\E]X3+]:V:_1]9D)*[6^:9M,?H+@0&))"!LE#;3A!GL,(@G/$D+Q,R/R) MF\F(5^1\FA>#PQQ^@S&>"" Y'<.(0@^",H:=&@B(ADB"$ 5V)FG)"5SHD(6@DO_Z#2\D-D.1U;2AP^NI] M_OW^SM.S8CN0O/.^E'J2D(FIQI:U%-ZB*G0WPYT:]T?*) +4G@ 7J%H'%@0G MBZ_MP"]>#%"M\WIA:*QQW:D"-:$5CG'4/FH0XB,CIF,-@L-&VX7Z<NF"RSD\=O;!(8XI0,'X3<=W4N (), )Y!O$2H:6A7X<,^N9/$VKM?':YE=; M5IOQE%?KNGCUGO4U2NB@.)M!;1#T4>4R]"?]-L -/:$-'*H$.*K<+"NI\K_L M=&;CGLTCJF<\-0PJ 0 J$4 J0+D)"9)!3PPVF>&V!9 C ":\0#D2 M#YOJ@"+ @>).: ]+\\8?Q(MI6?#Q#OKT$ /H !3#',"!08"#P;[;YJ72I)#K MQQ-NU7[P3D)@+ +*Q>'P9"=P,3[ 8[S)UZ1;F)$FSVG,UE/O9D+@\3+;HLPK M* &(\:!C0"PP&9;@ GB !_#O57EI\P6SO.1E:O($F'_T0W3 @$D:?M,31CX7 MHH,$SR':[JCW,A]V=M;IC0&P#$Z(U\-9D'/5UFT+%]D#/++?],,)YMO&]IJ\JM1#2TR%<&B@9GF)3(" GT%,$ M%#3#P*#Y+M[2 _%VT](:\RU-&/,U94C#Q!M-H.G]8$H#*.T!%"01,E&A+NI2 M/.K>;>:4&H!$N09=A (3]L!G#( >_&[C'WVZLWJ Q^-?.^YRX$&G_4A+(\AE M@,A-_1#Q>1>4Z:&@W#:\XB]XE*# I)Y0 EA[YCD]=:&;XJ'[^W[>^>C,.@6F MX"2B! CD4-$)B89#.76AG!X1RG?M'UC< !4 P3DA!'J*@9(AI<,T2ET@IP<" M^3&)?]#Z?DR_#&A(@9DW5)30,$&>!A>XZ8' O;?XEY=/HC[&_+-&['/5UFT$ M%[$I'K'UE"(5(FN;0(]GVZSLT2L M!^D$\: B1%0,$*0,G2Q/#P4RX=$')4P M#_M!FB6 _;@5X\>ZT$7[$(_V]VNIJ;\>UR]A/X!K>()"#G[W$X0Y% AQ%.CV M7'=!P*[J@L+.M2H0]B$C]A$\"QT9A#@9W*1_KO5,?3.M_'KG?@(5N=9&[O, M\O!&.B@2H SJ0ZN'N"DG>*C#C/! AJ#;DRMIHIQZM;PM])]6I@U <0 Z0/B* MW_\$:8Y 0IQ ]J2YW !KN4_M5SW\Q@R M#0$8"(%Y U#NDL3(CB$' Q$. UT1QT)=!$S4$PH\KD!!YH=LV' 7Y",RBD== M?NR Z2=$[V$>/5=MW49P0!"- 0*##!8.T6B[-Q@&;ME^7.3P 1/VP M'D [('!3QH^\D<.#Z& B?T^E>!$RS1O">VZ7.$%M0+X^FD1 RAPWX01U#@PB M' P>Q&J'5^L%EP.."X3_> *,U/C]3O7)G4V(. )T>^O7+W=>62FQ3;V]\PJS MY+[UT\'U+OPV(Y@NZJ,%(9-D>$$D1"4/$.R")<"#1SV.+ MZHA>4-JY]A)$P+9%@DRT(H%U#>VW<,M/* ]0P?V=S(',RPL9F- M7=\]V(%X[2,4,F"S)*'#'<@<];!#>QQWG/.PH+=G*EI!0'($5^00AN$(2KNDCL)_UL22,*9!#PPT83R7,40D[?-3! M:3L6KAFP\< G,3 Q $KBO>+X@QU>Z!9>@RCX)-*;O:QR5P6 .&!@. M#&\1*,PR.B*M3P*!3R%'[!?<:X.N.$<,#">&YDS1[4G>=RY@8! P#)[6<;00 MX[3PEGX;-Y[$ ^ W0@4W%N"Z&IUW!#CW& [L&WEK,U!=]=Z[(]2J+4LFY3[ M*E>\ -4 , "N .$VC8]>L8.*&(<**]=TY'[O@GH E* AD$H$"J*]XT BQ@]6 M/JY7J\)N[>6%9\XO9^MF:2?=)+ET"&@.,@]LMXS/>L;R7+5UF\.Q1WS@>(51 M;;<;&9_,VQ,CH.RW+W2TBOLX0N+A-&7L:"0^<):BHT7Q%QB<\%K&"#GS^DCL MB"5FISEQ6976CW>2R_K)/!8IXQ/R)8AGGZFV;AOMG! ]P$*[&=GMEG>-=T4N MUNZ!A[? @ZT#;/B,$^BT%%!2S[D1%W?\$Q_@GTIWK%1V*:R9DJ;-+U::JI"< M9MS'EF@20X$1X!N*'-EU?!/C?'/7AL$VA0=N%VCBI?;1S.":)B"- M/UX%#< MIQ5&$V"W%&[9^$23X.1SUVJQAV6..+26 *LXH"3\OB=(SNT M["][\&=-(DZTSGJS!;.R% =OO\2K'R,0R,OX" 8D M#FD2'&D>[1#8\\ZV#\WX(EY4^\H8/I="#.V3P.\S1BN0@!F>524.>!(<>#YW MO/73[>=VMC%5+N3#9_K/A4!)/RG#*$&T.<1)#IP919_$8W6>:P$HZ>=LPB < M7M9*'*8DA]9_Q#)?+YLS](<%G6M))P$2.;=L39\4VS'L*[ MFYBX5Z^G=9[E7,(CZ[E2.$D?BL( >>?*Q+',Y$ 6!QA/#7,*I0J!;]O':QZA MKJUH]Y4^) $Z\6KG[55+(>?VI5X&E[4W-F^%VOZZ?7'8C7U=UM[OG\C[V^;U M7ZZ:YFUDW[C4OEY[A9CI*OU?S'Q0-B_X:KZH:F7?D36ME*J6]N-"\$Q(4T#_ M?59IA&^_F!ML7[-V_7]02P,$% @ U8!,50)R/>E)+ DX8 !@ !X M;"]W;W)K*N[;ZXG;5]]G5?-^['![N^/_SP^+$K=G:?NV5[L W\LFF[?=[#QV[[V!TZ MFY?TTKY^?'%^_NSQ/J^:!R]?T'K M!_K%IVJ[Z_&+QR]?'/*MO;']+X>/'7QZ[$1#W7]J[_YN93_?X'A%6SOZ M?W8GSYX_R(K!]>U>7H85[*N&_\V_"AS^S L7\L(%K9LGHE6^SOO\Y8NNO"]_N6'3S]=OK_^K\O/UQ_>9Y?O7V7[^]OKI\_SF[O+KZ\,O[S]?O?\H^?OCY^NKZS^(KVVQS)ZL M%MG%^<7JGO&>>' \H?&>G )'M\V;ZG]SQ)A%=M4VKJVK,F<$:LKL8V>=;7K^ MHMUD;ZLF;XHJK[,;^-("MO8N^^_+M>L[P+?_F0,1+^#I_ *0!G]PA[RP/SXX MX%S=K7WP\F]_63T[?W[/]I[Z[3V];_1_]VG?/]G[#Y_?F%7VM[]\=[%:/<_^ MA;FS^%BRFT^7_W=AKALX^8VSJ_RSN;%6UW:#M:C4&^:,L,UG4Y;(%>LPM$ MQM5JF?UF,WQX!ZSR]R'O>MO!JKH'Q 9[E=07C-%6>K8>> M^%B6XXQE!8A4P7?PYFW5]0,@FBQMF7V&Y08,M:691<8"GH!1$%D12H3%%7Q_ MMVOK^IBU=PV,[8:UJ\H*N'+V\^OL755T[2)+(*Q?*T1P>P:WEV>]+79-6[?; M8[:INGVV:8%O,4ALL\,5-5M8QGX_-%5!0'/9VO9WUC;985C758&_PIXJZVAY M< X5R(T=# ^++&W'7U?-+4"N[1R!MABZ#C98'\TNO[59?]<2M*JFZ &(#G#1 MN0QF[-T"]EH5N^S.,C!@P*QO80FP0@N"!8ZRQR7BPS^8O_WE^V???@_H.G0& MOOE]L-E-GM]DASKO\:P7V8W]?:A@YX>NO87!8!:'2]S#H60;F_<#T*U,F=<@ M] !YW(!/P*3(%K[,;)"(Y-OGL"C83=7*CGO88>D6!IYO<)8,SCD_*SN08PV MPZ'$H6%MLP5$ M'1[T9P@R-SN+;NBZ5-%G @C:W=TF_T\ZYKA^W.A(,'0+5, M<):6L6L!?Q3Z",,-H')3X"YA0L!H))P]ODN/NSUL^RPK\H/,"R> WP,$&UQL M #_FZMA&H=GD/E,4$,<# =44S$N#X5/RD'5 [(RLN?H2_%4Q4Y:A0 M #9^: S((;M?PYP7W[,L(BB6MHCHDV;7?^4?6Z_V&9$>? ] M?>UYT4-B.1T0[Y<&1D%. 0I*8;CJ-FM:("+;V$V%[(39!!Y\WP'30#2J&F1GA!:X\)[7#8 R39O5 M;;.UA"BZ=_\,OM@2(#:>6<$XH$+QL1]L5[6E X0N<9J<%NJ!JX*>>=]T!, + MG<@H$AUMWM%X .W)0'2T\,H#"W=X,,<3AB.'2;IVCXP%-U\U YXBK)&Q M8)$UEAAKGW\%8FB9$.(C-RXP8G@NO.K9,""C[?EC7>7KJ@:\0C9(S\^L=[S, M$^_#R_&B333SS#)!KP7:+( F48]T#-Y=A60 &%^GS_HMX21%[G;9!IBT#B[,*K#:]CV'_P MVUAFOS0UDCR@*AX*#-?=P8P+VO?@R&@0UH2/,/<='T] H>B@8(X^KYA5\DF!I]S ?R PZ;/B-SO>(*]L"=>+W? *P6ONU0' M9&$\/6]8E_T*]AM.A@21 \-QN#D8CTF-C@*L+& *\RBW(*B%'94\(_%$_ .% M(3!:1?'_R%:+)T^_6YR?GQN6@17OQ0T;Y":(-[#\SR1E*,UW8$2G:[%I(> MF,J8B$_9/2IR,@8!NQ$L=?.D00>2GA#>+.E )\(3+T'X1: 4L@2);O;Y%UP6*$S,M9TC)@H"%U!=K(B<-&%0W]#K<8OGE-='W#X*#]17 M6.G-BJHKACVB*VIA?*HP^ \CR7IH7<5BG5X&1F"KM&F7"9=WOB Y!T86W:/'$\TG>B[@XXDK=4" ";88:E<"J1PF= V]V MC JZ*3.(@"@M$,0>('4OKY+5&^1.:B7XBP@-2[,J2,#,/**+3X00',''P M<3(;V$1T #%/!PA"U*$[0LX$.DB\EI54UK<5AB8\MW5$L8QO CI8Z.1E/**V3'J"R 0;!',=T!P]@C\9/ZA:RMV3JR(?;Y$3>T0;N$:-R! M'@GL':W?=*&P3E. @+2)=ESW[=;BH%[ J1YV]>'7Z]=GJ^^S;=VND@KIJH,BV)+7!% ,' Z0.T "B.* MZZ'%3_A:!7RE8-7'KPS%,P+R"-8!F6C+["IAV++,]9%YD[[GM\(^)I!4]BLO M8T!^AWH;@X,G3>94E9$$:+Q_V?28 48F4XPT 1X I%*$!QL7HO(*'R.,,# * MXW]$-X#I>Z#=3J%3=6PL=((E; +$\AZ8- !S4XDT@)>5>$#R16I9 ,L0]DP M^5L,RZEM!_8#:\!9,!ITPA9] JSK?D;ZBT?+Y9E ]$'^,'U)6L)AY\)92@NZ>BD6&E#$ MR?E(& 86*GX3=I)QH 9=DVM+)JR@X.>32A-S$7&,S6"WFFM31$4;JX_\+[&1 M]+$#J5P!#CNDFM25_N>45I7JI#2HC&Q3E?1^=V;%F%E'&(F.BT)>!LNJ<:SD M.4(AL8-CY 36OT>I:"@\ M-"/:S!B WGC\]L*K6.O2);,CU7K"&C A56+B-G)5.>IQT' M>%;GK* 0,LH7(J_02[[+,:H$B Q\H7#1N5X%38:<@29'A4)'+N)?'X)207P8 M3"RD\07+-X".Z^TAQC3W*-T=:*>@@;AL=7[^5V)<\-II]Q-Z>V@P-.1T*8M@ MJX JWY;(AQ;BRT#RS7OQPFY ;)#_UKKGPJBVI(H(GQ)O)2HX#8CJBG3G=HLN MZS(CR+MH#",^KPD9P;H7A!DB"8 9 TO@,X;%HK-\2P96-!A)YV@V]+WD78.J M3X9R DC?]GTM>(+(&68](Z&?55LNS65!P495$UFQ*2O8 M>; #[]-06#;N$25C;312=N0TX\/\QU!N/=E(!*U#4>;(.RJ&T:$%5H]_,WEZ M31!-5.2_B;R=LGB&A!"P*+AH3Y'(0%Y SC]T7GA9S1XA1.("J(!"BA1;4N]0 M9*AS^(@V$=N;KF^++V>8/E(:U#[@!)2%<9R!0@@+,'8[V)4C"UB6$Y'R(F*: MK$R#$ 48$#08?7 (@"V'NW#=R4+YI7E$6V9O@<>97XG'):D-U^B#'H+B$-$W MJN9EWI6TTHA'[N&8 G<)R8O<:4'H@%.?PV)Y\B M/6VF$_$.9)@*XX ;DL6B!S!("??N")W75CPN8J):%&@-@P<%(M@NI01M&X>( MGWMXL1K?&#+)ZT23]+%MQ@J6L^C^($QB8HY6+?8.H8;&9L;&FG#1',7T@F9> M.PS $K<)ORZ8WO+R%N8"FFH'C?SZD*H[@-ZT01-3-^EW1$Y*U6#2,TGU -(7 MT8#!\0-Z41H QLM1Y8X/=%>!@ "T/K(.U@"".G(E.Q8&'HZJ3U08<$G]C;'=,)/@(Z@!VI*_(@+E:!-B_D(FYC M/J&^B^XTQ79B\)_.9/0KJM2#'0.YV M'"Y"AV[?82I9H>+_+:?#Z6XFJTJ2V(*A#,2-@LDR?=GXE([(&\A]+9%>L84Q MHZ[2%#!.9(#)C\X?(:/1:-@>-1(%?IG(@*I+R2%[.+@!S\PDDH*\-57A\ZG@ M;LFZ=7) C'[R\2K[<:!F9&)>K1D<)LCQ-+0T1P@PH&6"#, M06[;>MBS:VHFB$(%+;< B?G++('C,QH5*7F"1ZV*\']I0(8"-K)M<$ MIC5IF[/:6XB5L@]9DV )($JB(IOHH,DFYJH+TMD0.#&T@)C;^I8,7]0OQ-,3 M08WLZ-_$PYJ\^F>A:0(T$2'ZJA_Z&2P0&Z#O&>]1OPL>1XXC^52_#4EGVEH2 MAA1B3$W$&4R@^/"LG]L%*8EJ"0(F.2+E:IH$-ME&/*J2I"/Q3F) 1+%'>?9? M1&H$S#)K^UWJ! 1K#.&P8Y+._4C*)8 6>)=B;&=!U\N;7E'7Q*A+-HR/2#:M MZ#P=KAEC"K&V,(?ZLGL_QU255+!F2/5'?,&;3L-K*H^%FD<)25FN:DZ3FK[\YA'\=(O5]Q MQ&*TB63/6;KG!9R8\KTC$4I(0V+'"M1^#?XLDCR8IZN+L40@>4C ML2G(J"PZ24_UI\/!_7^PO8N<.J!'8-*&LA+$YK"$Q45Y%F3.BV7*K5#L" R'L5J38QG)5]J^<_ MF&.@=14#IS'>![31,H(^A^C2BX,'35M1X)1U[=O2ULPL-$<63M!O50DV/?*1 M8G/=L!#"I)G@B'OS%9.KI]'G'#&S*\E".K*3,D?3-M8IO*J3=ZUF#RZN''#Q_? 7FJYY*B;M%8:3*C M/_8L[[V5'#*]G0]!9E:*6D2W5-];DI5/3[L);R3^0^F6'/N2-(>F;V B?/OC6LS?5<&=OY+:IQ_(F32MMN')2LW-PP4A8F"S,C(R7U'K,7.%ME M][B]?'H;9:HI\--16?D288?"["8R5NDK0V43B9)&"J[XC]:8!B#E7R18)$>A MBD)$.%$P=FK$++[KDQ4G9(2@5 MG#V'YVG5^">K3L JKW"$G\/MJM^0+2Q%9**W4>'/0 G1XHN-DF,"^FK*;JR) MB4O/BP"G M68A0ZH\X:7VB8^F#Q^PZO:1."7 M3#3OZ"'DD&X095\L\PQ,\PQL\^S)LU>I*N!-G\24\O.T&X,B0E'#:T&)N*DV MRW*(#*(6"0L<#69.FIIR(X3U+O"[$0/1F1<2') '/( M%QI@*BR%*+T.W%(*N*S=JV!AI\2< D,*OP"!]EB- 6E,E&N>JNIC%TL)^BG M:I..?9>[R"$H8T_63;HC%[&5;8T\+['<)F>F$=>P)"I@F&Y==B$IM5$YRDB> M)KAL1KB<8H:R\Q0/9@WP"HO1VB^DH[13KX6/$$BN,L]C"N\@UFPNS=@7SV\\ MR(*T$5_Z,/DU!I^$(!JIZ$LC7C-[SV>,Z%G/ 9?=B!L2AZLTWB&N=?3]>\F= M\N!NQ)]29V \:)3/B<9AXM&[3U^.=$7E;]RZBRY;B2V>4+8/A%<)[7$O"RL6T ]F5^-TIB> M,J?K%M&ZR9LO^ ?Z#SVVO[4EE:B_MN1BP$08KN"(ZZE]OMK;U]=7H6%$$]*' MV,?8L\-:(ZB)34SXQ9/51[\*]B!04>7%-^=84IFM%N??4W%E=G'.WUS*+.93 M*!ZZHBPET%-9&2S9OF:_)F) [-FW8V6ZZN:J .9H\EW(W&([FN6N1*F8,YFQ MP^I$L1-%7GSA(06>X:<*3!_QK\096B$J/30%,&.TEVB:VX5QHDN4UI:'S%LQ\DAF* MH0BS8;C_R%9/Y-B_H7^HQACM2(HS8U8]'32=S4T4MKZ2D\X^5>Y+2.0RL99. M>_.9_AB58E],HC&) N3GI(Q%GK/#H:/F(J>IBW-@)Z>^-/=3?\E$!R=#?"C@ M9"5><3ZG4)''":5<)ROJP,\GLQGF\X&G\(2G9W/3Z9X^63Y=97]=F-5J^>P<_T!D6)TOOWF2_96B MJ\8K;2<:.$RAT,2,CCEO$?QC>9+>,5+&2 >5!%$.[NKT9G[Z*5C20XBG%Y-R M]=URE?W<-MLS[%%2FDL.(056:E); &4@NJE#\M%<%$ KJ"0&,LH)C7AW[6?6 MW^XX&LKU^UT:(0+"0)Z.7JI149 4=5&%*^#HFU" E(:8HO0RK7;SJF.LT&1: ME< NM:ZC&@U)WM_\*_M#<2NFO8(N247 =?^AL8%L'K)G7X^-Y1Z#P>7QGY&3S=VRS/ 00!287DUX*+6@W![ MH.$>,[GF2YXG$\=RE>H3<66/7_QR8)1<;R,'>1D MX("("Y88OZ]]FE(4]9-1BD%59U$W*0'Y,% MB>?(C4V4Y*%E]KZ-9H]+.[R.'5S#U(_D?H+SQ9Q3>AL9SNX$ZUSA&,Q"@\>[ M/F+9(%*0!"^L;V!TXFN,(?5<#,,V MD;R'.'/45(*!C>83R!:V%>1Y^R$#CS MUARB,2;/GQ$-<0"-"T=WH=H!43Z9_B#0R5+HG%1O*4>A,?ZUMAO! M%',0]9#OR$%.-(5PVFA##]=+KC[#^13,Q93;M[R%3QI%J5SDI MIH>U+K*'%X^BDB.3#_V.7-)Q7Q??)X.X;BB:\&N3"?AT'CYYA&XTAN&:VS>$ M;!!>B79X\ OQY5HZIM%'-"=:- UQ(C:%F!9LSPLH0W_+^$(F/1-YT=+%!<$ M; S8.XQ[AMF#!'X)Q])!ON#J.Z$60[S MMRA0>4>91]&;V$8-UBU;6 /,VX9\UCY:=5N-+ ;MJZ4G2#.2KUT=$>B4D &T MH2_#K4CU+BS1)2KXJI!8A.ANG MMGL"Q50R"B3$#) C$"%F9JEYF?URV*)\9IG 36RCUFLQRG PZ1CU_,A+DJ+" ML7,B0F8/TH8I!E7$Z$V?NR^4X8:>P /J+NW@R!T,$W*VXT8?!L!$3"72'DFS M(,-K0=UB)?';^48NWF#3T@(X4U!D&FL[[B(Q*3W7BFF?R^5-DZ,DTROGI9;N M*#U^ 4A?!MO\9^KO\R'J*X8H0$]G\=/1PS][!A:7@FAF8Q+O&5NXX4PW RK; MG,XV[*D/'Y9P'*4A)\#%<$P9OT>+52,,R).UBK@]:#LLR13V"79';NE$2K&D MB]BOMBNP\>4B3H1GV9)'[F")@1><%P!2;MUV77M';@,N.SL>-(H-5KZ]RVN_ M$.X.Y/TJ?VHY&O2,^ #G^29*VWJH.'N.XC8 %,RF0X8,NB'CO_&)"KDW1"5V M&H$QJ0+$1_[D4<=@S^.2/TZR)S"8Y#S(D-5>2]ROQ6\Y=3B1(Y6,"TH;Q9R- MHB*"K5G)&1K^_KTE,4]::^/RR]/S(<:Y)>EG ,9]2;:0$/LX?4+P-<)4> MNYT.XE.G*'.)Z([<(C2W.BX2%!OI[!3PHY).6H\1[WDN=4T#AK6Y\J0 >[.Y MK;JV80OH)RD\]W\84:N[BJU"IL^T?+W=G&A",@U^1?7?#KU9;,C$#3M$L\&6 MN\$=T93FCWR#OA3$;T%CX:K[I?[YWB('U$+[D2GH)5K:-MP9+9-IT.0CJ%/5 M4.)=+?"\QCY6[W\:PX&.*9V&2A8MM12GTM+8HO69@7\\!%F&%-.8#K,@Q)XZ MJKR?:)QEAG514@PT=3]Y*$9AFG]N/>G9A$Z9^"15NV.D@"/)^PK %@P=Z MLD",6;-FDJ# I **^XJ8EMFKV:R"AA/:MHX%2OB]HW8R/F_+:;,>+_H9(=U=M]3OH@EU$[ MZ7I\CN.S(Y='8@7XHL)DF.FBNQ 'S+0!%XHIBN'6U1=*?$4V@P?G733_*K^\DXI"TJVR$!4&8(+/V$G;,B#K_1J>WU YAU(IEO.304R(.-B8=F_SFI5M? MTNZ#>JF+]PEVM06-M=_1HMW"*'\\&_.@!5V&PSV4I9-TE$Z-YXB6!4)):KFT M"9H\SEQ)BZG)'Q!U/0ZQVL"7V8\B<=G0=B)II!*C"S4^F@"+:PN8+=MH&(D) M8QR*$B;)^HI%)2D3Y(U&W3/)>=','4Z'T8MFM AIW&I,4BTYB_?MY+D";A]T;&S=:WZ.QGB+D1JIRXX7BV/_W99;A-KGT5T' M>=E2A[?+FU_P#J1OSU:@%[S1YG@'*W?>9 ]Y&1?/SA\M0N"!.S/M['QB@!9$ MSL+$2/4:>MBU4P%Q@5#-W/JNT=%["R0@["[#)44"U"S<88)A+"%H?EF'+Z+* M4-]]TL19#&$:B3*#9UIY'8+(@9-M];9==]J)ZD;FZD MV*DO#M,:U28-Z:5JG>*W.((W:6;@(;O5KA+!.Y.>OQ[Y_?#PDH--F_2.$IC; M\-RR-;LG^4>5OZ6_7(K'(7*/97G(]4M4E[0,Z?CIJAN9 ^B!>^G,65 M^#K*M)Q-JFDBIQESZ&/4VB_J]99V^3R1WS)_5\VHT?6D((N/5&[G_B6J0)(?O6BTAR$]:A<06^+TG7_O M+^J383A_X,IW'.+Y-=U/6YN(>'EV_NR13\[&I<,7<3]1(R7=;$SX\E+2WUON M!JK3R/UQXB&,@KAI'CSM@+L8^Y[!;;)9 !6%%5L^9X&2:8D4W2VWWRD,I'I&M\M-;W'9.G1 MB?" "AFH1.]XL&[$'O!HHHXBY)!%$UQ:PYL(]G=GD!@".Y^16@.(*+D5[KT.MBUPAQAWBZ^#95_UB'(Z8TSS! ML(%_$)[B<*4R(U87NXWVQR98&X[$Z<6SAX0BUMQSY.TC$I6T.T[UQ>QSV3?8TN^>_Y MHA]J?$>- X*0T ZR,?2EMY_ZXZ2M,;:7;[FM"C[,-!MROFA,ZOVB="?7MC#[ M5_^A8<TS$ VGGN5[$ZR[QLBUF M[(M4.B!\P'3JP\7)WE% V84@_JAYESIDIK= D1,,L)22SX- $P>HL^G=#=$- M6)@/YEO<1W['Y%:K-(+J[XV-6@\KETFS]QTW#4='(E]+ND9JB;QJV'B_+0*Q MC*7!<\H_B](_9N)^=&)G>8VE!(FLH(C2SGRP_W]@JKCO&;\\4?/GT4DS[I6>GYS5-L[)J4]M5$ MA,BJ47U8DZ=HPK@6@34#<\EK+G?7]&1^FDJ8Z$9(8'[<(@<7?]]&1YI&D6J< MH< DU3GB/+D]Q44G5,.FJ&@3P5OL1^3VSHU*&%'7*0."P];)]+G]Q< M=J].0SK@#%G'L:82/3]292D,T037M<_FK>'-QD6*G]Z1_%%N3>82-87!.!N) MK[9C"'BY&95&A+N7)IXF.C;26)7$IZ\&WBJ*WEGYA@3S3XCTJN-(K^CC5H]GVNT6V!ID. M(]F*N 3]SBR=0Y$UA[K"0)36=8O<=6D\%OM+%3JR0'S.N8>'^ 8:=,U@XQSU MS'/"/LAL4%_61ZJ_IP>ED1X"$!3T@R2VQC"+ &^T+U*,<.COPOP#9=^K/V6!X6RH 2A=W'D47Y67B60=FU$&E,)#KRS2 MF[GG Y.E-JC5O:@_*]X3OC@T$0Y$#2@$<3PL_LE-SMX&N0@V2!K^ZNR+Q_W+ M%X\K!_\KX+^NO8/_D^_M-1#FRQ> +EM[!?H%12N:_L<'JP?1M\AN?GQPN?KA M\N+!8W@S//[RQ0%LG'=YM\7*^MINX-7SY;??/&"YK1_Z]H!#8G0"<)/^W &Z MV X?@-\W+"P 1!X M !@ !X;"]W;W)KO(++I(@74 MQ)(OL7L)D(O;-= F09WNP<'!>: EVN96$EV2BN/]]6=F2,F2:WMW@?/01I;( MN7XS\U%ZOU;ZNUD*8=E+GA7FP\G2VM7;BPN3+$7.S;E:B0*>S)7.N86?>G%A M5EKPE#;EV47<[VY$9E:?SB)3JH; M7^5B:?'&Q=7[%5^(J;#?5H\:?EW44E*9B\)(53 MYA].KJ.W-SU<3PM^EV)M M&M<,/9DI]1U_3-(/)QTT2&0BL2B!PY]G<2NR# 6!&3^\S)-:)6YL7E?2/Y+O MX,N,&W&KLG_)U"X_G Q/6"KFO,SL5[7^37A_^B@O49FA_]G:K>WW3UA2&JMR MOQDLR&7A_O(7'X?&AF'GP(;8;XC);J>(K+SCEE^]UVK--*X&:7A!KM)N,$X6 MF)2IU?!4PCY[=3>9WC[$$W3E!\ M0% 4LR^JL$O#QD4JTK: "["J-BVN3+N)CTJ\$\DYZT8ABSMQ=$1>MW:U2_*Z MA^1)DX"%LBA%RAY60G/$A6&\2!D\6RG#,_9)JW)EV'^N9\9J@,Q_]T7"Z>GM MUX-E]-:L>"(^G$"=&*&?QB@"R(_*9T"P>N0R%[&DIV*W*5[S8D(#+=X:MERK+-DRM M"PBZ*6=&IA**G]U,/CVI[Z)@"6S(A(6GG.5"+T B!+XPW%7M6MHEN]'2BD>E MLI!-"@#%&8J/.^_J^_0[>OF5JSG"E6Q)N MK9'&(#JB83?L]?IAMQ^%@VX4F"6'C;A+6H,FYV :U&;RO;;E.OE12B/1Z&!* MRRO-#%HGXUE6*?4Z$';0)8V%"UDLF(#]=L.VJFKOSB'>;$^\.3H$D$Y)*ZD! M^4&2*8,"=WRTV^PP\9(L>;% 3WNCL#^(X=\@[ ][#4^;&=JZBTKB7AQV+H=[ MUM9IGPHMX=$=:"R>A;9REHG@$1JNT!JT3ENAJQ?3[3ILS5R.O<';;$YE#HGD MA5"E 8 13G!#M;+M<.+,$&D0QV$TB!NVX[*V!4P65K&H&PY&<=CM],*H.SCF M;#- (<-DKU9:O4B8&2+;!+WST8B]"HYG_V^*/\SLBB9(I-)0%=*#8^M* VB2 2;"5R!9AF>"P24W!N0)4]A+6'!QY%BU C* MQ]\?[W8L'?-DZ?PZ%&93R4-XN*@/HLMP&!_#5M .-_24/V#",]C+O3@B#)G, MI74.FS)!;'!+1A0EE1%(;F-@/]Z;.9)Y+J![45+YW(*0A7RFTIW/O0E5ACE& M]V 1^845.,N5*IJF[X\66 L]I% 6,L%R!5$%EXH*775+%(68RT3"*'N GJO- M4J[8YSH6V_KY3:W%\VY?($M012:,(?G,R!>[>:,*P5*^,3X)@"$).(>5$OP$ M(%1^AL!--I#)! BB$5@+J?#7%./CUC&>J[*P(%T]2R 1VZ3]U4:)9@?@$.R& MYB9$:M@((O.J"N:^K!^MM$.99W\C\U6MM^3]K2S3E/)/JDX&@;>^G>U IM( MVV9RRJ)3 =8L9W,N-7OF64EP;#4F=HKLJM/IL/.?BZP)8M3<&&^,QALI;YF9 M\-*(M(FG.K#[RP"H 4;78/AJF,RURG<:Z&#PBLJ[93SB_M4[;(?0SJ :VD N M%,M4@60"*9\&#N(M4UO>UT# .?L$9X-BK^TP37%MX 4Q]2ST$5%M.\ M>*XR M[+U@P781ITU[AKK$DTJB=$K1I^9]/;T-AE$'9ZD714HA:QP##H0#5395>7SM MMTG#PD4A_R3*Y;T#+$2=<##L(1Z"A&=)F:'%9.@1P\ M?&1W8V"&TX?/DSOBA QNW7R;3N['TVF AD+]NNB@/@'134''F^!C"X][\'S; M1(C#9W#+M=Y@N?G^ #MQP%6II0HMH"J%L:VF.P@[0.)0 E"/9PE,H6)9//T# MSE9PN+3FJ+2S"*@11 :KY'7PI"PTH*2=AK-!V.OV_(H;.'[B*5$ZL@C%[K1@ M6FNS>F'<)Y'!9XI^P=+J^(']:4N23T%_G17V&GH#9;K)C['HJAE^% %KWJ:_ M+] :ZW*##D,2S)NC)Q+1#\4-XR, MC'7AT@@;D&'&8KYJ/HFFT4R"N"8;\K_25,5]I\<63AKZFTD^DQD COHZ.B\< M6V-JAB M?@MVAN/F-6ND3-5LKH)&E?M4ID1%?88&B0*(<.\TSF GB,[C:B#I^SA@037M:L8(EU3FNF02D2FA7*B&. M%OFCM5K.2DNU[_-YJ$S<<<_-7^HVW&/,T.2BR"\66BRPB)/VE'3)QE[AT>![ MD72=/6V^#=M/9>KX-2A,,.,9X=Z],MZA,?YM7:=-%:ZGT_$3N[Z_8Y\GUS>3 MSY.GR7C*)O>W#U_&[./7AR_-]TR-UTR[<[_IT;8S&&IP1UQZ"W)@_!!9Q@M$ M,!0811 Z"57?M>ORQD\M?X@&!Z,P&HTJ"K'B@$ELGX41+J@>ZR54?&$KVP9^ M/9J 7 /6H#(L:!.XH2Y]2,X%>-C1T"\ MFO8D.Y3//3ED[1R>LLNP/QCM8UH4\29P_E'8ZZ"N^(: 2_60)!H7UF&$%MCO MDO*'5C";:GO]N.%_\\G_+PA1V.VX5D@U)PMXBM/!E7R[,+"H?14ZQ;Z_N4ZR MWPB726*%M-;R%T'D3Y6Z;5FU8*E5N5CN>].ZAKY*^WZB? F%+W7TX&CC..KA MV^#?@FN&/")ME7> !E"-!U_QN%U2!KM @=U1\I3A^[6A Y-R?%R[A8CZD1M\ MPXX;PI\T]E^81W-I86.WYX1 *KP(_YH>3]H.+\$X7V5J(T0]1!+08F!S+R(( M@RUQY-#RA6@4H1F 9X3KK37P(GRO1UM&?:?M$23B=RXO$\QP/)U==ES]W0D( M(<3,O:Q -.<*!O^?[D:_ZU;W_;'E$U ,C?6*"U,DC/A- ;]";8WHA9'#=K7; M8USM.LY&87]XZ5:&H^YP>WX@T+4[^*$Z.+L,X][ GR;.>F'_LCK:N-JK@OS1 M80.TNTB< 6>YC/V^-Y!YGA$?R/SYQ1%6PI@1@$!7FV] 7^3E3X"P2$U'(;!O M476^LPC.0L-:L/>]:0O:'/G OFX(W+I^R-D9O1=P+Y-,]8*\57QG42_L7C;B M,>A5XA\/[WKSU[KWU_KICL+3EDJV[^/01>/+'GT=P>^7>"2#ONH^\M5WZT^D MU^[+X':Y^[X*U;"0!1YYYK"UBVJ$O>\V2F]'FM MS3>[D#(3WY=):K\<+;)L=7-Z:J.%7(;V1*]DBIV9-LLPPT\S/[4K(\.8+RV3 MTU:C<7&Z#%5Z=/N9UY[,[6>=9XE*Y9,1-E\N0[.YDXE>?SEJ'A4+8S5?9+1P M>OMY%<[E1&8OJR>#7Z;-W1F=YP._*KFVE6=!FDRU M_D8_!O&7HP8))!,9940AQ)]7V95)0H0@QI^>YE')DBY6GPOJ]ZP[=)F&5G9U M\IN*L\67HZLC$=MOI_O-E,!D\#T;#R>?3#!1I_33RM^_<[=8/;C=;XE&GV<**?AK+>)? M*40IY6D5\MRUWJ78D]&):#?KHM5H-=^AUR[U:S.]]@_HW>46*]:*KEY.51JZ M4$ACT;$6(=^)_LR55;SZ[\[49@9A\I]#AG!LS@ZSH=2YL:LPDE^.D!M6FE=Y M=/N/GYH7C4_O*'%6*G'V'O6_==*[MP_+-AP]]X.V^,=/5ZUF\Y.H%2@]-DW/E770Q21$8H M>C()UZ&1(M)FI8US:"';$S:V9.O!LUZG=@Y!"S$F^50T':WZCX@Q8Q$K ^ 0 MZX5.DLTQZ$ TFT^MBA7 BS1SS$K>50Y;NSST@D<5&?U_Y]FJ\A1[/+MAH@#@ MJ0J#';-5G4*9 +]X,O5BO2!6=74LN@NC@$VK!;@_A OUAZH+(F9U@O\R'7V# M#C$V(3.M%]1W6$ZVYPKJ)T'5C,RJJJ,@NUF]E!D*@X4%$T;W5YELJ$)(0P&$ M\$$XO;'0B>^-=>79,M&-A&>G2A/7" ,Q! MSV5&WB-*!Z2H$#FHS@[+4AV^ML/T!$"+F$,1AYR-JZJ/X@*1M-!KT[V^?+OS39?VBZ9XFW:_]WLM#/QC= MBV[GH?ORT/% =R^>7L;=KYU)7SR-!]U^@$2)\L1EAP_=56ZB!>J^6!D5R9O@ M/E1&O(9)+ND$Q[I ]$0>%C^(LWKKXHP8@QITJNR58@:](EBA,2&A%:WZY27O M!P]4KM@<0 .)X(Y%K=UHLRH?@V<3IC9T+8W\CM[,(HR=HL%O:("(3Q2N5!8F M(HS_0 >Q9,1HMEN>PM..0A!X:RE*C:S"@' YC"*=(TUBN,2(W!9N#BNE$PFY MT#%\C;,FQHED4Q=SK6-V+Y@A="4="Q$JH(0%(B&_1Z2K-W2F2>:=6 GT*X*, MN2U)"$ACK9JG+LMI'4?33,V4#QO4=.LD8S8(PP1;*E&<[=C/EQ)RDI[Q&Q= MC@^B7892JW5=&F4W")!U49+'H+C^H<6M Q4"+.H:8T$1E1L0D(E"(T> +BUP M#-7).OPGZ5:D=N4NX/\/J@E0%P*D<^F$=]G!KF#-74^M_I+.L"%VHW>BN+#> M_VBP&S%Y>7SLC'^G#.H\/(RZG$!O\T<\CT1G,ND_3UQ',>[WQ,.@RV._%W1<3%D?X:1"7:3HQV!_%\J#-(.V"AM6G%U<\=K/14!=UB\;%[Q4 M$BJ1@PP912:7NYK4VJVS(O[#C=&$.D9G?C9(-)J5VEF1(2-&QB@W7&QWR%Q? M^C-E!F?A]_+(AO*LZ4\,H<^^@:O)ME4Q\,:;'1 ;#)\[PY\' M=P_]-];N3,139_Q,KKE[F0R&_/=X,ANXS1*_B5T>M!S62@4O&[#(TE M7(DQ[YEOD+'ED @2(DE4JC(9]#1->$$:+J5+D>KF4*<1\%RBSV)/B?-@PT2[ M/,"@BTR@EFA>L=-$V^]^*#S+(5TD W"F1%C+F,/@4(I''HY9&L'2K-$U8@Y# M\XBLPFVTCEN0HF23L^.9TU:!BBB67V[&:(5P(J@ 23@#R,1%#VN+B(N3ZB3#D6 #"'*\2].P! -#F M%IRSXDR9N#@D^% =>MI5T0DYA"@*+('O5DN&@@H"[<'"%C?L%K46U.EA&Y*K M=)5G7B-,FX3CT*(<%D0Q+#CC5A@%?XM(JL*1MJ<0&OS<:P=ND5]#E90YCN.H M?51JZFY*P&G-:9LMR.JN;^ <@@")^LO7$\>;_+PC3#7DB'QNY2Q/X/A7Z>J3 MS]3]A/X$-@?XB'T^MFC6]C)^APX(O4N$%L+W *_H!UR+5U.OAPE60ATKB.EC M[C9V*N^)Z.6F:%!]W>9&8B6-0O#6U@L5+<@-[$NW:*2'.907/%W #LE M!(5;U9];$N4(*4N1I&1]U3A:(0(G( M 24% 0Z-+G',Q*E2.P=HLX/O2W2B4X*-2,]3E-/828"XDA B3V+:=878ED74 MMR;DG8-$D0>O2N>6AY2",,5YN).+"']EZT+!)7*]KY\SIXR#<*KS#"Z,?!Y& MRD3YTB*P(FGWC%JV5OMVY7/,ZEN*,1,]/>L&@"'=;9YD/(A["&61*P%DR_#= M4[1@"!F(BP.BBGE@!YGF+F9+>-R?$(&CU* Z+?&0\'PY]Y>O!EMR]0::G[^=JOODD1OPT=VA+!KM\) 7YSX[I*TIO>9<>[G&+LEHV0ULX](GC N8M M\UAS2F/"IW%?4%F+- #?NH)H-REF30I JO.%); A9S,5*9GBGRT2F1:)B \[ MZ.6 C4#\P],>Y"UMK5[!04]\8=3HP#EJ,NWGO/SU 5OX(K MZN!*XZ9.$__2"Q=(W0(V5;*!++&B\OG*0^=Z4>)EEH/$X3#P&I;!$A4C]S;7 M.1S>Q@J'BHZ<'0ILGLJY2BEEBR+J0;_4C7#7L/38):ROBCS+,U20PY*>B">C M W[)+KK5E)[LI/1HJ]J]3^G?WTOI:L?\-!Z)^]'XL8-F>#@9/0PH-7MB\HP_ MCWV7Y*.G_MB]& CXC6/ ;QQW7^!5).ULA^NJ^,[8U:R_J)]=NDGR@[AN7_JG M8YX%SIINCNDB]((M0F+0:-8OKZX]0-2NK_S3,6U<715#R*@(]:!\%5!KXF:K M5=R\.B^N-GU37VNVZF>-Z^JH4]S&E%1O- M8JC6W3&F]?']@]*NBCS*!"V;$ ME:0IB)BWMG>.M[\(]H("]FCZN?"S&/UN-OF^V#^+@WZFX3KCI[ M+S$ME(#S'O#OC+;;*.GT?GF9/%-D3().!>[(1ZHRFE8&.__.IP]LU1LI V @ M![%#E5JK?>Z-<0]@!"3!:6Z+JT+@[5@C,[%="F-\%#L".++;YJ,0H#*:<%NP M.[MP#684TS3?,>$+]^>@P,*]H$[Y>TBYMD?%:W3H \=IY8L4O[*D[VXTX(* M^SA5KI:?]CKNB];VN/LN^!@"VY'SB9SA:N/D\OQ(&/>MS?W(](J_;TUU!I7Y M<2'A?T,'L#_3F//]#V)0?O"\_2]02P,$% @ U8!,5?Z/D\#,!P .A0 M !D !X;"]W;W)K&UL[5C;;ALY$GWOKRAH)H,$ MT%A22[[%%\!V/#L>9&(CCF[]^3Y'L5DN1/8N9UP7B MJ"]DU:FJ4Q?VZ4J;KW8AI:.G95':L]["N>K]8&"SA5P*NZ+-3)NE<+@U M\X&MC!2YW[0L!NEP>#!8"E7VSD_]LSMS?JIK5ZA2WAFR]7(IS/.E+/3JK#?J M-0\^J_G"\8/!^6DEYO)>NH?JSN!NT$K)U5*65NF2C)R=]2Y&[R\GO-XO^$/) ME>U<$ULRU?HKW]SD9[TA Y*%S!Q+$/AYE%>R*%@08'R+,GNM2M[8O6ZD_^)M MARU38>65+OZID6&5T,:7WA3_6Z 4R4' MY=X9O%78Y\[O+SY>T\6G#W3W\/GJUXO[:[K]A2ZNKFX?/GVYI\_75]VC[V\\0ORKHS,E:./VEKZU\74.@.._'N7I4'.9+<GVR_7R81^^N$H M'8U.Z'_53K=E\ILH:R0VI:D/T9!$F5/S<#P,#_OD%I*N]+(2Y3/)TDE$@53I M-,U4*)%2@WP564#KI.F)M MQ5(\]TDX4L!H-=#ERF9&363K*T6BC 7B%.5&H'FPHNJ8C ]'G3A+WD>C:3 MOLS216540<>;IC; :24L3'*2"P-"ZK#TM[J4E([#ACWZLI!):P5D(4*5>/91 M@]J.J2SYKG4BNI1_TL5?5]#8.C!:?P_[9JB>J( :AI;*I5_8]B;T$$5E;.!J^>=> KK3QOHJWW]-#& Z0RAD@8C"5 MB$2@Y7B(),NA/"ABC_!CV5(E1SJWSFERYX2F@+/"U?,:4?J7$(F9DR9"P0__ MRR"[C2DNZ:9,M,F;6@+_2];J9QZ.0V1Z].QVYC*;YP8E 8X68;L";.5KFT5& ME^_IK7H'=A_WA^EQ6U#2X_[^Z+@I,_<*FI)-R3N,PXM.=>O&.U8X@&BR8"N! ML%-0H<14%< 7&+=IBJ_ZARFQMOKW(VR(Y'Z7NJ:C5U *X6\[ARC7[.$P"ESD?OFZNOF.!!;L:@;KGN.K3R<* M_DV>;,CL&./Y"]"Y1+U64R;!5(/76+]1U$([Y"=-+VP#947A4Z ;:&W4' W1 MQ>81C4C^I+G":U7(JP(1OK HUQB@P6SAL38*??'U@_4&@[RA#%Q96\LMFH_3 M_L'!$8&[X]2W^ZXI_:U"#+6/Z+PR>BN6;M]>]T=#3_C146RS1T?^]V@4$F%_ M$AKM<;A-#T,73B?=V_]GRZYL01G#D"R74WCC3X:MC72)@Q#7Q/SG2J P4L'- M&;5M@2TH?YB3,93D77F-^63XY,.LF=4.E3.Q]90S(8 W\E&6-?/9Q_[0QSYA MGY]@T#*-3,M6&!^L9VK;U,PJRTHA" M_6<]J+0X TLB+C\BW8=&216V<=5G_OKC0"P&WC.TX9E ,\DLX4F-HY$TW3DT M5^\P3E/,!3S5\2LV.KZ.0*(104]CT50*8R-H^Y7-S\)AI>##2E2SB9&G0#0A M*SP5;<+];Y/DH$KH;?"(]Y8?M0TVS4/A\V!YQO/<;XI2',LQ&@EK)6N[*:E+ ML]'+-,/XI/'.=$OSPNAZOHA=NN%5H YUJ6.CH_S$H$&/@W3_-?(U1+5H##)2L07F1K8G/D].Y9K-1D&\SIWU(COL[ MPO*6\S4=GMQURUI,T:?Y*D+AJ79.+_WE0N*D87@!WL^T=LT-*V@_%Y[_ M%U!+ P04 " #5@$Q58\3,6C8# .!P &0 'AL+W=O=7$.ZP4QI_)-V*+@F09!DV8%V+MML.PPZR M3,=";CE5C2R'Q5H-I MJHKI[1Q+M9D$<;#?N!.KPKJ-<#JNV0KOT7ZM;S5)88>2B0JE$4J"QGP2S.*K M^X-O C?F8 TNDU2I1R=\RB9!Y AAB=PZ!$:_-2ZP+!T0T?BUPPRZD,[Q M<+U'_^!SIUQ29G"ARN\BL\4DN P@PYPUI;U3FX^XR^?"X7%5&O^%36N;# /@ MC;&JVCD3@TK(]L^>=G4X<+B,7G!(=@Z)Y]T&\BS?,\NF8ZTVH)TUH;F%3]5[ M$SDAW:'<6TU:07YVNKCY\G W6SSU[SY"3B>^0#&,9]2*(D/H$W[/(<>KSA2WEJ MS(2%S\H8^#%+C=5T'WX>R[3%&1W'<3UR96K&<1)0$QC4:PRFK\_B-]&[$RQ' M'L^18$%GZ.IBJ-TXBC5+2Z2E M!Y&TRRK5N#_-@MZF$+P J>0Y9Y)35^V,UR@;!-XA;80M=A<9M8&"K1%21 FY MD*P4OS&#M+%@"X2:;:G=+0CI13=Q0.5@D#=:6($&A#&-<]@Z@]X>%5HN7#4E MZ1 8+:N*6I[4_+$/Q#]'31>@W0"E';\U:BLH=U,D6S%*V9>DH=*X9494\ ME*;> 6:H7,26"L&/G$!0E@%K^!R-.I'443E@V.=$![,*#JS ME9_$QAV:M.VXZG:[83]K9]RS>?M27#.]$I+2PIQ@>P*G?P!02P,$% @ U8!,57>PS$FY!P M"A, !D !X;"]W;W)K&ULI5A=;]LX%GW7KR#< M09$"BFW9CC_:)$#BN)A@-FT1)YV'P3[0$FUS*XDJ2<7)_OH]EY1L.762P>Q# M8E(D#\_]OM+I1ND?9BV$98]9FINSUMK:XF.G8^*UR+AIJT+D6%DJG7&+J5YU M3*$%3]RA+.WTNMUA)^,R;YV?NF??]/FI*FTJ<_%-,U-F&==/ER)5F[-6U*H? MW,K5VM*#SOEIP5=B+NQ]\4UCUMFB)#(3N9$J9UHLSUH7TUW&[Y+L3&- M,2-)%DK]H,EU'%*C7N/]OXO?U1B\6EL2JK#H-! M)G/_RQ\K/30.C+LO'.A5!WJ.M[_(L;SBEI^?:K5AFG8#C09.5'<:Y&1.1IE; MC56)<_;\YN+VC]G=Q>6_9FP^F][?7M]=S^:G'0MHVM")*YA+#]-[ 2;JL1N5 MV[5ALSP1R3Y !YRVQ'HULJXA7(FZS?A2R7K<7O8+7WPK:=WC]%_"FW*P9 MSQ/F!K.?I7S@J[63!D[]^->U'TB1V\BEV56N:KP*X% M,R)6T-[/DFLK-%-+,DPW9+0V55G!\R>V$"N>8VDIZ%CEOD(;VBVAZ;F VC5A MK1#7EFW6BA6ECM<(*T:\9"RP.6^".H*C3R8HM"JT%!:I@\TYG[,BY9:RDMNM M"A?D%H#\R3T!76=5AE.Q8#(G$2"/E;A#&E.*A"W\UFE%%(1DO,;),L6:8!S# M+ ,LEN,?(9 $1-,B"=P#IC3=\B"TE8M4(!DL(%4)%;?9'3&H8&L1F@0RK-$5 MH)B0KBA!L?M<6K":6V[%WF[Q"!WE*]%FUY3(8J43GL.WK5A(W\ 3M=G!W -+=2*H$Z3(GZ6 R,L9."K:5HM_KNA#UXVCK MG-?0L;&9B];ZV9586+>90MG");;:"@,.Y94P9$/&FD><8R23BYLR1ZU, MY7]Q=(4:23YSE"IC/KC[R<$*E5,P0,<*!T@Y>"C8D7A$Y37B0YO=%U5,.(:5 M,;Q@!^P+W4.SWI(RYVGP[%Z9US8T*I5DTP0.CI^LI@&).#F/.< QAU/4#!V> M\_4@4P_^O$.'6U0&)P\!R%*E*/_F(YM/?Y]=W2/+?/W,;KY^G]W,OMRY\:'\ M$USRU'D(IQ02H"2(; $-45F8^LB<-N+OVS8\J68@C"A&K[9!63WXDVO-X4DU MN"'+(7/)/'>!N&1/@FOV&QN'@\$H[':[&(_"T7!0C8?C?C4ZIK_@(DFDUU9_ M$$XBOZTW"7OCR T'X;#;\;?;:NMN!2SF]3PU#PS6ZWB"C<."YL8FW MRUN&G41;2^Z&]0T'E3\>#2KOB;K>>XYZO4K_KZCX+?>EJ'U68UU^<=6ZP9B\ MBO*%@Q74W;$]Q5.LA6PC4-=Y@2+]*-$KB_3)4:B=./2EBC/JSZF-ENZ:YP=& MX7CH?"CPE1A)EAH65S=XE3^7!-P=U+!N7S,'^O3G\_M>0L5/6M)"E0 )#N)I ME1VV5;NIHCJ?>7U0,R,;10F(PI>A9H_Q4I&+CJ/N7DT[_K6(^0[B%] @XT_/ MRIC,T?38C6(QM+A2NJY<^Q6WD8.#]^\FP]'D4W5IT*!<&8G>[B0,D@BT>GCI M<(II>"0*3U7_Q+.Z%WJ(9T7/$Z)JX=2R,P-Z3 MZQPI.=2M:?L-U>&E]Q]H#R)(:B0A%7:78 >/DYJHATPB2/(GM)XI%F!'O\-W M@Z0G@[=/:M$==[4@INX^W_36^US]3X0&*_1MN>&QSV-U;)/:K8QY2E<8F:$I MT@T-;EL.3F%$K;-V%O7,B6YL ]5,6FWVSPS:9GC7?LF$I-XWE&LH(P@$WD&! M_Q]YX3+^% 4=Y3M6&M\,T\6^ %L1KW/Y$S2"@MA9LG")E*E=Y(]1CCX3U>_. M#VY\2^DN1 @+C^,QO25QNL'^B'I&"NSD/_3R\*OGVUW&V,G2#N9"4#> MQ'W M):7:^#SU[Z0HT!7&!,&^*-#9M>$-[@#Y#.7GL80.KW.T&J6S4YL=>NWM-+Y/ MX'UHY;["&.;RD_]4L7VZ_=!SX;]O[+;[KT0W7*\HH:1BB:/=]NBDQ;3_\N(G M5A7N:\="6;Q\N>$:/B,T;<#Z4D&H:D(7;#]_G?\/4$L#!!0 ( -6 3%5P MV&O5)00 (8) 9 >&PO=V]R:W-H965T,W*IJ)1J,(8$D@$2 W$9J 'I?5[L :^RWG5WUR'Y]W?6Q@XI)*IT M7V"_YLR9F;.>[>V4?C0QHH7G1$C3]V)KTZM&PX0Q)LRM[3:]<6/!M M;-U"8]!+V1:7:!_2N:99HT*)>(+2<"5!XZ;O#9M7-VUW/C_PB^/.'(S!1;)6 MZM%-[J*^YSM"*#"T#H'1WQ..4 @'1#1^[S&]RJ4S/!R7Z+=Y[!3+FAD<*?$O MCVS<][H>1+AAF; +M?N!^WC.'5ZHA,E_85><;?L>A)FQ*MD;$X.$R^*?/>_S M<�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 123 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 124 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.2.2 html 320 670 1 true 132 0 false 5 false false R1.htm 00000001 - Document - Cover Sheet http://srax.com/role/Cover Cover Cover 1 false false R2.htm 00000002 - Statement - Consolidated Balance Sheets Sheet http://srax.com/role/BalanceSheets Consolidated Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://srax.com/role/BalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Consolidated Statements of Operations Sheet http://srax.com/role/StatementsOfOperations Consolidated Statements of Operations Statements 4 false false R5.htm 00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://srax.com/role/StatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 5 false false R6.htm 00000006 - Statement - Consolidated Statements of Cash Flows Sheet http://srax.com/role/StatementsOfCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 7 false false R8.htm 00000008 - Disclosure - DISCONTINUED OPERATIONS Sheet http://srax.com/role/DiscontinuedOperations DISCONTINUED OPERATIONS Notes 8 false false R9.htm 00000009 - Disclosure - ACQUISITIONS Sheet http://srax.com/role/Acquisitions ACQUISITIONS Notes 9 false false R10.htm 00000010 - Disclosure - SALE AND PURCHASE OF ACCOUNTS RECEIVABLE Sheet http://srax.com/role/SaleAndPurchaseOfAccountsReceivable SALE AND PURCHASE OF ACCOUNTS RECEIVABLE Notes 10 false false R11.htm 00000011 - Disclosure - CONTRACTS RECEIVABLE Sheet http://srax.com/role/ContractsReceivable CONTRACTS RECEIVABLE Notes 11 false false R12.htm 00000012 - Disclosure - MARKETABLE SECURITIES Sheet http://srax.com/role/MarketableSecurities MARKETABLE SECURITIES Notes 12 false false R13.htm 00000013 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL Sheet http://srax.com/role/DesignatedAssetsForReturnOfCapital DESIGNATED ASSETS FOR RETURN OF CAPITAL Notes 13 false false R14.htm 00000014 - Disclosure - NOTES RECEIVABLE Notes http://srax.com/role/NotesReceivable NOTES RECEIVABLE Notes 14 false false R15.htm 00000015 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://srax.com/role/PropertyAndEquipment PROPERTY AND EQUIPMENT Notes 15 false false R16.htm 00000016 - Disclosure - INTANGIBLE ASSETS Sheet http://srax.com/role/IntangibleAssets INTANGIBLE ASSETS Notes 16 false false R17.htm 00000017 - Disclosure - RIGHT TO USE ASSET Sheet http://srax.com/role/RightToUseAsset RIGHT TO USE ASSET Notes 17 false false R18.htm 00000018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES Sheet http://srax.com/role/AccountsPayableAndAccruedExpenses ACCOUNTS PAYABLE AND ACCRUED EXPENSES Notes 18 false false R19.htm 00000019 - Disclosure - DEFERRED REVENUE Sheet http://srax.com/role/DeferredRevenue DEFERRED REVENUE Notes 19 false false R20.htm 00000020 - Disclosure - OTHER CURRENT LIABILITIES Sheet http://srax.com/role/OtherCurrentLiabilities OTHER CURRENT LIABILITIES Notes 20 false false R21.htm 00000021 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN Sheet http://srax.com/role/PaycheckProtectionProgramLoan PAYCHECK PROTECTION PROGRAM LOAN Notes 21 false false R22.htm 00000022 - Disclosure - SHORT TERM PROMISSORY NOTES Notes http://srax.com/role/ShortTermPromissoryNotes SHORT TERM PROMISSORY NOTES Notes 22 false false R23.htm 00000023 - Disclosure - TERM LOAN NOTE Sheet http://srax.com/role/TermLoanNote TERM LOAN NOTE Notes 23 false false R24.htm 00000024 - Disclosure - OID CONVERTIBLE DEBENTURES Sheet http://srax.com/role/OidConvertibleDebentures OID CONVERTIBLE DEBENTURES Notes 24 false false R25.htm 00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://srax.com/role/CommitmentsAndContingencies COMMITMENTS AND CONTINGENCIES Notes 25 false false R26.htm 00000026 - Disclosure - SERIES A PREFERRED STOCK Sheet http://srax.com/role/SeriesPreferredStock SERIES A PREFERRED STOCK Notes 26 false false R27.htm 00000027 - Disclosure - STOCKHOLDERS??? EQUITY Sheet http://srax.com/role/StockholdersEquity STOCKHOLDERS??? EQUITY Notes 27 false false R28.htm 00000028 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS Sheet http://srax.com/role/StockOptionsAwardsAndWarrants STOCK OPTIONS, AWARDS AND WARRANTS Notes 28 false false R29.htm 00000029 - Disclosure - RELATED PARTY TRANSACTIONS Sheet http://srax.com/role/RelatedPartyTransactions RELATED PARTY TRANSACTIONS Notes 29 false false R30.htm 00000030 - Disclosure - INCOME TAXES Sheet http://srax.com/role/IncomeTaxes INCOME TAXES Notes 30 false false R31.htm 00000031 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS Sheet http://srax.com/role/FairValueOfFinancialInstruments FAIR VALUE OF FINANCIAL INSTRUMENTS Notes 31 false false R32.htm 00000032 - Disclosure - REVENUE DISAGGREGATION Sheet http://srax.com/role/RevenueDisaggregation REVENUE DISAGGREGATION Notes 32 false false R33.htm 00000033 - Disclosure - SUBSEQUENT EVENTS Sheet http://srax.com/role/SubsequentEvents SUBSEQUENT EVENTS Notes 33 false false R34.htm 00000034 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 34 false false R35.htm 00000035 - Disclosure - DISCONTINUED OPERATIONS (Tables) Sheet http://srax.com/role/DiscontinuedOperationsTables DISCONTINUED OPERATIONS (Tables) Tables http://srax.com/role/DiscontinuedOperations 35 false false R36.htm 00000036 - Disclosure - ACQUISITIONS (Tables) Sheet http://srax.com/role/AcquisitionsTables ACQUISITIONS (Tables) Tables http://srax.com/role/Acquisitions 36 false false R37.htm 00000037 - Disclosure - MARKETABLE SECURITIES (Tables) Sheet http://srax.com/role/MarketableSecuritiesTables MARKETABLE SECURITIES (Tables) Tables http://srax.com/role/MarketableSecurities 37 false false R38.htm 00000038 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables) Sheet http://srax.com/role/DesignatedAssetsForReturnOfCapitalTables DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables) Tables http://srax.com/role/DesignatedAssetsForReturnOfCapital 38 false false R39.htm 00000039 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://srax.com/role/PropertyAndEquipmentTables PROPERTY AND EQUIPMENT (Tables) Tables http://srax.com/role/PropertyAndEquipment 39 false false R40.htm 00000040 - Disclosure - INTANGIBLE ASSETS (Tables) Sheet http://srax.com/role/IntangibleAssetsTables INTANGIBLE ASSETS (Tables) Tables http://srax.com/role/IntangibleAssets 40 false false R41.htm 00000041 - Disclosure - RIGHT TO USE ASSET (Tables) Sheet http://srax.com/role/RightToUseAssetTables RIGHT TO USE ASSET (Tables) Tables http://srax.com/role/RightToUseAsset 41 false false R42.htm 00000042 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Sheet http://srax.com/role/AccountsPayableAndAccruedExpensesTables ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables) Tables http://srax.com/role/AccountsPayableAndAccruedExpenses 42 false false R43.htm 00000043 - Disclosure - OTHER CURRENT LIABILITIES (Tables) Sheet http://srax.com/role/OtherCurrentLiabilitiesTables OTHER CURRENT LIABILITIES (Tables) Tables http://srax.com/role/OtherCurrentLiabilities 43 false false R44.htm 00000044 - Disclosure - OID CONVERTIBLE DEBENTURES (Tables) Sheet http://srax.com/role/OidConvertibleDebenturesTables OID CONVERTIBLE DEBENTURES (Tables) Tables http://srax.com/role/OidConvertibleDebentures 44 false false R45.htm 00000045 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS (Tables) Sheet http://srax.com/role/StockOptionsAwardsAndWarrantsTables STOCK OPTIONS, AWARDS AND WARRANTS (Tables) Tables http://srax.com/role/StockOptionsAwardsAndWarrants 45 false false R46.htm 00000046 - Disclosure - INCOME TAXES (Tables) Sheet http://srax.com/role/IncomeTaxesTables INCOME TAXES (Tables) Tables http://srax.com/role/IncomeTaxes 46 false false R47.htm 00000047 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Sheet http://srax.com/role/FairValueOfFinancialInstrumentsTables FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables) Tables http://srax.com/role/FairValueOfFinancialInstruments 47 false false R48.htm 00000048 - Disclosure - REVENUE DISAGGREGATION (Tables) Sheet http://srax.com/role/RevenueDisaggregationTables REVENUE DISAGGREGATION (Tables) Tables http://srax.com/role/RevenueDisaggregation 48 false false R49.htm 00000049 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Sheet http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) Details http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies 49 false false R50.htm 00000050 - Disclosure - SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details) Sheet http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details) Details 50 false false R51.htm 00000051 - Disclosure - SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details) Sheet http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details) Details 51 false false R52.htm 00000052 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative) Sheet http://srax.com/role/DiscontinuedOperationsDetailsNarrative DISCONTINUED OPERATIONS (Details Narrative) Details http://srax.com/role/DiscontinuedOperationsTables 52 false false R53.htm 00000053 - Disclosure - SCHEDULE OF CALCULATIONS OF PURCHASE PRICE (Details) Sheet http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails SCHEDULE OF CALCULATIONS OF PURCHASE PRICE (Details) Details 53 false false R54.htm 00000054 - Disclosure - SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED (Details) Sheet http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED (Details) Details 54 false false R55.htm 00000055 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION (Details) Sheet http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION (Details) Details 55 false false R56.htm 00000056 - Disclosure - SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE (Details) Sheet http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE (Details) Details 56 false false R57.htm 00000057 - Disclosure - SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS (Details) Sheet http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS (Details) Details 57 false false R58.htm 00000058 - Disclosure - SUMMARY OF PRO FORMA ADJUSTMENTS (Details) Sheet http://srax.com/role/SummaryOfProFormaAdjustmentsDetails SUMMARY OF PRO FORMA ADJUSTMENTS (Details) Details 58 false false R59.htm 00000059 - Disclosure - ACQUISITIONS (Details Narrative) Sheet http://srax.com/role/AcquisitionsDetailsNarrative ACQUISITIONS (Details Narrative) Details http://srax.com/role/AcquisitionsTables 59 false false R60.htm 00000060 - Disclosure - SALE AND PURCHASE OF ACCOUNTS RECEIVABLE (Details Narrative) Sheet http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative SALE AND PURCHASE OF ACCOUNTS RECEIVABLE (Details Narrative) Details http://srax.com/role/SaleAndPurchaseOfAccountsReceivable 60 false false R61.htm 00000061 - Disclosure - CONTRACTS RECEIVABLE (Details Narrative) Sheet http://srax.com/role/ContractsReceivableDetailsNarrative CONTRACTS RECEIVABLE (Details Narrative) Details http://srax.com/role/ContractsReceivable 61 false false R62.htm 00000062 - Disclosure - SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES (Details) Sheet http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES (Details) Details 62 false false R63.htm 00000063 - Disclosure - MARKETABLE SECURITIES (Details Narrative) Sheet http://srax.com/role/MarketableSecuritiesDetailsNarrative MARKETABLE SECURITIES (Details Narrative) Details http://srax.com/role/MarketableSecuritiesTables 63 false false R64.htm 00000064 - Disclosure - SCHEDULE OF DESIGNATED ASSETS (Details) Sheet http://srax.com/role/ScheduleOfDesignatedAssetsDetails SCHEDULE OF DESIGNATED ASSETS (Details) Details 64 false false R65.htm 00000065 - Disclosure - SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS (Details) Sheet http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS (Details) Details 65 false false R66.htm 00000066 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative) Sheet http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative) Details http://srax.com/role/DesignatedAssetsForReturnOfCapitalTables 66 false false R67.htm 00000067 - Disclosure - NOTES RECEIVABLE (Details Narrative) Notes http://srax.com/role/NotesReceivableDetailsNarrative NOTES RECEIVABLE (Details Narrative) Details http://srax.com/role/NotesReceivable 67 false false R68.htm 00000068 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Sheet http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails SCHEDULE OF PROPERTY AND EQUIPMENT (Details) Details 68 false false R69.htm 00000069 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative) Sheet http://srax.com/role/PropertyAndEquipmentDetailsNarrative PROPERTY AND EQUIPMENT (Details Narrative) Details http://srax.com/role/PropertyAndEquipmentTables 69 false false R70.htm 00000070 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details) Sheet http://srax.com/role/ScheduleOfIntangibleAssetsDetails SCHEDULE OF INTANGIBLE ASSETS (Details) Details 70 false false R71.htm 00000071 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details) Sheet http://srax.com/role/ScheduleOfEstimatedFutureAmortizationExpenseDetails SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details) Details 71 false false R72.htm 00000072 - Disclosure - INTANGIBLE ASSETS (Details Narrative) Sheet http://srax.com/role/IntangibleAssetsDetailsNarrative INTANGIBLE ASSETS (Details Narrative) Details http://srax.com/role/IntangibleAssetsTables 72 false false R73.htm 00000073 - Disclosure - SCHEDULE OF COMPONENT OF LEASE EXPENSE (Details) Sheet http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails SCHEDULE OF COMPONENT OF LEASE EXPENSE (Details) Details 73 false false R74.htm 00000074 - Disclosure - SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES (Details) Sheet http://srax.com/role/ScheduleOfOperatingLeaseAssetsAndLiabilitiesDetails SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES (Details) Details 74 false false R75.htm 00000075 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE (Details) Sheet http://srax.com/role/ScheduleOfWeightedAverageRemainingLeaseTermAndAppliedDiscountRateDetails SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE (Details) Details 75 false false R76.htm 00000076 - Disclosure - SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS (Details) Sheet http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS (Details) Details 76 false false R77.htm 00000077 - Disclosure - RIGHT TO USE ASSET (Details Narrative) Sheet http://srax.com/role/RightToUseAssetDetailsNarrative RIGHT TO USE ASSET (Details Narrative) Details http://srax.com/role/RightToUseAssetTables 77 false false R78.htm 00000078 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Sheet http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details) Details 78 false false R79.htm 00000079 - Disclosure - DEFERRED REVENUE (Details Narrative) Sheet http://srax.com/role/DeferredRevenueDetailsNarrative DEFERRED REVENUE (Details Narrative) Details http://srax.com/role/DeferredRevenue 79 false false R80.htm 00000080 - Disclosure - SCHEDULE OF OTHER CURRENT LIABILITIES (Details) Sheet http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails SCHEDULE OF OTHER CURRENT LIABILITIES (Details) Details 80 false false R81.htm 00000081 - Disclosure - OTHER CURRENT LIABILITIES (Details Narrative) Sheet http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative OTHER CURRENT LIABILITIES (Details Narrative) Details http://srax.com/role/OtherCurrentLiabilitiesTables 81 false false R82.htm 00000082 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Narrative) Sheet http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative PAYCHECK PROTECTION PROGRAM LOAN (Details Narrative) Details http://srax.com/role/PaycheckProtectionProgramLoan 82 false false R83.htm 00000083 - Disclosure - SHORT TERM PROMISSORY NOTES (Details Narrative) Notes http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative SHORT TERM PROMISSORY NOTES (Details Narrative) Details http://srax.com/role/ShortTermPromissoryNotes 83 false false R84.htm 00000084 - Disclosure - TERM LOAN NOTE (Details Narrative) Sheet http://srax.com/role/TermLoanNoteDetailsNarrative TERM LOAN NOTE (Details Narrative) Details http://srax.com/role/TermLoanNote 84 false false R85.htm 00000085 - Disclosure - SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details) Sheet http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details) Details 85 false false R86.htm 00000086 - Disclosure - OID CONVERTIBLE DEBENTURES (Details Narrative) Sheet http://srax.com/role/OidConvertibleDebenturesDetailsNarrative OID CONVERTIBLE DEBENTURES (Details Narrative) Details http://srax.com/role/OidConvertibleDebenturesTables 86 false false R87.htm 00000087 - Disclosure - SERIES A PREFERRED STOCK (Details Narrative) Sheet http://srax.com/role/SeriesPreferredStockDetailsNarrative SERIES A PREFERRED STOCK (Details Narrative) Details http://srax.com/role/SeriesPreferredStock 87 false false R88.htm 00000088 - Disclosure - STOCKHOLDERS??? EQUITY (Details Narrative) Sheet http://srax.com/role/StockholdersEquityDetailsNarrative STOCKHOLDERS??? EQUITY (Details Narrative) Details http://srax.com/role/StockholdersEquity 88 false false R89.htm 00000089 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details) Sheet http://srax.com/role/ScheduleOfStockOptionActivityDetails SCHEDULE OF STOCK OPTION ACTIVITY (Details) Details 89 false false R90.htm 00000090 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details) Sheet http://srax.com/role/ScheduleOfWarrantActivityDetails SCHEDULE OF WARRANT ACTIVITY (Details) Details 90 false false R91.htm 00000091 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS (Details Narrative) Sheet http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative STOCK OPTIONS, AWARDS AND WARRANTS (Details Narrative) Details http://srax.com/role/StockOptionsAwardsAndWarrantsTables 91 false false R92.htm 00000092 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative) Sheet http://srax.com/role/RelatedPartyTransactionsDetailsNarrative RELATED PARTY TRANSACTIONS (Details Narrative) Details http://srax.com/role/RelatedPartyTransactions 92 false false R93.htm 00000093 - Disclosure - SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE (Details) Sheet http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE (Details) Details 93 false false R94.htm 00000094 - Disclosure - SCHEDULE OF EFFECTIVE TAX RATE (Details) Sheet http://srax.com/role/ScheduleOfEffectiveTaxRateDetails SCHEDULE OF EFFECTIVE TAX RATE (Details) Details 94 false false R95.htm 00000095 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Sheet http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) Details 95 false false R96.htm 00000096 - Disclosure - INCOME TAXES (Details Narrative) Sheet http://srax.com/role/IncomeTaxesDetailsNarrative INCOME TAXES (Details Narrative) Details http://srax.com/role/IncomeTaxesTables 96 false false R97.htm 00000097 - Disclosure - SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details) Sheet http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details) Details 97 false false R98.htm 00000098 - Disclosure - SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details) Sheet http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details) Details 98 false false R99.htm 00000099 - Disclosure - SCHEDULE OF FAIR VALUE AT ASSETS (Details) Sheet http://srax.com/role/ScheduleOfFairValueAtAssetsDetails SCHEDULE OF FAIR VALUE AT ASSETS (Details) Details 99 false false R100.htm 00000100 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details) Sheet http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details) Details 100 false false R101.htm 00000101 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative) Sheet http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative) Details http://srax.com/role/FairValueOfFinancialInstrumentsTables 101 false false R102.htm 00000102 - Disclosure - SCHEDULE OF REVENUE BY BUSINESS UNIT (Details) Sheet http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails SCHEDULE OF REVENUE BY BUSINESS UNIT (Details) Details 102 false false R103.htm 00000103 - Disclosure - REVENUE DISAGGREGATION (Details Narrative) Sheet http://srax.com/role/RevenueDisaggregationDetailsNarrative REVENUE DISAGGREGATION (Details Narrative) Details http://srax.com/role/RevenueDisaggregationTables 103 false false R104.htm 00000104 - Disclosure - SUBSEQUENT EVENTS (Details Narrative) Sheet http://srax.com/role/SubsequentEventsDetailsNarrative SUBSEQUENT EVENTS (Details Narrative) Details http://srax.com/role/SubsequentEvents 104 false false All Reports Book All Reports [ix-0514-Hidden-Fact-Eligible-For-Transform] WARN: 1 fact(s) appearing in ix:hidden were eligible for transformation: us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1 - form10-k.htm 187 form10-k.htm ex10-37.htm ex10-38.htm ex10-39.htm ex21-01.htm ex31-1.htm ex31-2.htm ex32-1.htm srax-20211231.xsd srax-20211231_cal.xml srax-20211231_def.xml srax-20211231_lab.xml srax-20211231_pre.xml form10-k_001.jpg image_001.jpg http://fasb.org/us-gaap/2022 http://xbrl.sec.gov/dei/2022 true true JSON 127 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "form10-k.htm": { "axisCustom": 0, "axisStandard": 31, "contextCount": 320, "dts": { "calculationLink": { "local": [ "srax-20211231_cal.xml" ] }, "definitionLink": { "local": [ "srax-20211231_def.xml" ] }, "inline": { "local": [ "form10-k.htm" ] }, "labelLink": { "local": [ "srax-20211231_lab.xml" ] }, "presentationLink": { "local": [ "srax-20211231_pre.xml" ] }, "schema": { "local": [ "srax-20211231.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-roles-2022.xsd", "https://xbrl.fasb.org/srt/2022/elts/srt-types-2022.xsd", "https://xbrl.fasb.org/srt/2022q3/srt-sup-2022q3.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-gaap-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-roles-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022/elts/us-types-2022.xsd", "https://xbrl.fasb.org/us-gaap/2022q3/us-gaap-sup-2022q3.xsd", "https://xbrl.sec.gov/country/2022/country-2022.xsd", "https://xbrl.sec.gov/dei/2022/dei-2022.xsd" ] } }, "elementCount": 960, "entityCount": 1, "hidden": { "http://fasb.org/us-gaap/2022": 148, "http://srax.com/20211231": 97, "http://xbrl.sec.gov/dei/2022": 3, "total": 248 }, "keyCustom": 195, "keyStandard": 475, "memberCustom": 82, "memberStandard": 44, "nsprefix": "SRAX", "nsuri": "http://srax.com/20211231", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://srax.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "span", "p", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R10": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000010 - Disclosure - SALE AND PURCHASE OF ACCOUNTS RECEIVABLE", "role": "http://srax.com/role/SaleAndPurchaseOfAccountsReceivable", "shortName": "SALE AND PURCHASE OF ACCOUNTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CreditLossFinancialInstrumentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R100": { "firstAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputMaturityMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:DerivativeAssetMaturityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000100 - Disclosure - SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details)", "role": "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "shortName": "SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_FairValueInputsLevel3Member_us-gaap_ValuationTechniqueOptionPricingModelMember_us-gaap_MeasurementInputMaturityMember_srt_MinimumMember", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:DerivativeAssetMaturityMeasurementInput", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R101": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesReceivableFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000101 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative)", "role": "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:NotesReceivableFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R102": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000102 - Disclosure - SCHEDULE OF REVENUE BY BUSINESS UNIT (Details)", "role": "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails", "shortName": "SCHEDULE OF REVENUE BY BUSINESS UNIT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:DisaggregationOfRevenueTableTextBlock", "SRAX:RevenueDisaggregationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_SequirePlatformRevenueMember", "decimals": "0", "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R103": { "firstAnchor": { "ancestors": [ "span", "span", "p", "SRAX:RevenueDisaggregationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000103 - Disclosure - REVENUE DISAGGREGATION (Details Narrative)", "role": "http://srax.com/role/RevenueDisaggregationDetailsNarrative", "shortName": "REVENUE DISAGGREGATION (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "SRAX:RevenueDisaggregationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredRevenueCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R104": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000104 - Disclosure - SUBSEQUENT EVENTS (Details Narrative)", "role": "http://srax.com/role/SubsequentEventsDetailsNarrative", "shortName": "SUBSEQUENT EVENTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "td", "tr", "table", "us-gaap:SubsequentEventsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2018-11-292018-11-29_us-gaap_CommonStockMember_custom_SecurityAgreementsMember", "decimals": "INF", "lang": null, "name": "us-gaap:StockIssuedDuringPeriodSharesNewIssues", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R11": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000011 - Disclosure - CONTRACTS RECEIVABLE", "role": "http://srax.com/role/ContractsReceivable", "shortName": "CONTRACTS RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsAndNontradeReceivableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R12": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000012 - Disclosure - MARKETABLE SECURITIES", "role": "http://srax.com/role/MarketableSecurities", "shortName": "MARKETABLE SECURITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R13": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:DesignatedAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000013 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL", "role": "http://srax.com/role/DesignatedAssetsForReturnOfCapital", "shortName": "DESIGNATED ASSETS FOR RETURN OF CAPITAL", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:DesignatedAssetsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R14": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000014 - Disclosure - NOTES RECEIVABLE", "role": "http://srax.com/role/NotesReceivable", "shortName": "NOTES RECEIVABLE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R15": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000015 - Disclosure - PROPERTY AND EQUIPMENT", "role": "http://srax.com/role/PropertyAndEquipment", "shortName": "PROPERTY AND EQUIPMENT", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R16": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000016 - Disclosure - INTANGIBLE ASSETS", "role": "http://srax.com/role/IntangibleAssets", "shortName": "INTANGIBLE ASSETS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IntangibleAssetsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R17": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:RighttoUseAssetLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000017 - Disclosure - RIGHT TO USE ASSET", "role": "http://srax.com/role/RightToUseAsset", "shortName": "RIGHT TO USE ASSET", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:RighttoUseAssetLeasesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R18": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000018 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "role": "http://srax.com/role/AccountsPayableAndAccruedExpenses", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R19": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000019 - Disclosure - DEFERRED REVENUE", "role": "http://srax.com/role/DeferredRevenue", "shortName": "DEFERRED REVENUE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R2": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000002 - Statement - Consolidated Balance Sheets", "role": "http://srax.com/role/BalanceSheets", "shortName": "Consolidated Balance Sheets", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:PrepaidExpenseAndOtherAssetsCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R20": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000020 - Disclosure - OTHER CURRENT LIABILITIES", "role": "http://srax.com/role/OtherCurrentLiabilities", "shortName": "OTHER CURRENT LIABILITIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherLiabilitiesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R21": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:PaycheckProtectionProgramLoanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000021 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN", "role": "http://srax.com/role/PaycheckProtectionProgramLoan", "shortName": "PAYCHECK PROTECTION PROGRAM LOAN", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:PaycheckProtectionProgramLoanTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R22": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000022 - Disclosure - SHORT TERM PROMISSORY NOTES", "role": "http://srax.com/role/ShortTermPromissoryNotes", "shortName": "SHORT TERM PROMISSORY NOTES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ShortTermDebtTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R23": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000023 - Disclosure - TERM LOAN NOTE", "role": "http://srax.com/role/TermLoanNote", "shortName": "TERM LOAN NOTE", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DebtDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R24": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000024 - Disclosure - OID CONVERTIBLE DEBENTURES", "role": "http://srax.com/role/OidConvertibleDebentures", "shortName": "OID CONVERTIBLE DEBENTURES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R25": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000025 - Disclosure - COMMITMENTS AND CONTINGENCIES", "role": "http://srax.com/role/CommitmentsAndContingencies", "shortName": "COMMITMENTS AND CONTINGENCIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:CommitmentsAndContingenciesDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R26": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_SeriesAPreferredStockMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000026 - Disclosure - SERIES A PREFERRED STOCK", "role": "http://srax.com/role/SeriesPreferredStock", "shortName": "SERIES A PREFERRED STOCK", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_us-gaap_SeriesAPreferredStockMember", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PreferredStockTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R27": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000027 - Disclosure - STOCKHOLDERS\u2019 EQUITY", "role": "http://srax.com/role/StockholdersEquity", "shortName": "STOCKHOLDERS\u2019 EQUITY", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R28": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000028 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS", "role": "http://srax.com/role/StockOptionsAwardsAndWarrants", "shortName": "STOCK OPTIONS, AWARDS AND WARRANTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R29": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000029 - Disclosure - RELATED PARTY TRANSACTIONS", "role": "http://srax.com/role/RelatedPartyTransactions", "shortName": "RELATED PARTY TRANSACTIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R3": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:CommonStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000003 - Statement - Consolidated Balance Sheets (Parenthetical)", "role": "http://srax.com/role/BalanceSheetsParenthetical", "shortName": "Consolidated Balance Sheets (Parenthetical)", "subGroupType": "parenthetical", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_us-gaap_SeriesAPreferredStockMember", "decimals": "INF", "lang": null, "name": "us-gaap:TemporaryEquitySharesAuthorized", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R30": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000030 - Disclosure - INCOME TAXES", "role": "http://srax.com/role/IncomeTaxes", "shortName": "INCOME TAXES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:IncomeTaxDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R31": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000031 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS", "role": "http://srax.com/role/FairValueOfFinancialInstruments", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueDisclosuresTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R32": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:RevenueDisaggregationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000032 - Disclosure - REVENUE DISAGGREGATION", "role": "http://srax.com/role/RevenueDisaggregation", "shortName": "REVENUE DISAGGREGATION", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:RevenueDisaggregationTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R33": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000033 - Disclosure - SUBSEQUENT EVENTS", "role": "http://srax.com/role/SubsequentEvents", "shortName": "SUBSEQUENT EVENTS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:SubsequentEventsTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R34": { "firstAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000034 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "role": "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies", "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies)", "subGroupType": "policies", "uniqueAnchor": { "ancestors": [ "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BasisOfAccountingPolicyPolicyTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R35": { "firstAnchor": { "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:ScheduleOfDeconsolidationOfBusinessTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000035 - Disclosure - DISCONTINUED OPERATIONS (Tables)", "role": "http://srax.com/role/DiscontinuedOperationsTables", "shortName": "DISCONTINUED OPERATIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:ScheduleOfDeconsolidationOfBusinessTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R36": { "firstAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000036 - Disclosure - ACQUISITIONS (Tables)", "role": "http://srax.com/role/AcquisitionsTables", "shortName": "ACQUISITIONS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R37": { "firstAnchor": { "ancestors": [ "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000037 - Disclosure - MARKETABLE SECURITIES (Tables)", "role": "http://srax.com/role/MarketableSecuritiesTables", "shortName": "MARKETABLE SECURITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:MarketableSecuritiesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R38": { "firstAnchor": { "ancestors": [ "SRAX:DesignatedAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:DesignatedAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000038 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables)", "role": "http://srax.com/role/DesignatedAssetsForReturnOfCapitalTables", "shortName": "DESIGNATED ASSETS FOR RETURN OF CAPITAL (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "SRAX:DesignatedAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:DesignatedAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R39": { "firstAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000039 - Disclosure - PROPERTY AND EQUIPMENT (Tables)", "role": "http://srax.com/role/PropertyAndEquipmentTables", "shortName": "PROPERTY AND EQUIPMENT (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:PropertyPlantAndEquipmentTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R4": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000004 - Statement - Consolidated Statements of Operations", "role": "http://srax.com/role/StatementsOfOperations", "shortName": "Consolidated Statements of Operations", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:CostOfRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R40": { "firstAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000040 - Disclosure - INTANGIBLE ASSETS (Tables)", "role": "http://srax.com/role/IntangibleAssetsTables", "shortName": "INTANGIBLE ASSETS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R41": { "firstAnchor": { "ancestors": [ "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000041 - Disclosure - RIGHT TO USE ASSET (Tables)", "role": "http://srax.com/role/RightToUseAssetTables", "shortName": "RIGHT TO USE ASSET (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LeaseCostTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R42": { "firstAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000042 - Disclosure - ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)", "role": "http://srax.com/role/AccountsPayableAndAccruedExpensesTables", "shortName": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R43": { "firstAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000043 - Disclosure - OTHER CURRENT LIABILITIES (Tables)", "role": "http://srax.com/role/OtherCurrentLiabilitiesTables", "shortName": "OTHER CURRENT LIABILITIES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R44": { "firstAnchor": { "ancestors": [ "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000044 - Disclosure - OID CONVERTIBLE DEBENTURES (Tables)", "role": "http://srax.com/role/OidConvertibleDebenturesTables", "shortName": "OID CONVERTIBLE DEBENTURES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ConvertibleDebtTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R45": { "firstAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000045 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS (Tables)", "role": "http://srax.com/role/StockOptionsAwardsAndWarrantsTables", "shortName": "STOCK OPTIONS, AWARDS AND WARRANTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R46": { "firstAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000046 - Disclosure - INCOME TAXES (Tables)", "role": "http://srax.com/role/IncomeTaxesTables", "shortName": "INCOME TAXES (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R47": { "firstAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000047 - Disclosure - FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)", "role": "http://srax.com/role/FairValueOfFinancialInstrumentsTables", "shortName": "FAIR VALUE OF FINANCIAL INSTRUMENTS (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R48": { "firstAnchor": { "ancestors": [ "SRAX:RevenueDisaggregationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000048 - Disclosure - REVENUE DISAGGREGATION (Tables)", "role": "http://srax.com/role/RevenueDisaggregationTables", "shortName": "REVENUE DISAGGREGATION (Tables)", "subGroupType": "tables", "uniqueAnchor": { "ancestors": [ "SRAX:RevenueDisaggregationTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisaggregationOfRevenueTableTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R49": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:CashEquivalentsAtCarryingValue", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000049 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "role": "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashAndCashEquivalentsPolicyTextBlock", "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:CashFDICInsuredAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R5": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000005 - Statement - Consolidated Statements of Changes in Stockholders' Equity", "role": "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "shortName": "Consolidated Statements of Changes in Stockholders' Equity", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31_us-gaap_CommonStockMember", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:StockholdersEquity", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R50": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "SRAX:ScheduleOfDeconsolidationOfBusinessTableTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-12-282021-12-29", "decimals": "0", "first": true, "lang": null, "name": "SRAX:DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000050 - Disclosure - SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details)", "role": "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails", "shortName": "SCHEDULE OF DECONSOLIDATION OF BUSINESS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "SRAX:ScheduleOfDeconsolidationOfBusinessTableTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-12-282021-12-29", "decimals": "0", "first": true, "lang": null, "name": "SRAX:DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R51": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000051 - Disclosure - SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details)", "role": "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails", "shortName": "SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R52": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-12-282021-12-29", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:IssuanceOfAcquisitionSharesDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000052 - Disclosure - DISCONTINUED OPERATIONS (Details Narrative)", "role": "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "shortName": "DISCONTINUED OPERATIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-12-282021-12-29", "decimals": null, "first": true, "lang": "en-US", "name": "SRAX:IssuanceOfAcquisitionSharesDescription", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R53": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000053 - Disclosure - SCHEDULE OF CALCULATIONS OF PURCHASE PRICE (Details)", "role": "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "shortName": "SCHEDULE OF CALCULATIONS OF PURCHASE PRICE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-09-132020-09-15_custom_LDMicroIncMember", "decimals": "0", "lang": null, "name": "us-gaap:BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R54": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-09-15", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000054 - Disclosure - SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED (Details)", "role": "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails", "shortName": "SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-09-15_custom_LDMicroIncMember", "decimals": "0", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R55": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-09-15", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000055 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION (Details)", "role": "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-09-15_custom_TrademarkMember", "decimals": "0", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R56": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000056 - Disclosure - SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE (Details)", "role": "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails", "shortName": "SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:SummaryOfAmountsOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateTableTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31_custom_LDMicroIncMember", "decimals": "0", "lang": null, "name": "us-gaap:NetIncomeLoss", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R57": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000057 - Disclosure - SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS (Details)", "role": "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "shortName": "SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaRevenue", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R58": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:BusinessAcquisitionProFormaInformationTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:BusinessAcquisitionsProFormaNetIncomeLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000058 - Disclosure - SUMMARY OF PRO FORMA ADJUSTMENTS (Details)", "role": "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails", "shortName": "SUMMARY OF PRO FORMA ADJUSTMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:ScheduleOfProFormaAdjustmentsTextBlock", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31_us-gaap_ScenarioAdjustmentMember", "decimals": "0", "lang": null, "name": "SRAX:BusinessAcquisitionsProFormaAmortizationOfIntangiblesAcquired", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R59": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:PaymentsToAcquireBusinessesGross", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000059 - Disclosure - ACQUISITIONS (Details Narrative)", "role": "http://srax.com/role/AcquisitionsDetailsNarrative", "shortName": "ACQUISITIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:BusinessCombinationDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "lang": null, "name": "SRAX:EmployeeRelatedCosts", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R6": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProfitLoss", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "statement", "isDefault": "false", "longName": "00000006 - Statement - Consolidated Statements of Cash Flows", "role": "http://srax.com/role/StatementsOfCashFlows", "shortName": "Consolidated Statements of Cash Flows", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "lang": null, "name": "us-gaap:IncomeLossFromDiscontinuedOperationsNetOfTax", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R60": { "firstAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CreditLossFinancialInstrumentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-01-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000060 - Disclosure - SALE AND PURCHASE OF ACCOUNTS RECEIVABLE (Details Narrative)", "role": "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "shortName": "SALE AND PURCHASE OF ACCOUNTS RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "span", "p", "us-gaap:CreditLossFinancialInstrumentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-01-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsReceivableNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R61": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:ContractsReceivable", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000061 - Disclosure - CONTRACTS RECEIVABLE (Details Narrative)", "role": "http://srax.com/role/ContractsReceivableDetailsNarrative", "shortName": "CONTRACTS RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R62": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000062 - Disclosure - SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES (Details)", "role": "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "shortName": "SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31", "decimals": "0", "lang": null, "name": "us-gaap:MarketableSecuritiesCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R63": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:ProceedFromSaleAndMaturityOfMarketableSecurities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000063 - Disclosure - MARKETABLE SECURITIES (Details Narrative)", "role": "http://srax.com/role/MarketableSecuritiesDetailsNarrative", "shortName": "MARKETABLE SECURITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R64": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:MarketableSecurities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000064 - Disclosure - SCHEDULE OF DESIGNATED ASSETS (Details)", "role": "http://srax.com/role/ScheduleOfDesignatedAssetsDetails", "shortName": "SCHEDULE OF DESIGNATED ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "SRAX:DesignatedAssetsTableTextBlock", "SRAX:DesignatedAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31_custom_DesignatedAssetsMember", "decimals": "0", "lang": null, "name": "us-gaap:Cash", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R65": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:MarketableSecuritiesTextBlock", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ProceedsFromSaleAndMaturityOfMarketableSecurities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000065 - Disclosure - SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS (Details)", "role": "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails", "shortName": "SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "SRAX:ScheduleOfMovementInDesignatedAssetsTableTextBlock", "SRAX:DesignatedAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-09-20_custom_DesignatedAssetsMember", "decimals": "0", "lang": null, "name": "SRAX:AssetsDesignated", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R66": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CashCashEquivalentsAndMarketableSecuritiesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:ProceedFromSaleAndMaturityOfMarketableSecurities", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000066 - Disclosure - DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative)", "role": "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "shortName": "DESIGNATED ASSETS FOR RETURN OF CAPITAL (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "SRAX:DesignatedAssetsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_DesignatedAssetsMember", "decimals": "0", "lang": null, "name": "SRAX:ProceedFromSaleAndMaturityOfMarketableSecurities", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R67": { "firstAnchor": { "ancestors": [ "span", "span", "p", "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AmortizationOfDebtDiscountPremium", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000067 - Disclosure - NOTES RECEIVABLE (Details Narrative)", "role": "http://srax.com/role/NotesReceivableDetailsNarrative", "shortName": "NOTES RECEIVABLE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-012021-12-31_custom_RatedCorporateDebtMember", "decimals": "0", "lang": null, "name": "us-gaap:PaymentsToAcquireNotesReceivable", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R68": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000068 - Disclosure - SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "role": "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails", "shortName": "SCHEDULE OF PROPERTY AND EQUIPMENT (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:PropertyPlantAndEquipmentTextBlock", "us-gaap:PropertyPlantAndEquipmentDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R69": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:Depreciation", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000069 - Disclosure - PROPERTY AND EQUIPMENT (Details Narrative)", "role": "http://srax.com/role/PropertyAndEquipmentDetailsNarrative", "shortName": "PROPERTY AND EQUIPMENT (Details Narrative)", "subGroupType": "details", "uniqueAnchor": null }, "R7": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000007 - Disclosure - ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "role": "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies", "shortName": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R70": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000070 - Disclosure - SCHEDULE OF INTANGIBLE ASSETS (Details)", "role": "http://srax.com/role/ScheduleOfIntangibleAssetsDetails", "shortName": "SCHEDULE OF INTANGIBLE ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsGross", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R71": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000071 - Disclosure - SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details)", "role": "http://srax.com/role/ScheduleOfEstimatedFutureAmortizationExpenseDetails", "shortName": "SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R72": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:AmortizationOfFiniteLivedIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000072 - Disclosure - INTANGIBLE ASSETS (Details Narrative)", "role": "http://srax.com/role/IntangibleAssetsDetailsNarrative", "shortName": "INTANGIBLE ASSETS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IntangibleAssetsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:AmortizationOfFiniteLivedIntangibleAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R73": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000073 - Disclosure - SCHEDULE OF COMPONENT OF LEASE EXPENSE (Details)", "role": "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails", "shortName": "SCHEDULE OF COMPONENT OF LEASE EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LeaseCostTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseCost", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R74": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseRightOfUseAsset", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000074 - Disclosure - SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES (Details)", "role": "http://srax.com/role/ScheduleOfOperatingLeaseAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R75": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000075 - Disclosure - SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE (Details)", "role": "http://srax.com/role/ScheduleOfWeightedAverageRemainingLeaseTermAndAppliedDiscountRateDetails", "shortName": "SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "SRAX:ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:OperatingLeaseWeightedAverageRemainingLeaseTerm1", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R76": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000076 - Disclosure - SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS (Details)", "role": "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails", "shortName": "SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R77": { "firstAnchor": { "ancestors": [ "span", "span", "p", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000077 - Disclosure - RIGHT TO USE ASSET (Details Narrative)", "role": "http://srax.com/role/RightToUseAssetDetailsNarrative", "shortName": "RIGHT TO USE ASSET (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseRemainingLeaseTerm", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R78": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000078 - Disclosure - SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)", "role": "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails", "shortName": "SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "us-gaap:AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AccountsPayableTradeCurrent", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R79": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000079 - Disclosure - DEFERRED REVENUE (Details Narrative)", "role": "http://srax.com/role/DeferredRevenueDetailsNarrative", "shortName": "DEFERRED REVENUE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ContractWithCustomerAssetAndLiabilityTableTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R8": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000008 - Disclosure - DISCONTINUED OPERATIONS", "role": "http://srax.com/role/DiscontinuedOperations", "shortName": "DISCONTINUED OPERATIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R80": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "SRAX:ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "SRAX:RighttoUseAssetLeasesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OperatingLeaseLiabilityCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000080 - Disclosure - SCHEDULE OF OTHER CURRENT LIABILITIES (Details)", "role": "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails", "shortName": "SCHEDULE OF OTHER CURRENT LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": null }, "R81": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:OtherCurrentLiabilitiesTableTextBlock", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:OtherSundryLiabilitiesCurrent", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000081 - Disclosure - OTHER CURRENT LIABILITIES (Details Narrative)", "role": "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative", "shortName": "OTHER CURRENT LIABILITIES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:OtherLiabilitiesDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31_custom_LDMicroMember", "decimals": "0", "lang": null, "name": "SRAX:BusinessCombinationContractWithCustomerLiability", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R82": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:ForgivenessOfPayrollProtectionProgramLoan", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000082 - Disclosure - PAYCHECK PROTECTION PROGRAM LOAN (Details Narrative)", "role": "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "shortName": "PAYCHECK PROTECTION PROGRAM LOAN (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "SRAX:PaycheckProtectionProgramLoanTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-09-15_custom_LDMicroIncMember", "decimals": "0", "lang": null, "name": "us-gaap:BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R83": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:GainsLossesOnExtinguishmentOfDebt", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000083 - Disclosure - SHORT TERM PROMISSORY NOTES (Details Narrative)", "role": "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "shortName": "SHORT TERM PROMISSORY NOTES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:ShortTermDebtTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-02-28_custom_ShortTermPromissoryNotesMember", "decimals": "0", "lang": null, "name": "us-gaap:DebtInstrumentFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R84": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:CreditLossFinancialInstrumentTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DebtInstrumentUnusedBorrowingCapacityAmount", "reportCount": 1, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000084 - Disclosure - TERM LOAN NOTE (Details Narrative)", "role": "http://srax.com/role/TermLoanNoteDetailsNarrative", "shortName": "TERM LOAN NOTE (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DebtDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-02-28", "decimals": "0", "lang": null, "name": "us-gaap:DeferredFinanceCostsNet", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R85": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:OIDConvertibleDebenturesFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000085 - Disclosure - SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details)", "role": "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails", "shortName": "SCHEDULE OF OID CONVERTIBLE DEBENTURES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ConvertibleDebtTableTextBlock", "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "SRAX:OIDConvertibleDebenturesFaceAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R86": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000086 - Disclosure - OID CONVERTIBLE DEBENTURES (Details Narrative)", "role": "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "shortName": "OID CONVERTIBLE DEBENTURES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "SRAX:OriginalIssueDiscountConvertibleDebenturesTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "lang": null, "name": "SRAX:IncreaseDecreaseInAdditionalPaidInCapital", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R87": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000087 - Disclosure - SERIES A PREFERRED STOCK (Details Narrative)", "role": "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "shortName": "SERIES A PREFERRED STOCK (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:PreferredStockTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "lang": null, "name": "SRAX:FairValueOfPreferredStock", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R88": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:PreferredStockSharesAuthorized", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000088 - Disclosure - STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "role": "http://srax.com/role/StockholdersEquityDetailsNarrative", "shortName": "STOCKHOLDERS\u2019 EQUITY (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:StockholdersEquityNoteDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:PreferredStockParOrStatedValuePerShare", "reportCount": 1, "unique": true, "unitRef": "USDPShares", "xsiNil": "false" } }, "R89": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000089 - Disclosure - SCHEDULE OF STOCK OPTION ACTIVITY (Details)", "role": "http://srax.com/role/ScheduleOfStockOptionActivityDetails", "shortName": "SCHEDULE OF STOCK OPTION ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R9": { "firstAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000009 - Disclosure - ACQUISITIONS", "role": "http://srax.com/role/Acquisitions", "shortName": "ACQUISITIONS", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:BusinessCombinationDisclosureTextBlock", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R90": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unitRef": "Shares", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000090 - Disclosure - SCHEDULE OF WARRANT ACTIVITY (Details)", "role": "http://srax.com/role/ScheduleOfWarrantActivityDetails", "shortName": "SCHEDULE OF WARRANT ACTIVITY (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "div", "us-gaap:ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2019-12-31", "decimals": "INF", "lang": null, "name": "us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "reportCount": 1, "unique": true, "unitRef": "Shares", "xsiNil": "false" } }, "R91": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-04-012020-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000091 - Disclosure - STOCK OPTIONS, AWARDS AND WARRANTS (Details Narrative)", "role": "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "shortName": "STOCK OPTIONS, AWARDS AND WARRANTS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-04-012020-04-30", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R92": { "firstAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000092 - Disclosure - RELATED PARTY TRANSACTIONS (Details Narrative)", "role": "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative", "shortName": "RELATED PARTY TRANSACTIONS (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "p", "us-gaap:RelatedPartyTransactionsDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": null, "first": true, "lang": "en-US", "name": "us-gaap:LesseeOperatingLeaseTermOfContract", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } }, "R93": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000093 - Disclosure - SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE (Details)", "role": "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails", "shortName": "SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredFederalIncomeTaxExpenseBenefit", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R94": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000094 - Disclosure - SCHEDULE OF EFFECTIVE TAX RATE (Details)", "role": "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails", "shortName": "SCHEDULE OF EFFECTIVE TAX RATE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "INF", "first": true, "lang": null, "name": "us-gaap:EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "reportCount": 1, "unique": true, "unitRef": "Pure", "xsiNil": "false" } }, "R95": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000095 - Disclosure - SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "role": "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails", "shortName": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:DeferredTaxAssetsOperatingLossCarryforwards", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R96": { "firstAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000096 - Disclosure - INCOME TAXES (Details Narrative)", "role": "http://srax.com/role/IncomeTaxesDetailsNarrative", "shortName": "INCOME TAXES (Details Narrative)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "span", "p", "us-gaap:IncomeTaxDisclosureTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2020-01-012020-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R97": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000097 - Disclosure - SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details)", "role": "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "shortName": "SCHEDULE OF ASSETS MEASURED AT FAIR VALUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:AssetsFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R98": { "firstAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000098 - Disclosure - SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details)", "role": "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails", "shortName": "SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "td", "tr", "table", "us-gaap:FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "AsOf2022-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:LiabilitiesFairValueDisclosure", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } }, "R99": { "firstAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" }, "groupType": "disclosure", "isDefault": "false", "longName": "00000099 - Disclosure - SCHEDULE OF FAIR VALUE AT ASSETS (Details)", "role": "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails", "shortName": "SCHEDULE OF FAIR VALUE AT ASSETS (Details)", "subGroupType": "details", "uniqueAnchor": { "ancestors": [ "span", "td", "tr", "table", "us-gaap:FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "us-gaap:FairValueDisclosuresTextBlock", "body", "html" ], "baseRef": "form10-k.htm", "contextRef": "From2021-01-01to2021-12-31", "decimals": "0", "first": true, "lang": null, "name": "us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "reportCount": 1, "unique": true, "unitRef": "USD", "xsiNil": "false" } } }, "segmentCount": 132, "tag": { "SRAX_AccountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivable.", "label": "[custom:AccountsReceivable-0]" } } }, "localname": "AccountsReceivable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_AccountsReceivables": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Accounts receivables.", "label": "[custom:AccountsReceivables-0]" } } }, "localname": "AccountsReceivables", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_AccruedCommissionsCurrent": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accrued commissions current.", "label": "Accrued commissions" } } }, "localname": "AccruedCommissionsCurrent", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_AcquisitionOfLdMicroNetOfCashAcquired": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Acquisition of LD Micro net of cash acquired.", "label": "AcquisitionOfLdMicroNetOfCashAcquired", "negatedLabel": "Acquisition of LD Micro, net of cash acquired" } } }, "localname": "AcquisitionOfLdMicroNetOfCashAcquired", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_AdditionalPrincipalPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Additional principal percentage.", "label": "Additional principal percentage" } } }, "localname": "AdditionalPrincipalPercentage", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Adjustments to additional paid in capital reclassification of warrants from liability to equity.", "label": "Reclassification of warrants from liability to equity" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalReclassificationOfWarrantsFromLiabilityToEquity", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_AfterTheClosingDateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "After The Closing Date [Member]", "label": "After The Closing Date [Member]" } } }, "localname": "AfterTheClosingDateMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_AgreementsToSellAccountsReceivableAmmendedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements to Sell Accounts Receivable Ammended [Member]", "label": "Agreements to Sell Accounts Receivable Ammended [Member]" } } }, "localname": "AgreementsToSellAccountsReceivableAmmendedMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_AgreementsToSellAccountsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Agreements to Sell Accounts Receivable [Member]", "label": "Agreements to Sell Accounts Receivable [Member]" } } }, "localname": "AgreementsToSellAccountsReceivableMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_AmortizationMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Amortization [Member]", "label": "Amortization [Member]" } } }, "localname": "AmortizationMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "domainItemType" }, "SRAX_AmortizationOfFiniteLivedIntangibleAssets": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amortization of finite-lived intangible assets.", "label": "Amortization of finite-lived intangible assets" } } }, "localname": "AmortizationOfFiniteLivedIntangibleAssets", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_AmortizationOfPayments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amortization of payments.", "label": "Amortization of payments" } } }, "localname": "AmortizationOfPayments", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_AssetsDesignated": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Assets designated.", "label": "AssetsDesignated", "periodEndLabel": "Designated assets at ending balance", "periodStartLabel": "Designated assets at beginning balance" } } }, "localname": "AssetsDesignated", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_AtTheMarketSalesAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "At the Market Sales Agreement [Member]", "label": "At the Market Sales Agreement [Member]" } } }, "localname": "AtTheMarketSalesAgreementMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BIGTokensMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BIG Tokens [Member]", "label": "BIG Tokens [Member]" } } }, "localname": "BIGTokensMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BIGtokenMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "BIGtoken [Member]", "label": "BIGtoken [Member]" } } }, "localname": "BIGtokenMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BeneficialOwnershipPercenatge": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Beneficial Ownership Percenatge.", "label": "Beneficial Ownership Percenatge" } } }, "localname": "BeneficialOwnershipPercenatge", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_BigTokenIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Big Token Inc [Member]", "label": "Big Token Inc [Member]" } } }, "localname": "BigTokenIncMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BoardOfDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Board of Directors [Member]", "label": "Board of Directors [Member]" } } }, "localname": "BoardOfDirectorsMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BookBasisOfInvestmentInBigtoken": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Book basis of investment in bigtoken.", "label": "Book basis of investment in BIGToken" } } }, "localname": "BookBasisOfInvestmentInBigtoken", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BridgeNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Bridge Note [Member]", "label": "Bridge Note [Member]" } } }, "localname": "BridgeNoteMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BritePoolIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Brite Pool Inc [Member]", "label": "Brite Pool Inc [Member]" } } }, "localname": "BritePoolIncMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_BusinessAcquisitionsProFormaAmortizationOfIntangiblesAcquired": { "auth_ref": [], "calculation": { "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma amortization of intangibles acquired.", "label": "Amortization of intangibles acquired" } } }, "localname": "BusinessAcquisitionsProFormaAmortizationOfIntangiblesAcquired", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessAcquisitionsProFormaCostOfRevenues": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma cost of revenues.", "label": "Cost of revenues" } } }, "localname": "BusinessAcquisitionsProFormaCostOfRevenues", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessAcquisitionsProFormaEmployeeRelatedCosts": { "auth_ref": [], "calculation": { "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma employee related costs.", "label": "BusinessAcquisitionsProFormaEmployeeRelatedCosts", "verboseLabel": "Employee related costs" } } }, "localname": "BusinessAcquisitionsProFormaEmployeeRelatedCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessAcquisitionsProFormaFinancingCosts": { "auth_ref": [], "calculation": { "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma financing costs.", "label": "Financing costs" } } }, "localname": "BusinessAcquisitionsProFormaFinancingCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma income tax expense benefit.", "label": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit", "negatedLabel": "Provision for income taxes" } } }, "localname": "BusinessAcquisitionsProFormaIncomeTaxExpenseBenefit", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessAcquisitionsProFormaOperatingExpenses": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma operating expenses.", "label": "Operating expenses" } } }, "localname": "BusinessAcquisitionsProFormaOperatingExpenses", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessAcquisitionsProFormaOtherExpense": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Business acquisitions pro forma other expense.", "label": "Other expense" } } }, "localname": "BusinessAcquisitionsProFormaOtherExpense", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessCombinationContingentConsiderationLiabilityRelated": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business Combination Contingent Consideration Liability Related.", "label": "[custom:BusinessCombinationContingentConsiderationLiabilityRelated-0]" } } }, "localname": "BusinessCombinationContingentConsiderationLiabilityRelated", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessCombinationContractWithCustomerLiability": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": 3.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred payments related to acquisition.", "label": "Deferred payments", "verboseLabel": "Deferred payments related to acquisition" } } }, "localname": "BusinessCombinationContractWithCustomerLiability", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessCombinationContractWithCustomerLiabilityDiscounted": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred payments discounted under CCC rated corporate debt.", "label": "Deferred payments discounted under CCC rated corporate debt" } } }, "localname": "BusinessCombinationContractWithCustomerLiabilityDiscounted", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessCombinationLessCashReceived": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": 4.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination less cash received.", "label": "Less cash received" } } }, "localname": "BusinessCombinationLessCashReceived", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessCombinationTransactionExpenses": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": 5.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination transaction expenses.", "label": "Transaction expenses" } } }, "localname": "BusinessCombinationTransactionExpenses", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_BusinessCombinationWorkingCapitalAdjustment": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": 6.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Business combination working capital adjustment.", "label": "Working capital adjustment" } } }, "localname": "BusinessCombinationWorkingCapitalAdjustment", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_CVRAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "CVR Agreement [Member]", "label": "CVR Agreement [Member]" } } }, "localname": "CVRAgreementMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_CarryingAmountOfNoncontrollingInterestOfBigtoken": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying Amount Of Noncontrolling Interest Of Bigtoken.", "label": "Carrying amount of non-controlling interest of BIGToken" } } }, "localname": "CarryingAmountOfNoncontrollingInterestOfBigtoken", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_CashAndCashEquivalentsDiscontinuedOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash and Cash Equivalents Discontinued Operations", "label": "CashAndCashEquivalentsDiscontinuedOperations", "periodEndLabel": "Less: Cash from discontinued operations" } } }, "localname": "CashAndCashEquivalentsDiscontinuedOperations", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_CashCashEquivalentsAndRestrictedCashFromContinuingOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash, cash equivalents and restricted cash from continuing operations.", "label": "CashCashEquivalentsAndRestrictedCashFromContinuingOperations", "periodEndLabel": "Cash, cash equivalents and board designated restricted cash from continuing operations" } } }, "localname": "CashCashEquivalentsAndRestrictedCashFromContinuingOperations", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_CashReservedForDesignatedAssetForReturnOfCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash reserved for designated asset for return of capital.", "label": "CashReservedForDesignatedAssetForReturnOfCapital", "periodEndLabel": "Cash reserved for designated asset for return of capital" } } }, "localname": "CashReservedForDesignatedAssetForReturnOfCapital", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_ClassACommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class A common stock [Member]", "label": "Class A common stock [Member]" } } }, "localname": "ClassACommonStockMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ClassBCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Class B Common Stock [Member]", "label": "Class B Common Stock [Member]" } } }, "localname": "ClassBCommonStockMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_CommonStockIssuedForAcquisitionOfSubsidiaryShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Common stock issued for acquisition of subsidiary shares.", "label": "Common stock issued for the acquisition of a subsidiary, shares" } } }, "localname": "CommonStockIssuedForAcquisitionOfSubsidiaryShares", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "SRAX_CommonStockIssuedForAcquisitionOfSubsidiaryValue": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock issued for acquisition of subsidiary value.", "label": "Common stock issued for the acquisition of a subsidiary" } } }, "localname": "CommonStockIssuedForAcquisitionOfSubsidiaryValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_CommonStockIssuedToSettleLiability": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Common stock issued to settle liability.", "label": "Common stock issued to settle liability" } } }, "localname": "CommonStockIssuedToSettleLiability", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_CommonStockReceivedInLieuOfCashForAccountReceived": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Common stock received in lieu of cash for account received.", "label": "Common stock received in lieu of cash for accounts receivable" } } }, "localname": "CommonStockReceivedInLieuOfCashForAccountReceived", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_ConferenceRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conference Revenue [Member]", "label": "Conference Revenue [Member]" } } }, "localname": "ConferenceRevenueMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails" ], "xbrltype": "domainItemType" }, "SRAX_ContractsReceivable": { "auth_ref": [], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Contracts receivable.", "label": "Contracts receivable", "verboseLabel": "Contracts asset" } } }, "localname": "ContractsReceivable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ContractsReceivableDetailsNarrative", "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_ContractsReceivableMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Contracts Receivable [Member]", "label": "Contracts Receivable [Member]" } } }, "localname": "ContractsReceivableMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "SRAX_ConversionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Conversion [Member]", "label": "Conversion [Member]" } } }, "localname": "ConversionMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "domainItemType" }, "SRAX_ConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Convertible Debentures [Member]", "label": "Convertible Debentures [Member]" } } }, "localname": "ConvertibleDebenturesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "SRAX_CostAndOperatingExpenses": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cost and expenses.", "label": "CostAndOperatingExpenses", "totalLabel": "Total cost and expenses" } } }, "localname": "CostAndOperatingExpenses", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRAX_CreditAgreementAndRevolvingNoteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement and Revolving Note [Member]", "label": "Credit Agreement and Revolving Note [Member]" } } }, "localname": "CreditAgreementAndRevolvingNoteMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_CreditAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Credit Agreement [Member]", "label": "Credit Agreement [Member]" } } }, "localname": "CreditAgreementMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_CurrentPrincipalBalanceFeePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Current Principal Balance Fee Percentage.", "label": "Current principal balance fee amount" } } }, "localname": "CurrentPrincipalBalanceFeePercentage", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_CurrentValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Current valuation allowance.", "label": "Current Valuation allowance" } } }, "localname": "CurrentValuationAllowance", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_CustomerListMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer List [Member]", "label": "Customer List [Member]" } } }, "localname": "CustomerListMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "SRAX_CustomerOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer One [Member]", "label": "Customer One [Member]" } } }, "localname": "CustomerOneMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_CustomerThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Three [Member]", "label": "Customer Three [Member]" } } }, "localname": "CustomerThreeMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_CustomerTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Customer Two [Member]", "label": "Customer Two [Member]" } } }, "localname": "CustomerTwoMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_DebentureHoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debenture Holders [Member]", "label": "Debenture Holders [Member]" } } }, "localname": "DebentureHoldersMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_DebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Debentures [Member]", "label": "Debentures [Member]" } } }, "localname": "DebenturesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_DebtDiscountPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Original issue discount percentage.", "label": "Original issue discount percentage" } } }, "localname": "DebtDiscountPercentage", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_DebtInstrumentAdditionalBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Debt instrument, additional borrowing capacity.", "label": "Debt instrument, additional borrowing capacity" } } }, "localname": "DebtInstrumentAdditionalBorrowingCapacity", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredPaymentFairValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred payment fair value.", "label": "Deferred payment fair value" } } }, "localname": "DeferredPaymentFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredTaxAssetsContributionCarryover": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 7.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets: Contribution carryover.", "label": "Contribution carryover" } } }, "localname": "DeferredTaxAssetsContributionCarryover", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredTaxAssetsLeaseLiability": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 8.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Assets: Lease liability.", "label": "Lease liability" } } }, "localname": "DeferredTaxAssetsLeaseLiability", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredTaxAssetsTaxDeferredExpenseBadDebtExpenses": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Deferred tax assets, bad debt expense.", "label": "Bad debt expense" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseBadDebtExpenses", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredTaxLiabilitiesFixedAssets": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities, fixed assets.", "label": "DeferredTaxLiabilitiesFixedAssets", "negatedLabel": "Fixed assets" } } }, "localname": "DeferredTaxLiabilitiesFixedAssets", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredTaxLiabilitiesInterestExpenseLimitationCarryover": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred tax liabilities interest expense limitation carryover.", "label": "DeferredTaxLiabilitiesInterestExpenseLimitationCarryover", "verboseLabel": "Interest expense limitation carryover" } } }, "localname": "DeferredTaxLiabilitiesInterestExpenseLimitationCarryover", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredTaxLiabilitiesRightofuseAsset": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred Tax Liabilities: Right-of-use asset.", "label": "DeferredTaxLiabilitiesRightofuseAsset", "negatedLabel": "Right-of-use asset" } } }, "localname": "DeferredTaxLiabilitiesRightofuseAsset", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DeferredValuationAllowance": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Deferred valuation allowance.", "label": "Deferred Valuation allowance" } } }, "localname": "DeferredValuationAllowance", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DerivativeAssetMaturityMeasurementInput": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Derivative asset maturity measurement input.", "label": "Range, maturity" } } }, "localname": "DerivativeAssetMaturityMeasurementInput", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "durationItemType" }, "SRAX_DerivativeLiabilitiesTransferredToEquity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Derivative liabilities transferred to equity.", "label": "Derivative liabilities transferred to equity" } } }, "localname": "DerivativeLiabilitiesTransferredToEquity", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_DescriptionOfSaleOfAccountsReceivable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of sale of accounts receivable.", "label": "Description of sale of accounts receivable" } } }, "localname": "DescriptionOfSaleOfAccountsReceivable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "stringItemType" }, "SRAX_DesignatedAssetsForReturnOfCapital": { "auth_ref": [], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Designated assets for return of capital.", "label": "Designated assets for return of capital", "verboseLabel": "Balance" } } }, "localname": "DesignatedAssetsForReturnOfCapital", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DesignatedAssetsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated Assets [Member]", "label": "Designated Assets [Member]" } } }, "localname": "DesignatedAssetsMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails" ], "xbrltype": "domainItemType" }, "SRAX_DesignatedAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated Assets [Table Text Block]", "label": "SCHEDULE OF DESIGNATED ASSETS" } } }, "localname": "DesignatedAssetsTableTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalTables" ], "xbrltype": "textBlockItemType" }, "SRAX_DesignatedAssetsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Designated Assets [Text Block]", "label": "DESIGNATED ASSETS FOR RETURN OF CAPITAL" } } }, "localname": "DesignatedAssetsTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapital" ], "xbrltype": "textBlockItemType" }, "SRAX_DesignationOfMarketableSecuritiesForDividendDistribution": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Designation of marketable securities for dividend distribution.", "label": "DesignationOfMarketableSecuritiesForDividendDistribution", "negatedLabel": "Designation of marketable securities for dividend distribution" } } }, "localname": "DesignationOfMarketableSecuritiesForDividendDistribution", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_DisclosureDesignatedAssetsForReturnOfCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Designated Assets For Return Of Capital" } } }, "localname": "DisclosureDesignatedAssetsForReturnOfCapitalAbstract", "nsuri": "http://srax.com/20211231", "xbrltype": "stringItemType" }, "SRAX_DisclosureOidConvertibleDebenturesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Oid Convertible Debentures" } } }, "localname": "DisclosureOidConvertibleDebenturesAbstract", "nsuri": "http://srax.com/20211231", "xbrltype": "stringItemType" }, "SRAX_DisclosurePaycheckProtectionProgramLoanAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Paycheck Protection Program Loan" } } }, "localname": "DisclosurePaycheckProtectionProgramLoanAbstract", "nsuri": "http://srax.com/20211231", "xbrltype": "stringItemType" }, "SRAX_DisclosureRevenueDisaggregationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue Disaggregation" } } }, "localname": "DisclosureRevenueDisaggregationAbstract", "nsuri": "http://srax.com/20211231", "xbrltype": "stringItemType" }, "SRAX_DisclosureRightToUseAssetAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Right To Use Asset", "terseLabel": "Schedule Of Operating Lease Assets And Liabilities", "verboseLabel": "Schedule Of Component Of Lease Expense" } } }, "localname": "DisclosureRightToUseAssetAbstract", "nsuri": "http://srax.com/20211231", "xbrltype": "stringItemType" }, "SRAX_DiscountOnNotesReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Discount on notes receivable.", "label": "Discount on notes receivable" } } }, "localname": "DiscountOnNotesReceivable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued operation employee releated cost.", "label": "DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost", "verboseLabel": "Employee related costs" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationEmployeerelastedCost", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of Series D Stock and Common stock.", "label": "Fair value of Series D Stock and Common stock" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationFairValueOfSeriesDStockAndCommonStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationFinancingCosts": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued operation financing costs.", "label": "DisposalGroupIncludingDiscontinuedOperationFinancingCosts", "negatedLabel": "Financing costs" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationFinancingCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationImpairmentOfGoodwill": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued operation impairment of goodwill.", "label": "DisposalGroupIncludingDiscontinuedOperationImpairmentOfGoodwill", "negatedLabel": "Impairment of goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationImpairmentOfGoodwill", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationPlatformCost": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued operation platform cost.", "label": "DisposalGroupIncludingDiscontinuedOperationPlatformCost", "verboseLabel": "Platform costs" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPlatformCost", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationRealizedLossOnMarketableSecurities": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued operation realized loss on marketable securities.", "label": "DisposalGroupIncludingDiscontinuedOperationRealizedLossOnMarketableSecurities", "negatedLabel": "Realized loss on marketable securities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRealizedLossOnMarketableSecurities", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Disposal group including discontinued operation selling and marketing expense.", "label": "DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense", "verboseLabel": "Marketing and selling expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationSellingAndMarketingExpense", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_DispositionOfSubsidiary": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Disposition of shares.", "label": "Disposition of subsidiary" } } }, "localname": "DispositionOfSubsidiary", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_DividendsOnPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Dividends on preferred stock.", "label": "Dividends on preferred stock" } } }, "localname": "DividendsOnPreferredStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_DomainNameMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Domain Name [Member]", "label": "Domain Name [Member]" } } }, "localname": "DomainNameMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "SRAX_EffectiveIncomeTaxRateReconciliationFairMarketAdjustmentDerivatives": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation, fair market adjustment derivatives.", "label": "Fair market adjustment derivatives" } } }, "localname": "EffectiveIncomeTaxRateReconciliationFairMarketAdjustmentDerivatives", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "SRAX_EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Effective income tax rate reconciliation, permanent differences.", "label": "Permanent differences" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpensePermanentDifferences", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "SRAX_EmployeeRelatedCosts": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Employee related costs.", "label": "EmployeeRelatedCosts", "verboseLabel": "Employee related costs" } } }, "localname": "EmployeeRelatedCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_EmployeesAndMembersOfManagementTeamMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Employees and Members of Management Team [Member]", "label": "Employees and Members of Management Team [Member]" } } }, "localname": "EmployeesAndMembersOfManagementTeamMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ExcessAmountForEachUnit": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Excess amount for each unit.", "label": "Excess amount for each unit" } } }, "localname": "ExcessAmountForEachUnit", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "SRAX_ExchangedNumberOfSharesforCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Exchanged Number Of Shares for CommonStock.", "label": "[custom:ExchangedNumberOfSharesforCommonStock]" } } }, "localname": "ExchangedNumberOfSharesforCommonStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "SRAX_ExtensionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension [Member]", "label": "Extension [Member]" } } }, "localname": "ExtensionMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "domainItemType" }, "SRAX_FactoringFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Factoring Facility [Member]", "label": "Factoring Facility [Member]" } } }, "localname": "FactoringFacilityMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_FairValueOfPreferredStock": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of preferred stock.", "label": "Fair value of preferred stock" } } }, "localname": "FairValueOfPreferredStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_FairValueOfWarrantsIssuedForDebtFinancings": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrants issued for debt financings.", "label": "Fair value of warrants issued for debt financings" } } }, "localname": "FairValueOfWarrantsIssuedForDebtFinancings", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_FederalStateAndLocalTaxExpenseBenefitContinuingOperations": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of state, local, and federal tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Subtotal" } } }, "localname": "FederalStateAndLocalTaxExpenseBenefitContinuingOperations", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_FinancingCosts": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Financing costs.", "label": "FinancingCosts", "negatedLabel": "Financing costs" } } }, "localname": "FinancingCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRAX_ForecastMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Forecast [Member]", "label": "Forecast [Member]" } } }, "localname": "ForecastMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ForgivenessOfPayrollProtectionProgramLoan": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Forgiveness of payroll protection program loan.", "label": "Forgiveness of payroll protection program loan", "negatedLabel": "Forgiveness of payroll protection program loan" } } }, "localname": "ForgivenessOfPayrollProtectionProgramLoan", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_GainLossOnFairValueInPreferredStock": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 9.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain loss on fair value in preferred stock.", "label": "Change in fair value of preferred stock", "negatedLabel": "Change in fair value of preferred stock" } } }, "localname": "GainLossOnFairValueInPreferredStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRAX_GainOnMarketableSecurities": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Gain on marketable securities.", "label": "[custom:GainOnMarketableSecurities]", "verboseLabel": "Gain on marketable securities." } } }, "localname": "GainOnMarketableSecurities", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_HaylardMDLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Haylard MDLLC [Member]", "label": "Haylard MDLLC [Member]" } } }, "localname": "HaylardMDLLCMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_HoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Holders [Member]", "label": "Holders [Member]" } } }, "localname": "HoldersMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_IncreaseDecreaseDeferredRevenues": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 25.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase decrease deferred revenues.", "label": "IncreaseDecreaseDeferredRevenues", "negatedLabel": "Deferred revenue" } } }, "localname": "IncreaseDecreaseDeferredRevenues", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_IncreaseDecreaseInAdditionalPaidInCapital": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Increase in additional paid in capital.", "label": "Additional principal balance" } } }, "localname": "IncreaseDecreaseInAdditionalPaidInCapital", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_InstitutionalInvestorMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Institutional Investor [Member]", "label": "Institutional Investor [Member]" } } }, "localname": "InstitutionalInvestorMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_IntangibleAssetsLifeInYearsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Intangible assets life in years description.", "label": "Life in years, description" } } }, "localname": "IntangibleAssetsLifeInYearsDescription", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails" ], "xbrltype": "stringItemType" }, "SRAX_InternallyDevelopedSoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Internally Developed Software [Member]", "label": "Internally Developed Software [Member]" } } }, "localname": "InternallyDevelopedSoftwareMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "SRAX_IssuanceDuringTheYearMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance Beginning of Year [Member]", "label": "Issuance Beginning of Year [Member]" } } }, "localname": "IssuanceDuringTheYearMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "domainItemType" }, "SRAX_IssuanceOfAcquisitionSharesDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issuance of acquisition shares description.", "label": "[custom:IssuanceOfAcquisitionSharesDescription]" } } }, "localname": "IssuanceOfAcquisitionSharesDescription", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "textBlockItemType" }, "SRAX_IssuedAndOutstandingOfCommonStock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Issued and Outstanding of Common Stock.", "label": "[custom:IssuedAndOutstandingOfCommonStock]" } } }, "localname": "IssuedAndOutstandingOfCommonStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_LDMicroIncMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LD Micro Inc [Member]", "label": "LD Micro Inc [Member]" } } }, "localname": "LDMicroIncMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "domainItemType" }, "SRAX_LDMicroMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "LD Micro [Member]", "label": "LD Micro [Member]" } } }, "localname": "LDMicroMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_LineOfCreditFacilityPaymentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of credit facility payment description.", "label": "Payment description" } } }, "localname": "LineOfCreditFacilityPaymentDescription", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "SRAX_LineOfCreditFacilityPaymentPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line of credit facility payment percentage.", "label": "Payment percentage" } } }, "localname": "LineOfCreditFacilityPaymentPercentage", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_LiquidityAndGoingConcernPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Liquidity and Going Concern [Policy Text Block]", "label": "Liquidity and Going Concern" } } }, "localname": "LiquidityAndGoingConcernPolicyTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "SRAX_LongtermAssetsOfDiscontinuedOperations": { "auth_ref": [], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 8.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Long term assets of discontinued operations.", "label": "Long-term assets of discontinued operations" } } }, "localname": "LongtermAssetsOfDiscontinuedOperations", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "SRAX_LossOnDisposalOfSubsidiary": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on disposal of subsidiary.", "label": "LossOnDisposalOfSubsidiary", "negatedLabel": "Loss on disposal of subsidiary" } } }, "localname": "LossOnDisposalOfSubsidiary", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRAX_LossOnUnrealizedDesignatedAssets": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Loss on unrealized designated assets.", "label": "Unrealized loss on designated assets" } } }, "localname": "LossOnUnrealizedDesignatedAssets", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_MDCoInvestLLCMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "MD CoInvest, LLC [Member]", "label": "MD CoInvest, LLC [Member]" } } }, "localname": "MDCoInvestLLCMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_MarketableSecuritiesAddition": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Marketable securities addition.", "label": "Additions" } } }, "localname": "MarketableSecuritiesAddition", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_MarketableSecuritiesDesignationforDividendDistribution": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Marketable securities designation for dividend distribution.", "label": "MarketableSecuritiesDesignationforDividendDistribution", "negatedLabel": "Designation for dividend distribution" } } }, "localname": "MarketableSecuritiesDesignationforDividendDistribution", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_MarketableSecuritiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Marketable Securities [Member]", "label": "Marketable Securities [Member]" } } }, "localname": "MarketableSecuritiesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "SRAX_MarketableSecuritiesReceivedForAccountsReceivablePreviouslyWrittenOff": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 14.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Marketable securities received for accounts receivable previously written off.", "label": "MarketableSecuritiesReceivedForAccountsReceivablePreviouslyWrittenOff", "negatedLabel": "Marketable securities received for accounts receivable previously written off" } } }, "localname": "MarketableSecuritiesReceivedForAccountsReceivablePreviouslyWrittenOff", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_MaximumFairMarketValueThreshholdInCalendarYearForSingleHolder": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum fair market value threshhold in calendar year for single holder.", "label": "Maximum fair market value underlying options exercisable by any option holder during any calendar year" } } }, "localname": "MaximumFairMarketValueThreshholdInCalendarYearForSingleHolder", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_MaximumOptionLife": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum option life.", "label": "Maximum option life" } } }, "localname": "MaximumOptionLife", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "SRAX_MaximumOptionLifeForEligibleEmployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Maximum option life for eligible employees.", "label": "Maximum option life for 10% holder" } } }, "localname": "MaximumOptionLifeForEligibleEmployees", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "SRAX_MinimumPercentageOfFairMarketValueOfUnderyingShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of fair market value of underying share.", "label": "Minimum percentage of fair market value" } } }, "localname": "MinimumPercentageOfFairMarketValueOfUnderyingShare", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_MinimumPercentageOfFairMarketValueOfUnderyingSharesForEligibleEmployee": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Minimum percentage of fair market value of underying shares for eligible employee.", "label": "Minimum percentage of fair market value for eligible employee" } } }, "localname": "MinimumPercentageOfFairMarketValueOfUnderyingSharesForEligibleEmployee", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_NetChangeInRightOfUseAssetAndLiability": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 20.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Net Change In Right Of Use Asset And Liability.", "label": "NetChangeInRightOfUseAssetAndLiability", "negatedLabel": "Net change in right of use asset and liability" } } }, "localname": "NetChangeInRightOfUseAssetAndLiability", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_NewWarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "New Warrant [Member]", "label": "New Warrant [Member]" } } }, "localname": "NewWarrantMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_NolCarryforwardsDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "NOL carryforwards, description.", "label": "NOL carryforwards, description" } } }, "localname": "NolCarryforwardsDescription", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "SRAX_NonExecutiveDirectorsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Non-Executive Directors [Member]", "label": "Non-Executive Directors [Member]" } } }, "localname": "NonExecutiveDirectorsMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_NoncashFinancingExpense": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 21.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non cash financing expense.", "label": "Non-cash financing expense" } } }, "localname": "NoncashFinancingExpense", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_NoncompeteMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Noncompete [Member]", "label": "Noncompete [Member]" } } }, "localname": "NoncompeteMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "SRAX_NoncontrollingInterestIncreaseFromConvertibleDebtWithConversionFeature": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest increase from convertible debt with conversion feature .", "label": "Beneficial conversion feature FPVD series B convertible preferred stock" } } }, "localname": "NoncontrollingInterestIncreaseFromConvertibleDebtWithConversionFeature", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_NoncontrollingInterestIncreaseFromWarrantIssued": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 11.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Noncontrolling Interest Increase From Warrant Issued.", "label": "NoncontrollingInterestIncreaseFromWarrantIssued", "verboseLabel": "Warrants issued by FVPD for SRAX, Inc. debenture holders" } } }, "localname": "NoncontrollingInterestIncreaseFromWarrantIssued", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_NoncontrollingInterestIncreaseFromWarrantsIssued": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest increase from warrants issued.", "label": "Warrants issued by FVPD for SRAX, Inc. debenture holders" } } }, "localname": "NoncontrollingInterestIncreaseFromWarrantsIssued", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_NoncontrollingInterestSeriesBConvertiblePreferredStockIssued": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Non controlling interest series B convertible preferred stock issued.", "label": "Series B convertible preferred stock issued by FPVD" } } }, "localname": "NoncontrollingInterestSeriesBConvertiblePreferredStockIssued", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_NumberOfSharesPledgedForRepurchaseOfReceivables": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares pledged for repurchase of receivables.", "label": "Number of shares pledged for repurchase of receivables" } } }, "localname": "NumberOfSharesPledgedForRepurchaseOfReceivables", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "SRAX_NumberOfWarrantsCancelled": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number Of Warrants Cancelled.", "label": "[custom:NumberOfWarrantsCancelled]" } } }, "localname": "NumberOfWarrantsCancelled", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "SRAX_OIDConvertibleDebenturesDiscount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Debt discount.", "label": "Debt discount" } } }, "localname": "OIDConvertibleDebenturesDiscount", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_OIDConvertibleDebenturesFaceAmount": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Principal.", "label": "Principal" } } }, "localname": "OIDConvertibleDebenturesFaceAmount", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_OIDConvertibleDebenturesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OID Convertible Debentures [Member]", "label": "OID Convertible Debentures [Member]" } } }, "localname": "OIDConvertibleDebenturesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_OIDConvertibleDebenturesMembersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "OID Convertible Debentures [Member]", "label": "OID Convertible Debentures [Member] [Default Label]", "verboseLabel": "OID Convertible Debentures [Member]" } } }, "localname": "OIDConvertibleDebenturesMembersMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_OidConvertibleDebenturesShortTerm": { "auth_ref": [], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Oid convertible debentures short term.", "label": "OID notes payable", "verboseLabel": "Net book value" } } }, "localname": "OidConvertibleDebenturesShortTerm", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_OriginalIssueDiscountConvertibleDebenturesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Original Issue Discount Convertible Debentures [Text Block]", "label": "OID CONVERTIBLE DEBENTURES" } } }, "localname": "OriginalIssueDiscountConvertibleDebenturesTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebentures" ], "xbrltype": "textBlockItemType" }, "SRAX_OriginalIssueDiscountRecordedOnOidConvertibleDebentures": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Original issue discount recorded on oid convertible debentures.", "label": "Original issue discount recorded on OID convertible debentures" } } }, "localname": "OriginalIssueDiscountRecordedOnOidConvertibleDebentures", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_OtherRevenuesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Other Revenues [Member]", "label": "Other Revenues [Member]" } } }, "localname": "OtherRevenuesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails" ], "xbrltype": "domainItemType" }, "SRAX_PIPETechnologiesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "PIPE Technologies [Member]", "label": "PIPE Technologies [Member]" } } }, "localname": "PIPETechnologiesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_PaycheckProtectionProgramLoanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program Loan [Member]", "label": "Paycheck Protection Program Loan [Member]" } } }, "localname": "PaycheckProtectionProgramLoanMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_PaycheckProtectionProgramLoanTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Paycheck Protection Program Loan [Text Block]", "label": "PAYCHECK PROTECTION PROGRAM LOAN" } } }, "localname": "PaycheckProtectionProgramLoanTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoan" ], "xbrltype": "textBlockItemType" }, "SRAX_PercentageOfReceivablesUponExerciseOfPutOption": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Percentage of receivables upon exercise of put option.", "label": "[custom:PercentageOfReceivablesUponExerciseOfPutOption]" } } }, "localname": "PercentageOfReceivablesUponExerciseOfPutOption", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_PlacementAgentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Placement Agent [Member]", "label": "Placement Agent [Member]" } } }, "localname": "PlacementAgentMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_PlatformCosts": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "SRAX_CostAndOperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Platform costs.", "label": "Platform costs" } } }, "localname": "PlatformCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRAX_PremiumOnDebtFinancings": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Premium on debt financings.", "label": "Premium on debt financings" } } }, "localname": "PremiumOnDebtFinancings", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_PreviousEquityAdjustmentOfNoncontrollingInterest": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Previous Equity Adjustment Of Noncontrolling Interest.", "label": "Previous equity adjustments of non-controlling interest" } } }, "localname": "PreviousEquityAdjustmentOfNoncontrollingInterest", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_PriceToBePaidUponEarliar": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Price to be paid upon earliar.", "label": "Price to be paid upon earlier" } } }, "localname": "PriceToBePaidUponEarliar", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_PrincipalAmountExchange": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Exchange of principal amount.", "label": "Principal amount exchange" } } }, "localname": "PrincipalAmountExchange", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_PriorToClosingDateMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Prior To Closing Date [Member]", "label": "Prior To Closing Date [Member]" } } }, "localname": "PriorToClosingDateMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ProFormaAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pro Forma Adjustment [Member]", "label": "Pro Forma Adjustment [Member]" } } }, "localname": "ProFormaAdjustmentMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "SRAX_ProFormaCombinedMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Pro Forma Combined [Member]", "label": "Pro Forma Combined [Member]" } } }, "localname": "ProFormaCombinedMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "domainItemType" }, "SRAX_ProceedFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceed from sale and maturity of marketable securities.", "label": "[custom:ProceedFromSaleAndMaturityOfMarketableSecurities]", "verboseLabel": "Sale of marketable securities" } } }, "localname": "ProceedFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/MarketableSecuritiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_ProceedsFromAccountsReceivable": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from accounts receivable.", "label": "Proceeds from accounts receivable" } } }, "localname": "ProceedsFromAccountsReceivable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_ProceedsFromIssuanceInitialPublicOfferingNet": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from offering, net.", "label": "Net proceeds from issuance of Initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOfferingNet", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_ProceedsFromOidNotesPayableLessIssuanceCosts": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from oid notes payable less issuance costs.", "label": "Proceeds from OID notes payable, less issuance costs" } } }, "localname": "ProceedsFromOidNotesPayableLessIssuanceCosts", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_ProceedsFromPaymentsForAcquireOtherAssets": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Proceeds from payments for acquire other assets.", "label": "ProceedsFromPaymentsForAcquireOtherAssets", "negatedLabel": "Other assets" } } }, "localname": "ProceedsFromPaymentsForAcquireOtherAssets", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_ProceedsFromSaleOfDesignatedAssets": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Proceeds from sale of designated assets.", "label": "Proceeds from the sale of designated assets" } } }, "localname": "ProceedsFromSaleOfDesignatedAssets", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_ProceedsFromWarrantsPercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Proceeds from warrants percentage.", "label": "Proceeds from warrants percentage" } } }, "localname": "ProceedsFromWarrantsPercentage", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_PurchasePrice": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Purchase price.", "label": "[custom:PurchasePrice-0]" } } }, "localname": "PurchasePrice", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_PutOptionPricingModelMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Put Option Pricing Model [Member]", "label": "Put Option Pricing Model [Member]" } } }, "localname": "PutOptionPricingModelMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "SRAX_RatedCorporateDebtMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Rated Corporate Debt [Member]", "label": "Rated Corporate Debt [Member]" } } }, "localname": "RatedCorporateDebtMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ReceivablePurchaseAndSaleAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Receivable Purchase and Sale Agreement [Member]", "label": "Receivable Purchase and Sale Agreement [Member]" } } }, "localname": "ReceivablePurchaseAndSaleAgreementMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_RedemptionMember": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Redemption [Member]" } } }, "localname": "RedemptionMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails" ], "xbrltype": "domainItemType" }, "SRAX_RedemptionOfOidNotesPayable": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Redemption of oid notes payable.", "label": "RedemptionOfOidNotesPayable", "negatedLabel": "Redemption of OID notes payable" } } }, "localname": "RedemptionOfOidNotesPayable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_RelativeFairValueOfWarrantsIssuedWithTermLoan": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Relative fair value of warrants issued with term loan.", "label": "Relative fair value of warrants issued with term loan" } } }, "localname": "RelativeFairValueOfWarrantsIssuedWithTermLoan", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_RepaymentsOfShortTermNotesPayable": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repayments of short term notes payable.", "label": "RepaymentsOfShortTermNotesPayable", "negatedLabel": "Repayment of short-term notes payable" } } }, "localname": "RepaymentsOfShortTermNotesPayable", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_RepurchaseAndRetirementOfShares": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repurchase and retirement of shares.", "label": "Repurchase and retirement of shares" } } }, "localname": "RepurchaseAndRetirementOfShares", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_RepurchaseAndRetirementOfSharesShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Repurchase and retirement of shares,share", "label": "Repurchase and retirement of shares, shares" } } }, "localname": "RepurchaseAndRetirementOfSharesShare", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "SRAX_RepurchaseOfAuthorizedCommonStock": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Repurchase of authorized common stock.", "label": "Repurchase of common stock" } } }, "localname": "RepurchaseOfAuthorizedCommonStock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_RepurchaseOfShares": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Repurchase of shares.", "label": "RepurchaseOfShares", "negatedLabel": "Repurchase of shares" } } }, "localname": "RepurchaseOfShares", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_RevenueDisaggregationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue Disaggregation [Text Block]", "label": "REVENUE DISAGGREGATION" } } }, "localname": "RevenueDisaggregationTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/RevenueDisaggregation" ], "xbrltype": "textBlockItemType" }, "SRAX_RevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Revenue [Member]", "label": "Revenue [Member]" } } }, "localname": "RevenueMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_RightToFutureSubscriptionRevenues": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Right to future subscription revenues.", "label": "Right to future subscription revenues" } } }, "localname": "RightToFutureSubscriptionRevenues", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_RighttoUseAssetLeasesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Right to Use Asset Leases [Text Block]", "label": "RIGHT TO USE ASSET" } } }, "localname": "RighttoUseAssetLeasesTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/RightToUseAsset" ], "xbrltype": "textBlockItemType" }, "SRAX_SafeAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Safe Agreement [Member]", "label": "Safe Agreement [Member]" } } }, "localname": "SafeAgreementMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SaleOfStockNumberOfValueIssuedInTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sale of stock number of value issued in transaction.", "label": "Sale of stock, value" } } }, "localname": "SaleOfStockNumberOfValueIssuedInTransaction", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_ScheduleOfDeconsolidationOfBusinessTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Deconsolidation of Business [Table Text Block]", "label": "SCHEDULE OF DECONSOLIDATION OF BUSINESS" } } }, "localname": "ScheduleOfDeconsolidationOfBusinessTableTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "SRAX_ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Intangible Assets Acquired as Part of Business Combination [Table Text Block]", "label": "SCHEDULE OF INTANGIBLE ASSETS ACQUIRED AS PART OF BUSINESS COMBINATION" } } }, "localname": "ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "SRAX_ScheduleOfMovementInDesignatedAssetsTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule Of Movement In Designated Assets [Table Text Block]", "label": "SCHEDULE OF MOVEMENT IN DESIGNATED ASSETS" } } }, "localname": "ScheduleOfMovementInDesignatedAssetsTableTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalTables" ], "xbrltype": "textBlockItemType" }, "SRAX_ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Operating Lease Assets and Liabilities [Table Text Block]", "label": "SCHEDULE OF OPERATING LEASE ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfOperatingLeaseAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/RightToUseAssetTables" ], "xbrltype": "textBlockItemType" }, "SRAX_ScheduleOfProFormaAdjustmentsTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of pro forma adjustments.", "label": "SUMMARY OF PRO FORMA ADJUSTMENTS" } } }, "localname": "ScheduleOfProFormaAdjustmentsTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "SRAX_ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule of Weighted Average Remaining Lease Term and Discount Rate [Table Text Block]", "label": "SCHEDULE OF WEIGHTED AVERAGE REMAINING LEASE TERM AND APPLIED DISCOUNT RATE" } } }, "localname": "ScheduleOfWeightedAverageRemainingLeaseTermAndDiscountRateTableTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/RightToUseAssetTables" ], "xbrltype": "textBlockItemType" }, "SRAX_SecondDrawdownMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Second Drawdown [Member]", "label": "Second Drawdown [Member]" } } }, "localname": "SecondDrawdownMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SecuritiesPurchaseAgreementMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Securities Purchase Agreement [Member]", "label": "Securities Purchase Agreement [Member]" } } }, "localname": "SecuritiesPurchaseAgreementMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SecurityAgreementsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security Agreements [Member]", "label": "Security Agreements [Member]" } } }, "localname": "SecurityAgreementsMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SequirePlatformRevenueMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Sequire Platform Revenue [Member]", "label": "Sequire Platform Revenue [Member]" } } }, "localname": "SequirePlatformRevenueMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails" ], "xbrltype": "domainItemType" }, "SRAX_SeriesDConvertiblePreferredStockAndCommonStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D Convertible Preferred Stock and Common Stock [Member]", "label": "Series D Convertible Preferred Stock and Common Stock [Member]" } } }, "localname": "SeriesDConvertiblePreferredStockAndCommonStockMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SeriesDConvertiblePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series D Convertible Preferred Stock [Member]", "label": "Series D Convertible Preferred Stock [Member]" } } }, "localname": "SeriesDConvertiblePreferredStockMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SeriesOnePreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Series 1 Preferred Stock [Member]", "label": "Series 1 Preferred Stock [Member]" } } }, "localname": "SeriesOnePreferredStockMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedDate": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of warrant option grant date.", "label": "Fair value of warrant option grant date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGrantedDate", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercised In Period Weighted Average Grant Date Fair Value.", "label": "Weighted Average Grant Date Fair Value, Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Exercises In Period Total Intrinsic Value.", "label": "Aggregate Intrinsic Value, Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeited In Period Weighted Average Grant Date Fair Value.", "label": "Weighted Average Grant Date Fair Value, Warrants Forfeiture" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Forfeitures And Expirations In Period Weighted Average Intrinsic Value.", "label": "Aggregate Intrinsic Value, Warrants Forfeitures" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Grant Date Intrinsic Value.", "label": "Aggregate Intrinsic Value, Aggregate Intrinsic Value, Warrants Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodGrantDateIntrinsicValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Grants In Period Weighted Average Grant Date Fair Value.", "label": "Weighted Average Grant Date Fair Value, Warrants Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Intrinsic Value.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue", "periodEndLabel": "Aggregate Intrinsic Value, Warrants Outstanding Ending balance", "periodStartLabel": "Aggregate Intrinsic Value, Warrants Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingIntrinsicValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Outstanding Vested Weighted Average Grant Date Fair Value.", "label": "Weighted Average Grant Date Fair Value, Warrants Vested and Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingVestedWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average Exercise Price.", "label": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "periodEndLabel": "Weighted Average Strike Price/Share, Warrants Outstanding Ending balance", "periodStartLabel": "Weighted Average Strike Price/Share, Warrants Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average Grant Date Fair Value.", "label": "Weighted Average Grant Date Fair Value, Warrants Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options OutstandingWeighted Average Grant Date Fair Value1.", "label": "Weighted Average Grant Date Fair Value, Warrants Outstanding Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageGrantDateFairValue1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value.", "label": "Aggregate Intrinsic Value, Warrants Vested and Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Vested And Expected To Vest Outstanding Number.", "label": "Number of Shares, Warrants Vested and Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangement By Share Based Payment Award Non Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price.", "label": "Weighted Average Strike Price/Share, Warrants Vested and Exercisable" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value,Exercised.", "label": "Weighted Average Grant Date Fair Value, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value, Forfeited.", "label": "Weighted Average Grant Date Fair Value, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance.", "label": "Weighted Average Grant Date Fair Value, Vested and exercisable Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingVestedWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value, Outstanding Beginning balance.", "label": "Weighted Average Grant Date Fair Value, Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Grant Date Fair Value, Outstanding Ending balance.", "label": "Weighted Average Grant Date Fair Value, Outstanding Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageGrantDateFairValue1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangements By Share Based Payment Award Non Options Exercises InPeriod Weighted Average Exercise Price.", "label": "Weighted Average Strike Price/Share, Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangements By Share Based Payment Award Non Options Forfeitures InPeriod Weighted Average Exercise Price.", "label": "Weighted Average Strike Price/Share, Warrants Forfeiture" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Based Compensation Arrangements By Share Based Payment Award Non Options Grants In Period Weighted Average Exercise Price.", "label": "Weighted Average Strike Price/Share, Warrants Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_ShareBuyBackProgramMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share Buy-Back Program [Member]", "label": "Share Buy-Back Program [Member]" } } }, "localname": "ShareBuyBackProgramMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageExercisedRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Exercisable Weighted Average Exercised Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Years), Warrants Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageExercisedRemainingContractualTerm", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Exercisable Weighted Average Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Years), Warrants Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsExercisableWeightedAverageRemainingContractualTerm", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedInstricticValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Nonvested Instrictic Value.", "label": "Aggregate Intrinsic Value, Warrants Unvested and Non Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedInstricticValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Nonvested Number Of Shares.", "label": "Number of Shares, Warrants Unvested and Non-Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedNumberOfShares", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Non vested Weighted Average Grant Date Fair Value.", "label": "Weighted Average Strike Price/Share, Warrants Unvested and Non-Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Outstanding Nonvested Weighted Average Remaining Contractual Term1.", "label": "Weighted Average Remaining Contractual Term (Years), Warrants Unvested and non-exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingNonvestedWeightedAverageRemainingContractualTerm1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Outstanding Weighted Average Remaining Contractual Term1.", "label": "Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options OutstandingWeighted Average Remaining Contractual Term2.", "label": "Weighted Average Remaining Contractual Term (Years), Warrants Outstanding Beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Non Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1.", "label": "Weighted Average Remaining Contractual Term (Years), Warrants Vested and exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardNonOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageExercisedRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Exercised Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Years), Exercised" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageExercisedRemainingContractualTerm", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageForfeitedRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Options Exercisable Weighted Average Forfeited Remaining Contractual Term.", "label": "Weighted Average Remaining Contractual Term (Years), Forfeited" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageForfeitedRemainingContractualTerm", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term (Years), Granted.", "label": "Weighted Average Remaining Contractual Term (Years), Granted" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedInstricticValue": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance.", "label": "Aggregate Intrinsic Value, Unvested and non-exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedInstricticValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Share based Compensation Arrangement By Share based Payment Award Options Non vested Non Options Forfeited Weighted Average Grant Date Fair Value.", "label": "Weighted Average Grant Date Fair Value, Warrants Unvested and Non-Exercisable" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNonOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "perShareItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNOnvestedWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance.", "label": "Weighted Average Remaining Contractual Term (Years), Unvested and non-exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingNOnvestedWeightedAverageRemainingContractualTerm1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term (Years), Outstanding Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "SRAX_SharesIssuedForDebtExtinguishment": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares issued for debt extinguishment.", "label": "Shares issued for debt extinguishment" } } }, "localname": "SharesIssuedForDebtExtinguishment", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_SharesIssuedForDebtExtinguishmentShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Shares issued for debt extinguishment shares.", "label": "Shares issued for debt extinguishment, shares" } } }, "localname": "SharesIssuedForDebtExtinguishmentShares", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "SRAX_SharesOfCommonStockIssuedForExtensionAgreement": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Shares of common stock issued for extension agreement.", "label": "Fair value of BCF for debt financings" } } }, "localname": "SharesOfCommonStockIssuedForExtensionAgreement", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_ShortTermPromissoryNotesMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Short-Term Promissory Notes [Member]", "label": "Short-Term Promissory Notes [Member]" } } }, "localname": "ShortTermPromissoryNotesMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_SoftwareMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Software [Member]", "label": "Software [Member]" } } }, "localname": "SoftwareMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "SRAX_SolicitationFees": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Solicitation fees.", "label": "Solicitation Fees" } } }, "localname": "SolicitationFees", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_StockIssuedDuringPeriodSharesWarrantsExercised": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Stock issued during period shares warrants exercised.", "label": "Shares issued for exercise of warrants, net of offering costs, shares" } } }, "localname": "StockIssuedDuringPeriodSharesWarrantsExercised", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "SRAX_StockIssuedDuringPeriodValueWarrantsExercised": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Stock issued during period value warrants exercised.", "label": "Shares issued for exercise of warrants, net of offering costs" } } }, "localname": "StockIssuedDuringPeriodValueWarrantsExercised", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "SRAX_SubscriptionRevenues": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Subscription revenues.", "label": "Subscription revenues" } } }, "localname": "SubscriptionRevenues", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_SummaryOfAmountsOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Summary of amounts of revenue and earnings of acquiree since the acquisition date.", "label": "SUMMARY OF AMOUNT OF REVENUE AND EARNINGS OF ACQUIREE SINCE THE ACQUISITION DATE" } } }, "localname": "SummaryOfAmountsOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateTableTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "SRAX_TenPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Ten Percent [Member]", "label": "Ten Percent [Member]" } } }, "localname": "TenPercentMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TermLoanMaximumBorrowingCapacity": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Term loan, maximum borrowing capacity.", "label": "Term loan, maximum borrowing capacity" } } }, "localname": "TermLoanMaximumBorrowingCapacity", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "SRAX_TermloanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Term Loan [Member]", "label": "Term Loan [Member]" } } }, "localname": "TermloanMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ThirtySixPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Thirty Six Percent [Member]", "label": "Thirty Six Percent [Member]" } } }, "localname": "ThirtySixPercentMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_ThresholdOfEmployeeOwnershipForIncreaseInFairMarketValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Threshold of employee ownership for increase in fair market value.", "label": "Threshold of employee ownership for increase in fair market value and decrease in maximum life" } } }, "localname": "ThresholdOfEmployeeOwnershipForIncreaseInFairMarketValue", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_TrademarkMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trademark [Member]", "label": "Trademark [Member]" } } }, "localname": "TrademarkMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails" ], "xbrltype": "domainItemType" }, "SRAX_TrancheOneMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche One [Member]", "label": "Tranche One [Member]" } } }, "localname": "TrancheOneMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TrancheThreeMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Three [Member]", "label": "Tranche Three [Member]" } } }, "localname": "TrancheThreeMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TrancheTwoMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tranche Two [Member]", "label": "Tranche Two [Member]" } } }, "localname": "TrancheTwoMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TwentyPercentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Twenty Percent [Member]", "label": "Twenty Percent [Member]" } } }, "localname": "TwentyPercentMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TwoRemainingNoteHoldersMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two Remaining Note Holders [Member]", "label": "Two Remaining Note Holders [Member]" } } }, "localname": "TwoRemainingNoteHoldersMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TwoThousandAndFourteenteenEquityCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2014 Equity Compensation Plan [Member]", "label": "2014 Equity Compensation Plan [Member]" } } }, "localname": "TwoThousandAndFourteenteenEquityCompensationPlanMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TwoThousandAndSixteenEquityCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2016 Equity Compensation Plan [Member]", "label": "2016 Equity Compensation Plan [Member]" } } }, "localname": "TwoThousandAndSixteenEquityCompensationPlanMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TwoThousandAndTwelveEquityCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2012 Equity Compensation Plan [Member]", "label": "2012 Equity Compensation Plan [Member]" } } }, "localname": "TwoThousandAndTwelveEquityCompensationPlanMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "2012, 2014 and 2016 Equity Compensation Plans [Member]", "label": "2012, 2014 and 2016 Equity Compensation Plans [Member]" } } }, "localname": "TwoThousandTweleveFourteenAndSixteenEquityCompensationPlanMember", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "SRAX_UnrealizedLossOnDesignatedAssets": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Unrealized loss on designated assets.", "label": "UnrealizedLossOnDesignatedAssets", "negatedLabel": "Unrealized loss on designated assets" } } }, "localname": "UnrealizedLossOnDesignatedAssets", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "SRAX_ValuationAllowanceIncomeTaxBenefitContinuingOperations": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Valuation allowance, deferred tax assets.", "label": "Valuation allowance" } } }, "localname": "ValuationAllowanceIncomeTaxBenefitContinuingOperations", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "SRAX_VestingOfCommonStockAward": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Vesting of common stock award.", "label": "Vesting of common stock award" } } }, "localname": "VestingOfCommonStockAward", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "SRAX_WarrantExercisePricePercentage": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant exercise price percentage.", "label": "Warrant exercise price percentage" } } }, "localname": "WarrantExercisePricePercentage", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "percentItemType" }, "SRAX_WarrantLiabilityPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Warrant Liability [Policy Text Block]", "label": "Warrant Liability" } } }, "localname": "WarrantLiabilityPolicyTextBlock", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "SRAX_WarrantsIssuedAsInducementToExerciseWarrants": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Warrants issued as inducement to exercise warrants.", "label": "Warrants issued as an inducement to exercise warrants" } } }, "localname": "WarrantsIssuedAsInducementToExerciseWarrants", "nsuri": "http://srax.com/20211231", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r757" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r757" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditorFirmId": { "auth_ref": [ "r754", "r756", "r757" ], "lang": { "en-us": { "role": { "documentation": "PCAOB issued Audit Firm Identifier", "label": "Auditor Firm ID" } } }, "localname": "AuditorFirmId", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "nonemptySequenceNumberItemType" }, "dei_AuditorLocation": { "auth_ref": [ "r754", "r756", "r757" ], "lang": { "en-us": { "role": { "label": "Auditor Location" } } }, "localname": "AuditorLocation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_AuditorName": { "auth_ref": [ "r754", "r756", "r757" ], "lang": { "en-us": { "role": { "label": "Auditor Name" } } }, "localname": "AuditorName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "internationalNameItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2022", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r754", "r756", "r757" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r755" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r743" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r758" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r746" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated By Reference" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r749" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains." } } }, "localname": "EntityDomain", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r769" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r766" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r757" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r745" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [ "r767" ], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_IcfrAuditorAttestationFlag": { "auth_ref": [ "r754", "r756", "r757" ], "lang": { "en-us": { "role": { "label": "ICFR Auditor Attestation Flag" } } }, "localname": "IcfrAuditorAttestationFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_LegalEntityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The set of legal entities associated with a report.", "label": "Legal Entity [Axis]" } } }, "localname": "LegalEntityAxis", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "trueItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r756" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r750" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r751" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r744" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r748" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r747" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r752" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r753" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r768" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2022", "presentation": [ "http://srax.com/role/Cover" ], "xbrltype": "booleanItemType" }, "srt_ChiefExecutiveOfficerMember": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "label": "Chief Executive Officer [Member]" } } }, "localname": "ChiefExecutiveOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ChiefFinancialOfficerMember": { "auth_ref": [ "r211" ], "lang": { "en-us": { "role": { "label": "Chief Financial Officer [Member]" } } }, "localname": "ChiefFinancialOfficerMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MajorCustomersAxis": { "auth_ref": [ "r210", "r381", "r384", "r707" ], "lang": { "en-us": { "role": { "label": "Customer [Axis]" } } }, "localname": "MajorCustomersAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_MaximumMember": { "auth_ref": [ "r289", "r290", "r291", "r292", "r311", "r352", "r398", "r401", "r614", "r615", "r616", "r617", "r618", "r619", "r638", "r705", "r708", "r740", "r741" ], "lang": { "en-us": { "role": { "label": "Maximum [Member]" } } }, "localname": "MaximumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_MinimumMember": { "auth_ref": [ "r289", "r290", "r291", "r292", "r311", "r352", "r398", "r401", "r614", "r615", "r616", "r617", "r618", "r619", "r638", "r705", "r708", "r740", "r741" ], "lang": { "en-us": { "role": { "label": "Minimum [Member]" } } }, "localname": "MinimumMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "srt_NameOfMajorCustomerDomain": { "auth_ref": [ "r210", "r381", "r384", "r707" ], "localname": "NameOfMajorCustomerDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ProductOrServiceAxis": { "auth_ref": [ "r208", "r290", "r291", "r381", "r383", "r642", "r704", "r706" ], "lang": { "en-us": { "role": { "label": "Product and Service [Axis]" } } }, "localname": "ProductOrServiceAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails" ], "xbrltype": "stringItemType" }, "srt_ProductsAndServicesDomain": { "auth_ref": [ "r208", "r290", "r291", "r381", "r383", "r642", "r704", "r706" ], "localname": "ProductsAndServicesDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative", "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails" ], "xbrltype": "domainItemType" }, "srt_RangeAxis": { "auth_ref": [ "r284", "r289", "r290", "r291", "r292", "r311", "r352", "r387", "r398", "r401", "r438", "r439", "r440", "r614", "r615", "r616", "r617", "r618", "r619", "r638", "r705", "r708", "r740", "r741" ], "lang": { "en-us": { "role": { "label": "Statistical Measurement [Axis]" } } }, "localname": "RangeAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_RangeMember": { "auth_ref": [ "r284", "r289", "r290", "r291", "r292", "r311", "r352", "r387", "r398", "r401", "r438", "r439", "r440", "r614", "r615", "r616", "r617", "r618", "r619", "r638", "r705", "r708", "r740", "r741" ], "localname": "RangeMember", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "srt_ScenarioUnspecifiedDomain": { "auth_ref": [ "r153", "r158", "r288", "r399" ], "localname": "ScenarioUnspecifiedDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "domainItemType" }, "srt_StatementScenarioAxis": { "auth_ref": [ "r153", "r158", "r288", "r399", "r606" ], "lang": { "en-us": { "role": { "label": "Scenario [Axis]" } } }, "localname": "StatementScenarioAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualAxis": { "auth_ref": [ "r211", "r597" ], "lang": { "en-us": { "role": { "label": "Title of Individual [Axis]" } } }, "localname": "TitleOfIndividualAxis", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "srt_TitleOfIndividualWithRelationshipToEntityDomain": { "auth_ref": [], "localname": "TitleOfIndividualWithRelationshipToEntityDomain", "nsuri": "http://fasb.org/srt/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsAndNontradeReceivableTextBlock": { "auth_ref": [ "r224", "r251" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts receivable, contract receivable, receivable held-for-sale, and nontrade receivable.", "label": "CONTRACTS RECEIVABLE" } } }, "localname": "AccountsAndNontradeReceivableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ContractsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r62" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.", "label": "Accounts payable and accrued expenses" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r59" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.", "label": "ACCOUNTS PAYABLE AND ACCRUED EXPENSES" } } }, "localname": "AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AccountsPayableAndAccruedExpenses" ], "xbrltype": "textBlockItemType" }, "us-gaap_AccountsPayableMember": { "auth_ref": [ "r31" ], "lang": { "en-us": { "role": { "documentation": "Obligations incurred and payable to vendors for goods and services received.", "label": "Accounts Payable [Member]" } } }, "localname": "AccountsPayableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsPayableTradeCurrent": { "auth_ref": [ "r30", "r58" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accounts payable, trade" } } }, "localname": "AccountsPayableTradeCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableMember": { "auth_ref": [ "r735" ], "lang": { "en-us": { "role": { "documentation": "Due from customers or clients for goods or services that have been delivered or sold.", "label": "Accounts Receivable [Member]" } } }, "localname": "AccountsReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccountsReceivableNet": { "auth_ref": [ "r686", "r734" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business.", "label": "Accounts receivable" } } }, "localname": "AccountsReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetCurrent": { "auth_ref": [ "r212", "r213" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.", "label": "Accounts receivable, net", "verboseLabel": "Accounts receivable" } } }, "localname": "AccountsReceivableNetCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableNetNoncurrent": { "auth_ref": [ "r212", "r664", "r686" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as noncurrent.", "label": "Notes receivable", "verboseLabel": "Note receivable" } } }, "localname": "AccountsReceivableNetNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivablePurchase": { "auth_ref": [ "r235" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase from purchase of accounts receivable.", "label": "Accounts receivable purchase" } } }, "localname": "AccountsReceivablePurchase", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccountsReceivableRelatedParties": { "auth_ref": [ "r49", "r140", "r596", "r598", "r691" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "For an unclassified balance sheet, amount of receivables arising from transactions with related parties.", "label": "Accounts Receivable, Related Parties" } } }, "localname": "AccountsReceivableRelatedParties", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesCurrent": { "auth_ref": [ "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued expenses" } } }, "localname": "AccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AccruedLiabilitiesMember": { "auth_ref": [ "r64" ], "lang": { "en-us": { "role": { "documentation": "This item represents obligations incurred and payable, pertaining to costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered.", "label": "Accrued Liabilities [Member]" } } }, "localname": "AccruedLiabilitiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment": { "auth_ref": [ "r35", "r277" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated depreciation, depletion and amortization for physical assets used in the normal conduct of business to produce goods and services.", "label": "Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment", "negatedLabel": "Accumulated depreciation" } } }, "localname": "AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalCommonStock": { "auth_ref": [ "r50" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value received from shareholders in common stock-related transactions that are in excess of par value or stated value and amounts received from other stock-related transactions. Includes only common stock transactions (excludes preferred stock transactions). May be called contributed capital, capital in excess of par, capital surplus, or paid-in capital.", "label": "Additional paid in capital", "verboseLabel": "Conversion premium" } } }, "localname": "AdditionalPaidInCapitalCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdditionalPaidInCapitalMember": { "auth_ref": [ "r145", "r146", "r147", "r448", "r449", "r450", "r543" ], "lang": { "en-us": { "role": { "documentation": "Excess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders.", "label": "Additional Paid-in Capital [Member]" } } }, "localname": "AdditionalPaidInCapitalMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature": { "auth_ref": [ "r366", "r373", "r477" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in additional paid in capital (APIC) resulting from recognition of deferred taxes for convertible debt with a beneficial conversion feature.", "label": "Beneficial conversion feature" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other increase (decrease) in additional paid in capital (APIC).", "label": "Premium on debt extinguishment" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue": { "auth_ref": [ "r403", "r452", "r453" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase to additional paid-in capital (APIC) for recognition of cost for award under share-based payment arrangement.", "label": "Stock based compensation" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToAdditionalPaidInCapitalWarrantIssued": { "auth_ref": [ "r307", "r366", "r373" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in additional paid in capital (APIC) resulting from the issuance of warrants. Includes allocation of proceeds of debt securities issued with detachable stock purchase warrants.", "label": "Relative fair value of warrants issued with notes payable" } } }, "localname": "AdjustmentsToAdditionalPaidInCapitalWarrantIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Adjustments to reconcile net loss to net cash used in operating activities:" } } }, "localname": "AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_AllocatedShareBasedCompensationExpense": { "auth_ref": [ "r442" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.", "label": "Share-Based Payment Arrangement, Expense" } } }, "localname": "AllocatedShareBasedCompensationExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AllowanceForDoubtfulAccountsReceivable": { "auth_ref": [ "r55", "r219", "r234", "r237", "r239" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of allowance for credit loss on accounts receivable.", "label": "Allowance for doubtful accounts" } } }, "localname": "AllowanceForDoubtfulAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfDebtDiscountPremium": { "auth_ref": [ "r99", "r119", "r331", "r573" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense included in interest expense to amortize debt discount and premium associated with the related debt instruments. Excludes amortization of financing costs. Alternate captions include noncash interest expense.", "label": "Implied discount", "verboseLabel": "Amortization expenses" } } }, "localname": "AmortizationOfDebtDiscountPremium", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCosts": { "auth_ref": [ "r89", "r119", "r331", "r575" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 15.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt issuance costs.", "label": "Amortization of debt issue costs" } } }, "localname": "AmortizationOfFinancingCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfFinancingCostsAndDiscounts": { "auth_ref": [ "r119", "r331", "r339", "r340", "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization expense attributable to debt discount (premium) and debt issuance costs.", "label": "Amortization of Debt Issuance Costs and Discounts", "verboseLabel": "Implied discount" } } }, "localname": "AmortizationOfFinancingCostsAndDiscounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_AmortizationOfIntangibleAssets": { "auth_ref": [ "r119", "r262", "r268" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 19.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Amortization of intangibles" } } }, "localname": "AmortizationOfIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount": { "auth_ref": [ "r167" ], "lang": { "en-us": { "role": { "documentation": "Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.", "label": "Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount" } } }, "localname": "AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ArrangementsAndNonarrangementTransactionsMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations." } } }, "localname": "ArrangementsAndNonarrangementTransactionsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_Assets": { "auth_ref": [ "r39", "r136", "r191", "r200", "r206", "r232", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r522", "r529", "r565", "r601", "r603", "r659", "r687" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets [Default Label]", "totalLabel": "Total assets" } } }, "localname": "Assets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Assets" } } }, "localname": "AssetsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsCurrent": { "auth_ref": [ "r28", "r56", "r136", "r232", "r296", "r297", "r298", "r299", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r522", "r529", "r565", "r601", "r603" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Assets, Current", "totalLabel": "Total current assets" } } }, "localname": "AssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current assets" } } }, "localname": "AssetsCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_AssetsFairValueDisclosure": { "auth_ref": [ "r546" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.", "label": "Total assets" } } }, "localname": "AssetsFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation": { "auth_ref": [ "r2", "r3", "r18", "r20", "r24", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Assets", "totalLabel": "Total assets classified as discontinued operations in the consolidated balance sheet" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r2", "r3", "r18", "r20", "r24", "r274", "r279" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Current assets of discontinued operations" } } }, "localname": "AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_AwardTypeAxis": { "auth_ref": [ "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by type of award under share-based payment arrangement.", "label": "Award Type [Axis]" } } }, "localname": "AwardTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_BasisOfAccountingPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).", "label": "Organization" } } }, "localname": "BasisOfAccountingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionAcquireeDomain": { "auth_ref": [ "r397", "r400", "r501" ], "lang": { "en-us": { "role": { "documentation": "Identification of the acquiree in a material business combination (or series of individually immaterial business combinations), which may include the name or other type of identification of the acquiree." } } }, "localname": "BusinessAcquisitionAcquireeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "domainItemType" }, "us-gaap_BusinessAcquisitionAxis": { "auth_ref": [ "r397", "r400", "r496", "r497", "r501" ], "lang": { "en-us": { "role": { "documentation": "Information by business combination or series of individually immaterial business combinations.", "label": "Business Acquisition [Axis]" } } }, "localname": "BusinessAcquisitionAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionDateOfAcquisitionAgreement1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Date when the business acquisition agreement was executed, in YYYY-MM-DD format.", "label": "Business Acquisition, Date of Acquisition Agreement" } } }, "localname": "BusinessAcquisitionDateOfAcquisitionAgreement1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued": { "auth_ref": [ "r514" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of equity interests issued or issuable to acquire entity.", "label": "Number of shares issued in acquisition" } } }, "localname": "BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_BusinessAcquisitionLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Business Acquisition [Line Items]" } } }, "localname": "BusinessAcquisitionLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_BusinessAcquisitionProFormaInformationTextBlock": { "auth_ref": [ "r494", "r495" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.", "label": "SCHEDULE OF PRO FORMA CONSOLIDATED STATEMENT OF OPERATIONS" } } }, "localname": "BusinessAcquisitionProFormaInformationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessAcquisitionsProFormaNetIncomeLoss": { "auth_ref": [ "r494", "r495" ], "calculation": { "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.", "label": "Business Acquisition, Pro Forma Net Income (Loss)", "negatedTotalLabel": "Net income (loss)", "verboseLabel": "Net loss" } } }, "localname": "BusinessAcquisitionsProFormaNetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessAcquisitionsProFormaRevenue": { "auth_ref": [ "r494", "r495" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.", "label": "Business Acquisition, Pro Forma Revenue", "verboseLabel": "Revenues" } } }, "localname": "BusinessAcquisitionsProFormaRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationAndAssetAcquisitionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Business Combination and Asset Acquisition [Abstract]" } } }, "localname": "BusinessCombinationAndAssetAcquisitionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_BusinessCombinationConsiderationTransferred1": { "auth_ref": [ "r509", "r510", "r512" ], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration transferred, consisting of acquisition-date fair value of assets transferred by the acquirer, liabilities incurred by the acquirer, and equity interest issued by the acquirer.", "label": "Business Combination, Consideration Transferred", "totalLabel": "Purchase price" } } }, "localname": "BusinessCombinationConsiderationTransferred1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable": { "auth_ref": [ "r509", "r510" ], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": 1.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of equity interests of the acquirer, including instruments or interests issued or issuable in consideration for the business combination.", "label": "Fair value of stock at closing" } } }, "localname": "BusinessCombinationConsiderationTransferredEquityInterestsIssuedAndIssuable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationContingentConsiderationLiability": { "auth_ref": [ "r508", "r511", "r515" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liability recognized arising from contingent consideration in a business combination.", "label": "Business Combination, Contingent Consideration, Liability" } } }, "localname": "BusinessCombinationContingentConsiderationLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationDisclosureTextBlock": { "auth_ref": [ "r502", "r516" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).", "label": "ACQUISITIONS" } } }, "localname": "BusinessCombinationDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/Acquisitions" ], "xbrltype": "textBlockItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets": { "auth_ref": [ "r498" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Payroll protection loan in connection with acquisition" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables": { "auth_ref": [ "r498" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount due from customers or clients for goods or services, including trade receivables, that have been delivered or sold in the normal course of business, and amounts due from others, including related parties expected to be converted to cash, sold or exchanged within one year or the normal operating cycle, if longer, acquired at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Receivables", "verboseLabel": "Accounts receivable, net" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsReceivables", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities incurred for goods and services received that are used in an entity's business and related party payables, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Accounts Payable", "negatedLabel": "Accounts payable and accrued liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesAccountsPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of long-term debt due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Long-Term Debt", "negatedLabel": "Payroll protection loan" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesLongTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of other liabilities due within one year or within the normal operating cycle, if longer, assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other", "negatedLabel": "Other current liabilities" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities": { "auth_ref": [ "r498" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences assumed at the acquisition date.", "label": "Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Deferred Tax Liabilities", "negatedLabel": "Deferred tax liability" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill": { "auth_ref": [ "r498" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of intangible assets, excluding goodwill, acquired at the acquisition date.", "label": "Intangibles", "verboseLabel": "Fair value" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet": { "auth_ref": [ "r498" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.", "label": "Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net", "totalLabel": "Net assets acquired" } } }, "localname": "BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_BusinessCombinationsPolicy": { "auth_ref": [ "r493" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for completed business combinations (purchase method, acquisition method or combination of entities under common control). This accounting policy may include a general discussion of the purchase method or acquisition method of accounting (including for example, the treatment accorded contingent consideration, the identification of assets and liabilities, the purchase price allocation process, how the fair values of acquired assets and liabilities are determined) and the entity's specific application thereof. An entity that acquires another entity in a leveraged buyout transaction generally discloses the accounting policy followed by the acquiring entity in determining the basis used to value its interest in the acquired entity, and the rationale for that accounting policy.", "label": "Business Combinations" } } }, "localname": "BusinessCombinationsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CapitalizedComputerSoftwareNet": { "auth_ref": [ "r742" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The carrying amount of capitalized computer software costs net of accumulated amortization as of the balance sheet date.", "label": "Capitalized software development costs" } } }, "localname": "CapitalizedComputerSoftwareNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_Cash": { "auth_ref": [ "r33", "r603", "r715", "r716" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash" } } }, "localname": "Cash", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDesignatedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash and Cash Equivalents [Abstract]" } } }, "localname": "CashAndCashEquivalentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsAtCarryingValue": { "auth_ref": [ "r27", "r33", "r121" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and Cash Equivalents, at Carrying Value", "periodEndLabel": "Cash and cash equivalents" } } }, "localname": "CashAndCashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashAndCashEquivalentsAxis": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Information by type of cash and cash equivalent balance.", "label": "Cash and Cash Equivalents [Axis]" } } }, "localname": "CashAndCashEquivalentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CashAndCashEquivalentsPolicyTextBlock": { "auth_ref": [ "r122" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for cash and cash equivalents, including the policy for determining which items are treated as cash equivalents. Other information that may be disclosed includes (1) the nature of any restrictions on the entity's use of its cash and cash equivalents, (2) whether the entity's cash and cash equivalents are insured or expose the entity to credit risk, (3) the classification of any negative balance accounts (overdrafts), and (4) the carrying basis of cash equivalents (for example, at cost) and whether the carrying amount of cash equivalents approximates fair value.", "label": "Cash and Cash Equivalents" } } }, "localname": "CashAndCashEquivalentsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsAndMarketableSecuritiesTextBlock": { "auth_ref": [ "r228" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure of cash, cash equivalents, and debt and equity securities, including any unrealized or realized gain (loss).", "label": "MARKETABLE SECURITIES" } } }, "localname": "CashCashEquivalentsAndMarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/MarketableSecurities" ], "xbrltype": "textBlockItemType" }, "us-gaap_CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations": { "auth_ref": [ "r113", "r121", "r127" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage; including, but not limited to, disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.", "label": "Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Including Disposal Group and Discontinued Operations", "periodEndLabel": "Cash, cash equivalents and board designated restricted cash end of year", "periodStartLabel": "Cash, cash equivalents and board designated restricted cash beginning of year" } } }, "localname": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashEquivalentsAtCarryingValue": { "auth_ref": [ "r33" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.", "label": "Cash and cash equivalents", "verboseLabel": "Cash Equivalents, at Carrying Value" } } }, "localname": "CashEquivalentsAtCarryingValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashFDICInsuredAmount": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of cash deposited in financial institutions as of the balance sheet date that is insured by the Federal Deposit Insurance Corporation.", "label": "FDIC amount" } } }, "localname": "CashFDICInsuredAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits.", "label": "Cash [Member]" } } }, "localname": "CashMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of financing activities of discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net cash from discontinued operations" } } }, "localname": "CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations": { "auth_ref": [ "r17", "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of investing activities of discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net cash from (used in) discontinued operations" } } }, "localname": "CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations": { "auth_ref": [ "r17", "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivities", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of operating activities of discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net cash used in discontinued operations" } } }, "localname": "CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ClassOfStockDomain": { "auth_ref": [ "r46", "r47", "r48", "r133", "r136", "r160", "r161", "r162", "r164", "r166", "r173", "r174", "r175", "r232", "r296", "r300", "r301", "r302", "r305", "r306", "r350", "r351", "r355", "r359", "r366", "r565", "r759" ], "lang": { "en-us": { "role": { "documentation": "Share of stock differentiated by the voting rights the holder receives. Examples include, but are not limited to, common stock, redeemable preferred stock, nonredeemable preferred stock, and convertible stock." } } }, "localname": "ClassOfStockDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails", "http://srax.com/role/SeriesPreferredStock", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfStockLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Class of Stock [Line Items]" } } }, "localname": "ClassOfStockLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStock", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Date the warrants or rights are exercisable, in YYYY-MM-DD format.", "label": "Warrant expire date" } } }, "localname": "ClassOfWarrantOrRighstDateFromWhichWarrantsOrRightsExercisable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_ClassOfWarrantOrRightAxis": { "auth_ref": [ "r375", "r405" ], "lang": { "en-us": { "role": { "documentation": "Information by type of warrant or right issued.", "label": "Class of Warrant or Right [Axis]" } } }, "localname": "ClassOfWarrantOrRightAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the class or type of warrant or right outstanding. Warrants and rights represent derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months." } } }, "localname": "ClassOfWarrantOrRightDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Exercise price per share or per unit of warrants or rights outstanding.", "label": "Exercise price of warrant", "verboseLabel": "Warrants exercise price per share" } } }, "localname": "ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of securities into which each warrant or right may be converted. For example, but not limited to, each warrant may be converted into two shares.", "label": "Class of warrant issued", "terseLabel": "Shares issued upon exercise of warrants", "verboseLabel": "Warrant to purchase common stock, shares" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByEachWarrantOrRight", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights": { "auth_ref": [ "r367" ], "lang": { "en-us": { "role": { "documentation": "Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares.", "label": "Warrant to purchase common stock, shares", "terseLabel": "Number of common stock and warrants shares", "verboseLabel": "Class of warrant or right, number of securities called by warrants or rights" } } }, "localname": "ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ClassOfWarrantOrRightReasonForIssuingToNonemployees": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of reason for issuing warrant or right.", "label": "Warrant or Right, Reason for Issuance, Description" } } }, "localname": "ClassOfWarrantOrRightReasonForIssuingToNonemployees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ClassOfWarrantOrRightUnissued": { "auth_ref": [ "r375" ], "lang": { "en-us": { "role": { "documentation": "The number of warrants or rights which entitle the entity to receive future services in exchange for the unvested, forfeitable warrants or rights.", "label": "Class of warrant or right, unissued" } } }, "localname": "ClassOfWarrantOrRightUnissued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]" } } }, "localname": "CollaborativeArrangementsAndNoncollaborativeArrangementTransactionsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingencies": { "auth_ref": [ "r72", "r665", "r693" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Represents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.", "label": "Commitments and contingencies (Note 19)" } } }, "localname": "CommitmentsAndContingencies", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Commitments and Contingencies Disclosure [Abstract]" } } }, "localname": "CommitmentsAndContingenciesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CommitmentsAndContingenciesDisclosureTextBlock": { "auth_ref": [ "r285", "r286", "r287", "r293", "r736" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for commitments and contingencies.", "label": "COMMITMENTS AND CONTINGENCIES" } } }, "localname": "CommitmentsAndContingenciesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/CommitmentsAndContingencies" ], "xbrltype": "textBlockItemType" }, "us-gaap_CommonClassAMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Classification of common stock representing ownership interest in a corporation.", "label": "Common Class A [Member]" } } }, "localname": "CommonClassAMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockMember": { "auth_ref": [ "r145", "r146", "r543" ], "lang": { "en-us": { "role": { "documentation": "Stock that is subordinate to all other stock of the issuer.", "label": "Common Stock [Member]" } } }, "localname": "CommonStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CommonStockParOrStatedValuePerShare": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of common stock.", "label": "Common stock, par value", "verboseLabel": "Common stock par value" } } }, "localname": "CommonStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_CommonStockSharesAuthorized": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of common shares permitted to be issued by an entity's charter and bylaws.", "label": "Common stock, shares authorized", "verboseLabel": "Common stock shares authorized" } } }, "localname": "CommonStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesIssued": { "auth_ref": [ "r48" ], "lang": { "en-us": { "role": { "documentation": "Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.", "label": "Common stock, shares issued", "verboseLabel": "Common stock shares issued" } } }, "localname": "CommonStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockSharesOutstanding": { "auth_ref": [ "r48", "r366" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.", "label": "Common stock, shares outstanding", "verboseLabel": "Common stock shares outstanding" } } }, "localname": "CommonStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_CommonStockValue": { "auth_ref": [ "r48", "r603" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.", "label": "Class A common stock, authorized 250,000,000 shares, $0.001 par value, 25,995,172 and 16,145,778 shares issued and outstanding, respectively" } } }, "localname": "CommonStockValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConcentrationRiskBenchmarkDomain": { "auth_ref": [ "r182", "r183", "r210", "r561", "r562", "r735" ], "lang": { "en-us": { "role": { "documentation": "The denominator in a calculation of a disclosed concentration risk percentage." } } }, "localname": "ConcentrationRiskBenchmarkDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConcentrationRiskByBenchmarkAxis": { "auth_ref": [ "r182", "r183", "r210", "r561", "r562", "r714", "r735" ], "lang": { "en-us": { "role": { "documentation": "Information by benchmark of concentration risk.", "label": "Concentration Risk Benchmark [Axis]" } } }, "localname": "ConcentrationRiskByBenchmarkAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskByTypeAxis": { "auth_ref": [ "r182", "r183", "r210", "r561", "r562", "r714", "r735" ], "lang": { "en-us": { "role": { "documentation": "Information by type of concentration risk, for example, but not limited to, asset, liability, net assets, geographic, customer, employees, supplier, lender.", "label": "Concentration Risk Type [Axis]" } } }, "localname": "ConcentrationRiskByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ConcentrationRiskCreditRisk": { "auth_ref": [ "r178", "r682" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for credit risk.", "label": "Concentration of Credit and Significant Customer Risk" } } }, "localname": "ConcentrationRiskCreditRisk", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConcentrationRiskPercentage1": { "auth_ref": [ "r182", "r183", "r210", "r561", "r562" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the \"benchmark\" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.", "label": "Concentration risk percentage" } } }, "localname": "ConcentrationRiskPercentage1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ConcentrationRiskTypeDomain": { "auth_ref": [ "r182", "r183", "r210", "r561", "r562", "r735" ], "lang": { "en-us": { "role": { "documentation": "For an entity that discloses a concentration risk as a percentage of some financial balance or benchmark, identifies the type (for example, asset, liability, net assets, geographic, customer, employees, supplier, lender) of the concentration." } } }, "localname": "ConcentrationRiskTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ConsolidationPolicyTextBlock": { "auth_ref": [ "r128", "r524" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy regarding (1) the principles it follows in consolidating or combining the separate financial statements, including the principles followed in determining the inclusion or exclusion of subsidiaries or other entities in the consolidated or combined financial statements and (2) its treatment of interests (for example, common stock, a partnership interest or other means of exerting influence) in other entities, for example consolidation or use of the equity or cost methods of accounting. The accounting policy may also address the accounting treatment for intercompany accounts and transactions, noncontrolling interest, and the income statement treatment in consolidation for issuances of stock by a subsidiary.", "label": "Principles of Consolidation" } } }, "localname": "ConsolidationPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerAssetAndLiabilityTableTextBlock": { "auth_ref": [ "r379" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of receivable, contract asset, and contract liability from contract with customer. Includes, but is not limited to, change in contract asset and contract liability.", "label": "DEFERRED REVENUE" } } }, "localname": "ContractWithCustomerAssetAndLiabilityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DeferredRevenue" ], "xbrltype": "textBlockItemType" }, "us-gaap_ContractWithCustomerLiability": { "auth_ref": [ "r377", "r378", "r382" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of obligation to transfer good or service to customer for which consideration has been received or is receivable.", "label": "Contract with Customer, Liability" } } }, "localname": "ContractWithCustomerLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DeferredRevenueDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockAmountIssued1": { "auth_ref": [ "r124", "r125", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument issued [noncash or part noncash] in the conversion of stock. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Amount Issued" } } }, "localname": "ConversionOfStockAmountIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ConversionOfStockSharesConverted1": { "auth_ref": [ "r124", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "The number of shares converted in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Converted" } } }, "localname": "ConversionOfStockSharesConverted1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConversionOfStockSharesIssued1": { "auth_ref": [ "r124", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "The number of new shares issued in the conversion of stock in a noncash (or part noncash) transaction. Noncash is defined as transactions during a period that do not result in cash receipts or cash payments in the period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion of Stock, Shares Issued" } } }, "localname": "ConversionOfStockSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ConvertibleDebtSecuritiesMember": { "auth_ref": [ "r388" ], "lang": { "en-us": { "role": { "documentation": "Debt securities that can be exchanged for equity of the debt issuer at the option of the issuer or the holder.", "label": "Convertible Debt Securities [Member]" } } }, "localname": "ConvertibleDebtSecuritiesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ConvertibleDebtTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of convertible debt instrument. Includes, but is not limited to, principal amount and amortized premium or discount.", "label": "SCHEDULE OF OID CONVERTIBLE DEBENTURES" } } }, "localname": "ConvertibleDebtTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ConvertiblePreferredStockMember": { "auth_ref": [ "r350", "r351", "r355" ], "lang": { "en-us": { "role": { "documentation": "Preferred stock that may be exchanged into common shares or other types of securities at the owner's option.", "label": "Convertible Preferred Stock [Member]" } } }, "localname": "ConvertiblePreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_CostOfRevenue": { "auth_ref": [ "r94", "r136", "r232", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r565" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "SRAX_CostAndOperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate cost of goods produced and sold and services rendered during the reporting period.", "label": "Cost of revenue" } } }, "localname": "CostOfRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_CostOfRevenueAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cost and expenses" } } }, "localname": "CostOfRevenueAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityAxis": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Information by type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing.", "label": "Credit Facility [Axis]" } } }, "localname": "CreditFacilityAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_CreditFacilityDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Type of credit facility. Credit facilities provide capital to borrowers without the need to structure a loan for each borrowing." } } }, "localname": "CreditFacilityDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CreditLossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Credit Loss [Abstract]" } } }, "localname": "CreditLossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_CreditLossFinancialInstrumentTextBlock": { "auth_ref": [ "r236", "r243", "r244", "r245", "r246", "r247", "r248" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for credit loss on financial instrument measured at amortized cost basis, net investment in lease, off-balance sheet credit exposure, and available-for-sale debt security.", "label": "SALE AND PURCHASE OF ACCOUNTS RECEIVABLE" } } }, "localname": "CreditLossFinancialInstrumentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_CurrentFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r474" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Subtotal" } } }, "localname": "CurrentFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentFederalTaxExpenseBenefit": { "auth_ref": [ "r137", "r474", "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current Federal" } } }, "localname": "CurrentFederalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r474", "r482", "r484" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) pertaining to taxable income (loss) from continuing operations.", "label": "Current Total" } } }, "localname": "CurrentIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CurrentStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r137", "r474", "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Current State" } } }, "localname": "CurrentStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_CustomerConcentrationRiskMember": { "auth_ref": [ "r181", "r210" ], "lang": { "en-us": { "role": { "documentation": "Reflects the percentage that revenues in the period from one or more significant customers is to net revenues, as defined by the entity, such as total net revenues, product line revenues, segment revenues. The risk is the materially adverse effects of loss of a significant customer.", "label": "Customer Concentration Risk [Member]" } } }, "localname": "CustomerConcentrationRiskMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_CustomerListsMember": { "auth_ref": [ "r506" ], "lang": { "en-us": { "role": { "documentation": "Information about customers such as their name and contact information; it may also be an extensive database that includes other information about the customers such as their order history and demographic information.", "label": "Customer Lists [Member]" } } }, "localname": "CustomerListsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_DebtConversionConvertedInstrumentAmount1": { "auth_ref": [ "r124", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The value of the financial instrument(s) that the original debt is being converted into in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Converted debt", "verboseLabel": "Debt conversion, converted instrument, amount" } } }, "localname": "DebtConversionConvertedInstrumentAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtConversionConvertedInstrumentSharesIssued1": { "auth_ref": [ "r124", "r126" ], "lang": { "en-us": { "role": { "documentation": "The number of shares issued in exchange for the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or payments in the period.", "label": "Number of shares of common stock", "verboseLabel": "Debt conversion, converted instrument, shares issued" } } }, "localname": "DebtConversionConvertedInstrumentSharesIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_DebtConversionDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The name of the original debt issue that has been converted in a noncash (or part noncash) transaction during the accounting period. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Conversion, description" } } }, "localname": "DebtConversionDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtConversionOriginalDebtAmount1": { "auth_ref": [ "r124", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of the original debt being converted in a noncash (or part noncash) transaction. \"Part noncash\" refers to that portion of the transaction not resulting in cash receipts or cash payments in the period.", "label": "Convertible debt", "verboseLabel": "Converted debt" } } }, "localname": "DebtConversionOriginalDebtAmount1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Debt Disclosure [Abstract]" } } }, "localname": "DebtDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DebtDisclosureTextBlock": { "auth_ref": [ "r132", "r314", "r315", "r316", "r317", "r318", "r319", "r320", "r325", "r332", "r333", "r335", "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.", "label": "TERM LOAN NOTE" } } }, "localname": "DebtDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/TermLoanNote" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtInstrumentAxis": { "auth_ref": [ "r40", "r41", "r42", "r135", "r143", "r308", "r309", "r310", "r311", "r312", "r313", "r315", "r321", "r322", "r323", "r324", "r326", "r327", "r328", "r329", "r330", "r331", "r337", "r338", "r339", "r340", "r576", "r660", "r662", "r685" ], "lang": { "en-us": { "role": { "documentation": "Information by type of debt instrument, including, but not limited to, draws against credit facilities.", "label": "Debt Instrument [Axis]" } } }, "localname": "DebtInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentConvertibleBeneficialConversionFeature": { "auth_ref": [ "r372" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of a favorable spread to a debt holder between the amount of debt being converted and the value of the securities received upon conversion. This is an embedded conversion feature of convertible debt issued that is in-the-money at the commitment date.", "label": "Debt Instrument, Convertible, Beneficial Conversion Feature" } } }, "localname": "DebtInstrumentConvertibleBeneficialConversionFeature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentConvertibleConversionPrice1": { "auth_ref": [ "r310", "r336" ], "lang": { "en-us": { "role": { "documentation": "The price per share of the conversion feature embedded in the debt instrument.", "label": "Debt Instrument, Convertible, Conversion Price", "verboseLabel": "Conversion of convertible securities" } } }, "localname": "DebtInstrumentConvertibleConversionPrice1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SeriesPreferredStockDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_DebtInstrumentDescription": { "auth_ref": [ "r40", "r42", "r367", "r660", "r662", "r678", "r685" ], "lang": { "en-us": { "role": { "documentation": "Identification of the lender and information about a contractual promise to repay a short-term or long-term obligation, which includes borrowings under lines of credit, notes payable, commercial paper, bonds payable, debentures, and other contractual obligations for payment. This may include rationale for entering into the arrangement, significant terms of the arrangement, which may include amount, repayment terms, priority, collateral required, debt covenants, borrowing capacity, call features, participation rights, conversion provisions, sinking-fund requirements, voting rights, basis for conversion if convertible and remarketing provisions. The description may be provided for individual debt instruments, rational groupings of debt instruments, or by debt in total.", "label": "Debt instrument, description", "verboseLabel": "Debt Instrument, Description" } } }, "localname": "DebtInstrumentDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentFaceAmount": { "auth_ref": [ "r308", "r337", "r338", "r574", "r576", "r577" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Face (par) amount of debt instrument at time of issuance.", "label": "Debt instrument, face amount", "terseLabel": "Debt amount", "verboseLabel": "Debt face amount" } } }, "localname": "DebtInstrumentFaceAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentFairValue": { "auth_ref": [ "r323", "r337", "r338", "r560" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of debt instrument payable, including, but not limited to, notes payable and loans payable.", "label": "Corporate debt" } } }, "localname": "DebtInstrumentFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentInterestRateStatedPercentage": { "auth_ref": [ "r67", "r309" ], "lang": { "en-us": { "role": { "documentation": "Contractual interest rate for funds borrowed, under the debt agreement.", "label": "Interest rate", "terseLabel": "Debt Instrument, Interest Rate, Stated Percentage", "verboseLabel": "Debt instrument, interest rate" } } }, "localname": "DebtInstrumentInterestRateStatedPercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentMaturityDate": { "auth_ref": [ "r68", "r311", "r550" ], "lang": { "en-us": { "role": { "documentation": "Date when the debt instrument is scheduled to be fully repaid, in YYYY-MM-DD format.", "label": "Debt instrument, maturity date", "verboseLabel": "Debt Instrument, Maturity Date" } } }, "localname": "DebtInstrumentMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_DebtInstrumentNameDomain": { "auth_ref": [ "r71", "r135", "r143", "r308", "r309", "r310", "r311", "r312", "r313", "r315", "r321", "r322", "r323", "r324", "r326", "r327", "r328", "r329", "r330", "r331", "r337", "r338", "r339", "r340", "r576" ], "lang": { "en-us": { "role": { "documentation": "The name for the particular debt instrument or borrowing that distinguishes it from other debt instruments or borrowings, including draws against credit facilities." } } }, "localname": "DebtInstrumentNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_DebtInstrumentPaymentTerms": { "auth_ref": [ "r69", "r679" ], "lang": { "en-us": { "role": { "documentation": "Description of the payment terms of the debt instrument (for example, whether periodic payments include principal and frequency of payments) and discussion about any contingencies associated with the payment.", "label": "Debt instrument, payment term description" } } }, "localname": "DebtInstrumentPaymentTerms", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentRedemptionPricePercentage": { "auth_ref": [ "r681" ], "lang": { "en-us": { "role": { "documentation": "Percentage price of original principal amount of debt at which debt can be redeemed by the issuer.", "label": "Debt Instrument, Redemption Price, Percentage" } } }, "localname": "DebtInstrumentRedemptionPricePercentage", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_DebtInstrumentRestrictiveCovenants": { "auth_ref": [ "r142", "r680" ], "lang": { "en-us": { "role": { "documentation": "Description of covenants that limit or prohibit certain actions or activities without the lender's prior consent within a specified period of time or until certain specified targets are achieved for example, reduction of the debt or an increase in net worth to a specified amount).", "label": "Debt instrument, restrictive covenants" } } }, "localname": "DebtInstrumentRestrictiveCovenants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DebtInstrumentTerm": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Period of time between issuance and maturity of debt instrument, in PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Debt instrument term", "verboseLabel": "Term loan" } } }, "localname": "DebtInstrumentTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_DebtInstrumentUnamortizedDiscount": { "auth_ref": [ "r321", "r573", "r577" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt discount.", "label": "Debt instrument, original issue discount", "verboseLabel": "Debt discount" } } }, "localname": "DebtInstrumentUnamortizedDiscount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtInstrumentUnusedBorrowingCapacityAmount": { "auth_ref": [ "r70" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unused borrowing capacity under the long-term financing arrangement that is available to the entity as of the balance sheet date.", "label": "Debt Instrument, Unused Borrowing Capacity, Amount", "verboseLabel": "Debt instrument, unused borrowing capacity, amount" } } }, "localname": "DebtInstrumentUnusedBorrowingCapacityAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DebtPolicyTextBlock": { "auth_ref": [ "r295" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy related to debt. Includes, but is not limited to, debt issuance costs, the effects of refinancings, method of amortizing debt issuance costs and original issue discount, and classifications of debt.", "label": "Debt Discounts" } } }, "localname": "DebtPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable": { "auth_ref": [ "r240" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about allowance for credit loss on investment in debt security measured at amortized cost (held-to-maturity).", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Table]" } } }, "localname": "DebtSecuritiesHeldToMaturityAllowanceForCreditLossTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Debt Securities, Held-to-Maturity, Allowance for Credit Loss [Line Items]" } } }, "localname": "DebtSecuritiesHeldtomaturityAllowanceForCreditLossLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeconsolidationGainOrLossAmount": { "auth_ref": [ "r528" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) from deconsolidation of subsidiary and derecognition of group of assets constituting transfer of business or nonprofit activity, excluding conveyance of oil and gas mineral rights and transfer of good or service in contract with customer.", "label": "Total consolidations" } } }, "localname": "DeconsolidationGainOrLossAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits [Line Items]" } } }, "localname": "DeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredFederalIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r475", "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Federal" } } }, "localname": "DeferredFederalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFederalStateAndLocalTaxExpenseBenefit": { "auth_ref": [ "r459" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred federal, state, and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred national, regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred Subtotal" } } }, "localname": "DeferredFederalStateAndLocalTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredFinanceCostsNet": { "auth_ref": [ "r321", "r575" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after accumulated amortization, of debt issuance costs. Includes, but is not limited to, legal, accounting, underwriting, printing, and registration costs.", "label": "Debt instrument origination fee" } } }, "localname": "DeferredFinanceCostsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxExpenseBenefit": { "auth_ref": [ "r119", "r137", "r475", "r482", "r483", "r484" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.", "label": "Deferred Total" } } }, "localname": "DeferredIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilities": { "auth_ref": [ "r43", "r44", "r465", "r661", "r683" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences.", "label": "Deferred Tax Liabilities, Gross", "negatedTotalLabel": "Total Deferred Tax Liabilities" } } }, "localname": "DeferredIncomeTaxLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredIncomeTaxLiabilitiesNet": { "auth_ref": [ "r457", "r458" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences with jurisdictional netting.", "label": "Deferred tax liability" } } }, "localname": "DeferredIncomeTaxLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenue": { "auth_ref": [ "r45" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable.", "label": "Deferred revenue" } } }, "localname": "DeferredRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueCurrent": { "auth_ref": [ "r41" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred income and obligation to transfer product and service to customer for which consideration has been received or is receivable, classified as current.", "label": "Revenue from contract liabilities" } } }, "localname": "DeferredRevenueCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RevenueDisaggregationDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredRevenueRefundPayments1": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow to customers for refund payments of revenue that was previously reported as deferred or unearned revenue.", "label": "Deferred contractual payments" } } }, "localname": "DeferredRevenueRefundPayments1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredStateAndLocalIncomeTaxExpenseBenefit": { "auth_ref": [ "r137", "r475", "r482" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Deferred State" } } }, "localname": "DeferredStateAndLocalIncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetInterestCarryforward": { "auth_ref": [ "r472" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 6.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible interest carryforward.", "label": "Interest expense limitation carryover" } } }, "localname": "DeferredTaxAssetInterestCarryforward", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGross": { "auth_ref": [ "r466" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Gross", "totalLabel": "Total Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsGrossAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsGrossAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxAssetsLiabilitiesNet": { "auth_ref": [ "r468" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, after allocation of valuation allowances and deferred tax liability, of deferred tax asset attributable to deductible differences and carryforwards, without jurisdictional netting.", "label": "Deferred Tax Assets, Net", "totalLabel": "Net deferred tax / (liabilities)" } } }, "localname": "DeferredTaxAssetsLiabilitiesNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsNet": { "auth_ref": [ "r468" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards.", "label": "Deferred Tax Assets, Net of Valuation Allowance", "totalLabel": "Net Deferred Tax Assets" } } }, "localname": "DeferredTaxAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwards": { "auth_ref": [ "r472", "r473" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards.", "label": "Net operating loss carryforwards" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsDomestic": { "auth_ref": [ "r472", "r473" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible domestic operating loss carryforwards. Excludes state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, Domestic" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsDomestic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal": { "auth_ref": [ "r472", "r473" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible state and local operating loss carryforwards.", "label": "Deferred Tax Assets, Operating Loss Carryforwards, State and Local" } } }, "localname": "DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsPropertyPlantAndEquipment": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from property, plant, and equipment.", "label": "Fixed assets" } } }, "localname": "DeferredTaxAssetsPropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost": { "auth_ref": [ "r472", "r473" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 5.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation.", "label": "Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-Based Compensation Cost", "verboseLabel": "Stock based compensation" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities": { "auth_ref": [ "r472", "r473" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from accrued liabilities.", "label": "Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities", "verboseLabel": "Accrued interest" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther": { "auth_ref": [ "r472", "r473" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 9.0, "parentTag": "us-gaap_DeferredTaxAssetsGross", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences from reserves and accruals, classified as other.", "label": "Other accruals" } } }, "localname": "DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross": { "auth_ref": [ "r472" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary difference from unrealized loss on investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Unrealized gain on marketable securities" } } }, "localname": "DeferredTaxAssetsUnrealizedLossesOnAvailableforSaleSecuritiesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r467" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_DeferredTaxAssetsLiabilitiesNet", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.", "label": "Deferred Tax Assets, Valuation Allowance", "negatedLabel": "Valuation Allowance" } } }, "localname": "DeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Deferred Tax Liabilities" } } }, "localname": "DeferredTaxLiabilitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "stringItemType" }, "us-gaap_DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets": { "auth_ref": [ "r472", "r473" ], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 3.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax liability attributable to taxable temporary differences from intangible assets other than goodwill.", "label": "Deferred Tax Liabilities, Intangible Assets", "negatedLabel": "Intangibles" } } }, "localname": "DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DeferredTaxLiabilitiesPrepaidExpenses": { "auth_ref": [], "calculation": { "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails": { "order": 4.0, "parentTag": "us-gaap_DeferredIncomeTaxLiabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of deferred tax consequences attributable to taxable temporary differences derived from prepaid expenses.", "label": "Deferred Tax Liabilities, Prepaid Expenses", "negatedLabel": "Prepaid expenses" } } }, "localname": "DeferredTaxLiabilitiesPrepaidExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeferredTaxAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_Depreciation": { "auth_ref": [ "r119", "r275" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 18.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.", "label": "Depreciation expense", "verboseLabel": "Depreciation" } } }, "localname": "Depreciation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PropertyAndEquipmentDetailsNarrative", "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_DepreciationAmortizationAndAccretionNet": { "auth_ref": [ "r119" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 5.0, "parentTag": "SRAX_CostAndOperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate net amount of depreciation, amortization, and accretion recognized during an accounting period. As a noncash item, the net amount is added back to net income when calculating cash provided by or used in operations using the indirect method.", "label": "Depreciation and amortization" } } }, "localname": "DepreciationAmortizationAndAccretionNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativeAssetMeasurementInput": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure derivative asset.", "label": "Range" } } }, "localname": "DerivativeAssetMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "decimalItemType" }, "us-gaap_DerivativeGainLossOnDerivativeNet": { "auth_ref": [ "r539" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 10.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the fair value of derivatives recognized in the income statement.", "label": "Change in fair value of derivative liabilities", "negatedLabel": "Change in fair value of derivative liabilities" } } }, "localname": "DerivativeGainLossOnDerivativeNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DerivativesPolicyTextBlock": { "auth_ref": [ "r141", "r535", "r536", "r537", "r538", "r540" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for its derivative instruments and hedging activities.", "label": "Derivatives" } } }, "localname": "DerivativesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisaggregationOfRevenueTableTextBlock": { "auth_ref": [ "r381" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of disaggregation of revenue into categories depicting how nature, amount, timing, and uncertainty of revenue and cash flows are affected by economic factor.", "label": "SCHEDULE OF REVENUE BY BUSINESS UNIT" } } }, "localname": "DisaggregationOfRevenueTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RevenueDisaggregationTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock": { "auth_ref": [ "r406", "r407", "r443", "r444", "r446", "r454" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for share-based payment arrangement.", "label": "STOCK OPTIONS, AWARDS AND WARRANTS" } } }, "localname": "DisclosureOfCompensationRelatedCostsShareBasedPaymentsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrants" ], "xbrltype": "textBlockItemType" }, "us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Share-Based Payment Arrangement [Abstract]" } } }, "localname": "DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax": { "auth_ref": [ "r4", "r6", "r8" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount before tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Loss from discontinued operations before provision for income taxes" } } }, "localname": "DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax": { "auth_ref": [ "r4", "r6", "r8", "r21" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null }, "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Loss before income tax benefits", "verboseLabel": "Loss from discontinued operations, net of income taxes" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued operations" } } }, "localname": "DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTaxAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfDiscontinuedOperation": { "auth_ref": [ "r5", "r6", "r7", "r8", "r15", "r21", "r459", "r481", "r488" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) related to a discontinued operation. Includes, but is not limited to, tax expense (benefit) related to income (loss) from operations during the phase-out period, tax expense (benefit) related to gain (loss) on disposal, tax expense (benefit) related to gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and tax expense (benefit) related to adjustments of a prior period gain (loss) on disposal.", "label": "Income tax benefit" } } }, "localname": "DiscontinuedOperationTaxEffectOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation": { "auth_ref": [ "r6", "r8", "r21", "r488" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationGainLossOnDisposalOfDiscontinuedOperationNetOfTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of tax expense (benefit) on gain (loss) not previously recognized resulting from the disposal of a discontinued operation.", "label": "Provision for income taxes" } } }, "localname": "DiscontinuedOperationTaxEffectOfIncomeLossFromDisposalOfDiscontinuedOperation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DiscontinuedOperationsAndDisposalGroupsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Discontinued Operations and Disposal Groups [Abstract]" } } }, "localname": "DiscontinuedOperationsAndDisposalGroupsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet": { "auth_ref": [ "r2", "r3", "r18", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts, notes and loans receivable attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net", "verboseLabel": "Accounts receivable, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsNotesAndLoansReceivableNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent": { "auth_ref": [ "r2", "r3", "r18", "r274", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as accounts payable and accrued liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Accounts Payable and Accrued Liabilities, Current", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationAccountsPayableAndAccruedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents": { "auth_ref": [ "r2", "r3", "r18", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as cash and cash equivalents attributable to disposal group held for sale or disposed of.", "label": "Disposal Group, Including Discontinued Operation, Cash and Cash Equivalents", "verboseLabel": "Cash and cash equivalents" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationConsideration": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of consideration received or receivable for the disposal of assets and liabilities, including discontinued operation.", "label": "Consideration received" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationConsideration", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold": { "auth_ref": [ "r16", "r24" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of costs of goods sold attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Costs of Goods Sold", "verboseLabel": "Cost of revenue" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationCostsOfGoodsSold", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization": { "auth_ref": [ "r16" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 4.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of depreciation and amortization expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Depreciation and Amortization", "verboseLabel": "Depreciation and amortization" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationDepreciationAndAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense": { "auth_ref": [ "r16" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 5.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of general and administrative expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, General and Administrative Expense", "verboseLabel": "General and administrative expenses" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent": { "auth_ref": [ "r2", "r3", "r18", "r273", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 5.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as goodwill attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Goodwill, Noncurrent", "verboseLabel": "Goodwill" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGoodwillNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss": { "auth_ref": [ "r16", "r24" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gross profit attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Gross Profit (Loss)", "totalLabel": "Gross profit" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent": { "auth_ref": [ "r2", "r3", "r18", "r273", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 6.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as intangible assets, excluding goodwill, attributable to disposal group held for sale or disposed of, expected to be disposed of beyond one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Intangible Assets, Noncurrent", "verboseLabel": "Intangible assets, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationIntangibleAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingExpense": { "auth_ref": [ "r16" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Expense", "totalLabel": "Total operating expense" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss": { "auth_ref": [ "r16" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating income (loss) attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Operating Income (Loss)", "totalLabel": "Loss from operations of discontinued operations" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities": { "auth_ref": [ "r2", "r3", "r18", "r274", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as other liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Other Liabilities, Current", "verboseLabel": "Other current liabilities" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationOtherExpense": { "auth_ref": [ "r16" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 2.0, "parentTag": "us-gaap_DiscontinuedOperationGainLossFromDisposalOfDiscontinuedOperationBeforeIncomeTax", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of other expense attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Other Expense", "negatedTotalLabel": "Total other expense" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationOtherExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent": { "auth_ref": [ "r2", "r3", "r18", "r274", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 3.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as prepaid and other assets attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Prepaid and Other Assets, Current", "verboseLabel": "Prepaid expenses and other current assets" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPrepaidAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent": { "auth_ref": [ "r2", "r3", "r18", "r273", "r279" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 4.0, "parentTag": "us-gaap_AssetsOfDisposalGroupIncludingDiscontinuedOperation", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount classified as property, plant and equipment attributable to disposal group held for sale or disposed of, expected to be disposed of after one year or the normal operating cycle, if longer.", "label": "Disposal Group, Including Discontinued Operation, Property, Plant and Equipment, Noncurrent", "verboseLabel": "Property and equipment, net" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationPropertyPlantAndEquipmentNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupIncludingDiscontinuedOperationRevenue": { "auth_ref": [ "r16", "r24" ], "calculation": { "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": 1.0, "parentTag": "us-gaap_DisposalGroupIncludingDiscontinuedOperationGrossProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of revenue attributable to disposal group, including, but not limited to, discontinued operation.", "label": "Disposal Group, Including Discontinued Operation, Revenue", "verboseLabel": "Revenues" } } }, "localname": "DisposalGroupIncludingDiscontinuedOperationRevenue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock": { "auth_ref": [ "r25", "r283" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "DISCONTINUED OPERATIONS" } } }, "localname": "DisposalGroupsIncludingDiscontinuedOperationsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperations" ], "xbrltype": "textBlockItemType" }, "us-gaap_DividendsPayableNature": { "auth_ref": [ "r124", "r125", "r126" ], "lang": { "en-us": { "role": { "documentation": "Describes the declaration as being a special dividend (over and above the normal dividend); as the annual, semi-annual, quarterly dividend, or other normal periodic dividend; or as some other type of dividend.", "label": "Dividend description" } } }, "localname": "DividendsPayableNature", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_DividendsPreferredStockStock": { "auth_ref": [ "r373", "r676" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of paid and unpaid preferred stock dividends declared with the form of settlement in stock.", "label": "Dividends, Preferred Stock, Stock", "negatedLabel": "Dividends on preferred stock" } } }, "localname": "DividendsPreferredStockStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_EarningsPerShareAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Basic and diluted loss per share" } } }, "localname": "EarningsPerShareAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_EarningsPerShareBasic": { "auth_ref": [ "r85", "r150", "r151", "r152", "r153", "r154", "r159", "r160", "r164", "r165", "r166", "r169", "r170", "r544", "r545", "r672", "r699" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.", "label": "Net loss per share, basic and diluted" } } }, "localname": "EarningsPerShareBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_EarningsPerSharePolicyTextBlock": { "auth_ref": [ "r167", "r168" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for computing basic and diluted earnings or loss per share for each class of common stock and participating security. Addresses all significant policy factors, including any antidilutive items that have been excluded from the computation and takes into account stock dividends, splits and reverse splits that occur after the balance sheet date of the latest reporting period but before the issuance of the financial statements.", "label": "Earnings Per Share" } } }, "localname": "EarningsPerSharePolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_EffectiveIncomeTaxRateContinuingOperations": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Percentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Effective Income Tax Rate Reconciliation, Percent", "negatedLabel": "Provision for income tax benefit (expense)" } } }, "localname": "EffectiveIncomeTaxRateContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate": { "auth_ref": [ "r138", "r460", "r485" ], "lang": { "en-us": { "role": { "documentation": "Percentage of domestic federal statutory tax rate applicable to pretax income (loss).", "label": "Taxes calculated at federal rate" } } }, "localname": "EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance": { "auth_ref": [ "r460", "r485" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to changes in the valuation allowance for deferred tax assets.", "label": "Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent", "negatedLabel": "Change in valuation allowance" } } }, "localname": "EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost": { "auth_ref": [ "r460", "r485" ], "lang": { "en-us": { "role": { "documentation": "Percentage of difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying domestic federal statutory income tax rate to pretax income (loss) from continuing operation, attributable to nondeductible expense for share-based payment arrangement.", "label": "Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-Based Payment Arrangement, Percent", "negatedLabel": "Stock based compensation" } } }, "localname": "EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationOtherAdjustments": { "auth_ref": [ "r460", "r485" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other adjustments.", "label": "Effective Income Tax Rate Reconciliation, Other Adjustments, Percent", "negatedLabel": "Other adjustments" } } }, "localname": "EffectiveIncomeTaxRateReconciliationOtherAdjustments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes": { "auth_ref": [ "r460", "r485" ], "lang": { "en-us": { "role": { "documentation": "Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to revisions of previously reported income tax expense.", "label": "Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Percent", "negatedLabel": "Prior year true-ups" } } }, "localname": "EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEffectiveTaxRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_EmployeeRelatedLiabilitiesCurrent": { "auth_ref": [ "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued compensation" } } }, "localname": "EmployeeRelatedLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions": { "auth_ref": [ "r445" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cost to be recognized for nonvested award under share-based payment arrangement. Excludes share and unit options.", "label": "Share-Based Payment Arrangement, Nonvested Award, Excluding Option, Cost Not yet Recognized, Amount" } } }, "localname": "EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_EquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Equity [Abstract]" } } }, "localname": "EquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_EquityComponentDomain": { "auth_ref": [ "r0", "r78", "r79", "r80", "r145", "r146", "r147", "r149", "r155", "r157", "r172", "r233", "r366", "r373", "r448", "r449", "r450", "r478", "r479", "r543", "r566", "r567", "r568", "r569", "r570", "r571", "r592", "r709", "r710", "r711" ], "lang": { "en-us": { "role": { "documentation": "Components of equity are the parts of the total Equity balance including that which is allocated to common, preferred, treasury stock, retained earnings, etc." } } }, "localname": "EquityComponentDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAdjustmentOfWarrants": { "auth_ref": [ "r119", "r344" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (income) related to adjustment to fair value of warrant liability.", "label": "Fair Value Adjustment of Warrants", "verboseLabel": "Fair value of warrants" } } }, "localname": "FairValueAdjustmentOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable": { "auth_ref": [ "r546", "r547", "r556" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about asset and liability measured at fair value on recurring and nonrecurring basis.", "label": "Fair Value, Recurring and Nonrecurring [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Line Items]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis.", "label": "Fair Value Measurement Inputs and Valuation Techniques [Table]" } } }, "localname": "FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique used to measure similar asset in prior period by class of asset or liability on non-recurring basis.", "label": "SCHEDULE OF FAIR VALUE ASSETS SIGNIFICANT UNOBSERVABLE INPUTS" } } }, "localname": "FairValueAssetsMeasuredOnNonrecurringBasisValuationTechniquesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3).", "label": "SCHEDULE OF ASSETS MEASURED AT FAIR VALUE" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain": { "auth_ref": [ "r551" ], "lang": { "en-us": { "role": { "documentation": "Class of asset." } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationByAssetClassDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable": { "auth_ref": [ "r551", "r556" ], "lang": { "en-us": { "role": { "documentation": "Schedule of information required and determined to be provided for purposes of reconciling beginning and ending balances of fair value measurements of assets using significant unobservable inputs (level 3). Such reconciliation, separately presenting changes during the period, at a minimum, may include, but is not limited to: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income, and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table]" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock": { "auth_ref": [ "r551", "r556" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the fair value measurement of assets using significant unobservable inputs (Level 3), a reconciliation of the beginning and ending balances, separately presenting changes during the period attributable to the following: (1) total gains or losses for the period (realized and unrealized), segregating those gains or losses included in earnings (or changes in net assets) and gains or losses recognized in other comprehensive income (loss), and a description of where those gains or losses included in earnings (or changes in net assets) are reported in the statement of income (or activities); (2) purchases, sales, issues, and settlements (each type disclosed separately); and (3) transfers in and transfers out of Level 3 (for example, transfers due to changes in the observability of significant inputs), by class of asset.", "label": "SCHEDULE OF FAIR VALUE AT ASSETS" } } }, "localname": "FairValueAssetsMeasuredOnRecurringBasisUnobservableInputReconciliationTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueByAssetClassAxis": { "auth_ref": [ "r546", "r556" ], "lang": { "en-us": { "role": { "documentation": "Information by class of asset.", "label": "Asset Class [Axis]" } } }, "localname": "FairValueByAssetClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByFairValueHierarchyLevelAxis": { "auth_ref": [ "r323", "r337", "r338", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r396", "r547", "r611", "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Information by level within fair value hierarchy and fair value measured at net asset value per share as practical expedient.", "label": "Fair Value Hierarchy and NAV [Axis]" } } }, "localname": "FairValueByFairValueHierarchyLevelAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueByMeasurementFrequencyAxis": { "auth_ref": [ "r546", "r547", "r549", "r550", "r557" ], "lang": { "en-us": { "role": { "documentation": "Information by measurement frequency.", "label": "Measurement Frequency [Axis]" } } }, "localname": "FairValueByMeasurementFrequencyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FairValueConcentrationOfRiskNotesReceivable": { "auth_ref": [ "r563" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "This item represents disclosure of all significant concentrations of credit risk or market risk arising from the subject financial instrument (as defined), whether from an individual counterparty or groups of counterparties.", "label": "Fair value notes receivable" } } }, "localname": "FairValueConcentrationOfRiskNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueDisclosuresAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Fair Value Disclosures [Abstract]" } } }, "localname": "FairValueDisclosuresAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_FairValueDisclosuresTextBlock": { "auth_ref": [ "r555" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.", "label": "FAIR VALUE OF FINANCIAL INSTRUMENTS" } } }, "localname": "FairValueDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstruments" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueInputsLevel1Member": { "auth_ref": [ "r323", "r388", "r389", "r394", "r396", "r547", "r611" ], "lang": { "en-us": { "role": { "documentation": "Quoted prices in active markets for identical assets or liabilities that the reporting entity can access at the measurement date.", "label": "Fair Value, Inputs, Level 1 [Member]" } } }, "localname": "FairValueInputsLevel1Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel2Member": { "auth_ref": [ "r323", "r337", "r338", "r388", "r389", "r394", "r396", "r547", "r612" ], "lang": { "en-us": { "role": { "documentation": "Inputs other than quoted prices included within level 1 that are observable for an asset or liability, either directly or indirectly, including, but not limited to, quoted prices for similar assets or liabilities in active markets, or quoted prices for identical or similar assets or liabilities in inactive markets.", "label": "Fair Value, Inputs, Level 2 [Member]" } } }, "localname": "FairValueInputsLevel2Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueInputsLevel3Member": { "auth_ref": [ "r323", "r337", "r338", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r396", "r547", "r613" ], "lang": { "en-us": { "role": { "documentation": "Unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Inputs, Level 3 [Member]" } } }, "localname": "FairValueInputsLevel3Member", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations": { "auth_ref": [ "r546", "r547" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of subordinated debt obligations including, but not limited to, subordinated loan, subordinated bond, subordinated debenture or junior debt.", "label": "Fair value of debentures", "verboseLabel": "Fair value of debenture" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisSubordinatedDebtObligations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock": { "auth_ref": [ "r546", "r547" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of liabilities, including [financial] instruments measured at fair value that are classified in stockholders' equity, if any, by class that are measured at fair value on a recurring basis. The disclosures contemplated herein include the fair value measurements at the reporting date by the level within the fair value hierarchy in which the fair value measurements in their entirety fall, segregating fair value measurements using quoted prices in active markets for identical assets (Level 1), significant other observable inputs (Level 2), and significant unobservable inputs (Level 3). Where the quoted price in an active market for the identical liability is not available, the Level 1 input is the quoted price of an identical liability when traded as an asset.", "label": "SCHEDULE OF LIABILITIES MEASURED AT FAIR VALUE" } } }, "localname": "FairValueLiabilitiesMeasuredOnRecurringBasisTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueMeasurementFrequencyDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement frequency." } } }, "localname": "FairValueMeasurementFrequencyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1": { "auth_ref": [ "r552" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) recognized in income from asset measured at fair value on recurring basis using unobservable input (level 3).", "label": "Realized & Unrealized Gains (Losses)" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases": { "auth_ref": [ "r553" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of purchases of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Acquisitions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPurchases", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales": { "auth_ref": [ "r553" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of sale of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Sales and dispositions" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetSales", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3": { "auth_ref": [ "r554" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of transfer of financial instrument classified as an asset into level 3 of the fair value hierarchy.", "label": "Transfers intoLevel 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3": { "auth_ref": [ "r554" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of transfers of financial instrument classified as an asset out of level 3 of the fair value hierarchy.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Transfers out of Level 3", "negatedLabel": "Transfers out of Level 3" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue": { "auth_ref": [ "r551" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial instrument classified as an asset measured using unobservable inputs that reflect the entity's own assumption about the assumptions market participants would use in pricing.", "label": "Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value", "periodEndLabel": "Ending Balance", "periodStartLabel": "Beginning Balance" } } }, "localname": "FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueMeasurementsFairValueHierarchyDomain": { "auth_ref": [ "r323", "r337", "r338", "r388", "r389", "r390", "r391", "r392", "r393", "r394", "r396", "r611", "r612", "r613" ], "lang": { "en-us": { "role": { "documentation": "Categories used to prioritize the inputs to valuation techniques to measure fair value." } } }, "localname": "FairValueMeasurementsFairValueHierarchyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueMeasurementsRecurringMember": { "auth_ref": [ "r555", "r557" ], "lang": { "en-us": { "role": { "documentation": "Frequent fair value measurement. Includes, but is not limited to, fair value adjustment for impairment of asset, liability or equity, frequently measured at fair value.", "label": "Fair Value, Recurring [Member]" } } }, "localname": "FairValueMeasurementsRecurringMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FairValueOfAssetsAcquired": { "auth_ref": [ "r124", "r125", "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The fair value of assets acquired in noncash investing or financing activities.", "label": "Shares issued for the acquisition of a subsidiary" } } }, "localname": "FairValueOfAssetsAcquired", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_FairValueOfFinancialInstrumentsPolicy": { "auth_ref": [ "r558", "r559" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for determining the fair value of financial instruments.", "label": "Fair Value of Financial Instruments" } } }, "localname": "FairValueOfFinancialInstrumentsPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_FairValueOptionAggregateDifferencesLongTermDebtInstruments": { "auth_ref": [ "r564" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "This item represents the difference between the aggregate fair value and the aggregate unpaid principal balance of long-term debt instruments that have contractual principal amounts and for which the fair value option has been elected.", "label": "Difference between face value and fair value" } } }, "localname": "FairValueOptionAggregateDifferencesLongTermDebtInstruments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_FederalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r137", "r459" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred federal tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred national tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "Federal" } } }, "localname": "FederalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FinancialInstrumentAxis": { "auth_ref": [ "r226", "r227", "r229", "r230", "r231", "r236", "r240", "r241", "r242", "r245", "r247", "r248", "r249", "r250", "r334", "r364", "r541", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r759", "r760", "r761", "r762", "r763", "r764", "r765" ], "lang": { "en-us": { "role": { "documentation": "Information by type of financial instrument.", "label": "Financial Instrument [Axis]" } } }, "localname": "FinancialInstrumentAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentPerformanceStatusAxis": { "auth_ref": [ "r245" ], "lang": { "en-us": { "role": { "documentation": "Information by category of performance or non-performance status of financial instruments.", "label": "Financial Instrument Performance Status [Axis]" } } }, "localname": "FinancialInstrumentPerformanceStatusAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_FinancialInstrumentPerformanceStatusDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Category of performance or non-performance status of financial instruments, including but not limited to, financing receivables, loans, debt, and investments." } } }, "localname": "FinancialInstrumentPerformanceStatusDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortization": { "auth_ref": [ "r37", "r267" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Accumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Accumulated amortization" } } }, "localname": "FiniteLivedIntangibleAssetsAccumulatedAmortization", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2022" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEstimatedFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThree": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in third fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2024" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearThree", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEstimatedFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo": { "auth_ref": [ "r269" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of amortization for assets, excluding financial assets and goodwill, lacking physical substance with finite life expected to be recognized in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "2023" } } }, "localname": "FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEstimatedFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxis": { "auth_ref": [ "r263", "r264", "r267", "r270", "r643", "r644" ], "lang": { "en-us": { "role": { "documentation": "Information by major type or class of finite-lived intangible assets.", "label": "Finite-Lived Intangible Assets by Major Class [Axis]" } } }, "localname": "FiniteLivedIntangibleAssetsByMajorClassAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsGross": { "auth_ref": [ "r267", "r644" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Total cost" } } }, "localname": "FiniteLivedIntangibleAssetsGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_FiniteLivedIntangibleAssetsLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Finite-Lived Intangible Assets [Line Items]" } } }, "localname": "FiniteLivedIntangibleAssetsLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_FiniteLivedIntangibleAssetsMajorClassNameDomain": { "auth_ref": [ "r263", "r266" ], "lang": { "en-us": { "role": { "documentation": "The major class of finite-lived intangible asset (for example, patents, trademarks, copyrights, etc.) A major class is composed of intangible assets that can be grouped together because they are similar, either by their nature or by their use in the operations of a company." } } }, "localname": "FiniteLivedIntangibleAssetsMajorClassNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_FiniteLivedIntangibleAssetsNet": { "auth_ref": [ "r267", "r643" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Finite-Lived Intangible Assets, Net", "verboseLabel": "Intangible assets" } } }, "localname": "FiniteLivedIntangibleAssetsNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfEstimatedFutureAmortizationExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnDispositionOfAssets1": { "auth_ref": [ "r119" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 5.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 4.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee.", "label": "Realized loss on designated assets", "negatedLabel": "Realized loss on designated assets" } } }, "localname": "GainLossOnDispositionOfAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainLossOnSaleOfEquityInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The difference between the carrying value and the sale price of equity securities, not separately or otherwise categorized as trading or available-for-sale. This element includes investments in which the entity holds a small ownership stake (generally, less than 20 percent of the shares outstanding) and cannot exert significant influence.", "label": "Gain (Loss) on Sale of Equity Investments" } } }, "localname": "GainLossOnSaleOfEquityInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainOrLossOnSaleOfStockInSubsidiary": { "auth_ref": [ "r91", "r92", "r119", "r668", "r700" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of gain (loss) on sale or disposal of equity in securities of subsidiaries.", "label": "Loss on disposal of subsidiary" } } }, "localname": "GainOrLossOnSaleOfStockInSubsidiary", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfDeconsolidationOfBusinessDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GainsLossesOnExtinguishmentOfDebt": { "auth_ref": [ "r119", "r341", "r342" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 12.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Difference between the fair value of payments made and the carrying amount of debt which is extinguished prior to maturity.", "label": "Loss on extinguishment", "negatedLabel": "Loss on extinguishment of debt" } } }, "localname": "GainsLossesOnExtinguishmentOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_GeneralAndAdministrativeExpense": { "auth_ref": [ "r96" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "SRAX_CostAndOperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total of expenses of managing and administering the affairs of an entity, including affiliates of the reporting entity, which are not directly or indirectly associated with the manufacture, sale or creation of a product or product line.", "label": "General and administrative expenses" } } }, "localname": "GeneralAndAdministrativeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_Goodwill": { "auth_ref": [ "r36", "r252", "r254", "r257", "r259", "r603", "r658" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Goodwill" } } }, "localname": "Goodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/IntangibleAssetsDetailsNarrative", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAcquiredDuringPeriod": { "auth_ref": [ "r255", "r259" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized resulting from a business combination.", "label": "Goodwill Acquisition" } } }, "localname": "GoodwillAcquiredDuringPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Goodwill and Intangible Assets Disclosure [Abstract]" } } }, "localname": "GoodwillAndIntangibleAssetsDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_GoodwillAndIntangibleAssetsGoodwillPolicy": { "auth_ref": [ "r258", "r259", "r260" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for goodwill. This accounting policy also may address how an entity assesses and measures impairment of goodwill, how reporting units are determined, how goodwill is allocated to such units, and how the fair values of the reporting units are determined.", "label": "Goodwill and Intangible Assets, Goodwill, Policy [Policy Text Block]", "verboseLabel": "Goodwill" } } }, "localname": "GoodwillAndIntangibleAssetsGoodwillPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_GoodwillImpairmentLoss": { "auth_ref": [ "r119", "r253", "r256", "r258", "r259" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of loss from the write-down of an asset representing the future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.", "label": "Impairment loss" } } }, "localname": "GoodwillImpairmentLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IntangibleAssetsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock": { "auth_ref": [ "r272", "r282" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for recognizing and measuring the impairment of long-lived assets. An entity also may disclose its accounting policy for long-lived assets to be sold. This policy excludes goodwill and intangible assets.", "label": "Long-lived Assets" } } }, "localname": "ImpairmentOrDisposalOfLongLivedAssetsPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeLossFromContinuingOperations": { "auth_ref": [ "r93", "r120", "r150", "r151", "r152", "r153", "r163", "r166", "r520" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from continuing operations attributable to the parent.", "label": "Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent", "totalLabel": "Loss from continuing operations" } } }, "localname": "IncomeLossFromContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest": { "auth_ref": [ "r82", "r191", "r199", "r202", "r205", "r207", "r657", "r669", "r674", "r701" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income (loss) from continuing operations, including income (loss) from equity method investments, before deduction of income tax expense (benefit), and income (loss) attributable to noncontrolling interest.", "label": "Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest", "totalLabel": "Loss before provision for income taxes" } } }, "localname": "IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromContinuingOperationsPerBasicShare": { "auth_ref": [ "r81", "r85", "r148", "r150", "r151", "r152", "r153", "r160", "r164", "r165", "r545", "r667", "r670", "r672", "r695" ], "lang": { "en-us": { "role": { "documentation": "The amount of net income (loss) from continuing operations per each share of common stock or unit outstanding during the reporting period.", "label": "Continuing operations" } } }, "localname": "IncomeLossFromContinuingOperationsPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTax": { "auth_ref": [ "r4", "r5", "r6", "r7", "r8", "r21", "r24", "r489", "r696" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation including the portion attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest", "negatedLabel": "Less: Loss from discontinued operations, net of tax" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest": { "auth_ref": [ "r4", "r5", "r6", "r7", "r8", "r15", "r21", "r518", "r521" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the noncontrolling interest. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Net loss attributable to non controlling interest in discontinued operations", "negatedLabel": "Net loss attributable to non-controlling interest in discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity": { "auth_ref": [ "r4", "r5", "r6", "r7", "r8", "r15", "r21", "r521" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_ProfitLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount after tax of income (loss) from a discontinued operation attributable to the parent. Includes, but is not limited to, the income (loss) from operations during the phase-out period, gain (loss) on disposal, gain (loss) for reversal of write-down (write-down) to fair value, less cost to sell, and adjustments to a prior period gain (loss) on disposal.", "label": "Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent", "totalLabel": "Loss from discontinued operations" } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare": { "auth_ref": [ "r83", "r85", "r161", "r164", "r165", "r672", "r696", "r698", "r699" ], "lang": { "en-us": { "role": { "documentation": "Per basic share amount, after tax, of income (loss) from the day-to-day business activities of the discontinued operation and gain (loss) from the disposal of the discontinued operation.", "label": "Discontinued operations attributable to SRAX, Inc." } } }, "localname": "IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "perShareItemType" }, "us-gaap_IncomeStatementAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Statement [Abstract]" } } }, "localname": "IncomeStatementAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Income Tax Disclosure [Abstract]" } } }, "localname": "IncomeTaxDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_IncomeTaxDisclosureTextBlock": { "auth_ref": [ "r138", "r461", "r463", "r470", "r480", "r486", "r490", "r491", "r492" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.", "label": "INCOME TAXES" } } }, "localname": "IncomeTaxDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxes" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxExpenseBenefit": { "auth_ref": [ "r139", "r156", "r157", "r190", "r459", "r481", "r487", "r702" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": -1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.", "label": "Total", "negatedLabel": "Provision for income tax benefit (expense)" } } }, "localname": "IncomeTaxExpenseBenefit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncomeTaxPolicyTextBlock": { "auth_ref": [ "r77", "r455", "r456", "r463", "r464", "r469", "r476" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for income taxes, which may include its accounting policies for recognizing and measuring deferred tax assets and liabilities and related valuation allowances, recognizing investment tax credits, operating loss carryforwards, tax credit carryforwards, and other carryforwards, methodologies for determining its effective income tax rate and the characterization of interest and penalties in the financial statements.", "label": "Income Taxes" } } }, "localname": "IncomeTaxPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IncomeTaxesPaidNet": { "auth_ref": [ "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income, net of any cash received during the current period as refunds for the overpayment of taxes.", "label": "Cash paid for taxes" } } }, "localname": "IncomeTaxesPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsPayableAndAccruedLiabilities": { "auth_ref": [ "r118" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 24.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in the amounts payable to vendors for goods and services received and the amount of obligations and expenses incurred but not paid.", "label": "Increase (Decrease) in Accounts Payable and Accrued Liabilities", "verboseLabel": "Accounts payable and accrued expenses" } } }, "localname": "IncreaseDecreaseInAccountsPayableAndAccruedLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInAccountsReceivable": { "auth_ref": [ "r118" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 22.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.", "label": "Increase (Decrease) in Accounts Receivable", "negatedLabel": "Accounts receivable" } } }, "localname": "IncreaseDecreaseInAccountsReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInDeferredLiabilities": { "auth_ref": [ "r118" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 27.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Change during the period in carrying value for all deferred liabilities due within one year or operating cycle.", "label": "Increase (Decrease) in Deferred Liabilities", "verboseLabel": "Deferred tax liability" } } }, "localname": "IncreaseDecreaseInDeferredLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInOperatingCapitalAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Changes in operating assets and liabilities" } } }, "localname": "IncreaseDecreaseInOperatingCapitalAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_IncreaseDecreaseInOtherCurrentLiabilities": { "auth_ref": [ "r118" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 26.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in current liabilities classified as other.", "label": "Increase (Decrease) in Other Current Liabilities", "verboseLabel": "Other current liabilities" } } }, "localname": "IncreaseDecreaseInOtherCurrentLiabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets": { "auth_ref": [ "r118" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 23.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in prepaid expenses, and assets classified as other.", "label": "Increase (Decrease) in Prepaid Expense and Other Assets", "negatedLabel": "Prepaid expenses and other current assets" } } }, "localname": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntangibleAssetsDisclosureTextBlock": { "auth_ref": [ "r271" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for all or part of the information related to intangible assets.", "label": "INTANGIBLE ASSETS" } } }, "localname": "IntangibleAssetsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IntangibleAssets" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsFiniteLivedPolicy": { "auth_ref": [ "r129", "r266", "r639", "r640", "r641", "r643" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for finite-lived intangible assets. This accounting policy also might address: (1) the amortization method used; (2) the useful lives of such assets; and (3) how the entity assesses and measures impairment of such assets.", "label": "Intangible assets" } } }, "localname": "IntangibleAssetsFiniteLivedPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_IntangibleAssetsNetExcludingGoodwill": { "auth_ref": [ "r261", "r265" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.", "label": "Intangible assets, net" } } }, "localname": "IntangibleAssetsNetExcludingGoodwill", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_IntellectualPropertyMember": { "auth_ref": [ "r507" ], "lang": { "en-us": { "role": { "documentation": "Intangible asset arising from original creative thought. Include, but is not limited to, trademarks, patents, and copyrights.", "label": "Intellectual Property [Member]" } } }, "localname": "IntellectualPropertyMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InterestIncomeExpenseNet": { "auth_ref": [ "r673" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 7.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net amount of operating interest income (expense).", "label": "Interest income" } } }, "localname": "InterestIncomeExpenseNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestIncomeOther": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of interest income earned from interest bearing assets classified as other.", "label": "Interest Income, Other", "negatedLabel": "Interest income" } } }, "localname": "InterestIncomeOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPaidNet": { "auth_ref": [ "r111", "r115", "r123" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash paid for interest, excluding capitalized interest, classified as operating activity. Includes, but is not limited to, payment to settle zero-coupon bond for accreted interest of debt discount and debt instrument with insignificant coupon interest rate in relation to effective interest rate of borrowing attributable to accreted interest of debt discount.", "label": "Cash paid for interest" } } }, "localname": "InterestPaidNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_InterestPayableCurrent": { "auth_ref": [ "r64" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of [accrued] interest payable on all forms of debt, including trade payables, that has been incurred and is unpaid. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).", "label": "Accrued interest" } } }, "localname": "InterestPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfAccountsPayableAndAccruedExpensesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_InternetDomainNamesMember": { "auth_ref": [ "r504" ], "lang": { "en-us": { "role": { "documentation": "String of typographic characters used to describe the location of a specific individual, business, computer, or piece of information online. Formally known as the Uniform Resource Locator or URL, it is often considered to be the address of a certain World Wide Web site.", "label": "Internet Domain Names [Member]" } } }, "localname": "InternetDomainNamesMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_InvestmentTypeAxis": { "auth_ref": [ "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733" ], "lang": { "en-us": { "role": { "documentation": "Information by type of investments.", "label": "Investment Type [Axis]" } } }, "localname": "InvestmentTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "stringItemType" }, "us-gaap_InvestmentTypeCategorizationMember": { "auth_ref": [ "r719", "r720", "r721", "r722", "r723", "r724", "r725", "r726", "r727", "r728", "r729", "r730", "r731", "r732", "r733" ], "lang": { "en-us": { "role": { "documentation": "Asset obtained to generate income or appreciate in value." } } }, "localname": "InvestmentTypeCategorizationMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfAssetsMeasuredAtFairValueDetails" ], "xbrltype": "domainItemType" }, "us-gaap_IssuanceOfStockAndWarrantsForServicesOrClaims": { "auth_ref": [ "r119" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 13.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value of share-based compensation granted to nonemployees as payment for services rendered or acknowledged claims.", "label": "Warrant inducement charge" } } }, "localname": "IssuanceOfStockAndWarrantsForServicesOrClaims", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_LaborAndRelatedExpense": { "auth_ref": [ "r90" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "SRAX_CostAndOperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for salary, wage, profit sharing; incentive and equity-based compensation; and other employee benefit.", "label": "Employee related costs" } } }, "localname": "LaborAndRelatedExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCost": { "auth_ref": [ "r588", "r590" ], "calculation": { "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lease cost recognized by lessee for lease contract.", "label": "Lease amount", "totalLabel": "Total lease expense" } } }, "localname": "LeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative", "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LeaseCostTableTextBlock": { "auth_ref": [ "r588" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of lessee's lease cost. Includes, but is not limited to, interest expense for finance lease, amortization of right-of-use asset for finance lease, operating lease cost, short-term lease cost, variable lease cost and sublease income.", "label": "SCHEDULE OF COMPONENT OF LEASE EXPENSE" } } }, "localname": "LeaseCostTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RightToUseAssetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LegalFees": { "auth_ref": [ "r95" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.", "label": "Legal Fees" } } }, "localname": "LegalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeLeasesPolicyTextBlock": { "auth_ref": [ "r580" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for leasing arrangement entered into by lessee.", "label": "Right of Use Assets and Lease Obligations" } } }, "localname": "LesseeLeasesPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityMaturityTableTextBlock": { "auth_ref": [ "r589" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of undiscounted cash flows of lessee's operating lease liability. Includes, but is not limited to, reconciliation of undiscounted cash flows to operating lease liability recognized in statement of financial position.", "label": "SCHEDULE OF FUTURE MINIMUM CONTRACTUAL LEASE PAYMENTS" } } }, "localname": "LesseeOperatingLeaseLiabilityMaturityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RightToUseAssetTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue": { "auth_ref": [ "r589" ], "calculation": { "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease.", "label": "Lessee, Operating Lease, Liability, to be Paid", "totalLabel": "Total future lease payments, undiscounted" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths": { "auth_ref": [ "r589" ], "calculation": { "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails": { "order": 1.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in next fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year One", "verboseLabel": "2022" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDueYearTwo": { "auth_ref": [ "r589" ], "calculation": { "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails": { "order": 2.0, "parentTag": "us-gaap_LesseeOperatingLeaseLiabilityPaymentsDue", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payment for operating lease to be paid in second fiscal year following current fiscal year. Excludes interim and annual periods when interim periods are reported from current statement of financial position date (rolling approach).", "label": "Lessee, Operating Lease, Liability, to be Paid, Year Two", "verboseLabel": "2023" } } }, "localname": "LesseeOperatingLeaseLiabilityPaymentsDueYearTwo", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseLiabilityUndiscountedExcessAmount": { "auth_ref": [ "r589" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's undiscounted obligation for lease payments in excess of discounted obligation for lease payments for operating lease.", "label": "Lessee, Operating Lease, Liability, Undiscounted Excess Amount", "negatedLabel": "Less: Implied interest" } } }, "localname": "LesseeOperatingLeaseLiabilityUndiscountedExcessAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LesseeOperatingLeaseRemainingLeaseTerm": { "auth_ref": [ "r581" ], "lang": { "en-us": { "role": { "documentation": "Remaining lease term of operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lessee, Operating Lease, Remaining Lease Term" } } }, "localname": "LesseeOperatingLeaseRemainingLeaseTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RightToUseAssetDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_LesseeOperatingLeaseTermOfContract": { "auth_ref": [ "r582" ], "lang": { "en-us": { "role": { "documentation": "Term of lessee's operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Lease term" } } }, "localname": "LesseeOperatingLeaseTermOfContract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_Liabilities": { "auth_ref": [ "r63", "r136", "r201", "r232", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r523", "r529", "r530", "r565", "r601", "r602" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Sum of the carrying amounts as of the balance sheet date of all liabilities that are recognized. Liabilities are probable future sacrifices of economic benefits arising from present obligations of an entity to transfer assets or provide services to other entities in the future.", "label": "Liabilities", "totalLabel": "Total liabilities" } } }, "localname": "Liabilities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquity": { "auth_ref": [ "r54", "r136", "r232", "r565", "r603", "r663", "r690" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.", "label": "Liabilities and Equity", "totalLabel": "Total liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesAndStockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Liabilities and stockholders\u2019 equity" } } }, "localname": "LiabilitiesAndStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesCurrent": { "auth_ref": [ "r29", "r66", "r136", "r232", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r523", "r529", "r530", "r565", "r601", "r602", "r603" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 1.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.", "label": "Liabilities, Current", "totalLabel": "Total current liabilities" } } }, "localname": "LiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesCurrentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Current liabilities" } } }, "localname": "LiabilitiesCurrentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_LiabilitiesFairValueDisclosure": { "auth_ref": [ "r546" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of financial and nonfinancial obligations.", "label": "Total liabilities" } } }, "localname": "LiabilitiesFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent": { "auth_ref": [ "r2", "r3", "r18", "r20", "r24", "r274", "r279" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 7.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer.", "label": "Current liabilities of discontinued operations", "totalLabel": "Total liabilities classified as discontinued operations in the consolidated balance sheet" } } }, "localname": "LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfAssetAndLiabilitiesIncomeFromDiscontinueOperationsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityDescription": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Description of the terms of a credit facility arrangement. Terms typically include interest rate, collateral required, guarantees required, repayment requirements, and restrictions on use of assets and activities of the entity.", "label": "Credit facility, description" } } }, "localname": "LineOfCreditFacilityDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_LineOfCreditFacilityExpirationDate1": { "auth_ref": [ "r60" ], "lang": { "en-us": { "role": { "documentation": "Date the credit facility terminates, in YYYY-MM-DD format.", "label": "Expiration date" } } }, "localname": "LineOfCreditFacilityExpirationDate1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_LineOfCreditFacilityMaximumBorrowingCapacity": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Maximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.", "label": "Loan amount" } } }, "localname": "LineOfCreditFacilityMaximumBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LineOfCreditFacilityRemainingBorrowingCapacity": { "auth_ref": [ "r60" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).", "label": "Additional amount" } } }, "localname": "LineOfCreditFacilityRemainingBorrowingCapacity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock": { "auth_ref": [ "r222" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for claims held for amounts due a company, excluding disclosure for allowance for credit losses. Examples include, but are not limited to, trade accounts receivables, notes receivables, loans receivables. Also excludes disclosure for financing receivables.", "label": "NOTES RECEIVABLE" } } }, "localname": "LoansNotesTradeAndOtherReceivablesExcludingAllowanceForCreditLossesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivable" ], "xbrltype": "textBlockItemType" }, "us-gaap_LoansPayable": { "auth_ref": [ "r42", "r662", "r684" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, aggregate carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Loans Payable", "verboseLabel": "Outstanding loan" } } }, "localname": "LoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_LoansPayableCurrent": { "auth_ref": [ "r64" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of portion of long-term loans payable due within one year or the operating cycle if longer.", "label": "Payroll protection loan - current portion" } } }, "localname": "LoansPayableCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_LongTermLoansPayable": { "auth_ref": [ "r71" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying value as of the balance sheet date of loans payable (with maturities initially due after one year or beyond the operating cycle if longer), excluding current portion.", "label": "Payroll protection loan - long term" } } }, "localname": "LongTermLoansPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecurities": { "auth_ref": [ "r666" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security.", "label": "Marketable Securities", "verboseLabel": "Marketable securities" } } }, "localname": "MarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/MarketableSecuritiesDetailsNarrative", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesCurrent": { "auth_ref": [], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 4.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of investment in marketable security, classified as current.", "label": "Marketable securities", "periodEndLabel": "Balances at end of year", "periodStartLabel": "Balances at beginning of year" } } }, "localname": "MarketableSecuritiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesGainLoss": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized and realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Change in fair value of designated assets", "negatedLabel": "Change in fair value" } } }, "localname": "MarketableSecuritiesGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesRealizedGainLoss": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of realized gain (loss) on investment in marketable security, including other-than-temporary impairment (OTTI).", "label": "Realized gain on marketable securities", "negatedLabel": "Realized gain on marketable securities" } } }, "localname": "MarketableSecuritiesRealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MarketableSecuritiesTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of marketable securities. This may consist of investments in certain debt and equity securities, short-term investments and other assets.", "label": "SCHEDULE OF MOVEMENT OF MARKETABLE SECURITIES" } } }, "localname": "MarketableSecuritiesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/MarketableSecuritiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_MarketableSecuritiesUnrealizedGainLoss": { "auth_ref": [ "r87" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment in marketable security.", "label": "Unrealized gain (loss) on marketable securities", "negatedLabel": "Unrealized loss (gain) on marketable securities" } } }, "localname": "MarketableSecuritiesUnrealizedGainLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_MeasurementInputDiscountForLackOfMarketabilityMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using amount by which value of business ownership interest is reduced to reflect lack of ability to convert business interest into cash quickly.", "label": "Measurement Input, Discount for Lack of Marketability [Member]" } } }, "localname": "MeasurementInputDiscountForLackOfMarketabilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputDiscountRateMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate to determine present value of future cash flows.", "label": "Measurement Input, Discount Rate [Member]" } } }, "localname": "MeasurementInputDiscountRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedDividendRateMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using expected dividend rate to be paid to holder of share per year.", "label": "Measurement Input, Expected Dividend Rate [Member]" } } }, "localname": "MeasurementInputExpectedDividendRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputExpectedTermMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using period financial instrument is expected to be outstanding. Excludes maturity date.", "label": "Measurement Input, Expected Term [Member]" } } }, "localname": "MeasurementInputExpectedTermMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputMaturityMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using due date of last payment of principal and interest for financial instrument. Excludes expected term.", "label": "Measurement Input, Maturity [Member]" } } }, "localname": "MeasurementInputMaturityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputOptionVolatilityMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of option increases (decreases) for given set of returns.", "label": "Measurement Input, Option Volatility [Member]" } } }, "localname": "MeasurementInputOptionVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputPriceVolatilityMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using rate at which price of security will increase (decrease) for given set of returns.", "label": "Measurement Input, Price Volatility [Member]" } } }, "localname": "MeasurementInputPriceVolatilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputRiskFreeInterestRateMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Measurement input using interest rate on instrument with zero risk of financial loss.", "label": "Measurement Input, Risk Free Interest Rate [Member]" } } }, "localname": "MeasurementInputRiskFreeInterestRateMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_MeasurementInputTypeAxis": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Information by type of measurement input used to determine value of asset and liability.", "label": "Measurement Input Type [Axis]" } } }, "localname": "MeasurementInputTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_MeasurementInputTypeDomain": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Measurement input used to determine value of asset and liability." } } }, "localname": "MeasurementInputTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NetCashProvidedByUsedInContinuingOperations": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "The increase (decrease) in cash associated with the entity's continuing operating, investing, and financing activities. While for technical reasons this element has no balance attribute, the default assumption is a debit balance consistent with its label.", "label": "Net Cash Provided by (Used in) Continuing Operations", "totalLabel": "Net increase in cash from continuing operations" } } }, "localname": "NetCashProvidedByUsedInContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInDiscontinuedOperations": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Increase (decrease) in cash associated with the entity's discontinued operations.", "label": "Net Cash Provided by (Used in) Discontinued Operations", "totalLabel": "Net decrease in cash from discontinued operations" } } }, "localname": "NetCashProvidedByUsedInDiscontinuedOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivities": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities", "totalLabel": "Net cash from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from financing activities" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of financing activities, excluding discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.", "label": "Net Cash Provided by (Used in) Financing Activities, Continuing Operations", "totalLabel": "Net cash from continuing operations" } } }, "localname": "NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivities": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities", "totalLabel": "Net cash from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from investing activities" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations": { "auth_ref": [ "r113" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) of investing activities, excluding discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.", "label": "Net Cash Provided by (Used in) Investing Activities, Continuing Operations", "totalLabel": "Net cash from continuing operations" } } }, "localname": "NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivities": { "auth_ref": [ "r113", "r117", "r120" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": null, "parentTag": null, "root": true, "weight": null } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities", "totalLabel": "Net cash used in operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Cash flows from operating activities" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations": { "auth_ref": [ "r113", "r117", "r120" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInContinuingOperations", "weight": 1.0 } }, "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow (outflow) from operating activities, excluding discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.", "label": "Net Cash Provided by (Used in) Operating Activities, Continuing Operations", "totalLabel": "Net cash used in continuing operations" } } }, "localname": "NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_NetIncomeLoss": { "auth_ref": [ "r24", "r75", "r76", "r80", "r84", "r120", "r136", "r148", "r150", "r151", "r152", "r153", "r156", "r157", "r163", "r191", "r199", "r202", "r205", "r207", "r232", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r545", "r565", "r671", "r697" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.", "label": "Net loss attributable to SRAX, Inc.", "totalLabel": "Net loss attributable to SRAX, Inc.", "verboseLabel": "Nety income (loss)" } } }, "localname": "NetIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StatementsOfOperations", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_NewAccountingPronouncementsPolicyPolicyTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy pertaining to new accounting pronouncements that may impact the entity's financial reporting. Includes, but is not limited to, quantification of the expected or actual impact.", "label": "Recently Issued Accounting Standards" } } }, "localname": "NewAccountingPronouncementsPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_NoncashInvestingAndFinancingItemsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental schedule of noncash investing and financing activities" } } }, "localname": "NoncashInvestingAndFinancingItemsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_NoncompeteAgreementsMember": { "auth_ref": [ "r505" ], "lang": { "en-us": { "role": { "documentation": "Agreement in which one party agrees not to pursue a similar trade in competition with another party.", "label": "Noncompete Agreements [Member]" } } }, "localname": "NoncompeteAgreementsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_NoncontrollingInterestIncreaseFromBusinessCombination": { "auth_ref": [ "r374", "r499", "r527" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase in noncontrolling interest from a business combination.", "label": "Noncontrolling Interest, Increase from Business Combination", "negatedLabel": "Acquisition of noncontrolling interest of FVPD" } } }, "localname": "NoncontrollingInterestIncreaseFromBusinessCombination", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_NoncontrollingInterestMember": { "auth_ref": [ "r145", "r146", "r147", "r373", "r518" ], "lang": { "en-us": { "role": { "documentation": "This element represents that portion of equity (net assets) in a subsidiary not attributable, directly or indirectly, to the parent. A noncontrolling interest is sometimes called a minority interest.", "label": "Noncontrolling Interest [Member]" } } }, "localname": "NoncontrollingInterestMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_NonoperatingIncomeExpense": { "auth_ref": [ "r98" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 2.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).", "label": "Nonoperating Income (Expense)", "totalLabel": "Total other expense" } } }, "localname": "NonoperatingIncomeExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_NonoperatingIncomeExpenseAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other income (expense)" } } }, "localname": "NonoperatingIncomeExpenseAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "stringItemType" }, "us-gaap_NonperformingFinancingReceivableMember": { "auth_ref": [ "r218", "r245" ], "lang": { "en-us": { "role": { "documentation": "Category status of financial instruments in which payments are past due in accordance with the terms of the contract. Financial instruments include, but are not limited to, financing receivables, loans, debt, and investments.", "label": "Nonperforming Financial Instruments [Member]" } } }, "localname": "NonperformingFinancingReceivableMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_NotesReceivableFairValueDisclosure": { "auth_ref": [ "r560" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Fair value portion of an agreement for an unconditional promise by the maker to pay the holder a definite sum of money at a future date.", "label": "Notes Receivable, Fair Value Disclosure" } } }, "localname": "NotesReceivableFairValueDisclosure", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/FairValueOfFinancialInstrumentsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_NotesReduction": { "auth_ref": [ "r124", "r125", "r126" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The value of notes retired (or transferred to another entity) in noncash investing or financing transactions.", "label": "Convertible notes converted into shares" } } }, "localname": "NotesReduction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_OfficeEquipmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tangible personal property used in an office setting. Examples include, but are not limited to, computers, copiers and fax machine.", "label": "Office Equipment [Member]" } } }, "localname": "OfficeEquipmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_OperatingIncomeLoss": { "auth_ref": [ "r191", "r199", "r202", "r205", "r207" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net result for the period of deducting operating expenses from operating revenues.", "label": "Operating Income (Loss)", "totalLabel": "Income (loss) from operations" } } }, "localname": "OperatingIncomeLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseCost": { "auth_ref": [ "r583", "r590" ], "calculation": { "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails": { "order": 1.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of single lease cost, calculated by allocation of remaining cost of lease over remaining lease term. Includes, but is not limited to, single lease cost, after impairment of right-of-use asset, calculated by amortization of remaining right-of-use asset and accretion of lease liability.", "label": "Operating lease expense" } } }, "localname": "OperatingLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLeaseIncomeLeasePayments": { "auth_ref": [ "r171", "r591" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of operating lease income from lease payments paid and payable to lessor. Excludes variable lease payments not included in measurement of lease receivable.", "label": "Cash paid for operating lease" } } }, "localname": "OperatingLeaseLeaseIncomeLeasePayments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RightToUseAssetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiability": { "auth_ref": [ "r579" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease.", "label": "Total operating lease liabilities", "verboseLabel": "Present value of operating lease payments" } } }, "localname": "OperatingLeaseLiability", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFutureMinimumContractualLeasePaymentsDetails", "http://srax.com/role/ScheduleOfOperatingLeaseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityCurrent": { "auth_ref": [ "r579" ], "calculation": { "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails": { "order": 1.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.", "label": "Operating lease liabilities - current" } } }, "localname": "OperatingLeaseLiabilityCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfOperatingLeaseAssetsAndLiabilitiesDetails", "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseLiabilityNoncurrent": { "auth_ref": [ "r579" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 2.0, "parentTag": "us-gaap_Liabilities", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Present value of lessee's discounted obligation for lease payments from operating lease, classified as noncurrent.", "label": "Right of use liability - long term", "verboseLabel": "Operating lease liabilities - non-current" } } }, "localname": "OperatingLeaseLiabilityNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfOperatingLeaseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseRightOfUseAsset": { "auth_ref": [ "r578" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 5.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of lessee's right to use underlying asset under operating lease.", "label": "Right of use assets", "verboseLabel": "Operating lease right-of-use assets - non-current" } } }, "localname": "OperatingLeaseRightOfUseAsset", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfOperatingLeaseAssetsAndLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLeaseWeightedAverageDiscountRatePercent": { "auth_ref": [ "r587", "r590" ], "lang": { "en-us": { "role": { "documentation": "Weighted average discount rate for operating lease calculated at point in time.", "label": "Weighted Average Discount Rate" } } }, "localname": "OperatingLeaseWeightedAverageDiscountRatePercent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfWeightedAverageRemainingLeaseTermAndAppliedDiscountRateDetails" ], "xbrltype": "percentItemType" }, "us-gaap_OperatingLeaseWeightedAverageRemainingLeaseTerm1": { "auth_ref": [ "r586", "r590" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining lease term for operating lease, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Lease Term" } } }, "localname": "OperatingLeaseWeightedAverageRemainingLeaseTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfWeightedAverageRemainingLeaseTermAndAppliedDiscountRateDetails" ], "xbrltype": "durationItemType" }, "us-gaap_OperatingLossCarryforwards": { "auth_ref": [ "r471" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of operating loss carryforward, before tax effects, available to reduce future taxable income under enacted tax laws.", "label": "Operating Loss Carryforwards" } } }, "localname": "OperatingLossCarryforwards", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OperatingLossCarryforwardsLimitationsOnUse": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "A description of the limitations on the use of all operating loss carryforwards available to reduce future taxable income.", "label": "Operating Loss Carryforwards, Limitations on Use" } } }, "localname": "OperatingLossCarryforwardsLimitationsOnUse", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Organization, Consolidation and Presentation of Financial Statements [Abstract]" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock": { "auth_ref": [ "r26", "r144", "r187", "r534" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for the organization, consolidation and basis of presentation of financial statements disclosure, and significant accounting policies of the reporting entity. May be provided in more than one note to the financial statements, as long as users are provided with an understanding of (1) the significant judgments and assumptions made by an enterprise in determining whether it must consolidate a VIE and/or disclose information about its involvement with a VIE, (2) the nature of restrictions on a consolidated VIE's assets reported by an enterprise in its statement of financial position, including the carrying amounts of such assets, (3) the nature of, and changes in, the risks associated with an enterprise's involvement with the VIE, and (4) how an enterprise's involvement with the VIE affects the enterprise's financial position, financial performance, and cash flows. Describes procedure if disclosures are provided in more than one note to the financial statements.", "label": "ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES" } } }, "localname": "OrganizationConsolidationAndPresentationOfFinancialStatementsDisclosureAndSignificantAccountingPoliciesTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherAssetsNoncurrent": { "auth_ref": [ "r38" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncurrent assets classified as other.", "label": "Other assets" } } }, "localname": "OtherAssetsNoncurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherCurrentLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of other current liabilities.", "label": "SCHEDULE OF OTHER CURRENT LIABILITIES" } } }, "localname": "OtherCurrentLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherExpenses": { "auth_ref": [ "r97", "r703" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense classified as other.", "label": "Other Expenses" } } }, "localname": "OtherExpenses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesCurrent": { "auth_ref": [ "r64", "r603" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 }, "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails": { "order": null, "parentTag": null, "root": true, "weight": null } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of liabilities classified as other, due within one year or the normal operating cycle, if longer.", "label": "Other current liabilities", "totalLabel": "Total other current liabilities" } } }, "localname": "OtherLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherLiabilitiesDisclosureAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Other Liabilities Disclosure [Abstract]" } } }, "localname": "OtherLiabilitiesDisclosureAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_OtherLiabilitiesDisclosureTextBlock": { "auth_ref": [ "r65" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for other liabilities.", "label": "OTHER CURRENT LIABILITIES" } } }, "localname": "OtherLiabilitiesDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilities" ], "xbrltype": "textBlockItemType" }, "us-gaap_OtherNonoperatingIncome": { "auth_ref": [ "r88" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 8.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of income related to nonoperating activities, classified as other.", "label": "Other income" } } }, "localname": "OtherNonoperatingIncome", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_OtherSundryLiabilitiesCurrent": { "auth_ref": [ "r64", "r294" ], "calculation": { "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails": { "order": 2.0, "parentTag": "us-gaap_OtherLiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Obligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.", "label": "Other Sundry Liabilities, Current", "verboseLabel": "Other current liabilities" } } }, "localname": "OtherSundryLiabilitiesCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative", "http://srax.com/role/ScheduleOfOtherCurrentLiabilitiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PayablesAndAccrualsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Payables and Accruals [Abstract]" } } }, "localname": "PayablesAndAccrualsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PaymentsForProceedsFromInvestments": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The net cash paid (received) associated with the acquisition or disposal of all investments, including securities and other assets.", "label": "Investments" } } }, "localname": "PaymentsForProceedsFromInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsForRent": { "auth_ref": [ "r116" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Cash payments to lessor's for use of assets under operating leases.", "label": "Payments for Rent" } } }, "localname": "PaymentsForRent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsOfDebtIssuanceCosts": { "auth_ref": [ "r110" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow paid to third parties in connection with debt origination, which will be amortized over the remaining maturity period of the associated long-term debt.", "label": "Payments of Debt Issuance Costs" } } }, "localname": "PaymentsOfDebtIssuanceCosts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireBusinessesGross": { "auth_ref": [ "r105", "r513" ], "calculation": { "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails": { "order": 2.0, "parentTag": "us-gaap_BusinessCombinationConsiderationTransferred1", "weight": 1.0 }, "http://srax.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of business during the period. The cash portion only of the acquisition price.", "label": "Cash at closing", "negatedLabel": "Payment for deferred consideration to LD Micro", "verboseLabel": "Business combination, cash payable by entity" } } }, "localname": "PaymentsToAcquireBusinessesGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireIntangibleAssets": { "auth_ref": [ "r106" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.", "label": "Payments to Acquire Intangible Assets", "negatedLabel": "Acquisition of intangible assets" } } }, "localname": "PaymentsToAcquireIntangibleAssets", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireMarketableSecurities": { "auth_ref": [ "r225" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 3.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of cash outflow for purchase of marketable security.", "label": "Payments to Acquire Marketable Securities", "negatedLabel": "Purchase of marketable securities" } } }, "localname": "PaymentsToAcquireMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquireNotesReceivable": { "auth_ref": [ "r104" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow to acquire an agreement for an unconditional promise by the maker to pay the entity (holder) a definite sum of money at a future date. Such amount may include accrued interest receivable in accordance with the terms of the note. The note also may contain provisions including a discount or premium, payable on demand, secured, or unsecured, interest bearing or noninterest bearing, among myriad other features and characteristics.", "label": "Deferred payments of notes receivable" } } }, "localname": "PaymentsToAcquireNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_PaymentsToAcquirePropertyPlantAndEquipment": { "auth_ref": [ "r106" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 7.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.", "label": "Payments to Acquire Property, Plant, and Equipment", "negatedLabel": "Acquisition of property and equipment" } } }, "localname": "PaymentsToAcquirePropertyPlantAndEquipment", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_PlanNameAxis": { "auth_ref": [ "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by plan name for share-based payment arrangement.", "label": "Plan Name [Axis]" } } }, "localname": "PlanNameAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_PlanNameDomain": { "auth_ref": [ "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Plan name for share-based payment arrangement." } } }, "localname": "PlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Preferred shares may provide a preferential dividend to the dividend on common stock and may take precedence over common stock in the event of a liquidation. Preferred shares typically represent an ownership interest in the company.", "label": "Preferred Stock [Member]" } } }, "localname": "PreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "domainItemType" }, "us-gaap_PreferredStockParOrStatedValuePerShare": { "auth_ref": [ "r47", "r350" ], "lang": { "en-us": { "role": { "documentation": "Face amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.", "label": "Preferred stock par value" } } }, "localname": "PreferredStockParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_PreferredStockSharesAuthorized": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.", "label": "Preferred stock authorized", "verboseLabel": "Preferred stock shares authorized" } } }, "localname": "PreferredStockSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesIssued": { "auth_ref": [ "r47", "r350" ], "lang": { "en-us": { "role": { "documentation": "Total number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.", "label": "Preferred stock, shares issued" } } }, "localname": "PreferredStockSharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockSharesOutstanding": { "auth_ref": [ "r47" ], "lang": { "en-us": { "role": { "documentation": "Aggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.", "label": "Preferred stock, shares outstanding" } } }, "localname": "PreferredStockSharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_PreferredStockTextBlock": { "auth_ref": [ "r376" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for terms, amounts, nature of changes, rights and privileges, dividends, and other matters related to preferred stock.", "label": "SERIES A PREFERRED STOCK" } } }, "localname": "PreferredStockTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStock" ], "xbrltype": "textBlockItemType" }, "us-gaap_PrepaidExpenseAndOtherAssetsCurrent": { "auth_ref": [ "r56" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_AssetsCurrent", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.", "label": "Prepaid expenses and other current assets" } } }, "localname": "PrepaidExpenseAndOtherAssetsCurrent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromBankDebt": { "auth_ref": [ "r108" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 8.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from bank borrowing during the year.", "label": "Proceeds from payroll protection program" } } }, "localname": "ProceedsFromBankDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromConvertibleDebt": { "auth_ref": [ "r108" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of a long-term debt instrument which can be exchanged for a specified amount of another security, typically the entity's common stock, at the option of the issuer or the holder.", "label": "Proceeds from issuance of short-term notes payable, less issuance costs" } } }, "localname": "ProceedsFromConvertibleDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromDivestitureOfBusinesses": { "auth_ref": [ "r102" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from the sale of a portion of the company's business, for example a segment, division, branch or other business, during the period.", "label": "Total consideration" } } }, "localname": "ProceedsFromDivestitureOfBusinesses", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceInitialPublicOffering": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from entity's first offering of stock to the public.", "label": "Proceeds from issuance Initial public offering" } } }, "localname": "ProceedsFromIssuanceInitialPublicOffering", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfCommonStock": { "auth_ref": [ "r107" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the additional capital contribution to the entity.", "label": "Proceeds from the issuance of common stock units" } } }, "localname": "ProceedsFromIssuanceOfCommonStock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfDebt": { "auth_ref": [ "r108" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow during the period from additional borrowings in aggregate debt. Includes proceeds from short-term and long-term debt.", "label": "Proceeds from additional borrowing", "verboseLabel": "Proceeds from issuance of debt" } } }, "localname": "ProceedsFromIssuanceOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOfWarrants": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from issuance of rights to purchase common shares at predetermined price (usually issued together with corporate debt).", "label": "Proceeds from issuance of warrants" } } }, "localname": "ProceedsFromIssuanceOfWarrants", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromIssuanceOrSaleOfEquity": { "auth_ref": [ "r107" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.", "label": "Proceeds from issuanceor sale of equity" } } }, "localname": "ProceedsFromIssuanceOrSaleOfEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromNotesPayable": { "auth_ref": [ "r108" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 9.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from the issuance of notes payable", "verboseLabel": "Proceeds from notes payable" } } }, "localname": "ProceedsFromNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleAndMaturityOfMarketableSecurities": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the aggregate amount received by the entity through sale or maturity of marketable securities (held-to-maturity or available-for-sale) during the period.", "label": "Proceeds from Sale and Maturity of Marketable Securities", "negatedLabel": "Sale of marketable securities", "negatedTerseLabel": "Sales", "verboseLabel": "Marketable Securities" } } }, "localname": "ProceedsFromSaleAndMaturityOfMarketableSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfAvailableForSaleSecuritiesDebt": { "auth_ref": [ "r100", "r101", "r225" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from sale of investment in debt security measured at fair value with change in fair value recognized in other comprehensive income (available-for-sale).", "label": "Proceeds from sale of securities" } } }, "localname": "ProceedsFromSaleOfAvailableForSaleSecuritiesDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfHeldToMaturitySecurities": { "auth_ref": [ "r101", "r225" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of securities that had been designated as held-to-maturity. Excludes proceeds from maturities, prepayments and calls by the issuer.", "label": "Proceeds from the sale of marketable securities" } } }, "localname": "ProceedsFromSaleOfHeldToMaturitySecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfInvestmentProjects": { "auth_ref": [ "r103" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 4.0, "parentTag": "us-gaap_NetCashProvidedByUsedInInvestingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow from the sale of investment projects held by an entity in hopes of getting a future return or interest from it.", "label": "Proceeds from sale of SRAXmd, net" } } }, "localname": "ProceedsFromSaleOfInvestmentProjects", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfNotesReceivable": { "auth_ref": [ "r101" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the sale of a borrowing supported by a written promise to pay an obligation.", "label": "Proceeds from sale of non-performing receivables" } } }, "localname": "ProceedsFromSaleOfNotesReceivable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromSaleOfOtherAssets1": { "auth_ref": [ "r114" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of cash inflow from the sale of other assets as part of operating activities.", "label": "Proceeds from sale of other assets" } } }, "localname": "ProceedsFromSaleOfOtherAssets1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProceedsFromWarrantExercises": { "auth_ref": [ "r107" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 2.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The cash inflow associated with the amount received from holders exercising their stock warrants.", "label": "Proceeds from the exercise of warrants", "terseLabel": "Proceeds from warrant exercises", "verboseLabel": "Proceeds from issuance of warrant" } } }, "localname": "ProceedsFromWarrantExercises", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProductInformationLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Product Information [Line Items]" } } }, "localname": "ProductInformationLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ProfessionalFees": { "auth_ref": [ "r717", "r718" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "A fee charged for services from professionals such as doctors, lawyers and accountants. The term is often expanded to include other professions, for example, pharmacists charging to maintain a medicinal profile of a client or customer.", "label": "Attorneys fees" } } }, "localname": "ProfessionalFees", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ProfitLoss": { "auth_ref": [ "r24", "r75", "r76", "r80", "r112", "r136", "r148", "r156", "r157", "r191", "r199", "r202", "r205", "r207", "r232", "r296", "r297", "r298", "r300", "r301", "r302", "r303", "r304", "r305", "r306", "r521", "r525", "r526", "r532", "r533", "r545", "r565", "r674" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 1.0, "parentTag": "us-gaap_IncomeLossFromContinuingOperations", "weight": 1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_NetIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The consolidated profit or loss for the period, net of income taxes, including the portion attributable to the noncontrolling interest.", "label": "Net loss", "totalLabel": "Net loss" } } }, "localname": "ProfitLoss", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Property, Plant and Equipment [Abstract]" } } }, "localname": "PropertyPlantAndEquipmentAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentByTypeAxis": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Information by type of long-lived, physical assets used to produce goods and services and not intended for resale.", "label": "Long-Lived Tangible Asset [Axis]" } } }, "localname": "PropertyPlantAndEquipmentByTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentDisclosureTextBlock": { "auth_ref": [ "r283", "r737", "r738", "r739" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PropertyAndEquipment" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentGross": { "auth_ref": [ "r34", "r276" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount before accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Office equipment" } } }, "localname": "PropertyPlantAndEquipmentGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Property, Plant and Equipment [Line Items]" } } }, "localname": "PropertyPlantAndEquipmentLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_PropertyPlantAndEquipmentNet": { "auth_ref": [ "r278", "r603", "r675", "r692" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_Assets", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.", "label": "Property and equipment, net" } } }, "localname": "PropertyPlantAndEquipmentNet", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets", "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_PropertyPlantAndEquipmentPolicyTextBlock": { "auth_ref": [ "r278", "r737", "r738" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for long-lived, physical asset used in normal conduct of business and not intended for resale. Includes, but is not limited to, work of art, historical treasure, and similar asset classified as collections.", "label": "Property and equipment" } } }, "localname": "PropertyPlantAndEquipmentPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTextBlock": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "SCHEDULE OF PROPERTY AND EQUIPMENT" } } }, "localname": "PropertyPlantAndEquipmentTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PropertyAndEquipmentTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_PropertyPlantAndEquipmentTypeDomain": { "auth_ref": [ "r276" ], "lang": { "en-us": { "role": { "documentation": "Listing of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale. Examples include land, buildings, machinery and equipment, and other types of furniture and equipment including, but not limited to, office equipment, furniture and fixtures, and computer equipment and software." } } }, "localname": "PropertyPlantAndEquipmentTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ProvisionForDoubtfulAccounts": { "auth_ref": [ "r86", "r238" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 17.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense (reversal of expense) for expected credit loss on accounts receivable.", "label": "Provision for bad debts" } } }, "localname": "ProvisionForDoubtfulAccounts", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ReceivableWithImputedInterestDescription": { "auth_ref": [ "r574" ], "lang": { "en-us": { "role": { "documentation": "The description of the receivable with imputed interest.", "label": "Receivable description" } } }, "localname": "ReceivableWithImputedInterestDescription", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ReceivablesAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Receivables [Abstract]" } } }, "localname": "ReceivablesAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyDomain": { "auth_ref": [ "r395", "r595", "r596" ], "lang": { "en-us": { "role": { "documentation": "Related parties include affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests." } } }, "localname": "RelatedPartyDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RelatedPartyTransactionsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Related Party Transactions [Abstract]" } } }, "localname": "RelatedPartyTransactionsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsByRelatedPartyAxis": { "auth_ref": [ "r395", "r595", "r598", "r645", "r646", "r647", "r648", "r649", "r650", "r651", "r652", "r653", "r654", "r655", "r656" ], "lang": { "en-us": { "role": { "documentation": "Information by type of related party. Related parties include, but not limited to, affiliates; other entities for which investments are accounted for by the equity method by the entity; trusts for benefit of employees; and principal owners, management, and members of immediate families. It also may include other parties with which the entity may control or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests.", "label": "Related Party [Axis]" } } }, "localname": "RelatedPartyTransactionsByRelatedPartyAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_RelatedPartyTransactionsDisclosureTextBlock": { "auth_ref": [ "r593", "r594", "r596", "r599", "r600" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for related party transactions. Examples of related party transactions include transactions between (a) a parent company and its subsidiary; (b) subsidiaries of a common parent; (c) and entity and its principal owners; and (d) affiliates.", "label": "RELATED PARTY TRANSACTIONS" } } }, "localname": "RelatedPartyTransactionsDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactions" ], "xbrltype": "textBlockItemType" }, "us-gaap_RepaymentsOfDebt": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow during the period from the repayment of aggregate short-term and long-term debt. Excludes payment of capital lease obligations.", "label": "Payment of outstanding debt" } } }, "localname": "RepaymentsOfDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfNotesPayable": { "auth_ref": [ "r109" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 10.0, "parentTag": "us-gaap_NetCashProvidedByUsedInFinancingActivitiesContinuingOperations", "weight": -1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing supported by a written promise to pay an obligation.", "label": "Repayment of short-term note payable", "negatedLabel": "Repayment of notes payable" } } }, "localname": "RepaymentsOfNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfRelatedPartyDebt": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for the payment of a long-term borrowing made from a related party where one party can exercise control or significant influence over another party; including affiliates, owners or officers and their immediate families, pension trusts, and so forth. Alternate caption: Payments for Advances from Affiliates.", "label": "Related party payments" } } }, "localname": "RepaymentsOfRelatedPartyDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RepaymentsOfShortTermDebt": { "auth_ref": [ "r109" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cash outflow for a borrowing having initial term of repayment within one year or the normal operating cycle, if longer.", "label": "Repayment of loan principal and interest" } } }, "localname": "RepaymentsOfShortTermDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember": { "auth_ref": [ "r33" ], "lang": { "en-us": { "role": { "documentation": "Type of cash and cash equivalent. Cash is currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates." } } }, "localname": "RestrictedCashAndCashEquivalentsCashAndCashEquivalentsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_RetainedEarningsAccumulatedDeficit": { "auth_ref": [ "r51", "r373", "r603", "r689", "r712", "r713" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Accumulated deficit" } } }, "localname": "RetainedEarningsAccumulatedDeficit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_RetainedEarningsMember": { "auth_ref": [ "r0", "r145", "r146", "r147", "r149", "r155", "r157", "r233", "r448", "r449", "r450", "r478", "r479", "r543", "r709", "r711" ], "lang": { "en-us": { "role": { "documentation": "The cumulative amount of the reporting entity's undistributed earnings or deficit.", "label": "Retained Earnings [Member]" } } }, "localname": "RetainedEarningsMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "domainItemType" }, "us-gaap_RevenueFromContractWithCustomerAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Revenue from Contract with Customer [Abstract]" } } }, "localname": "RevenueFromContractWithCustomerAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_RevenueFromContractWithCustomerExcludingAssessedTax": { "auth_ref": [ "r188", "r189", "r198", "r203", "r204", "r208", "r209", "r210", "r380", "r381", "r642" ], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 1.0, "parentTag": "us-gaap_OperatingIncomeLoss", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount, excluding tax collected from customer, of revenue from satisfaction of performance obligation by transferring promised good or service to customer. Tax collected from customer is tax assessed by governmental authority that is both imposed on and concurrent with specific revenue-producing transaction, including, but not limited to, sales, use, value added and excise.", "label": "Revenues", "verboseLabel": "Total revenues" } } }, "localname": "RevenueFromContractWithCustomerExcludingAssessedTax", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails", "http://srax.com/role/StatementsOfOperations", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_RevenueRecognitionPolicyTextBlock": { "auth_ref": [ "r130", "r131" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for revenue. Includes revenue from contract with customer and from other sources.", "label": "Revenue Recognition" } } }, "localname": "RevenueRecognitionPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_RevolvingCreditFacilityMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Arrangement in which loan proceeds can continuously be obtained following repayments, but the total amount borrowed cannot exceed a specified maximum amount.", "label": "Revolving Credit Facility [Member]" } } }, "localname": "RevolvingCreditFacilityMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SaleOfStockConsiderationReceivedOnTransaction": { "auth_ref": [], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Cash received on stock transaction after deduction of issuance costs.", "label": "Sale of stock, consideration received on transaction" } } }, "localname": "SaleOfStockConsiderationReceivedOnTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SaleOfStockNumberOfSharesIssuedInTransaction": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The number of shares issued or sold by the subsidiary or equity method investee per stock transaction.", "label": "Sale of stock number of share", "verboseLabel": "Sale of stock" } } }, "localname": "SaleOfStockNumberOfSharesIssuedInTransaction", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SalesRevenueNetMember": { "auth_ref": [ "r182", "r210" ], "lang": { "en-us": { "role": { "documentation": "Revenue from sale of product and rendering of service and other sources of income, when it serves as benchmark in concentration of risk calculation.", "label": "Revenue Benchmark [Member]" } } }, "localname": "SalesRevenueNetMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ScenarioAdjustmentMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Domain member used to indicate figures that are adjustments during a period or as of a point in time. This domain member would never be expected to appear in a relationship group without the \"Scenario, Previously Reported\" Member with the same parent.", "label": "Scenario, Adjustment [Member]" } } }, "localname": "ScenarioAdjustmentMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the (a) carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business (accounts payable); (b) other payables; and (c) accrued liabilities. Examples include taxes, interest, rent and utilities. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer). An alternative caption includes accrued expenses.", "label": "SCHEDULE OF ACCOUNTS PAYABLE AND ACCRUED EXPENSES" } } }, "localname": "ScheduleOfAccountsPayableAndAccruedLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AccountsPayableAndAccruedExpensesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTable": { "auth_ref": [ "r496", "r497", "r501" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting each material business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities.", "label": "Schedule of Business Acquisitions, by Acquisition [Table]" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/ScheduleOfCalculationsOfPurchasePriceDetails", "http://srax.com/role/ScheduleOfIntangibleAssetsAcquiredAsPartOfBusinessCombinationDetails", "http://srax.com/role/ScheduleOfProFormaConsolidatedStatementOfOperationsDetails", "http://srax.com/role/SummaryOfAllocationOfPurchasePriceToAssetsAcquiredLiabilitiesAssumedDetails", "http://srax.com/role/SummaryOfAmountOfRevenueAndEarningsOfAcquireeSinceAcquisitionDateDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock": { "auth_ref": [ "r496", "r497" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.", "label": "SCHEDULE OF CALCULATIONS OF PURCHASE PRICE" } } }, "localname": "ScheduleOfBusinessAcquisitionsByAcquisitionTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Table]" } } }, "localname": "ScheduleOfCollaborativeArrangementsAndNoncollaborativeArrangementTransactionsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock": { "auth_ref": [ "r476" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of income tax expense attributable to continuing operations for each year presented including, but not limited to: current tax expense (benefit), deferred tax expense (benefit), investment tax credits, government grants, the benefits of operating loss carryforwards, tax expense that results from allocating certain tax benefits either directly to contributed capital or to reduce goodwill or other noncurrent intangible assets of an acquired entity, adjustments of a deferred tax liability or asset for enacted changes in tax laws or rates or a change in the tax status of the entity, and adjustments of the beginning-of-the-year balances of a valuation allowance because of a change in circumstances that causes a change in judgment about the realizability of the related deferred tax asset in future years.", "label": "SCHEDULE OF INCOME TAX (BENEFIT) EXPENSE" } } }, "localname": "ScheduleOfComponentsOfIncomeTaxExpenseBenefitTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable": { "auth_ref": [ "r385", "r386" ], "lang": { "en-us": { "role": { "documentation": "Schedule, table or text reflecting arrangements that are not equity-based payments, or pension and other postretirement benefits, with individual employees. The arrangements (for example, profit sharing, deferred bonuses or certain split-dollar life insurance arrangements) are generally based on employment contracts between the entity and one or more selected officers or key employees, and which contain a promise by the employer to pay certain amounts at designated future dates, sometimes including a period after retirement, upon compliance with stipulated requirements. This type of arrangement is distinguished from broader based employee benefit plans as it is usually tailored to the employee. Disclosure also typically includes the amount of related compensation expense recognized during the reporting period and the carrying amount as of the balance sheet date of the related liability.", "label": "Schedule of Deferred Compensation Arrangement with Individual, Excluding Share-Based Payments and Postretirement Benefits, by Title of Individual and by Type of Deferred Compensation [Table]" } } }, "localname": "ScheduleOfDeferredCompensationArrangementWithIndividualExcludingShareBasedPaymentsAndPostretirementBenefitsByTitleOfIndividualAndByTypeOfDeferredCompensationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RelatedPartyTransactionsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock": { "auth_ref": [ "r468" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the components of net deferred tax asset or liability recognized in an entity's statement of financial position, including the following: the total of all deferred tax liabilities, the total of all deferred tax assets, the total valuation allowance recognized for deferred tax assets.", "label": "SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES" } } }, "localname": "ScheduleOfDeferredTaxAssetsAndLiabilitiesTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock": { "auth_ref": [ "r3", "r9", "r10", "r11", "r12", "r13", "r14", "r19", "r22", "r23", "r24", "r280", "r281" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of information related to a disposal group. Includes, but is not limited to, a discontinued operation, disposal classified as held-for-sale or disposed of by means other than sale or disposal of an individually significant component.", "label": "SCHEDULE OF ASSET AND LIABILITIES INCOME FROM DISCONTINUE OPERATIONS" } } }, "localname": "ScheduleOfDisposalGroupsIncludingDiscontinuedOperationsIncomeStatementBalanceSheetAndAdditionalDisclosuresTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock": { "auth_ref": [ "r460" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the reconciliation using percentage or dollar amounts of the reported amount of income tax expense attributable to continuing operations for the year to the amount of income tax expense that would result from applying domestic federal statutory tax rates to pretax income from continuing operations.", "label": "SCHEDULE OF EFFECTIVE TAX RATE" } } }, "localname": "ScheduleOfEffectiveIncomeTaxRateReconciliationTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTable": { "auth_ref": [ "r263", "r266", "r643" ], "lang": { "en-us": { "role": { "documentation": "Schedule of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.", "label": "Schedule of Finite-Lived Intangible Assets [Table]" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock": { "auth_ref": [ "r263", "r266" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of assets, excluding financial assets and goodwill, lacking physical substance with a finite life, by either major class or business segment.", "label": "SCHEDULE OF INTANGIBLE ASSETS" } } }, "localname": "ScheduleOfFiniteLivedIntangibleAssetsTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfProductInformationTable": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Schedule detailing quantitative information concerning products or product lines by product or product line.", "label": "Schedule of Product Information [Table]" } } }, "localname": "ScheduleOfProductInformationTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfPropertyPlantAndEquipmentTable": { "auth_ref": [ "r278" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about physical assets used in the normal conduct of business and not intended for resale. Includes, but is not limited to, balances by class of assets, depreciation and depletion expense and method used, including composite depreciation, and accumulated deprecation.", "label": "Property, Plant and Equipment [Table]" } } }, "localname": "ScheduleOfPropertyPlantAndEquipmentTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfPropertyAndEquipmentDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock": { "auth_ref": [ "r500" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amounts recognized as of the acquisition date for each major class of assets acquired and liabilities assumed. May include but not limited to the following: (a) acquired receivables; (b) contingencies recognized at the acquisition date; and (c) the fair value of noncontrolling interests in the acquiree.", "label": "SUMMARY OF ALLOCATION OF PURCHASE PRICE TO ASSETS ACQUIRED LIABILITIES ASSUMED" } } }, "localname": "ScheduleOfRecognizedIdentifiedAssetsAcquiredAndLiabilitiesAssumedTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable": { "auth_ref": [ "r402", "r404", "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of information about share-based payment arrangement.", "label": "Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table]" } } }, "localname": "ScheduleOfShareBasedCompensationArrangementsByShareBasedPaymentAwardTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock": { "auth_ref": [ "r411", "r429", "r432" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value.", "label": "SCHEDULE OF STOCK OPTION ACTIVITY" } } }, "localname": "ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleOfShortTermDebtTable": { "auth_ref": [ "r61" ], "lang": { "en-us": { "role": { "documentation": "A table or schedule providing information pertaining to borrowings under which repayment was required in less than twelve months (or normal operating cycle, if longer) after its issuance. It may include: (1) description of the short-term debt arrangement; (2) identification of the lender or type of lender; (3) repayment terms; (4) weighted average interest rate; (5) carrying amount of funds borrowed under the specified short-term debt arrangement as of the balance sheet date and measures of the maximum and average amount outstanding during the period; (6) description of the refinancing of a short-term obligation when that obligation is excluded from current liabilities in the balance sheet; and (7) amount of a short-term obligation that has been excluded from current liabilities in the balance sheet because of a refinancing of the obligation.", "label": "Schedule of Short-Term Debt [Table]" } } }, "localname": "ScheduleOfShortTermDebtTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockByClassTable": { "auth_ref": [ "r46", "r47", "r48", "r133", "r173", "r174", "r346", "r348", "r349", "r350", "r351", "r352", "r353", "r355", "r359", "r364", "r366", "r367", "r368", "r369", "r370", "r371", "r372", "r373" ], "lang": { "en-us": { "role": { "documentation": "Schedule detailing information related to equity by class of stock. Class of stock includes common, convertible, and preferred stocks which are not redeemable or redeemable solely at the option of the issuer. It also includes preferred stock with redemption features that are solely within the control of the issuer and mandatorily redeemable stock if redemption is required to occur only upon liquidation or termination of the reporting entity.", "label": "Schedule of Stock by Class [Table]" } } }, "localname": "ScheduleOfStockByClassTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStock", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock": { "auth_ref": [ "r375", "r405" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.", "label": "SCHEDULE OF WARRANT ACTIVITY" } } }, "localname": "ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock": { "auth_ref": [ "r266" ], "lang": { "en-us": { "role": { "documentation": "Tabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.", "label": "SCHEDULE OF ESTIMATED FUTURE AMORTIZATION EXPENSE" } } }, "localname": "ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IntangibleAssetsTables" ], "xbrltype": "textBlockItemType" }, "us-gaap_SegmentReportingPolicyPolicyTextBlock": { "auth_ref": [ "r192", "r193", "r194", "r195", "r196", "r197", "r209" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for segment reporting.", "label": "Business Segments" } } }, "localname": "SegmentReportingPolicyPolicyTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SellingAndMarketingExpense": { "auth_ref": [], "calculation": { "http://srax.com/role/StatementsOfOperations": { "order": 3.0, "parentTag": "SRAX_CostAndOperatingExpenses", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "The aggregate total amount of expenses directly related to the marketing or selling of products or services.", "label": "Marketing and selling expenses" } } }, "localname": "SellingAndMarketingExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_SeriesAPreferredStockMember": { "auth_ref": [ "r46", "r47", "r366" ], "lang": { "en-us": { "role": { "documentation": "Series A preferred stock.", "label": "Series A Preferred Stock [Member]" } } }, "localname": "SeriesAPreferredStockMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails", "http://srax.com/role/SeriesPreferredStock", "http://srax.com/role/SeriesPreferredStockDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensation": { "auth_ref": [ "r118" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 16.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of noncash expense for share-based payment arrangement.", "label": "Share-Based Payment Arrangement, Noncash Expense", "verboseLabel": "Stock based compensation" } } }, "localname": "ShareBasedCompensation", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1": { "auth_ref": [ "r407" ], "lang": { "en-us": { "role": { "documentation": "Period over which grantee's right to exercise award under share-based payment arrangement is no longer contingent on satisfaction of service or performance condition, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, combination of market, performance or service condition.", "label": "Option vesting period" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate": { "auth_ref": [ "r408" ], "lang": { "en-us": { "role": { "documentation": "Date the equity-based award expires, in YYYY-MM-DD format.", "label": "Option expiration date" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardExpirationDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate": { "auth_ref": [ "r438" ], "lang": { "en-us": { "role": { "documentation": "The estimated measure of the percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.", "label": "Implied volatility" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate": { "auth_ref": [ "r440" ], "lang": { "en-us": { "role": { "documentation": "The risk-free interest rate assumption that is used in valuing an option on its own shares.", "label": "Risk free equivalent yield" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "percentItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised": { "auth_ref": [ "r421" ], "lang": { "en-us": { "role": { "documentation": "Number of non-option equity instruments exercised by participants.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Exercised", "negatedLabel": "Number of Shares, Warrants Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures": { "auth_ref": [ "r422" ], "lang": { "en-us": { "role": { "documentation": "Number of shares under non-option equity instrument agreements that were cancelled as a result of occurrence of a terminating event.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures", "negatedLabel": "Number of Shares, Warrants Forfeiture" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsForfeitures", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted": { "auth_ref": [ "r420" ], "lang": { "en-us": { "role": { "documentation": "Net number of non-option equity instruments granted to participants.", "label": "Number of Shares, Warrants Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber": { "auth_ref": [ "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Number of equity instruments other than options outstanding, including both vested and non-vested instruments.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Outstanding, Number", "periodEndLabel": "Number of Shares, Warrants Outstanding Ending balance", "periodStartLabel": "Number of Shares, Warrants Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfWarrantActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized": { "auth_ref": [ "r409" ], "lang": { "en-us": { "role": { "documentation": "Number of shares authorized for issuance under share-based payment arrangement.", "label": "Number of shares authorized" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant": { "auth_ref": [ "r447" ], "lang": { "en-us": { "role": { "documentation": "The difference between the maximum number of shares (or other type of equity) authorized for issuance under the plan (including the effects of amendments and adjustments), and the sum of: 1) the number of shares (or other type of equity) already issued upon exercise of options or other equity-based awards under the plan; and 2) shares (or other type of equity) reserved for issuance on granting of outstanding awards, net of cancellations and forfeitures, if applicable.", "label": "Number of shares reserved for grants" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue": { "auth_ref": [ "r431" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of accumulated difference between fair value of underlying shares on dates of exercise and exercise price on options exercised (or share units converted) into shares.", "label": "Aggregate Intrinsic Value, Exercised" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The combined weighted average of the accumulated differences between the fair values on underlying shares and exercises prices to acquire such shares as of the grant date on options that were either forfeited or lapsed.", "label": "Aggregate Intrinsic Value, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "The number of shares under options that were cancelled during the reporting period as a result of occurrence of a terminating event specified in contractual agreements pertaining to the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures in Period", "negatedLabel": "Number of Shares, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The grant-date intrinsic value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Aggregate Intrinsic Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrantDateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Gross number of share options (or share units) granted during the period.", "label": "Number of Shares, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue": { "auth_ref": [ "r430" ], "lang": { "en-us": { "role": { "documentation": "The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.", "label": "Weighted Average Grant Date Fair Value, Granted" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue": { "auth_ref": [ "r447" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Intrinsic Value", "periodEndLabel": "Aggregate Intrinsic Value, Outstanding Ending balance", "periodStartLabel": "Aggregate Intrinsic Value, Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber": { "auth_ref": [ "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Number of options outstanding, including both vested and non-vested options.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Number", "periodEndLabel": "Number of Shares, Outstanding Ending balance", "periodStartLabel": "Number of Shares, Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r412", "r413" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price", "periodEndLabel": "Weighted Average Strike Price/Share, Outstanding Ending balance", "periodStartLabel": "Weighted Average Strike Price/Share, Outstanding Beginning balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue": { "auth_ref": [ "r434" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest exercisable or convertible options. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Aggregate Intrinsic Value, Vested and exercisable Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue": { "auth_ref": [ "r433" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount by which current fair value of underlying stock exceeds exercise price of fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Number of fully vested and expected to vest options outstanding that can be converted into shares under option plan. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Number of Shares, Vested and exercisable Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Weighted-average exercise price, at which grantee can acquire shares reserved for issuance, for fully vested and expected to vest options outstanding. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Weighted Average Strike Price/Share, Vested and exercisable Ending balance" } } }, "localname": "ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": { "auth_ref": [ "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Award under share-based payment arrangement." } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r417" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which option holders acquired shares when converting their stock options into shares.", "label": "Weighted Average Strike Price/Share, Exercised" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r418" ], "lang": { "en-us": { "role": { "documentation": "Weighted average price at which grantees could have acquired the underlying shares with respect to stock options that were terminated.", "label": "Weighted Average Strike Price/Share, Forfeited" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice": { "auth_ref": [ "r416" ], "lang": { "en-us": { "role": { "documentation": "Weighted average per share amount at which grantees can acquire shares of common stock by exercise of options.", "label": "Weighted Average Strike Price/Share, Granted" } } }, "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_ShareBasedCompensationOptionAndIncentivePlansPolicy": { "auth_ref": [ "r410", "r435", "r436", "r437", "r438", "r441", "r451", "r454" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for award under share-based payment arrangement. Includes, but is not limited to, methodology and assumption used in measuring cost.", "label": "Stock-Based Compensation" } } }, "localname": "ShareBasedCompensationOptionAndIncentivePlansPolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_SharePrice": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Price of a single share of a number of saleable stocks of a company.", "label": "Share price" } } }, "localname": "SharePrice", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1": { "auth_ref": [ "r437" ], "lang": { "en-us": { "role": { "documentation": "Expected term of award under share-based payment arrangement, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Option term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of non-vested options outstanding.", "label": "Number of Shares, Unvested and non-exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options forfeited.", "label": "Weighted Average Grant Date Fair Value, Unvested and non-exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Weighted average grant-date fair value of non-vested options outstanding.", "label": "Weighted Average Strike Price/Share, Unvested and non-exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "perShareItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.", "label": "Weighted Average Remaining Contractual Term (Years), Outstanding Beginning balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r434" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest exercisable or convertible options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Weighted Average Remaining Contractual Term (Years), Vested and exercisable Ending balance" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1": { "auth_ref": [ "r433" ], "lang": { "en-us": { "role": { "documentation": "Weighted average remaining contractual term for fully vested and expected to vest options outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Includes, but is not limited to, unvested options for which requisite service period has not been rendered but that are expected to vest based on achievement of performance condition, if forfeitures are recognized when they occur.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Remaining Contractual Term" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1": { "auth_ref": [ "r431" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock.", "label": "Share-based payment award, fair value of options" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of options vested.", "label": "Number of option vested" } } }, "localname": "SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssued": { "auth_ref": [ "r366" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued as of the balance sheet date, including shares that had been issued and were previously outstanding but which are now held in the treasury.", "label": "Security shares" } } }, "localname": "SharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesIssuedPricePerShare": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Per share or per unit amount of equity securities issued.", "label": "Shares issued price per share" } } }, "localname": "SharesIssuedPricePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "perShareItemType" }, "us-gaap_SharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares issued which are neither cancelled nor held in the treasury.", "label": "Shares, Outstanding", "periodEndLabel": "Balance, shares", "periodStartLabel": "Balance, shares" } } }, "localname": "SharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares": { "auth_ref": [ "r345" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of shares that would be issued, determined under the conditions specified in the contract if the settlement were to occur at the reporting date.", "label": "Price to be paid for all of the units" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsFairValueOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares": { "auth_ref": [ "r345" ], "lang": { "en-us": { "role": { "documentation": "The number of shares that would be issued, determined under the conditions specified in the contract, if the settlement were to occur at the reporting date.", "label": "Redemption of class A units" } } }, "localname": "SharesSubjectToMandatoryRedemptionSettlementTermsNumberOfShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/NotesReceivableDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_ShortTermBankLoansAndNotesPayable": { "auth_ref": [ "r57", "r694" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of borrowings from a bank classified as other, maturing within one year or operating cycle, if longer.", "label": "Short term promissory notes" } } }, "localname": "ShortTermBankLoansAndNotesPayable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ShortTermDebtLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Short-Term Debt [Line Items]" } } }, "localname": "ShortTermDebtLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative", "http://srax.com/role/ScheduleOfOidConvertibleDebenturesDetails", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_ShortTermDebtTextBlock": { "auth_ref": [ "r343" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for short-term debt.", "label": "SHORT TERM PROMISSORY NOTES" } } }, "localname": "ShortTermDebtTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ShortTermPromissoryNotes" ], "xbrltype": "textBlockItemType" }, "us-gaap_ShortTermLeaseCost": { "auth_ref": [ "r584", "r590" ], "calculation": { "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails": { "order": 2.0, "parentTag": "us-gaap_LeaseCost", "weight": 1.0 } }, "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of short-term lease cost, excluding expense for lease with term of one month or less.", "label": "Short-term lease expense" } } }, "localname": "ShortTermLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfComponentOfLeaseExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StateAndLocalIncomeTaxExpenseBenefitContinuingOperations": { "auth_ref": [ "r137", "r459", "r481" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of current and deferred state and local tax expense (benefit) attributable to income (loss) from continuing operations. Includes, but is not limited to, current and deferred regional, territorial, and provincial tax expense (benefit) for non-US (United States of America) jurisdiction.", "label": "State" } } }, "localname": "StateAndLocalIncomeTaxExpenseBenefitContinuingOperations", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIncomeTaxBenefitExpenseDetails" ], "xbrltype": "monetaryItemType" }, "us-gaap_StatementClassOfStockAxis": { "auth_ref": [ "r46", "r47", "r48", "r133", "r136", "r160", "r161", "r162", "r164", "r166", "r173", "r174", "r175", "r232", "r296", "r300", "r301", "r302", "r305", "r306", "r350", "r351", "r355", "r359", "r366", "r565", "r759" ], "lang": { "en-us": { "role": { "documentation": "Information by the different classes of stock of the entity.", "label": "Class of Stock [Axis]" } } }, "localname": "StatementClassOfStockAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/AcquisitionsDetailsNarrative", "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfLiabilitiesMeasuredAtFairValueDetails", "http://srax.com/role/SeriesPreferredStock", "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementEquityComponentsAxis": { "auth_ref": [ "r0", "r74", "r78", "r79", "r80", "r145", "r146", "r147", "r149", "r155", "r157", "r172", "r233", "r366", "r373", "r448", "r449", "r450", "r478", "r479", "r543", "r566", "r567", "r568", "r569", "r570", "r571", "r592", "r709", "r710", "r711" ], "lang": { "en-us": { "role": { "documentation": "Information by component of equity.", "label": "Equity Components [Axis]" } } }, "localname": "StatementEquityComponentsAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_StatementLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.", "label": "Statement [Line Items]" } } }, "localname": "StatementLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails", "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StatementOfCashFlowsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Cash Flows [Abstract]" } } }, "localname": "StatementOfCashFlowsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfFinancialPositionAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Statement of Financial Position [Abstract]" } } }, "localname": "StatementOfFinancialPositionAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementOfStockholdersEquityAbstract": { "auth_ref": [], "localname": "StatementOfStockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_StatementTable": { "auth_ref": [ "r145", "r146", "r147", "r172", "r642" ], "lang": { "en-us": { "role": { "documentation": "Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed.", "label": "Statement [Table]" } } }, "localname": "StatementTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical", "http://srax.com/role/DiscontinuedOperationsDetailsNarrative", "http://srax.com/role/NotesReceivableDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/ScheduleOfRevenueByBusinessUnitDetails", "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/SummaryOfProFormaAdjustmentsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_StockIssued1": { "auth_ref": [ "r124", "r125", "r126" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The fair value of stock issued in noncash financing activities.", "label": "Shares of common stock issued for extension agreement" } } }, "localname": "StockIssued1", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodSharesAcquisitions": { "auth_ref": [ "r47", "r48", "r373" ], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued during the period pursuant to acquisitions.", "label": "Stock Issued During Period, Shares, Acquisitions" } } }, "localname": "StockIssuedDuringPeriodSharesAcquisitions", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DiscontinuedOperationsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities": { "auth_ref": [ "r73", "r326", "r366", "r367", "r373" ], "lang": { "en-us": { "role": { "documentation": "Number of shares issued during the period as a result of the conversion of convertible securities.", "label": "Conversion of convertible debt to equity, shares", "verboseLabel": "Stock issued during period, shares, conversion of convertible securities" } } }, "localname": "StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SeriesPreferredStockDetailsNarrative", "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesNewIssues": { "auth_ref": [ "r47", "r48", "r366", "r373" ], "lang": { "en-us": { "role": { "documentation": "Number of new stock issued during the period.", "label": "Shares issued for cash, shares", "terseLabel": "Number of shares issued", "verboseLabel": "Number of common shares option to purchase" } } }, "localname": "StockIssuedDuringPeriodSharesNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesOther": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Number of shares of stock issued attributable to transactions classified as other.", "label": "Shares issued for extension agreement, shares", "verboseLabel": "Shares issued for extension agreement" } } }, "localname": "StockIssuedDuringPeriodSharesOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity", "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercised": { "auth_ref": [ "r47", "r48", "r366", "r373", "r417" ], "lang": { "en-us": { "role": { "documentation": "Number of share options (or share units) exercised during the current period.", "label": "Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period", "negatedLabel": "Number of Shares, Exercised" } } }, "localname": "StockIssuedDuringPeriodSharesStockOptionsExercised", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfStockOptionActivityDetails" ], "xbrltype": "sharesItemType" }, "us-gaap_StockIssuedDuringPeriodValueConversionOfConvertibleSecurities": { "auth_ref": [ "r74", "r366", "r373" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The gross value of stock issued during the period upon the conversion of convertible securities.", "label": "Conversion of convertible debt to equity" } } }, "localname": "StockIssuedDuringPeriodValueConversionOfConvertibleSecurities", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueNewIssues": { "auth_ref": [ "r47", "r48", "r366", "r373" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering.", "label": "Shares issued for cash" } } }, "localname": "StockIssuedDuringPeriodValueNewIssues", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockIssuedDuringPeriodValueOther": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of shares of stock issued attributable to transactions classified as other.", "label": "Shares issued for extension agreement" } } }, "localname": "StockIssuedDuringPeriodValueOther", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockRepurchasedDuringPeriodShares": { "auth_ref": [ "r47", "r48", "r366", "r373" ], "lang": { "en-us": { "role": { "documentation": "Number of shares that have been repurchased during the period and have not been retired and are not held in treasury. Some state laws may govern the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Number of repurchased shares" } } }, "localname": "StockRepurchasedDuringPeriodShares", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "sharesItemType" }, "us-gaap_StockRepurchasedDuringPeriodValue": { "auth_ref": [ "r47", "r48", "r366", "r373" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Equity impact of the value of stock that has been repurchased during the period and has not been retired and is not held in treasury. Some state laws may mandate the circumstances under which an entity may acquire its own stock and prescribe the accounting treatment therefore. This element is used when state law does not recognize treasury stock.", "label": "Number of repurchased value" } } }, "localname": "StockRepurchasedDuringPeriodValue", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquity": { "auth_ref": [ "r48", "r52", "r53", "r136", "r221", "r232", "r565", "r603" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.", "label": "Stockholders' Equity Attributable to Parent", "periodEndLabel": "Balance", "periodStartLabel": "Balance" } } }, "localname": "StockholdersEquity", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfChangesInStockholdersEquity" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Stockholders\u2019 equity" } } }, "localname": "StockholdersEquityAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "stringItemType" }, "us-gaap_StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest": { "auth_ref": [ "r0", "r1", "r79", "r136", "r145", "r146", "r147", "r149", "r155", "r232", "r233", "r373", "r448", "r449", "r450", "r478", "r479", "r518", "r519", "r531", "r543", "r565", "r566", "r567", "r571", "r592", "r710", "r711" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 3.0, "parentTag": "us-gaap_LiabilitiesAndStockholdersEquity", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.", "label": "Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest", "totalLabel": "Total stockholders\u2019 equity" } } }, "localname": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_StockholdersEquityNoteDisclosureTextBlock": { "auth_ref": [ "r134", "r351", "r354", "r355", "r356", "r357", "r358", "r359", "r360", "r361", "r362", "r363", "r365", "r373", "r376", "r542" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.", "label": "STOCKHOLDERS\u2019 EQUITY" } } }, "localname": "StockholdersEquityNoteDisclosureTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquity" ], "xbrltype": "textBlockItemType" }, "us-gaap_SubsequentEventLineItems": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Detail information of subsequent event by type. User is expected to use existing line items from elsewhere in the taxonomy as the primary line items for this disclosure, which is further associated with dimension and member elements pertaining to a subsequent event.", "label": "Subsequent Event [Line Items]" } } }, "localname": "SubsequentEventLineItems", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventMember": { "auth_ref": [ "r572", "r605" ], "lang": { "en-us": { "role": { "documentation": "Identifies event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event [Member]" } } }, "localname": "SubsequentEventMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventTable": { "auth_ref": [ "r572", "r605" ], "lang": { "en-us": { "role": { "documentation": "Discloses pertinent information about one or more significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued.", "label": "Subsequent Event [Table]" } } }, "localname": "SubsequentEventTable", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeAxis": { "auth_ref": [ "r572", "r605" ], "lang": { "en-us": { "role": { "documentation": "Information by event that occurred after the balance sheet date but before financial statements are issued or available to be issued.", "label": "Subsequent Event Type [Axis]" } } }, "localname": "SubsequentEventTypeAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventTypeDomain": { "auth_ref": [ "r572", "r605" ], "lang": { "en-us": { "role": { "documentation": "Event that occurred after the balance sheet date but before financial statements are issued or available to be issued." } } }, "localname": "SubsequentEventTypeDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_SubsequentEventsAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Subsequent Events [Abstract]" } } }, "localname": "SubsequentEventsAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "xbrltype": "stringItemType" }, "us-gaap_SubsequentEventsTextBlock": { "auth_ref": [ "r604", "r607" ], "lang": { "en-us": { "role": { "documentation": "The entire disclosure for significant events or transactions that occurred after the balance sheet date through the date the financial statements were issued or the date the financial statements were available to be issued. Examples include: the sale of a capital stock issue, purchase of a business, settlement of litigation, catastrophic loss, significant foreign exchange rate changes, loans to insiders or affiliates, and transactions not in the ordinary course of business.", "label": "SUBSEQUENT EVENTS" } } }, "localname": "SubsequentEventsTextBlock", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEvents" ], "xbrltype": "textBlockItemType" }, "us-gaap_SupplementalCashFlowInformationAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "label": "Supplemental schedule of cash flow information" } } }, "localname": "SupplementalCashFlowInformationAbstract", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows" ], "xbrltype": "stringItemType" }, "us-gaap_TemporaryEquityCarryingAmountAttributableToParent": { "auth_ref": [ "r296", "r300", "r301", "r302", "r305", "r306" ], "calculation": { "http://srax.com/role/BalanceSheets": { "order": 6.0, "parentTag": "us-gaap_LiabilitiesCurrent", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Carrying amount, attributable to parent, of an entity's issued and outstanding stock which is not included within permanent equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. Includes stock with a put option held by an ESOP and stock redeemable by a holder only in the event of a change in control of the issuer.", "label": "Series A preferred stock, authorized 36,462,417 shares, $0.001 par value, 36,462,417 shares and none issued and outstanding, respectively" } } }, "localname": "TemporaryEquityCarryingAmountAttributableToParent", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheets" ], "xbrltype": "monetaryItemType" }, "us-gaap_TemporaryEquityParOrStatedValuePerShare": { "auth_ref": [ "r32", "r347" ], "lang": { "en-us": { "role": { "documentation": "Per share amount of par value or stated value of stock classified as temporary equity. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable.", "label": "Temporary equity, par value" } } }, "localname": "TemporaryEquityParOrStatedValuePerShare", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical" ], "xbrltype": "perShareItemType" }, "us-gaap_TemporaryEquitySharesAuthorized": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The maximum number of securities classified as temporary equity that are permitted to be issued by an entity's charter and bylaws. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares authorized" } } }, "localname": "TemporaryEquitySharesAuthorized", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesIssued": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been sold (or granted) to the entity's shareholders. Securities issued include securities outstanding and securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary equity, shares outstanding" } } }, "localname": "TemporaryEquitySharesIssued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TemporaryEquitySharesOutstanding": { "auth_ref": [ "r46" ], "lang": { "en-us": { "role": { "documentation": "The number of securities classified as temporary equity that have been issued and are held by the entity's shareholders. Securities outstanding equals securities issued minus securities held in treasury. Temporary equity is a security with redemption features that are outside the control of the issuer, is not classified as an asset or liability in conformity with GAAP, and is not mandatorily redeemable. Includes any type of security that is redeemable at a fixed or determinable price or on a fixed or determinable date or dates, is redeemable at the option of the holder, or has conditions for redemption which are not solely within the control of the issuer. If convertible, the issuer does not control the actions or events necessary to issue the maximum number of shares that could be required to be delivered under the conversion option if the holder exercises the option to convert the stock to another class of equity. If the security is a warrant or a rights issue, the warrant or rights issue is considered to be temporary equity if the issuer cannot demonstrate that it would be able to deliver upon the exercise of the option by the holder in all cases. Includes stock with put option held by ESOP and stock redeemable by holder only in the event of a change in control of the issuer.", "label": "Temporary Equity, Shares Outstanding" } } }, "localname": "TemporaryEquitySharesOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/BalanceSheetsParenthetical" ], "xbrltype": "sharesItemType" }, "us-gaap_TimeDepositsAtOrAboveFDICInsuranceLimit": { "auth_ref": [ "r677" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of time deposit liabilities, including certificates of deposit, in denominations that meet or exceed the Federal Deposit Insurance Corporation (FDIC) insurance limit.", "label": "Excess of federal insurance limit" } } }, "localname": "TimeDepositsAtOrAboveFDICInsuranceLimit", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TradeAndOtherAccountsReceivablePolicy": { "auth_ref": [ "r214", "r215", "r216", "r217", "r220", "r223" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for accounts receivable.", "label": "Accounts Receivable" } } }, "localname": "TradeAndOtherAccountsReceivablePolicy", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_TradeReceivablesHeldForSaleAmount": { "auth_ref": [ "r212" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount, before valuation allowance, of accounts receivable held for sale.", "label": "Purchase price of receivables" } } }, "localname": "TradeReceivablesHeldForSaleAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockholdersEquityDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_TrademarksMember": { "auth_ref": [ "r503" ], "lang": { "en-us": { "role": { "documentation": "Rights acquired through registration of a trademark to gain or protect exclusive use of a business name, symbol or other device or style.", "label": "Trademarks [Member]" } } }, "localname": "TrademarksMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfIntangibleAssetsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain": { "auth_ref": [ "r226", "r227", "r229", "r230", "r231", "r334", "r364", "r541", "r608", "r609", "r610", "r611", "r612", "r613", "r614", "r615", "r616", "r617", "r618", "r619", "r620", "r621", "r622", "r623", "r624", "r625", "r626", "r627", "r628", "r629", "r630", "r631", "r632", "r633", "r634", "r635", "r636", "r637", "r759", "r760", "r761", "r762", "r763", "r764", "r765" ], "lang": { "en-us": { "role": { "documentation": "Instrument or contract that imposes a contractual obligation to deliver cash or another financial instrument or to exchange other financial instruments on potentially unfavorable terms and conveys a contractual right to receive cash or another financial instrument or to exchange other financial instruments on potentially favorable terms." } } }, "localname": "TransfersAndServicingOfFinancialInstrumentsTypesOfFinancialInstrumentsDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/DesignatedAssetsForReturnOfCapitalDetailsNarrative", "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/ScheduleOfDesignatedAssetsDetails", "http://srax.com/role/ScheduleOfMovementInDesignatedAssetsDetails", "http://srax.com/role/ShortTermPromissoryNotesDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_TypeOfArrangementAxis": { "auth_ref": [ "r517" ], "lang": { "en-us": { "role": { "documentation": "Information by collaborative arrangement and arrangement other than collaborative applicable to revenue-generating activity or operations.", "label": "Collaborative Arrangement and Arrangement Other than Collaborative [Axis]" } } }, "localname": "TypeOfArrangementAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/OtherCurrentLiabilitiesDetailsNarrative", "http://srax.com/role/SaleAndPurchaseOfAccountsReceivableDetailsNarrative", "http://srax.com/role/StockholdersEquityDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_UnrealizedGainLossOnInvestments": { "auth_ref": [ "r119" ], "calculation": { "http://srax.com/role/StatementsOfCashFlows": { "order": 6.0, "parentTag": "us-gaap_NetCashProvidedByUsedInOperatingActivitiesContinuingOperations", "weight": -1.0 }, "http://srax.com/role/StatementsOfOperations": { "order": 6.0, "parentTag": "us-gaap_NonoperatingIncomeExpense", "weight": 1.0 } }, "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of unrealized gain (loss) on investment.", "label": "Gain on sale of SRAXmd, net", "negatedLabel": "Gain on sale of SRAXmd" } } }, "localname": "UnrealizedGainLossOnInvestments", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfCashFlows", "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued": { "auth_ref": [ "r462" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount accrued for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense": { "auth_ref": [ "r462" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of expense for interest on an underpayment of income taxes and penalties related to a tax position claimed or expected to be claimed in the tax return.", "label": "Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense" } } }, "localname": "UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UnsecuredDebt": { "auth_ref": [ "r42", "r662", "r688" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Including the current and noncurrent portions, carrying value as of the balance sheet date of uncollateralized debt obligations (with maturities initially due after one year or beyond the operating cycle if longer).", "label": "Unsecured loan" } } }, "localname": "UnsecuredDebt", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/PaycheckProtectionProgramLoanDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_UseOfEstimates": { "auth_ref": [ "r176", "r177", "r179", "r180", "r184", "r185", "r186" ], "lang": { "en-us": { "role": { "documentation": "Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.", "label": "Use of Estimates" } } }, "localname": "UseOfEstimates", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OrganizationAndSummaryOfSignificantAccountingPoliciesPolicies" ], "xbrltype": "textBlockItemType" }, "us-gaap_ValuationAllowanceDeferredTaxAssetChangeInAmount": { "auth_ref": [ "r468" ], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Amount of increase (decrease) in the valuation allowance for a specified deferred tax asset.", "label": "Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount" } } }, "localname": "ValuationAllowanceDeferredTaxAssetChangeInAmount", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/IncomeTaxesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_ValuationTechniqueAxis": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Information by valuation approach and technique.", "label": "Valuation Approach and Technique [Axis]" } } }, "localname": "ValuationTechniqueAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "stringItemType" }, "us-gaap_ValuationTechniqueDiscountedCashFlowMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating present value of future cash flows.", "label": "Valuation Technique, Discounted Cash Flow [Member]" } } }, "localname": "ValuationTechniqueDiscountedCashFlowMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueDomain": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Valuation approach and technique." } } }, "localname": "ValuationTechniqueDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_ValuationTechniqueOptionPricingModelMember": { "auth_ref": [ "r548" ], "lang": { "en-us": { "role": { "documentation": "Valuation technique calculating price of option.", "label": "Valuation Technique, Option Pricing Model [Member]" } } }, "localname": "ValuationTechniqueOptionPricingModelMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAssetsSignificantUnobservableInputsDetails" ], "xbrltype": "domainItemType" }, "us-gaap_VariableLeaseCost": { "auth_ref": [ "r585", "r590" ], "crdr": "debit", "lang": { "en-us": { "role": { "documentation": "Amount of variable lease cost, excluded from lease liability, recognized when obligation for payment is incurred for finance and operating leases.", "label": "Variable lease cost and sublease" } } }, "localname": "VariableLeaseCost", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/RightToUseAssetDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_VestingAxis": { "auth_ref": [ "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Information by vesting schedule of award under share-based payment arrangement.", "label": "Vesting [Axis]" } } }, "localname": "VestingAxis", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "stringItemType" }, "us-gaap_VestingDomain": { "auth_ref": [ "r407", "r408", "r409", "r412", "r413", "r414", "r415", "r416", "r417", "r418", "r419", "r423", "r424", "r425", "r426", "r427", "r428", "r430", "r431", "r433", "r434", "r437", "r438", "r439", "r440", "r441" ], "lang": { "en-us": { "role": { "documentation": "Vesting schedule of award under share-based payment arrangement." } } }, "localname": "VestingDomain", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/SubsequentEventsDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantMember": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Security that gives the holder the right to purchase shares of stock in accordance with the terms of the instrument, usually upon payment of a specified amount.", "label": "Warrant [Member]" } } }, "localname": "WarrantMember", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/ScheduleOfFairValueAtAssetsDetails", "http://srax.com/role/ScheduleOfMovementOfMarketableSecuritiesDetails", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative", "http://srax.com/role/SubsequentEventsDetailsNarrative", "http://srax.com/role/TermLoanNoteDetailsNarrative" ], "xbrltype": "domainItemType" }, "us-gaap_WarrantsAndRightsOutstanding": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "Value of outstanding derivative securities that permit the holder the right to purchase securities (usually equity) from the issuer at a specified price.", "label": "Proceeds from warrants exercise" } } }, "localname": "WarrantsAndRightsOutstanding", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative" ], "xbrltype": "monetaryItemType" }, "us-gaap_WarrantsAndRightsOutstandingMaturityDate": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Expiration date of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in YYYY-MM-DD format.", "label": "Warrants and rights outstanding, maturity date" } } }, "localname": "WarrantsAndRightsOutstandingMaturityDate", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "dateItemType" }, "us-gaap_WarrantsAndRightsOutstandingMeasurementInput": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Value of input used to measure outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur.", "label": "Warrants and rights outstanding, measurement input", "verboseLabel": "Warrants and Rights Outstanding, Measurement Input" } } }, "localname": "WarrantsAndRightsOutstandingMeasurementInput", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "decimalItemType" }, "us-gaap_WarrantsAndRightsOutstandingTerm": { "auth_ref": [ "r550" ], "lang": { "en-us": { "role": { "documentation": "Period between issuance and expiration of outstanding warrant and right embodying unconditional obligation requiring redemption by transferring asset at specified or determinable date or upon event certain to occur, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days.", "label": "Warrants and rights outstanding, Term", "verboseLabel": "Warrants and Rights Outstanding, Term" } } }, "localname": "WarrantsAndRightsOutstandingTerm", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/OidConvertibleDebenturesDetailsNarrative", "http://srax.com/role/StockOptionsAwardsAndWarrantsDetailsNarrative" ], "xbrltype": "durationItemType" }, "us-gaap_WeightedAverageNumberOfSharesOutstandingBasic": { "auth_ref": [ "r159", "r166" ], "lang": { "en-us": { "role": { "documentation": "Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.", "label": "Weighted average shares outstanding, basic and diluted" } } }, "localname": "WeightedAverageNumberOfSharesOutstandingBasic", "nsuri": "http://fasb.org/us-gaap/2022", "presentation": [ "http://srax.com/role/StatementsOfOperations" ], "xbrltype": "sharesItemType" } }, "unitCount": 5 } }, "std_ref": { "r0": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r1": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "105", "URI": "https://asc.fasb.org/extlink&oid=126987489&loc=SL124442142-165695" }, "r10": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1474-107760" }, "r100": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3151-108585" }, "r101": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r102": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r103": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3179-108585" }, "r104": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r105": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r106": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3213-108585" }, "r107": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r108": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3255-108585" }, "r109": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r11": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721659-107760" }, "r110": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3291-108585" }, "r111": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3367-108585" }, "r112": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3000-108585" }, "r113": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3521-108585" }, "r114": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r115": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r116": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r117": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3536-108585" }, "r118": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r119": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r12": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721663-107760" }, "r120": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3602-108585" }, "r121": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126954810&loc=d3e3044-108585" }, "r122": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4273-108586" }, "r123": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4297-108586" }, "r124": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4304-108586" }, "r125": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4313-108586" }, "r126": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=d3e4332-108586" }, "r127": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "230", "URI": "https://asc.fasb.org/extlink&oid=126999549&loc=SL98516268-108586" }, "r128": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r129": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r13": { "Name": "Accounting Standards Codification", "Paragraph": "4B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721665-107760" }, "r130": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r131": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=126899994&loc=d3e18823-107790" }, "r132": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(c))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r133": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(d))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r134": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(e)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r135": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(f))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r136": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(g)(1)(ii))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r137": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(1)(Note 1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r138": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h)(2))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r139": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(h))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r14": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721671-107760" }, "r140": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(k)(1))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r141": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08(n))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r142": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.4-08.(e))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690" }, "r143": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.12-04(a))", "Topic": "235", "URI": "https://asc.fasb.org/extlink&oid=120395691&loc=d3e24072-122690" }, "r144": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "235", "URI": "https://asc.fasb.org/topic&trid=2122369" }, "r145": { "Name": "Accounting Standards Codification", "Paragraph": "23", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21914-107793" }, "r146": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21930-107793" }, "r147": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124436220&loc=d3e21711-107793" }, "r148": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r149": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(3)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22499-107794" }, "r15": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r150": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r151": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22694-107794" }, "r152": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22583-107794" }, "r153": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22595-107794" }, "r154": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r155": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22644-107794" }, "r156": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22658-107794" }, "r157": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=124431687&loc=d3e22663-107794" }, "r158": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.M.Q2)", "Topic": "250", "URI": "https://asc.fasb.org/extlink&oid=122038215&loc=d3e31137-122693" }, "r159": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1448-109256" }, "r16": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r160": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1252-109256" }, "r161": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1278-109256" }, "r162": { "Name": "Accounting Standards Codification", "Paragraph": "55", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e2626-109256" }, "r163": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r164": { "Name": "Accounting Standards Codification", "Paragraph": "60B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=SL5780133-109256" }, "r165": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=126958026&loc=d3e1337-109256" }, "r166": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r167": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3550-109257" }, "r168": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=124432515&loc=d3e3630-109257" }, "r169": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e3842-109258" }, "r17": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r170": { "Name": "Accounting Standards Codification", "Paragraph": "52", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "260", "URI": "https://asc.fasb.org/extlink&oid=128363288&loc=d3e4984-109258" }, "r171": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "270", "URI": "https://asc.fasb.org/extlink&oid=126900988&loc=SL77927221-108306" }, "r172": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70191-108054" }, "r173": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=125520817&loc=d3e70229-108054" }, "r174": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70434-108055" }, "r175": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "272", "URI": "https://asc.fasb.org/extlink&oid=6373374&loc=d3e70478-108055" }, "r176": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r177": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r178": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e5967-108592" }, "r179": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6161-108592" }, "r18": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r180": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6191-108592" }, "r181": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r182": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6351-108592" }, "r183": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6404-108592" }, "r184": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6061-108592" }, "r185": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6132-108592" }, "r186": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "275", "URI": "https://asc.fasb.org/extlink&oid=99393423&loc=d3e6143-108592" }, "r187": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "275", "URI": "https://asc.fasb.org/topic&trid=2134479" }, "r188": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r189": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r19": { "Name": "Accounting Standards Codification", "Paragraph": "5B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721673-107760" }, "r190": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r191": { "Name": "Accounting Standards Codification", "Paragraph": "22", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599" }, "r192": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r193": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r194": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r195": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r196": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r197": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8864-108599" }, "r198": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r199": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r2": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1107-107759" }, "r20": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r200": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r201": { "Name": "Accounting Standards Codification", "Paragraph": "30", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599" }, "r202": { "Name": "Accounting Standards Codification", "Paragraph": "31", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599" }, "r203": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r204": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r205": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r206": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r207": { "Name": "Accounting Standards Codification", "Paragraph": "32", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e8933-108599" }, "r208": { "Name": "Accounting Standards Codification", "Paragraph": "40", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9031-108599" }, "r209": { "Name": "Accounting Standards Codification", "Paragraph": "41", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9038-108599" }, "r21": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r210": { "Name": "Accounting Standards Codification", "Paragraph": "42", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "280", "URI": "https://asc.fasb.org/extlink&oid=126901519&loc=d3e9054-108599" }, "r211": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4647-111522" }, "r212": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4428-111522" }, "r213": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=124259787&loc=d3e4531-111522" }, "r214": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e4975-111524" }, "r215": { "Name": "Accounting Standards Codification", "Paragraph": "11B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953423-111524" }, "r216": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5212-111524" }, "r217": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5033-111524" }, "r218": { "Name": "Accounting Standards Codification", "Paragraph": "29", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=SL6953659-111524" }, "r219": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5074-111524" }, "r22": { "Name": "Accounting Standards Codification", "Paragraph": "5C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721675-107760" }, "r220": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=123577603&loc=d3e5093-111524" }, "r221": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 4.E)", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=122038336&loc=d3e74512-122707" }, "r222": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "10", "Topic": "310", "URI": "https://asc.fasb.org/subtopic&trid=2196772" }, "r223": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "310", "URI": "https://asc.fasb.org/extlink&oid=84159169&loc=d3e10133-111534" }, "r224": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "310", "URI": "https://asc.fasb.org/topic&trid=2196771" }, "r225": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=124260329&loc=d3e26853-111562" }, "r226": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=d3e27232-111563" }, "r227": { "Name": "Accounting Standards Codification", "Paragraph": "5A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "320", "URI": "https://asc.fasb.org/extlink&oid=126970911&loc=SL120269820-111563" }, "r228": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "320", "URI": "https://asc.fasb.org/topic&trid=2196928" }, "r229": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r23": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721677-107760" }, "r230": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r231": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "321", "URI": "https://asc.fasb.org/extlink&oid=126980263&loc=SL75117539-209714" }, "r232": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "323", "URI": "https://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571" }, "r233": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=122640432&loc=SL121648383-210437" }, "r234": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255206&loc=SL82895884-210446" }, "r235": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r236": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919244-210447" }, "r237": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r238": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r239": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r24": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760" }, "r240": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919249-210447" }, "r241": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919253-210447" }, "r242": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919258-210447" }, "r243": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919269-210447" }, "r244": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919272-210447" }, "r245": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919230-210447" }, "r246": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124255953&loc=SL82919236-210447" }, "r247": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922888-210455" }, "r248": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922895-210455" }, "r249": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=124269663&loc=SL82922900-210455" }, "r25": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/subtopic&trid=2122178" }, "r250": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "326", "URI": "https://asc.fasb.org/extlink&oid=121590138&loc=SL82922954-210456" }, "r251": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "326", "URI": "https://asc.fasb.org/topic&trid=82887179" }, "r252": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13770-109266" }, "r253": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=99380562&loc=d3e13777-109266" }, "r254": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r255": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r256": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r257": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267" }, "r258": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=121556970&loc=d3e13854-109267" }, "r259": { "Name": "Accounting Standards Codification", "Paragraph": "24", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=122137925&loc=d3e14258-109268" }, "r26": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "205", "URI": "https://asc.fasb.org/topic&trid=2122149" }, "r260": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "20", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144439" }, "r261": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274" }, "r262": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274" }, "r263": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r264": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16265-109275" }, "r265": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "((a)(1),(b))", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r266": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r267": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(1)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r268": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(2)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r269": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)(3)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r27": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r270": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "350", "URI": "https://asc.fasb.org/extlink&oid=66006027&loc=d3e16323-109275" }, "r271": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "SubTopic": "30", "Topic": "350", "URI": "https://asc.fasb.org/subtopic&trid=2144471" }, "r272": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226317&loc=d3e202-110218" }, "r273": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2510-110228" }, "r274": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=126905981&loc=d3e2473-110228" }, "r275": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r276": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r277": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r278": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229" }, "r279": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r28": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6676-107765" }, "r280": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=d3e2941-110230" }, "r281": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=109226691&loc=SL51724579-110230" }, "r282": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 5.CC)", "Topic": "360", "URI": "https://asc.fasb.org/extlink&oid=27011434&loc=d3e125687-122742" }, "r283": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "360", "URI": "https://asc.fasb.org/topic&trid=2155823" }, "r284": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "410", "URI": "https://asc.fasb.org/extlink&oid=6393242&loc=d3e13237-110859" }, "r285": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r286": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "440", "URI": "https://asc.fasb.org/extlink&oid=123406679&loc=d3e25336-109308" }, "r287": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "440", "URI": "https://asc.fasb.org/topic&trid=2144648" }, "r288": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14615-108349" }, "r289": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14435-108349" }, "r29": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6904-107765" }, "r290": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=121557415&loc=d3e14557-108349" }, "r291": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q2)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r292": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "20", "Subparagraph": "(SAB Topic 5.Y.Q4)", "Topic": "450", "URI": "https://asc.fasb.org/extlink&oid=27011672&loc=d3e149879-122751" }, "r293": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "450", "URI": "https://asc.fasb.org/topic&trid=2127136" }, "r294": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=99376301&loc=d3e1243-112600" }, "r295": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123465755&loc=d3e1835-112601" }, "r296": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r297": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(ii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r298": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r299": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iii))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r3": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721533-107759" }, "r30": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=124098289&loc=d3e6935-107765" }, "r300": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r301": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-01(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442526-122756" }, "r302": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(i))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r303": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r304": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r305": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(4)(iv))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r306": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.13-02(a)(5))", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126975872&loc=SL124442552-122756" }, "r307": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466302&loc=d3e4724-112606" }, "r308": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r309": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r31": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r310": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r311": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r312": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r313": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(f)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r314": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r315": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(h)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r316": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(i)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r317": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495323-112611" }, "r318": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r319": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r32": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(27)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r320": { "Name": "Accounting Standards Codification", "Paragraph": "1C", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495334-112611" }, "r321": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r322": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r323": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495340-112611" }, "r324": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r325": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r326": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r327": { "Name": "Accounting Standards Codification", "Paragraph": "1E", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495348-112611" }, "r328": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r329": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r33": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r330": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r331": { "Name": "Accounting Standards Codification", "Paragraph": "1F", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495355-112611" }, "r332": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r333": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r334": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r335": { "Name": "Accounting Standards Codification", "Paragraph": "1I", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466505&loc=SL123495371-112611" }, "r336": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466204&loc=SL6031898-161870" }, "r337": { "Name": "Accounting Standards Codification", "Paragraph": "69B", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495735-112612" }, "r338": { "Name": "Accounting Standards Codification", "Paragraph": "69C", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495737-112612" }, "r339": { "Name": "Accounting Standards Codification", "Paragraph": "69E", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495743-112612" }, "r34": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(13))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r340": { "Name": "Accounting Standards Codification", "Paragraph": "69F", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=123466577&loc=SL123495745-112612" }, "r341": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12317-112629" }, "r342": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "40", "SubTopic": "50", "Topic": "470", "URI": "https://asc.fasb.org/extlink&oid=126972273&loc=d3e12355-112629" }, "r343": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "470", "URI": "https://asc.fasb.org/topic&trid=2208564" }, "r344": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262497&loc=d3e20148-110875" }, "r345": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=109262807&loc=d3e22047-110879" }, "r346": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(CFRR 211.02)", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r347": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "480", "URI": "https://asc.fasb.org/extlink&oid=122040564&loc=d3e177068-122764" }, "r348": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=65888546&loc=d3e21300-112643" }, "r349": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21553-112644" }, "r35": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(14))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r350": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r351": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r352": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r353": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r354": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(g)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r355": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r356": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r357": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496158-112644" }, "r358": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r359": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r36": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(15))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r360": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496171-112644" }, "r361": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496180-112644" }, "r362": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r363": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r364": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r365": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=SL123496189-112644" }, "r366": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21463-112644" }, "r367": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21475-112644" }, "r368": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21484-112644" }, "r369": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21488-112644" }, "r37": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(16))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r370": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21506-112644" }, "r371": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21521-112644" }, "r372": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=126973232&loc=d3e21538-112644" }, "r373": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.3-04)", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r374": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=120397183&loc=d3e187085-122770" }, "r375": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "50", "Topic": "505", "URI": "https://asc.fasb.org/extlink&oid=6784392&loc=d3e188667-122775" }, "r376": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "505", "URI": "https://asc.fasb.org/topic&trid=2208762" }, "r377": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130531-203044" }, "r378": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126919976&loc=SL49130532-203044" }, "r379": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130551-203045" }, "r38": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(17))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r380": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130543-203045" }, "r381": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130545-203045" }, "r382": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920106&loc=SL49130549-203045" }, "r383": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r384": { "Name": "Accounting Standards Codification", "Paragraph": "91", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "606", "URI": "https://asc.fasb.org/extlink&oid=126920602&loc=SL49130690-203046-203046" }, "r385": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "25", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409733&loc=d3e19524-108361" }, "r386": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "30", "SubTopic": "10", "Topic": "710", "URI": "https://asc.fasb.org/extlink&oid=6409875&loc=d3e20015-108363" }, "r387": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(i)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r388": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(ii)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r389": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(01)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r39": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(18))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r390": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r391": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(A)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r392": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(B)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r393": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(02)(C)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r394": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)(iv)(03)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r395": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(n)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123447040&loc=d3e1928-114920" }, "r396": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=123450688&loc=d3e4179-114921" }, "r397": { "Name": "Accounting Standards Codification", "Paragraph": "11", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450702-114947" }, "r398": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(d)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r399": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(f)(3)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450657-114947" }, "r4": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e957-107759" }, "r40": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(19))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r400": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "80", "Subparagraph": "(a)", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=65877416&loc=SL14450673-114947" }, "r401": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "80", "Topic": "715", "URI": "https://asc.fasb.org/extlink&oid=35742348&loc=SL14450788-114948" }, "r402": { "Name": "Accounting Standards Codification", "Paragraph": "1D", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=SL116886442-113899" }, "r403": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4534-113899" }, "r404": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "35", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126961718&loc=d3e4549-113899" }, "r405": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5047-113901" }, "r406": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r407": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r408": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r409": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r41": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(20))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r410": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r411": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r412": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r413": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r414": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r415": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r416": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r417": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r418": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r419": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(04)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r42": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(22))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r420": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r421": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r422": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)(iv)(3)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r423": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r424": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r425": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r426": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(01)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r427": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(02)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r428": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)(iii)(03)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r429": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r43": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r430": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r431": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r432": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r433": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r434": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(e)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r435": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r436": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r437": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r438": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(ii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r439": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iii)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r44": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r440": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(iv)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r441": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)(2)(v)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r442": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(1)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r443": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r444": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r445": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(i)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r446": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(l)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r447": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901" }, "r448": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(e)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r449": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(1)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r45": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(26)(c))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r450": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(f)(2)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=128097895&loc=SL121327923-165333" }, "r451": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 14.D.2.Q6)", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=122041274&loc=d3e301413-122809" }, "r452": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11149-113907" }, "r453": { "Name": "Accounting Standards Codification", "Paragraph": "13", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "718", "URI": "https://asc.fasb.org/extlink&oid=126964447&loc=d3e11178-113907" }, "r454": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "718", "URI": "https://asc.fasb.org/topic&trid=2228938" }, "r455": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32247-109318" }, "r456": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e32280-109318" }, "r457": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31917-109318" }, "r458": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123427490&loc=d3e31931-109318" }, "r459": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32672-109319" }, "r46": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(27)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r460": { "Name": "Accounting Standards Codification", "Paragraph": "12", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32687-109319" }, "r461": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32705-109319" }, "r462": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32718-109319" }, "r463": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32809-109319" }, "r464": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32840-109319" }, "r465": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r466": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r467": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r468": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32537-109319" }, "r469": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32847-109319" }, "r47": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(28))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r470": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32857-109319" }, "r471": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32559-109319" }, "r472": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32621-109319" }, "r473": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32632-109319" }, "r474": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r475": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r476": { "Name": "Accounting Standards Codification", "Paragraph": "9", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=121826272&loc=d3e32639-109319" }, "r477": { "Name": "Accounting Standards Codification", "Paragraph": "51", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126976462&loc=d3e34017-109320" }, "r478": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r479": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(d)(3)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=126983759&loc=SL121830611-158277" }, "r48": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(29))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r480": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.5.Q1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r481": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB TOPIC 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r482": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.7)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r483": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.1)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r484": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.2)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r485": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 6.I.Fact.4)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330036-122817" }, "r486": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.C)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=122134291&loc=d3e330215-122817" }, "r487": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r488": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=123586238&loc=d3e38679-109324" }, "r489": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=109227538&loc=d3e44648-109337" }, "r49": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(3)(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r490": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "270", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424409&loc=d3e44925-109338" }, "r491": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "740", "URI": "https://asc.fasb.org/extlink&oid=6424122&loc=d3e41874-109331" }, "r492": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "740", "URI": "https://asc.fasb.org/topic&trid=2144680" }, "r493": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "05", "SubTopic": "10", "Subparagraph": "(a)-(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6909625&loc=d3e227-128457" }, "r494": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(2)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r495": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(h)(3)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r496": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1392-128463" }, "r497": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=79982066&loc=d3e1486-128463" }, "r498": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r499": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(e)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r5": { "Name": "Accounting Standards Codification", "Paragraph": "3A", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721523-107759" }, "r50": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r500": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4845-128472" }, "r501": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r502": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=128092470&loc=d3e4946-128472" }, "r503": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r504": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r505": { "Name": "Accounting Standards Codification", "Paragraph": "14", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(e)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5263-128473" }, "r506": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5333-128473" }, "r507": { "Name": "Accounting Standards Codification", "Paragraph": "44", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=123410050&loc=d3e5558-128473" }, "r508": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "25", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476" }, "r509": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6578-128477" }, "r51": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30)(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r510": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "30", "SubTopic": "30", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966197&loc=d3e6613-128477" }, "r511": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "35", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126966325&loc=d3e6819-128478" }, "r512": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r513": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r514": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)(4)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r515": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(c)(1)", "Topic": "805", "URI": "https://asc.fasb.org/extlink&oid=126975305&loc=d3e6927-128479" }, "r516": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "805", "URI": "https://asc.fasb.org/topic&trid=2303972" }, "r517": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "808", "URI": "https://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434" }, "r518": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568447-111683" }, "r519": { "Name": "Accounting Standards Codification", "Paragraph": "16", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4568740-111683" }, "r52": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(30))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r520": { "Name": "Accounting Standards Codification", "Paragraph": "18", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4613673-111683" }, "r521": { "Name": "Accounting Standards Codification", "Paragraph": "19", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=126929396&loc=SL4569616-111683" }, "r522": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r523": { "Name": "Accounting Standards Codification", "Paragraph": "25", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=116870748&loc=SL6758485-165988" }, "r524": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=d3e5614-111684" }, "r525": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r526": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r527": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4573702-111684" }, "r528": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=109239629&loc=SL4582445-111684" }, "r529": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bb)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r53": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(31))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r530": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=123419778&loc=d3e5710-111685" }, "r531": { "Name": "Accounting Standards Codification", "Paragraph": "4I", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4590271-111686" }, "r532": { "Name": "Accounting Standards Codification", "Paragraph": "4J", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591551-111686" }, "r533": { "Name": "Accounting Standards Codification", "Paragraph": "4K", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "810", "URI": "https://asc.fasb.org/extlink&oid=120409616&loc=SL4591552-111686" }, "r534": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "810", "URI": "https://asc.fasb.org/topic&trid=2197479" }, "r535": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579240-113959" }, "r536": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5579245-113959" }, "r537": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41620-113959" }, "r538": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41638-113959" }, "r539": { "Name": "Accounting Standards Codification", "Paragraph": "4A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)(1)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=SL5618551-113959" }, "r54": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(32))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r540": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=125515794&loc=d3e41675-113959" }, "r541": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=d3e90205-114008" }, "r542": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126731327&loc=SL126733271-114008" }, "r543": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(3)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r544": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)(4)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r545": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)", "Topic": "815", "URI": "https://asc.fasb.org/extlink&oid=126732423&loc=SL123482106-238011" }, "r546": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r547": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r548": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r549": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r55": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(4))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r550": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(bbb)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r551": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r552": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(1)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r553": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(2)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r554": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)(3)", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r555": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19207-110258" }, "r556": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=d3e19279-110258" }, "r557": { "Name": "Accounting Standards Codification", "Paragraph": "6A", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=126976982&loc=SL6742756-110258" }, "r558": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "60", "SubTopic": "10", "Topic": "820", "URI": "https://asc.fasb.org/extlink&oid=7493716&loc=d3e21868-110260" }, "r559": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13279-108611" }, "r56": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02(9))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r560": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13433-108611" }, "r561": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13531-108611" }, "r562": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r563": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123594938&loc=d3e13537-108611" }, "r564": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)(2)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r565": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(f)", "Topic": "825", "URI": "https://asc.fasb.org/extlink&oid=123596393&loc=d3e14064-108612" }, "r566": { "Name": "Accounting Standards Codification", "Paragraph": "17", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32136-110900" }, "r567": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r568": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r569": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(c)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r57": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r570": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Subparagraph": "(d)", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=118261656&loc=d3e32211-110900" }, "r571": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32583-110901" }, "r572": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "830", "URI": "https://asc.fasb.org/extlink&oid=6450520&loc=d3e32618-110901" }, "r573": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28541-108399" }, "r574": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28551-108399" }, "r575": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124435984&loc=d3e28555-108399" }, "r576": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=124429444&loc=SL124452920-239629" }, "r577": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "55", "SubTopic": "30", "Topic": "835", "URI": "https://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400" }, "r578": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r579": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123391704&loc=SL77918627-209977" }, "r58": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r580": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918666-209980" }, "r581": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(1)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r582": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918673-209980" }, "r583": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r584": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r585": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(d)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r586": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(3)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r587": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(g)(4)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r588": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918686-209980" }, "r589": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=128292326&loc=SL77918701-209980" }, "r59": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(a),20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r590": { "Name": "Accounting Standards Codification", "Paragraph": "53", "Publisher": "FASB", "Section": "55", "SubTopic": "20", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=123414884&loc=SL77918982-209971" }, "r591": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(b)", "Topic": "842", "URI": "https://asc.fasb.org/extlink&oid=124258985&loc=SL77919372-209981" }, "r592": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "10", "Subparagraph": "(a)(3)(iii)(03)", "Topic": "848", "URI": "https://asc.fasb.org/extlink&oid=125980421&loc=SL125981372-237846" }, "r593": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r594": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r595": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(c)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r596": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(d)", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39549-107864" }, "r597": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39599-107864" }, "r598": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39603-107864" }, "r599": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "850", "URI": "https://asc.fasb.org/extlink&oid=6457730&loc=d3e39691-107864" }, "r6": { "Name": "Accounting Standards Codification", "Paragraph": "3B", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=SL51721525-107759" }, "r60": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19(b),22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r600": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "850", "URI": "https://asc.fasb.org/topic&trid=2122745" }, "r601": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r602": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=124433192&loc=SL2890621-112765" }, "r603": { "Name": "Accounting Standards Codification", "Paragraph": "10", "Publisher": "FASB", "Section": "55", "SubTopic": "10", "Topic": "852", "URI": "https://asc.fasb.org/extlink&oid=84165509&loc=d3e56426-112766" }, "r604": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r605": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314017-165662" }, "r606": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "855", "URI": "https://asc.fasb.org/extlink&oid=6842918&loc=SL6314020-165662" }, "r607": { "Name": "Accounting Standards Codification", "Publisher": "FASB", "Topic": "855", "URI": "https://asc.fasb.org/topic&trid=2122774" }, "r608": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r609": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)(ii)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r61": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r610": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r611": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r612": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r613": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(bb)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r614": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r615": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r616": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107207-111719" }, "r617": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r618": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r619": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r62": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19,20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r620": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(c)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=121570589&loc=d3e107314-111719" }, "r621": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "30", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=66007379&loc=d3e113888-111728" }, "r622": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "30", "Subparagraph": "(a)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=109249958&loc=SL34722452-111729" }, "r623": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r624": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r625": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r626": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)(i)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122625-111746" }, "r627": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r628": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r629": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r63": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.19-26)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r630": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(4)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r631": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(5)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r632": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(6)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r633": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(a)(7)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r634": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(b)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r635": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(1)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r636": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(2)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r637": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "50", "Subparagraph": "(e)(3)", "Topic": "860", "URI": "https://asc.fasb.org/extlink&oid=128311188&loc=d3e122739-111746" }, "r638": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Subparagraph": "(b)", "Topic": "910", "URI": "https://asc.fasb.org/extlink&oid=126937589&loc=SL119991595-234733" }, "r639": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r64": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r640": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(b)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155628-234783" }, "r641": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "350", "Subparagraph": "(a)", "Topic": "920", "URI": "https://asc.fasb.org/extlink&oid=120155617&loc=SL120155638-234783" }, "r642": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SAB Topic 11.L)", "Topic": "924", "URI": "https://asc.fasb.org/extlink&oid=6472922&loc=d3e499488-122856" }, "r643": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "926", "URI": "https://asc.fasb.org/extlink&oid=120154696&loc=d3e54445-107959" }, "r644": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "340", "Topic": "928", "URI": "https://asc.fasb.org/extlink&oid=6473545&loc=d3e61844-108004" }, "r645": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r646": { "Name": "Accounting Standards Codification", "Paragraph": "15", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61929-109447" }, "r647": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r648": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62059-109447" }, "r649": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r65": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.20,24)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r650": { "Name": "Accounting Standards Codification", "Paragraph": "28", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62395-109447" }, "r651": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r652": { "Name": "Accounting Standards Codification", "Paragraph": "33", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e62479-109447" }, "r653": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(a)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r654": { "Name": "Accounting Standards Codification", "Paragraph": "35A", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(b)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=SL6807758-109447" }, "r655": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(1)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r656": { "Name": "Accounting Standards Codification", "Paragraph": "8", "Publisher": "FASB", "Section": "50", "SubTopic": "235", "Subparagraph": "(c)(2)", "Topic": "932", "URI": "https://asc.fasb.org/extlink&oid=126939881&loc=d3e61872-109447" }, "r657": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "25", "SubTopic": "20", "Topic": "940", "URI": "https://asc.fasb.org/extlink&oid=126941158&loc=d3e41242-110953" }, "r658": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(10)(1))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r659": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(11))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r66": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.21)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r660": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(13))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r661": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(15)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r662": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(16))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r663": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(23))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r664": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03(9))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r665": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.17)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r666": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.9-03.4)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126897435&loc=d3e534808-122878" }, "r667": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r668": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(13)(g))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r669": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(15))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r67": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(1))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r670": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(20))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r671": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(22))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r672": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04(27))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r673": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.9-04.10)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260" }, "r674": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "235", "Subparagraph": "(SX 210.9-05(b)(2))", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=120399901&loc=d3e537907-122884" }, "r675": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=124429447&loc=SL124453093-239630" }, "r676": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "45", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=6957935&loc=d3e64057-112817" }, "r677": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "405", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=116652737&loc=d3e64164-112818" }, "r678": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(a)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r679": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(c)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r68": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(2))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r680": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "(g)", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r681": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "50", "SubTopic": "470", "Subparagraph": "e", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=123599511&loc=d3e64711-112823" }, "r682": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "942", "URI": "https://asc.fasb.org/extlink&oid=126941378&loc=d3e61044-112788" }, "r683": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(15)(b)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r684": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16)(a)(2))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r685": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r686": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(5))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r687": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r688": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(16))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r689": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(23)(a)(4))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r69": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(a)(3))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r690": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(25))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r691": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(3))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r692": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03(a)(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r693": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.(a),19)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r694": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "210", "Subparagraph": "(SX 210.7-03.16)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126734703&loc=d3e572229-122910" }, "r695": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(11))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r696": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(12))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r697": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(18))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r698": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(19))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r699": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(23))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r7": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "45", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222160&loc=d3e1012-107759" }, "r70": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22(b))", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r700": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(3)(a))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r701": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(8))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r702": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04(9))", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r703": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.7-04.7)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263" }, "r704": { "Name": "Accounting Standards Codification", "Paragraph": "4H", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=116884468&loc=SL65671331-158438" }, "r705": { "Name": "Accounting Standards Codification", "Paragraph": "7A", "Publisher": "FASB", "Section": "50", "SubTopic": "40", "Subparagraph": "(d)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124506351&loc=SL117782755-158439" }, "r706": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(a)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r707": { "Name": "Accounting Standards Codification", "Paragraph": "13H", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Subparagraph": "(c)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117783719-158441" }, "r708": { "Name": "Accounting Standards Codification", "Paragraph": "29F", "Publisher": "FASB", "Section": "55", "SubTopic": "40", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=126561865&loc=SL117819544-158441" }, "r709": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(e)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r71": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.22)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r710": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(1)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r711": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(f)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r712": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(g)(2)(i)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r713": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "65", "SubTopic": "40", "Subparagraph": "(h)(2)", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=124501264&loc=SL117420844-207641" }, "r714": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "50", "SubTopic": "825", "Topic": "944", "URI": "https://asc.fasb.org/extlink&oid=123600520&loc=SL75241803-196195" }, "r715": { "Name": "Accounting Standards Codification", "Paragraph": "20", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631418-115840" }, "r716": { "Name": "Accounting Standards Codification", "Paragraph": "21", "Publisher": "FASB", "Section": "45", "SubTopic": "210", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=118262064&loc=SL116631419-115840" }, "r717": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "45", "SubTopic": "220", "Subparagraph": "(k)", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=124433917&loc=SL114874205-224268" }, "r718": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "220", "Subparagraph": "(SX 210.6-07.2(a),(b),(c),(d))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=120401555&loc=SL114874292-224272" }, "r719": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r72": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.25)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r720": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r721": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column B)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r722": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r723": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r724": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column C)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r725": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 1))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r726": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 6))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r727": { "Name": "Accounting Standards Codification", "Paragraph": "3", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-12B(Column D)(Footnote 7))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611197-123010" }, "r728": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column B)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r729": { "Name": "Accounting Standards Codification", "Paragraph": "5D", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-13D(Column C)(Footnote 2))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=SL120429264-123010" }, "r73": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-30)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r730": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column A))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r731": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column B))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r732": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column C))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r733": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "S99", "SubTopic": "320", "Subparagraph": "(SX 210.12-15(Column D))", "Topic": "946", "URI": "https://asc.fasb.org/extlink&oid=122147990&loc=d3e611379-123010" }, "r734": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "45", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942793&loc=d3e3073-115593" }, "r735": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=126942805&loc=d3e3115-115594" }, "r736": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "440", "Subparagraph": "(a)", "Topic": "954", "URI": "https://asc.fasb.org/extlink&oid=6491277&loc=d3e6429-115629" }, "r737": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Subparagraph": "(d)", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99779-112916" }, "r738": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=d3e99893-112916" }, "r739": { "Name": "Accounting Standards Codification", "Paragraph": "7", "Publisher": "FASB", "Section": "50", "SubTopic": "360", "Topic": "958", "URI": "https://asc.fasb.org/extlink&oid=126982197&loc=SL120174063-112916" }, "r74": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-02.29-31)", "Topic": "210", "URI": "https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682" }, "r740": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(c)", "Topic": "976", "URI": "https://asc.fasb.org/extlink&oid=6497875&loc=d3e22274-108663" }, "r741": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "310", "Subparagraph": "(b)", "Topic": "978", "URI": "https://asc.fasb.org/extlink&oid=126945304&loc=d3e27327-108691" }, "r742": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(a)", "Topic": "985", "URI": "https://asc.fasb.org/extlink&oid=6501960&loc=d3e128462-111756" }, "r743": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12" }, "r744": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r745": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r746": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r747": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r748": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r749": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r75": { "Name": "Accounting Standards Codification", "Paragraph": "1A", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669619-108580" }, "r750": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r751": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r752": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r753": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r754": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" }, "r755": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r756": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r757": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r758": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r759": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(a)", "Publisher": "SEC", "Section": "1402" }, "r76": { "Name": "Accounting Standards Codification", "Paragraph": "1B", "Publisher": "FASB", "Section": "45", "SubTopic": "10", "Subparagraph": "(a)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126968391&loc=SL7669625-108580" }, "r760": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(1)" }, "r761": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)" }, "r762": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(b)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(3)" }, "r763": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(i)" }, "r764": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(ii)" }, "r765": { "Name": "Regulation S-K (SK)", "Number": "229", "Paragraph": "(c)", "Publisher": "SEC", "Section": "1402", "Subparagraph": "(2)(iii)" }, "r766": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r767": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "405" }, "r768": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r769": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r77": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL116659661-227067" }, "r78": { "Name": "Accounting Standards Codification", "Paragraph": "4", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442407-227067" }, "r79": { "Name": "Accounting Standards Codification", "Paragraph": "5", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124442411-227067" }, "r8": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Subparagraph": "(b)", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r80": { "Name": "Accounting Standards Codification", "Paragraph": "6", "Publisher": "FASB", "Section": "50", "SubTopic": "10", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=124431353&loc=SL124452729-227067" }, "r81": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(13))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868656-224227" }, "r82": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(10))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r83": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(14))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r84": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(20))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r85": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(25))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r86": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(5))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r87": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r88": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(7)(d))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r89": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(8))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r9": { "Name": "Accounting Standards Codification", "Paragraph": "1", "Publisher": "FASB", "Section": "50", "SubTopic": "20", "Topic": "205", "URI": "https://asc.fasb.org/extlink&oid=109222650&loc=d3e1361-107760" }, "r90": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(4))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r91": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(7)(c))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r92": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03(b)(9)(a))", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r93": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.13)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r94": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.2)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r95": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.3)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r96": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r97": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.4,6)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r98": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.7)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" }, "r99": { "Name": "Accounting Standards Codification", "Paragraph": "2", "Publisher": "FASB", "Section": "S99", "SubTopic": "10", "Subparagraph": "(SX 210.5-03.8)", "Topic": "220", "URI": "https://asc.fasb.org/extlink&oid=126953954&loc=SL114868664-224227" } }, "version": "2.1" } ZIP 128 0001493152-22-028254-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-22-028254-xbrl.zip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
  •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

    #OE$A:/QC'7Z-5O(&SJY48S87Z=PC.*@RU M8RL\Q[$U)1<0\@M[C:XJ.+5RO3J$')^-=JY&E4ZZY#&+]V_D#O'V,8Y0,,>K MZ+L=4,< Z\AC]>L29@*,@)8%97NF'WFNMXEI+._A497Y[&QB%[EICGK*2U8& MU+0#GVA<(9F.20IBGCXC9?@.S0&)_((W$ 4OT/<&G1%R]FEV$PYVQ6*RP/ ] MV?D8]+?%U*7#S^;H_C9Y)C RA]9D;MV.1VE(.OG5]?U\/#'GAWCSIEZ:[/E* MGEB1JV+NI4_Z=N,DS_+A22>3X<*#K#S#Z7LL&GF??Q&4/?FXF5EW^1>@1P] MFY5&^=-5H5<&;PM/N,!'K+J\((!S;C,2+=TJ?R^PHX3W.."DG38O 2H482SC M5/MH_]U^F'M.S0Z!!#NH,]^72QZ+D:W=-;^,4OIC@+BQX@)=U<0W\J3/QZI4 M CK%-38)FY9>@&:@;=4Q<$W4733%>$-T)Z9WH-APJ4;#%U\:F$>]=AO?I624 M%#F.:B215.?(Z9-(:G/*]$DDVTXB"=7-3C(ECL#ZE\SC1*RSOMDB*_( GC22 M@[]X)"7)RK=;[)^/4-E0K8?F2<4+Y @TW*M7%-+LDM1"B?W$Q2ZF+)1WZXC" MP.)9(V_8"9F\LPIHKEAU8,H:BS"@GP8A YA.Z!'G@J?IVSJ1$VSOE#W=SQ4E M.68OCE-/"^A"LU=AW:67EV-[ (#S)@$P]/@_>XP*;?D2F&"O&MO(@[4<_LS%@8"4F#]5!T2I@U/*H:@[J=LVG MXT\+_(T(@VT[/6ZE(K:Z[GK!;"X@.;]3>#,BQ^8X#&/DCN* YMXCMS[LIC6X MR\K+EMV2!(=8?M2\^'0U3B P):\9\]EYL/TUW<$ZGE)$RBB!(R4](S@PIRV4&>[*[Z@E:) ]FN"V -I6O:\%TKCL+( M)KNZO[96_/7#[:JG+TSBY(,J MMOP3A;X[L58YO3!=L",4.H&79'=G'"O\SOJB49$'")+WJE;/)R*%6QR&ED^3 M.UFKU-HX)G,KC(XJ.147$+>KOJA5X@#"[(/J:#FBO7SU_.0>OJ\C'9&?0L_- M KIW$>XO,(HU!M,>U[H\04A_E*Q35"IMY,()#GK7X5R_038MY (OW3JCZ0OXN4R!:"LS>NRKK1CNO^+T1+%6IR4R MB[ RNVF/'Y]Z$"AE09I)^:==\2H8F*-FV@-1I!84?,Z\T?XKPZ&]<>+,FV"M MIG'@/-@AF@:>@YC/[HI%+W//[H;&[?#^-GN&1OX]O9\-/QMSC!71KNV6]ZQ9>%@3UB0 MZTJ8!OCOC((1"E 8A7M'8F+U9:HT$C^BJI1##=5&-M?0W%&V[T[ME[1:*LX6 MPXYC%'X*<,BJ2RKV5,#VXEHK-HN\3/+&,ZP-H+#= &MVGR! MZD[CT-W2?]KA0YJSKHK-^[1GAP$J90544AK')-FSR7PA/S+,9 O)9T[C S$ M#02.['B4(D6_X>";YZ^SC'0'LZLX0M ('8:)R1*$E;(8E@HZ$R.BIV*N]/LK$Z61N_(QDT4*)J.+LS4J'Q2.O*'>(M6L-]GKT3$_C"2G/3S0?&\!_WXYEYG*&._.W^CORNMY3WEO+>4MY;RGM+ M>6\I[RWEO:6\MY3WEO(9:A)('#F-?GU;E^%FA&'=D9WF9R/_HO]]0(%6QHSKVIZYFGHYR8D%-G>(\7K49 M'V7I6!?V<^Z/[4S!\F__H#.0(0P!OUPG)N!.*2[EGUG^KJ$/7OY4$Y( -+_> M*_#[[CTCI[?9_>(ABFL0'3PG.8$P';YO6<^>QI.%,?DTOB;_.G7N&O/!U)@M MCBJN#:V[Z_$D]1#WCM[>T=L[>GM';^_H[1V]O:.W=_2VYNA=!+:+MG; KBER MTJI+;MX2TF7O=X!H4YHF]A8Q97O:3*/K!%^ZI<2#.Y-D 4\PK1O\B"*V@$^; MJ2IV4TO I<2#]DS) CX\3@DCIHB+#5O/E7V.D 'R08N)<$K-K;="8_]W9 D)^C,CL M,^W ]_QUF.70))OEW/,=E!/(R([8"8'>L9Y"W%GWD\3X-3._F)-[C3!O4VLMY&UMO(>AM9;R/K M;62]C:Q_#"'S!MR)QQ"9OGI#."Y+H6$^.YN85A:A6CGY#PV"@%=3C<$TLLSQ M5)6ZW,F^39Z-^01%8VH!0[?,W#Y'S3J$4Y%NG2Z,>YUJ&N ;'&QM^O(?;SR7 M)OG>I\*U5M9CE@P@9%X1W[.")Z8S:W!CS>Z,P=":S*W;,;WSC0;S!?F?.S.] M/5I3TO@_UEL+\,]I?!_C+87P;[RV!_&=3^,B@?CA9O@RP!2Z[PP2G$ MO=T3I>2<,= 9I^LI-^>=EZ^U4:EXAD+1+F1;7[E MI+$M(V>(PT-H""_/,'^ +H!4@R/9%H :0&5&5W\MF!-::(Q+@*N<*=DZT7H4:_'2P?8^?F $J!ZKKWL)3W:#L2LXI93X!T#8P-QA8'D??OK(3*X0'4_@E;C1L2 M=TQ5<7Q\#4 .:QI8^\SMXP:_(#1#&QK31RU==>Q(9<-T%SV0&PT6XHWGV[Y# M:VO5A.IX@.Z"5,*';!-?MVP/VB)9BQ,!6V!;%H<\P9E%8&('U,3\=+B/')D: M/IZ:&G)O60]FA<%^E#Z(N0]B[H.8&Y[:?1!S'\36 M'B]:)>]\A\982#\GWO49YR3YT2,@ ^9"8/_21^'TD?N]UZKU./[#7"3@Q M;G" ')MS6APWTCX8O(1<4)S*3*#[:3+81=KZQK^*,+IT],?BL"1@\ MVT4N3R+O(E?65LV%FR]AS*55AH>81(PZO5?85253%&.W6&+]+$T$FQ[)-%IR@EEQJ]++, M=+L\Z"_4?T[35'-#RZH/V FD9; H^TX!0'L<[;;;I #8RAMW!A(6^9"XZ[Y] M L1=(6:O-)*M*Z*&B0?54 7/D>P-3: _C0/GP0X3K2HMC#Y##O*>Z-8K%#/T M[I?"\R2#UI&B];;GR(D# MCY:Q^(S(?9!,C(C^^\78;/!WVW?0#0Z& 7*]B(9Z%? O'NYG#:I&WRF2O,!W M3)(Y04FU!]0F-DG"U#A1@0H#,FI,,&^??C-@OP4$M6-6HQY+UDJ#Z3&VLK&!9_'DGYF6%7PZFS M;7 *M&K9W9O P@6>H\VFJ,(/71'=@YW$K;;R\4A1*)P$=%D<@ M!K(#[ Y387>Q)=PD5]W=W&&B(MI]^;KM& MY.%7C$=1EU*7GN[&]X(N]B='U M2U+&,/7[,2\9C"X7\C9<8,?.,\D(+FONBFNL+'VU@=C0D<9WN.IDR UN]:BV0/R7[.T^+.&VF*FRF\56/.3R#[@[)6M_B._GNBQ TQ9:J"KZW MB@[ -@10[4+Q$$ /7A"]S+UG(8Q*&ZMZ9-0J3##G$%*U+U!]@'03:G@?)]W' M2?=QTEV(DSX?LB30.-5[>6Z38EM5SSGYH=1LDB$<)#_AK'+?2_,IV9NQ'T9! MS/)P7*% FK*G!/ER:-IL:Q5"0,A]=:%Y7_B[9=ROZ+( MX,/!%#?(L7ZG9??FCG)OO,K3NT7IOM\YY,I:[Z\4N0A:F3M8U&& M04>?.G<1H3:(D;N+-6U2:M"HZ[KUV4\@2;N=H!(20$U&=+DN$7+VBM#8AB@L%EM4[9$M=3K*DN] M52?:]?A3A+\AG[G!'S=J/]P&FI:832(X>=7E,2D&R4U065FP$]WNJ/GRM2+G MB_S7%PS^(/"4WT.*$5M5\-OUN6@0CYD$]2/) 9^IE\Y>(UID/^(??.9 M_,VCS^JF<60]1CGMY#00M-(@EP!B7:[!S57V%21T N\Q?2=+XR++GD:"]Q*! MOI>"805FM?-]IN0F7I"R! -C/Q=+R_!G5QCE$E"OS;9LSP.P=$L(2T(WQ$"E M0U08X1( K<5RHU?>NL^6A]A_0D&8)IH@/T64]+TY>TMW)482)=$1+@'S6BQ# MF+_3 W,K\-:>;V_H;RN"7=+U8E$&>87@?:\\B/O((%T>>C>/OQ)R:9H9Y%+. MK*\;;YU$W8F\"#GO QQ%S[0CD&30)!7"-Z/RO>+],)HK-S.U/:+O#.U'+[(WN;RA#.L:M^\%02_* M+ BQ^A>BAZ*TUNJWY*6LT((OZW9!P KP"6(JV=@V\]8/T0+?Q-3'3;2*O45I MAIZ0'R,H/QRWWR7 58%1$"_)&1,K0'3)J-0 0EF0;=$FF^4EG-H!%4857])Q MSTM LQ*K(+AU35^08RG #D)N>$,8%_8]L#M= E:B7((P*;56'53C>S\.D7N- M@P!_IW6@[4?;H=)(+#)LNY7@()> =EVN0?25&;/R MDR"4=/_ HD8]#_;D[_(124].='7PCGR$DZ*]]-VVF1NA\4.Y>SH5I[U/=EI 9TAWCYB M/\D+*9:#I;R;ND*5Y2@ 4+%XUBBM^@F9O!?'0'/%B5:8LL8B#.BGS(M[1#O=0HW8QQ,S"H\BJ3NJ6/%AT5KK.AJ[=BN!IR+^76):$LFXP>BS+ MYE9+ED'F(L#BY$NWP)Z];,H,9<.8*"(L-S&CT_*U(IB$;3%1Y+LM6Y"HMKA$)O MG5:*7N%@Y#UY+O+=D4>V=N]K7''9\0?3&,)SF0+U!YU.,?K.A/KIJAUCNUX: MHR=,/7A];=_7R/#'<9R-OYXZYM@.N!:]C;O5@MPT;S_3O_B&Y5\SARJX W M^Y7,(6^%PJW'D]XTTIM&>M-(;QKI32.Z*;K=N^+VII'>--*;1GK32&\:D?K8 M-U/V=V0 H)PV4Q40+ON=;QE;VIE#E$8R=1_HLUC73G$[9<-:6=$#"M*9S,AI MS>YWN3"7\"E@B5%O[SPS_NEB\.1R"2HQ[=O5^)9 L:"I=Z?FM:(9[<::#6;F MXGXVH2:WH3$=+XS;TC J3S-:;V?0VE_1FMM[,UIO9>C-; M;V9K(%_S.1:<7&[C"H^V.G\-K,UV;\:[K(EP%NLM+7-JF+#\"@L:[G !B DP M*&"*:\MX,\$1JIQ+\_VII69B+4QN'LT^R61UJOLDD\T;)T+D_'F-GUZYR$NQ M(3\<("'_6-ZBM;TQ_8AN!N4F"-*JT$C3M$5EI#9J0>#+-R4%O+>1)LN MK6O.C'J/ACAXQ $M;DY(8BKH4//E._W3H#)IA^3]3EF,Q?S!#E XC[_^"SD1 M#2OQ7?J5ET,YK3F*HG16TBKTX22FW%BKM"/#IGC>P,LKW7/026%0.S];9:[V MU>_^(?=,.-IX-;3:5NKZS@D;(:AJ'<;Z*PQ6E69D'TI ):)^>R0CZ9ED&]P8-K. MPSV1%;!*@-8:BYU+-23G-\K6B/V21C1AP_DC]@)TXH%F+!!.3XUAJL0!!-E; MR7%S7IB4^[1\/@))-!G47F.Y"] -:O9Z7(.IJB%Z :9M-0:#0S,$A++R]&1' M#2+OWTEF\;3Z^FXJ30.T]6(&+MRN^L,DR *$6MU*].>C5BAB/$'1!/L.KSX( MIV,'$!-A ,(K5[.^_7Q<1&M\1$'T8O@NK7WV2+EE9N+ZP,K$-9U94W.V^'U@ M3$8#\Q_WXVF2ETMQ"JX=C].-[4=Y1@NPEEX-N'T561T*&!9HY(6P"8^@37"; M.)2G-H:*TM+^C1[(QO4+?;' ]FX)=5;G[JJ*5>$B+"H9C1[NP:R2C_*\,4*= MU?C+JJ AB&-1(CKYTIH&4F65N2UMKN@57)45AL6X MZ,Z^^BE@)CMA]UN^U0PQKOV+SXYV?C5RJXJW\88ZAT?H,4".EUR)R<\;E$C9 M=_-799!%YL53RA_/TO+*/*>+(P)I_&]&V?'BG-;ZB@T"V1HGO* MI8!%1:RW:IL*@TIAJPI_#&WL*E4@!2TKHC+3WK;"8.3ZY<[^%PZ&&SL,N3F1 MQ ?1P-8BC%XA-5)566FD*3"H/] N$@];>2!E28\JHR6,-TMB.EEH5(&NL^6F M]8FAJ36'.NWP]A%%R%@'*!$>G-8HZP3W4637J;M&<06VM-O*":=HLT%.%-N; MW8V"AQS<1U4V%#G0@4\N "\C](0V!'!72/;CTB 0XPW""%UKTL6@>VBK1U\XYX[IRV7 M'SH)%HL;")X/Z@IVQF&$MRBX]4*^9E#2F.@]748)Y B^VBO5" (?12E#E#4N M8& 793%H\A0"!E\@>+4U@B8O:1S/':_G\NJ]=E#RC&QB/&GGP6.0G?- Y3U- MM6 %QKHPH)EO/V'L?O2?]R:!H&C)5@.3%F/B(K/7RV?",]K M-$-T<]JQ3E_OT"B-Q\>-A]S= Y%9DC^!(0!F(>W?S/&GSTG-GR]$$I_,P#ZT[LF,(()K<1:DV\\=&7,;;X?8CP([L74E MDMD]]6/*H5#Q*"^'; .Z(ZS?W=^1>3]9S(SAXMZXS>0P-7ZG<06-SX49G0 + M?)_-=+'=J) B>$91'2RLP?UN4JO8CG9O9 @\U)U(YZ[C!#%RLWV)C1?SV8DQ M3";AG.*2Y$!.INAP.+LG4S3;HAK':H16* B0.T-/R(_%TCF_+P2PC,P;[*@"%Z=0XL:G *M)F2\(9_& ;E_ MDQ^H(@E'E]#F0&M%$4%UEQ868DB[77:&$C/YU ZBESQWUR_YO["/TBIC7/[Y M6EVB&B6'RY/(B^DL:ZOFZ*PAD0GSF#MJ MHRIHDC'1,8M4<#$H.[@2@]4\]MW@)6>O&O(2*#&[J7J[V()A@,^W[) (8*GL MCA$3:5$O@"KJ>HPEPAM;3EHIX6>> 1F:$5FZLX[ M=06O9G:_2\1NK5LV4XU@ MWKT%>BHR-UL$.73A\.UQH9?]/E8E4I IR.J2=AT/K0D0ZO"4#SV'1%;\;Z9*G.Q^+HH6H^/B=?/ M@'SOA\B) YK6[RO#8'S4;*GH'4VE>VJ18MFF7=7E0[J D"V=LK9,9W)ZU<4 M)J\CDIH.[I3H2.0/]IIA[1$?HX/0<=G15I_+^01FR,%KW_LW7;N MM62RH[O'CX/(WPC[;N8A2EOR%0KIG^S$A&F6>U WD1RT183E/2'*A[4B5TTB MK$WI31,*XQ+MKS>DU5F!\%%6O8Y2MGL\!"_9?"N](8$(A@3_MGT/UYX1,CFV M7ACBX"4IY";FW"J^)?ULS1;I&\+IS+H;S^?6[/?!Q%KH](*F]VOU?JW>K]7[ MM7J_5N_7TLQ$V"V_%J0\L)-!,CMUP)O%9Z"=/2T,HMS"(?\Z+!KRC^6":FJT M2('K/7EN;&^ LX6T!9IVXFB!R6_'O%$5!1K"A M1GHP.C2 (OM$.V.186&&P!-.F>UX3ZSH90KLT(ECC\>$;-NKC)S'?KA" 8TE MGZ/@R7,\?VVM2A@(Z6OBL/Q//)U?[E>4%?!@8EK(J2Q=KCK=^[HW;[0\MY7/ M+4V+@60)RG+N+&[:!J"'*E=$(QM H90DS#*$Z?NZJ@!@;"!'(2$T#CCFA=-F MRX^7!PO()X3%1V5JF?'=#ES*(%L9.VG6)16LE$.-G*KS!SM UW:(7)HMEO!O MIW(\O.Z[?CFTR9[B)4P=./-=6F14Q.C:S-?4*&+ER.(6^-5/#>O^+-)9+5,U MTUKU%BR^XWU^8VHP_XPWY#OLTYS91UWP1X-K'E=A'M2]E%WSCQTI-[9#,\C' MK,064(_E5=D$U"VVATT]A(\F7M01"IW >XP\5E$.L$L7 2J0KV7XP1#[3V2A MIRDQR$\1K4*Q8R'96<)Q&)(;&3/#1)5QNH-E59[:\0+67H+WOIU6V#@D^!== MBB5=NP.C !O:F;#SLXNCNV:MNH%'D6+M+K&?",_A+0Y#%%J^^4RK@\1>^$#G MC[5BOX/B=NT&2()L0,B]587<##UFV7VL51(FPXWOAGIT R?R7DT@=;Z5M9Z^O&6Z?!'8QX!SD?Z,8L MD,HLZ%51/E>LY"9KK-E0>LV,SHB9_ MH*% 7>75'4>&^Z\XC%)-\+3&V/*!1# M^]&+[,T0;[?8GT?8^<9PCW+[=@,X43Y ])19;6H\3>T$(D6*0=GG["YMO4ZE M7% *Z45*[$5JH?IG\A8UR:M*7Z'VCU#[1ZC](]3^$6K_"+5_A-H_0FT*NG;# M2LB:W_#RJ!XWZL CTR+!VNU124XIRHGY1^Q%+_M:]"'[_.!TZ])1(B0!C5S/ M)V3R]BZ@N9KS1$S66(0!_%D!N 5^>#KL$IT&YF'T0X=T>! M_=W%W]E7J[*FJ@J82:B!#+(#B?YMJ_ED9I0;.)-/[L^=.-&.20:5B]8ES$KV M<=2@_4P[17GA1! MDI7]T'SG=,PHN,9!@+][_GIH/]H.7-B5UVUYI:@6AGCZ:#$6(!PTLW4",3;UL:S*<9B/O_-D' M[(AN@\+]-<>D!B_:&6!:+I&B-Z U^6GG3E(;U#L[B@.:R8_0+@IBOD\702O2 M#][-]0 I2P% N14.K,GWZ2)(1?HAD!2^?4IKT:>)E] 0AU$X04P=L;1#5^!A M$ _>K13J?BL4ALEQ>X,08]FY4TW-BTE%#F![2"F;=^B"8Q ME8.UFM-G-,G3FJ&]V9#;Q8MI.P_';6',E;9MI/SQNWN1*C*(S@CE(7UY>U&)UL9 M6V\">W4#33X'(%;*3#+Y]!!'S,) @5VZ@1*'?!"B+E6A[ 0018I!V:LH1+F/ M&K \-\N[X1%*#WF.LY=[>[*/WOV]+52B''XV1_>WYL"Z&5CCT6!H3;Z8L\7X MFOQJ9%Z;D\7]+%>4LG\%V+\"[%\!]J\ M7* ]J\ M7RMT;\"%&<.](E*#EBE MV0NI67L4T[P^BP?T.[+ADEVT"Z-'!]X'I?D=G&U/2)ZU:KXA6 M0[QE)$LW!0%"/60O8TKUM-E2T1VDBEA+:08W>,ER-=(TLTEF+Z9DBPV7BE*Y M5)$M0#6X 4N6[@RY:/O(E>UI,U4Y_*M(MI1FT&,J6:[D[EIZ&V:FUJ<]^1TU M-UM480)"0[*6 9'#2-W-XN*0[[JS0!RST)+: 5F(]NQ ./#Z=0$(,1[ 0[5] MRQ['GL=)Z/7NU+ G8,Q3G]QK]]Y=Q*17TE9Q0@^> >^DG3XF.U#L4.*.WD#7 MCH&N7-Z]2:XWR>D&2V^2:UI99MX/V9TZ8)CC,]"6DLPDY!P4PNX81<09D6XG M.3^_-[M6=TEF;ZB#WN<^KR:Y/OG3NE>+7I62H:[.O([:2??FCZ([+3?C$M!#E6NND0T B[,,JF3JCIJ.9[43.?C[/'9]'CL- M3N<^C]U%Y['+'MA-X\!YL$-DK .44,9+:L?NIRI[JYP,=P*\00B]D9QO9!IX M.%C@X0:'Y,RG3W&8P$#-E7GN) #"Y@G6320C8:PB%"P>D"@48/OE57<7!X^B*/4XV2M)21RKN_L_JH402Y N?C MHZ]11BY$.BMSTF#4U/YQ2O#,"[_=$(TFG]R)I[N+CZ$JM[' ZF+CR&$)PO6M MLGOW*0/F\R-R(N32**>J>!;[+M]U%$> %0B_=]K@EV1:^((W=D0K,K]4A;"T MNZKXX;-1A+F!@'RO#9"[&3CRGCP7^6Z=#18>8_FAHY!R6()P_2 75TYFZ&F MW=B)K""ULS-RR9>WU/2* -(+'FL*A'YP;R#8FW?@I*QY^_GFF6(M2!]FL7'= MOR4,M-3T)>#4JEUVNK&=U*Z\YIEBRYHN/[:?KIX_P;$ T9" /RH[W/?[:I8< M*2G#+EC"L=A%T^.!3SBH/BO.\Y60R+-+E+558S+B2[@T(U<)ESK9BL[#0LL3 M0QI>K9X;R>>-(=YNL9_0P'XB7=YZ>:7HZL^8[%B0:M !\4YNG"I'F5K0-UK6 M:NR[]*X3VQOX&@$TU?2@@ D&K^5*Y?Z;%SW,T"9Y]1T^>(\+;/H1S8W.4&TK M#]+^I8.- 0,K,7FHOHNH@%'+4Z@YJ%L]EO8/"S[CC>'G5MMGKC.6# MQ;@!#ZL/FKS?8R91*'UNDDL\\%K1^Q?A5ZYLRB%P-'G#=^_;:4(3:D\%LRN4 M0P]]^F/)IQZ"J4OYI+6'H4AM.WZVLUY%35 T MC(, L30)5B_]8>%3KYV9>Q>-E$TF+D#E[?6'AD5W.Z:E*CZA73*I:]O_EJSU M))Q:I 0KMZO^4 FR *&FK%B7Y,J0VN/$HQWTM>H!4./U6#L&()\7\/*KB')9 >'4Q#HX0J$3>$GB5U'X!=! >96:0 M8X)G9*\@LXFF>1SB)^33:Z$H3F5]NP88S .(G#)3A1:U"K7']PRV0,B5F3U* MF9DA.\3^#0YH_0):N !/L(^VCQO\PBSR6V.PCL(MPA0(MC)C2[[(FW@UNZ0* MG/8PE5,,8J#,DI*G4^RN#O7H%B;B-_,K90:5TJ5^[WMDC1]R: MN>[MN^J,D M0#X(E3(K"LO#(2#X(D.0*DI+ARR(T$87?26/JBQ(/25V83 MR5.]FRX\'1SNHS%$@K2#""FS?911/*;BM#?3^.O&!]=22X'7LS0K[E=]8='D 40-F6&"4KJP3N7N>R0FTNMG82,<_R7 M(B/H#V(U3D LE<9_,.F?/]@!"L>)^>4<1(_&N0!<2_@!T:UKOX#J5OM.@.P0 MC5#ZOV/?<-U$;N2HM3U"Y-!^]")[ R@=POTUAJD&'Q \LA]VY8@@ZH[C/9(? M>)=@9A_-81"@'12][#+8:83DGHYK>T/54*(#<1$0Z:HY$.(L@'CD3!)ME?J< MDTL!"HG*0VX' 7+3A^Y"93[?GY;YG)NSL3D?&(/IS+PQ9S-S-)@OK.'?]2GR MF7_-7\"2G1H<3 M[YP^;>)>R^L.W 7 9; (30AE;\):?2[= 9"K,0/!J2S$*N$Q/3%&,0T'FZ+ MPVZZ.QU8L%8YS@Y3EV6?/F?<+@ O@4-H-M2- /V%WRQ-S&R5L=G$.![ M!=MK#0N?R]K[V7MO:R]E[7WLO9>UFYX60$%+O4E6CX2])[2 M3LP^K9OHA;VG8J2#VY;L $8IM6K*5K VPF81#6Y)38CYNI*8BZV7BH)!*X@9 M(!K<1M2=P@F=Z=3@Q6@4VZJJ_BHJW M58C+T .Z<.NGUC>F-#;R?J) M+&Y@WXBRR_W>^)DZ'LEE^!'[-&&9H"^DO%L73C8Q3B#(E(72;/ TO9^)6)R/3(9'?@A%/A3VZB@S=!:HAMTGRNQB M"S*VM3)H!.0ZF7+LPPAHWJ%#B,FP1@&".0K3&EJ^??C-@OP4VDZB*O%64.6! MU!Q8;%SP>2SI=X2I@E?G8Z_!*=#JE625@$U'YYIHF2 4&M+.9Y'/OTXM&5N#L$-G TC8X73N!F2 7$'#* M,N"3.XN+#E2&G]'&O<$!92%-',ZP2/*Z=@(X02X@X)3EP#^03-VWX^UCG&0' M3ZN1"Q6!%AVA$S!68P9"LVX6?,#>L<]\D.SBTPURUXA.KAEZC /GP0[)-I&; M>H 5I.(H>L-5FR$(,F6E^9BOX:WH@9GED=M7;Q0KL@'>K"6;?_,3Z'!MS*E3 MP KC]M,;C0HLP'Y0'33'?6FT(%6A4L>OF.I8WE=OX"JR =OIE>V!]MX!?+RI MIYO"V,^9Q!F[8851.@%H=89@J[\&T ZQ'WJ$G"1 ,#V8D6M5QI8_3-? %>4( M1%>9924A_W!FE!S?'.6%V;<;. JR 8*G-H,50'EB<:V'7=*U\]#EN "1RUE; M6DM_=!PN926748/L$4^'3$A[BH\2('TL)$ :?C9'][?FP+K)JLM8T\78F@R, MX6+\)9\'Z4\Y/AOA)4O@)\+'QU]8?/QFS&;&9-$>"P<00N.[';C4F[]+1RB4 MF.KC56EBJ@R+^7\/#,+3:#XP)J,==W-]$E2E00AT[="P2D2.JW1Q[V,9KE\. M3;+RWHF<"DNS9(^1,+;RU%<\'D*("?%$6>=^0INT6O(F$YR#2PX>VF?LFFYL M?V)OH1(5NPOC42L=0H EP8,9;(((JL:*]PCBM)V:*-]289;+6]_G)_5$KG/D M;6586HVG77S'BP<LQ3H!,91E:RM*FJB MK("G5G. T8T /:'=O)*%7ZUA526%JP1G?<[ DT_]X_*+2;+;B#)?(R6ONHC> M/B6O-BI_GY*W[92\JG-IJO<_5$VEV=JKA!\B6Y?S5->*\(A?NWWH6;SDX5>,/0NV#^@OTQ65G:_8BW>=RZW.YJ09&2QU$-GB: M7K.S<"7>#?NHF;+POBHYW$HH!KTPM=-A0XH?^LZ3:Z(;G31;OM8Y-QY,,>PL M4:8.W"&;!M31A3OV'^.(YJ9B:P)PCXM5 GA"TNAI>!FIO+.&U4>-)L 5.!\? M?34!N1#IK!-(@U%3G>"48//YD=S;D;M 7Q)!I@M]EU>O5=SR@DL)S9P$"^@ M7O%>F?/QE/0T2OT+IB:!#3GKJ\)8WG]YI:ADV=E0LO@!X517T.R4_)D7?KL) M$-KE)IB12TI52.$QEE6KQ5-E.8> M"S0C(FC>*3OB9?'Y9'L;>L.XP<$G>BUL?O*=?K&?@]4D!6Z!/X:2F](1ZH^T 7-B',$ -X0)4>P MDK^&#WCC6JN=#\GZ[J. NIW(S!O[3D .:7(BGQ -1:[6'.["0#]/#."54O4: M#PGMYL9;>V1;VO$E;=V7#7YATT*F4&3[^*!)8C]3DD_(3.!C?VAOD._: MP>_(#FC2/$+Z!GTF?P(-YV>->6E3XGQ9R+;VLF=">O6^]5;@RC]M=YF(G?(' MH5 WJZS?3ZDUQ\KIK>W(I?O-"IUYBDP+FHU@=7A]\]:P91*+8I\_DH@29F(_>; M_7RL*BMP1JI+G%M7E"R.#^$.LV:.9/&/7^@<;4-HX&15EP=8)NME(1PM3=6R M3_<3M:;(P&FJ+N,QY2JY\W/F4]+F0H'/\08BI*R.5)8^(7MB8 4S;_T0[>_) MR(D#(GH4#NW-!KG7+[M4NUE#AEWCS($O;RY($0@X@909O$O9,I]1X'AA.O7W M?]SSPM#1:PWW@TP6,3& 4T1RD:SZ,5/83R^MZ1NHL1]&09R\J$EBII +6*\. M1;B;^N@%S:.VA 7.-K7F^SI<)_]%[2A[[Q//EB#I*QR"EVQ:HF*! M(WN3__L0A]$$1[^C:(8:HS6G=^(T%L3WM=-K+EW$*X MRLY7/<<;S_&BA+$;^!78:;,+@@1F#\1 =NK(S >_6]E#NM"I$QX VQ_8:AP M^ 3A45W^1S3"PK2=A^.VTJ)9BD-?T-R0*Q)P&N6,@&T5>T_RMU,I!-'+@E : MVDYBUA$K+/[ZM+#XS+PU%N9H,#5FB]\'BYDQF=,ZZ=9$HX+B([1"00!.#IK5 M_I#CWGQV-K&[RW.0GS%4&9[B, I0Y*77GVOD$TRBL#"-BHNK31I4%RAOG-?K MEV(=#Y^L/YK8K?SSPI7/]:5=FY+J[2\GL/2ZOFB!,4,MU'3_$2IQ:8]\[1)? M NWH2U6\$!E_-SB8(5:.XI.&/RR>97( ]2=5 MJ,[08T:FMC!=_&IC_G)J3N;DW MDOXIQW(C;)FK%7*HMD0XH\^IF?R\8?%CWMR8P\7X2\K2S%BTR,5N3A,F#'+R M)Y/SUK._TF0&'@J93+UE,34R;\S9S!PE/!GSN;F8#XS):' [-J['M^/%V)PW MS>5^XB%!8_R[4X8.,\TL-[\WC$X*218?Y!K1/D20BF,;^G\!B+ MP8TQG@V^&+?W^7FG.%"T9"[NQ&#Y,^HHHOD>28,)]H/=/\DNZXGX#B1_1G50 M;7TF.%9\B9_0QMC>R!0#(WDE0:/&[%UG,EZ_Y*(9;P+T1XQ\YX5=TE&HLS(3 MN7PP@TVX7'RIIB2>UK:M(A<6=N+/5-AP6AD M&#LF-0'*J[+8S!6LR$*=RS=C&.7V%!&0!"YF/$'I MI"VJ0%IG';*]V:"[]25YZ!\F+%\)&UV*G5J/-CQK90)X FR!YA;U1W:.XM=U MT,LZ+*H6O0^R2#S;J(U[ZB)<^XJ6/>.G- M-Y=AOM$J]*4WW_3FF]Y\TYMOJIIO+NL&><7W+ZK?M679;B[,\O9:Q/*F%7IG MV6XNS/+VJXCE35T-\^_CKR$*DKBY1+&D=!EJLE'-SW#>1W3U M-,B::FQ?@PR NN1M2+A.#EYA!\-I%UUN4%*@ [T*Y8+2T21UEC3RC I;HJ5_ M4;E[ D"[B:T#EKA.M\++F5TZWU!UF8&:WG.'>+O%OM#MMM!4M7.DJ3T"\]G6 M[J@:TO+%0>019FFR,8&7='OVF!V5QU"V!3)?"N#B509Z5GF#!_%1L^6['P+0 M(L\0?._4I=.L9%PL-- ^?!9A88;.)K_3RL*3+M=%*)K,[M M34OS,/E2/P=KB$L['Z%$-I.Z<40'"<=^A-. GE9F8\EW^[EYMO# F]PES50K MCJR5BJF:^W _5\^7'C19WUS 9/U$H+S%(5F@-!<_^:0<^:1)>M3)G&=_O MIZXT(4(S^*T>026)F.?>VO=6GF/[45$$C'B3JU]^$8TW28--YN-/D_'->&A, M%H/[B74]-V=?C&O2>CR9WFL7C%(K$(GV3_W R'GPO3]BU-8+6/:7M7#SR>*K MA7>R\%=U#6AI;+HV\)J6AVF70E[Z![:U4>[?W/9O;OLWM_V;V\MZQ7NSLZHB6T8>Q]F&L#8>QJGNU M?HC#K!8=Q^FH/)U$ZV&LH!1 S'4 76[LLJ+"%)K%+C=2VN)LT(OZ-OO> ;7_ MD2X=;)EI%,]0))2GT\$]U&C\'%'S<-%779<'C<[JLA3X6JV"-8TCZY$2,0T\ MAU8UQ"[:,,L",7HH4FFYZP +4]^%+>D.[?#A9H._\_05\3%4J2ZB M"-9C"-1"-$*UPB($A0!.[/<=197)$(3J>V6Z9&5I0W[??7.SNB5J7*X![W4Z76GHUC"1L@9-I@ MMIM\,SN""\QR)NZAKZK$ =+6X DK$'[OM,&/ZMOH"]X0#:[.OEK:7=45Y&P4 M86[ ^X>R6^4I[3,O_'83(#0F:D6 PEH+$AY#517HLR'EL 3A^D$;7,WG1^1$ MR!UY3YZ+?+<.KO 81!GL*+ \GB!DKWZ1"VT81#E8R;\.D))_+&>VOX;L N3O MN3__$$: 8Y8AC-ZVCA"XHG8$[QJT?(9LW:8[4 M[XC(MO&6)?>C)FW?=8&YBF'JM-@;[NQGKECS35JO!\27:X$\\&"4*]D**L\( M!=X3.3V>TA/H]*2']1Q.Q^65'L$Y;;T8%!('!+]D5_,I+7O;!A=;VEVP]P\# M<&69@(N\_>?P>UE9JQO/MWW'LS=C/XR".'G]DCU%G]!U'#^"O3A_ MYQZ]TR?PXXDQ&8Z-V\%X,E_,[N_,2>Z9^V _^)]R[$MD\?#B?X:>D$\#J*_C MD( 9AO=D=.;3_M>LI_TS\XLY(2Q>_SZXOI^/)^9\/KB?C!>J7_#O2_(49BRC MB->MZE?R>THX[]I/VVGS$AT6.U1$3(/7WAP5:QI@-W8B*YBCX,ES&'?E\I;* MKLV C#&'7H&=N36ATX,K(PY^$'/@I*QY^_=AIE@+TH=95'U1EH6!KI?HE4)0S1#TGVC[#%\1N0- M895,BRBPG20CVC .([Q%@?E,TYO1"R.YXI'_N O[&=93:PRF*IF[L.9:ER%.>W\]-_]Q3V[E \H0<#=7 MN$MUT8_I$=WL!SAW2JM!(Z[.FC&!P!VM'RBDIX Y%FARW M:/F\8$@, Q0V>R3(EJB66WQEJ;=J#;WVU@O\#?ECWV':B@KMVMZ0H:F).30V MNB74.0WI&6*M#%I/<)W,'?9% &BN]=;,)AVOD+$.4$(+VX=7;*GH3E%W M26$N,[)W5LB7]V4F)O-BP]:C9N7)'& &O-C)=J &R/4B0;F7M57E#Y(A>I ? M2/H?ZZIW8M(G?,S0$]X\>?YZ@AFOM$JH+^^K['66?'A8#,+F>LG+)4M;^+*G MBNT*AYHK*]LEXY!@\@0B\4[NS8@3&K6@WD1K-?9=^K@OMJ$B+Z0MT%3KFQ!, M-B1_N<_%JTJ?.N!G:)/XL<,'[W&!.1:8,@9Y@[0?2,C&@(&5F#Q4QQ>J@%'+ MVTUS4+=ZJZ%O)KPHII30!Q1/*"0]F><7HX>*AVIUUQ$6YP@\OR1K?I_QAHS+ MUAZ.VBS+9H/^\B[R ,YV9:93FH_Z\)Z(;3\MU MR\,]U-A &6)FX5%D52=+ISQ8M#S=94'7KH,M\-PUXAH)3ILMWZJY=W*G.^;0 M#.Y5RDZ-U#QQ8SM)IB?VJ5'6M@NG!LQC248R/8#@;4WEK=6<%@SQLG#0]Z0X M'PJ=3XBSX-(TB&YO4CVFF>>S9'93E;V/N4H*CT0X]$-0O5<65$Q3U1M^DK'> M_"/VGNQ-8L5E'SR,/ITX@+@\ER"D;BT1!<=SLJH"1;++?\M?:N>,JNA@X\-V MNA[/%YU.!Z%^4T'K@[7-Z:+I04QIY>%_:+.\4A3Q(&6A%O?X/%>@"?9*6<[C M+X1K^F247?LMWZ@+AVL)5R5Y;!7+G%OWZ[B9FO.N3)*ELM;WZE9'W#J?*14A M:=5X1P,MG =D^6SCW6FSY57;/B#FY,4\2L&-_->Z&SE;GHOO6$2>^V;*DO^) MRO.$4E">M8LY<.1)&@G-T%S#Y94B"[.P3$]I!:7Z5IFZL<]U056HZ&6(MX_8 MYU_V.=VZH)((<5X2EZD*J1,R>:+O%?JXJ/.-6?-I4670M>W64?3 M4;/E:T5O<416"N;1#:\H91$X4_LE>7]R@X-I@!V$W)!F_4NC>I._P,CP^RY? MMYT6M/R@NN4D,!/E! )0D[#"&]M!QI960(1!@WIT!2HV_:!JH0= (Q0Z@9>4 M6!=%*->EFQ 5& !W065[8&[)SVT:K6\\V=Z&*K=D0Z"_R=[K>2BDO#%VQ(HC M=071>GR!*H=<2^LT\'S'>[0WZ49@/CL/]#4F8&X%6FN/!)=V2-K*++#'V\"N M4L[(CAAY4>$^V@,DR $$D[('(Y0A:W42PY?6*[O&08"_TP@_^Y'\)7J!@:LR M2E>@K,X3!*ZZN.ZR:\LDIE*R5H<]>VAO-LB]?C%MY^&X;<5[=96ANS(-)#$* MS0UEH99ET]M\?O2"-%4ZV;&NJJWWD\Y=P5>8%0A!9>$]993/$!41+6]WWN8- MC]-E7'E<:><<+6-"Z!;)Z=AE$(5OE+4="L!-HXR8S'0T18%#_L<&[QU"?;5' MI2(G(#"24PHQ2&(O%@X_75HP55D!L5&:0V"(_2<4A$FM%D%;66D7[>$28P $ M25E&UL3;/@[#&+FCF);1)6O>P^[\P0Y0.$'?DS\Q ZQ$^G<%OBK<@%@JL]!4 MO-ED[<*L8=78!?&!NX*^%#;!:9&S"$%%L[+?T__Z:H>(_.;_!U!+ P04 M" #5@$Q5K0Q1O8/H "4KPT %0 '-R87@M,C R,3$R,S%?;&%B+GAM;.R] M>W/CR)$O^O^-N-^ASNR-$W:$>F:Z9]=>S^Z>$Q1%]?!:$KDDU>,YC@T'1!0I MN$% X!Z^-/?JL(;]01(5*5F[\;:5I.9R5\"O\IZ9_[[_WX]A.@9)VD01__Q MS<=OO_\&X6@;^T&T_X]O[MG$&>8?)'_\(_H7[[]^ O!0C\KRB M],?7-/B/;^CO%C_[\L.W<;+_[M/WWW_\[B^W-^OM(SYX'X*(/KA__]*<_?<>^+44YR=>')"Q_XX?O2CB59?)MH)!O($F#'U,&[R;>>AE[[=J? M05()^J\/I=@'^M&'CY\^_/#QV]?4_Z9\^.P))G&(5WB'F)L_9F]/A$II0)GP M3?'98X)W8C!ADGQ'];^+\-[+L$]_Z$_TAS[^@?[0/Q4?WW@/./P&44G"#ZE? M?VK9*I2^LPUVB9,@]F?1,-1=;4?P2=M)LA,<:.I;=V$39UXX"'Q3TSKL.SSL MB==Z]I\TB?-XV)-N:(X".^,A]WZ\XN<:T@]OR%\MB/@U(QT8]DN0U(0B K-? M8!U#8;NR'F];=D,:S>.$]YWVC,SFSDL?F.%C^F'O>4_D!SY]^@Z'65I^\H%^ MPAY"\<'?:-^(#SC*IJ&7IHO=.HNW7R>O05K^#G/R/[XQD/^NZP#5G"2E%UZR MU3R*0N*[;4PZLJ?L0Y@_]%Q]E\0'(QC%,XL-A/\6/E3V\X=,($@<:8DE.(V/ MR1;W>L=-;TR?:H'P$!(-.F##T8?[]3?_BXFA>(>8(/HK%?VO?_^N-NV&2R3B MXW2R)-9PDF"?@;O%AP>*^4-A\_?LH'D/^T7DW^\C?&Y@F9-!SB2,X9M:@-LIB I2Q1R3FGAP$X M<;29H"V3)U/%9Q499:M*+B76<]&0J^,+>3*3@G%Y] M4'9YEHNB6A9*QZ8+30HYFU12!B6I$!C*&(>C/ R=MVLZF2,3WP_H8HL7+KW MGT=3[RD@5TG%P3!,CY$?:S4T$%5!5 /,P/Q()J,'G'".J8?I.BVK M-#-SH44UM0HK.8YP0BW^.D#+2BA5*9D W&J %2GH@EG+-#"4O: MS9TGJ,BV5HI?643B&"$3LK>=(@-8;Z1T)9R_9R4LZ7LF@J-OI!6_M7F)]6^[ M(63];7, N;==2U#+"WS@&3OWOY$EFK MIQ]4<%NG'D2"SGEB@DY&F<:R A3R7![3(,)I.MG^>@Q2M@FJ6,R22MLDD 9R MDT(243 D4N/KTJB41@WQ<7N6RR3(\#*.PWFTE7L9)%CR$V.!X;R]-:^3HYTI%&#,U&"3JA55R M_/<*-=1M'P76.3")?*-SPL/L@*&BRDUC8HJ,O ^:*I /(BV=?%D\-:B9GV^" M+,2+W3SR@^? /WJA9((ND;,U0U?"+*?H0B'G)-,AZY*(R=+K-+7TR$.I^>=- M_!5'XG-[8A%[@R@QN'H$U?[>^=M6@.+&3O//*!<;NR.[N;H-R.-6#I5Y&6OO M6 :O>LE= 1AO68*J^YIOKA"3.^L >5"LKZY!K+')YPIUMAY&6NO5P:O>L%= 1BO6()*>."9B=G:7;T)5*U8)&5];Y6'R&VM MUB(P7K<4EW1CE4J._=CNB0O?^&K.]S#>LQ@4-_\JI<9^ MP5?QP0LBFA5*_H9Y&6NO6 :O>L== 1@O68*J^Y9S,9:3:^SWO$QB,APX>!/_ M[R1^T)&A_'W+9:V]=QW7I:="6M MDT(,E:-$6PP6(838Y'0HQ>%LC%?S2G4\T8M;/5NA =TZ7B&1=TG-?R^R1S([R1Z]"+651EU?FNP3S'X_W<1K'(:&5X)ZZEKKZ_JZ4_5^ MIHK.23@$+7>-J%)'68RH 63_9E&/,'?M!0G+N7OY-DE3G">W4X0ZA;S-<*>% MW0QY4F'GC#-%R+&,"J$\Y]>H,6R#HR5.MLK)&2]C;[U% J]><.D(.'_C*E3< MD@N.4"$W^JK:"_F1-_VK%HG9>]MRD/4+YV6 O',I,.ZU,TEK;_XQ2+*W=?"J M?_D227OO7PFUIH!0# @+5-@X(C!A1*3/3H8SI=O+^RGE/%LD:#_AG@@HGW&O M*>6<+UIHDIQ[92;0D>.&?IP\.1Q8DNU39CE=&X!F.V+W>LQZV@:<\^T4U -G M0:4M.&'M.HB\:!MXX3Q*L^2H6?>12EN="JDAMR9"8E'GU#/#QQTF*:51+0XM M_S/._=*1=9'X10A7E/6E)0B&/RITTGPOA3"<&$20)4?LWP3>0Q &68#5 MF4/EXI89I 3=(9%0%A*/5 %5*+BJ"$_^B$)_$"BW3&1<$,B8^^0A 1>?4BB M(^#\U:M0<8UCRL-*5L'G]30"M>?NM M\;7SERO')+C[QH3@3$;(6"O)1S=FBA"8:?V?F7/&17 M+.HKVR9S#J6XO4L7>M#U[0NYK'-J& (4Y$>NKMF/,%L/L>)-R94LL:7%]2P6ULR\$$9-TFZ5A14]S2S(S-+ZSE8V!@U-F M8*B^)%B+HOOY 9.Y;?7DWC.9F1I)DRF O%K$5S!<@JG MDG+]K#3#N ME=,D;+GH!3IG3)=M6M QPS1.GNB-&SI_56U22&7M;4IHX-:;$!)!&'S0H.,V M&=C KI)';($)S+QOF<1/.,G>E@1S-HE\6H'ZB792VC*%1IIVUQ*,76DO+6C5 MG/.N/U9N8R..]A]N@F="Q0WYG*U>Y?=<@)SI6NQVP197#BD7(B2R-LFFA-ND MEU 0#*%4Z+H4RF51)0PGB%T'49!AQNYYE!7TSJ?2EV]Y/2K=Q;L^%BR?/^WK M6N=,JJDZ&$[VQRPXNTHL%.&NME&NKCR\(6;FK%?\3B9QG=BK/M^MC((J!>NE MJ)7 N4+40FDP!-1"5.1D:YS-!Q,>:5'L,,3;[.B%Y0A"R2R5@DUFZ8$WF267 M!L,L+<0NLYH*J-08/05]O,M>O$210*$K82]MO!!:G1"^];7SUR['Q*T4%D)C MOUK*IR3RPO#M"C_CD/#)U[]M R5K!#!VH.*$5@,&34QABB)$KH M\*=,<*@>T_!B5M/\2$"V,OQT9)RS1P-,FFD2T "EF0M5S0^AI-4+SW*HK1O/ MO!@8HLBQ*5// N)+'O-P5J?=5+-&(6][.*N$W1W-"H7!\$B'4-Q3X0PUTJ". M?M3AVML2T2#:DS_H[3'QQ$+.><&0;@N*6:4AJ5XG#"S J' M=.]FZ9$Y%^DVHY1@#>(HO7QK?J-85>QCP&8@ZN]8,S*9:SLGY&#(_$TA)H:8 MW+AGPF_R"B_R.-41L%TQ1Q*36M\Z?_%22-)".6/?-?7>MH]X^W69Q!EFY"-_ M[1/OAB6I55.@BJCSZ>MUCG&0; MG!S(CQZ"-(V3MSL"1''$5Z=A;SW/"'J]OJ<4A\$C(XS<^A]5^D"U4*V&F)[; M@Z'3QP#OJEPP^19P(CT]J)2V=9;0 ')YLE AZIQ,9OBX*3O50'7RGD('SJ!Z M\N(EON9H44?&:J85$;Q6>I6F@'.2J%!QB52H#*)"(V>U?8E7F,[PR:R.1K"? MXM#'B:(WTBA8S(!J +R1"U4A[9P8QA#Y_*@QJI18#X0*M=%SI9+>+U2.AKL2 M%C,ABZ U\B WOP;R[D68^!S(B:4A*B:/V+]*O!<_?E&\8;&$.YA T*@UCE MB$2P/<8IOAO$+*LU(2#PF++]@E4Q*G_O+0,EF[V7F M0+,K4VO B%>F, 6=7*%7Y_<:.:W7D"EQXVKH/'HZ9IK9L5S7(4#NGE_C+B^3/^>L^NQT6@7IUVM">K;_CM.,7DA3'I?H8\ EY?2.J4@H MUP9+2RUD+5$O$+6!J!%46D'4#-QH.'M]PML,^W2NVHNV(D67=)4[HJ(IKP66 MGE*H!K0L=1%;D@!+QF42;/&7./0R^6&BGKHN*:ET1\5*H2)88JK0&G"3J:-: M'RX]RU9T%3P'/H[\WEV]R@"$V"EWS"2&\MI@*:N%W">FED;.V]/+3KJ$WC8O M+KM7SIS%F3(= MX+H>F4P2!CMT\+BC E0>$06K_*B6>K4G!F22]DNPJ,\(B,5@<$*)35J4Q=9A M@'F:'CWR#JZ.]'( 8>(OV!.?.].+V[N!]$ M[/Q(O$-4;6RVS%XS'*5!K#A9P(E88X4$7,6$SO-5U)CO^!\1U#] MAGD9RRGQ%>^X*P#C)4M0B3/>VWC-DT.<9,$_O$SYHD52]L:$4HCU8) 3@?&Z MI;BXX5]#PD3!XJ$* ^"- Q4*:1C4,('('Z2@.N@C&JM^A:S;IPG:+O/2ZQJ^2$7M M#0+48.NQ@%@.!CO4X+B1 4N@=XER>6@U300%KY:;* MEC-#]G"HDR720!,,3WO!%62/K)61B+.CK[9=QE[B+W9708)I.@[%RJM,TEYQ M2B74NDBE4,PY8?38N**55)BNHU7BHT_"L\TCOO62KSBCA7!3@U/06A5[TW,S M\/5<72T/@S!F(+E9?(:R1XQR/5;3.!WA]+,T)X&7X,OCVZ7',BK07 B*N9Y< MV&(F @W@1A("B20,LNC@\:D':*)(HO"!:E2)*\",XFFM YHJ3%6*HB5BM>:$ M %RKN$3C>^?T4( 2G!G)$[2-?E5\\Q@?4R_R)Y&_><'A,RM&D+U-:3[M*&5+ MD!2,/'CTMV'S0OD@]YIWS'L9<$ZQ4U!W.?CI^X^?4*Z'FHJ(D7/LR^@M'Z[) MP\DPZ3;)?T[CI[DE1RSMZZJ$JZ9F(#*V)W8!;_\9"&_7P>OIE#4RXHBM/1R4 M$-7 D2.FL,6T/,/$.A)^P7\C,O&=A:V#K3I@KPGN2_B\B"#X*A]BA>B <0% M8N&86$9*XH^^JG(71[-7O#UFP3,V6&=3BEOCJP'HBHH*61@LTP,4K,Q^J%3L M+<#-#D]A_(9Q2MB?_U*ZV-UZD;=G2S<;K%I+Z:%L[P1<7X?JLW&FFC HUAD)0IN[QYIG9(=>M,K.FDGBJC0E>QE[?*8%7=Y@= >?,4*'BND;\@@HY EJ MJT[:*$&M3-IJ@EHUY%:"6K&H<[J8X1,GJ*U'5> 2U%Y[0?+%"X_X\JT1Y:X3 M_.L11UM5N0:C0@T=$/5B^!DZ0(*9[@2H-. %Q'CWC-&/S%W5B,I&@W?I: M,J#MPEI=*3 ><'2.@QMCJ?GGS$K9*V-O;60ZY&X7)1Y[0P MP\?U:Y4":N0_!!--&AUV]>=/ 4[(LWU\NZ$53,U&6$IE1X,L XXF7\ -NMB*1LI<^F@VUA)I."&A'+J0>;PX/+I),:K&4;G2 M!6)JZ"/ ^-=PZU-ODGV"0K)/_4CVZ1V0[-- DGV"3;(?>I/L!R@D^Z$?R7YX M!R3[82#)?K"0:2%+O"V;NZKN'>F$;>9>4 -N)F$02SIGBA$\05J&7![5"G!" M4+L 0*:9.AIK6:WU;N9"J^Z[6L4YT?KA%"<"J>HR9" GF#1LLG,]&[Q]C()? MCZHE*YFP39JI 3?9)98$0RHEO"Z7*F$T>7I*8F_[R*:#E>JX:UK+J4@^ZSE8IEW7.%T. W)V48U8>,BAT$%."$WJZ1RJN@G0; M'Z/L.DYNO.U7>A0H7YOK?S3&S)3+@S)]G%4=FS&QXYS"9P!O<*2FM(9V<8*H MO?PH6,.BV[,7MT$4'([BPXB"[VV=KQ#"*D]4M+YTSB,9(HX!V&J!S M3#TUD&F#(6EOR/(I1&6A[C,)H3.Z : MW[4UP+#1"*;!F*W4@\NYLH7T+@XC4H0PX^A7#(;7 LM!*=0^JGE M+6:FU<-N)*:5"SNGE"E"/BTM4T&E#BJ4+.R1DLD1)J]'RQ6IJ,W]4178YNZH M2 X&.=3@!!/90MH6(Q;9(TZ*WU(5I!>)V2L_+P=9%YOG96 P0 Z,JR!/);25=SX"(7M9>V4 ZX2]70GG M+UX)BTO3&^P1$R3S[^WH$Q9OAPVR\@K%[$U/Y"#K60DO ^.URX%Q39U(VDNK M._VR,GCQ(BE[\PTIQ'JJP8G >.M27-P$X\O*WCNG>>"#[$C716@A!'KS+U:5 M0E2)VRN%J ==ET*4R\+@A1X@?T&SH8%*E;&9HJV;ZJIQM[(3@*O'MAU!&"\8 DJ;EC'Q!"5@[.0,$VP'V37WI8= M 5.L(8@$K9ZPD0)M':KAI)Q31 N-&Q P051*0EDI6.'G.'P.HGW;$>6*@4;' M)G^,X#>II%0 PRH3E'REQD('<50;><;!?LYDTB$6M#?O4 &MIQXB*>?,T$*3 MQ!M[\\XVMDGD5X14CTP,%5VQ1.V(C#5B+9 L4D+5LHK>R*DC#[!1D)<^$N_H M_]"DSL]>2#,NJ49#"@6KHR(M\-;H2"KMG&_&$#F>T8.9E%OLCX8.E'$3Q:4^ MR-X0L,T=Q?'TZEM0W%#''$H!,$'E"TXS$NI4-T:;$E8/F/'06B?(ZJ_!O'P> M$W<&+)<8N40@)O+K(0T? ^?M5H>J^X4(,$;G1BXOD M/[5YB;7ON2%C^SUS\+KON1( ]9Z[J&3OFL]$2-^B6U+6WS4/D7O;M0BL M]\WADKYQ*CG^&5V6:>*MFILH=CGDLA;/YJKA-L[EB@5A<$&#CC^/FXO7,TA MQ^^FH9>FBUV1M'Z1K(+]8Z::+LKEK8[X=;!;$P"9L',ZF2+DI@=4GEY[+XL- MQ EB.F-,%5.\_78?/W_GXR!G%/FC)A+YQ]^F\3-.)@\I2[S4<5'PO0VB2&%1 M8G!?.B>"#!%_AON95@4HI6R_Z*MX>RP3,0L\:']MZS6+0)5ON?D=B)(EBQ!Q=>A+&42%7+WF M*YQNDX#=+E/YT1*S_M(%(+EWWY"!10$>F)P)#5E'@7V%]P'M6BB$=>9E;+BJ M"&,2>=NA7PF[VQ<(A4&0Q@2AM+=H*J%*RQ&/)E%T],(5?HH3%7W:8K99(P+9 M)4M3!A1'!,"DU,AE42[LB!'_>?22#"?AFY84G*1M7DB@=JG1$0/%#C$V*4$J M<;<$E0C)'"DW*&::!"!0YMV!7$*S),,G2V(>^2/!QL%7\J8; 4 MZB(T9%%^?Y3J.6+2$B=![)-A=J+C$"=IFST2J%W>=,1 ,4:,3?0,4W%*F%^PEYC1I2'IABP<5#%5*C& 1.EBT]&$RCLA MR?28)"W4\AY'+FIM4U8#MMJ?EQ!I7YR<74Y(8+9)T1$"Q HQ M,@DM"F'$I!$1=T*,91(=3 MESW)QGN=^X2HP2[8LDUG#4ND\G;)HH'=YHQ$&!!UU @E#")*J*WEDDCS:!LG M3W'CN,.4IFA/WJ:Q+Q^A:+3LDLK(A3:UE"J "&:"4T*SENI%?B:%GE0N#"!J MP0GC)KY/'E1:_,]-$.&/4O^%LG;9I8#;YI1 $!"3Y.@D_"DD+\H_$-6A5^: MD.93#U<_N2?-)U/2? )-FD]#2+-YB8&0YH<>KO[@GC0_F)+F!]"D^6$0:>@5 M/I>TF9(_%\DF?A$=SI9*.J$,#U5(F%H,'ETX;#JR4 4ZGJ$J+FG"!E:+9)G$ MST&TE0^99>)."",!+61-1Q8>=<0 =?RI!L2EGM-8DP_*M8VD%',39=H@Q2$F MEX%'DC8P;7#)I5U28AFGF1?^G^!).1$7"SNAAQ"PD"0M27A4$<'3$2;7043) MQ<2ZH"O=T!!>)>M\;^\*L !6?06X\24($H@0\5> \]637,CV:Z8<3; GB0CM MKZV]9 &HZATWOH/QBGE W!MF[9K(N&C(-S$](_481_(# KR(K3^[>[W M(-ZX!%3WK3,QQ.0&[\9VUGKT+I^K(RR] O-TN&JZ;+K^W_#9_ M3H*,_/(T/AR.4;'+(SHW*)&S]9:5,,LW+A0"\?95R+I,*&116]@R+=9Q&&P# MFEWPEDP^D\ 3>242LD4(.<"2#;P$""I(87'YH"I!5$I:)L$RP92$M!0HNP2( M(Q\GB]U.V-NKA&V10@^X)(=<$@1)M/"Z9"$*'[8-#92K(*;CEC;S-#WBI!=Y M!"J.*"0%+R$2)P^13C*06E+EBBZY52;)^_CI81-DH6ARR8M8ZY,DX*H>J?,] M"&Y(0''Y*NEW-)7_@]*K4LO_Z[>)-X/ND2UV^'ASB49)\22MDB@0)B MR0.!" @JR'%UV7 7HT(4Y;(NLE.UP K MM:.0/WO=/A)06'(A02QF._2+0';#?U,&! 44P*1):DM9%Q<2ZBYKKQ\$[)T- M O::0< >XB!@;SH(V#L;!)0_FZ<((7%I\1 &>T^2G% I;9L4"LA=?@A$05%% MCD\:,RH55.O8SFC)4IS-HUV<'-CO7Y,_!%Y*Y*SEM%3!K)):BH1 <$2%C$MK MF2>=:P@C*FV;%T<_R+"?@[D.(B_:!EY8I4<4K8CK5:RQQ1!\11R-/ P.F8'D MZ)2KE;D,*\4ZU:7MI?3\ ,;/. S_',4OT1I[:1QA/U]+$>T4J>7MGIC1P&X? MFI$(@Z"3"4+)T1FJ].$KU4*E6K$2YH1)7^+P&&5>PNZ2)Z+())&SRQP)S#9C M.D* F")&)F%()8QR:3<7M//L$=4@BP8\80H8M;CEZ]I*T)U;VT)90)Q1 I3= MX2YR?M1CXUS+T17+#--Z$<$SOO(RK\ F]54L94PR)4.M?:PX)=Z1LI\XAH/(YXZI1 #10X1+D4$F0:6L$RZL M#UX87A[3(,*IO"/J2-GE@A!BFPLM$4!<$.&2<(&)HE+6"1=F!YSL2??V.8E? MLL/L1K"5D> M&0L =@;�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

    C?$;$(D(7HBL)%?TCADR*;J6\&'#"])NSYAK*=O([Y#-JZR$K M+3,%>73,T';=4[G7K*:P$A]N>/?:.M1J'8 HO+@%T_]&; NSHXAY&QG"$ZOE MP/'(B\;@JR+'80MY/@6>4[#@_\"$2HN2>\$KYI/4><0:8S3E57T\7F"$23> M+,P(P2,[:<^S98"/LY02GDB"Q[[N^2#K?('QJ+#Z*8T;ORAW>O6#@'!.?ZR 3W37ZG];CEH]+BJ[KHD&"8 F"W]K+U0]&6$2L'3I4(FM5,8EAZ2[# MDX!KZCZ,JPP<._#"*#%^B=AA3@4TSD&])V-"5Z,C\G(S1SLF[V&F1/K@8?%J MP*=%06V,NJQD36DC2_4@U<-+U,,5[$ET/VF]I()(E<>/,V_U"4\\2>S9R.>5 MBA8/-_MJM*3;3SI@$3QR=,9_!M/ P$3NV(4V4Z@_A/P>V "\'SW/.F2YOZL' MY'LB.1O--ZC-(45 MXX7O671%TC<7NNS"JZ"XW[')?#Y)&GCCE]!/EXZ,6_66SH93R?50:(5;8F;< MI 3P"M6L6TG]UH!5)2+6CG.,7W9N?!!(^+:(CK6M)NR8\V* MWBZ)Y226*P&6Z\YCN0L*((98RH5NP1$NKA_'E QAV]AP=F(L_558S47'UA'1 M]0,_25<.7HEPD[HPHBB)*Y-P@9F7<;Q*(B!H1:@0%I)B(" YIY$+(!-]9%XP M86$HX2<'CW/!8=Q83^*)%9F1"0:U%9(&[EG5T]:NO&83!X6\K HZ6&Q.&"% MG1A1_:/$B6&'N@%;DZQ"1GQ,:"L?$UP9+]*O*]+Q6F6\6+^N1D@.RGB1?ET] M0[C5Z]9ZAT_>4E?7IJP,X?+\D.?'6KKLK:(>F)N!9?\#1 _+34;AW!DM^5@4 M^.>S+[[SC=@\/I\=*EBQC;7%&WC4I' DK>@AS:P6B4%N/ SKD'9:4:!\]@H MSP<*10FGV+L-[X, D]85L,=G7>2'3E0_7J4N& MA$7/S0_#),%VPBP)EX[&8DOIH@,5L]C96K(REQ:=4-X-[\>&)3Y)89*9:_<$R8Z[FR2YBE:% TH&G8R"U2F'#: M1H'141@EG J8C9O2N2)!%*Q^0";V:$4%G\AXY,@*QXC3.]N]6J>KP?^[MOX(O3I=VH21SGY.Z!31MF1XTX;[WE"[LS4V5'$ M'JHN535R%\_OU#APKX\" 4?'DI:3%&&/^1M55M\7KU,9[SV^\]3T M9P,8+I1]KAQ?U0L7>]%RC%X:I!J5I;JS4/>LF48/EDYZ(MU,+*#T)H)B6&FWM2ECCNK$6I< M2?,@HT+L,F7/@%-[@)US##>RZ'OL+6!]5U5,_1'C@D&NR?NHD@,01?'5.C<@ M:T@Q 9'25S1370*GDDCPLO2'AMS*4G>6@N%ET)T17E75Q!W:+%BEZ/9+@!F6 MY1DP_(N;RW]4]D3(^VW_]$1$N*]84&8&(,7(=ABP\-D?6B(&@\7NV\J%[AKC M."TU_B#&F,:)IS\$36AWY-76W2&H,Q%A1#LHAZW_:F)4%9/ M,0.2:"N'7.&E5(2*7]&7HOOL%..W936^+*L=,_RZC=&A)WR/JQ:,=.X!YXMB MF,!Q-J6PPLN#[N(MG9<*G%F&-N9?7CWK8L89;8>B..3!0/9(:GJIZ&D .(7[ MM "3B"I"%&R_*>9]8D58;$LM&C-&N(M'^/3!?F+/8&$FO#>;H]Q\OKU0SL^O M-ZU?;$$7N,OEJ\VIS5EER"]Y,_3A?&;:(IL@*X>-\>:!8/0+CF&9'Q4Q^^A: MF27TI9X9TP!S02;^]$Z;S<][(BDP8\RL2: P+C.%3'HS1MDOICZH]9&9T_+'BH.DL/BP=[]W.KS8HA+OI6YAC94O8FU&M= M6(>74_\J8?AC3'WRC+Y*KWK]1K2D3J[^D]Q:EOD9O*D_]9FL9Y6$D*(W:.;R MW.G?Y:*48*,L/(40J5VQH,XLS;G*T;7T<;4L=U=[DN!_FU5K6VH>RU.RU6QX M [TQ+ZT:Y_B=X^O6<[/27K@Z['N*Z6#YXZ4.T16?$IZMAP=9R"!S%B\7T;(S MX4#- A@O8L*\5Z'Z)F5ER/]$.03;W>'G!_V958E3M8^\;+$!N&SDN)B":5B! M&7H:&%8/FV#Q\M;#J-B!Y\.76*9237')/05BX*-9[X=/93?G\*S=G?]$.9\W M!)OX>2QZU7$G0&_]/[S/7QB=R:Y[,5[5AO?QVCB\"3;#6@-)=P *$/W:\5*O[L+YSQ"C=\IR8 M6[IYSQ)G;<$SEF<2CSO1?1\3,<14\-F\BV,-X*#9QG=QG(GTX4'.:,OU&5I MB$BKX;@8V.P@IPS"PWI8#$P4)0-[#4@_"2.26=50SV/ATO"ZPT!V@I]B+![0 M45'YK/[V @-UI4T%)\20L%5%J0U%S<4-E"BVO]JF8H**=+#0'QIM67A-Z/_& MJR4;G^42/W!M3&Z,O*8\BS%+[@[]PE'I>O%J M-8^,)$;+ [.-9>D7"A$L2PR. 6C1^>#D)^M1DV$/8 BR'F0\>Z=^X M4;H:1N]S7&]1+T(K:15:'6%^F[T854-]LIQH2Y83+:2]6%2)Y=WRNW1 M+R?'OYVO(5JN\CHN6P?DW@KDV#$"YHG:W1E2BY?3P8)/'#U33SBE/JQ[HMH! M[#HF6)57=F74:,6>(Z_35(55-=E3WU=#F4:5L#F)M_'5!'R%, _)=[3ZCAR; M(7X>#12YEV\3[N7IE.@\S=%F*%4YK6=4-"Z)@)94)$M*UKJ/."DLZR9K3ZN( MPCKY/J8#ZGN;A^A>B!!4F-@1D#IP:4WYA5CW!"4?QM9MK_XZ>V@K=E'1]GY) M-_QV',$N$^+*^VJ*^R<*/:)**E(E):M"'%R#:70:N#;U MQL3<1@F5I%:1U.W6JI+4*I+*;55JC]["V92?KRYGEEPZ1<49O8FPE9;/Q\0S M7,JJ_^;([R6RW"N^#&O0"K\0EV!(O=P';Z66'7QF^W"L>Z7^IKR)*B=DF6)$N2) L'X MI"MCEPQ_>C?V_:GW87__X>&AX1&C,7+N]_NN,<96LOO$'.GNOJG[^K[::1UJ MZL%^L]E4U79;:[95K=EL'734_?L6O'AX^)5\;]6;*FV,_4D4SE>'9]8!Y;JZ M 7,DW+W^[NBI'2E@2Y*E[FOM?57;$LBBR;U4!LCR$LQR MA/4$>9-YS%M=&M"H$M%(LB2B*0U9'-%(-2PAC80T>6RFEH0TZX$TG4ZKU6G" MO)I:^["SCY$XB&?^Z;P S/0GQ#99]D_6(!#_=#!.I+$]0@, MA]VSO:F%T9,2W4BR"B3KL/[OTM%44E:U&IW2T5125H%.K7?:O5ZW=)25E&&] M?17^U]T27-.6N&:MN*:''IIV;]]S]>\,U[SL:FD%9./Q#Q.SII#A$'T[]T0Y MW-(:4K'YI*NOB1+@AEY^?3V9($NK;<.>JH$-,MN13B'F*[?"D#3D5[/ M]2.:EJ:F$,U2D$; $M9*XX:P5ENF\OG1TA]82Z-;A]5(O2$@9?YC#6%-(^IA MRVUHVEJ M4VMU#GK[/'1F&?C"NO=BQ$S:^W),/) F[GMAC1G#NIDP@1OL,LU[XYW3">4- M/3G8@:G!G/O*I6/7?W=8&[5K]E5LL7:+MU 2Y$BR),AY>\TL T0DP"F&K!Y& MU&CJEB"< XEPUHIP,$BXJ:K[+\MGXFP I/*[SOK8A%V:Y^^>L ,[B6.#?]7M M0'6[J&W!1NM T9A_I4DE)$@19)5%$CI MJ]KGTI%54FZU&U*Q2H12#%EJ<%Q,2XWS,;*/$=UU.HK5P9OC,@+L;#M"5\ MD605YF,I'4TE956[<5 ZFDK**IFCM"IV4??;^ZCGMP*ZM$K'_Y**12'0Y3 _ MZ$(Y=*'X 4(LY8*85%?NX#U/YS5G3!8$'&*95K,F\8PD2^*9,I#5;AR6CJ:2 MLDKB&8EGGL S[=+QOZ1BD=MED=J.\4SWQ7@F \:0J4\FPNW25:Z&0Y@)=BV3 M>$62)?'*&RM:>?Q*O%(07FGN=[?GZDC66EHC7F$E?+5FC%?:>>$5WTE>$K4D M6I%D2;12%K+D;9%$*P6B%2S5V]H2N"+E8MUPY? @ABO+U>E=#J[<-6X:RA_4 M]GSXT/_ID^E'_ 9,_S'\T.&^IC')EA!&DE6,[JS_IW1$E917;5F55V*8HO:A M"FI^>S",- ;6&_("($8MX(IH-D@W3(;&H!;I?Y%D2?]+6N9-BR MV&5?.]B>Z!89);81T2VST"4=ZB(QBR1+8I8W5[;R"):8I2#,LE41+KW2\;^D M8I$'9CE =TM3M$!:LGC+*YTM!]+9(LF2P*4L9,FR+BL %UG6945G2WM?/=@. MW*(V2\?^DDI% ;A%6RMN4?8TVPR_^5ZB&$F61#%OKG]E32V)8B2*>36*D<; MVZ&8ULNKNUBZ05@+ZOX(_SN?'2T=,)(L"5W*R*IV0];4DM!%0I=70Q=I :P9 MNK3:O;#3=/L?]>4^F.?12R)76E9VD605?^$NX8M4O!*_O#E9K?V6NCT 1MH! M:P0PA_"SALG2$8!YN?ME'K"<$WTZ=)U17%;7Q(NCOO%W0#V*Y74E>I%D2?3R MUF1)K2O12W'"M:_MJX=; EYD(=TU>U_:6L+[LI3SY=1Q)]AQ4=4:G1^!/B-P M :T<.383K(%%E&,R(+8/+R>@3'_J4DO>&TFRY+U1J:,WJP%'25E%W]NG2KR."5M6W% M#88DAQ*2K!.2M.''EG88ELI5F_^TEG*ML%K]$I9(LJ27I*2L4IN-EO23+ U* M9.>AU:1+W5>;6U.^7Y6E<->!2=1V6VNV5:W9;!UTU/U[WD81[WOJS:7B:@&5 M:!*52++63-:MM/Z7UZ5->1>Q)%FM5JNN'O34CI2NY5TE[?UT%OSF@A)-UKE] M:U"R4A0*#SNYFC) TA^YA$>?#!U6346K\?Z'NFTJ\LY'DB5A3)E9!3!&^E8D MC)$P)@<8(\7BK6%,>Q48 MD7@F!SPC_9MOC6+?'FR+,M91DM%A#$S*=#>3(%_F?8LR2J:+!G0*T-G"B!+ M)AFMBFB:^]K!UF09:=+9N49(T\,.1=U$@?_F4I7F0@?-HD(M0]>9Q#5:>A*L M2+(D6"D+60!6I#=!@I6"A(OE'O6V!*M(/^::L6Y12S8%1N#?3_]3KRNGE%CF!^5:'Y&/\("_ V(; M\,5V6ZG7PY4UZ7U(Q\!Q3>+6!X[O.Y,/RF=+A^-7;71@NIYC43.<5AT0'DQM MZD/B4 M+5V2[=T,MG-^1&(:"5]2/J;I$9.$X@RX1!2TB8H5]H2\)>5K5O[2TU)A6D= MZ,"E->478MT3E" 86;>]NA@^)7\+Y?1=62RGB.##'W,VHO(YJ"+ZM%SIR_', MRI3?B.QV,U>ZBS&X5NJ@)@RNS^P^6_QR]%;65Q7$HY -5@2%Y>=A-U<*\[+4 M*L3 O+5\3O?C%>*@FJ]"S]>LJQ ?\Y7$)XV]MT=9.4.KC2X27+@]4 R&6JDP MQ=,7[-)=+RVUHVD8(=CN'NZS M],V5;MS#Q >#NWP\YO*9!C"L[A'E8:ZIVRD9N('N/@*BT9H2T4BR)*(I"UGR M EXBFL+(:NUW]M,5,S<8T&QTN?** !I5:ZFM%P":*Y>.J*U;/&M3.::>X00 M86Z)31T7_C$"%Z#,D6,S$<1[XV,R(+8/+W.7S:^!322\D61)>%,JLB2\D?"F M,+*Z^ZWFUN";UD97/J\>OEDI8B=UNR2ABB1+0I72D25+34BH(J%*+E!EHR%_ M5:!*N]55.53IYA88(Z&+)&M=9-W69:C'\M!%GL3+WHFT6G6MW=0.-MJ>SI.L M@_V6NB7816UNN+^RW.!%A/:VX<=64]OW#)=^)=^U?Y:Z2[H.XU_B*N;ZQ+%' MR@V%UUVL=$Z(5>/_*!?$I'J-9U Y!M4MY88 5_S'F@)D$1.F@Y =FSU+@"/) MDKZ9-R5+:VRT5L[7-=.L=]J]G@2$RY[YZGZ;Z?GM@#<;[>.L!+PYA)^UPZ@T MJ-I<,OV[[WG$5S)@S@/UQ\HYT:>GKC/BR$:Y&D!Y M#&FHO0C0L._!H^"+$LY(LB2<>6NR-EX-2S@CXQ+&2+(DC"D]JT#]R@A?"6,DC,D!QLB6!26 ,:K:[B1C8G*^2KHR M?&= 7(ED)%D2R92*K(TO]B6AS)M*U[YVL#U81FW^ZU^E6X.M03-JNZTUVZK6 M;+8..NK^?0N;8Q\R0+-D)Z:3R=1R'D7=WU3V]='8I1[(VAA S 4=6=1VPA)Y M^_!7DUA&DE4,6;=U>3Q++),_65@"6 4LTY$<6U:\]K4V4_7;@654B65*BF56 MNF2Z=IVI2XF/G:_/["&\JN-]4PU^N0=X S]ZK #PD6,/J8FOL K ,0"2T$:2 M):'-VRMD65-&0IL"H4UGBZ"-)J%-2:'-4J5E0FAS9IMD8M,A"!H+H9GQV5P- MX1WB1;9I6@X+8A5+M; NPV6@3H1+ IMML M:NU>.P%LVLN%!E-;MPVL@L>:2\XG:3.<_$5]&SDBR)*QY:[)D 3T):R2LR076 MR-J_98 UK7:J?MY2S9C.B>\3-P%HPCB8CFR"+BQJ.BF\X4$8ON81Z3%EZ'2N B MR9+ Y:UYU6C)!+(%$=6>U]M[J?/]PT&,EJS= L@@4QSI4:13T3#N,Y$HAA)ED0Q)605 MHA@9\")1C$0Q.:"8C38'*H-B#K564>X8AF2"$,4@UC65#\[:!\ZGU'!&JY$EBT2121W6[F2O>KS*-V MKZ5V-(UE/W8/]WF3MI5NK.\(_'ONP&065 )GEM$I&;@!+T>E-?.WC:H@$H7L MJB(H+#\/N[E2F)<=52$&YJ[:<[KXKA +U7RU>+Y&5X7XF*\HMO8[^^E@_DWV M*V]T 99R^Y4S@=-*]^-G8"Y:%C'\0+>4:]>9@J@]OA6 *JD,2+*D<[GTK))Q M?]*Y7!Q9VX5H-EHL*H)H5*VEME[B"EHB>>'7P"82PDBR)(0I%5D2PD@(4QQ9 MW?U6Q#"2+(EA2L\JF;$@,8S$ M,#EA&%F1O%P89M5DA(<=#OM5:Z:8D2C\W1,&P'/!7%'Q!5=XF[)U">3 ?S>KG&T,R#^ R&V M;"]$7PA_/)M,%#4&GOL^;%R00W7X9_-,4BYJO+#4ULJ M06JYV5I&A+6M_,LS:GD[.9AWS/)VO<^CC MK[PJX6TG!R7ZDN@K'_2U?5901="7UFRK*]6C_,VFOG)#3#*9LMR]60?8E>$[ M"*Y:S47^KU]TZU%W3>7BN*:RU-(Z_EO)^W8YUER@GWXVQ;H_(@OO'FG+JN ;!"#&?& RF_4Y- MXB@G?P=TRCY^Y+A3G@1YK0>6M@/#RXW,W::R*I]IBZ$#CZ* 27 A/\7^5EMY"UUX26#H" M*Z+F#DO+S>74W&%:S7UVJ0DFT*7CDTBC68]8>T\JM*W>CI+ +5%HO=)RR!$I-6)?U1>@*K MH>#:S=)R\SD%]PI_.*JU5K.Y3[ZW5^P;>D/N'>L>:]/X%?J*Z>Z02WJ/U90J99^\S$W;VFI:S,?:FG)2W@H2TOC MX;ZJ[2,@J8YZ+>^2KT6]KMR76:C)F6Y 4L.6@>BR:UAQ355:^J2*+43%:J5E MY]I4[$IM8[^ =:_;\RW7I)(M ]%54++EW7'54+*?IJN3,]'=$052F@D=/:W2 M%7B[5=H569N>?FUKS#U,C7@OU75YB*Z"NB[OQJN&NJX@)FZ7EIUKT[5+U<%\ M2M>&K?6>U[=2RTHMVRSOEI-:MB MVRDM.]>F93NK:-EKW4?-NJCGNT2T92"Z M"KJVO!M/ZMJ"=&UYV;DV7=M=1=?>N;I))KK[3:I;J6Y?J6[+N_>DNBU(W58W M7RDW=7NP$K2U"&8*8#6:$\]PG0>I; M:E&X(^K!FZPN&$L]]:2^+2/15="WY=U\4M\6A&ZKF]65F[X]7$7?GA*BG!,? M-(Y4KN4AN@K*M;P[32K73:V]CS:%R5Y-3VVULMJ U6RVUU=V_;\'1TM2^ MDN^]WG*E?X\'Q'J..;0:&+TO'R=)Q92PY=5M7]_N2@Z]IW=AK M;)\>?W6,=P*;3+>+;[F1U=UO WBJ6*VX_*:OJ1) %0F@R'=-#9-;?[X-!AXU MJ>Y2>%C"06E+8%,$L/G7UG&TI&1)%DH6OCU9DH5;B7 21W%+%0Z(GUMJ@]6A MWT^_JT7O:O)$+H+6(Y2=(4@/NY,%".2/L7L3M0TZU2WEY#LQ I_>$^5J")\B M+F_<%+U_2FT=?H2?PO>O ]<+ $"!%.+E GMLJZF%C[[5W8%N$Z]^]=TBCTK? M\/$=; =:#7Y)M+7%'*W2QI9LE6R5;%T+6[<6O6D1>M,RT%OR78G>UH/>\D)N MZJ'R6^.V<=10D!T''Q6UU6E6@R<54B42HVYP.((LJQ8P28PU"->51H*TN$),\J-D-*1;AF!I;.[O7-J?QOH'JG&["JTP25NDB>1 M9*MDJV2KQ$WYXJ;CD],M%ZO"K-T),UR[Q0*!UZ6J2P*E*'*W2/I1LE6R5;%TS<-KW]8%%X.=7E4-=-[>G M0'#92?Y$?_[7[LXIM8BIC(E+J/UIG_YW;&EE.PVVMV7!ZP:U1S^]:[YCOT]UTPQ_7WE: M#]3TQ_C1YH\?E8'CFL2M&XYEZ5,/" I_>E<>.TD0W&P<=*B=J[@.Q,.H^=.[ M2_UK4U/?A8)S=G=RP6E6NR!0@WQ*E.1,_>G534ADL_YOY?:WBXO^S9]SY*Y% M>XL7J6T2?*!VP&C<9H5^Z=BHBRI$<2:3@>C_J=>54THL\X-R#9K](SS@[X#8 M!GRQW57J]7!#F/0^I$,HEH'C^\[D@_+9THUOBMKHP'0]QZ)F.*TZ: >8VM2/ M7@B_TF4"%"O!I-*;58KI0>>UV8S6F]]+L9[+T%YIOEMDR+X1;?YY,)8:#CZ; MX%_(N8_*W>,4QN^[^H :'Y5+?4(X=R\=Y&B[G?S6?O@U?"O>T^%^_K0/G,]: M!)?HW^H#,G1<>/B4+5V2[=T,MG-^1&(:"5]2/J;I$9.$X@RX1)1=V$%_AO,9 M% @7\H?G0/CMV9?+_MUO-R>WQ1(OD3F2'):_VMT!H(FE2EW8C8!/.61UADI8 MS51M(5I5.WOF^ZBJ*>_5CE7D3[X;8T2Z86E3M==JU\3SPN+RRECW%#.P'A5# M#SRP!/PQ]>#]J>.RZEL#HG@P36+N[L!X%(8?D+%N#97!(WM2 ,>ORS_!'NV2 MP(:OL2?J@3]V7)B7F>NI)('P>H#PNIP1,'%\^:=WVLH\S9/$VYO^?VN(48>=].5T%PD26Z6GL'U0,(EE$IT\9WIE^,Z P-FCU5@3S])9JY\? M/RPA,#-6PV#>:G@32YO^O._MSKMIRNK_XXN=G=N3I5^G=W5S>7)W]*"ZIXDD]T8[R[ M,P73Q$$'O^-Q,T;W Y%=1^)!#T=QB MNPM4(WPNW%X*VDB^&Q#V24M_& :6HL,1XMKDL4YM(!LL+O:4$<@4H,H'ZH\5 M^)2E3)T'>!!88UXPX .B(8>?=4GRI1I,RH6!)NP]:K,Q;7U":GB38?"A/9_H M8'=1?, C'Q"&,'2T6M $K*$)AQ/']W=WP@_ 4VR3&Y-[U#:L &T:H,SSZV0X M1-L2-$;\H?=\K& ZM80)RLS2R$ZLL??AM2'%NQ&P"CU&)YLTCB>ZMWK<0/2= M&B?%P5\54Q0L9'8QN^(=9TA!8N MH]8+C/'<"@F&L"5*+@Y[E=NN_B-^VW38:R!.0VQG3G1\&+Q X 0%MHNU!HX M%YFI[E&?+Q!,AGB>[CX*6]IT;& ,F-PX''L1^+.[ X+&.,!&"5Q8"9RA!_-0 M)G0T]OEE5F"92 JPB0MV+9RGJ^/^P='Q <##(74G[%>8DS_6 ^HA*Y2/*SRZ*IJ1U?UP#W,)KC=QN3V/:"R=]K;9J M[/Y8RYI<.QY+@?;DPBP]K_8Z%N88].[BNWOI4I!D2;(VPNT[+4)5K37,+_*' M+OLGPVR?"]-C#"T+S$P0G/+E)2@NL\27@JRCL0Z6KVYS8H3U\]G171-_.0Y# M/!>Z1S\JTZ@KU5P,:.EF6Z$(;W%=)&('M5I(=&X#S%U"E4P#EW'1)5D;0-9V M)[5N)[:YH,98)Y9RH5N.3I,Y M]0W#"6P?_;02O$CP(L&+)*N49$GPLH7@17<-Y5:_U[V2 Q>@DY,DB)6@95FR M0D=+Z0BKD.J2H*.$BR[)V@"R).C8/M!QY%@6QC0=TR-+#TQ:]KL@3BZG*D&S MA" 2@CRGR,+,G!P+^VDB+RYW#"(AB"1K&\F2$&3[(,@-:F5?^14FK,]7VBH5 M_."DB7TD-!C.Z!'E;,AGZF=="!K)Q52.ZDC:R=5.S.KD/#ZL\OCD__N M[MQ=*:=GE_W+H[/^N7)[U[\[N3BYO,N]D)),>5IT@K[BE,L$OI5-+IF=#7]H MHN!EE]KKR <"M9-OVLD F#)RG< V47(<]X/BC@9[6K-=TUJ'-:W3>5\:*8 O MZLK8)<.?WOTO*P&J93TJA<997F84TGQFFV1*6-5+Y8:E6A*7F,IU,+"HH?3C MR)]3ZDXBW+2OYY5YM4B(BA6;TWJ.CJ)Y>)74X)E!#"E&PM/8.+$(ZN2@:K&W$3)Z6ZQ0NF\5ER.6!4!5K/CUG>, M;V/'PD*0__>_AYIZ\%'!(@3^X[9(TH'402A4W5<+E>Z-E5/+>=@:'72XQ3KH MX#EQN71\(NJ:^8Z2%)Y$+'PL0945@M[6^2$//P+>8&#C XX4EC.6SLEGG).G M]9>X)U7IG2S0-A5/QX)''I8'^Z $4\#2AHX^J[QKOL^*SXSPSR\!WE5.1HKG M&CB,.U&;]6]?FTVU\==T]$[1+?^G=^^4_3S].WFY-!=.*7LY8X%:Z[#KDJ*9 MOC%:Q.C0.[2J9RA7]_,;K=4ZCK<[9WIH40/D?9'=GK&.=T\"D/FM\ M05C>[ 1&8+4TC:3!,1#N5(^[4[$'!^X>UBI V> M];R*8JB\=J/%!DN-[*5,9"=RT]7@G86.%U8'%*WI861-LZJEHB2*_^ (RUI4 M:(2G4@=L\J<,[22%-IIFRAZB8EXNUGJ$]X;$Q0,'JYJR6J\A3U+SB3.5XYF% MW&H /Q4G<&&3\-W"VY4\^WUERML?*T.=NM8CKXAK62!.<-[@1^'M*1#J\>?% MCYB*TG0A8\3J\47;W7EBU1(L\0*++PZ6N(T7B!?NA9=67X@9A\?N3CA^313) M18B Z\Q+[,8GNT@(MV!Q1L0&2K!6*[Q/IL@Z,<9O-A-XIG88W?T)C&KH\A0H M7EO>8D5='19+MT"\G&#@*_K "?RD](F]["G] ;5$">(C!Q<8*TZ#7"E?'%QL M>,T@KETYU5O!E;O#PK:+3X=,G<1.%U9)%[335$?-J'M>P HSLZ+,287S0$%= M&:E%'CEB'%SDAM+W%)-Z1N!YZ#R%K8SN,4551-W?9^FII<;#*K\NE@5V<1#+ M\;#B]-!U)JD3QJ(3IBHB#<;5'C 5>!%, HM[#II_"ZZ8077C=1Y%C_65S8W1U>M)N?#)RK.%68 M,@@0X;J?>DJ 4_%U:ON/#>4J]A? \]N >(KIW*KB].92MG=>7Y?XMX6>&P*'Z9"CZ2!7:1F)I'Z MX%MOYEN4=0T@WQ%7(I +MV9HO7G+:(J!C@WU'(9HN9GA-90_"-="RI2[91+@ M#:OVB]9\S'$3M3T0'IQ0=\>>G-V=JWO6?@^T#7=0[*7 W7ME[_JH?_69=W# M<45Y>%,4[:<)E]&\EHF/"\HT/DL% ",H(NRWQFU#&1(3@>;NCA>7F;?T!R]" MR/IT"N0S][L;(#3EW2Y&>'RP4V*^3/V"[@[1(]FLI.Y;@XV,AWE@H$C%4KQ( M'/"0-T$*HQ7ERP0'*VO $KTKA)"?8P^$M69/==A@4H-#H1PZ SPCL:^ [CDV M$R/$42X;FP.)AS%AO432QMV,S3 SD<\"(!'=]FCXJ6IX@B3",<+3%?64L5&9YC!S)GKP(UKZR&@^^.Z. M+1J]B/&E?BB8Y"OTU$0J@>'A: ]S;X1C$#. Q>$^(0_7GYW1U/OF+=R+H8AD M6S%9^Q1D4&S46E*/S-* ZH8?],(V0+7$:&DHMR@XB0]'\R'?@3LVVP%X %/ M/1^/=@JTD'MJLKM4;G"P$YGIK@D>T/P80Z,-["OQT(43XS!$,)/9*#$%][H5 MZ#ZW&\D"=P]KWLOZ-,%J@]E@L*8P0"N=,#?/1#=9>YX8^##7Y ,!NQ/^G1D# M-Q\ZT(1?34_ZR+*I_P-M78N2>Z'68Y4$:LIUD%' O(0.9RQDRL2)39_\MNP; MW>/EOH_?;!Y52K:!3^[N_.FXWVK*Y9_*'[J'K;A\$-GCHYIR#N+].^Q/^/[E M[_ ,&/,4P0/L2VR4V*]5::9]V($V;*DO-RS@$^XQ97+RN*2@PQ[7, M!] NJ;E6<+^])(ZJEQE']5'Y'90YO*^],J)*!E#Q "IM/0%4&\+C4)"?Y(Q, M0UV?Y^\3_?D(_2H&.FGZS/R\X YQ7H:B8A[!"BX"NSXRQ!H(#T!X)V$XDTE@ M\QZ(HMDBVN_QE05E9G5TBX!W-F@DB9OBE#OA69\DFB?,Y^*2],"..^L:3+TM MW(%\,'R' G5$N./@@7OTO8@-8)8>MU \?&K2_&$?AL>Z%/XIY*RF[Y3;&\ ^Q1PP0><'@+^YSJ/'>J1,PDK[#TIHC8:_P)8GF M*.R;!6MD.H1[?'0+?@_[[3[HCTG;)71W+',3IW\C-K_6>A@[%A$Q(,)U P/5 M%-:2.*).F&4+R&-2@]7@TTJ71P)U7G;]'GD] M4U^CT3KC=O/AZS^HO=I!LUEK-INP,_WYP"P,F(J_-'4I,(9:O)LY]=BY@%K$ ML7FP&/[.[YVP^;2KFRS8#$FBQ).[>0W7*>@O]/FM/LK#?;B=N3/4_4:X!9"X M2F.G1*;>YI<2X15=P'J&8V2!:];Q8H!+06!AY 6[A!!>N%% V;V-:'_NH:"P MNY3TG5_&52F*OTGNX;291LY(C&B9BG 1:D\#E'200[15,("!6)X2^&"T_Q/' MGUT'OC!;E6O^R=V="_[1O>NKZPOO/?=F1MVC+2.Z*L1N[ 3F/J$V8>>3<+3Z MX2X$J3;\*!R2VACZAB/Q;M.L:WLB_DY<=V*7-Q'AN;O#0CS%Y]$]F;&;X]N( MN%T[4,OL,1ZY GCC,;X8BV-]$U'XM]%]F+BZ/>W??GZ?NMV-/W+$8D$$4-GK MWQZ]5^Y@%0REA;&(J4/"8V&7JOH1U,6 -WD_X5&A\04KGA[L'1PSFZC?IL@" M'.NW][L[ETX#%([:K3=5-EP\HS/;\]T@/?"506>H#0W*9G@.;)K'8[*K%\UBD!=RD6 MQHVJ-AFK38?AQXD9/HBM7@/C3=./@;5C;YEQJ N[R->M1[S;$0M)01=2#!,T M4"4XTVCOZY$"3X88SGV?#84:U;%9N,[)[ IP=Q.)-12J15,\MF0W]^&FR^"&GQ/6AB9 M9:9V*F!HAG38,2]Q\A['K."*7^ZD Z.*W"S@/V? M&-*(U!;>"8NKWWL\GX4^2CX%PU#L.MM0F>\R[2H(9[N#21FG9JBSW+:4LD15 M)OB FS:AT.=15*B@(O7/!TCL!^I%.QQ'H>%'Q$$ &H#OS<3LV0?8'3^[?X[' M3VVSZ*F5$KDU[9*L^A /O#Y$KF61?W$>Q!8*+9:DPQFO9I6^:6*X3@SPV2?F M*B)7E@MO53SQQ142\Z[OO8#U495!K4/M2M0U7@?IO>Y!KT#:0A+ M]W"(!:.%9BES (3AQ 8ZWD,?/#?C .I-HR,CZ:80/GS0]8TD(Z)**+A[RBG4 M59+BK17;W[Q09 %L +CA?C3T4(S N-"I<(4B&KIWK&#"?3E@!/T5V+PN3>3' M"6AE9LT M,=GMD A\C,TFYIYBT1L)[V&4P*!/P<8&Z)2ZJ)'[JLRB6JE]]0?LBH0LQWYD M$$:L51(&=,<^[EC1L[AMC*05?HT)B+9C B ;<<]-PJV<\@5'SQ*F@XB1#:N$ MX?[D<>WLH>A3%DD&NGA.RG\X,@" MC(5O)CDWDKK%R/ !"NW+ATWD127T<:B!3=W7I;:JA@*HE+:Z8[N4TX?G(ARD MH>.QXU_LAOB60?F%PN'M&F-6+,(C[# &F ?%'<2+"9>*(=) M1K8R4C+KZTRYE5FX!;O)-5D^8)9W/=I4+"(#%5<8JO,$P)D?3507OV?P0D06 MX8> IVF5F/=:&$%^_\K &D:08&7AL_SM87XY%<809I MC>6RBEOF&905/PZ HA=@XA/%0XT9RK&3!P\V@6_#F"2!\_A00,+"W-P]]3U/ M;!4)IH&K&Z**' N=]E.YVPF2N&MJ3WL_1WQL@2Z< 0#3J0NVM<=O( %E EC% M^$D,FLB:@T2.U=@1E=R^S.N!_@>>:P%/AW&Y"\MS A?W* L?3 7D@-D%+]CB M#AU^HWJZ\ P^D'\QRN=.N#T2;J'((C2S_"(LGD#:3G('%+D#$L')++,G]L_. M>0=GSC/NJV#NT$3]@;3#U)FM7A"96*)N7+A!Q$9(1M!@&!VU9X)JTC<>8>QI M=K15+8ZBBCX9W^:$]R[\,_!2PH<:NV;EWJN&.%=J[Z4OU=,'3%1>9"8,5H0K MXB;41RXA+.+1B:+?1?F16OQ")-+BP,&Z@]SQ25BB%WL*3XQ;>R^2=44FA1*\ M*6%&,"60'6('H+P34?6;,\'-B8Q[8HC,]+(75W4U87@,M\'0<)<+1S(K3.!: M.PC+;&&J##^[,1J9W^AAL58@AX=I#PD\@.@N1GZR;QO -&?"$I,-0U3\8C>G M<$BRTFT\[MYFE<\PSA61;3KT/LHP';*D8T9E3,[N#HNVB,=!)3>=6H_A2.*J M(:J(CK;YVW25#$ I4K@WE)EPQ7K^-;>E_\&1P M=52_C_Q^1E@=8:'X% 7*@("DV^P.W [-#U&0*;5*5!2$TN_!XF;^-TS;CKB> M7K"(% ^+\ D:0YH&Q-##%(+PZ_@-$L5]L2RTB0BA'@ GA]2/S/J((G\,VV,T M#LL")V?&[Z-XV@2^AP73%Y:JS\ZS#,4,XP!^T+J- P7VL;66&G&;I"L+S(8, M5\A-)H@]D?J8(F0AA^]84 ,^IZS90'B]R5U4;+=D>\KX)2M' M6UD$1[4)=+#A1V/0QR-1=%)X^X9X28QZ(?%\_E8\"L_+3!1D2WL*H\V_X.(J M@ZY8R"LD'Q44:5938B[_;;Z$99S\QN7%BR[8PT,N-DWGLRVRTX2%RL70J;2< M\\+5X5$,G[-%-$&V^$0'+S\#$IDC<9Y&(ATDE8&1&C=5,2).)6&%[@=8'=6G MOL7I$+3COB!AT5]6991UPR*\1OW(<4QFK$13"3%2=&B=V9A&1KSY<>,3*>9> MJF Q<&VJ/XH2[L]/FY=(F'!-:'@)4T]'WH=-$,&WRP9[8G*52!/3VM/O57)@%TAX9;S93\A<,OPVU!NI MS&=66]O3,=A E(8>L+!55D@F\QN8)\/N9173,0+A#8L3I"-G1*2.:CP9QZN) MVRY0]H@C:\\BZK"9'GME*HJ0N\G&%A\K=C4DMUF%MUEZ-R4D-A&SCFEIR=N? MJMU=2@'=& &-O,]F6 8GZ8V=LZ$CL17)4FY&B11#RK.4Y]+A&BZ]B7!)=AT4 M!E.">+/@,E&&STPWXY 0LKS&^GG^=RT*! LSHPS*:;6&M'%"$_T'0"! G , M'I.ND60 ,^LYQ>]OF0^W%GEP676T@1.F$;/P,;PWL1YY5/XHNF>!ZQJ>,F*ZC"1^(>; +9L,T MZ,@":]-]#"^'I(A+$7\SQ)Z X8;C83UJ'IZ!]_'.9)!P N-&8-$*.S*^Q)BH% P#:]&0U\.&^!CM.%J.EW(;U@"& ?>Q:>)9K>8%N%> V,NF,QK @[>;10UETONQS&6!LLH(^%W]5*S;*""_-I\/.^ MMX]U)>*>+GD^G#^,FC^]^VY^_]IK=KX2D]!ZO<]7&FLD?#4P@+8)?[]^Q9]4 MK:5^_6=R^,NOSO34:!LM#)'Y_L%V[$N :"XU&$@$MMR0X4_O3EUG@M^J-_%_ MOL-^5K5Z2WVGV/#TG][!>!\2PX'"^7Q[H9R?7W_:3STV#J2I6'N;61Z?I'E\ M[G!_2C:?_^./!\U__AR?FOFQ.1QQID/J0GY7B-=7AN^P?J&JQ@*_M4I1?WW4 MO_J\NW-V_$&9%9IN6FA.J3LY,[-%YL_3/T8/]]KOVG_&^T5>VHLN1.SB5WVK+D3@4[J):^.?HZVJ GH=.E_K6I(0SB$[B]Z?^W!EK\ M\JA1+%8I9%I'5Y>W5^=GQ_V[D^/=G<_]\_[ET8ER^\O)R=UM!:?3O]W=N3I5 MCD^.3BX^G]Q@0E@%9Q%ND'G"EU-L(8YH 8Y05< (]NCBP1QUC?&OH/6""3:7 M89_X@*V^1#>S.N9*QGFFGWDG-.46&Z%Y+PA#74ZMSE3EFM6C_.A&NBC(E@?G>OLS,]U_'BZP#1\^:=W6KRL[=Y) O\U[?/^ MY._N+\>_FK-'VA/0)&-:.8KUNY^1O@4J' NEIC>E'Q'BJ+9 M^TH"KS[2]6F]SMMC]@<>NZ3]2C]__>?+\?B ]K_WIE?ZNZ=W158\FSL:[&G- M=DUK'=:T3N=]P0Z-L8?NO6YASES?/])=%\-SF<\;5(9V]G6B]X_^N3J]_OJ/ M3[[U?GG\\OBY7PRHR-(BPDG01==KGAH%<_C"9#Y."(GYL&"UPL"0'PO"]>EA MU'QG_,/3DU*[/^9K,H@[J%-7E,[@ETM"\CX\+7CO4E=6?>]JF+RFXA6D?WI' MO_L?[&!B.KY)##K1K7>*^,%C_J_ IOP!O]T>O_M9K;7:A[5FLQG>9(64_?P, M8_)=AB?5@12PMQ2PYNL$K-UIEE*\EL"+H@K?#7-8'?P83E#D<>,,:XI-?(E=7K/%GA*;(C3XH::NLL$DTJVVM+Q2':NU M=K-7'GG)UL+J5\)K4P 4=T1IBIA!L[KWX.3__?[E/\[C'WYG?0!\GBUQ,=58 MG4:;(A&OL(10)Z,;GA;*3-G"2_^&A[I4^KK MUJRJ)K>GCT3]Z_+/;N\M84=,N+@'$$7CD79,KC,X]6^(1)YG;1$:K%7K:9W- M@"8'^4*35@*:7+MDJE/SY/N4V![IV^85%J5(W93-ROU?K:[W*VF?']/UNSH$ MN:Q9K8UEC%F.-*NC8Z=@FN%B'R[=8B5UM)!+X0IKWRH&IU%[E/ M7KK3WNXL6,\R/O_!LE.S;/#0U?"8>E/'TZTOLL[!RYC$V<,<.;0$QKZ:B MFOL"=?F?\^/1S92:OVCM-:O+_",WQ11%R0F.-GCEHX@=BA/R8]%UX3K#2<7C MGH\/71?>7XV25UL$2R*, RV),%:)8ET7WZ30K$]HGO97OU@Q%N/-UIK=5:S, M-Q'C%4/3\ 2Y@R/$%T<(G"7_G$TNO_[3_G_MX.C8G/S^\)(@M951AI:WG_#. M\;&XT59&K2VQJ0JT##2MUCM\J34L[P??\GZP:/M'56N'!ZUR>NH*@LN+%%MY M#99R4?.\6RGS5OO2L8WHA%//XG/ME)S1?QZ#SU_^4U!:1HX2B\U'TS>\4KOE M'/T0RTD11V&OM>@8 MPPZ,FM&[VMF1H7WY[W\/_]/-T365(P/"N?"V8N%$9(SBJ[?14T)22#B!NBA* M2"K=#9265YLDI8\<.$UHW#/;U^T1A;.(&VO E9/OPB'VQ7%,[.K(#B^/;HZ/2HG"F;4XSUKX)$M M\YH7LXN>%(Y"W.^=$@$:*2Z%B\NK0Y)6NM-\"UU[D-2U<9S60A>O_L^OUYW3 MP+G[[:#T@)?-1RK:/'9.EF04$NQ;H@TCI:0P*7FE7BT]@CU,:-4%GH.;YC]W M^HG__P)KE -:??F<0O*DZ+]&] NU]0]JO=6"HZ1>K(YPO-:@+YEP/)L'?N[8 M(Y^XDT3\X7RDH3>C+,=.\^SXK*/]\FVP'M29?\@USKN.$X_CK3D5,NAZZ2U; MSJ#K7E<&74NA>?(D8.F3RVF^(@Z);JW57>G>MD31U:VYZ&H\&WA8-3\<6N9E M\[<_SNY_-[7"$G.R(PWG3PGME3N+158GTW*67*#7COO2'].WS5O?,;Z-'0MTL(?A;/YCHE%$CG"036MQ M Y)7,B(Q)Q8BZR5F)1H5QT6<_4WRKZ__?/G^[4_?^N=O[8^7!(N_=6WQ*9\VPRY%AO_YP>6B1#6NV@N5(? MDK>^5#@F0P)\,6_(_?]G[TN;TT;:M;^G*O]!)^_SG)JIDC.(GU^ Y@\%\!E$.CH'R>_I+VH')[I8N::Q.L]4W<_'AK]:3OU?-'D$HU%^[1T%65FQJZ M!0A*5+AWLHPSCSM/=0/]C5VX0RY9.PYE6B)S0-1HG]>2,R0I?ONT^WSK YN1U(JM6OT'_CW M*E2O77;PU^05+ADKF?/59.R.(:W,JO?=OM+J2XA'"=F< MT.][7^M:H@50E[*:*IH0BCCEJ_JFF,'/X 56.^[R\&>NP60 C/Z\4OW>+&6+ M5]\GE4^GE;R:W^V8R<6]&U\7GNEZ^;-3D39K7 MAB6N$Q#N8OIKUK(E(VC=- ,,@"PBB95GCK3R7)'/%[/($1#!OE;Q,_P?!V(\ M]Y]%8.57 PLRE+:!42/CT>X=8."5)'9;B@WCICF42M_0<(*5MV4J&MP+'C6_ M=$O6<,Y-FXG]MMR)LWGW:_5.;&VT4[91^9S) M"#M?( ]U_)*@R6SBS2W3M),4,K>#8:[<>QUFVDX?,T,B"IZ+5RN_%IPFATR9= I0]Z=(/%B\X06L16/7M;X>L)<.*U=9= M)W,C-(77S?=##QS&TB4I[7A)DMK0O*UDKN72O%L7XKXG^W)B5*6. />J&[() MM)-@,K**P[R]^YL+!][:#!S3U$! MHN 75W?7$++YC=TU3N$>JD?7D!PR:-1U%DW&F==G0:Y;W_8)Q5(\:#20&L.F MC=+NONMPMOUQ?[A,TIFWN*,NTC/]R)CNZM$Q3V(_!)!F8',J6*WR&ILE^ ML8XQ90!^M_7#[#1H.HW-;63"PR!FVVU7WZ3)X^A2. MT/ 95W6:N?G1JJZ-.-26;WXBA7TE MBBKN-T^J=4O,6YJD3T!/? O8YH'QX YOK#4R$SUS]ZP()\P^CC^VY!*!+,<2 MWWRUEH4#3AX.V)(E%S(LAL1 LU-?C15,+Q%G9$Y(:82H%!TA\F8G$-$ 142U MVY@_=)[[\_S8*KQ^L]NY\CZ-+N,=HW#H'0N,45@=)6(7G+(+'L!I0@&H2FZG M2G(F>1@PMP'FX2&O4GFGGGDG%S1Q6A',PGZW81AV&C2=1K2F&*S0K>F3B6*A MH@@T6Z&&T[%&0),Q,2&,-&.178:-)W&YG F4M1U#5\UW*7"K8CK-EJ=ZMRH?^_/;Z?W M2E;-/=J#?3I#GS[]#A>9_/CH[DD!(L70._7ZM=#BMVB8E-]M_3N4Z&]<27[!V0+VP*]P=N[9/JD0#;,86R=MA)M0 MU>;JL-,Q97$%W-9T3"KNM_XXK\ODY>*M]O:]=G6;VV+]VZ)NKR9*":!O^_Y) M^RX^P:N3:-NDM1QZ[Y9)&^$V'GZU"EVA^*NSGCFO:I147;?LPYHD;5S[6UXR M\JU6;W3CU%DV4Z!$KV_9.2E2N\)5*@1=*V9UO1U2_I-KVUR). M+OS3G%^W[YX%Z^YIOWNQ0JM>>2_B7'PN_VP\#=1G>R2?Y%X<07N)^5X<8<5" MD1?R!;Y4*N_;3HQU3$HZO6#1_$TD^8557K]S@!R:A$(10#;/M:G*LH+6)ZH= M49%;6DV<*I:H!@@5X4,JC>3>;6ER_F8_I:=&R-\I5.,5F5,T3B*;97?JD#NU M&4%)L.&"P&=*%'4W8+ Y#FP.9,[%"E\H[)2*?NI,HEM@B8H&Y(9H:) [FE5) MLB>VBIPI=3!4),6*8-"]B7:N-\O?'B[R[ZE0*;!WLB*94("E_9XZ[?>/]9=] M,XAC&K(#-_-_G\Z6BA(S?*Y 68NRQ6PY!MIW MK=I_M$@[8 0;O;;.)C@W9S M2[WE3!6O2V&'#) ,]S%&S1K@KC2 M]/F+.GE/15?FMEDSC'T7GHVO;E*/B]G*S;\+K$BKC_[,)-5J_B:'6AD0A/5@SF\E?./Q94YD#LHRE/4SI7W%O##Y^$"5)G\ GH@E!SFAP MT0 K+QLKV^3_7F? M*&(FC'$.]ZBJSH7#EQ?]&ZY.5]ECZ-O-71,0UR&*'7??JW>18DG4NT+UQO-H4KJ!J0\4E?N!O(#@EA;W1$ MPD+P2W^YWT)_\7F!RP?^^0M2.HKH!A"?S@8 LD?X["D^-(?,<%_OB<8N9M=2 M)DA01&B"5)IN8QHYYC^#0+[?C=C/H-E8S@;07'?^XX?63>WS/W\-_DW9MFKM MFV[[JE6O]AKUCQ^Z/?C?Z\9-K\NUFUR[T[BM]EKP$RG;H2/ 5/P%2!5 M'GU*E9.RJI9>%+]G?YVA!8F&?OU_G[+^">3SH2I6'[[.[YMW@*ZS MS5!UMEOWN:"*I1P!7ZL1GZ36=\Q])Y9L%R CQ>M=$3'(A)+&7H!F@Z:A3U#O M*>08>E"L<0V71P"C\>;$:JJF">#_RCWQK3\1VZVKN2RV^_-LY8>@_7B]SK\F M--[.40N*2"O8FS+.)E=U(W7>D3WD%5LX1ET-Y[]'<8"Z;RO^-]K3N2&A96=4 MA'V8Z)O8\9Y!_VOIL513E#*E%5[,Z*W'2^BU;.RWA% RSO*XL)8/1CV0IM5$"U4A5 9J6NVA V2_ MX])Y?WY=Z&FOU4QI-"C'*R__1>_$@6WP-@6:B80=?:2C:S7;=,D)'"1*GD"Z M3V.>N__6GP\NGU[U'Q=:]G*?]CB;\@ACFP:/8*$/.8/L@65+T9TM%0)4"6X$N$!5C7Y%N"R@ 81T@LB1;!O M,N#'K^]E24EEQ[7&9*KJ,P"@M,&[A,@P+38I_K# &I4'\V7>S6Q-IWVZW@4J,,:<9.7'JT<(J[SDUS!DJS&[+LPZ4 M6VBGR-0P%]FQGOO#:<_*S)54DR /K9F6X=8, 2J'UO M-H3YT-Z' 9]('PYN%:O$8F"_['(=HM1LB:*D.71YMR88C$._&Q#%QKY+)8H@ MM+EKR@70@"&JB$3R1-$4%&E&[6&CW1ARYYMV.9OV1MU]QDU3V^O+(0)9#6;L M(5JLA3X7(&R)DHL&OI><1N;P,KQA0K] ]97^N*]#O?0 M,H,$=(J+/)\8]OST^A/+$6$3T\L\OBX^-I\[3S_NE#C3;X[4L@M[?A:RM=@E MI_&28__!*G0>(^>YPF02@VN"<(TOP@!%D4!_.AF;>IQ.YP&;;ZT_UUJWS8Y\__"<>Z1S*C+9 M"_>'"G?S)S>$S)O3O5)\!M?U+]K0OSD",/&K=GY[KA5MG,L'#JGXD_&\-(#H M (5K(X1*?"9W*@?VZH[?3,U*#\B9FL5.8XV:%9PWICG.89FJ.*Q*%JOUU(2G0P28KKNIK@1W!4'T3'Q=NX,1/+V MSR[:(>D-VR J\3_+GG:6ETQI[J)QY^WAZCCH64*T7Q_<'L[L3OWA7P#I%") M1TP>L7<9(%;@C^T6\9;953R(OZ^'TRDBW8RI4XJDT!?/H(9UIKR=C159!O#A MD%%EE;>!H6:RN>*G?\^\]5##1 ,-!'QAXT#?XRP$]U&.Z)(MW#?*+X^%6B'M MNC-CJ$FY'C.[]B$"@OJDHLN^$3FR3(T8#&XQP/WO'!BN+.S MV]%^WW#[$Z["Y\LEZCL)!KN[NF/J0VE0?M\4CTG*=OWGM_K3K]EQQJS'SB_= M?3KI4NR*'7+%5H$F:062=4FA&S3;RM0"E2ID<+@43JU<3A-=Y(KU8L_Z=:M^ MNVU)Z5$=@VFC#-*'\,$5*$D\^8L7\A1%A1EL]N>$92HYX;GOC/1UZ*:H&'B8 M?$OK&& (# /(74N7GA:98K/V5JI\']_JE:=4JHJUL:B- &20W!!NF7M!>X8F M-EG&U-TZ?#+<.[L(^_!/[(W< EG).R3S1:924HV?+1EIX=1NFFT:EAK*BXC: M*P6BFM[O(DSN'_?3=G'8J]>_CXZL7,;?.XCP5+*81<8*;ZA+!4Y5Q(&B1J5& M+:Z?-6I)OE'+MIX^OPUH-K1*W< $$^XYEX*I<9NGOZPL7W5[SKDB M)-0GY$Z<]F:9K)2Q$DH1.%8'.AW[+YQR5W;A3WWA-Z1PK01K ME;T3E;0I'/ M9BB;Q+>8CL!PFV[<'I+Y&XW:')^AK2==C'U2ED9X,SLZ43N:-3U@I[%&NZR' M,@+<)E"(M]7@ZQ3-AHRE[?5L.P>0MP'RN9[X!LS&FV6(D'DKFFC,6A:8F)![ M(BYIZ'AFF!LO1KWL7)WTUV0&-=6 ?GK;;-0*SUUY>IX[CGYZ &$1=;@!)@,W M-?07Q40"!/[3[<9B(;*P:W"0!$X0B$?5/2NL9H !;K^64M5"OQ,A*\@RH," M @5O>&4K+V8D4N;-7('8XTF7[$Z#49.W$!E@3PW8K43:=HB-S>M.F]-]&\%T MOI-%A T;*V#8B)VK^1Q;-2\75:7U/+F?[Q/$W2$9)CER86,'M^V6O*T[72U6 MM?%F%Y_.B[\.P\>TB80B98*+J5KO%,#)V%3%G4QZYIEG/@@:?<'L-&@ZC6@] MM!G,(%1,1P,#LL?V%ENDB&I[&/G!&V"UAU#S#_4X']= =FA_,\6W?7KO'-?I M'MP5FR"3!DBSTZ#I-#8;NO$P&">/&5K#]?9\7M3Z\T:V\/;V#,RBN4_Q\(G* MY((Q/C^J1U;A>&H9[SE,IX\';\$=S?H'@(OFZ]L!49$4T9H$^90%9H+^-C:>[UI4&WY6H0S1)L8#:DSD[1@4L MIK=G=DGWNJ2X(' UDHXP3>-T?;898]\45 Q^<4T94HG.MA+U30HVBL8-AT"R M5L@>HD\'>>@X]S,SE5YGA1_'[I@;?TI$*SH)@OGC3^V/W_K:E5CU'P/-KJ#9 MW/B"HN*[W,ID@$B&;7JN5LLRE(&-F\GW]%LPU0U43M* 7[!F;K&>S]?]K(%> MME4>Y^QF]VL^K;5Z?M: '* 1RQN@[<;N%'8] .Y'\])D"WRFN-/0,Y9>P'"> M+,XI\!#1EU;7,72HZ)-Y4$@0.L(/=4"YFG_]*?7GOV[-6J/]71Y-]NDD=80) MS! 1N%_]:4UX]TLG\ZWZ)WDT+@_!G]TM^YFY;$[NYML2+PGD;.7Y4H:.<;D' M)6>MT>Q9X/[=!N[9:=!T&KO6"^RB2ZXJF_;&_3B*D3&;52Y>OSU=ONT31-OD M %ZP1EPEAQ,#:^4LG8-L]"RP7$[Q>ZR'C/Z0O;^5 130:&(Q8*(UI/T,D(3, MB!,7*A?Y?'&5@-S3D(@F>@I/?$N?9CGD"(^!:(FI"F'BK*7] =;&Y@]&/9"F MU6R>=PGOLG_EB1GK,^G.M[PVO[:JC22:P[M(RFY@TBBTSG-PD9\W83*[YTW$ MW^-DW89OC(+T?[:ZA:N?XAS@IGY-P9,X&MO,0<-B90OA+<@=1:\_?_>#.K+] M=]@Q,29-)9,.ZN,-T=#@D9H=8'3'H@%"%1"7SR\O7:,FE*Y4.GV,YZ*I2)RH MR5"G5FW+G9 )U4G.1+MAIB*UIB([#9I.8W-CWQ+H@_U;?4I][6UR1FK?4CL%R6=Y/+*&=J$#,96D%]F9#:-%C@NE(Y)_U]JW^(U=N-U3E5*G)V0.O MG^AJV?+ #EW0OOQ@DT,W=H5W/X=P4LP@$J7'EV'"YWQYWZN^ MTKNTA84MNV3 OJ79#1!%3-Z7E=FEGG91$,CM,[]U"9Z.Z1$\DFB7)I MH3Y3H78 M#,TI1O-!^ND2E@54T%;A2V6*3*EU-L8^)2%N()\DA+W1$0F+P2_]Y7X+_<5G"2X[^.[K/=%X,3,ODC)!@B)"$Z32=!M77#YZ%AC-ZLG#D %V(_8SV<(GE^7C MZ.W'#ZV;VN>T"0*XK5K[IMN^:M6KO4;]XX=N#_[WNG'3ZW+M)E>[K-Y<-+I< MZX;K]MJU;Y?MJWKCMON__Z^<%4I?N,;WNU;O9PKW_+-1O?WXH7%3;]2Y>J/6 MN#YOW'(Y@>>0\:_RM. M=1-"Z-G&?1UVINIV+/K3HKL3=99414A?7>:GO^;X\M!$HU:!."X\6@J_ZIIC^Q^#O M)[J&$7@-D#W6G]_S9WI485, %F HMH1%;FE MU<2I8HFJ2QOAU[=V^>>=I'4>/T6MYZ *AY- )K\SB6Z!)2H:D-VPDDN;RXMV MQ;Z=-&OCT:EPF8'3=K4O'2>_"JM:NGUX?GM)^_^K]^=/3A3A^LL9/ MYY6X;\S68;L-\BEQ*WKUIH[Q:G_O4&:C7__?I^*B2;=EIE7\RR7RARP12R%* MB$;7>64CKT[\B_&EWS\#@_O+6LQ%_OL2-BCJJ.0 CA2"!5Y#GY F@ZG^I$ MM[55??G9^9S\?!SO"%7T.?D":#J@.A@JTLK)%NR 3GY KO.'*@*=? $TG1!Q MY5%%GKWTRU1D0@>.F^+ULNVS[;/ML^W_CMN/K+K(-?L22@W)"!FAWT<_"=F< M$*C$"/IJB$#M*]W^O%-Y%3/5W+-6*293;>'D/.3R_SVH&YHJ:A+@N3J0<(S. MR8D1*BNT N>M63<5+AR)3#+UW,WQB'KS$;+.74!4RL7@X2\F>*.SC\++MH'4 MM>D+A4*W6KN\+G5JE4^_5\WV$,&- MY+R[N^\O;?ZP;/@<7ZF4^'QAZQX")P;;[W/95I494P/?)>Z>*'Z79^GN-$>7 MP9;!]A#8KDT1VQ?"^3(O9"L,Q@S&N_=WV!/'T7E\A[J1%3LAL'-/+6-_O@YH8.=_>ZF66+V2*5'*TK=MB5 /V>%5^ MM$T+5Z+T]!7:#+8*!Z()9&1[ \T4T8=N 22RJ5@ OOY%D4 'KD*7;X&DCS3\ M%%P'VI^_3B_UBT:Q:JNC&#N6QD@W#!P.[X^3 AM<<9Y'OM\G9&H)7^=5LXIH MVC$[VX0%?&&C@#\!D5AGIYTD;](R9+OV'\G:Y )?$G8:ZLY8UGME624:61:# MPZG@4*81#DR"I5""O1/9%&UTEG$_Q.!P*CCD:80# M$TDTB*1W(FPV&X8X%$' OKJDT?F1% M+^][JW-9R@H_*_(E6A@)4U-.IZ90&?U(-_^DA=7X8I8& M2[E$D>;"&,[I&$Z%1H;#X' B..0V9P0S^?.;R)_W(%E6VL22;4(;UBV8)<1J MZD8=#*S&FP5I9BOF&)DL_?GULW9_91O7XT?Z8Z/+5I@,=X1,L<"6WM7M\JWC M\QU.E7P@.0NYDV$EM9"%#41H&4U). MIZ2PK.;T*BG;<1L:+&2A3)$BP]C-Z=@-E3XY!H=3P8%E)#/I4*]O&D3>?;V(6=+U0DZZ^#H6+NNI9T.&CDOP%+1P; MK6'FC>0\J7F=%P2^F"W2P9>8@G,R!2=/9>9DNGDO+7QH.ZE-@_6=S^W4:8YQ MH_?*C:AT]C$XG H.11KAP(03;<+I78B=C='K@ '@N3.J$BF9QA3LV@-3D171 MF#GMHCK&1?%AJJI3H% ?S":[@]]$#:0"85-K##C1WR6T!?W.ONDH]UWK[V?@[M!(WNO!&SU;0\O=&ZGBG_O3,W31L+Y(EVQ\'3?+VJA MMD]_IMA:?6<9P!C CE>XG2U2!3AFX9W(PBM0Z7YD<#@5'%CA-A-'L19M9XO4 MF_A%W\S;IN;]%DBJ:)K*$%KQA*1.%;R)J'>EB -%A29=3W?F@ZNR#)6A>P9WV;]O=C9QBV3J2P:9#)Y>YF<@%2A MPXK,E'::'L%8U#ME444J6Q R.)P*#ED:X< D5@HDUCN11=&&9G/'MM%.E[#6 M_*(W>+YX'IO4!Y$[!I@H]H2#:-I<"LWX,[,6V=G&+7NIS.!CLGEOE*9*[C/&X5;'$_![HA \-[X[D*:4G>RYFZJL!%G9!M M'[RXI,S+R(,Z*:D8FNA'T]9JPN8H @,@ V"" -P'S"VP1$4#&!-N$&)[J0-JGB]E"KOHPRL 'N.!_LDX MZ;OGI.7-TXT8)V6<-$9.^ANPRDAG I0AJ-N0X'4;$G"WH86VPV-XD8!A.E6I M2K<_+ZHWAC3LOMW]W*<]U6)\^8 PLJB*F@1XK@XD+/.XG,!SZ%Q_7^]M:-*2 M?Y!D@*YMF9:H(>"AEG?09+&^OPM$!2Z7^&ZBP%P>?K!3XA1-I\3P M2!$>D\D4J/"%PDYA&II.C>$S$:5_3X FY#DI9/AW-9>$X;.A%T; M5/;%9G"@6)CNK<)5^&QV)Y?$T<\CVB>1V\\G\:P_?!T.2LT;,^?9EK)B3E41 MK@WN'GSA3NBB^'UO7*@K]HG\$8W'Q\;+_47OLO?$_!','Y&N"T0%+ID_@N$Q M_7AD_@B&3^:/.#U$F3^"$G]$A3F/MKL[%)7;G@(HX[,*A2\K$+A&&8G MLC@I:F_#,+HO?\EG-O?B8&='Z]EM[EC-SH[)!DN M&",-WX3_8O;GO;?B[+%EW*O3(IT]RTA\+#@D5Q+-\;NZC'ZLMK+Y D]_!-, M+'IK?M-^W=4JAO"4\Z*WT8=Q@K'$&X:E+Q!I1\4QWL!N(<<7A2(=;"/M-^64 M*L?F1MWL[*A2.;:2@#38E-DR13,7&QQF M(56L.]HHK&]I%/I=W]K#0%.X+I#@)RT%&8NYQTI1&72>.H]9ZN-D_G;0>%S) MWQ"9=+1J)&ZZ+Z%O26:VM20W'WMB%J;P4E:_SG_V\N=%S\+<]MAHM3DWDO.D MMFB.%[)97BB6Z&!8:;]NM$!O._Y]).0MR<@'K]>S >-SK=16F*RP%D],MI>G1WQG 8LL@SX6WTX!&CK$!JFM=AH/-V7 MT[>ZRQO/G)!N^= 3,[(?1Z^"='?^HM>4-6'>W?'0GL+SQC//="'I2,[O( ME[-EOB@(=/"GM-\O*G 6S:Q/95.7Z)%^#%VTH"N9A&>H;.5W*B!B<*/4"LMN M'O'%SH[6L]M<,LK.[AVR^5ARER$++^Q4AWX*>SGCVTXNA0@!JV9+DVT)VS\] MW:6:^YG^/']^#:X'V<=Z_HGZJ+2[:M?V$DT./DCQ]H<#G,X.R3I<:XQ=QO4O M8O6=E!S$UA*-U7?2=W:K)=HN/)D&NZ7$EW+,2J8:;%LRBAPKU$SOV;%"3?K. M+GDF'X?50AD#CS9:1V2RI.(BMQ1G+04KOV;$':NLH^[L-LV#W$<;VM%Q$/V. MG;NW0N4*1"B@E5-%/1?[M#+HG1AZ^YDSE.,JVJ"I^5&8S60,FXMHX,//;*UX MFP670NHB,8,9-EEP-ARRA7D.[O0SJCJ#UJ]M.-$8IU\KNZ#,L$G%06RK8.69 MCS6]9\=\K.D].Y:21=_9K?:/[ZH2G<2>"6N;Y3)+WF1HBR4B0Q64HLV7XB;S M!3T0F.>!LK6. 8; ,( -CC+.W7R[&SW2&8DA&^'.0STRINY>X!/1 MF !BVY!E( .G<\]B,LQT2<=!;*U",=]P>L^.=5U+[]FQ_$WZSFY797([=8@" M,Z; EXL9>K1/ACT:L!=/+PFJ@!5MUC1WBL^.%?JF]^Q8>BA]9W>(?WT;58H91PR% M=*/PMS&3:H%JG+KRHD#^+)MAHQ+_OW#1C7%_965SWTJ_ONXS_7G;4$^\YH^W M.PZ"R3-GR"*83<-LFO01SY5/5FK)L M_Y@X1)'EL*;W[%@.*W5GEQ!WC[>8AA[.'6V25/S(35TQISJIG6\/N_; 5&1% M-&:.)3)_[G[/#151>A@4D@G(Q&M_>'M!Q?ZFMQMVJ9C=D8J#V%HR,9\N=6>W M0C)A=]H*+GMJ>\.$&XVWA@=@LL4=& W! -#8IF M,RY[MI#G2_E3P8KQ,#IX6-S=$5:PL"*?.5E_^-^&@\6*E;@M,*@CK3C_TX>$ M&K[]=0NFMB&-11-4-1ER7L7 G>T@U?#8EOZ\^Z1\S;U^;;^U!C$&@L)F5^FS M<)#AY6^"$S69,[QMN+38]\'>H"8RW>==7:S( 4T;X(#_?W^J)#B::5 6K'SW M^D$V9&\TT\KS]8\FT0%,Z\32-A0[YMRE98'D#F 2"DPB4:KW;&MWEY@WG[JS M.X YG,C^CE992Y53S:1F["$N]L!2G--[=BS%F;JS2XBU[VEJTLVVHRW-\V K M<( 2./4)N-)-:%A6M$JU.KD'F?D^&88'U5J1Q_[-"9\+!]F=<$><"C?#B99E M* /;$@>JTQ//T@,-\U:<1=S+V>(61K[R"W>LR[G%ZY.*)=*XOE\GRIN-/,RN1/<=%X9Y"E@:-M MSARED5@,'G1PM%@-5/J9ULKV(I[IZI,-$:JNF(AVBF8#N3T%AH@V8T+JMH<] M\:T:L 5[>G2^07\N"4\]V;QZ^WJ]3U?XW>OK%NY9I.6*C%9X/%SD]"I%X^3 MOCG=V_B65]N]'%%7YRIJXH<=?B!Y^W]).?"G>V-P.A% MI(\"6PN60@P6]F]'M"(CVNY$*S&B>43;(-CC%D^GR:E;E4FW;2;5UJCXDP$B M1D#$JBPF=]J12EZN$IG(! *)3+KTY,RW(;E,?:71GV>:5:-]WKPN/B1;E>1N M+GN@=70NJJ(F 9ZK PE?2RXG\!S:[Y8<]M %_#/PT#_X=ZV5%GD=\.LY6;1B_?*UXZG'>:"REO M.Y+N8&?$8$4*KLN%EB@59B-5LSV,._MM*>DM6^ KE0(OE+(1'&7YR-?!_WC M^_TNX7_6D($Z6"_)A$1QO91;GBVN$) ,S@S.1X-S3,F("R5: I\IK=+_&+P9 MO*-6L\$6VA/?287P,GQN91[^:1'^)P,W?>#>UEU6":6/,E;YCM$4KT#?6PO- M\*7\.DV4'N 1UT_8\5/>S_'SXYMU59?FWWOBV#.[9<6*< MWLS5PUP][Q;<6[IZ"IDL<_7\)FABKI[]7#U_X6PF^!/\>1I\P]^Y_PZ_0])559R:<"WN3U^X M5T6VQFB#F?]&H=4R5F6[6?HT\H9'ER:0PPB][M._S;,@Z5RB?>%ZLRE<0=40 M!XKTA;N!_(\0]D9')"P%O_27^RWT%Y\AN.S@G[\@I:.(;@#QZ6P ('>$SY[B M0W/(#/?UGF@1AR-5\(_8SV>(GE^7C M3A$?/[1N:I_3)@C@MFKMFV[[JE6O]AKUCQ^Z/?C?Z\9-K\NUFURMVKWDFE?M MAVX*-_:S4;WM?OS0N*DWZER]46M9L"O>2C)IQM$5NQWS=*$XN4^T+ M0K8_?WQ\ZOQL3F^>+@%DS?8$+GR&/P(%C*MT<&=<+:B7>'\PD>)2$\TQUU3U M5S_VLCV=MI,"G[R\]*0#BJ3;*EKYYO*$M=4/&VL;O$!KI=&/B)?-[_3"Q6.V M>-/*KFO8&5TP<:R5"VB]&6_E&;)R6W_[;MW.FFT9Q+UT/TZ]0@,@)[^A[C-N MV;IZ!ZZ*@1_^"M#&T1I5.?Y.2^O*NR'XT:__[U-V?7@TI$9'K#E6(JZIK8@B MX8IJEJ55LF/=OE1JY3X..]8,]<<:+'7:EI.DHI5@ !(4K_=WWWYT.X52N!,@ MTJLZAHZFI@C3C1VQQKOQG3BU@SU/=]&M$<)1O@*)"5 M#!4+-Q95H+X^$5M7S5I[WGS(].<_[RZG3S_;I;NVDM@$"V)3.49=$7GV8J2( MVZQE!>V=MV;_FY B%GZ-$._>_K-^4T+QO_'&63=D$/@X.EK)>U[@L]F=IG4F M!T-7AFOQ48F)G )>;Z4V6GLQS' %8K8)I_D[4@ZA#EUSOG=_#4_[,_'6?7\\OKIL=,N)FSUQ$@E M7Z1)WHY#G2:9B1[;!8W"U-&,'J'("\6=C)X$10G#T5%PE(!U W648IX*%&WN M(5R5'VW3PHD%/?T60 ))B@I"/9E[^LYN\8QPWI_GS4IK_%2?C8?[-!..R=8Y M@)0!TJ >Q(9+'+(.S>U5C-H3PY\EY%JW(6E03^(HO_K?['Y3Z\IEIT'3:6S6 M0Z]%XPG@[*LND&P#WZ\[S0!P27,@7XB*YCC=L\0%8P94T*DB].Z_:U)+51-3 M0;-Q\R)__S3&02MH=0WAQZ0D;V=DL6( M>+_LYNVCF./YUIN@E'@,DL^5RDP-IQD\P2^NZ5>1W3Q]]]1>#E>,M+6Z8DYU M$[<[:@\)TH5H]??R99B[M>]>)GK*U5_&0I/S;:P'UM%\&B?37Q@GC9.3YC:/ M=3TU)UUVM+2UEO8"G/!.-"M5BL,+^2KW^+V0(D?QA>,U,$45H"0[I#5-9 ;U MF*">/S'4V=GM:J=ON/K)FN@EOES*46RD5T*Y762J'@G\MZTQ,%8$T&;BY.6U M^Z+^&J92Q70WRBEXI^Q^'9AVLP2;I(WP_$YSNYG/E$(Y6J9293SW?9:^L&B* MBH';H[6TC@&&P#" C#L<1G/'R=/P:^6^,/O52(_26!N+V@B@Q*4AW"SW@G8+ ME4>RC*F[:?ADN&MV!?9BE]A[N06HDG=@YHN,?5**G6W99UZ@DGT6 MID'7[W M1;24%Q!P-GF_NP%6-/>\LHN5TL_NU^[+*)6ZY5I.*GO[YU1%'"@JB^+'>2ER MS#:G[>PVV X;F42RUGDN2W,Z5-571INZ,8($T0 DT+ CS@Q=53N&;@&\7OC3 MR! G5[JH13/5NT[)?,A?=>;/4GITTL">D1]S2G;MJJ3NWM&/:/.<"G?/;N/^ MJNG6$$M:015X05C5U9TIJ&F1Q24J%=1 3M*-KB$<(YA#)A9P8AE - &"]8-H M&*)FM4S3!O)RBM(/8]RR[*ML^SR=@79G>R:GX UR@QG7O._4R3+@U<61(YZ# M%/D,K^L :)9M ,Z9ZL#NR=X93#L"+_$$U/).?5B8!DTIQRUDJ.2XPD(ZDXF4 M? #5_,8;*H^T%7.,PG#M81T,5K@$.G:I_MRI#AX?Q/1HKU=.]A((;=.IUQHB MAFHQY,>$_%.GG["SVR/];"TC.%:A/B]D3A6=WYJ#%H,A>J@2H,'+[2&.%50U MV=7BH/D&'_RB2)"D1DT5E4E$5OW;N?+4:\Z_-RYR:599.463;8E,29#&HC%B M(?R#KN-.J$I:'RWQI=RI.K PWAZK7"Y2J9$V?!] = F7!)07($/H5R4)\C_+ M^17Z6,< +XINF^KL 7[: EI[.(Q66H<-5?OU)OVMN;3=!9" M98)-JB8Z9)USD92I-,F(3FU4T\VHXM%,OC?LEJZ_6GOU&#R]FAOLL(%Y: MLA();9NA_Q"5=QV@$O>X%EC9TV^$G-BR%2J\D*6H]#B::]<#7+L+;7-P+II MKNF3*=!,3+1E?FV-NC]GTX&HY9 MS*E2#AA//BIJ8N/& E\4*(J<;B[OPOU;3;A :#O6=7M@#6W5M2$C>/+;C[98 MS]1L-9UYN-YNL<-B(,I8BV9:\W[^B,"@F)48.EK7@.Q.(R"8QX$6+KTS>.+C MU10%%#:KS74P->!>5BC+F=I$4.;%QD\[1=D0P2UQX V):!:S.^@R!2F:>$CN M5/5B3#<^ E#B:RY+O7.BL=*EW-(L41LI Q6LZDCX?6976K+^I,R.IA#'Z$)6 MO/TQ%3A&]]\B;!)W'><0:P2"%M2[M%1](> MWIF$3%5-OG)*9V?1F1>@/FG-)>5[+Y MS?",71<(B[-A9&( MV-YQNGD']%K6"R>^%S%V]+Y/8W.U[3*#6;TRGAE;C"&)9&\TQ9B[E<_1;$:7U[+QC@&F MHB+7G:ZACFE4U63<>]F+7T4P]NRW[G?QY[?22S-%16G.=EVCVL0JHXZVZE1# MV) *FL7FPB1S-[=!6^)A+^8NI15/1X-3_-T?\AF*U(A]' :NV.R(,R0S(1'A M;PP;>*YH:% C01#VM]X(K_8DKTXOQ6RZM?LIV3:6!R+9.%F+*RG8W4U&Z5^' MMZ1%08[/LOF+#%4QFP.%DS4"WJ4C\:=P6M9 MO-S'JW.RQ&%G](1!]L8NW_[1ZTVP.4+.0[%(A]G-D+-W:*U2H#*T=KX^M(:, MBQIQ%*Q5CJ\ZHV'U"O2JI72.-FLO^T58="TQU64%K!+7@0L4&:X,1H?[V';! M4?Q^D!R?R=,AEJ-9>W8M:W>UF+5LO6;<2M*S/IPV]^D(=(CN^X5S/T6>_SZ'?(\S=561H^1-X'E[ M/\F]-=,@#DA*R7H4?.$FHC%2X",R>]R=B/,_7B@RM\ILG"Y=FLB3C#J+/]\! M!K;3)8N9T!BS/>D57/?*03H> T$IO*(YQK7(,I#/9W^-ROPN9-5RC/[G#J,Q:]I5GCA9+WO MMM$T@_7!6U*SKI@.RP1R6$XLB89L?]XH&H\U<5AHS.08]="M=<[XQ(0K43'RBH.@?31Q5.8%8:=(W]8:8VQ"BD'[_4,[ M@;P3/I?;J7/?90FTC?A_9Q3*4C MB$:OSL4IU0?K]==CL_3S2P8D-\=D!,8M 5A7-XIQG!*F7>P M8<8";.^V[HZ=!DVGL7EBW@I6V-)>@!EFA7ZY]7E_W@92[>==H:[5J7?AUW#O M"55_-;DAY-]0!76VMEKU9!"F!\+L-&@ZC)"32 #()M*5NJ(*VL-+H,H] M_5JTT(RNF3^K"YF^GK5;;LSZ\_N?-]]:L^M?OUZ32\&-O86#NV'"7:PQX$RX M;6^2\21J9AQ#^"&)9MM#+/'".[Y89(,Q?ELDQ59A43A9U[)]ND\N4ZT.D&$K M6D#VRJL76'NY]/!T,ZQKS_-]2JMW3AQ>Q>6CF349(N=NP:N4=J[4ND2B;=.$ MXD\$6U/(L/E\DN:+Q?(JKKB<^+6)A+32?\L<+B$T/7+7[4??Q5I0WQ)G:-"W MV=.KTK.M&"!J+"JZCZ&*)WPGG\#KT^/58\V:IJAC5L?PEGWFB7Z+4U]$9_/L1L;$34N,F])V=NLZ*VS%&9)EIL4*'94; M6ZBCB[;7N6TJ&C!-8%X8NKG"EJ]]?_I647./WQZ.4I@?OSI*=HVGTXR6W0 M,\XZJJBAP30-^-LI^D@T9_UAOMJJ?"&HUCZNSAL:7*J1JG,@YZ"NC$YUO(Y:@ SL;&J$&?MDNSIFXX M1 N/1XC@XH^MO%KKG>L_Y7TF$1ZB"<=?EAAH!!C)O1=7QXJV3E6TM932M!:Y MB7LM=KKJK-CP-\!M8K!-H)5AEB[T[F6#;%^RM*)%6:#@'LDU-ZWC1_;5;5%V M>]MKU@HOK^5?C]37-WD%]CB1@_4GBST3X#"\)>]&KYS,;F&142K1%9]APV?I M'_Q0V-"4+(*2*YN2"4O"(-N?-SMO39 I7XT--9U-R;!@^ /U7R&K4+0_0PW* M6&^R!+3)G=LP;8W3Q(O:\JON/ 7J(<,D/99YHN07NW%(N@<]C" M08)L/C1?&ZVNH/SH/J6^CUBXB0-K(D8;LXA+W4U:S.7Y\FY#CIF\8Q". <(Q M6F>9_$[-!T[NSSO8>&*NBG?;68:=!DVGL7?CL*:BB9JTNG'8>-K+6\^OK9<, M_9[UQ>0@[: M9\WNS\N/';U@C-'PXW#76^AB?.4AEWPBMQ&?[ MED]5ZL(88YPIV@4ZI_NN:F?Q(!J&J%F--V!(BKG0A_9-E3 D5>/@2T_1L*0@_D\G\N-AV,<QN-OM]? M=_?I;'PB'Y2_2Z0_1#-4=O]BXIU%QCMI.[OUNNQ*#I!X0+]$1\/;S>.?@Q*F MIFN8X4$"U<' 6M8^S\]__7K2]&B3",]!E>M M,*Y*W=EM[4%<8!G)\M5*D?HVJD+(_^14BB)7"N0L/;-_> MIDH-=?8:9J-.!]4@+V57+QZV63IU/W9V=CLJHQNX0<+F^\DZ4&^CD)ZO4$C/ M1>TI6A.=/7X_'PXNBU]MX1UHHA :AJZJJ+V?!22_22K\]\@0)^S>Q<0S3QWT M9V=W@*KI,H.$&26?H2G%9[&7\1 MKD>$K9CHXEI9Y6+RE8M;LNGRYK[MK-SU=P'-AO8.JS@?90*"CI8-Y;U*Y-8T MJG,T\=[@W&E.YS9VP'*FHU_;7P??7O.9.(<3L.YTZ5'?#@/9$3*W\_E3=4=F MU@&5\(IQ0&*Y2%%5P,K,\K7MZ2(HN45[.E<<9/OSFUE#Z,RLZE59>1^]?8*M MZ1P[@_6GHT99W+T5V-8(3[[C3RE'?\,4AFJ:[>;-[LV3=]G9J7]U^?CQYCF_CXRAI06JU[^#-8VC[O[%I(0F7L>?X842ZQK','QL#)_. M:#JY/(O3IF'.A&2=":S=$SN-P[SCT:YPI(_BR2R#;[8J-%IWO]Y&]#J\%4TR M *K-5S3F_#Z!4#V%ISO/"UF*$L 8E(X,I=@4M#Q?R9YJE/->7NT5E%OEQ2:L M/-N?5^ZN7BYU0:QD]FG>=_PA6_#,(KCZ=H-4V&7<+>=@)TS%S]I7#)'(\H65 MLU&2OIIL1O"I$17_4)(\7Q!HKJ]I+L0NT?\UGFWE1511.M M,"U#D2P@HS]4 M-3G\B\ G6YJDVLB+ ,D]U4U1O8"\? J_L4I(=/OSJY?\ ]"KBF3&6="8O,\9 M;9W' H*\'/ADX$1-AFL6#1G" V%"A*3B#(]J1*P,P$C1-&PF#+D9$ WFVJ/; MM7?,JQ'F3%6S/8Q!XRSL)-281YO!G@;8"Y4#)Z>FRPV^>N+E\<1RHS]OW\_- M;*OXH/U(J&%PC!3U1?%&*4R6L2B*W\@ MPU]*5+Q32+5SOP6.0] %,JX12@]J93X$65%M%%-E*Z)FG']S-9;ZF@YU>+LD MP5)F<[\(9D/]-J!9W=MG%S:7A%"@W^J/EA2UL*18H-^2)';ZS45D%4#),9YG MQ1LC\_)-V:> [E3FS'Z>Q4.MF<4TA@T2ZL@JYM;M^9.ZROOBD-D;# P)*__4 M=]H0PBP=T@H8+T!NZD;=8V=5TP06_,TML&Q#:P]KXE2Q1!6S\;=KO?;:F9J- M7A+=+S?*/*S!&\ZBT2D%N;"(UHU_:>"5XP%_9.U;ZF7KYI3LHU=%WX[]]*)I M$!>D$\EZ5'SA)J(Q4N C,NM;'^X*A'CXZ(I0;;&\JG)LNK^J].<[./\M;2(A MU'=T3WIM'IA37W"-+ZO75:LF&L8,ON]>5&V NQ[1JN/@9U-MEO/P@Z7 MF_@XK 1I\.[HLSI3&0;140O=,9:<\I_C99:(C:,AIV&C2=QN8J M^Q:46,CKUA$5^0:0!N3SI_E(&A: ?6$>>TK]4OM M_M 5[!MKP._E9-T>J"!6O_5_=HDSK%[%L:)3V-,#;W8:-)W&YDQ"?3+1M:ZE2T^W0 +*"ZH.OU* C?(+S'%3-ZJ2 M!!F&Y?Z5F':7F4'C^:$NJ_5Q^GU[F 1D,28B!&T4M+U1("S^$ &T]D=## M=#ZUPP 8IL>OU^/7Y,3LBM+$&V*6^')^52$E!:8! R$=7L48T1N;T[',YS/O MP>V(A_+<0A42+Y[(I?9C^_%*UM3+YX3*=$\EHKRY\<$AX1+Y-194ELZ98]%@ M;D@J^8#7CB>$V:2E5(&OE'9*AV>RBF%T&XS&U_5OMW(-BB11QK>AW!1MN/#V M\%HTGH"%K((N_("!W14HC5M!_;=P[;-E* /;%5EXAN;\AW;WL"J[+]2/UJNPR.?*)>I9 M"L,TK;&^7)'^6%]D_9A[Z\RVUC' $!@&D+')20PCJ:)(#T^3.RG[^)X,(V_7 MCJC1N*F[>>++8]>.6E&R"K!)6T5,1#"L'B0B*FD2$8%8SST)K;:' 8=D]54T MG)A./M_-5^Y^"$.XP;0;(??!*#**WN =.^$=$>V97;947+:\0.=E8XBA2)58 MR=B2=5Y5TNJ[*O@RX1:HT)I_ 4U1,7#]:7OX(!J&B/KWF:8-Y ?%&O> ,;G2 M12?&,NCT7G^">Z5Z);\G4\*E!%G.$-*#>T$$0>+CU2$)IV":<*^0*'!)QH13 M(5D88TB'**$TC9*D'0R.&\H()>J6( T7%/N(>)*=) M#/Z>CCHA6#/'2?54R>4KN<&YND_!$%T6B+]SLB#5WS]G^03@+!UW.[%FC">D M0XJ4F!1AB-D8)MN.[24]4B^3VOK26K!=";+GB/05G,K2J\YCK?ES,#?V23^F MU@3IX@2N:*>58WF@F#ELE*DR.>$M J2AB]( M5CK]5589M$B!B9V==;^2;7N]AG_@ZU9DB$/%D,@##90AVGV%:V4)K@ MR!!#D6S9GA$F[<'*KNPT30]T-^;F=@PP4>Q)6XL2(DI-RF=*LV<]7TJ])>)L MU$O&92*"J@N_K8B@-,&1(88B$;&"IR4L#](:S@AD7+7AH4!RJ5B@XJEWI/(? MG:S9)-(+XGB\.E"5D.MC'(4%!(&M1G M!=,&"91VJ^Y6O2/R( 'CT(=QBE3(EF*6R1:&F VR94\6F7"O9KZ22ZN/*Q^( MI@=L.SQ1S*Q*S[9BN)V]Q,KCP-+L[Z-2^@,CP7AZP'%EC0$GHDV;"D:>/N1$ MSK0'IB(KHL$2L5(B278?-\TDR?M$S-I8^DI^E[CKJIC6^I!&9'](X@'LZ5U@ M6:J7V.:D[A:GA:RA-P8OWQ(:*'V0!*E%9%*AAEEX)UYJ[FS+"[SS[+E-%W"[ MX7.;+]"!TP:W9;SE(./=//!O)9"W&_B7%-$/I-9_HK9^FG/;JO/@BMN;L,Y< M7J4QQP0;CW_]A?O0P)_1_QQ$T/ K)8#FP>S-=+]P^+.F,@?N&,-_!MX.!O\& MKA'U"^^-P<;%A(IX9JM@D0O/"\ M3#P3V@D%H.;?%OS%A QX30\)UIT=7/K_G)UQ306H\M]<1QS!R]X%SS;0)/C] M0N$+A[40"&SN[,SE8;+RLI9WA :.DFUZGRCB%9&N6A)05><"X6N(_@U7)[G_ M#K\#2EU5G)IP+>Y/7[A71;;&:)^9_T9M?/6("4N?1K+7Z!;7Y$Q"K_OT;_,L M2#J7:%^XWFP*5U U(*^2OG WD*\1PM[HB(3EX)?^&^WA.-%[EF)&6"!$6$)D@]Y%(2,F:6P)M2-NNH MGV=9K'^>?HOD84ASOQ'[F6SID[M5)/[YCQ]:-[7/\1+@A)O%C2D_?H"*>RTH M5)J>4.D&A,H[V7-3-^".QX#["43#Y!H:"H34@00F V!P.8'G4$,D/"@#J6O) MZA2/T"A4AK.C75.B-=[8$_AE:>NN4,"4Q"EBB0::IAUV!K2-D:@I]>P+F>: 3_LL9?2G[\\]K+6,WCZV?5[P%&*B9MVK_'Q@\#] M[_\K9P7A"^?S.4S(;*T_UY\:W4KE5&]:OZJ]5ON&J][4N>[= M]77U]B?7;G+=UL5-J]FJ56]Z7+56:]_=]%HW%URG?=6JM1I=#W0INSD+WIS$ MKLRY:"IF>[B K!GY_RN G@^6[VWW@/Z\:Q2S^6MQ8J@CVN&Y ,=BIC\O7#VK MG6*E:G\MH'BV?[??%[ZH7K*K]&C29^X/Q#JRF2_H=_A'X0O/.;][!8N_L*X&R06?HRDB M-[ M[E4WGC@1O=)KF R_^:(8E@T5(&=MGSEHJX>4I(\?HK0D;)S#QR!K'=$) MJQ$*_/WK&-HL,TY_U5 ?32\RQEW5N6M%,G2>"]'8_;5+D\^I0DT*@?Z /#'( M[0)?)(TU7=5',VZH&!/X4: -G8&IZ%"8EN#"@*"II+@8X?(ETQR"@)" )HR9)?D\%LNF%B[$JV84 J;./'\;B"^"L5QWC M4=$D"\+45#1@FM@7"#?Q.E:D,?=*7$$*?")RO0\ 7"+@# !O"Y()^,-_I^H0 MHG'C^PJ"OH%%W\'.VPK9\@M#/[=_2H1?(2+4LO.J,I^S!45+D+913G\J5EDI MEBIQ+3-AN+9MIZ@'WK1G&W!=4>QR4U6TD)3BL==-@2QE:NBH+R^\O2:Z^_#) MD+, $2?8.%=95%7]E831X"?@94;#*)\B. ?6WDM?X&6'7$+1'59B&:CK+T\6 M [^DH5=Q4$R)9[*AO #D2C919 0_&V@CY(C"'=?"7 D*'--T1@M@+@?9G094 M\_/*".>)[PNE%^2WO1&]L:';(V>6NZ_:0$FE$_T=8+R.=:@AN?(/";$AU-8T M"5T'"$JHM"'E<(*^BS]N3N#]...@0>5@$ZX _1Y>-0T!6C+@;4)S,""XH#8V MT>&E@[)Y[/2)@K]&FIF;IQ1X+Y;AUFP%O+T 6!J%)M5+;H@2Q(BC(CLLS5S0 M=A8M*#&3O1L&QZDJN 3)CTD,<_T#MG W>>0CH80LZ"V M*?!%BHB:"IE,P4Y:6$+KS?.R9BO$RXI9@PQ"$4UTHA/Q43?@S5RVE\Y;%UQ/ M?P+:@L$$?X]_[1F1?V!3T8 VUY,&GX(LO*9N2) G= P=ZO@XL'\/Y;+.H$J H M@@NE/&)V:.4663A$XLZWV(C)]#I/ #O/!!MNHPLBFDLBZ; M4);+>(XS7NF2$YM8K[]PV<>,K1^J2 M! 2D@2Z=4%2J 0*B)2I$#)-7(SSZ-'P/?/6OD OXWQ@]PCBEZ H:#Y"[6;.J M)E_HD'PU'0+,T-;[@RM^1N&6#^C/6]\*@^PT4\]44N$_X*,4[$ MR]$/4RR!L3D@8M8$6=P$<@QH^F*.#?]&$NH0;QE!*8M^3[@HY#?@34(<#3)' M^#R/:4,,@+.&^IK[3Z$GJED,T)_7GG M/'==N,]4:C?2I@3L]<\-)R!6S?;P\ D_ I];T38 \<=0Q4!LV"*N$85@P[2' M2,M"LA3"86@3ORH7"!T@&^+C!V03:B'E WX.&Z78.XJ4'$=;PD(506I)Q$<* M.J1/D#QG+/--J/% "B /C&M^0B75@FA74-$ERDV%-LI MZVH=0:A[4IL$H,8 MZ<2]C!D9P3"\/T!$IL[*]8O$#A)MR!#A^K<(4P1VDRI^DU86N1E?CCD!.:-J MR\A-,N-$&2V'_!D?\@39O\C1KP'$_9 ]I Q#_$I!UC.VEJ.1A5>"H 7YGX2J M_^#OU!F_Y1W D0FLLT+->BH:)"HB0IT8VN*>66XC^@07]:JH:G@Q'S^$<8ZX M*[GNF'5-D!/5>0B\7*H3]\5E9;X6;\)?FD.'0<(_A:P"Q]A7'/(YVBW>,"*; M!.^+"; /PG4[L(N0\));T-B>!=F7"[B#!0!*$88>1#9<5 )J;CLD!I<8C+^#M#RI1$H@:0ZX@OHJ)B MYA)PTVH0-)R0Y:#J9HW9)3I&G)JI;T"L<*3]@YA-O'#P.PH)4*98K*G@!ZH*'9TE! MP[ZDH'YF@I5*V<(Y(5 +BCR2^5?>T/W[P/\9SV%R"G'< "8U% M*G(3 7T8S?,&0%7@43I2'_*ZL;=LE_%@G 39!D\>"3^H825&Q]J"@?FWPWN\ MSE;+WT:0LE' %*H?&@ R2>_!I0'H3R2$2I#GZ1IHOT$W)-PC5)@""T+;A$P7 MQ3Z114JH@E_TF6L- VY>S+J#:'=WJR %"%F4Z@S1!YJI4'Y,D"S ?C8DZK21 MB3W&$W&&=C1$;FA2+2G!(\3%FPLKY5".L@2U?A#RA*J6/@+HJ8MLEGZ^%[G[/VPO)C(6&,G@CZ["1+8!'Q[,!<,0:[[6GVOR1>7V>_O7BY%+6U"PTI^7+NS< ML/'UU99'J%FN AD3Y(DF9L.A?;.@(&T>;]=;19J'.:X)/>S/7E\^H1"9H@9D M"5+=G'X*9"@D\0^;A/D[R1M!N0+MV FR>(DY&01J=.WK4QP\. M4C4"&MW,SE1[;IQ"^=_-2 ZU2<3@U=E,9N,214JQWC9H99&*G@01D@IA?R(@$Z M]'LG.(<3'T7R)A+S14]Q%T\">Q$Y&9$;NC/=ST=L*YR$XP7&9&+_*"3DAL(% M_M*=)W,R,50\4\.$XET5B9.;* '.;QPK'W&WL8BR6>"Q0DQ(*3-)CIVRZ!6Q M.P2N^1$#DS#CY41%OW!]Y9?Z\T[V^\WWBW;'N"JDS0XI]N>Y9U%]^#H:=V_S M0?XP4QEX9^+75B>46Z>]&FJ-Z:^']7 5NI.LR'!Q01E@Q7BZH 1SC#(O T[( ,O ZE9(J&AF)='/*#J4XK4,+6 MD3#QWWJ&BW)0;EK 0L,?0K42ABU9MD'R&TPG5?N,#)JP%.'OY@?]Y[^=XH/Q2_JYUQVKAW MOC_O7@CSM^>[9^4-:M=W3F*8MSO&N&GS"$0D(A+G#=)2D4V/2P$#+!5']Q&O M\-WT4\]9Z/_9B1?<:0IF3SAA%G/R*KYBHE=N=E&M=KQ2,\*Y,)W)3'G&SLFW:?CH)F*1JB*1.(KT;[7KB^4Q655$YD2S9ZX*% M2Y9\F4.^1Q3HT!JA+NSN!$J$E"1%;AW/WMH763D/4@#JI>,+_($B>)@H#$0Q'(N3/"^/-KR MR-,7G,8(!G+$F;A:Q,D!FNK0)L4)!5@O\6)\*'$,V8DA=V&$+4JPYJ@N3O 2 MY0YAXQ9/846Y^RAMT_,UDFQCQ"DDR&IP"Q9QF'@<2Z$CA,=Y%,+D*]TD_ M@S8S8BO(/PU![JIOI'X2ET;RW-0VX+Y,G/#EK">@Q/ !A9$$2J'!#ZF Z4&N M*'J$1?I@DX6'5DJ^M.(ROX=+D;R*%)A^X)56M%#9DHTY7:0-?!X]+6;U]_OS MREOM^[VMU2]G@[0I5.7^W/ZA53K/F>F3F'6G']^[DX_]@I3 MIF.=5S6'%"$ M4.:$+!IDDD_ PIM 7@T5 :?.UVUB(T+Y"N\#[IJ&?8CX4^@Y0>,PJ!'Y.@4R M4$ H#GJMO0BO)UX"E#*+I8'1.D) M+-M)2,$,WBT;7TRG<11.$3D:>/SJ@8E3[O"T).^OO",W1?D%O@S*1MUV>_)X M/4S,*9"03/6WZ>WI*$P<#1N@&N,IO):H/,;U=(>O4]@%A2,+*#$(X<(7[KAM M'6I#A4+BP;LX5J 1!)6*&7'6:U ],'&=F$D,GJ@+##7L%BH$>5,F<(5028=( M-5X?6 MQSC7+;A,TM\B:J\*2J&SP$@W'/<4SG%#F5^X L%DC?&V:8SWA5N9CDMCS[R" MHAW[*&+LHQ?OTE/6.0RJD5?H8I(5"AQ2!,]\%F+ZHM762%TL_->SC1N:8)T M>T^0['YQ&4HP.HE:LSBNCX"P5-SZE7#)OTD<]V@A@3IM$9?S??["T=H,+UW0 M9UAWL)Y%4.>BL4Y$*>^5$L$%+&(>^SJP(,?/Y' #"Q&[6H)B&RCX$:3@4YT1 M8>O^Z_,7!^V:S,!-&X!2#>[<1G#[: TID2118ZE$0< ,>%&N%&DP\WAG (#F;U8P&.+ M>=DR]T+$4YAA E!44.0H5K^*:9L^@)VT% M_>\ZW=M0P$8WG6U'N0^(XP*UZ%4TO'DWT+%LS:]R-;P'5RW52R9.,G+XY"0@ MYJ*L;:=9Q*)]C&J<7U"G$8S?0%0 9?OY_\)A*=1V'D?M2)*>B,P"X-;^X%"T MTVJ(V+NND\!SZ@>8H>=TFQJV'(RI?.;J)#&.9 FBVZ"%BYN"^^.]R)GL)*"@ MUAVX>ME-M8=W@\3;<#(AVB3Y(/<*3[\]U@W+-_B@YQ_#'4' $CL3?8L/U7! M_CU=(U5:P>? B^ODHZ(G8&DL^RFSJFA:;L$!<),V2,Q0]&K&?#6.J=)'6/*U MJ"$M%HJ ,TC],QQW)FW/T903+YM/D9TDK2?7((SR8[G#(;!>.84Z!50ISQ7/ M'Q9HH VUPM$8:75^R)C,_0Q\=R&L:P!<\8[-,1W^C83,W&@R:AG[Y+_(:2X> MU!\#P>EU+R)AK<";2/[APLM2=<;QPW)Q4GT"BZYJB&+=76/!7KSCE'V?[ZQI6UG G+/15W#4+@AU: M8;BO,\ID"R_$ZS^(+S*IV%KH0;:J2;\S5> S]^ L@'2F]79&^#N\,!;.ZR?% M#FY!!2Y9$,TQZ5V&.FE8!AH2(KG1X2:9+N/N9VE95G 3(*EK^-7H41% M7@\8B9@+B%[6P=%U8X?"$A6\D3L^T\*1(H+3S70MXYE_YR MR%97C/"=X/ZP31L=6X <)&D8#7.4O$$.\-\BEA^.,1]X(USL!+EJR'/_#/>R MB54]. )32R4G#I7.NLY?T^GOXS0?78CNAATX(WA8.($7WLYJM\:5LYDS(7.6 M*YP5\C7L%5K\/A]J#^%F5D%.L^R#M5#6/A'C9&B:WP5P:! KG3#K%UVU)R1) MF:3+>=[=0+\=Y[[J&FGBBNMHH6KAM#)$. Y513G]E,';E*3E._ -)(2);FM[ M8O5'^HO]#HFD[M>=\(9)$@B$DWP;&Q40XQY.>,($=F,B^@0)!OFFKK[@_$'D M;XL,KD.V[A3:A;ZZ+3T_?O )BD!A*99M12#!B3Q8%F$PR.7IUYV19DG>+)B47!'BMK1?VD?PJ2[S,XG. MBJ6NHU]ZP"=1X8!R#%\3F8E5==^ R8T:GI!:&'SV,^QPA<2%<#&,=.O-Y;FNZH\@9:-4JW".K 41? V;_WDF7WJEN^1S1AE!GGEB:: M$ .BTTTK2E7SB(R&&N)J1%]3QY('2BC4*,R'?,"AC89* %*G(J) XP@5MBC. ME<0'Z@#2;1'BRQ#%%4YA88*DFQU>:H"_^;+8+5O'Q@3N!SH,B" (.0*#",PI M%HXUD ^CFXZ4$[?GM=NH62AGX$YF :^W0.I7%W81VC47WC0/#PUJA.Z"T:6; M8A7C,W=K0[ )^3P9:H3;86NH6REJ18 ![I -(X_BD-['3JUZ' M7&H?^ M\0/F:.*"2NC%>!M U\)&$W)![]R^C+R"#3#W!P!''LO%IX\\=MR$+V2,^.WV\")\P>4M(]R.T=V8&;;; M;,CSO(MK@.WUY!E]-R@ODHPN88**ZT MF.@R4 E[=J>LP$/T-NMRR/"IIUIM3_-];&E$R<+M3_VL[\8;&@Z7LKV@YO<]X[SK&ORK#\Z[K.,8<-.(0K,<\<=3)\=3:>XOJK-88\3IU:1(WFGF MJ.G:F3/K(&@^^#5DJ.H0N^\ U$X5RVM7Z[:H52E(ZAJA#S-0VH*9, M=% $7]>)Y0K[(ZE5WK">>GM^)-8E21BE>3->4D\"YHX%I(HB>5L M,#M#_W4=!;V%Y3BU[_!NH9'OOA7A+G '$IY*K?7F8;,F^=(U$%'-CCY%TD+ MUHW%!@:*&?4<9VP]"Z,ES];-T,@.T@,\5.3DYH!S:W*DO";GN%^Y"^_P4XE? MPC$!D877#3C-\:]PJJ6B+11_R?>Z1^XD MNVXGZ8)<>H/\4"%:C//?.MYU>%8!:,"SZA!^35B& E@NQNER,0S_C,S0&3DR M57+/"#F0R%P ) 6 &UK#\1*'63A?(9V]L%KF.;-PG,DDKD7'2T>F>=MX$IJ3 MD1IH8^F+/7>25-#QYJ1^> 8H>LG*)! DH+U-=K?5 .9_( M%>UZA'4\$*M1(.Y00B![A#"6>3@7?@1H]XR)SN#K$P@BHX_I,R M##_\%0^V=G,2G&+CC\N:=;3@350+3 M4!>,E=!E][L).+@)H\-5Y<)8B(Q+*6B"M_Z$[6Q].9SG9=LYPVK(>USV-PMT MNW2'V#D)*,&G\-C:\^86+OTU2$ GGP_57>#5A*HCHG8O1L26(B-J9"ZIDPJ! MGJ>XV8-.C@]*]/+LHK"H,A:8^$(^0O"I@;;U*& 2"GBO&!^HBF**?N,"N64NGT[2>#\27H5S!*==GN#$> M2HC%\@NQDY#2ZD31H)HNDN8S$S0Q*U!_Z(: O/9TF 6B=BID[B].D< =KTFV MSN( VL\$'5&S:;U.PH9,,KE)HI_3_P]U@GES>CB&^QF'&2E:.#(]\*>@[%GY M-A1'$K4G] /*D/&DUO]G[TV;$U>6=>'OCO!_T.M[]HWN".S+;+SZ[([ @+OI MMHW;V#U](00J0&TAT9*P#;_^KN!QC-*X"QUYQ%-*N1:_65C4J"W+^]\A\]O^A MQI[A^-!(H*=;1QK_P<."H@&UH? !]_7RT<=T+IE()I-"JXOA"&4!=A!N562C M)>D07M:NZ3W %@*<"'$F6'OI06,$W$52)X5INXP+._80F877\@D6\AN]CY;:]W\=*[, M52Y/\I7BGYPN_I-T1B !@!6G@TLH*2UKQX*BKVT+7-A7H2Z["C6UKT+=5Z%N MFU]V!^$=ZEC5P.$O>./HI)'AX$T]Q[9&L;<@F)PB''SA*M!@,9,D ]^&9J[0Z) M(@%,-Z[+F)"2L6(N("\#B@H1Q,4\WA3^& [8;=0-@<.(A[C>H=8K^)UTN>- M6:AJ'Q3YO O'+?.'C>N7B*5/^L_]7O*[_E0M2$N_.)V#?I8A.]\X5F+F9Z;; ML;%&?F[A)>0VOOOCH?S<3UW_^-S:@B5\I2N0RDU?P9G>Z1MS -;32AOL.:9H M;DWO@2EL^"EB1I3#G;0G?:LQTKO7K8O:9?N^M'/&0Z4Q>L@5^T_MWI?';Q:] MO=1YLE[:.%$4N;K"DE3B]YD&2[ W+]9'O">L T!Z!(@JO"K[#@"[6*Z25SB$ MPE<\IR_W%SO]L.W%:!JGZ,9?3P[:VD:<%7%";8VI@5X>EJ,W/<:"@7^L@*NYQG0NQ8 M"UG Q8%],F0A1JV;BVE7QHU,[Z<:?=-H&'UF&B;I_QH-:20V)C_A? @AG.*S MZ:F?XC,8^_05SG_Z\\ZIO'8A\1QYZ+CY(Y[FN?[Q\14$U<6+/?9=MI+!>&JV M^,[H--TO_KX@OSL_'V8F(::LVM$4 R"X_L4D&K,61GQNXES9C!IC$YK3VJM> M7U!S@'IE='K':<7TNQFXY CB;1/LOO\(':$M\U3$F9+C^0W YT-V+_!7V<&8 M?"J\V<>BL,"Q2,ICD5S-L5A D)=[E$9?G5R[H'_/Y2XR2S\627DLDB\\%I.D M?N9Y6+95:9 M_YJD-GF2RZQ/:OAQ)5<^FM57,WKF,,6G[-I3OT:+9(6-'=LG5Z MC8JK Y\I?\XU\85^.RO\*AH_?OS4NRD9# \]E05V@LW;/BT87ASQY=CY+DGY M%4XF>U[CPKU3BF!30?4J/=2F"Z'(FELVO;[CZ5:M?>G8G4OHSUE$CK#I8.J4 M5QCY!LM\FOPE.[_(+L6AC]OC,Q1[[Z7_?K4T:DS"%,]MF"NAP=LMOL0 M^SIIBWEFG=YEH0(L "L#45;0&"2.B8PUGFN;G(DMTJ9;R>5;K7AI0#A69< 7<@CUJY"-!XK8#FH@([?)=[ \KT/<<\2I",#+\Q! M%_FT33KL#70KJ."YT$Z-"@E=5Z='5:GO N/@AXCI1&\F"^OPXKL#J_5(W.ZB MCV;)C8 E"F#E']B6AD<\UNB^"9RL@![UX,XE'49FH>ZNV1Z7FK!U)B >3.P' M=AQSK,?Y.5ENQ5<[-@V KP#&2M<;GP/U2Y*:CJVO)U88R]>4\2![!A-T0R6. MPJHR:LX$!7#L^WSF$3EE4H@8F G#3TC2#OYBS-< P(11:,K.TPS7 B>&E2:$ M#@7_8VA$O*K9&ZL+"WWJ1+MVE-<+-G0@;I9%$0'C"0#:9QP[X.V8<.HB)8O> M)",]!0_9(PL6,X*H$P"\5\,;BY[ZHFU 150?MG9^PV?>1S1&*<.\>W;.[4_? M.[MF[!0;HZKU4T_]JK7/6]0@%Y-F*H.(*>\MGK4-><(.(%.BCWJ85V=AJ1=X MZ8,>L@ BRZX+K&*@V4\@CR[_2PN8.&4M+%Q)9J?K'^.%R!@YD?\0>6D$KA!H MQ0D N$"'>1'=*NO/@%L&._JA1GL+*FJKAPRD?@!'I3>CQR"4+H&[BS_M<_K2P^$V$AR*]M'UX(+\'J-20U$+/&7$? M/B%!%AH@((GM!.IMAS'E43)[@>Z:&1$%+1V)Z9FG#E M=H"[&&HDP;C@34H8"8@ZG4E@7I<\FN3)B['#8=F0\'?"T<4.V-*XV*W3L>&2 M@ZJTK)CK?0$,$ 0C#['E!BJD=>9W&Z.O%Y>__>93=M1/[=K-G6F,SO.WF:OG MROEC)0/$0V*VG#!]'Z98)^M3=/%5 !_H8P3:#W1+*HD$8TN!^++'?T;9]Q*\ M/XE]#%X6@1!#A]ZQZ)']>)/5&F#T0$=$' M.2T_:?D#>.MS.=92Y0=\GU M.8_)B594_BMD+H#V6JK)T :G_:T8"B\HDSS;ETDNNTPRO2^3W)=)OH4+I$0U M- 91L:.5P4C#4+5CK&T 756D@D=[DM\!&"5E'*2SCB(M^L#OXL\>3Q\[?0 < U#@V;. M&'!C--9M:NS)P?$WL)OJ7>8]$%>QZZ2)1TAI2L*&@OR#31*,1$0+Y3.AP0#[ MC&A8S2/-G+C+;G%H."OQ@W9='I*,\,7L4RO>97VN6<,='ZGVZ6)!5#A ID.< MVO98L%%\&3A35,(O#!RV\/DMHD-MGVC$(B?$>AI G%]TAN,SXRX.M.3&+<0Q M\K)$.K,3[88^]QAZAN$.L*N8O4LX1K)W.-M]O&K')20Q93I557#DKG%A0W>% MO1$M"683X/ D+7/(!N@1*B,&:RR)$U(*$H41T!9^J,N"Y:S1" L<,#- JT\> M!R-OH5,4\6'FL2G@ZUK5J$H]*5IRE&69^A$L+X#&\R M/D24E<%GZ=>QUP6$HVTU3@U&E0.NL:CD,.,V]^3PX(4OC;3*433+%(&)8\W) MAEASY&-*7&#%ME^3* W+K][@P;IYRG[R,@&88JYQS&;6F3:,5=1FGBY"P%)^ M\_CZJ__STZ]G??,K]\J2S'PF,VWEWEYB9*N'7,;$U>$!E;1\6$,T M24>W STAK@JI%[BHL19D3$,=3[BX IY*1H"/@3=V]_7UH>L@T3]DU@\/0A2. M_*;RQ.T558S\KHVZS<%QP!N,!?QBKJ@$S-&T14+>CM@GP($U^5[?J5W>0<$, M$^])+25D0=J!2N85NZ8QVR^D"#V!J@S):3BTPD6-)\ZYD/,H"#4]X@R@$^V^ MWX$0#S.EB=V%\'Q P*]>L8SW=LCCULAK9V IE3$&YO'A M@:][#]B=#@@5^A#!=@8>\MW1-[)NA6WQ:;HTBB&F9!$P.H5HA010$.J\2ZY' MQ\),!HER$+V8Z;&QZ=X3PA1&8%!*DY0#)H+>8#*=/^3-A[F]NE."N*EL]R6P MC)!+]$>F)[C5^/B4;S5&3]5LSVK[?YI%:^F1\0]:4V\]=+#%$01)'/:CNLZ3PBXHQ]9O3)=RT:OR4)9C] .^[)- MA$ML\J1;4C;0, A0HG-)B&#-5^Q?UCTYE(MI#DS6(!,)@ZF<0L-,B"NX5'YY M[Q+9#427B#K.OJ^(-K(ON!@Z9Q[!G.=//0JZK;2X8TWB<1VH8E8/"2+R ,8P MA+;C$ H))AT&T*Y#S/&7)G9;I!\Z2>=,>R_[+YQ+D;?5=K%A,G2P:9EH[UHL ML"J@Q^!9F5;0-P7LUK#_R?HKVJKNT\*J#_E61+]4+=#/LJ,X#$7W(ZU4A-8/ M#@ = ;0K=L539 Y*(Q2NG=VN6GLZ^C6^/HHYC:'D6RMB&+)<=X$L3&7).A MY)B=*EC_>:N3=N!WT\\V.2NC%T-9';1=H1BMOP.3EP'PK(A-K]8 MR6X;=" SJDM:2.YHG&AB[+)_C4@=A0F:? *A@([XV#H36)1O U-5[G(*L,HGTAZ4;AU0B>QWCU@EQ(A:OK90,*;P\/ M!8$=":DW@ T!R0QDFMC:RQ<&!E$MS4C1FI"RZZTS!.O81UE&<<8 MEHM80Y[#>R)HT B1A'[J3CLJ_C.S=#))]Q8,@*T>5IZ!O%'*M3*GOZO-^A_]*"^@OZ+;=Z@A1P( &]\A=/SPIV:,:/! MRHMT W%">,:@5:2G]%9\ZCJLM9728-&Q(0LMCA6.69PN$9-M.P.7/O_O@-J? M;Z*C\/P0/?K=/41OR1"]S!ZBMX?HO87K@)6Y*&TXT2B/J_VF:EQU M3=<3=P%8C@"'@@\C% W@7H]$<,JKB7 HPPZ78">@E5++=62QLV2GQR_R7]&S $MGO(/PCOUNJ2"7[+N'>GJHE Y4C$2R!K"2WL-C6' M$;1FL/6\;Q^C%>#IA/&QC FNJ+./OM<7:)EHZ?[$[P1P7_"*.S:&374O[#GO MQ7$MUQWOWF&@WJ%" '<')(0&KL)+ 34]@583>X7$)3 P.!J/,[889KM-7.[WRMDXJLC O3R^7"W,HC # M@RB/X6PQ;^',KS[E42;8X!ORO?-C@29_J3$ZK5]F'._Z5_:^N6M)C5QC]+5_ M5\_>C?Y<77:./BK3W.4(TT&!-*8B._ :8Z'#H+T2J MUA0@2M:A?F!3/UZ[*-;/M6*]I-TY?7J.KIT3+5M()K3_-3^6332'!Z;71:OX M4GD.G#'LENT/ZP U\%O@WQQ_!0 39JP*HR M8YU#CT+Q:GJCHI/"X9 $FH#Q'@A#EM2&O \4H!#^LXC5!<]@0!"91S!MH35A M 95N7F!(X7 XS@/*N4(NB1%,DD7%"57#+?8<3( S$#[D2OPGQ&'TF@01JH:Z M/*C9><+=4#N5\))BR'&#/8&7GL\"G-R9BXFXQPK*6[@/MGK(D0@X2([3APTL MUN^U=#)U>IQ*);2*[@(XV,->T5X7=OX=.SOI?/)](J@D1Q\8)GOC^I#I>,+WL.9TL@S.^2 '<$XAPPTP!"070XIUF+' MQ(OL W0U1X(%!XR?>MOQ6 M(EX?QSV'3V(Z1?7A0!+H'C;IL96V-)QPEOH0^'CHI"Y@+D%3>P%X@=_"(_:' M>-7<%#QQ'2-Q7)Z>J"+69>-VA,\@?A.:_&J%ZU$V+53HX6(?L\,,$N$7R)G@D5N@8U&^+/__Y MP?980C"GNP;)!A&$V3.^V!C]*;NUD5%O=?X4=LT]2#=&OWXXA8)9]?]>6$Z2 M<(.4^0YC7I H"P=O"#/$#'''VHKC$R&(DSU-'J=Y( B&@W\H!:\"O5M#_ZC6 MYZ5^$,RY4VI[(P9QX*8%VC:LX9F%B^7KU$$":Q9G*?DJ<5WD'1*&'@:%[''E MQ=)[,K&C.WU,P W':%YX@0(OM#T.;0&2M(^-7=X4D8MBIX3PM<"OU![XM6S@ M5W8/_-H#OUY6>+QZHXFW,;IEQC0HNIF.L#2A9GZW,;I)]YK?"^54KKASOG". MCK[]IWYYWOL^&N:./O+9'AXH\UV1544_*O_?9@5PU;/8N=6JV8<'7W1[ -R! M6("0*C H2#@1D#U.GB4T\$33R0]< M\9LY884F<6,P+X(8RANP:KX6(!5(;"A!D*;J)W='D.#_+) MW'MF.MB:B>4!4= Y:)@* M=9?5) J"!)&LBQ)MQ$&. -9&_P6!9C4S M)G9%E&E]]B8Z7)_[IPK[ID!%\50]!T,'[3=K U>>8\V1##+8,X'^B7F%0:O/ MPX.@.(?G23W>>:H]P%P(<*T*EQ=+'9E3C'!I\79> MHWAQ4/L8?2]=CM#M L+O>L!IP83]%? R4#FZFQ :HB%D8=<\$X@^P:OB-H_6@U0NU]^2UH]PU1?I]4/U@ MV23"YA&L4)\J.:[!Z%LD2!<[V% +$!=>P*$9/S<_^8)0T'6HAL"6D(%)QXMH M@"XGN.D8T3>#[3.:;H'14$M7@LMCC K(0$A;2_3,"<;4)!&4E4?06(52%,?E M:@G23?+]]"Q;U'<-5%7T0OZ O. *@V<,+PIN&I5B:"(=NJZQ2K]>OTG(TE8Y M]/BI?C@\ ,YP-E".,182"Z*"5SLW9F'5PV/ODO'Q2YB:N"Q5(6=='-]EWZN: ME[D;X3V,5YAJ^84+F&J/J4"X+,&&;B)2>^SB2 27(U7NNH4X0=DQD'T:2M ! MH*U[V.16>>-[2/0QIK,8Y(8;TT&MEWQB M M,>MC"N>+8$\:6\9#Q\O\LB--E;%.70F\>F1Q]T7*ON[)[MN,BI.2/$W1*/ M\UIP40P*_F3>R:([9GN*OU]G5X=V0]T;[*< VK NA"_*H0S?$*(G;76E26^? M/R4A>A_A]0*(8F#],.FO0$,F>'TITLD"FADL;&9L]'73H$Z,8>HA7@,13QKS M6*'ULHG7-[;D92<*3Y]CJ50='@=+3CQ("84B >U5E_.&(=N>3+Z)@ZV 0:1C MHXQ,G$!M[ "&:1Q>?'(OXB)W3,H=_*4X2\PSYD9'.#T0HI4 I MDL$D"405O40F8&.-M*288;(WX!WGB6>#L1EQ3I!U<<14\J M&Y@FG5A3!'%X)P 2IQQ&@B*S1!!O#9?2BY=,-'$&P+_+UUV8 M.^/HFIT1-C@Y>RC@ZIBKW!Y]M4=?S3R@6SW8'52 ",V0 MB!:X=W5&Y$NZX"\^!BZB&Z"J6(V$B-YQPA!I!C@1(IRX(,?D""+U3UT2#7VH M@1P/ RGQ(<3Q 8OX56Q -PD.=&*2DLE.JZ@@IZNA"22@8 1? M<*N3)"I&A M]/0'_NL@$XE$6 PN@WR;K@3_3']EL)0Z=IP^]GS2/SQ@:\W;/_&*0D!&B.R M YPCK)*>;8#G4RW80W1UF^HJY\G[9Z=$<@=/$75RJIS,IZ7+IJNJ>9I@V2SN M\0NR!"G4S#G:K1FK;MT.C;P(B#@>,HGL J\H9QKKG?D>]4:0B\8:>7JD6T0D MUN*?@BJ'^E> ;. T&;JK5-:SQ!MHF(Z.A,M!W#>42V&:5%6%F$T6K%%,V_%& M/CS['.ZZ&Y?_2-")F>]#LLEJY0#? <5]NB6: ;<0<8=?8&NA)I Q"VY91";X MPAV$04.%%3$$[F+F* JXE6EB:%#B-R1(10V)R;7$GF^<\HE7.$([.7T8OF9" M0WD#A2+;/63 <,"%-51 "6$*C=B]E$6PB)E FE*&0Z/;F8@!8NF8Y"8LQB%8 M.8/\-G*LC[U$@2&)HP.F 7T.QES;6$)G<07&H('?N MCMO=V_DFV!&Z2\J62%5N,K@BOWNQ]6; HQBZ+";<-H*K!"+_%"P6Z$V+#@&@17B&+C($=O?R6MA1U5.3L#C*1"(DYUR5D$3OM%# M@$*58VH*.HAW#@:A0!T&O%N<5=$N 0:S&=%";$NW'(2BHDOXS^$!X"K!BJ83 MZ:M-CB38A#L$@GN-GW5._D)'@-XGT ,Y!4BU16 S#MI'26"SC82W4*W M!MB*L7O'Q%?U^#/%K-XSS0(8R"(U@2P+8-T,]\XL-C6?!/::,_#XNWW?-9L# M7^AE;T %C-7F<-2 3K='JC=%%@0*2.3_?AR*TC*R.ES:9BSG@<=XYB+BH.X;"*&D_&BA.) M#P=U/J'6Q!0MMKB^&)]:4)<9J25B]9BR8RH):Z3 ?Q6UI2%B)+YN7GP&'JX_&5.*G66DCP0+4@%8 MTWF2!B+C:^)].4*T3<&;Y$BPP"L$96*Q_=U2F^MM4+YD%5.490F35:>X/_=. M\[:-7!!FRO/#ZY,\+*JV.]:D36/F,2A5=\))Y_4J@?4T]7DGP*L4*G\1E5*! MDS%!>KA6Q,S>'#4R=#2"@#KF<:+PD(%6(28.%T4=T8U%+/JI\Z*?&WR:J..' MPA]9Q(\@5[P= C^'?B!\9;'1Z+ZB:/OQ(0S><;D)Q6F6H?C*)]J.@1/7B:C< MD24I#UP6YF4WG$/O8MZ.$$08FE^&^60&QND>Q>L56Y'INJ63 M,KZQ$[02VCR5PE-)@H:EV13$ !R9#C4\-FL6"U(8= V3OQ4]TL0Q 3&"J)-L M7L>JQ 'J"1:V86)O,Q0Y@'PE)ENLV.%9-#7 4=''JU8W3^%@ 6>O3T=D^^$@ MCZ GCX@Z)BLA,PRI8\*/H3[KT6/A3T;3"B41_#41URATDC1@D0XX7EG]9W"R MD!"5+VT+AT8'9D25"V/6"%GD3 ^,'5QDB*$+R;OB /(V54C2@S?TXI0:!-4B M#Q!G/7A!W&A]?D7Z *H)B8':(#QXM<.?(IIE2Q41H<]!I]UH!F";@,!@V]@T3 A MQM8(T@^7/0)03F,\<<;:(C7 ^Q.M%&[4&&D('C_5B3.4N0]C()V1B=.44>"9 M;GOX\MAN2W\78W,+4UQF]B#K98.L\WN0]1YD_88B'W3D"MLC7BJ2SZ=+;$1= MZBQ]R6NIF#D:$S/8Q;GOZ*[]P*HQT7Q%EMRR@'.X0EX6E0ED8_SF(?H -]CD MK0#4),"L'/!81B":W.4O!02F;&HM.+^T&"P1:=,?.3U15Q_ONXQ1-_R,\.^A M/W8XL8I4&K("F9I6=%4L1S=$;S+&L +40%A^R-ZN/+BW"&3&/*FZGC.IZ'S9GE&!%W M!)!XAW/V!B.9^?XPUGWL_:[*'L/9=SF)*'J\4%*.(5J^-,K.XAAQW1BO)P\F M\6QZ=.&50<#DW>.* M!8*5 HU%.$\W@ZUX7;,?9*[4 6)1YY#38M$/4'OS\("1#2*+#_\=F')4E#W9 MGB9DN._4QN^N[D&!<4WO0;G9)BL3)E_8BBUR[RHU&;' MSO@.:R?T3(><_1F-I::O!XE::2U PB!D9++ZA>#@BAR9RI$Z3M.'T#6&Y_9, MG]DN&+]1I0[RR-0B"QED,JG'Z\*5'($Z*E9S:?%<$J;$\//O/%;MJ;NV2C>S MXRIF=^6.CASSS3SAA$&4 )]M(J.OCH5X@8T#ND; )39NVHAUWX7%ECI]KB56 MCP- 5+P)B[XZVM4UT:^MCK=L'<=' /&"WL FV0=>UC?R8/VM8/U%-0Q:-[(. MA1.^<=@UL^N;S'WSPN"'"!G+B!AH?\,-+9+P\BEC=Q>RN*OT*$;<,QIZIP8/26_;/GU"R%I,1 )\Y93"25J@KFH[.3RVTK%(P#=,:UH MAI%N'!D?IM7DW351=SGAOR!7PHD6OT.!M1J4BEM Z/D4_@5;$<9.)_IXJ,_A M?E:HXCSLYV MZ'3LSC'2M<9M*?5'6>4%XG%J"@(F&N#55D%FRJ\MXR:.V9C$X'S"FN! MP;'9BX'LM<#+S IWE1GOE,+837_P)H#D500DCVFPRC/I]??A_@V9"W12P5 %548$H4N/+B:85P*Q/Q M+4>((E%0+/.^X$C 3P(XR_QCBZ4@YP->.@=P9-5]XS4CGPGR&9].>NGS.U6O17UW]-Y&ECI'!8Q!J7J9TT8IS&[>)/K@ML!\L'L066[ MRYC2V#"$9QY#[A)D"H62WRODG1"Q-SB!O:QM[5;]RQ0RKRM@"%K6VQ1P("9] M.35L??V9> 'I7$QW3/KI-R?8NR;';V&\>\'9T$;LE+Z;/]P AB:@5$VO93F\ M@9FLC!W807G')$.SK5*L"P(#:J6:'=/F;X*@ !L-:QL75Y-^$B_DO/9K)X.< M+RBZS.Z++I==='FZ+[K<%UV.K^+2JLY7U3-T/9WZN(0L%;O#Q\W_62YV9^>; M5\X>OG@/'"C;L:\'/?J0UL?_#?VG"-K8CN;&H&W.#OA =7U\SC?\>/1O/C4*VV"#\8-B,-8>L1S[8['Q MX6/]#O/QT6@%\ Z2RVMD3[9[ABH"-B/TJ$1Y.R_$PQ<;['ALBD]8![F/6ZCE$ M7!3BMM&?=)=WL0DU^(2*74&>II8$*UT_!AYKXHS/)"P/&70U!P20*#J4L%6Z M)]C0F+XSP*@JL15)%JNW)(,EO@_J)075C:"6A6;U@'1#^AO;H\J,H^SBVMJ< M:%5?TRW/@0)K: E-O/@WJ9PZ=FO@>F$45I3:=DK_G-"BC[,*L9=(VJZ8B3B\ MZP%@"8&DD/A([],Q'?F,F#-UX/RA.91.%=LG1HX7Y+YA^^2@C)CB?K(B>I1MD6C2N8Z+7F M*1TRD!8U3##"SZL7?[5YW*SP0 5.XP^-O$.HDO&/\F%S_P>!Q'+ M<$U;8F@0GSB1='Z'!T+[AM5,=+P(6R8V<:5=(YD,P\HL5H^=3* /E,]6*':, M,%G*,9*E(+TQ\JVHW5E< O:?V $D .1&J8+VEK"PN-V6Q4!H0,!7\$X87__F M,"H67@"JAT(%Q._C&F L5YC 2K, ":R7<'I1UA#TKX5*0;2D<%#4^Z2GQ;8) M(QNE0NAV%')K^+.PS'6$+F!5=3 7J \P6'D INM,)-KO[J^%S5T+/W07=<_^ M*GC9\#]0%=!ZZ+A4V V( CON/Z#J?+)4:GH;VZW:/'V-!UE TB4 E+40@@,- M+/% #@4[RBBFO3!Q-K9: @960WOB^XZL%@.7'F6/WD>HLM" -"/7$5-ISL!' MIQ!>(Y\ FH^YBD@.KUK)TL&"]%1_X+,0.[;]H1^'+:M :FO(8-[T0K6A8OZ [M7OQ[<:V?P<\@2HP!6PUX5-"C!&2.Q 6+^UK, M.L%1;&Y )AWY\N[> %,;EZP^!%RUZ3Z3._V9!63OZ//.+;KCD3AO6HGS3OI* M8U2J&I73VU&_;&9V.9A[VAC=_6W9^K.3SUP50(O"A \/[@#)3X\D(,W MV?P9$DTH9^Z(B-&/#1;L 38/P&+@X VS39_(_BRK0/AWP2=A-26QJR0[]IEJ M<^: "),5K7B@[N%UQ\"/+R.HQ-:Q>,32GSBVCB[$@%[U0[8(V 0 :>5;>.4' M?9$@0A3$=M$.4"Y'L^*$.A3.DR+)S:M+?MGQ6 MPP0RT'<\4Q@R:*C%'AH;&N&VV>D+OL%C");Y0-#OI\,'@T*V0_7HU)!ZE>J8 M/HCCLR[Z&J)UJ3^C! _HL6-M&Q+AX+]/6ET;L55P2?L!02T? :,&Y @LM&<8 MA3^GXX7.Z]#P 23__P'Q&')P\7YMTO,/SCC=+=_'=A^V^EMN=JU=FNE[=D?D M5M8S;NT&S$9,QXKN A&5=T-<3/U/MR#/%0MRQC<;HS^9YL\'XGVZO]%WV9"\ M:(R\Q^=/9X6>;MZUCCZ*>1\>T)EK./6].;GQX8OT'9B2Z7PRH=B28L,T9;\" MBQ(1K[K5&@"[(@\(0%RWA6:+85H#4-=$/.,=Q$+?@Z'"(KNX<' M$S\,=X]A<@Y*X*/ERIY_CC>*?R(0808_G+K; ,RS![VF8/-C[CP/T 1QF!.M M'!GIX<'8VWGH>S#6&6G*&X-84"B4T+<&GE*:S$Q-.@!DSW%\2)73R[,ELDUC MXQ44YDJ1\&/>=0MQF#'H M8807EIDTT!;[6*ZQ]#I@.W7A^XBQ*N*YLP=ZQ_71'6ML]@3AKO"-YX9&.Q_2B['GS>P$.#+"_U+Z,?8]L/G^>9ZD#W\VL* M=0('V1M!F6%$EXL[!G2Z-"B4N\;CH1EV3U!-$UP?&*#2E>U=]RT0)NY\4>U, M;E\[L^S:F<*^=F;W:F>V)X:R^A@$'6A10HIO7,>F/[98 ) %%:8')4Z5J_6E MCVJ,OMUD*M>?TGWSV^DN1RG2C=&#?O?UB]ZIG%FY(VCI1B=M#0\/JBPI'2P+ M:^+.D'\KBEMLIA7YCC2!WLG.U0!"^:+; ^B?&_1BORC6SP7JH5B_U[CQ)VH. M6I;N F"#)P! VPKTODA&(26BIV72]$N9= :-IT(JQPL2X)GJ0W1?K2OPNFCS MR,X93A/P!"R?I%8*H!O.7B&YH[4C- M P-!] =NWQ$Y-+7'M@H1T2TZ:T@],*\]BLACE)!T^L#K0PQ3]R&CP7M"R(?2 M$6(>(Q@F?]7A06BD2/TO4"$)SC5+#5663&$K.8RKX9!X(L?%^I*@!ASY+3DT MR!"!%/%UGHW$^IK# S87W#U(CV"Q.K=F?;&;AFFPEL(\&S07O2_?(,M!6,\Z M.M7S7YIT8O#(3/HDF>LOM\9R5?RH< .)NV@M:N%*I](Q4RED94CVEO!LKG8+ M$*%;@@VHWW'IR1;>_Z-=4&O1,@-G"!Y;"4@08Y]P>$ _>R'%YU8DJGF@5^@D MV6F<">XA'X>,T!M6IMQA(>'#&(:/HQ MT%]^R!),$KK$Z,"GU4X_;$P,K152:BSQC1A@]FU7+@IDUX$1FBX*^Y/9/CP0 M)[Q%_7Q@#\-H)=4:)UHQ=$[)E/4 6DADT7DDHMY#H;GM8V96+7$B0449;X$Y M[B^G3[20.$X$5 +"3ZH40!#;#IM=0(?&=8JMPAUEO5:@6406-P'I6,!+,OKO MOFBMR*"4T%6]#0R])Y$@P\X=TJ49'+&*,G9.R]82G.^;EW3(/Z72S>,T MH@5ZH+D(B_I0*XAA9_ =B--Q ,8#;1%6 MK!7C$D_E_ZE+F$VD3$BTD6SAXAG\(@:CA^H=2-A@(P)H'!RL1]0&D06$5'G[7(1'2:V VIB(*OX, 0WLP:2D@1GKK@ MXD,QC]8['>C.1-7_D^-:QA.]Z*#WE/M ?([F-:FI^JB;%EC)'^ATQN?#X"